Citrus Sinensis ID: 008644
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4J2 | 567 | Mitogen-activated protein | yes | no | 0.991 | 0.975 | 0.816 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | yes | no | 0.965 | 0.994 | 0.791 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | yes | no | 0.888 | 0.995 | 0.825 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.894 | 0.816 | 0.737 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.905 | 0.887 | 0.662 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.897 | 0.826 | 0.714 | 0.0 | |
| Q9LV37 | 510 | Mitogen-activated protein | no | no | 0.804 | 0.880 | 0.784 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.870 | 0.854 | 0.685 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.736 | 0.713 | 0.785 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | no | no | 0.788 | 0.758 | 0.752 | 0.0 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/572 (81%), Positives = 503/572 (87%), Gaps = 19/572 (3%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PLALRLLE+ML+FE
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPER-QHASLPRPCVLY 419
P+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPER QHASLPR CVLY
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SDKT----VQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ----AGAARPG 471
SD Q+SA VTD LSKCSI++ DR + +PM+R+PI VPQ A ARPG
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTIQGAAVARPG 480
Query: 472 KVVSSVLRYNNCGAAAAAEALD--QRRVVRNPAVSTQYAASSYPRRSSACKNERVNDE-- 527
KVV SVLRYNNCGAA EAL+ QRR+VRNPA AAS YP+R+ CK+ R +++
Sbjct: 481 KVVGSVLRYNNCGAATGVEALEQQQRRMVRNPA-----AASQYPKRTQPCKSNRGDEDCA 535
Query: 528 -SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 558
+ EG + L+P QYI +KV+AAQ + S WY
Sbjct: 536 TAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/548 (79%), Positives = 483/548 (88%), Gaps = 9/548 (1%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TG+KVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPSP
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
E I+R+RNEKARRYL+SMR+KKPIPF+QKFPNA+PLA+RLLERMLAF+PKDRP+AEEALA
Sbjct: 241 ETISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFK +A V+REPSAQP+TK+EFEFERRRITKED+RELIYREILEYHP+ML+EFLEG+E
Sbjct: 301 DPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
TGFMYPSAVDHFKKQFAYLEEHY KG+T APPERQH SLPRPCV+YSD Q++A+VT+
Sbjct: 361 STGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRPQSTASVTE 420
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVLRYNNCGAAAAAEAL 492
DLS+C I++ D S + +R +PQ AARPGK V SVLRY NC +AA +
Sbjct: 421 DLSRCLIRDNNLKSQDSAS-VGASR----IPQGAAARPGKAVGSVLRYGNCSTSAAEQQY 475
Query: 493 DQRRVVRNPAVSTQYA---ASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAA 549
+QRRVVRNPA++ + SSYPRR+ CK+E + E ++ S PKP Y+A K+ A
Sbjct: 476 EQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGDVERIDSSQTGPPKP-YVANKLPAT 534
Query: 550 QGGSGSNW 557
G +W
Sbjct: 535 VDGRSGHW 542
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 865 bits (2234), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/503 (82%), Positives = 450/503 (89%), Gaps = 7/503 (1%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TGEKVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
EAI+R+RNEKARRYLSSMR+KKPIPF+QKFPNA+PLALRLLERML+FEPKDRP AEEALA
Sbjct: 241 EAISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYF+ +A V+REPSAQPVTK+EFEFERRRITKED+RELIYR+ILEYHP ML+E+LEG+E
Sbjct: 301 DPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
GFMYPSAVDHFKKQFAYLEEHY KG+T APPERQH SLPRP VLYSD QN+A + +
Sbjct: 361 SAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAE 420
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVLRYNNCGAAAAAEAL 492
DLSKC + + + ++ + R VPQ GAARPGKVV S LRY NC + + AE
Sbjct: 421 DLSKCVLGDNTQKMHQGSASVCANR----VPQGGAARPGKVVGSALRYGNC-STSTAEQY 475
Query: 493 DQRRVVRNPAVSTQYAA--SSYP 513
+ RR RNPA++T + SYP
Sbjct: 476 EHRRTDRNPALATNTVSPRGSYP 498
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/510 (73%), Positives = 426/510 (83%), Gaps = 11/510 (2%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ DQRKKSS + DFFTEYG+ SRYKI+EVIGKGSYGVVCSA D TGEKVAIKKI+DIF
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILAN++CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRN+KARRYLSSMRKK+PI FSQKFP+A+PLAL LL+++LAF+
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAKVEREPS QP+TKMEFEFERRR+TKED+RELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ G+E T F+YPSAVD F+KQFA+LEE+ G G V P +R+H SLPR +++S
Sbjct: 361 PQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEENGGNG-PVIPMDRKHTSLPRSTIVHS 419
Query: 421 DKT-VQNSAAVTDDLSKCSIKEVEKP-PMDRTSGIP--MARLPIQVPQAGAARPGKVVSS 476
+ + K S + P DR SG ++ P +VP ARPG+VV
Sbjct: 420 TPIPAKEQPRIGPSRDKPSDEPYSNPREFDRFSGNAPRTSQAPQRVP---TARPGRVVGP 476
Query: 477 VLRYNNCGAAAAAEALDQRRVVRNPAVSTQ 506
VL Y N A ++ D RR+ N Q
Sbjct: 477 VLPYEN---GATKDSYDARRLAMNSGYPPQ 503
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/539 (66%), Positives = 429/539 (79%), Gaps = 34/539 (6%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ +RYKI+EVIGKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ + R+RNEKARRYLSSMRKK+P+PFS++FP A+P AL+LL+R+LAF+PKDRPTAEEALA
Sbjct: 241 DTVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFKGLAK EREPS QP+TKMEFEFERR++TKEDV+ELI+REILEYHPQ+LK+++ G+E
Sbjct: 301 DPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
T F+YPSA+D+F++QFA LEE+ GK P +R+H SLPR T +SA +
Sbjct: 361 KTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPR-------TTTVHSAPI-- 411
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVLRYNNCGAAAAAEAL 492
PP D + + QVPQ R G+ V+ + N A
Sbjct: 412 ------------PPKDHQN------ITSQVPQRIPGRTGRGACPVIPFENLSAMG---PY 450
Query: 493 DQRRVVRNPAV---STQYAASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAA 548
+QRRVVRNP + +T +A +Y R+S + + E + E + QP ++ KV +
Sbjct: 451 NQRRVVRNPVLPPATTNLSAYAYHRKSDSSERE-LQQELEKDRMRYQPSEHFMDAKVVS 508
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/514 (71%), Positives = 423/514 (82%), Gaps = 13/514 (2%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL+L+LLER+LAF+
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+RELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+HASLPR V++
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIH- 419
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ--AGAARPGKVVSSVL 478
S AV + + T IP IQ Q AA+P + V
Sbjct: 420 ------STAVARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVA 473
Query: 479 RYNNCGAAAAAEALDQRRVVR--NPAVSTQYAAS 510
++N + +A D R +R N S Q AA+
Sbjct: 474 PFDN--GRISRDAYDPRSFIRSTNLPFSQQSAAT 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/450 (78%), Positives = 395/450 (87%), Gaps = 1/450 (0%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDATRILREIKLLRLLRHPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PLALRLL R+LAF+PKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
RP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDVRELIYREILEYHPQM
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKT 423
L+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQHASLPR V K
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKE 421
Query: 424 VQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 452
+ ++ S S + +E PP + G
Sbjct: 422 NGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 716 bits (1849), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/519 (68%), Positives = 423/519 (81%), Gaps = 33/519 (6%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ SRYKI+E++GKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+AI+R+RN+KARRYLSSMR+K+P+PFS+KFPN +PLAL+LL+R+LAF+PKDRPTAEEALA
Sbjct: 241 DAISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DPYFKGLAKVEREPS QP++KMEFEFERR++TK+D++ELI+REILEYHPQ+LK+++ GSE
Sbjct: 301 DPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSE 360
Query: 373 PTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTD 432
T F+YPSAVD+F++QFA LEE+ GK + +R+H SLPR ++S N
Sbjct: 361 NTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNEG---- 413
Query: 433 DLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVLRYNNCGAAAAAEAL 492
+D TS + R+P ARPG+ V VL + N GAA A
Sbjct: 414 --------------LDATSQV-TQRIP-------TARPGRTVGPVLPFENPGAADPHSA- 450
Query: 493 DQRRVVRNPAVSTQYA-ASSYPRRSSACKNERVNDESVE 530
RRVVRNP V A S Y + ++R + E +E
Sbjct: 451 --RRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEELE 487
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 711 bits (1834), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/411 (78%), Positives = 371/411 (90%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
TRILREIKLLRLL HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P ALRLLER++AF+PKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKE 366
AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+RELIYREILEYHPQML+E
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 FLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCV 417
+L G FMYPS VD F++QFA+LEE+ G G +RQHASLPR V
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERV 482
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/449 (75%), Positives = 392/449 (87%), Gaps = 9/449 (2%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
+ KK++ +++FFTEYGE S+Y+I+EVIGKGSYGVV +A DTRTGE+VAIKKIND+FEHV
Sbjct: 66 ESHKKNTVEMEFFTEYGEASQYQIQEVIGKGSYGVVAAAVDTRTGERVAIKKINDVFEHV 125
Query: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDATRILREIKLLRLLRHPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVI+ANDDL
Sbjct: 126 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFQDIYVVFELMESDLHQVIRANDDL 185
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLR LKYIH ANVFHRDLKPKNILAN+DCKLKICDFGLAR +FND P+A
Sbjct: 186 TPEHYQFFLYQLLRALKYIHAANVFHRDLKPKNILANSDCKLKICDFGLARASFNDAPSA 245
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG+PLFPGKNVVHQLDI+
Sbjct: 246 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGKNVVHQLDII 305
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TDLLGTPS E ++R+RNEKARRYLS+MRKK +PFSQKF N +PLALRLLER+LAF+PKD
Sbjct: 306 TDLLGTPSSETLSRIRNEKARRYLSTMRKKHAVPFSQKFRNTDPLALRLLERLLAFDPKD 365
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
R +AEEALADPYF LA VEREPS P++K+EFEFERR++TK+DVRELIYREILEYHPQM
Sbjct: 366 RSSAEEALADPYFASLANVEREPSRHPISKLEFEFERRKLTKDDVRELIYREILEYHPQM 425
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCV-----L 418
L+E+++G E F+YPS VD FK+QFA+LEE+Y KG +P +R+HASLPR V
Sbjct: 426 LQEYMKGGEQISFLYPSGVDRFKRQFAHLEENYSKGERGSPLQRKHASLPRERVGVSKDG 485
Query: 419 YSDKTVQNSAAVTDDLSKCSIKEVEKPPM 447
Y+ + + D +++ ++ PPM
Sbjct: 486 YNQQNTNDQERSADSVARTTV----SPPM 510
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| 224107249 | 562 | predicted protein [Populus trichocarpa] | 0.998 | 0.991 | 0.912 | 0.0 | |
| 224102587 | 562 | predicted protein [Populus trichocarpa] | 0.998 | 0.991 | 0.909 | 0.0 | |
| 255551501 | 564 | big map kinase/bmk, putative [Ricinus co | 1.0 | 0.989 | 0.904 | 0.0 | |
| 359477479 | 563 | PREDICTED: mitogen-activated protein kin | 1.0 | 0.991 | 0.902 | 0.0 | |
| 356549019 | 563 | PREDICTED: mitogen-activated protein kin | 0.998 | 0.989 | 0.890 | 0.0 | |
| 449454432 | 565 | PREDICTED: mitogen-activated protein kin | 0.998 | 0.985 | 0.886 | 0.0 | |
| 449523117 | 565 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.998 | 0.985 | 0.885 | 0.0 | |
| 356555610 | 561 | PREDICTED: mitogen-activated protein kin | 0.994 | 0.989 | 0.884 | 0.0 | |
| 297748113 | 554 | mitogen-activated protein kinase 16 [Gos | 0.985 | 0.992 | 0.880 | 0.0 | |
| 357447643 | 564 | Mitogen activated protein kinase 16-2 [M | 0.998 | 0.987 | 0.892 | 0.0 |
| >gi|224107249|ref|XP_002314421.1| predicted protein [Populus trichocarpa] gi|222863461|gb|EEF00592.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/563 (91%), Positives = 535/563 (95%), Gaps = 6/563 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS D+DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDIDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QAGAARPGKVVSSV 477
D T+Q SA VT+DLSKCSIKE+EKP +DR+ G+PM RLP+QVP QAGAAR GKV SSV
Sbjct: 421 DNTIQKSAEVTNDLSKCSIKEIEKPHVDRSDGMPMTRLPLQVPQSIQAGAARSGKVASSV 480
Query: 478 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGL 535
LRYNNCG AAAAE LDQ+R+VRNPA+STQYA + SYPRR+ ACKNER DE VEG NGL
Sbjct: 481 LRYNNCG-AAAAENLDQQRMVRNPAISTQYATANCSYPRRNPACKNERGEDEGVEGPNGL 539
Query: 536 QPKPQYIARKVAAAQGGSGSNWY 558
QPKPQY+ARKVAAAQGG G++WY
Sbjct: 540 QPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102587|ref|XP_002312737.1| predicted protein [Populus trichocarpa] gi|222852557|gb|EEE90104.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/563 (90%), Positives = 535/563 (95%), Gaps = 6/563 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF+ELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFSELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTP+PEAIARVRNEKARRYLSSMRKKKP+PFSQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPTPEAIARVRNEKARRYLSSMRKKKPVPFSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE L+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G V PPERQHASLPR CVLYS
Sbjct: 361 PKMLKEHLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVTPPERQHASLPRACVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QAGAARPGKVVSSV 477
D T+QNSA VT+DLSKCSIKE+EKP +DR+ GIPM RLP+QVP QAGAARPGKVVSSV
Sbjct: 421 DNTIQNSAEVTNDLSKCSIKEIEKPHVDRSGGIPMTRLPLQVPQSIQAGAARPGKVVSSV 480
Query: 478 LRYNNCGAAAAAEALDQRRVVRNPAVSTQY--AASSYPRRSSACKNERVNDESVEGSNGL 535
LRYNNCG A +AE LDQRR+VRNPA+STQY A SS+PRR+ ACKNER DE VEGSNGL
Sbjct: 481 LRYNNCG-APSAENLDQRRMVRNPAISTQYTTANSSHPRRNPACKNERGEDEGVEGSNGL 539
Query: 536 QPKPQYIARKVAAAQGGSGSNWY 558
QPKPQY+ARKVAAAQGG G++WY
Sbjct: 540 QPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551501|ref|XP_002516796.1| big map kinase/bmk, putative [Ricinus communis] gi|223543884|gb|EEF45410.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/564 (90%), Positives = 532/564 (94%), Gaps = 6/564 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PLAL LLERMLAFE
Sbjct: 241 DLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPLALHLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PK+RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKNRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEGSEPT FMYPSAVDHFKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGSEPTSFMYPSAVDHFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QAGAARPGKVVSSV 477
D TVQ+SA V +DLSKCSIKE+EKP +DR+ GIPM RLP+QVP QA AARPGKVV SV
Sbjct: 421 DNTVQSSAEVANDLSKCSIKEMEKPQVDRSGGIPMTRLPLQVPQSIQASAARPGKVVGSV 480
Query: 478 LRYNNCGAAAAA-EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNG 534
LRYNNCGA A EAL+QRR+VRNPA+STQY A+ SYPRR+ CKNER DE VEGS G
Sbjct: 481 LRYNNCGATATTVEALEQRRMVRNPAISTQYTAANCSYPRRNPVCKNERGEDEGVEGSGG 540
Query: 535 LQPKPQYIARKVAAAQGGSGSNWY 558
LQPKPQY+ARKVAAAQGG G++WY
Sbjct: 541 LQPKPQYMARKVAAAQGGPGNHWY 564
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477479|ref|XP_002279719.2| PREDICTED: mitogen-activated protein kinase 16-like [Vitis vinifera] gi|297736969|emb|CBI26170.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/563 (90%), Positives = 535/563 (95%), Gaps = 5/563 (0%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+K+S +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRRKASVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHCGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSSREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP SQKFPNA+PLALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSQKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRP+AEEALADPYFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVR+LIYREILEYH
Sbjct: 301 PKDRPSAEEALADPYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRDLIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEG+EPT FMYPSAVD FKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGTEPTSFMYPSAVDQFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQA---GAARPGKVVSSV 477
D ++ NSA V DDLSKC IKEVEKP MDR+ GIPMARLP+QVPQ+ GAARPGKVV SV
Sbjct: 421 DNSLHNSAEVADDLSKCCIKEVEKPHMDRSCGIPMARLPLQVPQSTQGGAARPGKVVGSV 480
Query: 478 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGL 535
LRYNNCGAAAAAE L+QRR+VRNP V++QY AS SYPRR+S+CKNER ++E VEGSNGL
Sbjct: 481 LRYNNCGAAAAAEVLEQRRMVRNPPVASQYNASSCSYPRRNSSCKNERGDNEGVEGSNGL 540
Query: 536 QPKPQYIARKVAAAQGGSGSNWY 558
QPKPQY+ARKVAAAQGGSGS+WY
Sbjct: 541 QPKPQYMARKVAAAQGGSGSHWY 563
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549019|ref|XP_003542896.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1039 bits (2686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/564 (89%), Positives = 526/564 (93%), Gaps = 7/564 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+P SQKFPNA+PLALRLLE+MLAFE
Sbjct: 241 DLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPLSQKFPNADPLALRLLEKMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKG TV PPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVTPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QAGAARPGKVVSSV 477
D ++QN++ V DDLSKC IKEVEK P+D +S IPM+RLP+Q P Q AARPGKVV SV
Sbjct: 421 DHSMQNTSEVADDLSKCCIKEVEKQPIDSSSAIPMSRLPLQAPQNIQGVAARPGKVVGSV 480
Query: 478 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDE-SVEGSNG 534
+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+S K+ER +E +EGSNG
Sbjct: 481 MRYNNCGVAGTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNSGYKSERGTEEGGIEGSNG 539
Query: 535 LQPKPQYIARKVAAAQGGSGSNWY 558
LQPKPQY+ARKVAAAQ G G WY
Sbjct: 540 LQPKPQYMARKVAAAQAGPGGQWY 563
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454432|ref|XP_004144959.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] gi|449471012|ref|XP_004153181.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/566 (88%), Positives = 531/566 (93%), Gaps = 9/566 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFE
Sbjct: 241 DLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQA---GAARPGKVVSSV 477
D VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ+ ARPGKVV SV
Sbjct: 421 DNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSV 480
Query: 478 LRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGS 532
LRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG
Sbjct: 481 LRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGP 539
Query: 533 NGLQPKPQYIARKVAAAQGGSGSNWY 558
NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 540 NGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523117|ref|XP_004168571.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1029 bits (2660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/566 (88%), Positives = 530/566 (93%), Gaps = 9/566 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP NILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPXNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFE
Sbjct: 241 DLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQA---GAARPGKVVSSV 477
D VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ+ ARPGKVV SV
Sbjct: 421 DNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSV 480
Query: 478 LRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGS 532
LRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG
Sbjct: 481 LRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGP 539
Query: 533 NGLQPKPQYIARKVAAAQGGSGSNWY 558
NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 540 NGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555610|ref|XP_003546123.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1024 bits (2647), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/564 (88%), Positives = 523/564 (92%), Gaps = 9/564 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+P ALRLLERMLAFE
Sbjct: 241 DLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPRALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRETLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKEFLEG+EPTGFMYPSAVDHFKKQFAYLEEHYGKG TVAPPERQHASLPRPCVLYS
Sbjct: 361 PKMLKEFLEGAEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVAPPERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QAGAARPGKVVSSV 477
D ++QN++ V DDLSKC IKEVEK P++R+S IPM+RLP+Q P Q AARP KVV SV
Sbjct: 421 DHSMQNTSEVADDLSKCCIKEVEKQPIERSSAIPMSRLPLQAPQNIQGVAARPRKVVGSV 480
Query: 478 LRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER-VNDESVEGSNG 534
+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+ KNER D+ +EGSNG
Sbjct: 481 MRYNNCGVAVTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNPGYKNERGAEDDGIEGSNG 539
Query: 535 LQPKPQYIARKVAAAQGGSGSNWY 558
LQPK Y+ARKVAAAQ G G WY
Sbjct: 540 LQPK--YMARKVAAAQAGPGGQWY 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297748113|gb|ADI52623.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] gi|297748125|gb|ADI52629.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/562 (88%), Positives = 520/562 (92%), Gaps = 12/562 (2%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KS+ADVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDQRRKSAADVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHIL PPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILFPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP S KFPNA+PLA+ LLERMLAFE
Sbjct: 241 DLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSHKFPNADPLAVLLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRP+AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 PKDRPSAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
P+MLKE+LEGSEPTGFMYPSAVDHFKKQFA+LEEHYG GTT AP ERQHASLPRPCVLYS
Sbjct: 361 PKMLKEYLEGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGTTAAPLERQHASLPRPCVLYS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQA--GAARPGKVVSSVL 478
D +VQNS VTD+LSKCSIKE EKP +R+ IPM+RLP QVPQ+ GAARPGKVV SVL
Sbjct: 421 DNSVQNSTDVTDNLSKCSIKETEKPQPERSFPIPMSRLPPQVPQSIQGAARPGKVVGSVL 480
Query: 479 RYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQ 536
RYNNCGA AA EAL+QRR+ RNP+V TQY A+ SYPRR+ CK++ N+ LQ
Sbjct: 481 RYNNCGAVAAGEALEQRRMARNPSVPTQYTATNCSYPRRNPVCKDDEENE--------LQ 532
Query: 537 PKPQYIARKVAAAQGGSGSNWY 558
PKPQY+ARKVAAAQGGS S WY
Sbjct: 533 PKPQYMARKVAAAQGGSRSQWY 554
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447643|ref|XP_003594097.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] gi|355483145|gb|AES64348.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1014 bits (2623), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/565 (89%), Positives = 524/565 (92%), Gaps = 8/565 (1%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M DQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MSHDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
DIMTD LGTPSP+AIARVRNEKARRYLSSMRKKKP+PFS KFPNA+PLALRLLERMLAFE
Sbjct: 241 DIMTDFLGTPSPDAIARVRNEKARRYLSSMRKKKPVPFSHKFPNADPLALRLLERMLAFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH
Sbjct: 301 AKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHA-SLPRPCVLY 419
P+MLKEFLEG+EPTGFMYPSAVD FKKQFAYLEEHYGKG TVAPPERQHA SLPR CVLY
Sbjct: 361 PKMLKEFLEGAEPTGFMYPSAVDLFKKQFAYLEEHYGKGGTVAPPERQHASSLPRACVLY 420
Query: 420 SDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGI-PMARLPIQVP---QAGAARPGKVVS 475
SD T+QN+A V DDLSKC IKEVE+PP+DR+S I PM R+P+Q P Q AARPGKVV
Sbjct: 421 SDNTMQNTAEVADDLSKCCIKEVERPPVDRSSDIHPMTRIPLQAPQNMQGLAARPGKVVG 480
Query: 476 SVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSN 533
S +RYNNCG A AE +QRRVVRNP VS+QYAAS SYPRR+ K+ERV D+ +EGSN
Sbjct: 481 SAMRYNNCGVAVTAET-EQRRVVRNPPVSSQYAASSCSYPRRNPNYKSERVEDDVIEGSN 539
Query: 534 GLQPKPQYIARKVAAAQGGSGSNWY 558
GLQPKPQYIARKVAAAQGG+G WY
Sbjct: 540 GLQPKPQYIARKVAAAQGGAGGQWY 564
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 558 | ||||||
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.989 | 0.973 | 0.780 | 2.7e-235 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.851 | 0.783 | 0.714 | 4e-188 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.804 | 0.880 | 0.755 | 2.4e-186 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.971 | 0.906 | 0.634 | 2.6e-182 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.860 | 0.780 | 0.672 | 4.5e-178 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.750 | 0.727 | 0.747 | 6.5e-177 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.801 | 0.758 | 0.709 | 8.3e-177 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.822 | 0.944 | 0.637 | 1.3e-162 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.594 | 0.627 | 0.507 | 5.9e-89 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.582 | 0.864 | 0.481 | 1.8e-85 |
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2269 (803.8 bits), Expect = 2.7e-235, P = 2.7e-235
Identities = 447/573 (78%), Positives = 484/573 (84%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDAT HPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PLALRLLE+ML+FE
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDVRELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ-HASLPRPCVLY 419
P+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPERQ HASLPR CVLY
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SDKT----VQNSAAVTDDLSKCSIKEVEKPP-MDRTSGIPMARLPIQVPQ----AGAARP 470
SD Q+SA VTD LSKCSI++ E+P DR + +PM+R+PI VPQ A ARP
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRD-ERPRGADRNAQMPMSRIPINVPQTIQGAAVARP 479
Query: 471 GKVVSSVLRYNNCGXXXXXXXLDQ--RRVVRNPAVSTQXXXXXXXXXXXXCKNERVNDE- 527
GKVV SVLRYNNCG L+Q RR+VRNPA ++Q CK+ R +++
Sbjct: 480 GKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQP-----CKSNRGDEDC 534
Query: 528 --SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 558
+ EG + L+P QYI +KV+AAQ + S WY
Sbjct: 535 ATAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1808 (641.5 bits), Expect = 4.0e-188, Sum P(2) = 4.0e-188
Identities = 346/484 (71%), Positives = 398/484 (82%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL+L+LLER+LAF+
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+RELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+HASLPR V++S
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAG--AARPGKVVSSVL 478
+A K P + T IP IQ Q AA+P + V
Sbjct: 421 ------TAVARGGQPKLMNNTNTLNP-ETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVA 473
Query: 479 RYNN 482
++N
Sbjct: 474 PFDN 477
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1807 (641.2 bits), Expect = 2.4e-186, P = 2.4e-186
Identities = 340/450 (75%), Positives = 382/450 (84%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PLALRLL R+LAF+PKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
RP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDVRELIYREILEYHPQM
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKT 423
L+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQHASLPR V K
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKE 421
Query: 424 VQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 452
+ ++ S S + +E PP + G
Sbjct: 422 NGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1769 (627.8 bits), Expect = 2.6e-182, P = 2.6e-182
Identities = 351/553 (63%), Positives = 415/553 (75%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ Q KK+ +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT+TGEKVAIKKIND+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
D++TDLLGTP E IA VRNEKAR+YL+ MRKK +PFSQKFPNA+PLALRLL+R+LAF+
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPTA EALADPYFK LAKVEREPS QP++KMEFEFERRR+TK+D+RELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ SE + F+YPSA+ H +KQFAYLEE+ GK V PP+R+HASLPR V S
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAVHSS 419
Query: 421 --DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVL 478
+ Q S +D + SI+ + TS L P+ + +PG+VV S +
Sbjct: 420 AVNSNAQPSLNASDS-RRVSIEPSRNGVVPSTSAYSTKPLG-PPPRVPSGKPGRVVESSV 477
Query: 479 RYNNCGXXXXXXXLDQRRVVRNPAVSTQXXXXXXXXXXXXCKNERVNDESVEGSNGL-QP 537
Y N D R ST N +N E G+ QP
Sbjct: 478 TYEN-DRNLKESSYDARTSYYR---STVLPPQTVSPNCYFLPNT-MNQEKRSGTEAASQP 532
Query: 538 KPQYIARKVAAAQ 550
KPQ++ + +A+
Sbjct: 533 KPQFVPTQCNSAK 545
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1729 (613.7 bits), Expect = 4.5e-178, P = 4.5e-178
Identities = 329/489 (67%), Positives = 394/489 (80%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ +Q KK + +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT TGEKVAIKKIND+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
+++TDLLGTP E I+ VRN+KAR+YL+ MRKK P+ FSQKF A+PLALRLL+R+LAF+
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
PKDRPT EALADPYFKGL+K+EREPS+Q ++KMEFEFERRR+TK+D+RELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 420
PQ+LK+++ GSE + F+YPSA+ H ++QF YLEE+ + V P ER+HASLPR V +
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTVHST 420
Query: 421 --DKTVQNSAAVTDD--LS-KCSIKEVEKPPMDRTSGIPMARL--PIQVPQAGAARPGKV 473
T Q + TD +S + S TS P + P +VP +G RPG+V
Sbjct: 421 VVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSG--RPGRV 478
Query: 474 VSSVLRYNN 482
V S + Y N
Sbjct: 479 VESSVSYEN 487
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1718 (609.8 bits), Expect = 6.5e-177, P = 6.5e-177
Identities = 314/420 (74%), Positives = 365/420 (86%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
T HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P ALRLLER++AF+PKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKE 366
AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+RELIYREILEYHPQML+E
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 FLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS-DKTVQ 425
+L G FMYPS VD F++QFA+LEE+ G G +RQHASLPR V S ++TV+
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVE 491
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1717 (609.5 bits), Expect = 8.3e-177, P = 8.3e-177
Identities = 323/455 (70%), Positives = 372/455 (81%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA D+ TGE+VAIKKIND+FEHV
Sbjct: 85 DPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHV 142
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPD+VEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 143 SDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 202
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTA
Sbjct: 203 TPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTA 262
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLD+M
Sbjct: 263 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLM 322
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
TD LGTP PE+I+R+RNEKARRYLSSMRKK+P+PFS KFP A+PLALRLLER+LAF+PKD
Sbjct: 323 TDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKD 382
Query: 304 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
R +AE+ALADPYF GL+ EREP+ QP++K+EF+FER+++ K+DVRELIYREILEYHPQM
Sbjct: 383 RASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYHPQM 442
Query: 364 LKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGK-----GTTVAPPERQHASLPRPCV- 417
L+E+L G + FMYPS VD FK+QFA+LEE+ GK G R HASLPR V
Sbjct: 443 LEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRERVP 502
Query: 418 LYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSG 452
+ +T + S+ V + +E D G
Sbjct: 503 APNGETAEESSDVERRAAAAVASTLESEEADNGGG 537
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1583 (562.3 bits), Expect = 1.3e-162, P = 1.3e-162
Identities = 301/472 (63%), Positives = 379/472 (80%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXX 73
+FFTEYGE S+Y+I+EV+GKGSYGVV SA TG KVAIKK+ ++FEHVSDA
Sbjct: 5 EFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILREI 64
Query: 74 XXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
HPDIVEIKHI+LPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QFFLY
Sbjct: 65 KLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFFLY 124
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARV+F D+P+A+FWTDYVATR
Sbjct: 125 QLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVATR 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
WYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+++TDLLGTPSP
Sbjct: 185 WYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPSPI 244
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
++R+RNEKAR+YL +MR+K P+PF+ KFPN +P+AL+LL+R++AF+PKDRP+AEEALAD
Sbjct: 245 TLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEALAD 304
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEP 373
PYF+GLA V+ EPS QP++K+EFEFERR++T++DVREL+YREILEYHPQML+E+L+G E
Sbjct: 305 PYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGEEN 364
Query: 374 TG--FMYPSAVDHFKKQFAYLEEHYG-KGTTVAPP-ERQHASLPRPCVLYSDKTVQNSAA 429
F+YPS VD FK++FA LEEH + +PP +R++ SLPR V S+ + S +
Sbjct: 365 INSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSSED--EGSDS 422
Query: 430 VTDDLSKCSIKEVEKPPM--DRTSGIPMARLPIQVPQAGAARPGKVVSSVLR 479
V S S+ V PP + +G+ + QV +A A P K + ++R
Sbjct: 423 VHAQSSSASV--VFTPPQTPNTATGLSSQKAS-QVDKA--ATPVKRSACLMR 469
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
Identities = 173/341 (50%), Positives = 234/341 (68%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPD 83
RY I + IG G+YGVVCSA D TGEKVAIKKI+ F+++ D H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
++ IK IL P S+ +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+LRGLK+IH
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N DC LKICD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ +KYT AIDIWS+GCIFAELL KPLF GK+ +HQ+ ++ + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
R+++ +M + + F+ FP ANP A+ LLERML F+P R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSL---- 440
Query: 324 REPSAQPVT--KMEFEFERRRITKEDVRELIYREILEYHPQ 362
+PS +P+ K FE + ++ ++ELIY E+L YHP+
Sbjct: 441 HDPSDEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 1.8e-85, P = 1.8e-85
Identities = 160/332 (48%), Positives = 232/332 (69%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPDIVEIKHI 90
IG+G+YG+VC+A ++ TGE+VAIKKI + F+++ DA H +++ +K I
Sbjct: 49 IGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDI 108
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
+ PP R F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQLLRGLKY+H+ANV HR
Sbjct: 109 IKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHR 168
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
DLKP N+L NA+C LK+ DFGLAR ++T F T+YV TRWYRAPEL + S+YT
Sbjct: 169 DLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SEYTA 223
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
AIDIWS+GCI E +T +PLFPGK+ VHQL ++T+L+G+P ++ +R++ ARRY+ +
Sbjct: 224 AIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQL 283
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
+ F+ +FPN + A+ LLE+ML F+P R T +EAL PY L + EP
Sbjct: 284 PQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC-- 341
Query: 331 VTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
V F+FE+ +T+E+++ELIYRE ++++PQ
Sbjct: 342 VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7844 | 0.8046 | 0.8803 | no | no |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8250 | 0.8888 | 0.9959 | yes | no |
| Q8W4J2 | MPK16_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8164 | 0.9910 | 0.9753 | yes | no |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7372 | 0.8942 | 0.8166 | no | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7668 | 0.7437 | 0.8201 | N/A | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7140 | 0.8978 | 0.8267 | no | no |
| Q75KK8 | MPK14_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7919 | 0.9659 | 0.9944 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.994 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_X4145 | hypothetical protein (562 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 558 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-164 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-150 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-145 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-127 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-124 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-123 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-110 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-110 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-100 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-98 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-96 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-93 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-93 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-92 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-92 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-90 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-89 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-88 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-85 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-81 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-80 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-76 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-74 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-71 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-71 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-71 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-71 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-69 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-68 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-68 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-67 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-67 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-66 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-64 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-63 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-62 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-61 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-61 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-60 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-59 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-54 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-54 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-52 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-46 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-42 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-40 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 750 bits (1939), Expect = 0.0
Identities = 318/338 (94%), Positives = 334/338 (98%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI+EVIGKGSYGVVCSA DT TGEKVAIKKIND+FEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSPE I+RVRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
RRYLSSMRKK+P+PFSQKFPNA+PLALRLLER+LAF+PKDRPTAEEALADPYFKGLAKVE
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
REPSAQP+TK+EFEFERRR+TKEDVRELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 549 bits (1418), Expect = 0.0
Identities = 193/332 (58%), Positives = 247/332 (74%), Gaps = 2/332 (0%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY++ + IG G+YGVVCSA D RTG KVAIKKI+++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
I+ + IL PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
S+YT AIDIWS+GCIFAELLT KPLFPG++ + QL+++ ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
R YL S+ KK P S+ FP A+P A+ LLE+ML F+PK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
EP A+P +F F+ +T+E+++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 470 bits (1211), Expect = e-164
Identities = 191/339 (56%), Positives = 248/339 (73%), Gaps = 6/339 (1%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+++ IK I+ PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ S+YT AID+WS+GCIFAELL KPLFPGK+ VHQL ++T+LLG+PS E + +RNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
ARRY+ S+ F++ FP+ANPLA+ LLE+ML F+P R T EEALA PY L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
EP Q T F+FE +T+ED++ELIY E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 432 bits (1114), Expect = e-150
Identities = 174/341 (51%), Positives = 237/341 (69%), Gaps = 14/341 (4%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY+ IG+G+YG+VCSA TG KVAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N +C LKICDFGLAR+A + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+++ +LGTPS E + + +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+AR Y+ S+ K +P+++ FPNA+P AL LL++ML F P R T EEALA PY
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY------ 294
Query: 322 VER--EPSAQPVTKMEFEFE---RRRITKEDVRELIYREIL 357
+E+ +PS +PV + F F+ + KE ++ELI+ EI+
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 420 bits (1083), Expect = e-145
Identities = 175/335 (52%), Positives = 243/335 (72%), Gaps = 5/335 (1%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRYK E IG G+YGVVCSA DTR+G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I+ IL PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKY
Sbjct: 64 DNIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPEL 200
IH+ANV HRDLKP N+L N DC+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL ++ +LG+PS E + R+ +
Sbjct: 183 LLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
++ R+Y+ ++ +K+P+P+S+ FP A+P AL LL +ML F+P++R T E+AL P+
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 321 KVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
+ EP+ P +F+FE +++E ++E I +E
Sbjct: 302 DPDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 375 bits (966), Expect = e-127
Identities = 155/339 (45%), Positives = 218/339 (64%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA+DT+TG KVAIKK++ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 84 IVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LRGLKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI N DC+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELLTGK LFPG + + QL + +L+GTP E + ++ +E
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR Y+ S+ + F + F ANPLA+ LLE+ML +P R TA EALA PY
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E EP A P + FE R +T ++ +EL+Y+EI+ + P
Sbjct: 308 EDEPVAPP---YDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 368 bits (946), Expect = e-124
Identities = 150/339 (44%), Positives = 212/339 (62%), Gaps = 13/339 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
+Y+I + +GKG+YG+V A D RT E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 82 PDIVEIKHILLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVA--FNDTPTAIFWTDYVATRWYRAP 198
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+++ A L S+ + P + P A+ AL LL+++L F P R TAEEAL PY
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 318 GLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 300 QFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 365 bits (938), Expect = e-123
Identities = 168/340 (49%), Positives = 225/340 (66%), Gaps = 15/340 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEI--KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H +I + I+ P + F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L G
Sbjct: 61 HKNITCLYDMDIVFPGN---FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYR 196
LKYIH+ANV HRDLKP N+L NADC+LKICDFGLAR F++ P A F T+YVATRWYR
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ SF YT AID+WS+GCI AELL KP+F GK+ V QL+ + +LGTP E ++
Sbjct: 177 APEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ + KA+ Y+ S+ PF FPNANPLAL LLE++LAF+P R + EEAL PY
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
+ EP Q FE E + E++R++I E+
Sbjct: 296 AIWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-110
Identities = 137/294 (46%), Positives = 181/294 (61%), Gaps = 13/294 (4%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y+ +DIWS+GCIFAELL+ +PLFPGK+ + QL + LGTP PE + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
AR Y S KK +P + FPNA+P AL LL +ML ++P R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-110
Identities = 155/335 (46%), Positives = 219/335 (65%), Gaps = 18/335 (5%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ+LRGLKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ KY +DIWS GCIFAE+L GKPLFPGK+ V+Q I+TDLLGTP + I + +E
Sbjct: 179 TW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
R++ S+ K++P+PFS+KF NA+P A+ LLE+ML F+P+ R +A EALA PY
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY--- 294
Query: 323 EREPSAQPVTKMEFE--FERRRITKEDVRELIYRE 355
+P+ +PV + +F+ F + + + ++Y E
Sbjct: 295 -HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-105
Identities = 127/297 (42%), Positives = 175/297 (58%), Gaps = 20/297 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRLLRH 81
Y+ E +G+G+YGVV A D +TGE VA+KKI N+ E + LREI LL+ L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTA--LREISLLKELKH 57
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
P+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL
Sbjct: 58 PNIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ + HRDLKP+NIL N D LK+ DFGLAR T +T V T WYRAPE
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---YTHEVVTLWYRAPEI 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ E+ V
Sbjct: 170 LLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV- 226
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K Y + K P + P +P + LL +ML + P R +A+EAL PYF
Sbjct: 227 -TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 308 bits (791), Expect = e-100
Identities = 146/354 (41%), Positives = 211/354 (59%), Gaps = 32/354 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++GVV S D R G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 269
A+DIWS+GCIFAELL + LF ++ + QLD++TDLLGTPS EA+ E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKKPIPFSQKFPNANPL---ALRLLERMLAFEPKDRPTAEEALADPYFKG-------- 318
KP + ++ A+ LL RML F+P R +A +ALA PY
Sbjct: 243 -GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 319 ------------LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360
+ + EPSA P E+E+ + V+E +++ ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 301 bits (772), Expect = 3e-98
Identities = 146/339 (43%), Positives = 215/339 (63%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E + ++ +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR Y+ S+ + + F+ F ANPLA+ LLE+ML + R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ EP A P + FE R + ++ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 7e-96
Identities = 149/339 (43%), Positives = 214/339 (63%), Gaps = 12/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSAYDTR +KVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AELL GK LFPG + + QL + +++GTPSPE + ++ +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
AR+Y+ S+ + F ANPLA+ LLE+ML + R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E EP A+P + E + T E+ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 1e-93
Identities = 143/340 (42%), Positives = 209/340 (61%), Gaps = 12/340 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 83 DIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N DC+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS E + ++++E
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + + F PNANPLA+ +LE+ML + + R TA EALA PYF+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 322 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
E E A P + F+ + E+ + L + EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 288 bits (739), Expect = 3e-93
Identities = 138/339 (40%), Positives = 204/339 (60%), Gaps = 13/339 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + +G G+YG VCSA D RTGEKVAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P PE + ++ ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322
A+ Y+ S+ K FS FP A+P A+ LLE+ML + R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ E QP + E +++ ++ ++ IY+E+ + P
Sbjct: 307 DEETEQQP---YDDSLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 1e-92
Identities = 108/293 (36%), Positives = 152/293 (51%), Gaps = 40/293 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+I E +G+GS+G V A D +TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y A+DIWS+G I ELLTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
PF + +P A L+ ++L +P+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 6e-92
Identities = 122/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL- 200
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEA 254
S Y+ +DIW++GCI AEL T +PLFPG + + QL + +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ A + + P Q PNA+P A+ L++ ML ++PK RPTA +AL P
Sbjct: 227 Y-----KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 9e-90
Identities = 124/300 (41%), Positives = 165/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRI--LREIKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR +F + T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKM--THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L F Y +D+WS+GCIFAELL P PG + + QL + + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
V + + P P Q FP A+ AL LL+R+L P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 2e-89
Identities = 135/348 (38%), Positives = 203/348 (58%), Gaps = 24/348 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + IG G+ G+VC+AYDT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS E ++R+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARRYLSSMRKKKPIPFSQKFP-------NANPLALR------LLERMLAFEPKDRPTAE 308
R Y+ + K F + FP + + L+ LL +ML +P+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 356
+AL PY E A P + + R T E+ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (699), Expect = 5e-88
Identities = 116/302 (38%), Positives = 172/302 (56%), Gaps = 25/302 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
Y+ IG+G+YG V A + +TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H+ + HRD+K NIL N D LK+ DFGLAR + +A + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G+ ++Y P +D+WS+GCI AEL GKP+F G + QL+ + +L G+P+ E V
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 261 EKARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ +++ KKP F + AL LL+++L +PK R +A++AL
Sbjct: 232 LP---WFENLKPKKPYKRRLREFFKHLIDPS---ALDLLDKLLTLDPKKRISADQALQHE 285
Query: 315 YF 316
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 7e-85
Identities = 124/299 (41%), Positives = 175/299 (58%), Gaps = 20/299 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN- 260
G+ KY P +D+W++GCIFAELL G PLFPG+N + QL I+ LGTP+ E + +
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 261 ---EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + KPIP + FP+A+P AL LL+ +L ++P R +A EAL PYF
Sbjct: 232 PDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 1e-81
Identities = 132/337 (39%), Positives = 184/337 (54%), Gaps = 27/337 (8%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI---LREIKL 75
+ GSRY +G GS G+V SA D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 126
+R L H +IV++ +L P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 185
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + + Q+ ++ +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPE---AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 302
+ E + V R R+ P P NP AL LE++L F P
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLEQILTFNPM 289
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 339
DR TAEEAL PY + EP + +E E +
Sbjct: 290 DRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 3e-80
Identities = 114/296 (38%), Positives = 171/296 (57%), Gaps = 12/296 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ N+ HRD+KP+NIL + LK+CDFG AR A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G + Y +D+W+IGCI AELL G+PLFPG + + QL ++ LG P +
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYF 316
++ +P +++P + AL L+ L +PK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 4e-80
Identities = 95/293 (32%), Positives = 144/293 (49%), Gaps = 34/293 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ Y P +D+WS+G I ELLTGKP F G+N++ QL + I R+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + + A L+++ L +P RPTAEE L P+F
Sbjct: 215 ------LGPPLEFDEPKWSSG-SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 1e-76
Identities = 121/303 (39%), Positives = 168/303 (55%), Gaps = 31/303 (10%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+IEE G+YGVV A D +TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 11 NRIEE----GTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G+ +Y+ AID+WS+GCIFAELLT KPLFPGK+ + QL+ + LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARRYLSSMRKKKPI--PFSQ---KFPNA--NPLALRLLERMLAFEPKDRPTAEEALAD 313
L +KK P++Q KFP + LL R+L ++P R +AE+AL
Sbjct: 237 ------LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 314 PYF 316
PYF
Sbjct: 291 PYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-74
Identities = 115/297 (38%), Positives = 177/297 (59%), Gaps = 20/297 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD 83
YKI IG+G++ V A +TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKHILL-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 141
I+ + +L + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + + R
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K+R + KK + PNA+ L LL+++LA++P +R TA++AL PYF
Sbjct: 228 --KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 114/302 (37%), Positives = 154/302 (50%), Gaps = 25/302 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---H 81
Y+ IG+G+YG V A D TG VA+KK+ LREI LL+ L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
P+IV + + P + +VFE ++ DL + L PE + + QLLRG+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ + HRDLKP+NIL +D ++KI DFGLAR+ + T V T WYRAPE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TSVVVTLWYRAPE 176
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEA 254
L S Y +D+WS+GCIFAEL +PLF G + QLD + D++G PS P
Sbjct: 177 VLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
++ R SS P F P L LL++ML F P R +A EAL P
Sbjct: 234 VSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 315 YF 316
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-71
Identities = 130/348 (37%), Positives = 198/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+A+DT G VA+KK++ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI +L E + LYQ+L G+K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNFMMTPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI EL+ G +F G + + Q + + + LGTPS E + R++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARRYLSSMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEA 310
R Y+ + + I F + FP+ A LL +ML +P R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 358
L PY + E A P + + E R E+ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 2e-71
Identities = 122/297 (41%), Positives = 170/297 (57%), Gaps = 22/297 (7%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD---ATRILREIKLLRLLRHP 82
K+E+ IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L HP
Sbjct: 3 KVEK-IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y + K S+ PN + L LL +ML ++P R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 3e-71
Identities = 110/313 (35%), Positives = 167/313 (53%), Gaps = 28/313 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
Y+I +G+G++G V A +TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 81 HPDIVEIKHILL---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 136
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------WTD 188
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL ++ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 248 GTPSPEAIARVRN----EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303
GTP+ E R+ E + + R ++F P L LL ++L+ +P
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRT-----LEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 9e-71
Identities = 122/293 (41%), Positives = 170/293 (58%), Gaps = 19/293 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIK 88
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 147
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFS 206
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE--KAR 264
YT AID+W++GCI AELL KPL PGK+ + QLD++ LLGTP+ E+I ++
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPLVG 243
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
++ ++ K+ KFP + LRLL +L ++PK R TAEEAL YFK
Sbjct: 244 KF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 5e-69
Identities = 114/296 (38%), Positives = 170/296 (57%), Gaps = 17/296 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+K E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ +
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y + + P Q FP+A+PL + LL R+L P+ R +A +AL P+F
Sbjct: 231 --LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 4e-68
Identities = 131/347 (37%), Positives = 203/347 (58%), Gaps = 23/347 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE + +++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNA--------NPL----ALRLLERMLAFEPKDRPTAEEA 310
R Y+ + K + F + FP++ N L A LL +ML +P R + +EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 357
L PY + E A P + + + R T E+ +ELIY+E++
Sbjct: 309 LQHPYIN-VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 9e-68
Identities = 135/371 (36%), Positives = 211/371 (56%), Gaps = 29/371 (7%)
Query: 8 KSSADVDFFT-EYGEGS-----RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+S D +F++ E G+ + RY+ + IG G+ G+VC+AYD VAIKK++ F+
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAN 120
+ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI+
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 121
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 176
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--------NPL---- 288
+ + + LGTP PE + +++ R Y+ + K F + FP+ N L
Sbjct: 235 NKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 293
Query: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
A LL +ML + R + +EAL PY + E A P + + + R T E+
Sbjct: 294 ARDLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEW 352
Query: 349 RELIYREILEY 359
+ELIY+E+++
Sbjct: 353 KELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 3e-67
Identities = 119/320 (37%), Positives = 168/320 (52%), Gaps = 35/320 (10%)
Query: 23 SRYK-IEEVIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATR----------I 69
RY +G+G+YG V AYDT TG+ VAIKK I +I V+ +
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 129
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT +
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVK 122
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAI 184
L Q+L GL +H HRDL P NI N+ KI DFGLAR +
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 185 F------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
T V T WYRAPEL G+ KY A+D+WS+GCIFAELLTGKPLFPG+N +
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
QL + +LLGTP+ + + + + +KP FPNA+ A+ LL+ +L
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFT---PRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 298 AFEPKDRPTAEEALADPYFK 317
P +R +A+EAL YFK
Sbjct: 298 KLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 5e-67
Identities = 116/324 (35%), Positives = 171/324 (52%), Gaps = 39/324 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAY--DTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRL 78
+Y+IE IG+G+YG V A + + G++ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIFWTD- 188
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VH 238
V T WYRAPEL G+ YT AIDIW+IGCIFAELLT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS------QKFPNANPLALRL 292
QL+ + ++LGTP+ + ++ L K K P + +K + L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 293 LERMLAFEPKDRPTAEEALADPYF 316
L ++L ++P R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 1e-66
Identities = 117/299 (39%), Positives = 170/299 (56%), Gaps = 20/299 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI----LREIKLLRLL 79
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
EL G ++Y P +D+W+IGC+FAELLTG+PL+PGK+ V QL ++ LG P
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + LS + P KFPN + AL L+ L +P +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 4e-64
Identities = 116/295 (39%), Positives = 172/295 (58%), Gaps = 17/295 (5%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
KIE+ IG+G+YGVV + +TG+ VA+KKI E + +REI LL+ L+HP+IV
Sbjct: 4 KIEK-IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ +L+ SR +Y++FE + DL + + + E + +LYQ+L+G+ +
Sbjct: 63 CLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
GS +Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ + V
Sbjct: 175 GS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--T 230
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y ++ K K N + L LLE+ML ++P R +A++AL PYF
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 8e-63
Identities = 115/291 (39%), Positives = 165/291 (56%), Gaps = 15/291 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ +Y+VFE + DL + + A+ + + +L+QLL+GL + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
V HRDLKP+N+L N + +K+ DFGLAR AF P + T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCKY 177
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V +
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--D 233
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y S K FS+ P + LL +ML ++P R +A+ ALA P+F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 1e-62
Identities = 114/304 (37%), Positives = 168/304 (55%), Gaps = 19/304 (6%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ YK + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ E
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 256 ARV-RNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 312
V N + + Y S P P P + P L + L +EPK R +A EA+
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 5e-62
Identities = 122/306 (39%), Positives = 171/306 (55%), Gaps = 35/306 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHV-SDATRILREIKLLRLLR 80
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 139
H +IV + +L + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARRYLSSMRKKKPIP-------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
E++ +S + KP P P N LL+ +L P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 4e-61
Identities = 116/308 (37%), Positives = 178/308 (57%), Gaps = 38/308 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-LREIKLLRLLRHP 82
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 133
++V L+ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 EAIARVRNEKAR-RYLSSMR---KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
R + + + MR K+ P ++FP + L L L ++ L +P DRP++
Sbjct: 223 ----RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 309 EALADPYF 316
+ L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 6e-61
Identities = 114/302 (37%), Positives = 166/302 (54%), Gaps = 20/302 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 83 DIVEIKHILLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLL 136
+IV +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PEL G +Y PAID+WS GCI EL T KP+F + QL++++ L G+P P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 256 ARVRNEKARRYLSSMRKKKPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
V Y ++M+ KK ++F AL LL+ ML +P R TAEEAL
Sbjct: 243 PDVIKLP---YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 314 PY 315
P+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 114/300 (38%), Positives = 165/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PD 83
Y+ E IG+G+YG V A D TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 138
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LKI D GL R AF+ P + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
V R + KP S+ P+ +P L LL++ML ++P R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 119/303 (39%), Positives = 169/303 (55%), Gaps = 16/303 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 141
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 142 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ E V
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
+ Y S+ K P + P P + LL +ML +P R TA AL YFK L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 320 AKV 322
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 7e-59
Identities = 111/314 (35%), Positives = 157/314 (50%), Gaps = 31/314 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRL 78
E S+Y+ IG+G++G V A +T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 79 LRHPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 134
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVA 191
LL GL YIH + HRD+K NIL D LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--------NANPLALRLLERMLAFEPK 302
+PE V + KK +P QK +P AL L++++L +P
Sbjct: 244 TPEVWPGVDK-------LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 303 DRPTAEEALADPYF 316
R A+ AL +F
Sbjct: 297 KRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 7e-55
Identities = 115/305 (37%), Positives = 169/305 (55%), Gaps = 16/305 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L ++ LLGTP+ E
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ N++ + Y + K KP P P + + LL + L +E K R +AEEA+ Y
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
Query: 316 FKGLA 320
F+ L
Sbjct: 289 FRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-54
Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ E++G+GS+G V A D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++D +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y A DIWS+GC E+ TGKP + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LYKIGSSGEPP---------- 223
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
IP + + A L + L +PK RPTA+E L P+
Sbjct: 224 ------------EIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 4e-54
Identities = 113/306 (36%), Positives = 165/306 (53%), Gaps = 16/306 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ NE+ + Y + K + P + LL ++L FE + R +AEEA+ PY
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
Query: 316 FKGLAK 321
F L +
Sbjct: 289 FHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 6e-52
Identities = 110/301 (36%), Positives = 165/301 (54%), Gaps = 16/301 (5%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L ++ LLGTP+ E
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 257 RV-RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ NE+ R YL + + P P + + LL +L +E K R +AE AL Y
Sbjct: 230 GITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
Query: 316 F 316
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 9e-52
Identities = 71/197 (36%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V A D +TG+KVAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 LLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAEL 224
Y+ DIWS+G I EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 101/296 (34%), Positives = 166/296 (56%), Gaps = 11/296 (3%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + + LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ Y A+D+WS+GCI EL G+PLFPG++ + QL + +LG E + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYF 316
L P +++ + + L L++ +L P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 4e-51
Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 35/303 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT---PTAIFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE+ G + + + DIWS+G ELLTG P F G+ +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ + S + P + A LL+++LA +PK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFK 317
Sbjct: 277 LLA 279
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 57/304 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 82 PDIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQ 134
P+I++ + E + +V E + DL Q IK PE Q + Q
Sbjct: 59 PNIIKYYESFE------EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQ 111
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y +PELC + Y DIWS+GC+ EL T K F G+N+ E
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENL---------------LEL 211
Query: 255 IARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
++ + PIP +S + N L+ +L +P++RP+ + L
Sbjct: 212 ALKILKG----------QYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQ 254
Query: 313 DPYF 316
P+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 114/315 (36%), Positives = 163/315 (51%), Gaps = 41/315 (13%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G + Y E +G+GSY V G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ +
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR--------------LLERMLAFEP 301
V S + KP + F P LR L +ML P
Sbjct: 230 PGV---------SKLPNYKP----EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 302 KDRPTAEEALADPYF 316
KDR +A++AL PYF
Sbjct: 277 KDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 5e-46
Identities = 110/337 (32%), Positives = 175/337 (51%), Gaps = 29/337 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
YK+ +IG GS+GVV A T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKHILLPPS-RREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLR 137
+ +K ++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 GLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L YIH+ + HRDLKP+N+L + + LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAFEPKDRPTAEEALADP 314
+ A + KP + FP P A+ + + L +EP R EALADP
Sbjct: 296 KEMNPNYADIKFPDV---KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVREL 351
+F L R+P + ++ + +++E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 45/294 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I E IGKG +G V A RTG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKY 141
V+ L ++++V E L ++K+ + E + +LL+GL+Y
Sbjct: 60 VKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL +D ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI 169
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y DIWS+G EL GKP + +L M +A+ ++
Sbjct: 170 --NGKPYDYKADIWSLGITAIELAEGKPPY------SELPPM---------KALFKIATN 212
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ K F + F L++ L P+ RPTAE+ L P+
Sbjct: 213 GPPGLRNPE--KWSDEF-KDF----------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 103/305 (33%), Positives = 160/305 (52%), Gaps = 28/305 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLR-- 80
+Y+ IG+G+YG V A D + G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKHI-LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWY 195
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ +F T++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE-- 253
RAPE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 254 --AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+A R + P + + + L LL + L F P R +A AL
Sbjct: 234 PRDVALPRQAFHSKSAQ--------PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
Query: 312 ADPYF 316
+ PYF
Sbjct: 286 SHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-43
Identities = 92/298 (30%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILREIKLLRLLRH 81
Y++ ++IG+G++GVV + TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGL 139
P+IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAP 198
Y+H V HRD+K NIL D +K+ DFG+A ++ V T ++ AP
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAP 168
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ S + A DIWS+GC ELLTG P + DL + I +
Sbjct: 169 EVIE--MSGASTASDIWSLGCTVIELLTGNPPY------------YDLNPMAALFRIVQ- 213
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P+P +P L + +P RPTA++ L P+
Sbjct: 214 ------------DDHPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 56/305 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 135
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 136 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T +Y +PE Y DIWS+GC+ EL P F +N QL
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QL---------- 216
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ ++++ K RR IP + N +++ ML +P RP+ EE
Sbjct: 217 --QLASKIKEGKFRR----------IP-YRYSSELN----EVIKSMLNVDPDKRPSTEEL 259
Query: 311 LADPY 315
L P
Sbjct: 260 LQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 101/299 (33%), Positives = 145/299 (48%), Gaps = 17/299 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--- 80
+Y+ IG G+YG V A D +G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRG 138
HP+IV + + + +VFE ++ DL + L E + + Q LRG
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRAP
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRAP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P +
Sbjct: 177 EVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-- 232
Query: 259 RNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ R S R +P+ Q P +LL ML F P R +A AL P+F
Sbjct: 233 RDVTLPRGAFSPRGPRPV---QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-41
Identities = 108/310 (34%), Positives = 169/310 (54%), Gaps = 25/310 (8%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPE-- 253
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 254 ----AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
++ + E+ Y ++ S +A LA +LL+ PK+R +A+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSY-VNHAEDLASKLLQ----CFPKNRLSAQA 284
Query: 310 ALADPYFKGL 319
AL+ YF L
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 89/310 (28%), Positives = 136/310 (43%), Gaps = 73/310 (23%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
+IV+ L+ +++VV E M+ L +I N + + ++L+GL
Sbjct: 76 NIVDYYDSYLVG------DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
+Y+H+ NV HRD+K NIL + D +K+ DFG A R + TP +W
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP---YWM--- 183
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
APE+ Y P +DIWS+G + E+ G+P P L P
Sbjct: 184 ------APEVIKR--KDYGPKVDIWSLGIMCIEMAEGEP--P-------------YLREP 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN---PLALRLLERMLAFEPKDRPTA 307
A+ + K IP N P L + L +P+ RP+A
Sbjct: 221 PLRALFLIT-------------TKGIP---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264
Query: 308 EEALADPYFK 317
EE L P+ K
Sbjct: 265 EELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 8e-40
Identities = 114/327 (34%), Positives = 168/327 (51%), Gaps = 59/327 (18%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 245 DLLGTPS----------PEAIARVRNEKARRY-----LSSMRKKKPIPFSQKFPNANPLA 289
+++G P+ PE +++ + Y + M K K P S+ F
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF------- 291
Query: 290 LRLLERMLAFEPKDRPTAEEALADPYF 316
LL+++L +P R T+E+A+ DPYF
Sbjct: 292 -HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-39
Identities = 117/327 (35%), Positives = 169/327 (51%), Gaps = 59/327 (18%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 245 DLLGTPS----------PEAIARVRNEKARRYLSS-----MRKKKPIPFSQKFPNANPLA 289
++G P+ PE ++ + Y +S M K K P S+ F
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF------- 291
Query: 290 LRLLERMLAFEPKDRPTAEEALADPYF 316
LL+++L +P R T+E+AL DPYF
Sbjct: 292 -LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 67/301 (22%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V + +VA+K + E S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 193 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----------- 210
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
E + ++N R +P PN P L+ + A +P+DRPT
Sbjct: 211 ----EVLEYLKNGY--------RLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 309 E 309
E
Sbjct: 252 E 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 39/291 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+G+GS GVV TG+ A+KKI+ + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANV 147
I +V E M+ L ++K + + Q+L+GL Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG--ES 176
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
Y+ A DIWS+G E GK F ++M + P P
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------- 223
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
FS +F + + L +PK RP+A E L P+ K
Sbjct: 224 ------PAEEFSPEFRD-------FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 87/288 (30%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++G V +A + TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 91 LLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 149
+ RE +Y+ E L ++++ L + + QLL GL Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 150 RDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSK 207
RD+KP NI + + +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
+ A DIWS+GC+ E+ TGK + +LD NE +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD------------------NEFQIMFH 218
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
K PIP S + +P L+R L +PK RPTA E L P+
Sbjct: 219 VGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 54/295 (18%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 89 HILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
Y A+D WS+G + E+LTGKP F ++ R
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAED----------------------------R 198
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYF 316
+ + K P+ F + P A L+ +L +P R AEE A P+F
Sbjct: 199 KEIYEKILKDPLRFPEFLS---PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V +VA+K + + S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 136
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
RG++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 193 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---------- 211
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307
E + ++ R KP PN P +L+ + A +P+DRPT
Sbjct: 212 -----EVLEYLKKGY--------RLPKP-------PNCPPELYKLMLQCWAEDPEDRPTF 251
Query: 308 EE 309
E
Sbjct: 252 SE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 86/327 (26%), Positives = 140/327 (42%), Gaps = 84/327 (25%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK---------- 74
+K ++IG+GS+ V A + T ++ AIK ++ +++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--------LIKEKKVKYVKIEKEV 54
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 130
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------AFNDTPT 182
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V + T
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 183 AIFWTD---------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
I +V T Y +PEL + D+W++GCI ++LTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
N ++ + F FP P A L+
Sbjct: 225 SN---------------EYLTFQKILKLE-------------YSFPPNFP---PDAKDLI 253
Query: 294 ERMLAFEPKDRPTA----EEALADPYF 316
E++L +P+DR +E A P+F
Sbjct: 254 EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I I ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI-ARVRN 260
++ +D WS+GCI E L G P F G+ PE I + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGET----------------PEEIFQNILN 215
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFK 317
K I + + + A+ L+ ++L +P+ R A EE P+FK
Sbjct: 216 GK-------------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
Query: 318 GL 319
G+
Sbjct: 262 GI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-------DYYRKRGGGKLPI 168
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
R++ E++G GS+G V + G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 136
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWY 195
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y A DIWS+GC E+ TGKP + QL+ + A+
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGV---------AAV 211
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ K PIP A L+ L+R +P RPTA E L P+
Sbjct: 212 FKIGRSKEL---------PPIPDHLS-DEAKDFILKCLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 90/315 (28%), Positives = 134/315 (42%), Gaps = 78/315 (24%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATR-----ILREIKLLRLLR 80
E+IGKG+YG V A + TGE +A+K++ I + + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 128
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPT-- 182
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ + ND
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 183 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ P +
Sbjct: 171 QGSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE---- 215
Query: 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300
EAIA A L + R PIP N +P+AL L
Sbjct: 216 ------------EAIA------AMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTIN 256
Query: 301 PKDRPTAEEALADPY 315
P +RPTA E L P+
Sbjct: 257 PDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATRILREIKLLRLLRH 81
+ + E IGKGS+G V A D RT + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H HRD+K NIL + + +K+ DFG V+ T T +V T ++ A
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
PE+ S Y DIWS+G EL G+P
Sbjct: 167 PEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 55/289 (19%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATR-ILREIKLLRLLRH 81
+++ VIGKG++G VC T + A+K +N E + R +L E ++L+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNH 59
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 60 PFLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ + HRD+KP NIL + + I DF +A DT T T T Y A
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMA 167
Query: 198 PELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE+ + Y+ A+D WS+G E L GK + G T + I
Sbjct: 168 PEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH------------SRTIR-DQIR 211
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDR 304
+ +P + ++L +P+ R
Sbjct: 212 AKQETA----------------DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 77/305 (25%), Positives = 125/305 (40%), Gaps = 73/305 (23%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+ +G+G++G V + G+ VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 133
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 193 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
RW APE S +T D+WS G + E+ T
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFT------------------- 202
Query: 246 LLGTPSPEAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304
L TP P + NE+ YL R KP + L+ +P+DR
Sbjct: 203 LGATPYPG----LSNEEVLEYLRKGYRLPKPEYCPDEL-------YELMLSCWQLDPEDR 251
Query: 305 PTAEE 309
PT E
Sbjct: 252 PTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR---ILREIKLLRLLRHPDIVEI 87
IG+GS G+VC A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+K +IL +D ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267
Y +DIWS+G + E++ G+P + P +A+ R+R+
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP---- 232
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
P + +P L+RML +P R TA E L P+
Sbjct: 233 ---------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 85/299 (28%), Positives = 137/299 (45%), Gaps = 54/299 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ I E +G+GSYG V A TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 137
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H+ HRD+K NIL N + + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ Y DIWS+G E+ GKP P + +H + + + P P
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP--PYSD-IHPMRAIFMIPNKPPPTL--- 219
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P +S +F + +++ L +P++RP+A + L P+
Sbjct: 220 ---------------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 74/208 (35%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
+KIE+ IGKG + VV A G VA+KK+ IFE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 136
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+++H+ + HRD+KP N+ A +K+ D GL R F+ TA V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEL 224
+PE + Y DIWS+GC+ E+
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 45/303 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ EVIG G+ VV +A EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 138
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ HRD+K NIL D +KI DFG+ A +A T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----LFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ Y DIWS G EL TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPS 226
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
L + K +S+ F ++ L +P RPTAEE L
Sbjct: 227 -------------LETGADYK--KYSKSFRK-------MISLCLQKDPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
Y V+GKG++G T V K++N + E L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 135
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG---TPSP 252
+PELC KY DIW++GC+ ELLT K F N L+++ ++ TP
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
Y S + L+ +L +P+ RPTA+E L
Sbjct: 223 S-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEVLD 252
Query: 313 DP 314
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 89/303 (29%), Positives = 134/303 (44%), Gaps = 61/303 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+K+ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 135
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVATRW 194
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + T I T
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI------GTPH 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y+ DIWS+GC+ E+ T P F ++ M DL
Sbjct: 167 YMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL-------- 209
Query: 255 IARVRNEKARRYLSSMRKK-KPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
R K PIP +SQ N + ML +PK RP ++ L
Sbjct: 210 -----------RYKVQRGKYPPIPPIYSQDLQN-------FIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEI 87
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+N+L +++ +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 204 FFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+K Y ++D WS+G + ELLTG+P F G++ ++I D+L
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-----ILREIKLLRLL 79
++ +++G+G++G V YD TG ++A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+H IV+ L R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ Y D+WS+GC E+LT KP P EA+A +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAI 216
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + P Q + +P A L R K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G+ GVV TG+ +A+K I +I E + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFY 65
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA- 145
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 66 GAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQG-- 173
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
+ Y+ DIWS+G EL TG+ FP E + + NE R
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGIF------ELLQYIVNEPPPR 223
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
S FS F + + L +P++RP+ +E L P+ K
Sbjct: 224 LPSGK-------FSPDFQD-------FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + + V +A+ R+R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV---------------QAMKRLRDS--------- 232
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P P + +P+ LERML EP++R TA+E L P+
Sbjct: 233 ----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 53/299 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 137
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L ++HT + HRDLK +NIL + +KI DFG++++ + + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYI 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAI 255
+PELC Y DIW++GC+ EL + K F N+ L IM+ GT +P
Sbjct: 169 SPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---GTFAP--- 220
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ RY +R +L+ ML +P RP + +A P
Sbjct: 221 ------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 88/304 (28%), Positives = 133/304 (43%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATRIL-----REIKLLRLLRHP 82
+IG GS+G V + +GE +A+K+ + + D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+IV+ L + +I++ E + + N E + F+ Q+L+GL Y
Sbjct: 67 NIVQY---LGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST--------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP T L
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---------CTQL----- 218
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+AI ++ E A P S N + A+ LE+ + RPTA E L
Sbjct: 219 -QAIFKI-GENAS----------PEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I IGKGS+GVV A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +KI D G+A++ + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y D+W++G + E TGK H D N+
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGK---------HPFD----------------ANNQ 206
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
A L +R P P SQ + + +L+++ L + + RP + L +P
Sbjct: 207 GA-LILKIIRGVFP-PVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + TG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + P +A+ R+R+ R S
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPRVKDSH 242
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + + L+ ML EP R TA+E L P+ K
Sbjct: 243 K-------------VSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 54/309 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-R 80
+++ EVIG+G+YG V A +TG+ VAIK ++ I + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 134
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAIFWTDY 189
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ + +T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--------F 173
Query: 190 VATRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
+ T ++ APE C + Y D+WS+G EL GKP +H + + +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD---MHPMRALFKI 230
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
P P K P +S+KF + + L + RP
Sbjct: 231 PRNPPP------------------TLKSPENWSKKFND-------FISECLIKNYEQRPF 265
Query: 307 AEEALADPY 315
EE L P+
Sbjct: 266 MEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 93/300 (31%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 90 ILLPPSRREFKDIYVVFELME-------SDLHQV----IKANDDLTPEHYQFFLYQLLRG 138
L S F I+ ME S L + +K N+ F+ Q+L G
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTI----IFYTKQILEG 120
Query: 139 LKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYR 196
LKY+H + HRD+K N+L N +KI DFG + R+A + T F T Y
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF----TGTLQYM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ Y DIWS+GC E+ TGKP F + LG P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP------ 217
Query: 257 RVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+A + M K P IP S A LR E +P R +A + L DP+
Sbjct: 218 -----QAAMFKVGMFKIHPEIPESLS-AEAKNFILRCFEP----DPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY--QLLRGLK 140
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+IH + HRD+K +NI + + + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSME--LAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+C + Y DIWS+GC+ EL T K F G N +HQL
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 85/299 (28%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H HRD+K NIL D +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E Y DIW++G EL + P+F L M L
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMF-------DLHPMRALFLISKSNFPP 223
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+K + +S F + +++ L +PK RPTA + L P+
Sbjct: 224 PKLKDKEK-------------WSPVFHD-------FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 58/305 (19%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++ A D +TG +A+K++ N E + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ + + E + E M L + + + + QLLRGL
Sbjct: 66 IR-----MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL---LGTPS-P 252
PE L G +Y + D+WS+GC+ E+ T KP + + + L ++ + PS P
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
E ++ P + LR LE +P+DRP + E L
Sbjct: 234 EHLS--------------------------PGLRDVTLRCLEL----QPEDRPPSRELLK 263
Query: 313 DPYFK 317
P F+
Sbjct: 264 HPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 90/309 (29%), Positives = 134/309 (43%), Gaps = 50/309 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
S Y+ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 80 RH---PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL 135
R P+I + L R ++++ E E + ++KA + ++ + ++
Sbjct: 57 RQSQPPNITKYYGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREV 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L LKYIH V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y DIWS+G E+ TG P + V M L+ P +
Sbjct: 168 MAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSD---VDAFRAM-MLIPKSKPPRL 222
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ Y +R+ F +A L E EPK+R +AEE L +
Sbjct: 223 ------EDNGYSKLLRE-----F---------VAACLDE-----EPKERLSAEELLKSKW 257
Query: 316 FKGLAKVER 324
K +K
Sbjct: 258 IKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 73/212 (34%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + V+G+GS+G + +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRGL 139
IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G+
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLGV 113
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y PE
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + Y DIWS+GCI EL T K F
Sbjct: 171 IWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R P P + +P L+R+L +P R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 102/333 (30%), Positives = 150/333 (45%), Gaps = 74/333 (22%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLLRHPDIVE 86
IG GS+G V A D RT E VAIKK++ E D I++E++ L+ LRHP+ +E
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---IIKEVRFLQQLRHPNTIE 79
Query: 87 IKHILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
K L RE + + +ME SD+ +V K L + L+GL
Sbjct: 80 YKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ HRD+K NIL +K+ DFG A + +P F V T ++ APE+
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +Y +D+WS+G EL K PLF ++ M+ L IA
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALY------HIA-- 227
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
+N+ LS +S F N ++ L P+DRP++EE L +
Sbjct: 228 QNDSPT--LS------SNDWSDYFRN-------FVDSCLQKIPQDRPSSEELLKHRF--- 269
Query: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVREL 351
V RE +P T + +R TK+ VREL
Sbjct: 270 ---VLRE---RPPTVIIDLIQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
C + Y DIW++GC+ E+ T K F N+
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIF-----EHVSDATRILREIKL 75
+ + +G G++G V D + A+K + ++ +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y APE+ S + A+D W++G + E+L G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 8e-22
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 35/219 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIF-----EHVSDATRILREIKLLR 77
++ + +G GS+G V +G+ A+K I EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 78 LLRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLY 133
+RHP +V + F+D +Y+V E + +L ++ + +F+
Sbjct: 57 SIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A+ T +T T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTP 162
Query: 194 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLF 231
Y APE+ SK Y A+D W++G + E+L G P F
Sbjct: 163 EYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR 80
RY +++ +GKGS+G V D + + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 135
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
+PE Y DIWS+GCI E+ F G+N L ++ ++ P+P
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL- 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
Y + N+ +++ ML +P RP+A E L +P+
Sbjct: 226 -------PETYSRQL-------------NS------IMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A + VA+KK+ IFE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L ++++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 50/298 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 138
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N A + + T +Y +P
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSP 171
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
EL F +K Y D+W++GC E+ T K F K++
Sbjct: 172 EL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------------------- 207
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
N R + K P+P + +P L+ ML+ P+ RP+ + L PY
Sbjct: 208 --NSLVYRIIEG--KLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE+VIG G +G VC G+K VAIK + SD R+ L E ++
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G
Sbjct: 64 HPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +NIL N++ K+ DFGL+R + T + RW AP
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAP 177
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT 226
E + K+T A D+WS G + E+++
Sbjct: 178 EAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ S KIE+VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 135 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRH 81
+++ +++G+G++G V YD TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV+ L P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y D+WS+ C E+LT KP P E A
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP--------------------PWAEYEA----- 214
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++++ K P P+ A R + + E K RPTAE L P+
Sbjct: 215 -----MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 31 IGKGSYGVVCSA-YD---TRTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDI 84
+G+G +G V YD TGE+VA+K +N E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 138
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR----- 193
+ Y+ + HRDL +NIL ++ +KI DFGLA+V D DY +
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGES 174
Query: 194 ---WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE C SK++ A D+WS G EL T
Sbjct: 175 PIFWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 7e-20
Identities = 70/255 (27%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIF 246
Query: 260 NEKARRYLSSMRKKK 274
+ R L +K+
Sbjct: 247 RDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 29/248 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKIN--------DIFEHVSDATRILREIKL 75
Y + E +G G++G V G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 128
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 129 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ P + T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES-KLT 171
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V T Y PE+ + Y D+W+ GCI ++ T +P F N++ + + +
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 248 GTPSPEAI 255
P PE +
Sbjct: 230 YEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 90/296 (30%), Positives = 140/296 (47%), Gaps = 33/296 (11%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREI 73
FF E E + E IG GS+G V A D RT E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 130
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A +A +P +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 191 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T ++ APE+ + +Y +D+WS+G EL KP N + L +
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQN 239
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
SP + ++ R ++ S QK P P + LL+ M F ++RP
Sbjct: 240 ESPTLQSNEWSDYFRNFVDSCL--------QKIPQDRPTSEELLKHM--FVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPD 83
++I +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H HRDLKP+N L +A +K+ DFGL++ + + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A G VA+KK+ IF+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L L+++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 70/329 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVAFNDTPT 182
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 183 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ D+ V T Y APE L G + Y D WS+G I E+L G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
+ E ++ N K L P P A+
Sbjct: 231 YSDTLQ---------------ETYNKIINWK--ESLR-------FPPDPPVS---PEAID 263
Query: 292 LLERMLAFEPKDR-PTAEEALADPYFKGL 319
L+ R+L +P+DR + EE + P+FKG+
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
V HRD+K N+L D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
P+ L R L + + R +A+E L P+ K L
Sbjct: 243 ---------------------------PIFRDFLNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 9/211 (4%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+ +++ +++G+G++G V YD TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H IV+ L P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARVR 259
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAVF 245
Query: 260 NEKARRYL 267
+ R L
Sbjct: 246 RDFLNRCL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A ++ T E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL ++K+ DFG A + +P +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y +D+WS+G EL KP N + L + SP + +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTLQSNEWTDS 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
R ++ QK P P + LL F +DRP
Sbjct: 249 FRGFVDYCL--------QKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 76/306 (24%), Positives = 135/306 (44%), Gaps = 43/306 (14%)
Query: 26 KIEEV--IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
KI E+ +G+G+ G V TG A+K I + +ILRE+++ + + P
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRG 138
IV+ L S I + E E +++ +K E + + +L+G
Sbjct: 61 IVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H+ + HRD+KP NIL ++K+CDFG++ N + T +Y AP
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-----LAGTFTGTSFYMAP 172
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSPEAI 255
E + G Y+ D+WS+G E+ + FP G+ + +++++ ++ P+PE
Sbjct: 173 ERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
N I +S++F + +++ L +P RPT + L P+
Sbjct: 230 DEPGNG--------------IKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPW 268
Query: 316 FKGLAK 321
K K
Sbjct: 269 IKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 43/299 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---------------------- 224
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
YL + + +K + + L R L + + R +A+E L P+ K +AK
Sbjct: 225 ---YLIATNGTPELQNPEKL---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 23/250 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLKP+NIL + + +CDFGL ++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKARR 265
YT A+D W++G + E+LTG P F +NV I+ + L P + A+
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG------FDRDAKD 222
Query: 266 YLSSMRKKKP 275
L + + P
Sbjct: 223 LLIGLLSRDP 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 33/217 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
KIEEVIG G +G VC G++ VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 136
HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 137 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +DT + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
EV+GKG+YG V T G+ +A+K++ +++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V+ L + I + E + + ++ L + + Q+L G+ Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE 199
V HRD+K N++ + +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E +G G +G V T KVA+K + L+E ++++ LRH +V
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGT-TKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYI 142
++ + S E IY+V E M L +K+ + L Q+ G+ Y+
Sbjct: 65 QLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
+ N HRDL +NIL + KI DFGLAR+ +D TA I WT
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-------- 171
Query: 196 RAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 -APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R VAIK I E + E K++ L HP++V++ +
Sbjct: 12 LGSGQFGVVHLGK-WRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKYIHTAN 146
+ + I++V E M + L ++ ++ L + ++Y+ +
Sbjct: 68 CT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
HRDL +N L D +K+ DFGLAR +D T+ T + +W PE+ +S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVFD--YS 176
Query: 207 KYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+++ D+WS G + E+ + GK +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-18
Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D+D T+ R+KI ++G+G++G V A+D + E A+K + ++ ++ DA +I
Sbjct: 123 DIDVSTQ-----RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI-- 174
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD----IYVVFELMESDLHQVIKANDDLTPEH 127
EI+ + +R D + L +R F++ + +V L I + + H
Sbjct: 175 EIQFMEKVRQADPAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRH 232
Query: 128 YQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD----------------CKLKICDF 170
++Q L Y HT ++ H DLKP+NIL C+++ICD
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G + TAI V+TR YR+PE+ Y+ D+WS+GCI EL TGK L
Sbjct: 293 G-GCCDERHSRTAI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLL 344
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
+ + + L +M LG E R E+AR +S + +P
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
|
Length = 467 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRHPDIV 85
+++G+G++G V YD TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ L R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKA 263
Y D+WS+GC E+LT KP + + + I T P I+ E A
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS----EHA 238
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R +L + E + RP+AEE L P+
Sbjct: 239 RDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D R E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL + +K+ DFG A + P +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+Y +D+WS+G EL KP N + L + SP + +E
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPALQSGHWSEY 242
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
R ++ S QK P P + LL+ F ++RP
Sbjct: 243 FRNFVDSCL--------QKIPQDRPTSEVLLKHR--FVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 35/213 (16%)
Query: 31 IGKGSYGVV--CSAYD---TRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDI 84
+GKG++G V C YD TGE VA+KK+ + EH+ D REI++L+ L+H +I
Sbjct: 12 LGKGNFGSVELCR-YDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNI 67
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKY 141
V+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y
Sbjct: 68 VKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-------- 193
+ + HRDL +NIL ++ ++KI DFGL +V D +Y R
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIF 176
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK++ A D+WS G + EL T
Sbjct: 177 WY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G K A+K I+DI E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ S Y D+WS+G EL G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 29 EVIGKGSYG---VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + + +K+ DFGL++ + + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARVRN 260
+T + D WS G + E+LTG F GK+ + I+ LG P SPEA + +R
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++VIG G +G V G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 142
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPEL 200
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R KVAIK IN E + E K++ L HP +V++ +
Sbjct: 12 LGSGQFGVV-HLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ K +Y+V E ME+ L+ + + L+ + + G++Y+ +
Sbjct: 68 CT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+ FSKY
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN--FSKY 178
Query: 209 TPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ D+WS G + E+ T GK F K+
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 47 TGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103
TG +VAIK + + + R RE L L HP+IV LL ++
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLF 55
Query: 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LANA 161
VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 56 AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 162 DCK--LKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ K+ DFG+ V D T T+ + T Y APE L G TP D+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDL 172
Query: 215 WSIGCIFAELLTGKPLFPGKNV 236
++ G IF E LTG+ + G +V
Sbjct: 173 YAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 61/300 (20%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRH-----PD 83
I KG++G V A TG+ AIK K +D+ A + +K R + P
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-----IAKNQVTNVKAERAIMMIQGESPY 58
Query: 84 IVEIKHILLPPSRREFKD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ + + KD +Y+V E L D +IK L + + ++ +++ G++
Sbjct: 59 VAKLYYSF------QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRD+KP+N+L + LK+ DFGL+R + +V T Y APE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETI 165
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
G D WS+GC+ E L G P F + +P+A+ N
Sbjct: 166 LG---VGDDKMSDWWSLGCVIFEFLFGYPPFHAE----------------TPDAV--FDN 204
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFK 317
+RR K+ +P A+ L+ R+L +P R A +E + P+FK
Sbjct: 205 ILSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 82/296 (27%), Positives = 126/296 (42%), Gaps = 49/296 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G+ G V TG +A KK+ I S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 148
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFN---DTPTAIFWTDYVATRWYRAPELCGSFF 205
HRD+KP NIL N+ ++K+CDFG++ N DT +V T Y +PE
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTSTYMSPERIQG-- 176
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-----VHQLDIMTDLLGTPSPEAIARVRN 260
KYT D+WS+G EL GK F N+ + I+ DLL ++
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLL--------QQIVQ 227
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
E R SS FP ++ L +P +RPT ++ A P F
Sbjct: 228 EPPPRLPSS-----------DFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G A+K I+D+ E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H + HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ + Y D+WS+G EL G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 23/237 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
+ +E +G G +G V + +VAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
++ + + S E +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISLFAVC---SVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYR 196
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG N D +T P P
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 74/300 (24%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL-------R 137
+ ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYV 190
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT--- 170
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249
APE + +T D+WS G + E++T G+ +PG MT+
Sbjct: 171 ------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG---------MTN---- 209
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRPTAE 308
PE I + E+ R P+ P L L+ +P++RPT E
Sbjct: 210 --PEVIQNL--ERGYRMPR--------------PDNCPEELYELMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+GKG +G VC+ TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 90 ILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 146
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLKP+N+L + ++I D GLA T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQG--E 169
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
Y ++D +++GC E++ G+ F R R EK +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQRKEKVEKE 204
Query: 267 -LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
L + + + KF +P A L E +L +P+ R +A+E P FK L
Sbjct: 205 ELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLR 80
S +++ E +G GS+G V A TGE AIK K +I + + + +E +L L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELS 76
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP IV + +R F +VV + + L + + +D+ +F+ +L+ +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAELVLAFE 132
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T T Y APE+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------LCGTPEYLAPEV 186
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 187 IQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 51/288 (17%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 143
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
S Y DIWS+G EL G+P P + +H + ++ + P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLTGE------ 224
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
FS+ F ++ L +P RPTA+E L
Sbjct: 225 --------------FSKPFK-------EFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + + IG G +G+V Y KVAIK I + D + E +++ L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEED---FIEEAQVMMKLSHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+V++ + E I +VFE ME L ++A + E + G+
Sbjct: 60 KLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ ++NV HRDL +N L + +K+ DFG+ R +D T+ T + +W +PE+
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
FSKY+ D+WS G + E+ +
Sbjct: 173 FS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 86/351 (24%), Positives = 147/351 (41%), Gaps = 69/351 (19%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLK N+L +++ +KI DFG+ + T+ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y PA+D W++G + E+L G+ F G + + + + E
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----------------EDELFQSILED 211
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR----PTAEEALAD-PYFK 317
RY + K+ A +L+ L P+ R PT E+ + P+F+
Sbjct: 212 EVRYPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 318 GL--AKVER---EPSAQPVTKMEF-------EFERRRITKEDVRELIYREI 356
+ K+ER +P +P K F EF + + E I R I
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 82/316 (25%), Positives = 126/316 (39%), Gaps = 47/316 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y + + + GS G V A + V +K + L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY-QLLRGLKYIH 143
+ +K L+ + V SDL+ + P + Q+L GL+Y+H
Sbjct: 120 IRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLAR 230
Query: 204 FFSKYTPAIDIWSIGCIFAELLT-GKPLF---------PGKNV-VHQLDIMTDLLGTPSP 252
KY DIWS G + E+L +F K+ H L I++ L P
Sbjct: 231 --DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL--KVHP 286
Query: 253 EAIARVRNEKARR----YLSSMRKKKPIPFSQKFPNANPLALR-----LLERMLAFEPKD 303
E R + R Y S R+ P+++ +P + L L+ +ML F+
Sbjct: 287 EEFPRDPGSRLVRGFIEYASLERQ----PYTR-YPCFQRVNLPIDGEFLVHKMLTFDAAM 341
Query: 304 RPTAEEALADPYFKGL 319
RP+AEE L P F L
Sbjct: 342 RPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 83/299 (27%), Positives = 126/299 (42%), Gaps = 54/299 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLL----RHPD 83
V+G+G +G V A +TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V + + V E DL I + P F+ ++ GL+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPEL 200
H + +RDLK N+L + + +KI DFGL + + F D T+ F T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTF----CGTPEFLAPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
+ YT A+D W +G + E+L G+ FPG + E + N
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVN 215
Query: 261 EKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
++ R R+LS ++ I ++ NP ER L KD AE+ P+F+
Sbjct: 216 DEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD---AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 67/297 (22%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
IG+G +G V Y + EK VA+K K S + L+E ++R HP
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPH 68
Query: 84 IVE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLK 140
IV+ I I P +++V EL +L ++ N L + YQL L
Sbjct: 69 IVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR------W 194
Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++ W
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLPIKW 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSP 252
APE F ++T A D+W G C++ L+ G KP G +
Sbjct: 175 M-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNN 215
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ I R+ E R P+P PN P L+ + A++P RP E
Sbjct: 216 DVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G YG V + VA+K + E + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ---- 66
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANV 147
LL RE Y++ E M +L ++ + ++ + Q+ ++Y+ N
Sbjct: 67 LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N L + +K+ DFGL+R+ DT TA I WT APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE- 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 176 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 47/293 (16%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A TG A K I E + + EI +L +HP+IV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 91 LLPPSRR----EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ EF D + +M + LT ++ Q+L L ++H+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL--CGSF 204
V HRDLK NIL D +K+ DFG V+ + T ++ T ++ APE+ C +F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 205 FSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y DIWS+G EL +P P ++ + ++ +L + P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKILKSEPPTLDQ------- 230
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
P +S F + L+ L +P DRPTA E L P+
Sbjct: 231 -----------PSKWSSSFND-------FLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)
Query: 30 VIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+IGK +V A T VA+KKIN D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLRG 138
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 65 VTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVAFNDTPTAI----F 185
L YIH+ HR +K +IL + D K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
W +PE+ Y DI+S+G EL G P K++ ++
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEK 222
Query: 246 LLGTPS--------PEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERM 296
+ GT P + ++ + R P+++ F + + L+R
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR- 281
Query: 297 LAFEPKDRPTAEEALADPYFKGLAKVE 323
+P+ RP+A + L +FK +
Sbjct: 282 ---DPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVE 86
+E++G G+ G V AY T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 87 IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTA 145
+R I + E M+ V + PEH +++GL Y+ +
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERISG-- 167
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
+Y D+WS+G F EL G+ FP
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR--FP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 52/312 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEI 87
+G G+ GVV +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 145
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 146 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
+ YT DIWS+G E+ G+ P + +L+ M G P E A+ +
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAM---FGRPVSEGEAKESHRPV 226
Query: 264 RRYLSSMRK------------KKPIP------FSQKFPNANPLALRLLERMLAFEPKDRP 305
+ + +P P FS +F + +++ L PK+R
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD-------FVDKCLKKNPKERA 279
Query: 306 TAEEALADPYFK 317
+E P+ K
Sbjct: 280 DLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
IGKG +G V G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 89 HILLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++L + +Y+V E M S VI L F + G+
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVCEGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRWYR 196
+Y+ N HRDL +N+L + D K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVV 237
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVEI 87
V+GKG +G VC+ TG+ A KK+ I + +A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSL 65
Query: 88 KHILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 66 AYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL + ++I D GLA + +T V T Y APE+
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG-----RVGTVGYMAPEVVK 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ +YT + D W +GC+ E++ GK F R R EK
Sbjct: 175 N--ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQRKEK 207
Query: 263 ARRYLSSMR-KKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYF 316
+R R K+ +S+KF + A + ++L +P R AEE A P+F
Sbjct: 208 VKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
Query: 317 KGL 319
+
Sbjct: 265 RTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLR---LLRHPDIVE 86
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAELLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A +DT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
V +RDLK NIL +A+ K+ DFG+ + + T T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
VIGKG +G V G+K+ A+K +N I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 205 FS-------KYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ K+T D+WS G + EL+T G P +P V DI LL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLL 216
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 71/253 (28%), Positives = 111/253 (43%), Gaps = 42/253 (16%)
Query: 22 GSRYKIE-------EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILRE 72
G +Y + IG G+ G V +TG +A+K++ E RIL +
Sbjct: 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMD 63
Query: 73 IKLLRLLRH--PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 130
+ ++ L H P IV+ + S D+++ ELM + L +++K PE
Sbjct: 64 LDVV-LKSHDCPYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILG 117
Query: 131 FL-YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ +++ L Y+ V HRD+KP NIL +A +K+CDFG++ D
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVD 167
Query: 189 YVA-TR-----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
A TR Y APE KY D+WS+G EL TG+ FP KN +
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEF 225
Query: 241 DIMTDLLGTPSPE 253
+++T +L P
Sbjct: 226 EVLTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK N+L + + K+ DFG+ + FN T+ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y P++D W++G + E+L G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+RDLK N++ +A+ +KI DFG+ + F T F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N HRDL +N L + LKI DFG++R T + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 205 FSKYTPAIDIWSIGCIFAELLTG 227
+ +YT D+WS G + E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 62/250 (24%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y A+D W +G + E++ G+ F ++ + +L +M D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 266 YLSSMRKKKP 275
LS + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 22/241 (9%)
Query: 30 VIGKGSYGVVCSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K K I + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL +A +K+ DFGL + + T T F T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF----CGTIEYMAPEILM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARV 258
S + A+D WS+G + ++LTG P F +N +D I+ L P +PEA +
Sbjct: 174 R--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL 231
Query: 259 R 259
+
Sbjct: 232 K 232
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ + IG G+YG V A + TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y DIW++G EL +P + + L +MT P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ K + +S F + +A L PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMA-------LTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 73/334 (21%), Positives = 132/334 (39%), Gaps = 78/334 (23%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+K +++GKG G V TG+ A+K ++ + R+L E ++L L H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P + + S + + +V + +L ++++ L+ E +F+ ++L
Sbjct: 61 PFLPTLYA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT----------- 187
L+Y+H + +RDLKP+NIL + + + DF L++ + + P +
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVN 174
Query: 188 ----------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGK 228
+V T Y APE+ G + A+D W++G + E+L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGT 229
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 288
F G N R+E L KK + F P ++
Sbjct: 230 TPFKGSN-----------------------RDETFSNIL-----KKEVTFPGSPPVSS-S 260
Query: 289 ALRLLERMLAFEPKDR----PTAEEALADPYFKG 318
A L+ ++L +P R A E P+F+G
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+E+ +G G +G V A Y+ T KVA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V++ ++ + IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATR 193
+I N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 31 IGKGSYG-VVCSAYDTRTGE--KVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVE 86
+G G++G VV Y ++G+ +VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDT----PTAIFWTDYVATRWYRAPEL 200
+ HRDL +N+L + KI DFG++R + TA W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNVVHQLD 241
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/250 (24%), Positives = 118/250 (47%), Gaps = 19/250 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
Y A+D W +G + E++ G+ F + + +L +M ++ R + +A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------RFPRTLSPEAKS 224
Query: 266 YLSSMRKKKP 275
L+ + KK P
Sbjct: 225 LLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVA+K + V L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
+ ++ ++ E IY++ E M + L +K+++ L P+ F Q+ G+ Y
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMAY 118
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ N+L + KI DFGLARV ++ TA I WT
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 --APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 31 IGKGSYGVV--CSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
+G+G +G V C YD TGE+VA+K K H++D + +EI++LR L H +
Sbjct: 12 LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHEN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
IV+ K I K ++ E + S L + + N + + + + Q+ +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRDL +N+L ++ ++KI DFGL + D D + ++ APE
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLT 226
SK+ A D+WS G ELLT
Sbjct: 185 --IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + D +KI DFG+ + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +G V T VA+K + D L E ++++ LRHP ++++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANV 147
+ E IY+V ELM+ L + ++ L Q+ G+ Y+ N
Sbjct: 70 C---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N+L + K+ DFGLARV D A I WT APE
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT---------APE- 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 175 -AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 56/310 (18%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
IG G+ G V TG A+K I + + D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +I V+ E M+ + D+ Q+L G+ Y+H ++
Sbjct: 139 DMF-----DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-----LCGS 203
HRD+KP N+L N+ +KI DFG++R+ T V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC--NSSVGTIAYMSPERINTDLNHG 247
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD---IMTDLLGTPSPEAIARVRN 260
+ Y A DIWS+G E G+ F V Q D +M + + PEA
Sbjct: 248 AYDGY--AGDIWSLGVSILEFYLGRFPFG---VGRQGDWASLMCAICMSQPPEA------ 296
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
P S++F + + L EP R +A + L P+
Sbjct: 297 --------------PATASREFRH-------FISCCLQREPAKRWSAMQLLQHPFILRAQ 335
Query: 321 KVEREPSAQP 330
+ +
Sbjct: 336 PGQGQGGPNL 345
|
Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 53/303 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDI 84
IEE +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 5 VIEE-LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 137
V L RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 138 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 197 APELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE ++ Y D+WS+G EL TG+ FP + + ++ PSP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP-- 226
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
++ EK FS +F + + + L K+RP E L P
Sbjct: 227 --QLPAEK---------------FSPEFQD-------FVNKCLKKNYKERPNYPELLQHP 262
Query: 315 YFK 317
+F+
Sbjct: 263 FFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES---DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+YT + D W +GC+ E++ G+ F G+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G++G V GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253
A E YT D+WS G EL+T G + G V D++ P P
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+GKG+YG V TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 145
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE----LC 201
N+ HRD+KP N+L N + ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK---NVVHQLDIMTDLLGTPSPEAIARV 258
+ YT D+WS+G E+ G+ +P + N+ QL + D G P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP------- 228
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
P +S +A + L ++ P RPT + L P+
Sbjct: 229 --------------TLPSGYS---DDAQDFVAKCLNKI----PNRRPTYAQLLEHPWLVK 267
Query: 319 LAKVERE 325
+ +
Sbjct: 268 YKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 26 KIEEVIGKGSYGVV-CSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + +G G +G V ++ T KVA+K + L E ++++ LRH +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKY 141
V++ ++ S IY+V E M + L +K + + Q+ G+ Y
Sbjct: 64 VQLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ NIL KI DFGLAR+ ++ TA I WT
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT------- 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
APE + + ++T D+WS G + EL+T G+ +PG N
Sbjct: 171 --APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E+IG+G +G V TG+KVA+K I D+ A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLRGLKYIH 143
++L +Y+V ELM + +L ++ + QF L + G++Y+
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAEGMEYLE 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVATRWYRAPEL 200
+ + HRDL +NIL + D K+ DFGLARV +++ + WT APE
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEA 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232
K++ D+WS G + E+ + G+ +P
Sbjct: 169 LKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 64/250 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFNDTPTAIF 185
+ IH HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 186 WTDY-----------------------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIF 221
V T Y APE+ F Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV---FLQTGYNKECDWWSLGVIM 229
Query: 222 AELLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 29 EVIGKGSYGVV-----CSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHP 82
+G+G++G V E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 127
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
DY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK NIL + D +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWTDYVATRWYRAPELCG 202
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAE 223
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 78/321 (24%), Positives = 125/321 (38%), Gaps = 50/321 (15%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E + + I E G+ G + D +T E V IK E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK--------AGQRGGTATEAHILRAIN 141
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 199
Y+H + HRD+K +NI N + + DFG A + + W +AT APE
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPE 253
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV------VHQLDIMTDLLGTPSP 252
L Y PA+DIWS G + E+ T LF + Q+ ++ GT
Sbjct: 254 LLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE----------RMLAFEPK 302
E + Y+ +K S + P + PL L E +MLAF+
Sbjct: 312 EFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 303 DRPTAE--------EALADPY 315
RP+AE + + DPY
Sbjct: 366 HRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/253 (24%), Positives = 119/253 (47%), Gaps = 25/253 (9%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLLGTPSPEAIARVRNEK 262
Y A+D W +G + E++ G+ P N H +L +M ++ R + +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEI-------RFPRTLSPE 221
Query: 263 ARRYLSSMRKKKP 275
A+ L+ + KK P
Sbjct: 222 AKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 84/313 (26%)
Query: 31 IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+GS+G+V A GE +VAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKHILL---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY- 133
+ ++ P VV ELM + DL +++ N L P Q F+
Sbjct: 73 RLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 134 --QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
++ G+ Y+ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYYR 176
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDI 242
+ RW APE +T D+WS G + E+ T + + G +
Sbjct: 177 KGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS------- 226
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERMLAF 299
NE+ +++ + + P + L L L+ +
Sbjct: 227 -----------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMRMCWQY 260
Query: 300 EPKDRPTAEEALA 312
PK RPT E ++
Sbjct: 261 NPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 26/254 (10%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 145
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + D +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLLGTPSPEAIARVRNE 261
+ Y A+D W +G + E++ G+ P N H +L +M ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 262 KARRYLSSMRKKKP 275
+A+ LS + KK P
Sbjct: 222 EAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 79/311 (25%), Positives = 121/311 (38%), Gaps = 68/311 (21%)
Query: 24 RY-KIEEVIGKGSYG-VVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILR-----EI 73
RY K V+G+G +G V YD TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 131
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVAFN-DT 180
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVH 238
P +FW A E K++ A D+WS G ELLT P K
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219
Query: 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERML 297
+ + R + + + +P P P + L++
Sbjct: 220 MIGPKQGQM--------------TVVRLIELLERGMRLP----CPKNCPQEVYILMKNCW 261
Query: 298 AFEPKDRPTAE 308
E K RPT
Sbjct: 262 ETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 18/234 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIA 256
+ Y + D +S+GC+ +LL G F H++D MT + P++ +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 38/290 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ + +G G+YG V A + TGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y DIW++G EL +P + + L +M+ P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP----------- 229
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ K +S F N ++ L PK RPTAE L
Sbjct: 230 --------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 30 VIGKGSYGVV--CSAY---DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPD 83
+G G++G V +AY + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 140
IV LL I V+ E DL ++ + LT E F YQ+ +G+
Sbjct: 101 IVN----LLGACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 87/332 (26%), Positives = 132/332 (39%), Gaps = 78/332 (23%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHP 82
RY I +IGKG G V AYD +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 137
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 138 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VAFNDT---- 180
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 181 -----PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP-- 232
P I V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FPYR 232
Query: 233 ---GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 289
G+ + ++ I SP +A R IP P
Sbjct: 233 RKKGRKISYRDVI-------LSPIEVAPYRE---------------IP---------PFL 261
Query: 290 LRLLERMLAFEPKDRPTAEEALAD---PYFKG 318
++ + LA +P +R ++ + L P+ +G
Sbjct: 262 SQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+++ +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
+ ++ + IY+V E M + L +K D + Q Q+ G+ YI
Sbjct: 65 PLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL+ NIL + KI DFGLAR+ ++ TA + +W APE
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ + ++T D+WS G + EL+T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 20/233 (8%)
Query: 8 KSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT 67
+S D+D +++ EV+G G+YG V +TG+ AIK + D+ E +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEE 57
Query: 68 RILREIKLLRLLRHPDIVEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKA 119
I EI +L+ H + + PP + +++V E +DL + K
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKG 115
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
N L + + ++LRGL ++H V HRD+K +N+L + ++K+ DFG V+
Sbjct: 116 NA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQL 171
Query: 180 TPTAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
T ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 70/311 (22%), Positives = 133/311 (42%), Gaps = 55/311 (17%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDT------RTGEKVAIKKINDIFEHVSDATRILREI 73
+++ +V+G G+YG V + +DT + +K A+ + EH +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+ + P +V + + ++ YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y APE+ + A+D WS+G + ELLTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAE 308
+ RN ++ ++ P P P A LL ++L +PK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 49/300 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
+YT + D W++GC+ E++ G+ +P + +++ E+
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVE 214
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
R + K+ +S+KF +P A L + +L +PK+R A E P FK +
Sbjct: 215 RLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 86/358 (24%), Positives = 148/358 (41%), Gaps = 57/358 (15%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
D T + +Y I V+G G+ G V A GE A+K ++ +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---P 125
+ L IV+ R +++ ++ +++ DL Q IK+
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHYQFFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
EH L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244
T + T +Y APE+ Y+ D++S+G + ELLT K F G+N+ ++M
Sbjct: 202 GRT-FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMH 255
Query: 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304
L A RY P+P P+ +P ++ +L+ +PK R
Sbjct: 256 KTL---------------AGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADPYFKGLAKVERE----------------PSAQPVTKMEFEFERRRITKE 346
P++ + L P K E TK + ERRRI ++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQ 346
|
Length = 496 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 45/293 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVF 148
LL + K ++++ E I D LT Q Q+L L+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK N+L D +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
TP DIWS+G E+ +P H+L+ M R
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPM---------------------R 222
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDRPTAEEALADPYFK 317
L + K +P SQ P+ + R L+ L P+ RP+A + L P+
Sbjct: 223 VLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 67/306 (21%), Positives = 135/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
+++ +V+G G+YG V S +D+ + + K I + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
R P +V + + ++ Y+ + + L Q + + Q + +++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
++ + A+D WS+G + ELLTG F + +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKNS 216
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR----PT-AEEALAD 313
+ E +RR L K +P P+ Q+ + LA +++R+L +PK R P+ A+E
Sbjct: 217 QAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 66/309 (21%), Positives = 129/309 (41%), Gaps = 52/309 (16%)
Query: 25 YKIEEVIGKGSYGVVCSA-----------YDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+++ V+G G+YG V Y + +K I + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y APE+ + A+D WS+G + ELLTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEA 310
+ +N ++ ++ K P P + A ++++L +PK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 23/236 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMT-----DLLGTPSPE 253
+ Y + D +S+GC+ +LL G F H++D MT +L + SPE
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVE 86
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIA 256
Y +D W +G + E+L G P F ++V D I+ L P + +A
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL 70
+ V F E GEG+ GK G + + + VAIK + + E
Sbjct: 5 SAVRFLEELGEGA-------FGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFR 56
Query: 71 REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQ----------VIKA 119
+E +L+ L+HP+IV + + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 120 NDDLTPEH---YQFFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ D T + FL Q+ G++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 174 RVAFNDTPTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 93 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAELLT-GKPLFPG 233
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIK-LLRLLRHPDIV 85
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHYSFQTADK-----LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCG 202
N+ +RDLKP+NIL ++ + + DFGL + + + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 29 EVIGKGSYGVVCSA--------YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+VIGKGS+G V A Y + +K AI K + +S+ +L+ +K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK------ 54
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP +V + + +Y V + + +L ++ +F+ ++ L
Sbjct: 55 HPFLVGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPE 166
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
+ Y +D W +G + E+L G P F +N D
Sbjct: 167 VLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E +G+G +G V T +VAIK + L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
++ ++ + IY+V E M + L +K Q Q+ G+ Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
I ++++ ++ ++Y+V E DL ++ +D E QF+L +L+ +
Sbjct: 63 IPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H HRD+KP+N+L + +K+ DFG AR+ N + V T Y APE+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSKLPVGTPDYIAPEV 174
Query: 201 C----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
G Y D WS+G I E++ G+ F
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N++ + D +KI DFG+ + F D + F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KYT ++D WS G + E+L G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/256 (23%), Positives = 119/256 (46%), Gaps = 23/256 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ E++G G+YG V +TG+ AIK ++ + + I +EI +L+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRN 64
Query: 85 VEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ + PP + +++V E +DL + K N L E + ++L
Sbjct: 65 IATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREIL 121
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
RGL ++H V HRD+K +N+L + ++K+ DFG V+ T ++ T ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 178
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
APE+ + + Y D+WS+G E+ G P +H + + + P+P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRNPAPR 235
Query: 254 AIARVRNEKARRYLSS 269
++ ++K + ++ S
Sbjct: 236 LKSKKWSKKFQSFIES 251
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 50/285 (17%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 141
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
+ R + + +P + P+A RL+ER ++P RP+
Sbjct: 204 QTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVS-----DATRILREIKLLRLLRHPDI 84
+G GS+G V+ + Y VAIK+ FE + E K+L + HP
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKR----FEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 85 VEIKHILLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V + FKD +Y+V E ++ + ++ N + F+ Q++ +
Sbjct: 94 VNL--------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + N+ +RDLKP+N+L + D +K+ DFG A+V T T T Y APE+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEI 199
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + A D W++G E+L G P F
Sbjct: 200 LLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKK 274
S G + E+ + G +PG ++ E +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 275 PIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
P NA P R++ +PK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 83/340 (24%), Positives = 135/340 (39%), Gaps = 60/340 (17%)
Query: 23 SRYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL---------- 70
+ +++ + + G++G +C A T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 71 -----REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND---D 122
EI L L H +I++I+ IL + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 123 LTPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND- 179
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP----GKN 235
W VAT +PE+ Y DIWS G I ++L+ P G
Sbjct: 322 EAFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGK 375
Query: 236 VVHQLDIMTDLLGT-----PSP-----EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 285
QL + D L P P + I + A + + + +P ++P
Sbjct: 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP-- 433
Query: 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
L +ML F+ RP A E LA P F A+ E E
Sbjct: 434 -------LVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 146
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
S + DIWS+G EL G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 53/245 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLR 77
R + + +G+G++G V A D VA+K + D D + ++ E+++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ LL +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPTAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GK 228
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 37/308 (12%)
Query: 24 RYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+Y I + GS G VC+ + +KV +K V+ REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKA-------VTGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+ + H + R + +V + DL + + L E +LL L Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTPSPEAIA 256
L Y DIWS G + E+ GK V QL + + E
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF-- 313
Query: 257 RVRNEKAR------RYLSSMRKKKPIPFSQKFPNANPL--ALRLLERMLAFEPKDRPTAE 308
+N +Y ++ + P L+ +ML F+ + RP+A+
Sbjct: 314 -PQNGSTNLCKHFKQY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370
Query: 309 EALADPYF 316
+ L+ P F
Sbjct: 371 DILSLPLF 378
|
Length = 392 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 46/285 (16%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E++GKG++G V + VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L + LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
+Y+ D+WS G + E + G +PG MT N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG---------MT---------------NQQAR 204
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ K + QK P+ ++++R ++P++RP E
Sbjct: 205 E---QVEKGYRMSCPQKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 30 VIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLR 137
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-------- 189
G++Y+ + N HRDL +N + N + + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
IG+G++G V +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKHILLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFFL----Y 133
L F+ D ++ ELM+ L ++V+K+ PE L
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---ILGKIAV 114
Query: 134 QLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I T
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGC 170
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQL 240
R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 NDTPTAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPGKNV 236
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGE--KVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDI 84
+ +G GS+GVV + T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 141
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYR---- 196
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 197 ---APELCGSFFSKYTPAIDIWSIGCIFAELLT 226
APE ++ A D+W G E+ T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIKLLRLLRHP 82
Y + +VIG+G++G V ++ +KV K+ FE + SD+ E ++ P
Sbjct: 45 YDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ L I
Sbjct: 104 WVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HRD+KP N+L + LK+ DFG + TA+ DY+ +P
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI------SP 212
Query: 199 ELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E+ S Y D WS+G E+L G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 110 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 226
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 227 GKPLFPGKNV 236
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I+ E + + EI +L HP+IV+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVK---- 66
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
LL E +++++ E + + LT + Q L L Y+H +
Sbjct: 67 LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK NIL D +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+V+G G++G V GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKP 229
+ K+T D+WS G EL+T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + IGKG +G V D R G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDVMLG-DYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFWTDYVATRWYRAPE 199
N HRDL +N+L + D K+ DFGL + A + T + WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVVHQLD 241
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 31 IGKGSYGVVCSAYDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+G G +GVV Y G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 90 ILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 67 VC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDL +N L + +K+ DFGL+R +D T+ + + RW PE+ +SK
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYSK 177
Query: 208 YTPAIDIWSIGCIFAELLT-GK 228
++ D+W+ G + E+ + GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEK-----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + +G+G +G V A R + VA+K + + S+ +L E LL+ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNH 62
Query: 82 PDIVEI-----------------KHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-- 122
P ++++ K+ L RE + + + + + + N D
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 123 -LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 183 YVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPG 233
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 3 PDQRKKSSADVDFFTEYGE-----------GSRYKIEEVIGKGSYGVVCSAYDTRTGEKV 51
P RK + D +F Y + Y++ +VIG+G++G V T +
Sbjct: 13 PALRKNKNID-NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 71
Query: 52 AIKKINDIFEHV--SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109
A+K ++ FE + SD+ E ++ P +V++ + ++ + +Y+V E M
Sbjct: 72 AMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYM 125
Query: 110 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +N D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ D
Sbjct: 126 PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 170 FG----LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAE 223
FG + + TA+ DY+ +PE+ S Y D WS+G E
Sbjct: 186 FGTCMKMNKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 224 LLTGKPLFPGKNVV 237
+L G F ++V
Sbjct: 240 MLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 21/223 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + E++ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKHILLPPSRREFKD---IYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
I + F+D +Y+V + + DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRW 194
+ IH + HRD+KP N+L + + +++ DFG D + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+A E KY P D WS+G E+L G+ F +++V
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 15/220 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + +KV KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRWYRA 197
+H + HRD+KP NIL + + +++ DFG D + A+ DY++ +A
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E KY P D WS+G E+L G+ F +++V
Sbjct: 178 ME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSA---YDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 82 PDIVEIKHILLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLY 133
P+++++ + S + V+ M+ DLH ++ + PE F+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 189
+ G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQG 172
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 173 RIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRIL---REIKLLRLLRHP 82
+G+G +G V A + GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHYQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244
+ RW APE ++ D+WS G + E+ T G+ F G ++
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---------LS 223
Query: 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKD 303
D E + R++ K P P L +L+ R A PKD
Sbjct: 224 D------EEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 62/307 (20%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLRHPD 83
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 138
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + D ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
EL +Y ++D +++G E++ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 259 RNEKA-RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALA 312
R EK + L + + KF +P + E +LA +P+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKF---SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 313 DPYFKGL 319
P F+ L
Sbjct: 257 HPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 77/319 (24%), Positives = 127/319 (39%), Gaps = 66/319 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ Y++ + IG G +G V RT E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 137
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 138 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 173
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + V T +Y +PEL Y D+W++GCI EL +GK F
Sbjct: 190 K----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
N QL +S +++ +P K N L+
Sbjct: 246 ANNFSQL--------------------------ISELKRGPDLPIKGKSKELN----ILI 275
Query: 294 ERMLAFEPKDRPTAEEALA 312
+ +L K+RP+A + L
Sbjct: 276 KNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
KI E +G G+ GVV +G +A K I+ + A R I+RE+++L P
Sbjct: 9 KISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPY 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 65 IVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFP 232
G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 175 QGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 22/123 (17%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 51 VAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108
VA+K + SD R L+E+K+L L P+I LL + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIAR----LLGVCTVD-PPLCMIMEY 100
Query: 109 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 156
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 157 ILANADCKLKICDFGLARVAF-ND-------TPTAIFWTDYVATRWYRAPELCGSFF-SK 207
L + +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 208 YTPAIDIWSIGCIFAELLT 226
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEI-- 87
+GKG +G VC+ TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 -----KHILLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ ++ +RD+KP+N+L + ++ D GLA + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQRAGTNGYMAPE 164
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ Y+ +D +++GC E++ G+ F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
VIG+GSY V +T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
Y ++D W++G + E++ G+ F DI+ + +P+ + Y
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF---------DIVGM---SDNPD-------QNTEDY 212
Query: 267 LSSMRKKKPIPFSQKFPNANPL-ALRLLERMLAFEPKDR--PTAEEALAD----PYFK 317
L + +K I + P + + A +L+ L +PK+R + D P+F+
Sbjct: 213 LFQVILEKQI----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 125
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVE 86
+I G+YG V T ++ A+KKIN I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ S + + +V E +E D ++K L + + + + + L+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPELCGS- 203
+ HRDLKP N+L + +K+ DFGL+++ T ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 204 --------FFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +D W++G I E L G F G
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 112 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227
DFG ++ ++D+ + + + T +Y APEL +Y+ D+WS+G I ELLT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 228 KPLFPGKNVVHQLDIMTDLL-GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
F G + Q +IM +L G P P P S
Sbjct: 268 HRPFKGPS---QREIMQQVLYGKYDP---------------------FPCPVSSGMK--- 300
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
LL+ +L+ P RPT ++ L + K +A + ++
Sbjct: 301 ----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 48/236 (20%)
Query: 24 RYKIEEVIGKGSYGVV--CSA----------YDTRTGEK--VAIKKINDIFEHVSDATR- 68
+ +++E +G+G +G V C A G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 69 ----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI------ 117
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 118 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
G++R ++ I + RW + K+T A D+W+ G E+ T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 31 IGKGSYGVV--------CSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+G+G++G V C D VA+K + D SD R RE +LL L+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKIL---VAVKTLKD----ASDNARKDFHREAELLTNLQ 65
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPE 126
H IV+ + + E + +VFE M+ DL++ ++A+ +LT
Sbjct: 66 HEHIVKFYGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
Q+ G+ Y+ + + HRDL +N L + +KI DFG++R ++ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW PE + K+T D+WS+G + E+ T
Sbjct: 181 HTMLPIRWM-PPE--SIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 46/293 (15%)
Query: 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
+ +G+G +G V + KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKHILLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 138
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
V N + YL R K+P P+ L+ PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 59/246 (23%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 89 HILLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
IL+ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF------------- 177
+ IH HRD+KP N+L +A +K+ DFGL R F
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 178 ----NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225
N A W V T Y APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 53/243 (21%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+K + D+ E H+ IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ S ++ ++Y++ E + D+ ++ D LT E QF++ + + +
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF---------------- 177
IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 178 -NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
N A W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEK----VAIKKIND-----IFEHVSDATRILREIKLLRLL 79
+++G G +G V G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 22/247 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL--RLLRHPDIVEI 87
VIG+GSY V + + A+K + H + ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR +++V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +AD +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266
+Y ++D W++G + E++ G+ F DI+TD + + + +V EK R
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRI 222
Query: 267 LSSMRKK 273
+ K
Sbjct: 223 PRFLSVK 229
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 51/227 (22%)
Query: 31 IGKGSYGVV----CSAYDTRTGEK-VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+G+G++G V C + VA+K + + S++ R RE +LL +L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQH 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEH 127
IV + E + + +VFE M DL++ ++++ LT
Sbjct: 69 IVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ T
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYST 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DY + RW PE + K+T DIWS G + E+ T
Sbjct: 176 DYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRHPDIVEI 87
VIG+GSY V +T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +++ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE F YT D+WS G + E+ T G +PG
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 22 GSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIK 74
R K E+ VIG+G++G V + + A+K ++ FE + SD+ E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERD 95
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
++ IV++ + K +Y+V E M DL ++ +N D+ + +F+
Sbjct: 96 IMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTA 149
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDY 189
+++ L IH+ HRD+KP N+L + LK+ DFG + TA+ DY
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 190 VATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ +PE+ S Y D WS+G E+L G F
Sbjct: 210 I------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 50/214 (23%)
Query: 50 KVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVFE 107
KVA+K + +D E D + ++ E+++++++ +H +I+ LL ++ +YV+ E
Sbjct: 52 KVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIIN----LLGACTQD-GPLYVIVE 104
Query: 108 LM-ESDLHQVIKA----------NDDLTPEHYQFF------LYQLLRGLKYIHTANVFHR 150
+ +L + ++A N PE F YQ+ RG++Y+ + HR
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--------VATRWYRAPELCG 202
DL +N+L D +KI DFGLAR I DY + +W APE
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKKTTNGRLPVKWM-APE--- 212
Query: 203 SFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ F + YT D+WS G + E+ T G P +PG
Sbjct: 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y R + VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 89 HILLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW---YRAPELCGS 203
HRDL +N+L KI DFGL++ D ++ A +W + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN- 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLT--GKP 229
F K++ D+WS G E + KP
Sbjct: 172 -FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR + DY
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVHDIDYYKK 192
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 193 TSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVVCSA--YD-TRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+G++G V A Y+ + T +K VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHY 128
+ + + + +VFE M+ DL++ ++A +L
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R ++ +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATR--ILR 71
E R IE V IG+G++G V A VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 121
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 122 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DFGL+R ++ D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K ++VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 125
+I+ ++L R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPT 182
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-- 181
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 182 ----MGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 55/244 (22%)
Query: 23 SRYKIEEVIGKGSYGVV--CSA------------YDTRTGEK--VAIKKINDIFEHVSDA 66
+E +G+G +G V C ++ R G VA+K + DA
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR------PDA 58
Query: 67 TR-----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA- 119
+ L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q + +
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSH 113
Query: 120 ---------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANA 161
ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
Query: 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTL 230
Query: 222 AELL 225
E+L
Sbjct: 231 WEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKHILLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 132
E + +L+ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTD 188
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y++ +A E +Y P D WS+G E+L G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLL 79
+ +K +V+G G++G V GEKV I I ++ E S IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLR 137
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ YT D+WS G EL+T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 31 IGKGSYGVVC--SAYD---TRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 136
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 31 IGKGSYGVVC--SAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI---- 84
IG G +G V A+ + +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 85 ---VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQL 135
+E LL V E DL +++N + Q ++
Sbjct: 62 GQCIESIPYLL------------VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD---YVAT 192
GL ++H A+ H DL +N AD +KI D+GL A P + T V
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPL 166
Query: 193 RWYRAPELCGSFFS-----KYTPAIDIWSIGCIFAELLT 226
RW APEL T +IWS+G EL T
Sbjct: 167 RWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA--YDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLR 77
S + E +G+ +G V + T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI----------KANDD---- 122
L+HP+IV LL +E + + ++F SDLH+ + +DD
Sbjct: 64 RLQHPNIV----CLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 123 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L P + + Q+ G++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW +PE + K++ DIWS G + E+ +
Sbjct: 179 YYKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 46/232 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K E+VIG+G++G V A + G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 129
+I+ ++L R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 130 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFND 179
QLL+ G++Y+ HRDL +N+L + KI DFGL+R V
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
T + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 T------MGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRL 78
S + E +G+ ++G + + G + VAIK + DI + +E L+
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAE 63
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFE-LMESDLHQVI-----------KANDDLTP- 125
L HP+IV LL +E + + ++FE L + DLH+ + +++D T
Sbjct: 64 LHHPNIV----CLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 126 ---EHYQFF--LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+H F Q+ G++Y+ + H+DL +NIL +KI D GL+R ++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW PE + K++ DIWS G + E+ +
Sbjct: 179 YYRVQPKSLLPIRWM-PPE--AIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 65/255 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E +++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + ++ PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGL----------------ARVAFNDTPTAI 184
+H HRD+KP NIL + D +K+ DFGL + + + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 185 FWTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWS 216
W D V T Y APE+ YT D WS
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWS 233
Query: 217 IGCIFAELLTGKPLF 231
+G I E+L G+P F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGEKVAIKKINDIFEHVSDA--TRILREIKLL 76
R + +++ +G++G + E+V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 77 RLLRHPDIVEIKH----------ILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 125
L H +I+ I H +L P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ +W L +S A D+WS G + EL+T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLLRHPDIVE 86
V+G G++G V GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 87 IKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNV 236
++T D+WS G EL+T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 82/348 (23%), Positives = 128/348 (36%), Gaps = 100/348 (28%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIF-----EHVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E ++R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + + PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------------- 185
+H HRD+KP NIL + D +K+ DFGL F T + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 186 --WTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIW 215
W D V T Y APE+ + YT D W
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWW 232
Query: 216 SIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
S+G I E+L G+P F L TP + K + +S+
Sbjct: 233 SVGVILYEMLVGQPPF--------------LAQTPLETQM------KVINWQTSLH---- 268
Query: 276 IPFSQKF-PNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGL 319
IP K P A+ L ++L P+DR A+E A P+FK +
Sbjct: 269 IPPQAKLSPEASDLIIKLCR-----GPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
GL ++ TP+ Y T Y +PE + G Y + D W++G + ELLTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 47/230 (20%)
Query: 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKL 75
E G+GS + E I KG VV +TR VAIK +N E S RI L E +
Sbjct: 13 ELGQGSFGMVYEGIAKG---VVKDEPETR----VAIKTVN---EAASMRERIEFLNEASV 62
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEH 127
++ +V + ++ + + V+ ELM DL +++ N P
Sbjct: 63 MKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117
Query: 128 YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
+ + ++ G+ Y++ HRDL +N + D +KI DFG+ R I
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ TDY + RW L F+ Y+ D+WS G + E+ T
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLR 77
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 133
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ + ++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLL + YIH + HRD+K +N+L N + + DFG A A T + T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTV 326
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTGKPLFPGKN-------------VVHQ 239
APE+ YTP++DIWS G IF + LF ++ Q
Sbjct: 327 DTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 299
+ D A +R+ ++ R + R P ++ + L+ R L F
Sbjct: 385 AQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441
Query: 300 EPKDRPTAEEALADPYFK 317
+ RP+A E L P F+
Sbjct: 442 DGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHPDIV 85
+VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 137
++L R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWT 187
G+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT------M 170
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 171 GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 39/156 (25%), Positives = 55/156 (35%), Gaps = 59/156 (37%)
Query: 125 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL T
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC--------TG 150
Query: 184 IFWT------------------------------------------------DYVATRWY 195
WT V T Y
Sbjct: 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
APE+ + YT D WS+G I E+L G+P F
Sbjct: 211 IAPEVLLR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LR 71
E SR KI + +G+GS+G+V A D GE +VA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 123
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 124 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 181 PTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 115 QVIKANDDLTPE--HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ + + +TP+ Q ++ GL ++H N H DL +N L AD +KI D+GL
Sbjct: 87 RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAELL 225
+ + + +V RW APEL T ++WS+G EL
Sbjct: 147 SHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK------KINDIFEHVSDATRILREIKLLRLLRHPDI 84
I +G++G V + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ HRDLKP N+L + + +K+ DFGL++V N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVAT 192
+++ L +H + RDL P NIL + +++ F + V + A+
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------E 145
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
Y APE+ G S+ T A D WS+G I ELLTGK L
Sbjct: 146 NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 31/213 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI----- 84
IG G +G V+ S T TG + K + L++ R+L+HP+I
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 85 --VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLR 137
VE LL VFE E DL + L ++
Sbjct: 63 QCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ ++H N H DL +N +D +K+ D+G+ + + V RW A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169
Query: 198 PELCGSFF-----SKYTPAIDIWSIGCIFAELL 225
PEL G F ++ T ++W++G EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ KIE ++G G +G +C ++ VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 133
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-DYVAT 192
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 75/330 (22%), Positives = 122/330 (36%), Gaps = 48/330 (14%)
Query: 30 VIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 138
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY----VATRW 194
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT----- 249
+ +PE+ Y DI+S+G EL G P K++ ++ L GT
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLL 231
Query: 250 -----PSPEAIARVRNEKARRYL------SSMRKKKPIPFSQKFPNA-NPLALRLLERML 297
P+ E + A L S+ R S + +P +E+ L
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291
Query: 298 AFEPKDRPTAEEALADPYFKGLAKVEREPS 327
P RP+A L +FK +++R S
Sbjct: 292 QRNPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 30 VIGKGSYGVVCSA-YDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V Y R G+ +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR------ 137
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 138 -GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDY-- 189
G KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+ +W PE L G F SK D+WS G + E+ + G +PG+
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 80/330 (24%), Positives = 137/330 (41%), Gaps = 66/330 (20%)
Query: 31 IGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR-EIKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHT 144
+ S ++V+ M + ++K + ++ L+ LRGL Y+H
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ 119
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFNDTPTAIFWTDYVAT 192
HR++K +IL + D + + GL A+V + D P F T +
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTSVLP- 173
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS- 251
W +PEL Y DI+S+G EL TG+ P ++++ ++ L G P
Sbjct: 174 -WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKGPPYS 229
Query: 252 -------PEAIARVRNEKA---------------RRYLSSMRKKKPIP--FSQKFPNANP 287
P +R++N ++ + ++S R + P FS F N
Sbjct: 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN--- 286
Query: 288 LALRLLERMLAFEPKDRPTAEEALADPYFK 317
L+E L +P+ RP+A L+ +FK
Sbjct: 287 ----LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 62/237 (26%), Positives = 89/237 (37%), Gaps = 76/237 (32%)
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVAFNDTPTAI 184
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY-LSSMRKKKPIPFSQK 281
++ FP L + S I R K Y L + RK
Sbjct: 371 QM-----AFPN-------------LRSDS-NLIQFNRQLKRNDYDLVAWRKLVE------ 405
Query: 282 FPNANP--------------LALRLLERMLAFEPKDRPTAEEALADPYF--KGLAKV 322
P A+P LL+ M+ F+ + R +A+ ALA PYF +GL +
Sbjct: 406 -PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGL 461
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S K E VI +G G + G + +K+IND+ + EI + L+HP
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV------NSIPSSEIADMGKLQHP 743
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV++ + R K Y++ E +E +L +V++ +L+ E + + + L++
Sbjct: 744 NIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 142 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+H + V +L P+ I+ + + + L + DT I + Y AP
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAP 847
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
E + T DI+ G I ELLTGK
Sbjct: 848 ETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.64 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.56 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.31 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.2 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.06 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.27 | |
| PLN02236 | 344 | choline kinase | 96.01 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.17 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.09 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.9 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.56 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.57 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 92.24 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.35 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.62 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-77 Score=596.22 Aligned_cols=342 Identities=60% Similarity=0.995 Sum_probs=324.6
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
+.|.+..+|..++.||+|+||+||.|.++.+|+.||||+|.+.|.+...+++.+||+++|+.++|+||+.+++++..+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 44777888888999999999999999999999999999999999999999999999999999999999999999998788
Q ss_pred CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+.+.++|+|+|+|+.||+++|+.+..+++++++++++|||+||+|+|++||+||||||+|+|+|.+|.+||||||||+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... ....+++.++.|+||+|||++... ..|+.++||||+||||+||++|+++|+|++..+|+..|++++|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 665 556678999999999999999764 899999999999999999999999999999999999999999999999999
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchh
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (558)
.+.++.++.|+++++...+.+|...|+++++.++||+++||.+||.+|+|++|+|+||||..++.+++||++++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988876554
Q ss_pred hHhhhcCCHHHHHHHHHHHHHhhChhhH
Q 008644 337 EFERRRITKEDVRELIYREILEYHPQML 364 (558)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei~~~~p~~~ 364 (558)
++.. ++.+++++++|+|+++|+|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4444 8999999999999999999643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=479.67 Aligned_cols=338 Identities=94% Similarity=1.478 Sum_probs=308.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667789999999999999999999998766655566799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
+|||||+++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
..+...+||+.|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 34566789999999999865435788999999999999999999999999999999999999999999999999998888
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhHhhhcC
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRI 343 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (558)
..++..+....+.++...++.+++.+.+||.+||+.||++|||++|+|+||||+++....+.+...+...+.+.++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88999888888888888889999999999999999999999999999999999999998888999999999999999999
Q ss_pred CHHHHHHHHHHHHHhhCh
Q 008644 344 TKEDVRELIYREILEYHP 361 (558)
Q Consensus 344 ~~e~~~e~i~~ei~~~~p 361 (558)
+.+++++.+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=463.11 Aligned_cols=285 Identities=36% Similarity=0.701 Sum_probs=246.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|+.+.++|+|+||+||+|+++.||+.||||++.....+..-.+-.+|||++|++|+|+|+|.++++|- ..+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 4799999999999999999999999999999999866556666677899999999999999999999994 34569
Q ss_pred EEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
++|||||+.++.+.+... ..++++.++.+++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 999999998777777664 4699999999999999999999999999999999999999999999999999998753
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....++|+.|+||+|||++.|. ..|++++|||++||++.||++|.++|+|.++++|+..|.+.+|.-.+.-..-....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 22356899999999999999875 78999999999999999999999999999999999999999998877654332221
Q ss_pred HHHHHHhhhcc---CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.++..++- ..+.++...+|+++..+.||+++||..||.+|++.+|+|.|+||.++
T Consensus 233 ---~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 ---PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ---CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 12222222 22345556789999999999999999999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-59 Score=446.13 Aligned_cols=287 Identities=43% Similarity=0.715 Sum_probs=251.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+|..++.||+|.||+||+|+|..||+.||||+|+............+|||++|+.++|+||+.++++|...+ .+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 5899999999999999999999999999999999854334344567889999999999999999999995544 69
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
.||+|||+.||..+|+.+. .++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998765 599999999999999999999999999999999999999999999999999998754433
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
. .+..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.+.|+|.++.+|+..|...+|+|.++.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2445899999999999875 68999999999999999999999999999999999999999999999999877543
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
. +|.+ +......+....|+.++.++.||+.+||.+||.+|+|+.|+|+|+||+....
T Consensus 233 p--dY~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 233 P--DYVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred c--cHHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 2 2222 1223334445589999999999999999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-59 Score=480.62 Aligned_cols=287 Identities=37% Similarity=0.614 Sum_probs=251.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|+.+++||+|.||.||+|++..||+.||+|++..............|||.||++|.||||++|.++.+.. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4679999999999999999999999999999999986655666777888999999999999999999998765 2357
Q ss_pred EEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||||+.||.-++...+ .|++.+++.|++||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999998754 79999999999999999999999999999999999999999999999999999875444
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.. .++..+.|+||+|||+|.|. ..|+.++|+||+||||.||++|++.|+|++.++|+..|.+++|+|..+.|....-
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 32 36889999999999999874 7899999999999999999999999999999999999999999999998873322
Q ss_pred HHHHHHHhhhcc--CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 261 EKARRYLSSMRK--KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 261 ~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+ ..+.. .....+.+.|..+++.+++|+..||..||.+|.||.++|.|+||..
T Consensus 350 P~~----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 PHA----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred Ccc----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 211 11111 1122344557888999999999999999999999999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=479.81 Aligned_cols=292 Identities=39% Similarity=0.689 Sum_probs=255.4
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~ 97 (558)
..+.+||.+++.||.|+||.||+|..+.+|+.||||++++.+....+.-. +||++.|++|. |||||+|++++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~-- 82 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND-- 82 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC--
Confidence 34567999999999999999999999999999999999987776555444 58999999998 999999999996543
Q ss_pred CCccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+|||||+.+|.++++.++ .|++..++.|++||++||+|+|.+|+.||||||+||||..+..+||+||||||..
T Consensus 83 --~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 83 --RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred --ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 3799999999999999999865 5999999999999999999999999999999999999999999999999999977
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.+..+ .++|+.|+||+|||+|... ..|+.++|||++|||++|+.+-+++|+|.+..+|+.+|++++|+|..+.+.
T Consensus 161 ~SkpP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccCCC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 55443 4889999999999998664 679999999999999999999999999999999999999999999988776
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
...+ -+...--.+....+.++...++.+++++.+||.+||.+||.+||||+|+|+||||+.-..
T Consensus 236 eg~~-La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 236 EGYN-LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hHHH-HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 5411 111111123455667778889999999999999999999999999999999999986443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-58 Score=450.63 Aligned_cols=289 Identities=39% Similarity=0.624 Sum_probs=250.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|+.+..|++|+||+||+|+|+.|++.||+|+++..-......-.-+|||++|.+++|||||.+..+.+..+. ..+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---cee
Confidence 57999999999999999999999999999999998654444445556899999999999999999999876543 469
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|||||||+.||..++...+ +|...+++.++.|+|+||+|||.+.|+||||||+|+|++..|.+||+||||||.+.+...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999999999999998865 899999999999999999999999999999999999999999999999999998765422
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.++..+.|.||+|||+|.+. ..|+.++|+||+|||++||++++++|+|.+..+|+++|..++|+|+...|......
T Consensus 233 ---~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 ---PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred ---cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 35788999999999999885 78999999999999999999999999999999999999999999999988776554
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+...+. +.......+...|+.. +....+|+..+|.+||.+|.||+|+|+|.||...
T Consensus 309 p~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 309 PAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred chhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 4333221 1222233344445544 4899999999999999999999999999999964
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=457.29 Aligned_cols=263 Identities=36% Similarity=0.596 Sum_probs=222.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-----hHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
+.+.|.+.+.||+|+||.|.+|+++.||+.||||+|++..... .....+.+|+++|++|+|||||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 4567999999999999999999999999999999998543221 1234468999999999999999999999544
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEeecc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~DFG 171 (558)
...|||||||+ |+|.+.+..++.+.++..+.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 249 ----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 249 ----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 35899999998 5999999999999999999999999999999999999999999999999877 889999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGT 249 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~lg~ 249 (558)
+|++...+ .++.+.|||+.|.|||++.+....+. .++||||+||+||.+|+|.+||.+....- ..++|.
T Consensus 325 lAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~----- 395 (475)
T KOG0615|consen 325 LAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL----- 395 (475)
T ss_pred hhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh-----
Confidence 99987533 36788999999999999976433444 48999999999999999999998765332 222222
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+......+..|..++.++++||.+||..||++|||++|+|+||||+..
T Consensus 396 ----------------------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 396 ----------------------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ----------------------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 222222335677889999999999999999999999999999999854
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=437.39 Aligned_cols=286 Identities=40% Similarity=0.688 Sum_probs=248.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|+-.+++|+|+||+||.|....+++.||||++-. +.+--.+|+.+|+.+.|||||++...|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~------d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ------DKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecC------CCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 58889999999999999999999999999999842 111224799999999999999999988765433334677
Q ss_pred EEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccceeccC
Q 008644 104 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFN 178 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~~~~~ 178 (558)
+|||||+.+|.++++. +..++.-.++-+++||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999984 5679999999999999999999999999999999999999987 9999999999999877
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
+.+. .+|+.|+.|+|||++.|. ..|+.++||||.||+++||+.|++.|+|.+..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 7665 678999999999999884 78999999999999999999999999999999999999999999999999877
Q ss_pred hhHHHHHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
....... ........++.. .+...++++.+|+.++|..+|.+|.++.|+|+||||..+....
T Consensus 254 n~~y~~~---~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYTEF---KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Ccccccc---cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 6543211 122233344444 5678899999999999999999999999999999999987663
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=453.11 Aligned_cols=263 Identities=33% Similarity=0.572 Sum_probs=233.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+|+..+.||+|+|..||.+++..+|+.||+|+|.+ .........++.+||+|.+.|+|||||++++.| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 689999999999999999999999999999999975 344566778899999999999999999999999 55568
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||+|+|. ++|..++++++.++|.++++|++||+.||.|||+.+|+|||||..|+|++++..|||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999998 7999999999999999999999999999999999999999999999999999999999999999876553
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.. ..+.||||.|.|||++.. ..++..+||||+|||||.||.|+|||...+..+.++.|...
T Consensus 173 Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------- 233 (592)
T KOG0575|consen 173 ER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------- 233 (592)
T ss_pred cc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence 33 367899999999999986 78999999999999999999999999998888777766531
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (558)
.. .....++.+|.+||.+||+.||.+|||++++|.|+||+.-..+...+
T Consensus 234 ------------~Y-----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 234 ------------EY-----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred ------------Cc-----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 01 11236789999999999999999999999999999996544444443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=430.64 Aligned_cols=293 Identities=38% Similarity=0.669 Sum_probs=251.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC-ccccceeecCCCc-CCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSR-REF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn-Iv~l~~i~~~~~~-~~~ 99 (558)
...|+.++.||+|+||+||+|+++.+|+.||+|++........-.....||+.+|+.|+|+| |+.+++++...+. ...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34578889999999999999999999999999999865544344456789999999999999 9999999976542 334
Q ss_pred ccEEEEEecCcccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 100 KDIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~----~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+||||++.||..++.... .++...++.+++||++||+|||++||+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4799999999999999998765 588899999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..-.. ...+..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.+..+|+..|.+++|+|+.+.|
T Consensus 170 ~~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 43222 125778999999999999875 57999999999999999999999999999999999999999999999988
Q ss_pred HHhhhHHHHHHHhhhccCC-CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKK-PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+..-...+. ..+... +.++....+..++.+.+|+.+||+.||.+|.|++.+|.||||..+.
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 77643221111 222333 5566667788889999999999999999999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=419.30 Aligned_cols=260 Identities=29% Similarity=0.515 Sum_probs=227.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
--.+.|+++++||+|+||+||.++.+.|++.||+|++++. .....+...+.+|..||..++||+||.++..|.+.
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~---- 97 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE---- 97 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC----
Confidence 3467899999999999999999999999999999999853 23335678899999999999999999999998554
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|+||+. |+|+..+++.+.|+|+.+++++.+|+.||.|||+.|||||||||+|||+|.+|.++|+||||++...
T Consensus 98 -~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 98 -EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred -CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 47999999998 5999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.+... ..++|||+.|||||++.+ ..|+.++|.|||||++|+|++|.+||.+.+....++.|...
T Consensus 177 ~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~----------- 240 (357)
T KOG0598|consen 177 KDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG----------- 240 (357)
T ss_pred cCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-----------
Confidence 43322 255899999999999988 69999999999999999999999999999877766665431
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCC----CHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRP----TAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~mL~~dP~~Rp----ta~elL~hp~f~~~~ 320 (558)
+ ....+. ++.++++||+++|..||.+|. ++++|-+||||.++.
T Consensus 241 ----------------k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 241 ----------------K----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ----------------c----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 1 112234 789999999999999999995 799999999999753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=420.37 Aligned_cols=261 Identities=28% Similarity=0.493 Sum_probs=223.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+..+.++.||+|+.|+||+|+|+.|++.+|+|+|.. ..+....+++.+|+++|+..+||+||.+|++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 467888999999999999999999999999999953 3455677889999999999999999999999976531 59
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+ |+|..+++..++++|..+..++.+|++||.|||. .+||||||||+|||||..|.|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999998 6999999998999999999999999999999995 99999999999999999999999999999876554
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
...+++||..|||||.+.+ ..|+.++||||||+.+.||++|+.||... .....+.++..++..|++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP------ 300 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP------ 300 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC------
Confidence 2367899999999999988 78999999999999999999999999764 223333333333322222
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.+... .+++++++||..||++||.+|+|+.|+|+|||+++...
T Consensus 301 ------------------~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 301 ------------------RLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ------------------CCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 11111 47999999999999999999999999999999986543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-53 Score=414.34 Aligned_cols=341 Identities=38% Similarity=0.688 Sum_probs=295.6
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-c
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-R 96 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-~ 96 (558)
.|-+..||.-++.+|.|+- .|..|.|..++..||+|++...+.+....++..+|+.++..+.|+||++++.+|.+.. .
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 3566889999999999999 8999999999999999999888888888899999999999999999999999997643 3
Q ss_pred CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
.++..+|+|||+|..+|.+++.- .++-+.+.+|++|+++|++|||++||+||||||+||+++.+|.+||+|||+|+..
T Consensus 91 ~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 56778999999999999999983 5888999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..+ ...++++.|+.|+|||++.+ ..|...+||||+|||+.||++|+.+|+|.+..+|+.+|.+.+|+|.+.++.
T Consensus 169 ~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 169 DTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred Ccc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 433 35689999999999999988 569999999999999999999999999999999999999999999999998
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCC------------CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 324 (558)
++. +.++.|+..+.+.....+...||+. +..+++|+.+||..||++|.+++++|+||||+-| -..+
T Consensus 243 qL~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw-~~~~ 320 (369)
T KOG0665|consen 243 QLQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW-YDPD 320 (369)
T ss_pred Hhh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee-cccc
Confidence 875 4567777777666666666655543 3569999999999999999999999999999944 4444
Q ss_pred CCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhHHhhhc
Q 008644 325 EPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLE 369 (558)
Q Consensus 325 ~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~~~ 369 (558)
++..++....+..++.+..+.++|+|+||+|+.+|.+....+.++
T Consensus 321 ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~~~~I~~ 365 (369)
T KOG0665|consen 321 EVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFNKNNIMN 365 (369)
T ss_pred cccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcccccchhhc
Confidence 554544445556677788889999999999999998854444443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=422.94 Aligned_cols=337 Identities=56% Similarity=0.998 Sum_probs=292.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|.++++|++.+.||+|+||+||+|++..++..||||++............+.+|+.+|+.++|+||+++++++.......
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 45788999999999999999999999999999999998765444455667889999999999999999999886655455
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+|+||++++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999999888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+..+
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 21 123456789999999987642 35888999999999999999999999999999999999999999998888777
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhH
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (558)
.......++..+.......+...++++++.+.+||++||+.||++|||++++|+||||..+......+..+. .+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~ 314 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDF 314 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhh
Confidence 777777777766555545555566789999999999999999999999999999999999877776665543 457788
Q ss_pred hhhcCCHHHHHHHHHHHHHhhCh
Q 008644 339 ERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 339 e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
|....++++++|.++.|.+.|||
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 315 EEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhhcCHHHHHHHHHHHHhhcCC
Confidence 88889999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=436.94 Aligned_cols=283 Identities=36% Similarity=0.656 Sum_probs=239.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-C-----CCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-H-----pnIv~l~~i~~~~~ 95 (558)
+.||+|+++||+|+||.|-+|.|..|++.||||+|++ +.....+...|+.+|..|+ | -|+|++++.|....
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 5599999999999999999999999999999999985 3355667788999999997 4 37999999996654
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC--CcEEEeecc
Q 008644 96 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~--~~lKL~DFG 171 (558)
++|||+|+++.+|.++++.+. .|+...++.|+.|||.||.+||+.||||+||||+||||.+- +.|||+|||
T Consensus 262 -----HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 -----HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred -----ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 799999999999999999876 58999999999999999999999999999999999999864 579999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
.++...... ..|+-++.|+|||++.| ..|+.++||||||||++||++|.++|+|.+..+|+..|.+++|.|+
T Consensus 337 SSc~~~q~v------ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQRV------YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCcc------eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 998654322 37899999999999998 7999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhHHHHHHHhh----------------------------hccCCCC-----CCCCCCC-CCCHHHHHHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSS----------------------------MRKKKPI-----PFSQKFP-NANPLALRLLERML 297 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~----------------------------~~~~~~~-----~~~~~~~-~~s~~~~~Li~~mL 297 (558)
..+++..... ..|+.+ ....... .+....+ .-...+.|||++||
T Consensus 409 ~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 409 PKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred HHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 9998765443 233333 1111111 1112222 22456899999999
Q ss_pred ccCCCCCCCHHHHhcCccccCcccC
Q 008644 298 AFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 298 ~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
.+||.+|+|+.++|+||||.+....
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred ccCchhcCCHHHHhcCccccccccc
Confidence 9999999999999999999976543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=417.33 Aligned_cols=331 Identities=44% Similarity=0.831 Sum_probs=274.7
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+.+.++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 456789999999999999999999999999999999997544444455678899999999999999999998864332 3
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3456899999999999887754 469999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ...++||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..
T Consensus 170 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 32 2456899999999998652 4688999999999999999999999999999999999999999999998888
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+.....+.++..+.......+...+...++.+.+||.+||..||.+|||+.|+|+||||..+......+...+. ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~ 319 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DES 319 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccc
Confidence 88777777777666555555555667788999999999999999999999999999999987665544433322 223
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhC
Q 008644 338 FERRRITKEDVRELIYREILEYH 360 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~ 360 (558)
.+....+.+++++..+.+...+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~ 342 (343)
T cd07878 320 PENKERTIEEWKELTYEEVSSFK 342 (343)
T ss_pred hhhhhccHHHHHHHHHHHHHhcC
Confidence 33455666777777777665443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=423.77 Aligned_cols=263 Identities=30% Similarity=0.525 Sum_probs=228.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
-.++|.+++.||.|+|++|++|+++.+++.||||++.+.. .......-+.+|-.+|.+| .||.|++|+..|.+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~---- 146 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE---- 146 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc----
Confidence 3567999999999999999999999999999999987532 2334455678899999999 799999999998544
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|+||++ |+|.++|++-+.|++..+++++.||+.||+|||++|||||||||+|||+++|+++||+|||.|+...
T Consensus 147 -~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 147 -ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred -cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 46999999998 7999999999999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCC----------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 178 NDTPT----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 178 ~~~~~----------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
..... ......++||-.|++||+|.. ...++.+|||+||||||.|+.|++||.+.+....+++|+++-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 22111 111256899999999999987 678899999999999999999999999999998888887641
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
. ...++.++.++|||+++|..||.+|+|+++|.+||||.++..
T Consensus 304 ----------------------------y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 304 ----------------------------Y---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred ----------------------------c---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 1 122456799999999999999999999999999999998753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=412.55 Aligned_cols=335 Identities=51% Similarity=0.895 Sum_probs=281.9
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|.++++|++.+.||+|+||.||+|++..+|+.||||++... ........+.+|+.+|+.++|+||+++++++.......
T Consensus 1 ~~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred CccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 46788999999999999999999999999999999998632 23345567889999999999999999999887666555
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 667999999999999888754 4699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
...........+||..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...++.|..+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33222233456889999999987542 46788999999999999999999999999999999999999999999988888
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhH
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (558)
.....+.++.........++....+..++.+.+||.+||+.||++|||+.|+|+||||+.+.+...++..+....++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 317 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFEL 317 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcc
Confidence 77777777776665555555556677899999999999999999999999999999999988776666554444444443
Q ss_pred hhhcCCHHHHHHHHHHHHH
Q 008644 339 ERRRITKEDVRELIYREIL 357 (558)
Q Consensus 339 e~~~~~~e~~~e~i~~ei~ 357 (558)
. ..+.++..+++|+.+|+
T Consensus 318 ~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 318 F-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred c-cccCHHHHHHHHHHHhc
Confidence 3 45668999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=415.34 Aligned_cols=329 Identities=43% Similarity=0.721 Sum_probs=262.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++|+||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 37889999999999999999999999999999976555555667889999999999999999999998766544445799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
+||||+.++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986533221
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
......++|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+...++..|.+.+|.|..+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 123456789999999998762 4578999999999999999999999999999999999999999999877765433 22
Q ss_pred HHHHhhhccCCCC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC-------------------
Q 008644 264 RRYLSSMRKKKPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV------------------- 322 (558)
Q Consensus 264 ~~~~~~~~~~~~~--~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~------------------- 322 (558)
..++.......+. .........++.+.+||.+||+.||.+|||+.|+|+||||.+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYT 316 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCC
Confidence 3333222211111 0112334568899999999999999999999999999999874211
Q ss_pred -CCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHh
Q 008644 323 -EREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 358 (558)
Q Consensus 323 -~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~ 358 (558)
..++. ....+++.++....+..++++.++.++.+
T Consensus 317 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (372)
T cd07853 317 SDFEPS--ANPPFDDEYEKNLTSVRQVKEELHQFILE 351 (372)
T ss_pred cccCCC--CCCCCCcccccccCCHHHHHHHHHHHHHH
Confidence 01111 11223445555566777788877776653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=412.95 Aligned_cols=329 Identities=37% Similarity=0.674 Sum_probs=262.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (558)
...++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 44689999999999999999999999999999999998655555666788899999999999999999998865432 34
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 457899999999999888864 488999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++.+..+
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 2245689999999999977 67899999999999999999999999999999999999999999988776655
Q ss_pred hhHHHHHHHhhhccCCCCCCCCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQK------------FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (558)
... ...++..........+... ....+..+++||.+||..||.+|||++|+|+||||..+......+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 432 2333333222111111111 122356799999999999999999999999999998776655443
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHHHHh
Q 008644 327 SAQPVTKMEFEFERRRITKEDVRELIYREILE 358 (558)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~ 358 (558)
...+.. -+...+.+..+.+++++.++.++++
T Consensus 332 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 332 APPPKI-PDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCCC-CCccchhhhccHHHHHHHHHHHHHc
Confidence 322211 1222344567788888888887753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=406.00 Aligned_cols=258 Identities=32% Similarity=0.486 Sum_probs=221.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
-.+|.+.+.||+|+||+||+|+++.++..||||.|.+........+-+..||.+|+.++|||||.+++++...+ .
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----F 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----e
Confidence 45799999999999999999999999999999999865546667778899999999999999999999995554 6
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC------CcEEEeecccce
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLAR 174 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~------~~lKL~DFGla~ 174 (558)
+|+|||||. |||..+|++.+.++|..++.|+.||+.||++||+++||||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999998 6999999999999999999999999999999999999999999999999875 458999999999
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....+. ...+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-.
T Consensus 164 ~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------ 231 (429)
T KOG0595|consen 164 FLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------ 231 (429)
T ss_pred hCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc------
Confidence 876443 3467899999999999976 6899999999999999999999999998887666543332110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+ ......+....+|+..+|..+|..|.+..+-+.|+++..
T Consensus 232 ------------------~~~----~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ------------------IVP----VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ------------------ccC----chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 000 011223455678999999999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=411.25 Aligned_cols=326 Identities=39% Similarity=0.703 Sum_probs=255.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (558)
...++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34689999999999999999999999999999999997655555666788899999999999999999999865432 34
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999998888754 489999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...++..+.+.++.|..+.....
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2245689999999999977 67899999999999999999999999999999999999999999988776654
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFP------------NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (558)
.. ....++..........+...++ ..++.+.+||.+||+.||++|||+.|+|+||||..+.......
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 328 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence 32 2233333322222222222221 2367899999999999999999999999999998765443322
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 008644 327 SAQPVTKMEFEFERRRITKEDVRELIYRE 355 (558)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~e 355 (558)
...+.. .....+.+....+.+.+.|+..
T Consensus 329 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 356 (359)
T cd07876 329 APPPQI-YDAQLEEREHAIEEWKELIYKE 356 (359)
T ss_pred CCCccc-cccccccccccHHHHHHHHHHH
Confidence 222211 1112234445555556655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=419.61 Aligned_cols=259 Identities=32% Similarity=0.577 Sum_probs=230.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|.+.+.||+|+||+||+|+.+.|.+.||||.+.+.....++...+.+|++|++.|+||||+.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999998877888889999999999999999999999988 455689
Q ss_pred EEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
|+|.|||.|+|+.++..++.++|+.++.|.+|++.||.|||+++|+|||+||.|||++++|.+|+||||+|+....+.
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999764432
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
...+...|||.|||||++.+ ..|+..+|+||||||+|||+.|++||...+..+..+.|..
T Consensus 155 -~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred -eeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 24577889999999999987 7999999999999999999999999976665544443321
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
. +..+ .+.++..+++||+.+|.+||.+|+|..++|.|||+++--..
T Consensus 215 ----------d-~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 215 ----------D-PVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred ----------C-CCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 1 1111 13778999999999999999999999999999999875433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=415.55 Aligned_cols=257 Identities=33% Similarity=0.538 Sum_probs=220.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC---hhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~ 96 (558)
...+|++.+.||+|+||+|++|.+..+|..||+|++++.... ......+.+|+.+|+.++ ||||+++++++.+.+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 456899999999999999999999999999999987653111 134566779999999999 999999999997665
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccce
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~ 174 (558)
++|+|||||.| +|+++|...+++.|..++.+|+||+.||+|||+.||+||||||+|||++.+ +.+||+|||++.
T Consensus 94 ----~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 ----KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ----eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 59999999985 999999998999999999999999999999999999999999999999999 999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
... .......+.|||+.|+|||++.+ .. |+ .++||||+||+||.|++|+.||...+....+..|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 12234578999999999999987 34 65 789999999999999999999998776655544322
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. .. .....+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 238 --------------------~-~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 --------------------G-EF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------C-Cc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0 11 112233 999999999999999999999999999999995
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=389.96 Aligned_cols=262 Identities=31% Similarity=0.495 Sum_probs=227.7
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.-..+.|++.++||+|.|++|+++.+..||..+|+|+|+...-...+.+.+.+|+.|-+.|+||||+++++.+ ..
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~ 81 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QE 81 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cc
Confidence 3445689999999999999999999999999999999985444445788899999999999999999999977 33
Q ss_pred CccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEeecccce
Q 008644 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLAR 174 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~DFGla~ 174 (558)
....|||||+|+| +|..-|.++.-++|..+.++++|||+||.|||.+||+|||+||.|+|+-.. .-+||||||+|.
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 4469999999985 899888887779999999999999999999999999999999999998643 459999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
.... ...|..++|||.|||||++.. ..|+..+|||+.|||||.||.|.+||.+.+....++.|..
T Consensus 162 ~l~~----g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~--------- 226 (355)
T KOG0033|consen 162 EVND----GEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA--------- 226 (355)
T ss_pred EeCC----ccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc---------
Confidence 7752 335678999999999999987 6899999999999999999999999999887666665543
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
....-....|+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 227 ------------------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 ------------------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------------------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 1111223468899999999999999999999999999999999984
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=400.17 Aligned_cols=286 Identities=35% Similarity=0.649 Sum_probs=237.4
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|+.-++|++++.||.|+||.||+|++..++..||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 75 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE---- 75 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC----
Confidence 567788999999999999999999999999999999986432 222345678999999999999999999988543
Q ss_pred CccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+.++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 76 -RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred -CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 3689999999999999987654 48999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12446789999999998652 4688999999999999999999999999999999999999999999888776
Q ss_pred hhhHH-HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 258 VRNEK-ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 258 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
+.... ...++ .......+.....+.+++++++||.+||.+||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 54321 11111 11111122223346778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=422.05 Aligned_cols=264 Identities=31% Similarity=0.509 Sum_probs=231.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+.-.-|++.+.||.|+.|.|.+|.|..||+.+|||+|.+... .......|.+||-||+.|.|||++.++++| ++
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----EN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----cc
Confidence 445579999999999999999999999999999999987633 344567899999999999999999999999 44
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..++|+|.||+. |.|++++...|++++.+++++++||+.||.|||..+|+||||||+|+|++.++.+||+|||.|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 568999999998 6999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.+. .+.+.||++.|.|||++.| .+| +.++||||+|||||.||+|+.||++.|....+.++...
T Consensus 164 ~gk----lLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G---------- 227 (786)
T KOG0588|consen 164 PGK----LLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG---------- 227 (786)
T ss_pred CCc----cccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC----------
Confidence 543 4578999999999999988 455 47899999999999999999999988766555544321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 325 (558)
..+...++++++++||.+||+.||.+|+|.+||+.|||+.+.......
T Consensus 228 ---------------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 228 ---------------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---------------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 123346889999999999999999999999999999999988665443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=392.70 Aligned_cols=261 Identities=30% Similarity=0.445 Sum_probs=220.9
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
....-..|+|+++||+|+||.||++.+..+|..||+|+|+-...+....+.+..|+.+|++|+|||||++++.-+. +
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~ 90 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---E 90 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---c
Confidence 3455667999999999999999999999999999999998555566777889999999999999999999883322 2
Q ss_pred CCccEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEeCCCCcEEEe
Q 008644 98 EFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs--~g--IiHrDIKP~NILl~~~~~lKL~ 168 (558)
+..-++||||||+ |||.+.|+. ...++|..+|.++.||+.||..||+ .+ |+||||||.||+++.+|.+||+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 2234899999998 799999864 3469999999999999999999999 45 9999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
||||++...+.. .+..+++|||.||+||++.+ .+|+.++||||+||++|||+.-++||.|.+......+|...-
T Consensus 171 DfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd- 244 (375)
T KOG0591|consen 171 DFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD- 244 (375)
T ss_pred cchhHhHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-
Confidence 999999875543 24578999999999999988 799999999999999999999999999998877776665421
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
++..+ ..+|..+..||..|++.||..||+. +|++..+..
T Consensus 245 -----------------------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 245 -----------------------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred -----------------------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 11122 2457788999999999999999997 666665543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=385.76 Aligned_cols=254 Identities=25% Similarity=0.466 Sum_probs=225.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||.|+||.|.+++++.+|..+|+|++++ ........+...+|..+|+.+.||+++.+.+.|.+ ...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-----~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-----NSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-----CCe
Confidence 579999999999999999999999999999999974 23344567788999999999999999999998844 457
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||||++ |.|+.++++.++|++.++++++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence 999999998 5999999999999999999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.+.||||.|+|||++.+ ..|+.++|.|||||++|||+.|.+||.+.+....+++|...-
T Consensus 199 ------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------- 257 (355)
T KOG0616|consen 199 ------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------- 257 (355)
T ss_pred ------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-------------
Confidence 56899999999999988 789999999999999999999999999999877777776420
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC-----CCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R-----pta~elL~hp~f~~~~ 320 (558)
-...+..++++++||+++|+.|-.+| ...++|..||||+++.
T Consensus 258 ------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 258 ------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred ------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 11224568999999999999999999 3578999999999753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=393.04 Aligned_cols=292 Identities=38% Similarity=0.630 Sum_probs=241.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
-..|+++..||+|.||.||+|..+.++. .+|||+|+............-||+.+++.|+|||++.+..+|+..+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d-- 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD-- 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence 3469999999999999999997766544 6899999754344444566789999999999999999999998643
Q ss_pred CCccEEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC----CcEEEe
Q 008644 98 EFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKIC 168 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~----~~lKL~ 168 (558)
+.++|++||.+.||+++|+-. ..++...++.|++||+.|+.|||++=|+||||||.|||+..+ |+|||+
T Consensus 101 --~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 101 --KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred --ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 479999999999999999743 248999999999999999999999999999999999999988 999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---------hhhH
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---------VVHQ 239 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---------~~~~ 239 (558)
|||+||...+-...-......+.|.||+|||+|.|- .-|++++|||++|||++||++-.++|.|.. ..+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999875543333234567899999999999874 679999999999999999999999998752 4679
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHH-HHHHHhhhccCCCCC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKPIP-----FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
++.|.+++|+|+.+.|..+.+-. ....++.++...... +.+....-++.+.+|+.+||..||.+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 99999999999999988775532 224455554333222 112334446779999999999999999999999999
Q ss_pred ccccC
Q 008644 314 PYFKG 318 (558)
Q Consensus 314 p~f~~ 318 (558)
+||..
T Consensus 338 ~yF~~ 342 (438)
T KOG0666|consen 338 PYFTE 342 (438)
T ss_pred ccccc
Confidence 99985
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=405.23 Aligned_cols=327 Identities=38% Similarity=0.685 Sum_probs=256.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (558)
...++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34679999999999999999999999999999999998655555666788899999999999999999999865432 34
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 456899999999999888764 489999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|.++.....
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 2245689999999999977 67899999999999999999999999999999999999999999988877665
Q ss_pred hhHHHHHHHhhhccCCCCCCC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCC
Q 008644 259 RNEKARRYLSSMRKKKPIPFS------------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (558)
... ...++..........+. ......+..+.+||.+||..||++|||+.|+|+||||..+.......
T Consensus 246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 324 (355)
T cd07874 246 QPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVE 324 (355)
T ss_pred cHH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhcc
Confidence 432 23333322221111111 11123456789999999999999999999999999998765432221
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHHH
Q 008644 327 SAQPVTKMEFEFERRRITKEDVRELIYREI 356 (558)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei 356 (558)
..++ ............+.+.+++.++.++
T Consensus 325 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T cd07874 325 APPP-QIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_pred CCCc-cccccchhhhhccHHHHHHHHHHHh
Confidence 1111 1111122233445666777666655
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=387.55 Aligned_cols=288 Identities=43% Similarity=0.760 Sum_probs=248.9
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
-.+.||.|+||+||.+.|.++|+.||+|++.+.+.+-...+++.+|+++|..++|.|++..+++...+...-+..+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 34789999999999999999999999999999888888889999999999999999999999998877666677899999
Q ss_pred ecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 107 ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 107 E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
|+|..||+..|.+...++.++++-+++||++||+|||+.||+||||||.|+|+|.||.+||||||+|+....+.. ..+
T Consensus 137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~hM 214 (449)
T KOG0664|consen 137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LNM 214 (449)
T ss_pred HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654433 345
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
+..+.|.+|+|||++-|. ..|+.++||||+|||+.||+-.+.+|...+...|++.|++++|+|+.|........ ++..
T Consensus 215 TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG-Ak~H 292 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG-AKNH 292 (449)
T ss_pred HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh-hHHH
Confidence 778899999999999774 67999999999999999999999999999999999999999999999987654433 2222
Q ss_pred HhhhccCCCCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKF-----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~-----~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+-.-..+. ..+...+ .....++++++.+||.+||.+|++.++++.|+|+...
T Consensus 293 ~LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCCC-CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22111111 1122222 1334678999999999999999999999999999754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=400.91 Aligned_cols=332 Identities=46% Similarity=0.858 Sum_probs=286.4
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+.++++|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 456889999999999999999999999999999999987544444455678899999999999999999998765433 3
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 3456899999999999998876 469999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.+.++.+.+
T Consensus 170 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 32 2446789999999998642 3678899999999999999999999999999889999999999999999888
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+..+....++..+.......+...+...++.+.+||.+||..||++|||+.++|+||||+.+...+.++.. ......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~---~~~~~~ 319 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA---PPYDQS 319 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccc---cccCcc
Confidence 88888888887777666666666667789999999999999999999999999999999988777655542 223456
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
++...+..+++++++|.++.+|+|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 320 FESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhhhcCHHHHHHHhHHHHHhccC
Confidence 788899999999999999998876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=401.29 Aligned_cols=330 Identities=52% Similarity=0.947 Sum_probs=281.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-.+++|++.+.||.|+||.||+|.++.+|..||+|++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (334)
T cd07855 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF 80 (334)
T ss_pred chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence 4568999999999999999999999999999999999765444455677889999999999999999999875543 344
Q ss_pred ccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..+|+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 57999999999999999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCC-cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .......+++.+|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+...++..+...+|.|..+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 1122346789999999998652 45889999999999999999999999999999999999999999999998888
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhH
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (558)
.......++.........++...++..++.+.+||++||+.||.+|||++++|.||||.++...+.++.+. ..+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~ 317 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCP--PPFDFDF 317 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCC--CCCCCCh
Confidence 87777777777766666777777788899999999999999999999999999999999988777766543 3456677
Q ss_pred hhhcCCHHHHHHHHH
Q 008644 339 ERRRITKEDVRELIY 353 (558)
Q Consensus 339 e~~~~~~e~~~e~i~ 353 (558)
+....+.|.+.+.|.
T Consensus 318 ~~~~~~~~~~~~~~~ 332 (334)
T cd07855 318 EAIELSREQLKEAIV 332 (334)
T ss_pred hhhhcChhhHHHHhh
Confidence 777778777766653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=362.14 Aligned_cols=278 Identities=41% Similarity=0.696 Sum_probs=241.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|.-.+.||+|.||+||+|++..+++.||+|.+.....+..-....+|||.+|+.|+|.|||+++++... .+.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence 4666789999999999999999999999999997555555556778999999999999999999998743 34699
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|+|||..+|..+..+ ++.++.+.++.++.|+++||.|||+.++.||||||+|+||+.+|.+||+|||+++... .+.
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg--ipv 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPV 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC--Cce
Confidence 9999999999999977 6789999999999999999999999999999999999999999999999999998752 222
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
...+..+.|.||++|.++.|- .-|+.++|+||.|||++|+.. |+++|+|.+..+|+..|..++|+|+.+.|..+.
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t-- 231 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT-- 231 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc--
Confidence 234567899999999999873 679999999999999999987 889999999999999999999999988876542
Q ss_pred HHHHHHhhhccCCCC-------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPI-------PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~-------~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+...++. .|++..|.++..-+||++++|.-+|.+|++++++|+||||...
T Consensus 232 -------~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 -------KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -------cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22222222 3445567777889999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=395.90 Aligned_cols=290 Identities=34% Similarity=0.593 Sum_probs=228.7
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
||..++|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 75 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTK---- 75 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecC----
Confidence 6888999999999999999999999999999999999874322 22334677899999999999999999998543
Q ss_pred CccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+.++|.+++..+ +.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 76 -ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred -CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 469999999999999888764 469999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... ......++|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.. ...++..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 122456789999999998652 457889999999999999999999998754 456777777778887765554
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......... ...+....+..+...+ ...++.+.+||.+||+.||.+|||++|+|+||||+.+
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 231 GVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred chhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 332110000 0000000011111111 1245789999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.87 Aligned_cols=330 Identities=58% Similarity=0.984 Sum_probs=285.8
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||.|++|.||+|.+..+++.||||++............+.+|+.+|+.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667899999999999999999999998766544556799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
+||||+.++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998765443211
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
.......++.+|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+...++.|..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999999772 2788999999999999999999999999999999999999999999988887777777
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhHhhhcC
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRI 343 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (558)
..++.........++...++.+++.+.+||.+||++||.+|||++++|.||||+++.....+.......++. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 888887777777777777888999999999999999999999999999999999988777666555444331 3567789
Q ss_pred CHHHHHHHHHHH
Q 008644 344 TKEDVRELIYRE 355 (558)
Q Consensus 344 ~~e~~~e~i~~e 355 (558)
++++.++.|+.|
T Consensus 319 ~~~~~~~~~~~~ 330 (330)
T cd07834 319 TEEELKELIYEE 330 (330)
T ss_pred CHHHHhHHhhcC
Confidence 999999988753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.93 Aligned_cols=284 Identities=35% Similarity=0.609 Sum_probs=231.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~~~ 98 (558)
++|++++.||+|+||+||+|.+.. +|..||+|++............+.+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 568899999875433333445566788887766 6999999999986544344
Q ss_pred CccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4579999999999999998764 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.+..+.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 4321 2245679999999999876 578899999999999999999999999999999999999988888776543
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
....-. . ..+......++....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP-R---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc-c---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 321100 0 0111222333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=402.33 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=225.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-.+.|+++++||+|+||.||+|+.+.||+.+|+|++++.. ........++.|-.+|.....|.||+|+..|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~----- 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK----- 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----
Confidence 4568999999999999999999999999999999998632 2345667899999999999999999999999554
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.++||||||++ ||+..+|...+.|+++.+++++.+++.|+..||..|+|||||||+|+|||..|.+||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 47999999998 59999999999999999999999999999999999999999999999999999999999999964211
Q ss_pred ------------------C-CCCc-c------------------------cccccccCccccCccccccccCCCCCcchh
Q 008644 179 ------------------D-TPTA-I------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (558)
Q Consensus 179 ------------------~-~~~~-~------------------------~~~~~~gT~~Y~APE~l~~~~~~y~~~~DI 214 (558)
. .+.. . .....+|||.|+|||++.+ .+|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 0000 0 0124689999999999988 689999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHH
Q 008644 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 294 (558)
Q Consensus 215 WSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~ 294 (558)
||||||+||||.|.+||.+.+..+.+.+|..+-. .+ .+. .-..++++|.|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------------~l------~fP-~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------------TL------KFP-EEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------------hc------cCC-CcCcccHHHHHHHH
Confidence 9999999999999999999998888877765310 00 111 11345689999999
Q ss_pred HhcccCCCCCC---CHHHHhcCccccCccc
Q 008644 295 RMLAFEPKDRP---TAEEALADPYFKGLAK 321 (558)
Q Consensus 295 ~mL~~dP~~Rp---ta~elL~hp~f~~~~~ 321 (558)
+||. ||++|. .++||-+||||+++..
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999 999996 4999999999998753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=410.14 Aligned_cols=287 Identities=35% Similarity=0.606 Sum_probs=230.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---C
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---R 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~---~ 97 (558)
...+|++++.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346899999999999999999999999999999988531 2234579999999999999999998765432 1
Q ss_pred CCccEEEEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeeccc
Q 008644 98 EFKDIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGL 172 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGl 172 (558)
....+++||||++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2235789999999988877753 45799999999999999999999999999999999999999665 799999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
|+....... ...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|+|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 986543322 2456889999999988652 46899999999999999999999999999999999999999999988
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
+.+.......... .+....+..+...+ ...++++++||.+||.+||.+|||+.|+|+||||..+..
T Consensus 293 ~~~~~~~~~~~~~---~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPNYADI---KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchhhhcc---cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 7665432211000 00011111111222 246789999999999999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=385.61 Aligned_cols=282 Identities=35% Similarity=0.655 Sum_probs=226.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|+++.++..||||++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 47999999999999999999999999999999997543344455678899999999999999999998843 3479
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||+++++...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766665544 45799999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 2245679999999999976 57899999999999999999999999999888888888887777665544322111
Q ss_pred HHHHHHhhhccC---CCCC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKK---KPIP-FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~---~~~~-~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... ...... .... .......++..+.+||++||++||++|||++|+|+||||
T Consensus 232 ~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRF---HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chh---cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 000000 0000 011123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=393.79 Aligned_cols=327 Identities=39% Similarity=0.701 Sum_probs=261.2
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RR 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-~~ 97 (558)
|.+.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 45678999999999999999999999999999999998765555556677889999999999999999999886543 23
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
+....|+||||+.++|.+.+... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44578999999999999988754 8999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...++.|..+....
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 3221 244578899999999977 6789999999999999999999999999999999999999999998877665
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCC-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQK-------------FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 324 (558)
..... ..++.........++... ....+..+++||.+||+.||.+|||+.|+|.||||+.+.....
T Consensus 244 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 244 LQPTV-RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhhh-hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 44322 222222221111111111 1234667899999999999999999999999999998766443
Q ss_pred CCCCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 008644 325 EPSAQPVTKMEFEFERRRITKEDVRELIYRE 355 (558)
Q Consensus 325 ~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~e 355 (558)
.....+ ...+...+.+..+.+++++.+|.+
T Consensus 323 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 323 VEAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCCC-CccccccccccccHHHHHHHHHhh
Confidence 322222 223344456677788888887765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=388.37 Aligned_cols=291 Identities=36% Similarity=0.660 Sum_probs=241.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|+..++|++.+.||+|+||.||+|+++.+++.||+|++..... ......+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 76 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD---- 76 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC----
Confidence 5777899999999999999999999999999999999874322 22334577899999999999999999998543
Q ss_pred CccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 77 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 77 -KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred -CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 3699999999999999887654 58999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345789999999988652 4688999999999999999999999999999999999999999999887766
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
+.......... .....+.++....+.+++++.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNYN-FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhhh-cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 54432211111 122223333345567899999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=383.78 Aligned_cols=283 Identities=35% Similarity=0.597 Sum_probs=229.6
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+|++++.||+|+||+||+|.++.+|+.||+|.+............+.+|+.+++.+ .||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433333334566787777665 699999999988655444455
Q ss_pred cEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 78999999999999988764 3489999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 221 244678999999999976 57899999999999999999999999999888888888888887765443321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..... .......+.......+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 10000 0111122233344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=387.52 Aligned_cols=332 Identities=42% Similarity=0.778 Sum_probs=279.6
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+.+.++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 557889999999999999999999999999999999986544444445678899999999999999999998865432 2
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+||||++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 2346799999998899888764 469999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+....
T Consensus 170 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 170 SE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 22 1345678999999998652 3578899999999999999999999999988888888888888888888888
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+.......++..+.......+....+.+++.+.+||.+||..||++|||+.+++.||||+.....+.++... .+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~---~~~~~ 319 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDDS 319 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC---Ccccc
Confidence 777777777776665555555556678899999999999999999999999999999999887665554333 34556
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
++.-..+.|+++.+.+-||+.+.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 320 FDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred HHhhccchHHHHHHHHHHHHhcCC
Confidence 777888899999999999998875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=387.07 Aligned_cols=332 Identities=43% Similarity=0.839 Sum_probs=277.8
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 556789999999999999999999999999999999997544444455678899999999999999999998864322 2
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+++++++++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 33468999999988998877654 69999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....++.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+.+.....
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 2345789999999988652 4678899999999999999999999999988888889999999998888887
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+.....+.++..+.......+...+...++.+.+||.+||..||.+|||+.++|+||||+++...+.++...+ ++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCc
Confidence 7777677777766655555555555677899999999999999999999999999999999887776664432 4444
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
++...+..+++....|+++..|-|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 555566678888999999877654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=408.92 Aligned_cols=286 Identities=26% Similarity=0.431 Sum_probs=228.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCC------CccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP------DIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hp------nIv~l~~i~~~~~ 95 (558)
.++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++|. +++.++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 478999999999999999999999999999999996421 2234456788888777654 477777777432
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCC-----------
Q 008644 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 163 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~----------- 163 (558)
..++|+||++++++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 2478999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----cEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh
Q 008644 164 -----KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 238 (558)
Q Consensus 164 -----~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~ 238 (558)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754321 1245789999999999987 679999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCC---------CC--CCCCHHHHHHHHHhcccCCCCCCCH
Q 008644 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ---------KF--PNANPLALRLLERMLAFEPKDRPTA 307 (558)
Q Consensus 239 ~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~s~~~~~Li~~mL~~dP~~Rpta 307 (558)
++..|.+.+|.++.+..........+.++.......+..... .+ ...++.+.|||.+||.+||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999998877665544444444443332211110000 00 0125678899999999999999999
Q ss_pred HHHhcCccccCcccC
Q 008644 308 EEALADPYFKGLAKV 322 (558)
Q Consensus 308 ~elL~hp~f~~~~~~ 322 (558)
+|+|+||||..+...
T Consensus 433 ~e~L~Hp~~~~~~~~ 447 (467)
T PTZ00284 433 RQMTTHPYVLKYYPE 447 (467)
T ss_pred HHHhcCccccccCCc
Confidence 999999999976543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=399.26 Aligned_cols=281 Identities=25% Similarity=0.360 Sum_probs=222.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.|+||||+++++++... ...
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----Cee
Confidence 57999999999999999999999999999999753 23467899999999999999999988543 368
Q ss_pred EEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
++|+|++.++|..++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975322211
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC-------ChhhHHHHHHHhhCCCCHHHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-------~~~~~~~~i~~~lg~p~~~~i 255 (558)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+. +...++..+...+|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 12245689999999999977 67899999999999999999999776433 234577778888887654432
Q ss_pred HHhhhHHHHHHHhhhccCCC----CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKP----IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..........++........ .+.......++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11111111111111111111 111111224567899999999999999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=386.67 Aligned_cols=272 Identities=28% Similarity=0.437 Sum_probs=220.7
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc------------CChhHHHHHHHHHHHHHhcCCCCc
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF------------EHVSDATRILREIKLLRLLRHPDI 84 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~------------~~~~~~~~i~~Ei~iL~~l~HpnI 84 (558)
...-.-++|++++.||+|.||+|.+|++..+++.||||++.+.. ......+++.+||.+|++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33456689999999999999999999999999999999996421 111233578999999999999999
Q ss_pred cccceeecCCCcCCCccEEEEEecCcccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC
Q 008644 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (558)
Q Consensus 85 v~l~~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~ 163 (558)
|+|+++.-++ ....+|||+|||...-..+.-.... +++.+++.|+++++.||.|||.+|||||||||+|+||+++|
T Consensus 171 V~LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999998543 3468999999998432223333334 99999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCC--CCCcccccccccCccccCcccccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH
Q 008644 164 KLKICDFGLARVAFND--TPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239 (558)
Q Consensus 164 ~lKL~DFGla~~~~~~--~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~ 239 (558)
++||+|||.+.....+ ......+...+|||.|+|||+|.+.. ...+.+.||||+||+||.|+.|+.||-+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998754222 22233455689999999999986521 2245689999999999999999999999888877
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.++|.. .+..| ...+++.+.++|||.+||++||++|++..++..|||...-
T Consensus 328 ~~KIvn----------------------------~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FDKIVN----------------------------DPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHhc----------------------------CcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 776653 11112 2234678999999999999999999999999999999765
Q ss_pred c
Q 008644 320 A 320 (558)
Q Consensus 320 ~ 320 (558)
.
T Consensus 379 g 379 (576)
T KOG0585|consen 379 G 379 (576)
T ss_pred C
Confidence 3
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=385.98 Aligned_cols=331 Identities=41% Similarity=0.774 Sum_probs=269.5
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+.+.++|.+.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++|+||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 344579999999999999999999999999999999987544443445668899999999999999999998865432 2
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+|+||+..+|..++. ..++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 334679999999988877653 368999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.+.....
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 2345788999999998652 3578899999999999999999999999998888999999999999888877
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
........+...+.......+...++..++.+.+||.+||+.||++||+++++|.||||..+...+.++...+ +...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 318 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDS 318 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccch
Confidence 7665555555554444444455566788999999999999999999999999999999999876655544332 2333
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
.+......+++...||.++..+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 319 LENEKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhhhhCCHHHHHHHhhhhhhccCC
Confidence 344466678888888888655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=397.90 Aligned_cols=255 Identities=31% Similarity=0.533 Sum_probs=222.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
...|...+.||+|+.|.||.|+...+++.||||.+....+ ...+-+++|+.+|+.++|+|||.+++.|+.. ..
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc-----ce
Confidence 4678999999999999999999999999999999975332 3456689999999999999999999998765 36
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||+| +|.+++... .++|.++..|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||++.......
T Consensus 345 LWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999995 777777654 59999999999999999999999999999999999999999999999999998765544
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ...+.+||++|||||++.. ..|++++||||||+|+.||+-|.+||-..+....+.+|... |+|.
T Consensus 424 ~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~--------- 488 (550)
T KOG0578|consen 424 S---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK--------- 488 (550)
T ss_pred C---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC---------
Confidence 3 3477899999999999977 68999999999999999999999999887777666666532 3322
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
-.....+|+.+++||.+||+.|+++|++|.|||+||||+
T Consensus 489 ------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 489 ------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 223467899999999999999999999999999999995
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=381.55 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=214.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 47999999999999999999999999999999986421 122345668899999999999999999988743 347
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 34579999999999977 67899999999999999999999999887755444333210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. . ......++.+.+||++||+.||.+|++ ++++++||||+.+
T Consensus 214 ------------~--~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 ------------K--L---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ------------C--c---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 0 112345789999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=383.93 Aligned_cols=264 Identities=28% Similarity=0.453 Sum_probs=214.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
....|...+.||+|+||.||++.+..+|...|||.+... +......+.+|+.+|+.|+|||||++++...... . .
T Consensus 15 ~~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~ 89 (313)
T KOG0198|consen 15 EISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-D 89 (313)
T ss_pred ccchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-e
Confidence 356799999999999999999999999999999998753 2222677899999999999999999999643221 1 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~~~ 177 (558)
.++++|||+. |+|.+++...+ .+++..++.+.+||++||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 6899999998 69999999877 7999999999999999999999999999999999999999 7999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~-~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.............||+.|||||++... .....++|||||||++.||+||++||... ..... +.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~---~~------------ 233 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA---LL------------ 233 (313)
T ss_pred cccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHH---HH------------
Confidence 311221223568899999999999741 23335999999999999999999999763 11111 11
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. +...... ......+++++++||.+||..||++||||+++|.|||.+..
T Consensus 234 -----------~-ig~~~~~--P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 234 -----------L-IGREDSL--PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----------H-HhccCCC--CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1 1111111 14445689999999999999999999999999999999754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.22 Aligned_cols=327 Identities=50% Similarity=0.840 Sum_probs=269.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCC--CcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~t--g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+|++.+.||+|+||.||+|.+..+ +..||||++............+.+|+.+++.+ .||||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999988 99999999875544444566788999999999 4999999998754321 2335
Q ss_pred cEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.+|+++++++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999998653322
Q ss_pred CC-cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .......+||..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1122346799999999987542 468899999999999999999999999999999999999999999998888777
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhHh
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 339 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (558)
......++..+.......+....+..+..+.+||.+||+.||.+|||+.++|.||||+.+......+.+.......|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 7766666666655555566666777899999999999999999999999999999999988776666665554444432
Q ss_pred hhcCCHHHHHHHHHHH
Q 008644 340 RRRITKEDVRELIYRE 355 (558)
Q Consensus 340 ~~~~~~e~~~e~i~~e 355 (558)
..+.++++..|..+
T Consensus 318 --~~~~~~~~~~~~~~ 331 (332)
T cd07857 318 --EDSMEELRDMIIEE 331 (332)
T ss_pred --cccHHHHHHHHhhc
Confidence 34566677666543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=384.06 Aligned_cols=331 Identities=44% Similarity=0.764 Sum_probs=273.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
.+.++|++.+.||+|+||.||+|++..+|+.+|||++...+........+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--- 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--- 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---
Confidence 356789999999999999999999999999999999875555555566788999999999 9999999999875422
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+||||+.++|..++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 2468999999999999998776 789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCC--cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 179 DTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 179 ~~~~--~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......+.||.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+....+.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3211 1223456799999999987542 467889999999999999999999999999999999999999999888888
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchh
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 336 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (558)
.+........+..+............+.++..+.+||.+||+.||.+|||+.++|+||||+++.....+++........+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPL 318 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCc
Confidence 77766666666665555555566667778999999999999999999999999999999999877666654432222222
Q ss_pred hHhhhcCCHHHHHHHHHHHH
Q 008644 337 EFERRRITKEDVRELIYREI 356 (558)
Q Consensus 337 ~~e~~~~~~e~~~e~i~~ei 356 (558)
. ..+.+...+.+..+|+||
T Consensus 319 ~-~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07852 319 D-DNVKLSVAEYRNKLYEEI 337 (337)
T ss_pred c-ccceeeHHHHHhhhhhcC
Confidence 2 345666777777777764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=385.04 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=214.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
-+.|++.+.||+|+||.||+|+++.+++.||||++... .........+.+|+.+|+.++||||+++++.+... .
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence 36799999999999999999999999999999998642 12223456788999999999999999999988543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+||||+. ++|.+.+...+.++++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6999999997 599999998888999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 2 34579999999999977 5788999999999999999999999987765443332221
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKG 318 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~ 318 (558)
.. . .....++..+.+||.+||+.||.+|++ +++++.||||++
T Consensus 230 -------------~~-~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 -------------GR-L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -------------CC-c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 00 0 111346788999999999999999997 799999999985
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=386.65 Aligned_cols=264 Identities=31% Similarity=0.520 Sum_probs=228.2
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~ 96 (558)
..+...|++.+.||+|.||+||+|+++.||+.+|+|+|.+... +......+.+|+.+|++++ |||||.++++|.+..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~- 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD- 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence 4566789999999999999999999999999999999975433 2335578999999999998 999999999995543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC----CcEEEeecc
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFG 171 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~----~~lKL~DFG 171 (558)
.+|+|||+|. |+|++.|... .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 110 ----~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 110 ----SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred ----eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 7999999998 5999999887 49999999999999999999999999999999999998653 479999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
++..... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|..
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~------ 252 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR------ 252 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc------
Confidence 9988755 223477899999999999986 6899999999999999999999999999886655443322
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.........|+.++..+.+||.+||.+||.+|+|+.++|+|||++....
T Consensus 253 ---------------------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 253 ---------------------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred ---------------------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 2223345678899999999999999999999999999999999987543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=377.99 Aligned_cols=273 Identities=28% Similarity=0.440 Sum_probs=223.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..+.|++.++||.|..++||+|+...+++.||||+++... ...+...+.+|+..|+.+.||||++++..|....
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk-c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~----- 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK-CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS----- 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh-hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----
Confidence 4678999999999999999999999999999999997432 2244788999999999999999999999997654
Q ss_pred cEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
.+|+||.||. |+++++++.. ..++|..+..|++++|+||.|||.+|-||||||+.||||+.+|.|||+|||......
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 5999999998 6999999873 459999999999999999999999999999999999999999999999999887765
Q ss_pred CCCCCcccc-cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~-~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
......... .+++||++|||||++...-..|+.|+||||||++..||.+|..||...-.... ++.++-+.|+--...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDPPTLLTS 255 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCCCCcccc
Confidence 544333332 77899999999999654447899999999999999999999999965443322 233444444311111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
....+ .....+..++.+|..||+.||.+||||+++|+|+||+...
T Consensus 256 ~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 256 GLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 11111 1123355789999999999999999999999999999654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=379.42 Aligned_cols=281 Identities=34% Similarity=0.611 Sum_probs=217.1
Q ss_pred EeEeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
.+.||+|+||+||+|+++ .++..||+|.+... .....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 367999999999999976 47789999998642 22345678999999999999999999886432 2468999
Q ss_pred EecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----CCCCcEEEeeccc
Q 008644 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (558)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl----~~~~~lKL~DFGl 172 (558)
|||++++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887632 248999999999999999999999999999999999999 4567899999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~~~~i 243 (558)
++...............+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223457899999999998652 4588999999999999999999999976542 4677888
Q ss_pred HHhhCCCCHHHHHHhhhHH-HHHHHhhhccCCCC------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 244 TDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKPI------PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
...+|.|....+....... ....+..+...... .+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8999998887766543211 11111111111000 0011122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=383.96 Aligned_cols=250 Identities=25% Similarity=0.453 Sum_probs=210.2
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999987432 2234456788999999999999999999988543 46999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
|+. ++|...+..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 22
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45689999999999977 6789999999999999999999999987765443332211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. .. .....+++.+.+||++||+.||++|| ++.++|+||||.++
T Consensus 210 ------~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 ------E-EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ------C-CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11245789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=364.50 Aligned_cols=299 Identities=33% Similarity=0.528 Sum_probs=248.7
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC---
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS--- 95 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~--- 95 (558)
....+.|+-+..||+|.||.||+|+.+++|+.||+|++-............++|+++|..|+|+|++.++++|-...
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 45678899999999999999999999999999999987543334445566789999999999999999999886432
Q ss_pred cCCCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 96 RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+...+|+||++|+.||..++... .+++..+++.++.+++.||.|+|++.|+|||+|+.|+||+.+|.+||+|||+|+
T Consensus 93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2344569999999999999999775 579999999999999999999999999999999999999999999999999997
Q ss_pred ecc-CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAF-NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~-~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
... .........+..+.|.||++||++.|. ..|++++|||..|||+.||++|.+.|.+++...++..|..++|.-..+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 643 222223346788999999999999874 789999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhHHHHHHHhh--hccCCCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 254 AIARVRNEKARRYLSS--MRKKKPIPFSQK--FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.|..+.+-....-++. +.+......... .-.-++++.||+.+||..||.+|+++.++|.|.||..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 9988877655444421 111111111110 1122678999999999999999999999999999974
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=375.19 Aligned_cols=291 Identities=35% Similarity=0.636 Sum_probs=235.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|+.-++|++++.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~---- 76 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE---- 76 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecC----
Confidence 4667889999999999999999999999999999999864322 22344677899999999999999999998543
Q ss_pred CccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 77 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 77 -KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred -CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 369999999999999988764 468999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2221 12345678999999998652 4578899999999999999999999999999899999999999888776654
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
+........ ...............+.+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 422111000 00000111111123356788999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=384.88 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=214.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----Ce
Confidence 47999999999999999999999999999999996421 2223445678999999999999999999998544 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH
Q 008644 181 PTA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (558)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 225 (558)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 01123579999999999976 67899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 008644 226 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305 (558)
Q Consensus 226 tG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp 305 (558)
+|.+||.+.+....+..+... .....+. ....+++.+.+||.+||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW--------------------------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC--------------------------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887765544333221 0001111 112468899999999997 999999
Q ss_pred C---HHHHhcCccccCc
Q 008644 306 T---AEEALADPYFKGL 319 (558)
Q Consensus 306 t---a~elL~hp~f~~~ 319 (558)
+ ++|+|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=374.52 Aligned_cols=322 Identities=48% Similarity=0.866 Sum_probs=268.4
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+.+.++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++.+++....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL--- 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC---
Confidence 56789999999999999999999999999999999998654444445567889999999999999999999885432
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...|+|+||++++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||+++....
T Consensus 83 -~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 83 -EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred -CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 36899999999999888764 4689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+.+.+|.++.+....+
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345788899999987542 46889999999999999999999999999988888889999999998888777
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhH
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 338 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (558)
.......++..+....+.+.....+.+++.+.+||++||+.||++|||++++|.||||.....+..++... ..+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCch
Confidence 66665666666666666666667778899999999999999999999999999999998876655444322 2455666
Q ss_pred hhhcCCHHHHHHHHHH
Q 008644 339 ERRRITKEDVRELIYR 354 (558)
Q Consensus 339 e~~~~~~e~~~e~i~~ 354 (558)
+...+..+.|+-+.|.
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 312 NDADLPVDTWKVMMYS 327 (328)
T ss_pred hcccCCHHHHHHHhcC
Confidence 6667777777765553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.86 Aligned_cols=255 Identities=30% Similarity=0.537 Sum_probs=224.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+.-.||++.+.||+|.||.|-+|++...|+.||||.|++ ...+..+.-+|.|||+||..|+||||+.++.+|. +
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----N 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----N 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----C
Confidence 556799999999999999999999999999999999974 4567778889999999999999999999999994 4
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...+.|||||.. |+|.++|..++.|++.++++|++||+.|+.|||.++++|||||.+|||+|.||.+||+||||+..+.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 446999999998 6999999999999999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.+ .+++++||++.|.+||++.| ..| ++.+|.|||||+||.|+.|.-||+|.+....+.+|...
T Consensus 205 ~~----kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G---------- 268 (668)
T KOG0611|consen 205 DK----KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG---------- 268 (668)
T ss_pred cc----cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc----------
Confidence 33 46789999999999999988 455 57899999999999999999999999876665555321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
.. .-|..+..+.-||+.||-.||++|.|+++|-.|=|++
T Consensus 269 -----------------aY-----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 -----------------AY-----REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------------cc-----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 00 0134456688999999999999999999999997776
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=379.16 Aligned_cols=261 Identities=25% Similarity=0.471 Sum_probs=218.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++... ..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CE
Confidence 47999999999999999999999999999999997432 2223456788999999999999999999988443 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999997 59999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 1245679999999999987 58899999999999999999999999887765554443321000
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+ ..+ ........+++++.+||.+||..+|.+||+++++++||||...
T Consensus 217 ---------~--~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 ---------L--QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ---------c--cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 000 0111113568899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.21 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=222.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-ccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.|.++++||+|+||+|++|..+.+++.||||.+++ ......+....+.|.+|+.... ||.++.++..|.+.+
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~----- 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE----- 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-----
Confidence 489999999999999999999999999999999985 3345567888999999998875 999999999996655
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
++|+||||+.| | .-.+...+.|++..+++|+..|+.||+|||++||||||||.+|||+|.+|.+||+|||+++..-..
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 69999999985 6 444555678999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
....+++|||+.|+|||++.+ ..|+.++|.|||||+|||||.|..||+|.+..+.++.|..-
T Consensus 522 ---g~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------- 583 (694)
T KOG0694|consen 522 ---GDRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------- 583 (694)
T ss_pred ---CCccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 223478999999999999988 79999999999999999999999999999988877766430
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
-....-.++.++.++|++||..||++|.. +++|..||||+.+.
T Consensus 584 ------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 584 ------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred ------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 01122467899999999999999999975 68899999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=383.03 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=212.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|.++.+++.||||++.... ........+.+|+.+|..++|+||+++++.+... ..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Ce
Confidence 46999999999999999999999999999999996422 1223446788999999999999999999988543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999997 5999999988899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC
Q 008644 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (558)
Q Consensus 181 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (558)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134689999999999977 67899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCC---CCC
Q 008644 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK---DRP 305 (558)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~---~Rp 305 (558)
.||.+.+....+..+.... ....+.. ...+++.+++||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK--------------------------ETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc--------------------------CcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998877655544443210 0011111 12468899999999876 444 458
Q ss_pred CHHHHhcCccccCc
Q 008644 306 TAEEALADPYFKGL 319 (558)
Q Consensus 306 ta~elL~hp~f~~~ 319 (558)
+++|+++||||++.
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=385.10 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=212.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||+||+|++..+++.||||++... .........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CE
Confidence 3699999999999999999999999999999999642 22334556789999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCccccCccccccccCCCCCcchhhh
Q 008644 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (558)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 216 (558)
. ........+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 0 0000124589999999999976 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008644 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (558)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~m 296 (558)
|||++|||++|+.||.+.+..+....+..... . .. ......+++++.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------~--~~-~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN------------------------T--LH-IPPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------------------------c--cC-CCCCCCCCHHHHHHHHHH
Confidence 99999999999999987765443333221100 0 00 111235789999999996
Q ss_pred cc--cCCCCCCCHHHHhcCccccCc
Q 008644 297 LA--FEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 297 L~--~dP~~Rpta~elL~hp~f~~~ 319 (558)
|. .++..|++++++++||||+++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 64 455569999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=369.59 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=210.7
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++|+||+.+++.+... ..+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEE
Confidence 889999999999999999999999999999986432 2223344678999999999999999999988443 4699
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||. |+|...+... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998 5888777543 368999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-------------- 216 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-------------- 216 (285)
T ss_pred ----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH--------------
Confidence 1244679999999999977 67899999999999999999999999876543222222111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
+.. ........+++.+.+||++||+.||.+||+ ++++++||||.++.
T Consensus 217 ---------~~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ---------VKE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ---------hhc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 000 011223457889999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=385.84 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=212.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CE
Confidence 46999999999999999999999999999999987421 1233456788999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCccccCccccccccCCCCCcchhhh
Q 008644 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (558)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 216 (558)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999977 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008644 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (558)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~m 296 (558)
|||++|||++|++||.+.+.......+.... ..... .....+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~~~~~---p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ------------------------TSLHI---PPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC------------------------CCcCC---CCcccCCHHHHHHHHHH
Confidence 9999999999999998876544333322110 00001 11245789999999998
Q ss_pred cccCCCCCCC---HHHHhcCccccCc
Q 008644 297 LAFEPKDRPT---AEEALADPYFKGL 319 (558)
Q Consensus 297 L~~dP~~Rpt---a~elL~hp~f~~~ 319 (558)
+ .||.+|++ ++++++||||+.+
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=361.84 Aligned_cols=264 Identities=29% Similarity=0.495 Sum_probs=221.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC------hhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------VSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~------~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~ 95 (558)
+.|+-.+.||+|..++|.++.++.+|..+|+|+|...... ..-.+....|+.||+++. ||+|+.+.++|.+++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3577788999999999999999999999999999642211 112244568999999885 999999999996665
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+++|+|+|. |.|++++.+.-.++|...+.|++||++|+.|||.++|+||||||+|||++++.++||+|||+|+
T Consensus 97 -----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 -----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred -----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4899999998 8999999988889999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccc----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
....+. .+.+.||||.|+|||.+.-. ...|+..+|+|++|||+|.||.|.+||-.....-.+..|++
T Consensus 172 ~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime----- 242 (411)
T KOG0599|consen 172 QLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME----- 242 (411)
T ss_pred ccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh-----
Confidence 765443 45789999999999987532 24688899999999999999999999965544333333332
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
.+...-+..|.+++..++|||.+||+.||.+|+|++|+|+||||..+...
T Consensus 243 ----------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 243 ----------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ----------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 22333456678889999999999999999999999999999999876543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=368.13 Aligned_cols=282 Identities=38% Similarity=0.621 Sum_probs=226.7
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.+++.++|+||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 69999999999999999999999999999999874333333345678899999999999999999988543 4699
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|+||++++|.+.+.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988875 45799999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+...++..+.+.++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345688999999988652 4578999999999999999998866 6777777888888888888876655433211
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
......... .....+.+..+.+++.+.+||++||+.||.+|||++++|.||||
T Consensus 232 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMY--PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCC--CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 100000000 00111233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=380.12 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=213.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC-cEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-+.|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----- 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----- 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence 457999999999999999999877655 689999986421 2233456788999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||+. |+|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 46999999997 69999999888999999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 184 ~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------------ 243 (340)
T PTZ00426 184 RT------YTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------------ 243 (340)
T ss_pred Cc------ceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence 21 34679999999999976 57889999999999999999999999887654443333210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. . ...+.+++.+.+||++||+.||.+|+ +++++++||||+++
T Consensus 244 --------------~--~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 244 --------------I--I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 11245678899999999999999995 89999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=386.02 Aligned_cols=259 Identities=31% Similarity=0.462 Sum_probs=229.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..+.|+++++||+|+||.+++++++..++.|++|+|...............|+.++++++|||||.++++|...+ .
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----Q 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----c
Confidence 356899999999999999999999999999999999865555555667889999999999999999999996544 3
Q ss_pred cEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
.++|||+||+ |+|.+.|+... .|+++.++.|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 5999999998 59999997644 59999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .+..+++||+.|+.||+|.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|...+..|.+
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----- 227 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----- 227 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence 554 13467899999999999998 79999999999999999999999999999998888888765444432
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
...+.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 228 -------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 -------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 456788999999999999999999999999988764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=384.54 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=212.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Ce
Confidence 46999999999999999999999999999999986421 1233456788999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6999999888889999999999999999999999999999999999999999999999999996321100
Q ss_pred CC------------c--------------------------------ccccccccCccccCccccccccCCCCCcchhhh
Q 008644 181 PT------------A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (558)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWS 216 (558)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999976 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008644 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (558)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~m 296 (558)
|||++|||++|.+||.+.+..+.+..+.... . ...+ .....+++.+.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------------~--~~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR------------------------E--TLYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC------------------------C--ccCC-CCCCCCCHHHHHHHHHH
Confidence 9999999999999998877655544433210 0 0111 11234688999999999
Q ss_pred cccCCCCC---CCHHHHhcCccccCc
Q 008644 297 LAFEPKDR---PTAEEALADPYFKGL 319 (558)
Q Consensus 297 L~~dP~~R---pta~elL~hp~f~~~ 319 (558)
|. +|.+| +|+.|+|.||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=384.97 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=212.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CE
Confidence 47999999999999999999999999999999986421 1223456688999999999999999999988543 47
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999997 6999999988889999999999999999999999999999999999999999999999999985321000
Q ss_pred C----------------------------------------CcccccccccCccccCccccccccCCCCCcchhhhHHHH
Q 008644 181 P----------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (558)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~i 220 (558)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999977 678999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 008644 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300 (558)
Q Consensus 221 l~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~d 300 (558)
+|+|++|+.||.+.+..+....+.... .... ......+++.+.+||.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~------------------------~~~~---~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE------------------------TTLH---IPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC------------------------cccc---CCCCCCCCHHHHHHHHHHh-cC
Confidence 999999999998877554433322110 0000 1112457899999999987 59
Q ss_pred CCCCC---CHHHHhcCccccCc
Q 008644 301 PKDRP---TAEEALADPYFKGL 319 (558)
Q Consensus 301 P~~Rp---ta~elL~hp~f~~~ 319 (558)
|.+|+ |+.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=369.10 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=223.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-.||..+.||.+..||..|.+ ...
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-----~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-----DKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-----cce
Confidence 578999999999999999999999999999999986433 35566788999999999999999999999844 457
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+|||||. |||+.+.++. +.|+++.+++++.+|+.||+|||-.|||+|||||+||||.++|.|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999998 5999998874 4699999999999999999999999999999999999999999999999998843200
Q ss_pred ---------------------------------C--------------------CCCcccccccccCccccCcccccccc
Q 008644 179 ---------------------------------D--------------------TPTAIFWTDYVATRWYRAPELCGSFF 205 (558)
Q Consensus 179 ---------------------------------~--------------------~~~~~~~~~~~gT~~Y~APE~l~~~~ 205 (558)
. .+.......++||-.|+|||++.|
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-- 309 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-- 309 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--
Confidence 0 001112245799999999999998
Q ss_pred CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCC
Q 008644 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 285 (558)
Q Consensus 206 ~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (558)
...+.++|.|+|||.+||||.|.-||+|.+..+.+..|.. ++..|.. .+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~-~~~v 360 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPE-EPEV 360 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCC-CCcc
Confidence 6889999999999999999999999999997766655432 1122222 2366
Q ss_pred CHHHHHHHHHhcccCCCCCCC----HHHHhcCccccCcccC
Q 008644 286 NPLALRLLERMLAFEPKDRPT----AEEALADPYFKGLAKV 322 (558)
Q Consensus 286 s~~~~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~~~~ 322 (558)
+..++|||+++|.+||.+|.. |.||-+||||+++...
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 789999999999999999998 9999999999998654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=361.74 Aligned_cols=280 Identities=31% Similarity=0.489 Sum_probs=230.4
Q ss_pred cCCCCcccccccCCCCcEEEE-eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCcc
Q 008644 8 KSSADVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIV 85 (558)
Q Consensus 8 ~~~~~~~~~~~~~~~~rY~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv 85 (558)
+...+|+| .+|.+.+.|.|- ++||-|-.|.|..+.++.||+++|+|++. +..+..||+++--.. .|||||
T Consensus 47 ~~~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV 118 (400)
T KOG0604|consen 47 SEESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIV 118 (400)
T ss_pred chhhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceE
Confidence 34556777 899999999887 58999999999999999999999999884 345667888886444 699999
Q ss_pred ccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-
Q 008644 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA- 161 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~- 161 (558)
.++++|. +++...+.+.||||.|+ |+|+..|..++. |+|.++..|+.||..|+.|||+.+|.||||||+|+|...
T Consensus 119 ~IidVye-Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 119 SIIDVYE-NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT 197 (400)
T ss_pred Eeehhhh-hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC
Confidence 9999984 44556678999999998 599999998876 999999999999999999999999999999999999875
Q ss_pred --CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH
Q 008644 162 --DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239 (558)
Q Consensus 162 --~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~ 239 (558)
|..+||+|||+|+..... ..+.+-|-|++|.|||+++. .+|+...|+||+|||+|.||+|.+||..+...
T Consensus 198 ~~na~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-- 269 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-- 269 (400)
T ss_pred CCCcceEecccccccccCCC----ccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCc--
Confidence 567999999999865431 23466789999999999987 78999999999999999999999999765531
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..++.+-.+ ++........+.|..+|..++|||+.||..+|.+|.|+++++.|||+.+.
T Consensus 270 ---------aispgMk~r------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 270 ---------AISPGMKRR------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ---------cCChhHHhH------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 112222111 22223333445677889999999999999999999999999999999986
Q ss_pred ccCCCC
Q 008644 320 AKVERE 325 (558)
Q Consensus 320 ~~~~~~ 325 (558)
......
T Consensus 329 ~~vp~t 334 (400)
T KOG0604|consen 329 EAVPQT 334 (400)
T ss_pred ccCCCC
Confidence 655433
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=379.48 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=216.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 479999999999999999999999999999999874321 22445678899999999999999999998844 346
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred --------------------------CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008644 181 --------------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (558)
Q Consensus 181 --------------------------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (558)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 00012245679999999999987 57899999999999999999999999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcC
Q 008644 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALAD 313 (558)
Q Consensus 235 ~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-a~elL~h 313 (558)
+.......+..... .... .....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~------------------------~~~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE------------------------SLRF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC------------------------cccC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 75544433322100 0001 1122368999999999998 9999999 9999999
Q ss_pred ccccCc
Q 008644 314 PYFKGL 319 (558)
Q Consensus 314 p~f~~~ 319 (558)
|||+++
T Consensus 286 p~~~~~ 291 (350)
T cd05573 286 PFFKGI 291 (350)
T ss_pred CCcCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=373.95 Aligned_cols=248 Identities=31% Similarity=0.502 Sum_probs=208.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++.+... ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence 799999999999999999999999986422 2334556788999999999999999999988543 4699999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccc
Q 008644 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (558)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (558)
. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred cccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHh
Q 008644 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (558)
Q Consensus 189 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~ 268 (558)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999977 6789999999999999999999999987665433322211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCc
Q 008644 269 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 319 (558)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp---ta~elL~hp~f~~~ 319 (558)
. +. .....+++.+.+||.+||..||.+|| ++.|+|.||||...
T Consensus 208 ----~-~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ----E-PL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----C-CC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0 11 12245788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=362.75 Aligned_cols=282 Identities=38% Similarity=0.644 Sum_probs=228.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++++.||+|++|.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence 48999999999999999999999999999999875433334456788999999999999999999998543 4699
Q ss_pred EEEecCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888653 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112344678999999988652 4578899999999999999999999999888887777777777776665543322
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ..+..................+++++.+||++||+.||.+|||+.++|.||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11211111111112223345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=368.81 Aligned_cols=295 Identities=40% Similarity=0.620 Sum_probs=236.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 46799999999999999999999999999999998643333333345678999999999999999999885432 246
Q ss_pred EEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 8999999999998888763 569999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 163 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 K---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred C---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 1 12344568899999998652 4578999999999999999999999999999999999999999887766544322
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 324 (558)
......+. +.......+...+...++.+.+||.+||.+||++|||++++|+||||++...+.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 239 LPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 11100000 0011111122334556899999999999999999999999999999987665433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=375.12 Aligned_cols=250 Identities=23% Similarity=0.444 Sum_probs=209.0
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
++||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997432 2234556788999999999999999999988543 46999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
|+. ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 22
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 45679999999999976 5789999999999999999999999987665433322210
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. . ......+++.+.+||++||..||.+|+ ++.++++||||.+.
T Consensus 210 ------~-~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 ------E-D---IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ------C-C---ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 011245788999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=373.40 Aligned_cols=250 Identities=25% Similarity=0.453 Sum_probs=209.4
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 47999999999999999999999999987432 2233456678899999999999999999988543 36999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
|++ ++|..++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322221 12
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 44679999999999976 5789999999999999999999999987765444333221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. . .....+++.+.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 210 -----~~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----EE--I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CC--C---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 0 11235689999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=374.16 Aligned_cols=262 Identities=23% Similarity=0.391 Sum_probs=214.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.++.+|+.||||+++.... .......+.+|+.+++.++|+||+.+++++... ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----Ce
Confidence 469999999999999999999999999999999975322 223456688999999999999999999988443 46
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 67999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCccccCccccccc----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12345799999999998631 145788999999999999999999999877655444333221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..... ....+.+++.+.+||++||. ||.+|||++++++||||..+
T Consensus 225 -----------------~~~~~-~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 -----------------QRFLK-FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCccC-CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 00011 11224678999999999998 99999999999999999854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=367.06 Aligned_cols=281 Identities=35% Similarity=0.602 Sum_probs=214.8
Q ss_pred EeEeeccCceEEEEEEECC--CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
...||+|+||.||+|.++. ++..||+|.+... .....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 3679999999999998654 6689999998642 22345778999999999999999999886532 2468999
Q ss_pred EecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----CCCCcEEEeeccc
Q 008644 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (558)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl----~~~~~lKL~DFGl 172 (558)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998887532 248899999999999999999999999999999999999 5667899999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~~~~i 243 (558)
++...............++|+.|+|||++.+. ..++.++|||||||++|||++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98754333222223456789999999998652 4578999999999999999999999975432 3567778
Q ss_pred HHhhCCCCHHHHHHhhhHHH-HHHHhhhccCC-----C-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 244 TDLLGTPSPEAIARVRNEKA-RRYLSSMRKKK-----P-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~-~~~~~~~~~~~-----~-~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
...+|.+..+.+..+..... ........... . ..........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88888888777655432110 00000000000 0 00011122346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=375.55 Aligned_cols=260 Identities=28% Similarity=0.487 Sum_probs=226.7
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-++.-|.+.+.||+|-|.+|.+|+|.-||+.||||+|.+.-.+.-....++.|++.|+.++|||||++|+++-+.+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT---- 90 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT---- 90 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc----
Confidence 3567799999999999999999999999999999999876555556678999999999999999999999985444
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE-eCCCCcEEEeecccceec
Q 008644 100 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVA 176 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NIL-l~~~~~lKL~DFGla~~~ 176 (558)
.+|||+|+-+ |||+++|.+.. .+.|+.++.++.||+.|+.|||...++||||||+||+ +.+-|-|||.|||++...
T Consensus 91 -KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 91 -KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred -eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 6999999998 59999998754 6999999999999999999999999999999999986 456799999999998655
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..+. .+++.||+..|.|||+|.| ..|+ +++||||||||||-|++|++||...++.+.+-.|++.--
T Consensus 170 ~PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------- 236 (864)
T KOG4717|consen 170 QPGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------- 236 (864)
T ss_pred CCcc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-------
Confidence 4433 4578999999999999988 4665 689999999999999999999999998888777765311
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.....++.+++|||.+||..||++|.+.+||..|+|++....
T Consensus 237 ------------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 ------------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ------------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 123467889999999999999999999999999999997643
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=371.44 Aligned_cols=261 Identities=23% Similarity=0.400 Sum_probs=209.2
Q ss_pred cEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~ 97 (558)
.|++++.||+|+||+||+|++. .+++.||+|++.+.. ........+.+|+.+|+.++ |+||+.+++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--- 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence 4899999999999999999864 578999999986421 22334566889999999995 89999999988443
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. ++|.+++..+..++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 78 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 78 --AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 46999999998 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 332221 12346799999999998752 357889999999999999999999997543221111111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
..+.... ....+.+++.+.+||.+||+.||++|| +++++++||||+..
T Consensus 221 -----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -----------RRILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------HHHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0011111 112245789999999999999999999 89999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=372.71 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=208.5
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997432 2233456678899999999999999999988543 46999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|++ ++|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5899988888889999999999999999999997 7999999999999999999999999999875332221 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999976 5789999999999999999999999987765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. .. .....+++.+.+||++||+.||++|+ ++.++|+||||.+.
T Consensus 211 -------~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 -------E-EI---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -------C-CC---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 0 00 11235688999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=369.48 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=212.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCcc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~Hp-nIv~l~~i~~~~~~~~~~~ 101 (558)
.|++++.||+|+||.||+|.+..+++.||||++.... ........+..|+.+|+.+.|+ +|+.+++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence 4899999999999999999999999999999987432 2234556788999999999765 577788877443 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||++ ++|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1245679999999999977 67899999999999999999999999887765544433210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~ 319 (558)
. ......+++.+.+||.+||..||.+|++. +++++||||+..
T Consensus 217 -------------~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 -------------N----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -------------C----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 01123568899999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=376.73 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=213.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+|+.++||||+++++++... .
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----K 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----C
Confidence 46899999999999999999999999999999998642 12223445678899999999999999999988543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 6999999997 5899888654 6899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccCccccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 262 (370)
T cd05596 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH----------- 262 (370)
T ss_pred Cc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------
Confidence 21 112456799999999998642 124788999999999999999999999887765544433221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~ 318 (558)
.....+ .....++..+.+||.+||..+|.+ |+|++++++||||+.
T Consensus 263 ---------------~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 263 ---------------KNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ---------------CCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 011111 122357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=370.06 Aligned_cols=250 Identities=24% Similarity=0.433 Sum_probs=208.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 2233456677899998876 699999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|||. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244679999999999976 6789999999999999999999999988776554443321
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta------~elL~hp~f~~~ 319 (558)
... .....+++.+.+||.+||+.||.+|+++ ++++.||||+.+
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 211 -------DEV----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 000 1123468899999999999999999998 999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.49 Aligned_cols=279 Identities=24% Similarity=0.385 Sum_probs=217.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|++..+|..||+|.+.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 468999999999999999999999999999999987432 233456789999999999999999999998543 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999998 59999998888899999999999999999999986 6999999999999999999999999998755322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH---
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA--- 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~--- 256 (558)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+... .++.+......
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCc
Confidence 1 234679999999999987 578999999999999999999999998766543222 22221100000
Q ss_pred --------------------HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 257 --------------------RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 257 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..........+..+....... ......++++.+||.+||.+||++|||++|+|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000011111111111111 1123467899999999999999999999999999999
Q ss_pred cCc
Q 008644 317 KGL 319 (558)
Q Consensus 317 ~~~ 319 (558)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=369.18 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=208.1
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHH---HhcCCCCccccceeecCCCcCCCc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLL---RLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL---~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.++ +.++||||+++++++... .
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence 789999999999999999999999999999997432 1223445677777765 456799999999988543 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+||||+.+ +|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 69999999985 88877754 47999999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 11 1245689999999999977 6789999999999999999999999988776554433321
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
... .....+++.+.+||.+||..||.+|| ++.++++||||+.+
T Consensus 216 -------------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 -------------DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 11235688999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.42 Aligned_cols=282 Identities=39% Similarity=0.645 Sum_probs=228.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++++.||.|++|.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 3899999999999999999999999999999987443333344678899999999999999999998743 34699
Q ss_pred EEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 104 VVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 34689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||++.+. ..++.++|||||||++|+|+||+.||.+.+....+..+...++.+....+......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12334678899999988652 34678899999999999999999999999888888888888888876554433221
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..+...+.......+....+.+++.+++||.+||+.||.+|||++++|.||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111222222222233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=367.49 Aligned_cols=280 Identities=33% Similarity=0.584 Sum_probs=228.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC--CC----ccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PD----IVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H--pn----Iv~l~~i~~~~~ 95 (558)
.+||+|++.+|+|.||.|..+.|..++..||||+|+.+. ...+..+-|+++|+++.+ |+ ++.+.+.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 689999999999999999999999999999999997532 233445679999999953 22 45555545
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC------------
Q 008644 96 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------ 161 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~------------ 161 (558)
+-.+++|||+|.++.+++++++.|+ .++..+++.+.+||+.+++|||+++|+|.||||+|||+.+
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 4446899999999999999999876 5899999999999999999999999999999999999643
Q ss_pred --------CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008644 162 --------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (558)
Q Consensus 162 --------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 233 (558)
+..++|+|||.|+...... +..+.|+.|+|||++.+ -+++..+||||+||||+||.+|..+|.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2348999999998754332 56789999999999998 5899999999999999999999999999
Q ss_pred CChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhcc---------------CCCCCCCCCCCCCC---HHHHHHHHH
Q 008644 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK---------------KKPIPFSQKFPNAN---PLALRLLER 295 (558)
Q Consensus 234 ~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~s---~~~~~Li~~ 295 (558)
.+..+++..|..++|..+..++.+.+. .+|+...+- ..+.++.......+ ..+.|||++
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~---~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRK---EKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhh---HhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 999999999999999888888777642 333332210 11222222222222 348899999
Q ss_pred hcccCCCCCCCHHHHhcCccccCcc
Q 008644 296 MLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 296 mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
||.+||.+|+|+.|+|.||||+.+.
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcCC
Confidence 9999999999999999999998754
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=368.77 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=209.2
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++||+|+||.||+|.++.+++.||||++.... ........+..|+.+|..+ +||||+.+++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 46999999999999999999999999987432 2234456677899999866 799999999998543 3699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||++ ++|...+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999976432221 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-------------------- 210 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999976 6789999999999999999999999998876555444322
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-------TAEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-------ta~elL~hp~f~~~ 319 (558)
... .....++..+.+||.+||+.||++|+ +++++++||||..+
T Consensus 211 -------~~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 211 -------DDV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 000 11134678999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.34 Aligned_cols=285 Identities=42% Similarity=0.735 Sum_probs=234.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeE
Confidence 59999999999999999999999999999999875443344567789999999999999999999998543 4689
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|+||++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45699999999999999999999999999999999999999999999999999986543322
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.......++.+|+|||.+.+. ..++.++||||+||++|+|++|.++|.+.+....+..+...++.|....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112445789999999998652 456889999999999999999999999999888899999988988876665432211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
....+ .........+...+++.+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11000 0111222233445567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=375.72 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=213.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|..++|+||+++++.+... ..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence 46999999999999999999999999999999986421 2233456788999999999999999999988443 47
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC
Q 008644 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (558)
Q Consensus 181 ~~--------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (558)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999977 67999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---
Q 008644 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP--- 305 (558)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp--- 305 (558)
.||.+.+....+..+... .....+.. ...+++.+.+||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887765544433211 00011111 12368899999999874 999998
Q ss_pred CHHHHhcCccccCc
Q 008644 306 TAEEALADPYFKGL 319 (558)
Q Consensus 306 ta~elL~hp~f~~~ 319 (558)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.52 Aligned_cols=251 Identities=28% Similarity=0.484 Sum_probs=208.1
Q ss_pred EeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 28 EEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++.||+|+||.||+|++. .+++.||||++.... ........+.+|+.+|+.++||||+++++.+... ..+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence 368999999999999864 578899999986421 2223445678999999999999999999988543 369
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 59999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234679999999999976 5788999999999999999999999988765444333221
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. ....+.+++.+.+||.+||+.||++|| +++++++||||...
T Consensus 215 ----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112345688999999999999999999 89999999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.82 Aligned_cols=300 Identities=42% Similarity=0.681 Sum_probs=232.6
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-- 96 (558)
|+.+.+|++.+.||.|+||.||+|.++.+|..||+|++... .......+.+|+.+|+.++||||+++++.+.....
T Consensus 1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 46689999999999999999999999999999999998643 22445678899999999999999999987754321
Q ss_pred -------CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEe
Q 008644 97 -------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKIC 168 (558)
Q Consensus 97 -------~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~ 168 (558)
.+...+|+||||++++|.+.+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 12246899999999999888764 46999999999999999999999999999999999999984 5678999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
|||+++................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997653222111122334688999999987542 4678899999999999999999999998888777777766655
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
.+..+......+... ..+.........++....+.++..+.+||.+||..||.+|||+.++|.||||+.+..+.
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 237 VVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred CCChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 554443333222111 11111111222223334567889999999999999999999999999999999775443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.60 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+++.||+|++.+. .........+.+|+.+++.++||||+++++.+... .
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-----K 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence 46899999999999999999999999999999998642 12223455678999999999999999999988543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 6999999997 5999988654 6899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCccccCcccccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 196 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (370)
T cd05621 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK---------- 263 (370)
T ss_pred Cc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 11 1224568999999999986521 237889999999999999999999998877655444433211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~ 318 (558)
....+. ....++..+++||.+||..++.+ |+|++|+++||||+.
T Consensus 264 ----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 ----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 001111 12356889999999999865544 899999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.48 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=212.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||++++..+++.||||++.+. .........+.+|+.+++.++|+||+.+++++... .+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----Ce
Confidence 4799999999999999999999999999999998642 12223445678899999999999999999988543 47
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 599999976 457999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11235799999999998631 135788999999999999999999999887655544433211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~~ 319 (558)
.....+....+.+++.+++||++||..++++ |++++++|+||||.++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 1112223334567899999999999765544 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=358.20 Aligned_cols=288 Identities=37% Similarity=0.630 Sum_probs=230.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++ |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998754333334467888999999995 699999999886554333445
Q ss_pred EEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeeccccee
Q 008644 102 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~ 175 (558)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999888653 35899999999999999999999999999999999999999 89999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......++++|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 11334678899999987542 45789999999999999999999999999888888888888887776654
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
......... . ......+.......+.+++.+.+||.+||..||.+|||++|+|.||||+
T Consensus 237 ~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDW--H-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccch--h-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 332221110 0 0111122222334467889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.54 Aligned_cols=286 Identities=42% Similarity=0.681 Sum_probs=233.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC---hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+|++.+.||.|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence 589999999999999999999999999999999743322 23345677899999999999999999998553 4
Q ss_pred cEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 699999999889999998776 7999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334678899999988542 467889999999999999999999999988888888888877777665544322
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
... .+. ......+.+....+...+..+.+||.+||.+||++|||+.|+|.|+||++...
T Consensus 232 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccc--ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 111 111 11112223334455677889999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=357.36 Aligned_cols=287 Identities=37% Similarity=0.661 Sum_probs=227.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
||.-++|++.+.||+|++|.||+|.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 75 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK---- 75 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC----
Confidence 57788999999999999999999999999999999998643222 2234567899999999999999999998543
Q ss_pred CccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 76 -KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred -CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 479999999999999988764 468999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.. ..+++..+.+.++.+..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11334578899999988652 457889999999999999999999998776 567778888888888776655
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNAN--PLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
........... .............++.++ ..+.+||.+||..||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPY-SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccccc-cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 44221100000 000011111222333445 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=365.71 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=212.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.|++++.||+|+||.||+|++..+++.||||++.+.. ........+..|..++..+ .|++|+.+++++... ..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 4899999999999999999999999999999987432 2233445677888888877 478899998888443 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. |+|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999997 6999999888889999999999999999999999999999999999999999999999999997543222
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245679999999999977 67899999999999999999999999887765554443321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. . .....++..+.+||.+||+.||.+|++ ..++++||||+.+
T Consensus 217 ------------~--~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 ------------N--V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ------------C--C---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 112356889999999999999999998 4899999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.04 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=224.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+.-++|++.+.||+|-||.||+|+.+.++..||+|++.+. .........+.||++|-..|+||||+++++.|.+.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--- 94 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--- 94 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---
Confidence 45567899999999999999999999999999999998642 23334456788999999999999999999999554
Q ss_pred CCccEEEEEecCc-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 98 EFKDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~--~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+|+++||.. |+|...+. ....+++...+.+++|++.||.|||..+|+||||||+|+|++..+.+||+|||-+.
T Consensus 95 --~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 95 --KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred --ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 46999999997 79999998 56679999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...+ ....+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+..|.++-
T Consensus 173 ~~p~-----~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------- 238 (281)
T KOG0580|consen 173 HAPS-----NKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------- 238 (281)
T ss_pred ecCC-----CCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------
Confidence 6532 23367899999999999988 689999999999999999999999999888777666665420
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
-. ....++..+.|||.+||..+|.+|.+..|++.|||+...
T Consensus 239 -----------------~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 239 -----------------LK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -----------------cc-------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 00 115778999999999999999999999999999998753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.81 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=206.0
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~-iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||+||+|++..+|+.||||++.... ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence 47999999999999999999999999986422 22233455666655 45789999999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999977 6789999999999999999999999988765544333321
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f~~~ 319 (558)
. + ....+.+++.+.+||++||+.||.+||++ .+++.||||..+
T Consensus 211 -------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 -------K-P---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred -------C-C---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 11235678999999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=373.91 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=221.9
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
....|..++.||+|+||.||+|+|..+++.||||+++.. ........+..|+.+|.+++++||.++|+.|+...
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~----- 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT----- 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----
Confidence 345788889999999999999999999999999999743 33345677899999999999999999999998765
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.++++||||. |++.++++..+.+.+..+..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+....+.
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 4999999998 589999998887899999999999999999999999999999999999999999999999999876554
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... ..+++||+.|||||++.+ ..|+.++||||||++.+||++|.+||......
T Consensus 165 ~~r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------------- 217 (467)
T KOG0201|consen 165 VKR---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------------- 217 (467)
T ss_pred hhc---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------------
Confidence 433 367899999999999986 78999999999999999999999999765532
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+++-.+.+..|..+. ..+++.+++||..||++||+.||+|.++|.|+|++.
T Consensus 218 -----rvlflIpk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 218 -----RVLFLIPKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----eEEEeccCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 122223333333333 267899999999999999999999999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=355.24 Aligned_cols=282 Identities=38% Similarity=0.698 Sum_probs=220.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence 479999999999999999999999999999999864322223345678999999999999999999988543 468
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 4555555566799999999999999999999999999999999999999999999999999987543321
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST- 230 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc-
Confidence 12345688999999998652 4578899999999999999999999999887777766666555433321111000
Q ss_pred HHHHHHhhhccCCC---CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKP---IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..+...+....+ .+....++.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 --NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred --ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001111110000 11112345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.29 Aligned_cols=281 Identities=23% Similarity=0.293 Sum_probs=218.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~----- 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK----- 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-----
Confidence 357999999999999999999754 45688999987531 2346899999999999999999988433
Q ss_pred ccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..+|+|||++.++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 46999999999999999977788999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---VVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..+.+.++....+...
T Consensus 239 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 221 12235679999999999976 678999999999999999999999997754 345666666666654433221
Q ss_pred HhhhHHHHHHHhhhcc--CCCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRK--KKPIPFSQK--FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.... .....+..... ..+...... ....+.++.+||.+||..||++|||+.|+|.||||..
T Consensus 316 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGST-NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccch-hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 1111 11111111111 111111111 1245678999999999999999999999999999975
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=364.95 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=205.9
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++||+|+||.||+|.++.+|+.||||+++.... .......+..|..+|..+ .||||+++++++... ..+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence 479999999999999999999999999974321 123445677788888754 899999999988443 4799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245689999999999977 6789999999999999999999999987765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-~elL~hp~f~~~ 319 (558)
.. ......++..+.+||++||+.||.+|+++ ++++.||||+..
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DT----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 00 01123468899999999999999999997 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=357.91 Aligned_cols=295 Identities=34% Similarity=0.546 Sum_probs=228.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~--- 96 (558)
..-++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 44568999999999999999999999999999999986433333334556789999999999999999998865432
Q ss_pred CCCccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.....+|+||||+.++|.+.+.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 1234679999999999988887653 689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC-cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... ........++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+.......+..+.|...++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 5332211 1112345678899999987652 3478899999999999999999999999998888888888888777665
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFS--QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
+...........+. +......... -.....+..+.+||.+||..||.+|||++++|+||||
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 44332211111100 0000000000 0011236778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.94 Aligned_cols=258 Identities=36% Similarity=0.608 Sum_probs=212.9
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++|+||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999998643333333445679999999999999999999865 346899
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
|||++.+ +|.+++...+.+++..++.++.||+.||.+||+.||+|+||||+|||++.++.++|+|||++..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999997 9999999777899999999999999999999999999999999999999999999999999976411 11
Q ss_pred ccccccccCccccCccccc-cccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 184 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~-~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.......++..|+|||++. + ..++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------- 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---------- 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH----------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccc----------
Confidence 2335678999999999987 4 57889999999999999999999999887555554444432211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.... ........+.+||.+||+.||++|||+.++++||||
T Consensus 221 -----~~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 221 -----SSSQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----HHTT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----cccc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0000 001112789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=367.67 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=209.1
Q ss_pred EeEeeccCceEEEEEEE---CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 28 EEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d---~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
++.||+|+||.||++++ ..+|+.||+|++............+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEE
Confidence 36799999999999986 46789999999975433334455678899999999999999999998543 46999
Q ss_pred EEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 105 VFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 105 V~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
||||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999997 69999998888899999999999999999999999999999999999999999999999999876433211
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1245679999999999976 57889999999999999999999999887655444333210
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. ......+++.+.+||++||+.||++||+ +++++.||||..+
T Consensus 214 ---------~-----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ---------K-----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------C-----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 0112356889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.50 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=205.4
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRL-LRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~-l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|.+..+++.||||+++... ........+..|..++.. ++||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 122344556677777765 4899999999988443 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---K 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999976433221 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999977 5789999999999999999999999988775444333221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-~elL~hp~f~~~ 319 (558)
.. ......++..+.+||.+||+.||.+||++ .+++.||||...
T Consensus 211 -------~~----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DR----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 01123467889999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=364.34 Aligned_cols=264 Identities=23% Similarity=0.406 Sum_probs=213.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++.+... ..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CE
Confidence 47999999999999999999999999999999986421 1223344578899999999999999999988543 46
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999997 699999977 457999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... .....+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Ccc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 211 12345799999999998531 14578899999999999999999999988776555443321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~~ 319 (558)
......+......+++.+.+||++||..++.+ |++++|+++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11112233334567999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=355.85 Aligned_cols=288 Identities=39% Similarity=0.677 Sum_probs=230.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|++|.||+|.++.+|+.||||++............+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence 579999999999999999999999999999999865433334446688999999999999999999998543 479
Q ss_pred EEEEecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeecccceeccCC
Q 008644 103 YVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~~~~~ 179 (558)
|+||||++++|.+.+..... +++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999988876543 578899999999999999999999999999999999985 567999999999754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999988652 457889999999999999999999999988888888888888888766554221
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.. ..+................+..++.+.+||.+||+.||++||++.++|+||||..+..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 11 1111111111122222334677899999999999999999999999999999987653
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=370.03 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=212.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++.+.||+|+||.||+|.++.+++.||+|++... .........+.+|+.+++.++||||+++++.+... .
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----R 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----C
Confidence 47999999999999999999999999999999998642 12223445678999999999999999999988543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 6999999997 5898888654 5899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCccccCcccccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------- 262 (371)
T cd05622 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH----------- 262 (371)
T ss_pred Cc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 11 1124568999999999986521 23788999999999999999999999887765544433321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~ 318 (558)
.....+ .....++..+.+||.+||..++.+ |++++++++|+||++
T Consensus 263 ---------------~~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 ---------------KNSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred ---------------CCcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 111111 123467899999999999844433 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=363.14 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=208.1
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||+||+|.+..++..||||++.... ........+.+|+.+++.+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987432 2233456678899999888 699999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234679999999999977 6789999999999999999999999987765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~ 319 (558)
... .....++..+.+||++||..||.+|||+ .++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 100 1123568899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=364.12 Aligned_cols=259 Identities=23% Similarity=0.413 Sum_probs=205.4
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 47999999999999999999999999997532 2233456688999999888 699999999988543 3699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|||+ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322111 2
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~--------~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTE--------DY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccch--------HH
Confidence 245689999999999977 678999999999999999999999996432110 0000000 00
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt------a~elL~hp~f~~~ 319 (558)
....+... .. .....+++.+.+||++||..||.+|+| ++++++||||..+
T Consensus 213 ~~~~~~~~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILEK-QI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHcC-CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00111111 11 122456889999999999999999987 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.66 Aligned_cols=281 Identities=41% Similarity=0.693 Sum_probs=231.1
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 6789999999999999999999999999999875433333446688999999999999999999998543 46999
Q ss_pred EEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 105 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 105 V~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999989999998765 699999999999999999999999999999999999999999999999999875422211
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+..++|....+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 11334578899999987652 35788999999999999999999999999888888888888888887765443221
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..+................+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 12222222222333344456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=379.12 Aligned_cols=282 Identities=25% Similarity=0.324 Sum_probs=212.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+..|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+.+|+.|+|+||+++++++... .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----G 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----C
Confidence 4568999999999999999999999999999999642 22356899999999999999999987543 3
Q ss_pred cEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..|+|||++.++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 68999999999999988764 46999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCC------hhhHHHHHHHhhCCCCH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKN------VVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~------~~~~~~~i~~~lg~p~~ 252 (558)
... ......+||..|+|||++.+ ..++.++|||||||+||||++|..+ |.... ...++..+....+....
T Consensus 314 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 314 WST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 211 12234679999999999977 6789999999999999999998754 43321 12334444443332211
Q ss_pred HHHHHhhhHHHHHHHhh----hccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 253 EAIARVRNEKARRYLSS----MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+............+... .......+....+..+++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11100000001111111 1111111112233456788999999999999999999999999999973
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.53 Aligned_cols=269 Identities=25% Similarity=0.371 Sum_probs=220.8
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-- 96 (558)
-...++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345689999999999999999999999999999999997554455566778899999999999999999887754321
Q ss_pred -CCCccEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 97 -REFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 97 -~~~~~~~lV~E~~~-g~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.....+++||||+. |+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 11224789999998 6999988652 46899999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
|+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 188 Gls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----- 259 (496)
T PTZ00283 188 GFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----- 259 (496)
T ss_pred ccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----
Confidence 999865432211 12245689999999999977 6789999999999999999999999987765443332211
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. .....+.+++.+.+||.+||..||.+||++.++|+|||++.+.
T Consensus 260 ----------------------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 260 ----------------------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ----------------------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 00 1112356789999999999999999999999999999998653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=355.33 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=203.5
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||+|+||+||+|.++.+|+.||+|++.... ........+..|+.+|+.++|+||+.+.+++... ..+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence 799999999999999999999999986422 2223345678899999999999999999988443 3699999999
Q ss_pred c-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 110 E-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 110 ~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
. ++|...+.. +..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 588877643 346999999999999999999999999999999999999999999999999999765433221
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~ 264 (558)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 234679999999999987 678899999999999999999999997654321111110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
..+.. .+ ....+.+++.+.+|+.+||+.||++|| |++++++||||+++.
T Consensus 211 ---~~~~~-~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 211 ---QRILN-DS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ---Hhhcc-cC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 00000 01 112245788999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=357.25 Aligned_cols=294 Identities=36% Similarity=0.619 Sum_probs=230.9
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---C
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---R 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~---~ 97 (558)
.-++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++|+||+++++++..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3579999999999999999999999999999999986433332333456789999999999999999998765432 2
Q ss_pred CCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
....+|+|+||+.++|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 34468999999999888887653 47999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCC--------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 177 FNDTPT--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 177 ~~~~~~--------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
...... ....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 332211 1122445778999999987652 4578899999999999999999999999999988888888888
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.+.+..+.....-..... .......+......+...++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 776654432211000000 0001111112223345667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=352.51 Aligned_cols=282 Identities=37% Similarity=0.696 Sum_probs=222.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+|+.++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 47999999999999999999999999999999986543333345668899999999999999999998843 3469
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|+||+.+ .|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999996 5666655556799999999999999999999999999999999999999999999999999976533321
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+......-......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ---ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 23456789999999998652 45778999999999999999999999988877777777766665433211111000
Q ss_pred HHHHHHhhhcc---CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. .+..+.. .........++.++..+.+||.+||..||++|||+.++|+||||
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 P---LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred h---HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 0000000 00111223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=368.89 Aligned_cols=279 Identities=25% Similarity=0.343 Sum_probs=209.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
...|++++.||+|+||.||+|.+..++..||+|+... .....|+.+|+.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence 4569999999999999999999999999999997542 1235699999999999999999988544 35
Q ss_pred EEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 8999999999999988764 569999999999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCCh---------hhHHHHHHHhhCCC
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV---------VHQLDIMTDLLGTP 250 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~---------~~~~~~i~~~lg~p 250 (558)
......||..|+|||++.+ ..++.++|||||||++|||+++. ++|.+... ..++..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234679999999999977 57899999999999999999855 44443221 22333333444433
Q ss_pred CHHHHHHhhhHHHHHHHhhhcc-CCCCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 251 SPEAIARVRNEKARRYLSSMRK-KKPIPF--SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+.+............++..... +.+... .....+++..+.+||.+||++||.+|||++|+|+||||+.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2222111111111122211110 111100 01123567788999999999999999999999999999853
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=354.11 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=210.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+|+.++||||+.+++.+... ..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 4899999999999999999999999999999986422 2222345577899999999999999999988543 369
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+|||||. ++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5888877653 35999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 21 134578999999999976 57889999999999999999999999876643332222111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
+... . ......+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 217 ----------~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 ----------VKED-Q---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------hhhc-c---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0000 0 112245688899999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=365.13 Aligned_cols=253 Identities=31% Similarity=0.423 Sum_probs=207.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcE-EEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~-vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.....+.+.||+|+||+||.+. ..|.. ||+|++............+.+|+.+|..++|||||++++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 4455667779999999999995 45666 9999998654444447789999999999999999999999966542
Q ss_pred cEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEeCCCC-cEEEeeccccee
Q 008644 101 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~g-IiHrDIKP~NILl~~~~-~lKL~DFGla~~ 175 (558)
.++||||||. |+|.+++.. ...++...+..|+.||++||.|||+.+ ||||||||+|||++.++ .+||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999998 699999987 568999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..... ...+...||+.|||||++.+....|+.++||||||+++|||+||+.||.+.........+.....+
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R------ 264 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR------ 264 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC------
Confidence 65421 122447899999999999841157999999999999999999999999988864333222211111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+ ...+++.+..||++||..||++||++.+++.
T Consensus 265 ------------------p~~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 265 ------------------PPI-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------------------CCC-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 111 1237888999999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=352.06 Aligned_cols=281 Identities=37% Similarity=0.689 Sum_probs=228.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||.|++|.||+|.+..+|..||||++..... ......+.+|+.+++.++|+||+++++.+... ...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEE
Confidence 48999999999999999999999999999999874322 23345677899999999999999999998543 3689
Q ss_pred EEEecCcccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||++++|.+++.... .++++.+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 999999999999887643 58999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|++||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678999999987552 4578899999999999999999999999998888888888888888776654431
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ..+................+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111222345668889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=354.96 Aligned_cols=286 Identities=40% Similarity=0.661 Sum_probs=230.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|++.+.||.|+||.||+|.+..+++.+++|.++...........+.+|+.+|+.++||||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5799999999999999999999999999999999743333333446778999999999999999999886542 2479
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|+||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999999999999887654 599999999999999999999999999999999999999999999999999986543321
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|....+.....-
T Consensus 162 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 162 ---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12345678899999998652 34688999999999999999999999999988888888888898887766543221
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..... ..........+...++.. ++.+.+||++||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 10000 001111112223344544 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.03 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=210.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.|++.+.||+|+||.||+|.++.+|+.||||++.... ........+..|+.+++.+. |++|+.+++++... ..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence 4788999999999999999999999999999987432 12234566788999998886 56777888877443 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1244679999999999976 67899999999999999999999999887755444333210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. ......++..+.+|+.+||+.||.+|++ .+++++||||..+
T Consensus 217 ------------~-----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 ------------N-----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------C-----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0112356789999999999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=362.41 Aligned_cols=259 Identities=22% Similarity=0.415 Sum_probs=204.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 47999999999999999999999999997542 2334456688899998776 799999999988543 3699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|||. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58999888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~~--------~~~ 212 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNT--------EDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Cccccc--------HHH
Confidence 245689999999999977 678999999999999999999999995321100 000000 000
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt------a~elL~hp~f~~~ 319 (558)
....+... .. .....++..+.+||++||..||++|+| ++++++||||+..
T Consensus 213 ~~~~i~~~-~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 213 LFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHhcC-CC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00111111 11 122457889999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.99 Aligned_cols=280 Identities=39% Similarity=0.733 Sum_probs=222.9
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
|++++.||+|+||.||+|.+..++..||+|+++...... ......+|+.+++.+. |+||+++++++.... ...++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEE
Confidence 788999999999999999999999999999987543332 2234467999998885 999999999986541 24689
Q ss_pred EEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||+|+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888764 46899999999999999999999999999999999999999 9999999999976543222
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..+.........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1345689999999976432 456889999999999999999999999999988889998888888775533221111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
...+ .........+....+.++..+.+||.+||..||++|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000111112234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=360.28 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=206.3
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRL-LRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~-l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||+||+|.+..+++.||||++..... .......+..|..++.. +.||||+++++++... ..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999874321 12344556778888875 4899999999998543 3699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. |+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999976 6789999999999999999999999987765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCccccCcc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 320 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~-elL~hp~f~~~~ 320 (558)
..+ .....++..+.+||.+||+.||++|+++. ++++||||+.+.
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 000 01134678899999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=363.67 Aligned_cols=250 Identities=28% Similarity=0.492 Sum_probs=205.3
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~-iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||+||+|.++.+|+.||||++.... ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence 46999999999999999999999999986432 22234455666665 46789999999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|...+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58999998888899999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999977 6789999999999999999999999987765443332221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f~~~ 319 (558)
. . ....+..+..+.+||++||+.||.+||++ .+++.||||...
T Consensus 211 -------~-~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K-P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C-C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11234678899999999999999999976 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=367.09 Aligned_cols=258 Identities=26% Similarity=0.331 Sum_probs=203.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCe
Confidence 357889999999999999999999999999999986422 22345678899999999999999999998843 346
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||.+ +|... ...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999985 66432 346788889999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12446799999999987431 12345689999999999999999999974332211111110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+.... .......++..+.+||.+||..||++|||+.|+|+||||.+.
T Consensus 288 ------------~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 ------------ICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------HhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00000 112234678899999999999999999999999999999874
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=343.95 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=211.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC---hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+.|++.+.||+|++|.||.|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 4699999999999999999999999999999998643221 12345688999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|+||+. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 37999999997 58999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2221111134568899999999987 5688999999999999999999999976544332221110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... .......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 000 112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.72 Aligned_cols=263 Identities=22% Similarity=0.382 Sum_probs=212.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.+++.++|+||+.+++.+... ..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence 47999999999999999999999999999999986421 2223345578899999999999999999988443 47
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. |+|.+++.. .+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999997 699999987 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCcccccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... .....+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 211 113357999999999986421 2577899999999999999999999987765544433321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~ 318 (558)
.....++......++..+.+||.+||..++.+ |++++++++||||++
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 11112233344567899999999999976654 579999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=360.84 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=204.3
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~-iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||+||+|++..+++.||+|++.... ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 47999999999999999999999999986421 11223344555544 56889999999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 48999998888899999999999999999999999999999999999999999999999999975322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999977 6789999999999999999999999988775544333321
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCccccC
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE----EALADPYFKG 318 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~----elL~hp~f~~ 318 (558)
. + ....+.+++.+.+||++||+.||.+|+++. ++++|+||..
T Consensus 211 -------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 211 -------K-P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred -------C-C---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 0 1 112356789999999999999999999865 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=360.37 Aligned_cols=283 Identities=22% Similarity=0.365 Sum_probs=215.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CE
Confidence 468999999999999999999999999999999887432 233456789999999999999999999998543 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999997 59999999888899999999999999999999975 7999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHH-hhCCCCHHHHHH-
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIAR- 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~-~lg~p~~~~i~~- 257 (558)
. ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. ..+.+.......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134579999999999977 5788999999999999999999999987654322211110 011111000000
Q ss_pred ----------hhh-----HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 ----------VRN-----EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ----------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... .........+....+... .....+.++.+||.+||++||++|||++|+|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 000011111111111111 112357889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=360.33 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=203.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~-iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|.. +++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence 47999999999999999999999999986422 12233345556654 57889999999999988443 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999976 6789999999999999999999999988765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f~~~ 319 (558)
. +. ...+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 -------~-~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 -------K-PL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------C-CC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0 11 1224567889999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.89 Aligned_cols=286 Identities=38% Similarity=0.691 Sum_probs=225.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+|+.++|+||+++++++... ..+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence 479999999999999999999999999999999875444444557789999999999999999999998543 469
Q ss_pred EEEEecCcccHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~-i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||+++++... +.....+++..++.++.||+.||.|||+.||+||||+|+||++++++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765544 44556799999999999999999999999999999999999999999999999999987544332
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998762 37889999999999999999999999998888888777777776665433322111
Q ss_pred HHHHHHhhhccCCCCCCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
....-...........+...++ .+++.+.+||++||..||++|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000000000000000111122 348889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=347.40 Aligned_cols=286 Identities=36% Similarity=0.621 Sum_probs=220.9
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
||....|++++.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 75 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK---- 75 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC----
Confidence 4667899999999999999999999999999999999864322 22334567899999999999999999988433
Q ss_pred CccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...|+||||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 76 -ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred -CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 368999999998888877653 468899999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+. .+++..+...++.|......
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2211 12344678999999998652 4578899999999999999999999976553 45666666777777666544
Q ss_pred HhhhHHHHHHHhhh-ccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 257 RVRNEKARRYLSSM-RKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
...... .+.... ....+......+. ..++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKLP--NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhcc--cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 332110 000000 0000111111111 126789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.23 Aligned_cols=288 Identities=38% Similarity=0.653 Sum_probs=220.9
Q ss_pred cEEEEeEeeccCceEEEEEEECC--CCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.+|+.++||||+++++.+... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999987532 1223346678899999999999999999998654 124
Q ss_pred cEEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC----CCcEEEeecc
Q 008644 101 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 171 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~----~~~lKL~DFG 171 (558)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 69999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---------hHHHH
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---------HQLDI 242 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---------~~~~~ 242 (558)
+++...............+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998653322211122445789999999987652 45788999999999999999999999866532 35566
Q ss_pred HHHhhCCCCHHHHHHhhhHHH-HHHHhhhccCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 243 MTDLLGTPSPEAIARVRNEKA-RRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
+...++.+....+........ ........ ....+ +...+...+..+.+||.+||+.||++|||+.|++.|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 667777776655433222111 01000000 00000 00111256788999999999999999999999999999
Q ss_pred c
Q 008644 316 F 316 (558)
Q Consensus 316 f 316 (558)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=363.24 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=202.5
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCccEEEEE
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
||+|+||+||+|+++.+|+.||||++.+. ............|..++..+ .||||+.+++.+... ..+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 79999999999999999999999998642 12223344566777777665 699999999988543 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456899999999998652 4578999999999999999999999987765443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP----TAEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp----ta~elL~hp~f~~~ 319 (558)
.... +. ...+++.+.+||++||..||.+|| +++++++||||...
T Consensus 212 ------~~~~--~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 ------GKVR--FP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ------CCCC--CC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 0000 00 124688999999999999999998 79999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=345.85 Aligned_cols=282 Identities=48% Similarity=0.791 Sum_probs=234.7
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999999875444434567788999999999999999999988544 46999
Q ss_pred EEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
|+||++++|.+.+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999888774 579999999999999999999999999999999999999999999999999997764432
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
.......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+..+++..+...++.+.++.+.....-.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA- 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-
Confidence 112345688899999998762 368899999999999999999999999999999999998888888777665543311
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
....-.+............+.++..+.+||.+||..||.+||++.++|.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122223333344556788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.71 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=210.5
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++++.||+|++|.||++.++.+++.||+|++............+.+|+.+++.++|+|++++++.+... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 49999999999999999999999999999999975444445566788999999999999999998876432 23589
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5899888763 358999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......+++.|+|||++.+ ..++.++|+|||||++++|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2244578999999999877 6788999999999999999999999987664333222111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. . ........++.+.+||.+||+.||++|||+.++|+||||
T Consensus 217 --------~---~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 --------G---K----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------c---C----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0 011224567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=356.63 Aligned_cols=295 Identities=39% Similarity=0.611 Sum_probs=234.4
Q ss_pred cCCCCcEEE-EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChh------------HHHHHHHHHHHHHhcCCCCcc
Q 008644 19 YGEGSRYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------DATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 19 ~~~~~rY~i-~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~------------~~~~i~~Ei~iL~~l~HpnIv 85 (558)
+.+.+||.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 467889975 5779999999999999999999999999864322110 012477999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcE
Q 008644 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~l 165 (558)
++++++... ..+|+||||+.++|.+++.....++++.+..++.||+.||.|||+.||+||||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 999998543 369999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCC-----------CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008644 166 KICDFGLARVAFNDT-----------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (558)
Q Consensus 166 KL~DFGla~~~~~~~-----------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (558)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334678899999998652 35788999999999999999999999999
Q ss_pred ChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 235 ~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
+..+.+..+...++.|....+....... .+ .......+..+...++..+..+.+||.+||+.||++|||++|+|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9999898998888888765443221100 00 00111112223334556788999999999999999999999999999
Q ss_pred cccCcccC
Q 008644 315 YFKGLAKV 322 (558)
Q Consensus 315 ~f~~~~~~ 322 (558)
||+.....
T Consensus 315 ~~~~~~~~ 322 (335)
T PTZ00024 315 YFKSDPLP 322 (335)
T ss_pred ccCCCCCC
Confidence 99876443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=356.53 Aligned_cols=257 Identities=22% Similarity=0.397 Sum_probs=205.1
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+.+++++... ..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence 47999999999999999999999999997532 2234456688999999888 699999999988443 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~---------~-----------~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT---------E-----------DY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc---------H-----------HH
Confidence 245689999999999976 6789999999999999999999999964321110000 0 00
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt------a~elL~hp~f~~~ 319 (558)
....+. ..+.. ....++..+.+||.+||..||.+|++ +++++.||||+.+
T Consensus 211 ~~~~~~-~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 211 LFQVIL-EKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHH-hCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 001111 11111 22356889999999999999999998 5799999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=347.67 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=207.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++|+||+.+++.+... ..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence 4788999999999999999999999999999986432 2223345677899999999999999999988443 369
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999997 5898888653 35899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ....+||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+.
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 21 133579999999999976 578999999999999999999999997643211111111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
..+.... ......+++.+.+||.+||+.||++||| ++|+++||||+++
T Consensus 215 -----~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 215 -----RLVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----hhhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0111100 0112456788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=344.52 Aligned_cols=281 Identities=43% Similarity=0.737 Sum_probs=234.0
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6788999999999999999999999999999975443344456778999999999999999999988543 47999
Q ss_pred EEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
|+|+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999886 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
......++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999998652 378899999999999999999999999999999999999999988887765543321
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.+-..+...........++..+..+.++|.+||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0111112222223334556778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.92 Aligned_cols=291 Identities=37% Similarity=0.626 Sum_probs=229.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-----c
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-----R 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-----~ 96 (558)
.++|++.+.||.|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 36799999999999999999999999999999998743333334456778999999999999999999886543 1
Q ss_pred CCCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+...+|+|+||++++|...+... ..+++..++.++.||+.||.|||+.||+|+||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888764 3699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
....... ......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+....+..+...++.+.+..+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 11233567889999988542 45788999999999999999999999998888888889888888876554
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..+............. .........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKK-QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccc-ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3321110000000000 00011122344568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=387.24 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=214.0
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.--.-++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+||||+++++.|....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-- 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-- 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--
Confidence 334456899999999999999999999999999999998754444456678899999999999999999999886432
Q ss_pred CCccEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEeCC----
Q 008644 98 EFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA---- 161 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~-------gIiHrDIKP~NILl~~---- 161 (558)
...+||||||+. ++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 246899999998 599998865 35699999999999999999999985 4999999999999964
Q ss_pred -------------CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC
Q 008644 162 -------------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (558)
Q Consensus 162 -------------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (558)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++|+
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 3458999999997653222 12446799999999998653346889999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 008644 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308 (558)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~ 308 (558)
.||...+...++... +..... ......+..+.+||.+||.+||.+||++.
T Consensus 241 ~PF~~~~~~~qli~~--------------------------lk~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 241 TPFHKANNFSQLISE--------------------------LKRGPD----LPIKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred CCCCcCCcHHHHHHH--------------------------HhcCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 999765543322111 111111 11235678999999999999999999999
Q ss_pred HHhcCccccCc
Q 008644 309 EALADPYFKGL 319 (558)
Q Consensus 309 elL~hp~f~~~ 319 (558)
|+|.|+||+.+
T Consensus 291 QlL~h~~ik~i 301 (1021)
T PTZ00266 291 QCLGYQIIKNV 301 (1021)
T ss_pred HHhccHHHhhc
Confidence 99999999754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.04 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=211.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC-CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t-g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
..|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++.+... ..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CE
Confidence 4599999999999999999999888 78899998743 2334456678899999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+||||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999997 599887753 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 220 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----------- 285 (478)
T PTZ00267 220 SDSVSL-DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----------- 285 (478)
T ss_pred CCcccc-ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 432211 12345679999999999977 6789999999999999999999999987765443333221
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... ......+++.+.+||.+||..||++||+++++|.|+|++.+
T Consensus 286 ----------------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 286 ----------------GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ----------------CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 000 01123567899999999999999999999999999999754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.45 Aligned_cols=282 Identities=40% Similarity=0.653 Sum_probs=225.6
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCcc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
|++.+.||.|+||.||+|.++.++..||+|++............+.+|+.+++.+ .|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433333345677888888766 5999999999987654333345
Q ss_pred EEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|++||++.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 4899999999999999999999999999999999999999999999999999775433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 134467889999999976 578899999999999999999999999999888888887776655443222111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... ...........+....+.+++.+.+||.+||+.||.+||+++++|.||||
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLP----RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccc----hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 00111222223344455678889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.85 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=200.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||+|+||.||++.++.+|+.||+|++..... .......+..|+.+|+.++||||+++++.+... ..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence 7999999999999999999999999864221 222334566799999999999999999988443 4699999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 110 ~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
. ++|..++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 7 58988876543 48899999999999999999999999999999999999999999999999997654322 12
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---------------------- 207 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---------------------- 207 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----------------------
Confidence 34578999999999976 568999999999999999999999997643211100000
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f~~~ 319 (558)
...... . .......+++++.+||.+||+.||++||++ ++++.||||+.+
T Consensus 208 -~~~~~~-~--~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 208 -RRTLED-E--VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred -HHhhcc-c--cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 000000 0 011123578899999999999999999999 778899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.30 Aligned_cols=283 Identities=40% Similarity=0.696 Sum_probs=228.5
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++.+.||.|+||.||+|.+..+|+.+|+|++............+.+|+.+++.++|+|++++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999754434445567889999999999999999999985431 247999
Q ss_pred EEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
|+||++++|..++... ..+++..++.++.||+.||.|||+.|++|+||+|+|||+++++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999987644321
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.+.++.+....+.....-.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112345678899999987542 457899999999999999999999999999888888888888887766544322110
Q ss_pred HHHHhhhccCC--CCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 264 RRYLSSMRKKK--PIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 264 ~~~~~~~~~~~--~~~~~~~~~~~-s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
+........ +..+...+... ++.+.++|++||..||.+||++++++.||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 001110000 00111223333 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.55 Aligned_cols=283 Identities=24% Similarity=0.379 Sum_probs=215.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEE
Confidence 36999999999999999999999999999999986432 233456688999999999999999999998543 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999997 599999999999999999999999999986543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH-----
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI----- 255 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i----- 255 (558)
....+++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134678999999999876 56889999999999999999999999876643322222111000000000
Q ss_pred ----HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ----ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..............+....+. ......+++.+.+||.+||..||++|||+.++|+||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 000000000111111111110 111123678899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=343.02 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=210.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.|++.+.||+|+||+||+|.+..+++.||+|++... .........+.+|+.+|+.++|+||+.+.+.+... ..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence 478899999999999999999999999999998642 22223345578899999999999999999888543 369
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998 5888777543 36999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL----------- 218 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-----------
Confidence 1 1234579999999999976 5789999999999999999999999987665433332221100
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
... ....+.+++.+.+|+.+||+.||++||| +.+++.|+||+..
T Consensus 219 ------------~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 219 ------------ETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ------------ccc----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 000 0122456788999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.32 Aligned_cols=253 Identities=26% Similarity=0.470 Sum_probs=199.4
Q ss_pred CcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++.+.||+|+||.||+|.+ ..++..||||++... ........+.+|+.+|+.+ +||||+++++++....
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 6899999999999999999975 245678999998643 2234456789999999999 8999999999885432
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC-------------------------------------------------------
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (558)
..+|+||||+. |+|.+++...
T Consensus 85 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 85 ---GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 35899999998 6999888653
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCc
Q 008644 121 -------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193 (558)
Q Consensus 121 -------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~ 193 (558)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCc
Confidence 2377888999999999999999999999999999999999999999999999986532211 11112344667
Q ss_pred cccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhcc
Q 008644 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 272 (558)
Q Consensus 194 ~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~ 272 (558)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.... ..
T Consensus 241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~~ 292 (338)
T cd05102 241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------KD 292 (338)
T ss_pred cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999876 578999999999999999997 999998755332211110 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 273 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||..||++|||+.|+++
T Consensus 293 ~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 GTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 0112456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.02 Aligned_cols=275 Identities=25% Similarity=0.400 Sum_probs=222.5
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
+.||+|+|+.|-.++...||..||||+|.+.. .....++.||++++.+.+ |+||++++++| ++...+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVfE 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVFE 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEEe
Confidence 68999999999999999999999999998753 345678999999999996 99999999998 44456999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecccceeccCCCC--
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTP-- 181 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFGla~~~~~~~~-- 181 (558)
-|. |.|...|.++..|+|.++..++.+|+.||+|||.+||.||||||+|||..+.. -+|||||.|+........
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 997 59999999999999999999999999999999999999999999999987654 489999999865432211
Q ss_pred --CcccccccccCccccCccccc---cccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 182 --TAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 182 --~~~~~~~~~gT~~Y~APE~l~---~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
....+.+.+|+-.|||||+.. +....|+.+.|.||||||+|.||.|.+||.|....+. |=-..+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe--- 305 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGE--- 305 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCC---
Confidence 122345678999999999753 3335799999999999999999999999987653221 000000
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
....=-..+++++...+.-.....|..+|.+++|||..+|..|+..|.++.++|+|||++.....
T Consensus 306 -~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 306 -VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred -ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 00001134556666665555567788899999999999999999999999999999999976543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.15 Aligned_cols=286 Identities=23% Similarity=0.307 Sum_probs=208.1
Q ss_pred EEeEeecc--CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 27 IEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 27 i~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
++++||+| +|++||++.++.+|+.||||++............+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57899999 678999999999999999999975444444556788899999999999999999998554 36899
Q ss_pred EEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 105 VFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 105 V~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|||||+ ++|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 5899988653 4599999999999999999999999999999999999999999999999987544321111
Q ss_pred C----cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH-
Q 008644 182 T----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA- 256 (558)
Q Consensus 182 ~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~- 256 (558)
. ........++..|+|||++.+....|+.++|||||||++|+|++|+.||............. .+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~-~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVP-CLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcc-ccccc
Confidence 0 00112245778899999986532468899999999999999999999998655433222211 11110 0000
Q ss_pred -HhhhHHHHHHHh------hhcc----------CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 -RVRNEKARRYLS------SMRK----------KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 -~~~~~~~~~~~~------~~~~----------~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
....+....... .+.. ............+++.+.+||.+||+.||++|||++|+|+||||+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000000000000 0000 00000111223457889999999999999999999999999999864
Q ss_pred c
Q 008644 320 A 320 (558)
Q Consensus 320 ~ 320 (558)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=341.85 Aligned_cols=254 Identities=25% Similarity=0.458 Sum_probs=213.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++|+.+.||||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence 47999999999999999999999999999999986421 2234456788999999999999999999988443 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999995 799999998888999999999999999999999999999999999999999999999999999765433
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
....++++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134578999999999876 5678899999999999999999999987664332222210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
... ......++.+.+||++||..||.+|+ +++|+++||||+.+.
T Consensus 213 -----------~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GKV-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCc-----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 000 11234578899999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=332.47 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=211.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+|+.++||||+++++.+... ...|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 48899999999999999999999999999999875434455667889999999999999999999988543 4699
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5999998774 468999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234578899999999877 5688999999999999999999999987664332222211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. .......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 011112567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=337.34 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=207.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+|+.++||||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 468999999999999999999999999999999864322 2234467889999999999999999999875422 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+++++||+. ++|.+++...+.+++...+.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 46899999998 58999998887899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~-------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP-------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC--------
Confidence 2111111233568889999999876 5788999999999999999999999976543222211110 00
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
. .......+++.+.+|| +||..||++||+++|+++||||+
T Consensus 226 ---------------~---~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 ---------------T---NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------C---CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 0111234577888998 68888999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.05 Aligned_cols=268 Identities=28% Similarity=0.441 Sum_probs=208.3
Q ss_pred ccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeec
Q 008644 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILL 92 (558)
Q Consensus 14 ~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~ 92 (558)
++++. .+..|+++++||+||.+.||++.... ...||+|++.....+......+.+|+.+|.+|+ |.+||+|+++-+
T Consensus 354 ~~i~V--kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKV--KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEE--CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 44444 35689999999999999999997543 456788877766666778888999999999996 999999999876
Q ss_pred CCCcCCCccEEEEEecCcccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 93 PPSRREFKDIYVVFELMESDLHQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l-~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
.. +++|||||+-+.||..++++.... ..-.++++.+|+|.|++++|..||||.||||.|+|+- .|.+||+|||
T Consensus 431 ~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 431 TD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred cC-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeec
Confidence 64 369999999999999999887643 3348899999999999999999999999999999886 5789999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccC---------CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~---------~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
.|.....++. .+.....+||+.||+||.+..... +.+.++||||||||||+|+.|++||..- ..++.+
T Consensus 505 IA~aI~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aK 581 (677)
T KOG0596|consen 505 IANAIQPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAK 581 (677)
T ss_pred hhcccCcccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHH
Confidence 9988765543 344567899999999998754211 2567899999999999999999999421 111111
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+..+ -.| ...++|....+. .+++++++.||+.||++|||+.++|+|||++.
T Consensus 582 l~aI-~~P----------------------~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 LHAI-TDP----------------------NHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHhh-cCC----------------------CccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1110 011 111222222211 23999999999999999999999999999984
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=342.32 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=224.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|..+++||+|.||+|.+++.+.+|+.||||++++. ......+...+.|-++|+..+||.+..+...|.+.. .
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-----r 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-----R 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----e
Confidence 5688899999999999999999999999999999853 334556778889999999999999999998886554 5
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||.. |+|+-.+.....++++..+++...|+.||.|||+.+|+.||||.+|+|++++|.+||+||||++.....
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 999999998 589988888888999999999999999999999999999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....++||||.|+|||++.. ..|+.++|.|.+||++|||++|+.||...+....+.+|..
T Consensus 322 --g~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--------------- 382 (516)
T KOG0690|consen 322 --GDTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--------------- 382 (516)
T ss_pred --cceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---------------
Confidence 233478999999999999987 6899999999999999999999999999888777766642
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
..+ .....++++++.|+..+|.+||.+|. .+.||.+|+||.++.
T Consensus 383 -------ed~---------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 383 -------EDL---------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred -------hhc---------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 000 12246799999999999999999996 489999999999753
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.70 Aligned_cols=267 Identities=28% Similarity=0.483 Sum_probs=225.4
Q ss_pred cccccccCCCCcE-EEEeEeeccCceEEEEEEECCCCcEEEEEEeC--CccCChhHHHHHHHHHHHHHhcCCCCccccce
Q 008644 13 VDFFTEYGEGSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89 (558)
Q Consensus 13 ~~~~~~~~~~~rY-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~--~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~ 89 (558)
...+-+.....|| +..++||+|+|-+||+|.|..+|..||.-.++ +..+.....+++..|+.+|+.|+||||+++++
T Consensus 29 ~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~ 108 (632)
T KOG0584|consen 29 ESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYD 108 (632)
T ss_pred cccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeee
Confidence 3455666667787 77889999999999999999999999987654 55566777899999999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCC-CcE
Q 008644 90 ILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CKL 165 (558)
Q Consensus 90 i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~-~~l 165 (558)
.|.+... +.+-+|+|+|. |+|..++++.++++...++.|++|||+||.|||+.. |||||||++||+||.+ |.|
T Consensus 109 SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 109 SWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred heecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 9987553 57899999997 899999999999999999999999999999999986 9999999999999986 899
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (558)
||+|+|||+....... ...+|||.|||||+... .|+..+||||||+|+.||+|+..||.......|+.+-.
T Consensus 186 KIGDLGLAtl~r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV- 256 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV- 256 (632)
T ss_pred eecchhHHHHhhcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH-
Confidence 9999999988644332 45799999999999874 79999999999999999999999998776655543221
Q ss_pred hhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 246 ~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... .+|..+.. --+|++++||.+||.. ...|+|+.|+|.||||..-
T Consensus 257 -~SG-----------------------iKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 257 -TSG-----------------------IKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -HcC-----------------------CCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111 11211111 1268899999999999 9999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.17 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=217.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
-|.|++.||+|+||.||+|+|+.+|..+|||++.. ..+.+.|..||.|++++..|++|++|+.|+-.+ ++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceE
Confidence 47788999999999999999999999999999863 368899999999999999999999999886544 799
Q ss_pred EEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 104 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+|||||+ |++.+.++.+ ..++++++..+++..|.||.|||...-+|||||..|||+|.+|..||+|||.|-.......
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999998 7999999864 5799999999999999999999999999999999999999999999999999976544332
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
...+.+||+.|||||++.. -.|++++||||||++..||..|++||.+-... ..|..
T Consensus 185 ---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFM---------------- 240 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFM---------------- 240 (502)
T ss_pred ---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEe----------------
Confidence 3367899999999999987 68999999999999999999999999654322 22211
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+. ..|.+.......++.++.|||++||.++|++|.||.++++|||++.
T Consensus 241 --------IP-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 241 --------IP-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred --------cc-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 11 2222333344567889999999999999999999999999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=343.51 Aligned_cols=263 Identities=25% Similarity=0.434 Sum_probs=214.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+|+.++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence 4799999999999999999999999999999998753222 2355678899999999999999999998843 346
Q ss_pred EEEEEecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999974 999988764 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCC--------------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 008644 179 DTPT--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (558)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (558)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 011124578999999999977 568899999999999999999999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HH
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT----AE 308 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt----a~ 308 (558)
+.+....+..+.. .. ..+ .....+++.+.+||++||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~--~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KE--VTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CC--ccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7765443322211 00 011 111236889999999999999999999 99
Q ss_pred HHhcCccccCccc
Q 008644 309 EALADPYFKGLAK 321 (558)
Q Consensus 309 elL~hp~f~~~~~ 321 (558)
|+|.||||++...
T Consensus 285 ~ll~~~~~~~~~~ 297 (316)
T cd05574 285 EIKQHPFFRGVNW 297 (316)
T ss_pred HHHcCchhhcCCh
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=338.11 Aligned_cols=280 Identities=42% Similarity=0.728 Sum_probs=227.0
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
|++.+.||.|++|+||+|.+..+++.|+||++...... .......+|+..++.++ |+||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 9999999998854 34699
Q ss_pred EEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 104 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+||||+.++|.+.+.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999989999988764 789999999999999999999999999999999999999999999999999976543221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....++..|+|||++.+. ..++.++|+|||||++++|++|++||++.+..+.+..+...++.|..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2446789999999988542 45788999999999999999999999999999999999999998877654332110
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ...-..+....+......++..+..+.+||++||..||++|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000111111122223344557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.77 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=209.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
...++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~----- 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR----- 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Confidence 3446899999999999999999999999999999998642 223445678899999999999999999988543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 46899999998 59999998888999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ......|+..|+|||++.. ....++.++|+|||||++|+|++|..||........+..+..
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------ 223 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------------
Confidence 221 1234578999999998742 114578899999999999999999999865443222111110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
....+ +.......++..+.+||.+||..||++|||++++|+|||
T Consensus 224 -------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -------------SNFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cCCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001 111112246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.58 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=212.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
...+.|++++.||.|+||.||+|.+..++..|++|.+.. ........+.+|+.+++.++|+||+++++.+...
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD----- 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----
Confidence 456789999999999999999999999999999999864 2334567788999999999999999999988543
Q ss_pred ccEEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+.+ +|..++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 369999999985 77777654 4568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
.... ......++..|+|||++.+. ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 229 (292)
T cd06644 162 KTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 229 (292)
T ss_pred cccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---------
Confidence 2211 12345688999999998531 13578899999999999999999999976554322211110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. .+.......++..+.+||.+||..||++||+++++|+||||..+.
T Consensus 230 ------------------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 ------------------SE-PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------------------CC-CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 011122345678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.71 Aligned_cols=289 Identities=30% Similarity=0.592 Sum_probs=233.5
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~ 95 (558)
.+||..+.|++++.+|+|.|+.||.|++..+.++++||+++- -..+.|.||++||+.|+ ||||+.++++..++.
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 468999999999999999999999999999999999999863 45678999999999998 999999999987643
Q ss_pred cCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccc
Q 008644 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla 173 (558)
.+...+||||++. |...+.. .++.-.++++++|||.||.||||+||.|||+||.|++||.. -.++|+|+|||
T Consensus 107 ---SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 ---SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred ---ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 2456899999985 6665553 48888999999999999999999999999999999999975 56999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~lg~p~~ 252 (558)
.+...+.. ..-.+.++.|--||++... ..|+.+-|+|||||+|+.|+..+.| |.|.+..+|+-+|.+++|+-..
T Consensus 181 EFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 181 EFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 88755432 2446889999999999874 6799999999999999999998865 5789999999999999997643
Q ss_pred HHH-HHhhhHHHHHHHhhhccCCCCCCCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 253 EAI-ARVRNEKARRYLSSMRKKKPIPFSQKF-----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 253 ~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
... .+..-+-...+-..+......+|.... .-++++++|||.++|..|-.+|+||.|++.||||..+..
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 322 222211112222222222223333222 234799999999999999999999999999999986554
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=339.97 Aligned_cols=262 Identities=24% Similarity=0.425 Sum_probs=211.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+|+.++|+||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeE
Confidence 46999999999999999999999999999999986432 334456788999999999999999999988543 469
Q ss_pred EEEEecCcc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 103 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~---~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
|+||||+.+ +|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999985 888888763 369999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCcccccccc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...........+..
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 221 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------- 221 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH--------
Confidence 221 13356888999999985421 2357899999999999999999999976543322222111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
+.... .....+.+++.+.+||.+||..||++||++++++.||||......
T Consensus 222 ----------------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 222 ----------------IVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ----------------HhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 11111 112334578999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.68 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=214.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC-hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+--..|.=++.||.|+||.||.|+|..+.+.||||++...... ...-..|+.|+..|++|+|||+|.+.++|+-..
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--- 99 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--- 99 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc---
Confidence 4445788889999999999999999999999999999754332 234467999999999999999999999997654
Q ss_pred CccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..|+|||||-|+-.+++.- ..++.+.++..|+.+.|.||.|||+.+.||||||..|||+++.|.|||+|||.|.+..
T Consensus 100 --TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 100 --TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred --hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 5899999998755555543 2369999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. .+++|||+|||||++.. ..+.|+-++||||||++..||...++|+-+.|....+.-|..
T Consensus 178 PA-------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ----------- 239 (948)
T KOG0577|consen 178 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 239 (948)
T ss_pred ch-------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----------
Confidence 22 56899999999999753 225699999999999999999999999877776555444432
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+. .-.-++++..+++||..||++-|.+|||.+++|.|+|...
T Consensus 240 ----------------NesP--tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 ----------------NESP--TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----------------cCCC--CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1110 1113567889999999999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.17 Aligned_cols=259 Identities=28% Similarity=0.552 Sum_probs=218.5
Q ss_pred CCCcEEEE--eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIE--EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~--~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+..-|+|. ++||+|-||+||-|+++++|+.||||+|.+..-.......+.+|+.||+.+.||.||.+.-.|.++.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--- 636 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE--- 636 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc---
Confidence 34445554 8999999999999999999999999999875444455678899999999999999999988885554
Q ss_pred CccEEEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecccc
Q 008644 99 FKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLA 173 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFGla 173 (558)
.+++|||-+.||+.+.|.+ .+++++...++++.|||.||+|||-+||+|+||||+|||+.... .+||||||+|
T Consensus 637 --rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 637 --RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred --eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence 5999999999999998875 46899999999999999999999999999999999999998763 5999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
++..... +....+||+.|+|||+|.. ..|..+-|+||+|||+|.-|.|..||....+.+ ++|..
T Consensus 715 RiIgEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQN-------- 778 (888)
T KOG4236|consen 715 RIIGEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQN-------- 778 (888)
T ss_pred eecchhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHhhc--------
Confidence 9875443 5578899999999999987 789999999999999999999999996543322 11111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
....-...-|.+++++++|||+.+|+..-.+|.|.+..|.|||+++.
T Consensus 779 -------------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 -------------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -------------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 11111223456789999999999999999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=334.27 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=208.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-------hHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-------~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
+|.+.+.||.|++|.||+|.+..++..||+|.+....... .....+.+|+.+|+.++||||+++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 5888999999999999999999999999999886432221 1235678999999999999999999987543
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
...++||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||+++.
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 368999999974 8999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCc---ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 176 AFNDTPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 176 ~~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
........ .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 64221111 11123568889999999876 5788899999999999999999999987554332221111
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ........++..+.+||++||+.||.+||++.++++||||
T Consensus 227 --------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 --------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0111224567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.36 Aligned_cols=262 Identities=29% Similarity=0.502 Sum_probs=214.8
Q ss_pred ccC-CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 18 EYG-EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 18 ~~~-~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
++| ...+|++.+.||.|+||.||+|++..+|+.|+||.+... .......+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 88 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVG-- 88 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecC--
Confidence 344 356899999999999999999999999999999998642 223456788999999999999999999988543
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|+||+.+ +|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 89 ---~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 89 ---DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred ---ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 369999999984 888877654 699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--------- 230 (296)
T cd06655 165 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------- 230 (296)
T ss_pred cccccc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 433221 1134568899999999876 56889999999999999999999999877654433222110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+.......+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 231 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 231 -------------------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -------------------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0011122345788999999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=335.58 Aligned_cols=260 Identities=23% Similarity=0.416 Sum_probs=207.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC-C
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE-F 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~-~ 99 (558)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.+ +|+||+++++.+....... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 3345678899999998 6999999999986543221 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 100 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5899988763 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
..... ......|+..|+|||++.+. ...++.++|||||||++|+|++|+.||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32221 22446789999999998531 1357889999999999999999999996544322111110
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 230 ------------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 0011123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=335.21 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=208.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++.+...
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~----- 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR----- 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----
Confidence 3456799999999999999999999999999999998642 223445688999999999999999999988543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||++ ++|.+++..++.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 36899999998 58999998888899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ......++..|+|||.+.. ....++.++|+||+||++|+|++|+.||...+.......+..
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------ 223 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------------
Confidence 221 1134578899999998742 114577899999999999999999999865432221111100
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
....+ +.......++..+.+||++||..||++|||++++|+|+|
T Consensus 224 -------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 -------------SNFQP-PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -------------CCCCC-CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 011112356789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.15 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=213.7
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++++.||.|+||.||.+.+..++..+++|++............+.+|+.+|+.++|+||+++++.+... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 69999999999999999999999999999999875444455667788999999999999999999998543 4699
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||. ++|.+.+... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999775 468999999999999999999999999999999999999999999999999998653332
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2245678999999999876 4678899999999999999999999987665444333221
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. +......++..+.+||.+||..||.+||+++++|+|+|+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------GN---YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 111124568889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.50 Aligned_cols=262 Identities=26% Similarity=0.435 Sum_probs=211.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||.|+||+||+|.+..++..+++|++...... .....+.+|+.+|+.++|+||+++++.+... ...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-TSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEE
Confidence 4799999999999999999999999999999998643322 2567789999999999999999999988443 468
Q ss_pred EEEEecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 103 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
|+|+|++. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||++++++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899998764 4589999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCc-ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... ......+|+..|+|||.+... ..++.++|+|||||++|+|++|+.||...+....+..+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~-------- 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---N-------- 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---C--------
Confidence 32211 112345789999999998662 3678899999999999999999999976554332221111 0
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..........+..+++.+.+||.+||..||++|||++++|.||||
T Consensus 223 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 223 --------------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000111111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.86 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=209.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.+ +|||++++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999999999999998642 12345677899999998 799999999998765433345
Q ss_pred cEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 101 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 7899999997 488887753 35689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCcccccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
....... .....++..|+|||.+.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 5332211 13356889999999875421 1367899999999999999999999976654333222111
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
..+ +.......++..+.+||.+||+.||++||++.|+|+||||+
T Consensus 248 --------------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 00111234567899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=330.41 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=209.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+|+.++||||+++++.+... ..+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEE
Confidence 5799999999999999999999999999999998643 223567789999999999999999999988443 469
Q ss_pred EEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|++|||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999985 888888776 689999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
. ......++..|+|||.+.+. ...++.++|+|||||++|+|++|++||.+.+.......+...
T Consensus 156 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~------------- 219 (262)
T cd06613 156 A---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS------------- 219 (262)
T ss_pred h---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 1 11345788899999998651 126788999999999999999999999876644333222110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
...+ ........++..+.+||++||..||..|||+.++|.|+|
T Consensus 220 ------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ------------NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000 000112345678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.27 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=213.3
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.-+...+|++++.||+|+||.||+|++..++..|++|.+.... ......+.+|+.+++.+.|+||+++++.+...
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--- 89 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG--- 89 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC---
Confidence 3445679999999999999999999999999999999986422 23456788999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 90 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 90 --DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred --CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 36999999998 589888865 46899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~----------- 230 (296)
T cd06654 167 TPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----------- 230 (296)
T ss_pred ccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-----------
Confidence 32221 1234578899999999876 5688999999999999999999999977654332211110
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. ..+.......+++.+.+||.+||..||++|||+.++++||||...
T Consensus 231 ---------------~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ---------------N--GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---------------C--CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0 001112234567889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.06 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=210.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+|+.++|+||+++++.+.. ....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence 6999999999999999999999999999999987433334455678999999999999999999998843 34799
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||+. ++|.+.+.... .+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999997 59999887643 58999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.. .....|+..|+|||++.+ ..++.++|+|||||++++|++|+.||...+..+....+..
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 11 133568889999999876 5688899999999999999999999976654443322211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. ........+..+.+||.+||+.||.+||++.++|+||||
T Consensus 216 -----------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----------GS----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CC----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 011223567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.22 Aligned_cols=255 Identities=33% Similarity=0.528 Sum_probs=212.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++++.||.|+||.||+|.+..++..||+|.+............+.+|+.+|+.++|+||+++++.+.... ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence 589999999999999999999999999999998754444556677889999999999999999999875432 24689
Q ss_pred EEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 104 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLH-----s~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
++|||+. ++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999997 589988865 357999999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
........ ......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+.......+.
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 223 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------- 223 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh---------
Confidence 87643322 1244678999999999876 568899999999999999999999998766333222111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... +.......+..+.+|+.+||..||++|||++++|+|||+
T Consensus 224 ------------------~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 ------------------EGK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------cCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 111 111223567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.47 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=208.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..|++.+.||+|+||.||.|++..+|..||||++..... .......+.+|+.+|+.++||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 579999999999999999999999999999999853211 1234567889999999999999999999874422 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 36889999997 58999998877899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111111234568899999999876 578899999999999999999999997654332221111 100
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
. .....+..+..+.++|.+||. +|++||+++++++|||+.
T Consensus 226 ----------------~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ----------------T--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------C--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 011223557789999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=328.25 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=209.5
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||+|.+..++..+|||.+............+.+|+.+|+.++||||+++++.+... ..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence 59999999999999999999999999999999975444445567889999999999999999999987433 4689
Q ss_pred EEEecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccceeccCC
Q 008644 104 VVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 179 (558)
Q Consensus 104 lV~E~~~g-~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~~~~~~ 179 (558)
+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999984 899999764 348999999999999999999999999999999999999865 46899999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SKA----YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred ccc----cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 221 33568899999999976 5688999999999999999999999987665433322211
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. .......+++.+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 -------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 111223468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.79 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=209.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC----hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED----- 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence 478889999999999999999999999999998643211 12356788999999999999999999998443
Q ss_pred ccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccceecc
Q 008644 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~~~~ 177 (558)
..+++|+||+.+ +|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 468999999984 8999998878899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCCc-ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 332111 11123568889999999876 578899999999999999999999997654333322221110
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
. ...........++.+.++|.+||..||.+|||+.++|.||||+
T Consensus 225 ---------------~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 ---------------S--ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------c--cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0001122245678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.63 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=208.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~----~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+|++.+.||.|+||.||+|.+ .+|..+|+|.+..... .......+.+|+.+|+.++|+||+++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD----- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence 588999999999999999986 4788999999863221 122345688999999999999999999988543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 47999999997 59999998878899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 179 DT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 179 ~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.. ..........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------- 223 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH--------- 223 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc---------
Confidence 11 11112234678999999999976 57889999999999999999999999765533322111110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..........++..+.+||++||..||.+|||+.++|+||||
T Consensus 224 -------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 224 -------------------RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=368.80 Aligned_cols=286 Identities=24% Similarity=0.292 Sum_probs=205.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC-cEEEEEE--------------eCC-ccCChhHHHHHHHHHHHHHhcCCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKK--------------IND-IFEHVSDATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~--------------i~~-~~~~~~~~~~i~~Ei~iL~~l~HpnIv 85 (558)
.++|++++.||+|+||+||+|..+... ..+++|. +.+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998765432 2222221 111 111223445678999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCcccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~-----~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
++++++... ...|+|++++.++|..++.... ......++.|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999998543 3689999999999988875432 244677889999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCC--Chh
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGK--NVV 237 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~--~~~ 237 (558)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+. +..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 12234689999999999977 6799999999999999999998854 4322 344
Q ss_pred hHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccC-CCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK-KPIPFSQK--FPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 238 ~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
.++..+...++.+..+.... ......++...... .+..+... ...++..+.+||.+||.+||.+|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 55555555555443321110 01122222221100 00001111 123567789999999999999999999999999
Q ss_pred cccC
Q 008644 315 YFKG 318 (558)
Q Consensus 315 ~f~~ 318 (558)
||..
T Consensus 456 ~f~~ 459 (501)
T PHA03210 456 LFSA 459 (501)
T ss_pred hhhc
Confidence 9975
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.55 Aligned_cols=267 Identities=24% Similarity=0.410 Sum_probs=210.9
Q ss_pred ccccC-CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 16 FTEYG-EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 16 ~~~~~-~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
|+.++ ..++|++++.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44444 568999999999999999999999999999999987632 12235677899999999 69999999998865
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
........+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44444567999999997 588887652 3468999999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (558)
|||+++....... ......|+..|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+.
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~- 242 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP- 242 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence 9999876532211 12345789999999987531 1357889999999999999999999997655332221110
Q ss_pred hhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 246 ~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
..... .......++..+.+||.+||+.||++|||+.|+|+|+||
T Consensus 243 --------------------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------------RNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------------ccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00000 001112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.25 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=203.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~i-L~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||.||+|.++.+|+.||||.+...... .....+..|+.+ ++.+.||||+++++.+... ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----Cc
Confidence 4699999999999999999999999999999998754332 233456667665 6777899999999988543 36
Q ss_pred EEEEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988877754 34689999999999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~lg~p~~~ 253 (558)
..... .+...++..|+|||.+.+. ...++.++|+|||||++|+|++|+.||.... ....+..+.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1334688899999988541 1346889999999999999999999996422 111111111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. .. .......++..+.+||.+||..||++|||++++++||||...
T Consensus 222 --------------~~----~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 --------------EE----PS--PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------------hc----CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 00 000112467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.42 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=209.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-CCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR-REF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~-~~~ 99 (558)
.++|++.+.||.|+||.||+|.++.++..+++|++.... .....+.+|+.+++.+ .|+||+++++.+..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999999999999986421 2346788999999999 69999999999876543 334
Q ss_pred ccEEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 100 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 578999999985 88887764 3579999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
....... ......++..|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6533221 12446789999999987531 13467889999999999999999999976543332222111
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... +.......++..+.+||.+||..||++|||+.++++|||+
T Consensus 233 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0011112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.54 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=204.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|+++++||+|+||.||+|++..++..||+|.+.... .......+.+|+.+|+.+.||||+++++.+... ...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEE
Confidence 36899999999999999999999999999999986432 233456788999999999999999999998554 368
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
++||||+++ +|... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999996 55433 357899999999999999999999999999999999999999999999999997653221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
....++|..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... +..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cch---------
Confidence 234679999999999976 57889999999999999999999999653211100 000
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......+....+. .......++.+.+||.+||+.||.+||+++|++.||||...
T Consensus 206 --~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000111111111 11123467899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.10 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=210.8
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-----EENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-----CCeE
Confidence 58999999999999999999999999999999974322 22456788999999999999999999998743 3479
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|+||+. ++|...+.....+++..+..|+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 4999999887789999999999999999999999999999999999999999999999999987654332
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.... ..+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------------ 210 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQI------------------ 210 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHH------------------
Confidence 1234568889999999876 5688999999999999999999999987663211 000
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA--EEALADPYF 316 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta--~elL~hp~f 316 (558)
...... ......+.++..+.+||.+||..||.+||++ .|+++||||
T Consensus 211 -----~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 211 -----RAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----HHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 111110 1112224567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.11 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=211.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 47999999999999999999999999999999986432 234456788999999999999999999988543 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|+||+. ++|.+++..+ .+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 4899988775 799999999999999999999999999999999999999999999999999987643321
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1234578889999999977 5689999999999999999999999976553322211111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..+.... ...+++.+.++|.+||..||++|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000000 11267889999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=337.87 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=211.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CE
Confidence 469999999999999999999999999999999874321 223456788999999999999999999988433 46
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||++| +|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 8999999984 999999888889999999999999999999999999999999999999999999999999987421110
Q ss_pred CC------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 181 PT------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 181 ~~------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
.. ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 00 001123467889999999876 5788999999999999999999999987654333222211
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 319 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt---a~elL~hp~f~~~ 319 (558)
. ..........+++.+.+||++||+.||++||+ +.++|+||||...
T Consensus 231 ------------------------~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 ------------------------D-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ------------------------c-ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 0 00111112356888999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.57 Aligned_cols=261 Identities=28% Similarity=0.478 Sum_probs=213.2
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+...+|++++.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++.+...
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----- 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVG----- 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 4458999999999999999999999999999999998642 223456688999999999999999999988543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 46999999998 588888865 4689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+.. .+
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~---------- 231 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG---------- 231 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC----------
Confidence 221 1234578899999999876 5788999999999999999999999976654322211110 00
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.+.......++..+.+||.+||..||++||+++++|.||||+....
T Consensus 232 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 232 -----------------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred -----------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 1111123456788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=327.43 Aligned_cols=261 Identities=30% Similarity=0.468 Sum_probs=212.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
||++.+.||+|+||.||+|.+..++..|++|.+............+.+|+.+++.++|+||+++++.+... ..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence 69999999999999999999999999999999875444445678899999999999999999999987443 3689
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|+||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 589999988777999999999999999999999999999999999999999999999999999876443322
Q ss_pred ccc-ccccccCccccCcccccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 183 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 183 ~~~-~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 211 22456888999999987631 2378899999999999999999999976532211111000
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ...+.......+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 221 -----------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 -----------A-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------c-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0011111223458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.96 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=208.1
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|++.+.||.|+||.||+|.+..++..+++|.+... .......+.+|+.+++.++|+||+++++.+... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 78899999999999999999999999999998642 234566788999999999999999999988543 36899
Q ss_pred EEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 105 VFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
|+||+.+ +|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999985 77777654 45699999999999999999999999999999999999999999999999999876432211
Q ss_pred cccccccccCccccCcccccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 183 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
......++..|+|||++.. ....++.++|||||||++|+|++|++||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234578999999999742 1145778999999999999999999999876644333222110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. +.......++..+.+||.+||..||.+|||++++++||||...
T Consensus 224 --------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 224 --------------EP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------------CC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00 0011223467889999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.03 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=211.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----Ce
Confidence 4679999999999999999999999999999999863 2334556788999999999999999999998543 36
Q ss_pred EEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999985 898888764 46999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. ......++..|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred cc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 21 12345689999999997421 13467899999999999999999999977654332222211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... +.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 ----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0111123567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.31 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=208.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-C
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~-~ 97 (558)
...+.|++.+.||.|+||.||+|.+..+++.||+|.+... ......+..|+.+++.+ .|+||+++++.+..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3457899999999999999999999999999999998532 23445678899999988 69999999998864322 2
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 3457899999998 4899888763 358899999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
....... .....+|+..|+|||++... ...++.++|||||||++|+|++|+.||........+..+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~------- 239 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------- 239 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------
Confidence 5432111 12346789999999987521 1467889999999999999999999996554322211110
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. .........++..+.+||.+||..||.+|||+.|+|.||||
T Consensus 240 --------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 01111223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=379.32 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=224.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+.|+|+++||+|+||.|.+++++.|++.||+|++++... ...+...|..|-.+|..-..+=|+.++..|. +..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-----D~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-----DER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-----Ccc
Confidence 4679999999999999999999999999999999986322 2345567888999998888888999999884 445
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
++|+|||||. |||..++.+-++++++.+++++..|+.||+-||+.|+|||||||+||||+..|.+||+|||.+-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999997 699999999889999999999999999999999999999999999999999999999999988665433
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. ......+|||-|.+||+|... ...|++.+|.||+||++|||+.|..||...+.++.+.+|+..
T Consensus 229 G~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 GT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred Cc--EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 22 234668999999999998432 256999999999999999999999999888877777666542
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLAK 321 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt---a~elL~hp~f~~~~~ 321 (558)
+..+.|+ ...++|+.+++||+++|. +|+.|.. ++++-.||||.++..
T Consensus 297 ----------------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 ----------------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----------------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 2233333 224589999999999987 6888888 999999999998754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=355.06 Aligned_cols=262 Identities=27% Similarity=0.467 Sum_probs=226.4
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..-.-|.+.+.||+|.|++|.+|++..||..||||.|++...+......+.+|+++|+.|.|||||+++.++.+..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~---- 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA---- 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence 3345699999999999999999999999999999999988878777788999999999999999999999996544
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+. |++++++.+++++.+..++.++.|++.|++|||+.+|+|||||.+|||++.+..+||+|||++.....
T Consensus 129 -~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 129 -TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred -eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 6999999997 69999999999999999999999999999999999999999999999999999999999999988754
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
+. ...++||++.|.|||++.+. ..-++.+|+||+|++||.|+.|..||+|.+....-..
T Consensus 208 ~~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------- 266 (596)
T KOG0586|consen 208 GL----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------- 266 (596)
T ss_pred cc----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccch----------------
Confidence 43 34788999999999999884 3446899999999999999999999998874332110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
-++.+..+++ -++.++.+||+++|..+|.+|++.+++..|.|.......
T Consensus 267 ----------vl~gk~rIp~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 267 ----------VLRGKYRIPF-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ----------heeeeecccc-----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1112222222 346779999999999999999999999999999876544
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=327.63 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=208.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||.|+||.||+|.+..++..|++|.+... .....+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence 36799999999999999999999999999999998642 2267789999999999999999999988554 46
Q ss_pred EEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+++||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999984 89998875 446899999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------------- 212 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---------------
Confidence 21 1133457889999999877 578899999999999999999999997654432211110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. ..........++..+.+||.+||+.||++|||+.|+|+||||
T Consensus 213 ------------~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 ------------NK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------cC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 001111223467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.01 Aligned_cols=266 Identities=32% Similarity=0.519 Sum_probs=215.9
Q ss_pred cccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008644 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (558)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~ 92 (558)
++|--||.+.++= -+||+|.||+||.|+|..|...+|||.|.. .+....+.+..||.+-++|+|.|||++++.+
T Consensus 568 iefeYeyde~~er---vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~- 641 (1226)
T KOG4279|consen 568 IEFEYEYDESNER---VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV- 641 (1226)
T ss_pred eEEEeeecCCCce---EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-
Confidence 5565555555542 368999999999999999999999999964 3446678899999999999999999999987
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEE
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKI 167 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l--~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL 167 (558)
.+.+++-|.||-++ |+|..+++.. |++ .|..+.++..||++||+|||.+.|+|||||.+|||||. .|.+||
T Consensus 642 ----senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKI 717 (1226)
T KOG4279|consen 642 ----SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKI 717 (1226)
T ss_pred ----CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEe
Confidence 33447889999997 5899998763 567 78999999999999999999999999999999999986 689999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
+|||-++....-.+ ...++.||..|||||++......|+.++|||||||++.||.||++||-...
T Consensus 718 SDFGTsKRLAginP---~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg------------ 782 (1226)
T KOG4279|consen 718 SDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG------------ 782 (1226)
T ss_pred cccccchhhccCCc---cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC------------
Confidence 99999877644333 235678999999999996555789999999999999999999999995432
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.|... -|--.|.+..| .....++.+++.||.+|+.+||.+||+|.++|.+||++.-
T Consensus 783 -spqAA-----------MFkVGmyKvHP----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 783 -SPQAA-----------MFKVGMYKVHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -ChhHh-----------hhhhcceecCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 22211 11122222211 1224567889999999999999999999999999999865
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=328.64 Aligned_cols=262 Identities=27% Similarity=0.485 Sum_probs=208.5
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC--------hhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--------VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--------~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
+|.+.+.||.|+||.||+|.+..+|+.||||.+...... ....+.+.+|+.+++.++|+||+++++.+...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 689999999999999999999999999999988532111 11234678899999999999999999987443
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.++.++|+|||+++
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 46899999997 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... ........++..|+|||.+......++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 6432211 111234568889999999876322478899999999999999999999965443222111100
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
............+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0001111112335678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=324.77 Aligned_cols=254 Identities=28% Similarity=0.492 Sum_probs=208.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+|++.+.||+|+||+||+|.+..++..|++|.+..... .......+.+|+.+|+.++|+||+++++.+... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence 58889999999999999999999999999999864221 123456788999999999999999999987433 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|+||+.+ +|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 68999999984 99999988878999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
. ......++..|+|||.+... ..++.++|+|||||++|+|++|+.||...........+..
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------- 216 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-------------- 216 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--------------
Confidence 2 12345688999999998652 2388899999999999999999999976553222211110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. .......+.+++.+.+||.+||..||.+|||+.++|.|||+
T Consensus 217 -------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 217 -------------S--KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------------c--ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0 01112234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.21 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=210.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 368899999999999999999999999999999875432 24556788999999999999999999988554 469
Q ss_pred EEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+|+||+. ++|.+++... ..+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 679999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+. ....+.
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL--------------- 212 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH---------------
Confidence 11 12568889999999877 5789999999999999999999999965431 001111
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+..+...... ..... +++.+++||.+||..||++|||+.+++.||||+.+
T Consensus 213 ---------~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 213 ---------LQYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ---------HHHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 1111111110 11111 68889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.36 Aligned_cols=260 Identities=28% Similarity=0.520 Sum_probs=210.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++.+... .
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~ 92 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----D 92 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----C
Confidence 335566678899999999999999999999999998642 233456688999999999999999999988543 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..|+||||+.+ +|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 93 ~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred eEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 68999999985 7777764 456999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+...+
T Consensus 172 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------ 234 (292)
T cd06658 172 VP---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL------------ 234 (292)
T ss_pred cc---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------
Confidence 21 1234678999999999876 578899999999999999999999998766544332221100
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
+ .........+..+.+||.+||..||.+|||++++|+||||.....
T Consensus 235 ---------------~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 235 ---------------P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ---------------C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0 001112346788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=333.19 Aligned_cols=246 Identities=19% Similarity=0.247 Sum_probs=200.5
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChh-HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~-~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
..||+|++|.||+|.. +|+.||||.+........ ....+.+|+.+|+.++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5789999999999976 789999999975433222 2466789999999999999999999885411 22346899999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||. |+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 998 5899999988889999999999999999999998 499999999999999999999999999997643221
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
...++|..|+|||++.+....++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 237 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------------------- 237 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 235688999999998764457899999999999999999999999877655443333211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ....+++.+.+||.+||+.||++|||++|++.
T Consensus 238 -------~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 238 -------NNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00011 11256889999999999999999999999985
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=334.45 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=205.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++.+.||+|+||.||++.+..++..||||++...... .....+.+|+.+|.++. |+||+++++++... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 3567788999999999999999999999999998743222 44567889999999996 99999999988543 36
Q ss_pred EEEEEecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 102 IYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~-----~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+++|||+..+|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999876555432 235799999999999999999999975 999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCcccccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... ....|+..|+|||++.+.. ..++.++|||||||++|+|++|+.||...+. ....+.....
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~------ 225 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK------ 225 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC------
Confidence 5332211 3346888999999986521 2688999999999999999999999975441 1111111110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
...+.........++..+.+||.+||..||++|||++++++||||...
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 226 -----------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 011111111224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.13 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=208.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+... ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence 58999999999999999999999999999999864322334456788999999999999999999988443 4699
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc-EEEeecccceeccCC
Q 008644 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFND 179 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~-lKL~DFGla~~~~~~ 179 (558)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||++++++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999997 59999887643 4799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+....+..+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1133568899999999876 5688999999999999999999999976654332221110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. .+....+.++..+.++|.+||..+|++|||+.+++.||||
T Consensus 217 -------------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 -------------G---YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------------c---cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 1112234667889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.65 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC----------------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~----------------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv 85 (558)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999987432 233456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 008644 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 145 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-------------------~l~e~~~~~i~~QIl~aL~yLHs~ 145 (558)
++++++... ...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 35899999997 59999886532 367788999999999999999999
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 225 (558)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 11123456788999999876 57899999999999999998
Q ss_pred h--CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 008644 226 T--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 303 (558)
Q Consensus 226 t--G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~ 303 (558)
+ +..||.+.+....+..+... +.... ...+....+.++..+.+||.+||..||++
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEF--------------------FRDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHH--------------------hhhcc---ccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 55788766544433322211 11000 00111123456788999999999999999
Q ss_pred CCCHHHHhc
Q 008644 304 RPTAEEALA 312 (558)
Q Consensus 304 Rpta~elL~ 312 (558)
|||+++|.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.43 Aligned_cols=259 Identities=31% Similarity=0.474 Sum_probs=214.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|++.+.||.|++|.||+|.+..+++.|+||++...... .....+.+|+.+++.++|+||+++++.+... ...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 3689999999999999999999999999999998753222 4567789999999999999999999998554 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+||||+. ++|.+++.....+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998754333
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.....+.+..
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------------- 214 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------------- 214 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------------
Confidence 22 134568899999999877 5788899999999999999999999976642111111111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+..... ...... ++..+.+||.+||..+|++|||+.++|+||||+..
T Consensus 215 ---------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 ---------ICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------HhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 111111 111223 67889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.44 Aligned_cols=251 Identities=20% Similarity=0.301 Sum_probs=201.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG---- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC----
Confidence 457999999999999999999765 456789999987532 223446788999999999999999999988543
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||.+...
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 -NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred -CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 36899999998 5888888764 46899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+.+.
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG--------- 224 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence 221110 0112335678999999876 678999999999999999775 99999877655443333211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .....++..+.+|+.+||+.||.+|||+++|++
T Consensus 225 ------------------~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 ------------------FRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 111 123456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.17 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=209.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc---CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12344567889999999999999999999875432 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 36889999997 58999998877899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF---KIATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH---HHHcCCC-------
Confidence 2111112234578999999999876 568899999999999999999999997654332221 1111110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.......+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.29 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=215.8
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.+-.+.|+|+..||-|+||.||+|..+.++-..|.|+|.. ........++-||.||..+.||+||+|++.|+...
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--- 102 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--- 102 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC---
Confidence 4445568889999999999999999999999999999853 34456788899999999999999999999987654
Q ss_pred CccEEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
.+||+.|||+| -...++.. ...|++++++.+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+...
T Consensus 103 --kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 103 --KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred --ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 59999999996 45555544 446999999999999999999999999999999999999999999999999988654
Q ss_pred cCCCCCcccccccccCccccCcccccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
.... ....+++|||+|||||+... ...+|++++||||||++|.||..+.+|-..-+....+-+|.+
T Consensus 181 ~~t~---qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-------- 249 (1187)
T KOG0579|consen 181 KSTR---QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 249 (1187)
T ss_pred hhHH---hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh--------
Confidence 3222 23367899999999998521 125799999999999999999999999877665544433322
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..|.. --....++..+.|||++||.+||..||++.+||+||||+..
T Consensus 250 -------------------SePPT-LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 250 -------------------SEPPT-LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -------------------cCCCc-ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11111 12235678889999999999999999999999999999854
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.72 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=205.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++|+||+++++.+... ..+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 5899999999999999999999999999999986432 234567788999999999999999999988443 4799
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||||+. ++|.+++... ..++++.+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999997 5898888653 358999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 2234678999999999876 5788999999999999999999999987664433222211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. .......++..+.+||.+||+.||++|||+.++|+
T Consensus 215 ------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 215 ------------GS---YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ------------CC---CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 00 01112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.70 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=205.5
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+... ..+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 699999999999999999999999987432 2234456789999999999999999999987443 4699999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccc
Q 008644 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (558)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (558)
. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 7 5999999888789999999999999999999999999999999999999999999999999998764432 1134
Q ss_pred cccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 189 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||..... ...+..+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578899999999876 5788999999999999999999999976652 221111110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
..... ......++.+.+||.+||..||++||+ ++|+++||||+.+
T Consensus 209 -----~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 -----GNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00011 111234788999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=326.80 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=212.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (558)
++|++.+.||+|+||.||+|.+..+|..||+|++... .........+.+|+.+++.++ |+||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 4799999999999999999999999999999998752 223344567889999999998 99999999987433 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6999999995 699999998888999999999999999999999999999999999999999999999999999865433
Q ss_pred CCC-----------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 180 TPT-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 180 ~~~-----------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
... ........++..|+|||.+.+ ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011234567899999999876 5688899999999999999999999987664332222
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYF 316 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f 316 (558)
+.. .. ......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 234 ~~~--------------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------LE-----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------cC-----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 211 00 11223558889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.41 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=203.4
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+.+++.+... ..+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence 6999999999999999999999999864322 223345667899999999999999999988433 4689999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 110 ~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 8 59999987765 69999999999999999999999999999999999999999999999999987643321 12
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 34567889999999876 4688999999999999999999999976553211111110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
.. ... .....+..++.+.+||.+||+.||.+|| ++.++++||||..+.
T Consensus 209 --~~-~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 --RT-LEM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --cc-ccc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00 000 1122345688999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.08 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=211.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|...+.||.|++|.||++.+..++..+++|++... .......+.+|+.+++.+.|+||+++++.+... ...
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeE
Confidence 3466678999999999999999999999999998632 223456688999999999999999999988543 368
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|+||+. ++|.+++.. +.++++.++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999997 589888877 5799999999999999999999999999999999999999999999999998875433322
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 134568999999999876 56889999999999999999999999776644433322210
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
. .+.......++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 231 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 ------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0111112346788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.77 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=203.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCC-----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 47999999999999999999876655 689999986432 233456788999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
...|++|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 35899999998 5999998764 4578899999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999764332211 11234567889999999876 578999999999999999998 9999987665433
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...+.. ... ......+++.+.+|+.+||+.||.+||++.|++++
T Consensus 236 ~~~i~~---------------------------~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRS---------------------------RQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322211 111 11224678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.24 Aligned_cols=260 Identities=28% Similarity=0.525 Sum_probs=211.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+...-|+....||+|+||.||+|.+..++..||||++... .......+.+|+.+|+.+.||||+++++.+...
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~----- 90 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG----- 90 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----
Confidence 3445566677899999999999999999999999998642 223456688999999999999999999988543
Q ss_pred ccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|+||+++ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 468999999985 78776654 5699999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 231 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------- 231 (297)
T ss_pred ccc---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 221 1234678999999999976 5788999999999999999999999987665444332211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
. ..........++..+.+||.+||+.||.+||+++++++||||....
T Consensus 232 --------------~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 --------------S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --------------c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0 1111222345678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.21 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=207.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||.|++|.||+|.+..+++.+|+|.+... ........+.+|+++|+.++||||+++++++.... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeE
Confidence 4799999999999999999999999999999998743 22245577899999999999999999999885432 2468
Q ss_pred EEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 103 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 488777643 3468999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhhCCCCHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~--~~~~~~i~~~lg~p~~~~i 255 (558)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23457889999999876 6789999999999999999999999976532 11111111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
++..............-..+++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 ----------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ----------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 111100000000000011346789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=318.70 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=212.5
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|+||.||++.+..++..|++|++............+.+|+++++.++|+|++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999999999999999976544446667889999999999999999999988554 4699
Q ss_pred EEEecCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 104 VVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 104 lV~E~~~g-~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+|++++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 899988763 6799999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+.
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 216 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------------- 216 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------------
Confidence 321 1234578899999999876 568889999999999999999999997665332222111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
... .......++..+.++|.+||..||++|||+.++|+||||
T Consensus 217 -------------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -------------KGQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------cCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 111 111223567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.81 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=210.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
....+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~---- 87 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE---- 87 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC----
Confidence 34567999999999999999999999999999999986432 2334456788999999999999999999998643
Q ss_pred CccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...|+|+||+.++|.+.+.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....
T Consensus 88 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 88 -HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred -CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 35899999999988888764 4569999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. ....++..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----------- 228 (307)
T cd06607 167 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 228 (307)
T ss_pred CC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----------
Confidence 21 235688899999987431 14578899999999999999999999977664433222110
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+ .......++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 ----------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 ----------------NDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----------------CCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 00111235778999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.49 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=197.5
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeCCccCC-hhHHHHHHHHHHHHHh---cCCCCccccceeecCCCcCCCccEEEE
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRL---LRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~~Ei~iL~~---l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+||+|+||.||++.+..++..+|+|.+...... ........+|..+++. ..||||+.+++.+... +.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 489999999999999999999999998643322 1222334455544443 4799999999988543 368999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
|||+. ++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~ 264 (558)
.....||..|+|||.+.+. ..++.++||||+||++|+|++|..||.+....... .+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~------------------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR------------------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH-------------------
Confidence 1235799999999998531 46789999999999999999999999754321110 0000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
...... ....+.+++.+.+||.+||..||.+|+ |+.++++||||+++.
T Consensus 210 -----~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 -----MTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -----HhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000000 112345788999999999999999999 699999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.00 Aligned_cols=246 Identities=29% Similarity=0.444 Sum_probs=203.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.+++++.||+|-||.||+|.... ...||+|.++.. ......+.+|+++|++|+|+|||++++++... ..+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cce
Confidence 345778999999999999996542 238999998743 23456788999999999999999999999543 259
Q ss_pred EEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|||||||. |+|.++++. ...+.......|+.||++|++||+++++|||||-..||||+++..+||+|||||+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999998 899999997 446999999999999999999999999999999999999999999999999999954443
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
..... ...--..-|.|||.+.- ..++.++|||||||+|+||+| |+.||++.+..+.++.+.+...-|
T Consensus 357 ~Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------- 424 (468)
T KOG0197|consen 357 EYTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------- 424 (468)
T ss_pred ceeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------
Confidence 33211 12222345899999976 689999999999999999999 889999998877776665432222
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
..+.+++.+-+|++.||..+|++|||++.+.
T Consensus 425 ----------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ----------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1256889999999999999999999999765
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=316.36 Aligned_cols=253 Identities=32% Similarity=0.542 Sum_probs=212.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+++++.++|+|++++++++... ..+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 58999999999999999999999999999999976544445667899999999999999999999988543 4699
Q ss_pred EEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|||++++ +|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234568889999999876 457889999999999999999999997655322211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. ......+.++..+.++|.+||..||++|||+.+++.||||
T Consensus 213 ---------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---------QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 0112234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.41 Aligned_cols=266 Identities=27% Similarity=0.402 Sum_probs=211.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||++.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 57999999999999999999999999999999886432 234456789999999999999999999998554 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+||||+. ++|..++...+.+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998 5898988887889999999999999999999997 699999999999999999999999999986542221
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ...+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....... ..
T Consensus 159 ~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~-------- 215 (284)
T cd06620 159 A-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DP-------- 215 (284)
T ss_pred c-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hh--------
Confidence 1 23578999999999876 5788999999999999999999999986543211000 00
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......+..+....+..+ ....++..+.+||.+||..||++|||++|+++|+||...
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 216 MGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000111111111111111 112367789999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.15 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=217.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
-+.|..-++||+|+||.||-+.-+.||+-||+|++.+. ........-.++|-.||.+++.+.||.+-..|.+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd----- 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD----- 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence 45688899999999999999999999999999998743 223334455789999999999999999999885554
Q ss_pred cEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
.+|+|+.+|+ |||+-.|.+.+ .|+++.+.+++.+|+.||.+||+.+||+|||||+|||+|++|.++|+|.|||....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999998 59999888766 79999999999999999999999999999999999999999999999999998766
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.+.+. ...+||..|||||++.+ ..|+.+.|.|||||+||||+.|+.||........
T Consensus 339 ~g~~~----~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------------ 394 (591)
T KOG0986|consen 339 EGKPI----RGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------------ 394 (591)
T ss_pred CCCcc----ccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------------
Confidence 55443 55699999999999987 6799999999999999999999999965432111
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
.+ -++.+....+..++ ...|+++++|.+.+|++||++|. .++++-+||||+.+.
T Consensus 395 --~e----Evdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 395 --RE----EVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred --HH----HHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 11 11112222222222 45689999999999999999996 588999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.16 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=208.7
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~~~~~~~~ 100 (558)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++.+... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----P 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----C
Confidence 5888999999999999999999999999999986432 2234567889999999997 99999999988543 3
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 68999999975 88888765 47999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 32 12445789999999987542 457889999999999999999999997655432221110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
...+..+ ....++..+.+||.+||..||++||++.+++.|+||+...
T Consensus 216 ------------~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 0001001 1112678899999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=320.86 Aligned_cols=248 Identities=22% Similarity=0.443 Sum_probs=202.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCc
Confidence 4699999999999999999999999999999998642 23456788999999999999999999988543 368
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
++||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999997 69999987643 5899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 220 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 220 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------------
Confidence 2211 112234567999999876 578899999999999999998 9999988765443332211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||..||++|||+.++++
T Consensus 221 --------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 --------------GYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 0122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.59 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=200.2
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL-~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||.|+||.||+|.+..+|+.||||.+..... .......+..|..++ ..+.|+||+++++.+... ..+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence 579999999999999999999999999864321 112223445555544 455899999999988433 4699999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 133468889999999877 4588999999999999999999999987665433222211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 319 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp---ta~elL~hp~f~~~ 319 (558)
............+++.+.+||.+||+.||++|| +++|+|.||||+.+
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000011122235788999999999999999999 45899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.20 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=197.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC-----cEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|++..+| ..||||++.... .......+.+|+.+|+.+ +|+||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 357999999999999999999865443 579999997432 223456788999999999 899999999988543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (558)
..+|+|||||. |+|.+++...
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 36899999998 6999887542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 121 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 121 ----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 13788899999999999999999999999999999999999999999999999765332211 1
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122345667999999876 578999999999999999997 9999976543222111110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ......++++.+||.+||+.||++|||++++++
T Consensus 330 --------~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 --------RGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 011235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.70 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=199.7
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
...||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++... ..+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEe
Confidence 35799999999999999999999999988642 234556789999999999999999999988543 46999999
Q ss_pred cCc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeecccceeccCCCCC
Q 008644 108 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 108 ~~~-g~L~~~i~~~-~~l--~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~~~~~~~~ 182 (558)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999988764 445 88899999999999999999999999999999999986 67899999999876533222
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
......++..|+|||.+.+....++.++|+|||||++|+|++|+.||............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------------------- 223 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------------------- 223 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------------------
Confidence 12334688999999998653234788999999999999999999999653321110000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
...... .......+++.+.+||.+||+.+|.+|||+.|++.||||
T Consensus 224 -----~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFKI----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhcc----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 000000 011223567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.33 Aligned_cols=282 Identities=32% Similarity=0.526 Sum_probs=228.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC------CCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH------PDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H------pnIv~l~~i~~~~~ 95 (558)
.++|.|....|+|-||+|..|.|...|..||||+|.+ +..-...=++|+.||++|.. -+++.++..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk- 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK- 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-
Confidence 5799999999999999999999999999999999974 22334455789999999963 3578888777443
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecc
Q 008644 96 RREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFG 171 (558)
+++|||||.+.-+|.+++++-| .|....++.+++||+.||+.|...||+|.||||+|||+|+. ..+||||||
T Consensus 507 ----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 ----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 4799999999999999998754 58999999999999999999999999999999999999986 568999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
.|.....+. .+.|..++.|+|||++.| ..|+..+|+||+||+||||.||+.+|+|.+.-+.+...+++-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997654332 377899999999999999 6899999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhHH--HHHHHh----------------hhccCCC-CC----------CCCCCCCCCHHHHHHHHHhcccCCC
Q 008644 252 PEAIARVRNEK--ARRYLS----------------SMRKKKP-IP----------FSQKFPNANPLALRLLERMLAFEPK 302 (558)
Q Consensus 252 ~~~i~~~~~~~--~~~~~~----------------~~~~~~~-~~----------~~~~~~~~s~~~~~Li~~mL~~dP~ 302 (558)
..++.+..-.. +..-+. -|...+| .. +...-+..-..+++||.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 88886543211 000000 0001111 00 0111111224589999999999999
Q ss_pred CCCCHHHHhcCccccC
Q 008644 303 DRPTAEEALADPYFKG 318 (558)
Q Consensus 303 ~Rpta~elL~hp~f~~ 318 (558)
+|.|..++|.||||.+
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.77 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=205.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCcccccee-ecCCCcCC-C
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHI-LLPPSRRE-F 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i-~~~~~~~~-~ 99 (558)
.+++|.++|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 5789999999999999999999999899999998543 6677888999999999998 9999999994 33332223 3
Q ss_pred ccEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 100 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..++|.||||. |.|.+++.. ..+|+|.++..|++|+++||.+||..+ |||||||-+||||+.+|.+||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46889999999 699999985 346999999999999999999999998 9999999999999999999999999997
Q ss_pred eccCCCCCcc---cc---cccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 175 VAFNDTPTAI---FW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 175 ~~~~~~~~~~---~~---~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
-......... .. -....|+.|||||.|.-. ....+.|+|||+|||+||.|+....||.+......+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------- 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------- 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-------
Confidence 5432221110 00 123578999999986311 146789999999999999999999999765322110
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..+..+ ..++.++..+.+||..||+.||.+||++.+++.+
T Consensus 268 -----------------------ng~Y~~---P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 -----------------------NGNYSF---PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -----------------------eccccC---CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 111111 2236788999999999999999999999999863
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=320.82 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=202.6
Q ss_pred EEEEeEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~ 100 (558)
|++.+.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 34789999987544444556778999999999999999999998865443 3334
Q ss_pred cEEEEEecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..++|+||+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 6899999998 5898887432 35899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654332110 0112234667999999876 578899999999999999999 8899977654433222211
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .......++..+.+||.+||+.||++|||+.|++.+
T Consensus 231 --------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GN---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CC---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 011234567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=328.04 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=210.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----Cc
Confidence 47899999999999999999999999999999998632 223456788999999999999999999988543 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.|+|+||+. ++|.+++... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 5898888654 58999999999999999999999999999999999999999999999999887543222
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+...++..+..
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------------- 229 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------------- 229 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---------------
Confidence 1 2234568899999999876 5688999999999999999999999987654332211110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
. ..+.......++..+.+||.+||+.||++||++.+++.|+||+...
T Consensus 230 ------------~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 ------------N-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ------------C-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0 0011112234677899999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.12 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=198.1
Q ss_pred CcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 5899999999999999999964 4567789999986432 234456788999999999 899999999988544
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC------------------------------------------------------
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (558)
...|+|||||. |+|.+++....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 36899999998 69988886431
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 122 ---------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 122 ---------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 36788999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~--------------- 330 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI--------------- 330 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH---------------
Confidence 111 1122345667999999977 678999999999999999998 889997654332211111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. ..... ......+.++.+||.+||+.||++|||+.|+++.
T Consensus 331 --------~---~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 331 --------K---EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------H---hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1 00000 0112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.66 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=196.5
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeCCccCC-hhHHHHHHHHH---HHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREI---KLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~~~~~~i~~Ei---~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+||+|+||.||+|.+..+++.||+|++...... .........|. .+++...||+|+.+++.+... ..+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 489999999999999999999999998743222 12222233443 344556799999999988543 368999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
|||+. ++|..++...+.+++..++.|+.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~ 264 (558)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1345799999999998642 46889999999999999999999999765322111000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
....... .......++.+.+||.+||..||.+|| ++.++++||||+..
T Consensus 209 ----~~~~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 209 ----RMTLTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ----HHhhccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0000001 112234588999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.83 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=213.5
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|.+.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999998754433456778899999999999999999999886542 24689
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+|+|++. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988778999999999999999999999999999999999999999999999999999876544321
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ....+..+
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---------------- 216 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKI---------------- 216 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhc----------------
Confidence 01234568889999999876 4588999999999999999999999987651 11111110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. ...........+..+.+||.+||..||.+||++.++|.||||
T Consensus 217 --------~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 --------GS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------cc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00 011112234557899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=316.85 Aligned_cols=260 Identities=24% Similarity=0.428 Sum_probs=210.7
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.+++..||.|+.|+||+++.+.+|...|||.+.+. .+.....+|+..+.++.... +|+||+.+++|.... +++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 35678899999999999999999999999999854 45567788999999886665 899999999998765 589
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|.||.|..-+..+++. .+.++|..+-++...++.||.||.. .||+|||+||+|||+|..|.+||||||.+-.......
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999766666554 3469999999999999999999985 5899999999999999999999999999876543322
Q ss_pred CcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.+...|-+.|||||.+.-. ...|+..+||||||+.++||.||+.||++.+..- +.+++++
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvl------------- 308 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVL------------- 308 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHH-------------
Confidence 2445688999999998532 4679999999999999999999999999876432 1122211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
+..| +.-..-.+.++.+.+|+..||.+|+.+||...++|+|||+.....
T Consensus 309 -----------n~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 309 -----------NEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred -----------hcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 1112 111112347899999999999999999999999999999986543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=319.58 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred EeeccCceEEEEEEE--CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
.||+|+||.||+|.+ ..++..+|+|++............+.+|+.+|+.+.|+||+++++.+.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 5678899999987544444556778999999999999999999997632 24789999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 998 5899999887789999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....++..|+|||.+.. ..++.++|||||||++|||++ |+.||.+.+.......+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22334578999999865 578889999999999999998 9999987665433332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+++.+.+||.+||+.||++||++++|..
T Consensus 214 -------~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1111 122457899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=366.88 Aligned_cols=264 Identities=32% Similarity=0.487 Sum_probs=205.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-------
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS------- 95 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~------- 95 (558)
+.|+.+++||+||||.||+|+++-+|..||||+|.... ......++.+|+.+|.+|+|||||+++..|+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35688999999999999999999999999999998655 5567788999999999999999999988771000
Q ss_pred ----------------------------------------------c---------------------------------
Q 008644 96 ----------------------------------------------R--------------------------------- 96 (558)
Q Consensus 96 ----------------------------------------------~--------------------------------- 96 (558)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ---------------------CC-------CccEEEEEecCcccHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhCC
Q 008644 97 ---------------------RE-------FKDIYVVFELMESDLHQVIKANDDL--TPEHYQFFLYQLLRGLKYIHTAN 146 (558)
Q Consensus 97 ---------------------~~-------~~~~~lV~E~~~g~L~~~i~~~~~l--~e~~~~~i~~QIl~aL~yLHs~g 146 (558)
.+ ...+||-||||+.+|.+.+...+.+ ..+.+|++++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 0248999999997666666555555 48899999999999999999999
Q ss_pred ceecCCCCCcEEeCCCCcEEEeecccceecc--------------CC-CCCcccccccccCccccCcccccccc-CCCCC
Q 008644 147 VFHRDLKPKNILANADCKLKICDFGLARVAF--------------ND-TPTAIFWTDYVATRWYRAPELCGSFF-SKYTP 210 (558)
Q Consensus 147 IiHrDIKP~NILl~~~~~lKL~DFGla~~~~--------------~~-~~~~~~~~~~~gT~~Y~APE~l~~~~-~~y~~ 210 (558)
||||||||.||+++.++.|||+|||+|+... .. .......+..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 00 11112357789999999999997742 16999
Q ss_pred cchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCC-CCCCCCCCHHH
Q 008644 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLA 289 (558)
Q Consensus 211 ~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~ 289 (558)
|+||||||+||+||+. ||... .+.... +..+++ ..++. ...+.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts--MERa~i------------------------L~~LR~-g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS--MERASI------------------------LTNLRK-GSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch--HHHHHH------------------------HHhccc-CCCCCCcccccccchHH
Confidence 9999999999999985 57432 222222 223332 11222 22233344667
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 290 LRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 290 ~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
..+|+.||+.||.+||||.|+|.+.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8899999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=325.82 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=210.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
...|++++.||.|+||.||.|.+..++..||||.+... ........+.+|+.+++.+.|+||+++++++... ..
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CE
Confidence 34688899999999999999999999999999998643 2234567788999999999999999999998543 46
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.|+||||+++ +|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999985 88888865 469999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---------------- 214 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP---------------- 214 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh----------------
Confidence 1 1133568889999999876 568899999999999999999999997655432221110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... .......++..+.+||.+||..||++||+++++|+|+||...
T Consensus 215 -----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 -----------KNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -----------cCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 000 112223457789999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=330.39 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=201.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcE----EEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~----vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..+|++.+.||+|+||.||+|.+..++.. ||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 35799999999999999999998766664 899998642 2334556788999999999999999999988643
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..++|++|+. |+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3679999997 69999998754 689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (316)
T cd05108 159 LGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 225 (316)
T ss_pred ccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----------
Confidence 5433221 11122334678999999876 678999999999999999997 999997765433211111
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..... ...+.++..+.+||.+||..||.+|||+.+++.+
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 -----------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01111 1124567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.33 Aligned_cols=289 Identities=21% Similarity=0.276 Sum_probs=205.4
Q ss_pred EeEeecc--CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
.+.||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEE
Confidence 3457777 999999999999999999999875444444567889999999999999999999998543 368999
Q ss_pred EecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 106 FELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99998 5899888764 35899999999999999999999999999999999999999999999999865432211110
Q ss_pred c-c---cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH---
Q 008644 183 A-I---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI--- 255 (558)
Q Consensus 183 ~-~---~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i--- 255 (558)
. . ......++..|+|||++.+....++.++|||||||++|+|++|+.||.+......+..+............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 0 00112345679999998663345789999999999999999999999877654433322221110000000
Q ss_pred ---HHhhhH--HHH-HHHhhhcc-----CC--CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ---ARVRNE--KAR-RYLSSMRK-----KK--PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ---~~~~~~--~~~-~~~~~~~~-----~~--~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
....+. ... ........ .. ...-.......++.+.+||.+||..||++|||++|+|+||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 000 00000000 00 00000112345678999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.72 Aligned_cols=251 Identities=28% Similarity=0.455 Sum_probs=210.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
+|++.+.||.|+||.||++.+..+++.+++|++............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875444445566788999999999999999999988554 4699
Q ss_pred EEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 104 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999997 489988866 34689999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 133568889999999876 6788899999999999999999999987664332221111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. +.......+.++.++|.+||..||++|||+.++|+||++
T Consensus 216 --------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 111123567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=324.67 Aligned_cols=263 Identities=21% Similarity=0.390 Sum_probs=208.9
Q ss_pred cEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (558)
.|++.+.||.|+||.||+|.+. .+|..||+|.+.... ........+.+|+.+|+.+ +|+||+.+++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 3899999999999999999875 478999999986421 2223456788999999999 589999999887433
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||+++..
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 78 --TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred --CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 46899999998 599999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...+.......+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 332211 1234678999999999865334577899999999999999999999965432221111111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
.+....+ .....+++.+.+||++||..||++|+ ++++++.||||+.+.
T Consensus 223 ------------~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 ------------RILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ------------HhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 1101100 11234688899999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.22 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=202.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 568999999999999999998753 467899999874322 23456889999999999999999999998554
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~--------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
...|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 46999999998 59999997643 37889999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (558)
+.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999764332211 11133456788999999876 678999999999999999998 999997766544333
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+.. ... ......++..+.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQ---------------------------GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2211 100 1112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=335.91 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=200.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++++.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+.+++.+ +|+||+++++.+....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 689999999999999999997543 45789999987432 233456788999999999 7999999999885433
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC-------------------------------------------------------
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (558)
..++++|||+. ++|.+++...
T Consensus 85 ---~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 85 ---GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred ---CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 36899999998 5898888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCcc
Q 008644 121 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194 (558)
Q Consensus 121 ------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~ 194 (558)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~ 240 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLK 240 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCcc
Confidence 25789999999999999999999999999999999999999999999999999865332211 11233456778
Q ss_pred ccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccC
Q 008644 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK 273 (558)
Q Consensus 195 Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~ 273 (558)
|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.... ...
T Consensus 241 y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~~ 292 (337)
T cd05054 241 WMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KEG 292 (337)
T ss_pred ccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hcc
Confidence 999999877 689999999999999999998 999997654322211110 000
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 274 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 274 ~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ......++.+.+|+.+||+.+|++||+++|+++|
T Consensus 293 ~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 TRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=321.03 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=201.7
Q ss_pred EEEEeEeeccCceEEEEEEECCCCc--EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (558)
|.+.+.||+|+||.||+|.+..++. .||+|.+............+.+|+.+|+.++|+||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999887775 69999987554455667788999999999999999999998754322 22346
Q ss_pred EEEEEecCc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 102 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 689888742 1248899999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.......+.+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 654322110 1122345678999999877 578999999999999999999 8899987654332222111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.... ...+.++..+.+||.+||+.||++|||+.+++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111 1224567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=329.48 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=215.1
Q ss_pred cccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
+.+|......+.|...+.||+|+||.||+|.+..+|..|+||++..... .......+.+|+.+++.++|||++++++++
T Consensus 11 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 90 (313)
T cd06633 11 ADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY 90 (313)
T ss_pred HHHhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3445666667789999999999999999999999999999999864322 233446788999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 92 LPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
... ...|+||||+.++|..++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+||
T Consensus 91 ~~~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 91 LKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred EeC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeec
Confidence 543 36899999999998888865 446899999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
|++..... .....|+..|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 166 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---- 234 (313)
T cd06633 166 GSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---- 234 (313)
T ss_pred CCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----
Confidence 99854321 1345788999999997421 14578899999999999999999999977664443332211
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
... .....+.++..+.+||.+||+.||.+||++.++|.||||..
T Consensus 235 ----------------------~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ----------------------NDS---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ----------------------cCC---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 01112345678999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.93 Aligned_cols=254 Identities=20% Similarity=0.369 Sum_probs=200.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
..++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 4578999999999999999999865 24578999998642 2233456688999999999999999999988433
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~----------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~ 164 (558)
...++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.
T Consensus 82 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 82 ----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred ----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 46899999998 59999887532 2577889999999999999999999999999999999999999
Q ss_pred EEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 008644 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i 243 (558)
++|+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543322111 1122345778999999876 578999999999999999999 78999876654433322
Q ss_pred HHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ... .......+..+.+||.+||+.||++|||+.|++++
T Consensus 235 ~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 ME---------------------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred Hc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 000 01123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=318.99 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=205.7
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||.|+||.||+|.+..+|+.+++|.+.... ........+.+|+.+++.++|+||+++++.+.. ...+|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 689999999999999999999999986432 223455678899999999999999999988743 34699999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC-----c
Q 008644 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-----A 183 (558)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~-----~ 183 (558)
. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 7 599999988778999999999999999999999999999999999999999999999999998765433110 0
Q ss_pred ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 184 ~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 4588899999999999999999999987664433322211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCccccCc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFKGL 319 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta---~elL~hp~f~~~ 319 (558)
. ...+.. ...++..+.+||.+||+.||.+|||+ .++|+||||+.+
T Consensus 216 ---------~-~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ---------G-KIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---------C-CcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0 001111 11247889999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.90 Aligned_cols=275 Identities=24% Similarity=0.304 Sum_probs=201.3
Q ss_pred CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCc-ccH
Q 008644 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDL 113 (558)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L 113 (558)
++|.||.+++..+++.||||++............+.+|+.+|+.++|+||+++++++... ...|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 456677777788999999999975434455677899999999999999999999988544 36899999998 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC----ccccc
Q 008644 114 HQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----AIFWT 187 (558)
Q Consensus 114 ~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~----~~~~~ 187 (558)
.+++... ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 8888763 46899999999999999999999999999999999999999999999999998754322111 11123
Q ss_pred ccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHH
Q 008644 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (558)
Q Consensus 188 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~ 267 (558)
...++..|+|||++.+....++.++||||+||++|+|++|+.||........+. ....+..... +...... ...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~~~~~---~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LDKSTYP---LYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-cccCchh---hhc
Confidence 456788999999986533458899999999999999999999998765433221 1111111100 0000000 000
Q ss_pred hhhcc---------CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 268 SSMRK---------KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 268 ~~~~~---------~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+.. ............++..+.+||.+||..||++|||++++|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 000000011123457789999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.76 Aligned_cols=255 Identities=28% Similarity=0.401 Sum_probs=207.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+... ..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----Cce
Confidence 457788899999999999999999999999999864322 23456788999999999999999999988543 368
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998 488887754 5699999999999999999999999999999999999999999999999999876533221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------------ 213 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------------ 213 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------------------
Confidence 1233468889999999976 57889999999999999999999999654432221111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.... .......++..+.+||.+||..+|++|||+.++|+||||..+
T Consensus 214 ---------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 ---------PKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ---------hcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0000 011123467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.45 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=203.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4689999999999999999997652 35589999886432 223445678999999999999999999988443
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~----------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~l 165 (558)
...|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 36899999997 69999997532 34667889999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (558)
+|+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+..+.+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997643322111 1122345678999999876 578899999999999999998 788997765443322221
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CccccC
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA------DPYFKG 318 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~------hp~f~~ 318 (558)
. .. ........++.+.+||.+||+.||++|||+.++++ ||||.+
T Consensus 236 ~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 D---------------------------GG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred c---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 00 01112345788999999999999999999999987 999986
Q ss_pred c
Q 008644 319 L 319 (558)
Q Consensus 319 ~ 319 (558)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=328.70 Aligned_cols=288 Identities=30% Similarity=0.501 Sum_probs=223.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-----C---CCccccceeec
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHILL 92 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-----H---pnIv~l~~i~~ 92 (558)
.+.||.++++||.|-|++||+|+|..+.+.||+|+++.. ....+..+.||++|++++ | ..||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 458999999999999999999999999999999998742 234456789999999985 2 35999999886
Q ss_pred CCCcCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCC-------
Q 008644 93 PPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANAD------- 162 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~------- 162 (558)
... .+..++|||||+++.+|..+|+... .++...++.|++|||.||.|||. .||||.||||+|||+..+
T Consensus 153 hsG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 153 HSG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred ecC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 543 6678999999999999999998754 69999999999999999999995 599999999999995211
Q ss_pred --------------------------------------------------------------------------------
Q 008644 163 -------------------------------------------------------------------------------- 162 (558)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (558)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 008644 163 -------------------------------------------------------------------------------C 163 (558)
Q Consensus 163 -------------------------------------------------------------------------------~ 163 (558)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC------CChh
Q 008644 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG------KNVV 237 (558)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~------~~~~ 237 (558)
++||+|||-|+-.. ..++.-+.|+.|+|||++.| ..|++.+||||++||+|||+||..+|.- ..+.
T Consensus 392 ~vKIaDlGNACW~~------khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 392 RVKIADLGNACWVH------KHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred eEEEeeccchhhhh------hhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 12333333332211 12355678999999999998 7999999999999999999999999953 2357
Q ss_pred hHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhc------cCCCCCCCCC------CC-CCCHHHHHHHHHhcccCCCCC
Q 008644 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR------KKKPIPFSQK------FP-NANPLALRLLERMLAFEPKDR 304 (558)
Q Consensus 238 ~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~------~~~~~~~~~~------~~-~~s~~~~~Li~~mL~~dP~~R 304 (558)
+.+..|+++||..+...+..-+. -++||..-. +-++.++... |+ .-..++.+||.-||+++|++|
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~--SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKY--SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcc--hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 78999999999988877654332 345555432 2222222211 11 113458899999999999999
Q ss_pred CCHHHHhcCccccCcccC
Q 008644 305 PTAEEALADPYFKGLAKV 322 (558)
Q Consensus 305 pta~elL~hp~f~~~~~~ 322 (558)
|||.++|+|||++.....
T Consensus 542 ~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 542 PTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccHHHHhcCccccCCCCC
Confidence 999999999999977654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.29 Aligned_cols=148 Identities=24% Similarity=0.429 Sum_probs=132.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
-++|++++.||+|+||.||+|++..+++.||||++... .........+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----N 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----C
Confidence 36799999999999999999999999999999999742 22334456788999999999999999999887433 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
++||||||+. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 6999999996 5999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=307.60 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=208.8
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.-.++||+|.+.||+|+|+-||++.+..++..||+|+|... ...+....++|+..-++++|||++++++..+....+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34578999999999999999999999999999999999643 3467788999999999999999999998877655445
Q ss_pred CccEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
....|++++|.. |+|.+.|... ..++|.++..|+.+|++||++||+.. .+||||||.|||+.+.+..+|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 567999999997 7899988652 36999999999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCCCC------cccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 172 LARVAFNDTPT------AIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 172 la~~~~~~~~~------~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
.++...-.... -..|.....|..|+|||++.- .....+.++|||||||+||.|+.|..||... .
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~ 245 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------Y 245 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------h
Confidence 98754211111 112344567889999999732 1245778999999999999999999999421 1
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...|.-.. .+ ......+... +.++..+..||+.||+.||.+||++.++|.+
T Consensus 246 ~~GgSlaL----Av-------------~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 QQGGSLAL----AV-------------QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hcCCeEEE----ee-------------eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 10000000 00 0001112222 2378899999999999999999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=321.84 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=196.6
Q ss_pred CcEEEEeEe--eccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVI--GKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~I--G~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
+.|++.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.+...+ .|+||+++++.+....
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~---- 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK---- 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC----
Confidence 456676666 99999999999999999999999986421111 133333323 6999999999985543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccceecc
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~~~~ 177 (558)
.+|+||||+. ++|.+++..+..++++.++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||+++...
T Consensus 83 -~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 83 -GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred -eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 6999999997 69999998888899999999999999999999999999999999999999998 99999999987653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~lg~p~~~~i~ 256 (558)
.. ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||........ ...
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-------------- 218 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES-------------- 218 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH--------------
Confidence 22 23468899999999976 5788999999999999999999999975432210 000
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFK 317 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-a~elL~hp~f~ 317 (558)
+.... .......+..++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 219 ---------~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 219 ---------LLKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---------HHHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00111 0111233468899999999999999999996 59999999996
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.07 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=207.9
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
-|++++.||+|+||.||+|.+..++..||||.+... ........+.+|+.+++.++||||+++++.+... ...|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEE
Confidence 478899999999999999999999999999987632 2223456788999999999999999999988543 4689
Q ss_pred EEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999985 88888764 4689999999999999999999999999999999999999999999999999876533211
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 214 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------------ 214 (277)
T ss_pred --hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------------
Confidence 1234568899999999876 567889999999999999999999997654332222111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... .......++..+.++|.+||..||.+||++.++++||||...
T Consensus 215 ---------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 ---------KNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------cCC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 111224567889999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.49 Aligned_cols=251 Identities=31% Similarity=0.529 Sum_probs=208.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|++.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.++|+||+++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999999999999999875322 3567889999999999999999999988554 3689
Q ss_pred EEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 104 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+++||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998776 5799999999999999999999999999999999999999999999999999977644332
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 234578899999999876 4588899999999999999999999976653332221111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
. ..+.......++..+.+||.+||+.||++|||+.++|+|||
T Consensus 212 -----------~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 -----------N-GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------c-CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 00000111224788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.45 Aligned_cols=260 Identities=32% Similarity=0.527 Sum_probs=215.1
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
-+..+.|++.+.||.|++|.||+|.+..++..|++|++..... ....+.+|+.+|+.++|+||+++++.+...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG---- 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC----
Confidence 3556779999999999999999999999999999999864322 456788999999999999999999998654
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 36999999999 69999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------- 230 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------- 230 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 32211 1133457889999999876 5788999999999999999999999977654433222211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... +.......++..+.+||.+||+.||.+|||+.++|+|+||+..
T Consensus 231 ----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 1111223467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.42 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=201.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|++..+++.||||++... .........+.+|+.+|+.++||||+++++.+... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 5799999999999999999999999999999988642 22334456788999999999999999999988543 46
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+|+|+||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999998 588887753 345899999999999999999999999999999999999999999999999998865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ... +.
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~-~~------------ 217 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFS-LC------------ 217 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHH-HH------------
Confidence 33221 1234568889999999876 56888999999999999999999998654321 000 00
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+..... ........+..+.+||.+||..||++||++.++|+
T Consensus 218 -----------~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 218 -----------QKIEQCDY--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -----------HHHhcCCC--CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 00100000 00112245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.20 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=198.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCc--EEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
++|++.+.||+|+||.||+|+++.++. .+++|.++. .........+.+|+.++.++ +||||+++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----- 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENR----- 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----
Confidence 579999999999999999999887765 468888763 22334556788999999999 799999999988443
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 100 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
..+|+|+||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 36899999997 69999987542 48889999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (558)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 111223456999999876 578899999999999999997 999998776544332
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+.. ... ......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 000 01123578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.42 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=200.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++.+... ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CC
Confidence 468999999999999999999864 5678999987632 23456788999999999999999999987433 46
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 6999998753 4689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.........+..
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 219 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR------------ 219 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc------------
Confidence 2211 1123345678999999876 568889999999999999998 9999987654433322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....++..+.+||.+||..||++|||++++++
T Consensus 220 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 ---------------GYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1011 122456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.30 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=198.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||++..+ .+..+|+|.+... ......+.+|+.+|+.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCE
Confidence 57999999999999999999765 4568999987632 12345688899999999999999999988443 468
Q ss_pred EEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999997 6899988753 468999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+...
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------------- 217 (256)
T cd05114 155 YT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------------- 217 (256)
T ss_pred ee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------------
Confidence 11 1122335567999999876 578899999999999999999 89999877755544433221
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+..+.+||.+||+.||.+|||++++++
T Consensus 218 --------------~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 --------------FRLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------CCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 01234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.68 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=208.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
...+|.+.+.||.|+||.||+|+++.++..+|||.+... .........+.+|+.+|+.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 445688899999999999999999999999999998642 22233456788999999999999999999988653
Q ss_pred ccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 36899999999988887754 44689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+.......+..
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------ 228 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------ 228 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh------------
Confidence 1 235688899999997431 13578899999999999999999999876543322221110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
...+ ......++..+.+||++||..+|++||++++++.|||+...
T Consensus 229 --------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 --------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 11123567889999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.92 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=210.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
......|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+|+.++|+|++++++++...
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 97 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--- 97 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC---
Confidence 344556899999999999999999999999999999986432 2233456788999999999999999999988544
Q ss_pred CCccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||+.|+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 98 --~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 98 --HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred --CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 35899999999988887765 456899999999999999999999999999999999999999999999999998653
Q ss_pred cCCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
... ....++..|+|||.+... ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 176 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------- 239 (317)
T cd06635 176 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 239 (317)
T ss_pred CCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc---------
Confidence 221 235688999999987421 145788999999999999999999999766544333322210
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+ ......+++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus 240 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -----------------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0112346778999999999999999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.13 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=193.9
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~ 108 (558)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence 46999999999999999999999999886432 234456789999999999999999999998543 368999999
Q ss_pred Cc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 109 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 109 ~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 97 59999987644 58999999999999999999999999999999999999999999999999987543221110 01
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 568899999999999999998 8889865543222111110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+|+.+||..||++|||+.++++
T Consensus 212 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 112345788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.99 Aligned_cols=252 Identities=22% Similarity=0.376 Sum_probs=200.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
+.|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 579999999999999999999987 78899999886422 223345688999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEE
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLK 166 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lK 166 (558)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+|
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 35799999997 59999987653 489999999999999999999999999999999999998765 599
Q ss_pred EeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 008644 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTD 245 (558)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~ 245 (558)
|+|||+++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCcccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999998653221110 0112233567999999876 578999999999999999997 9999987765443332211
Q ss_pred hhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 246 ~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. .. ......++..+.+||.+||+.||++|||+.++|+|
T Consensus 237 ~---------------------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G---------------------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 01124567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.59 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=199.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|.+. +++.||||.+.... .....+.+|+.+|+.++|+||+++++.+... ...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCe
Confidence 67999999999999999999875 45789999986422 2345688999999999999999999987433 468
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 69999997654 6899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... ......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+..
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------- 219 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------------- 219 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 111223457999999876 578899999999999999999 9999987665443332221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+|+.+||..||.+||++.++++
T Consensus 220 --------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 --------------GYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1011 112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=313.75 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=202.9
Q ss_pred eEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999999866 8999999997543332 46788999999999999999999998855 3469999
Q ss_pred EecCc-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 106 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99995 6999999875 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 644321 111234567889999999876 478899999999999999999 6999987754443332221
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .......+++.+.++|.+||..||++|||++|++++
T Consensus 223 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.75 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=196.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcE--EEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
+.|++.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.+|..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----- 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence 5799999999999999999999887764 577776532 2234456788999999999 899999999998443
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 100 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 46999999997 69999987542 47899999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (558)
+.+||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhhc----ccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 99999999998643211110 11234567999999876 568899999999999999998 999997665433222
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+. ..... ......++.+.+||.+||+.||++||+++++|.+
T Consensus 235 ~~~---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLP---------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHh---------------------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 00000 1112457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.06 Aligned_cols=252 Identities=21% Similarity=0.389 Sum_probs=201.1
Q ss_pred CcEEEEeEeeccCceEEEEEEE----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+.|++.+.||+|+||+||+|.. ..++..|++|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 5689999999999999999985 345678999998743 2234456788999999999999999999987543
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 35899999998 5999988532 2378889999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998653322111 1233446678999999876 578999999999999999998 9999987664333
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...+.. .... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 322211 1111 1224568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.03 Aligned_cols=258 Identities=27% Similarity=0.513 Sum_probs=209.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
...|.....||+|+||.||++.+..+|..||||++... .......+.+|+.+++.++|+||+++++.+... .+
T Consensus 19 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 91 (292)
T cd06657 19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE 91 (292)
T ss_pred HHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CE
Confidence 34455567899999999999999999999999998532 223456688999999999999999999988543 46
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.|+||||+.+ +|.+++. .+.+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 92 LWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 9999999985 7777664 4578999999999999999999999999999999999999999999999999987543322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 171 ~---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~--------------- 230 (292)
T cd06657 171 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--------------- 230 (292)
T ss_pred c---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1234578899999999876 5788999999999999999999999987665443322211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+.. ......+++.+.+||.+||+.||.+||++.++|+||||....
T Consensus 231 ------------~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 ------------NLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------hCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00111 112345688899999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.46 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++.+.||+|+||+||+|.+..+ ...||||.+.... .......+.+|+.+|+.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS---- 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC----
Confidence 45799999999999999999988754 4579999886432 233456788999999999999999999987433
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||+. ++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 78 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 78 -RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred -CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 36899999998 5999998764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+...
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 224 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG--------- 224 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---------
Confidence 421111 11112334578999999876 578899999999999999998 99999765544333222211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...+ ....++..+.+|+.+||+.||++||++.+++++
T Consensus 225 ------------------~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 ------------------YRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0001 123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.88 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=202.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
..+|++.+.||+|+||.||+|.++.++. .+|+|.+..... ......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---- 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence 4689999999999999999999876554 799998864322 23456789999999999999999999988433
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 78 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 78 -KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred -CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 36899999997 5899998765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..............++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-------- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--------
Confidence 433221111122233567999999876 578999999999999999886 999997766544433332211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. .....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 -------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 -------------------RL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------cC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 01 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.10 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=201.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.+.|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+|+.++|+||+++++.+...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-- 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 457999999999999999999853 35567999988642 234456789999999999999999999988543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++++
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ---CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 36899999998 69999987543 48999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (558)
+.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999975433221 111233456778999999876 578899999999999999998 999997766544333
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+.. .... ......++.+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~i~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQ---------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2221 1111 112346788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.44 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=198.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
..+|++.+.||+|+||.||+|.+..+ ..||+|++.... .....+.+|+.+++.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 46899999999999999999988765 469999987422 223568899999999999999999887622 24
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 5999999763 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 22111 122346678999999866 578999999999999999999 8889987654433322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....++..+.+||.+||+.||.+|||+.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ---------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.74 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=196.2
Q ss_pred eEeeccCceEEEEEEECCCC---cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+.||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+|+.+.|+||+++++++.. ...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 46999999999999876655 78999998753332 455678899999999999999999997632 257999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
|||+. ++|.+++..+..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99997 59999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~ 263 (558)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999999876 578999999999999999998 9999976654333222211
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......++..+.+||.+||..||++|||+.++++
T Consensus 214 ---------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ---------GER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 1122456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=317.19 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=200.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..++|++++.||+|+||+||+|.+..+|. .||+|.+... ........+.+|+.+++.+.|+||+.+++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence 45789999999999999999999877776 4899988643 2334456788999999999999999999988543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+++++|+. |+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 ----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred ----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 3689999998 6999998764 469999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+.
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--------- 225 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--------- 225 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Confidence 65432211 11122334678999999876 578999999999999999998 899997654332221111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ...+..+..+.+||.+||..||++||++.+++.
T Consensus 226 ------------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 ------------------KGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 112456788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=314.42 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=201.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.+.|+..+.||+|+||.||+|.++.++. .+|+|++.... .......+..|+.+++.++|+||+++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF---- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC----
Confidence 4578999999999999999999887665 79999886432 233456788999999999999999999988443
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||++ ++|..++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 -KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 36899999998 5898888764 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...............+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 433221111111223457999999876 578899999999999999997 999997766544433332211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+ ....++..+.+|+.+||..||++||++.++++
T Consensus 228 -------------------~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------RLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111 11246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.56 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=198.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----Cce
Confidence 46899999999999999999876 46789999986422 2234678899999999999999999987443 368
Q ss_pred EEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+||||++ ++|.+++..+ ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997 5899998764 468999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-------------- 216 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc--------------
Confidence 111 111223457999999876 578899999999999999999 8999977654433322211
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.... .....+++.+.+|+.+||..+|++|||+.++++.
T Consensus 217 -------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 -------------GYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------CCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000 1123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.03 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=202.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|++++.||.|+||.||+|.+.. +..+++|++... .......+.+|+.+|+.++|+||+++++.+... ..+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence 368999999999999999999988 899999998642 223456788999999999999999999988443 368
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999999763 35899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 221 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY----------- 221 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----------
Confidence 211 123345678999999876 578899999999999999998 899998776544443332110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .......++.+.++|.+||..||.+|||+.++++
T Consensus 222 ----------------~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 ----------------R---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------c---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.71 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=198.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+. .+..+|+|++..... ....+.+|+.+|+.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 457999999999999999999765 566799999864222 23568899999999999999999987632 24
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999998763 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER------------ 218 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------
Confidence 22111 122345667999999866 578899999999999999999 8999987665444333321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+||.+||..||++|||+.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 219 ---------------GYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ---------------CCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1011 122456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=312.81 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=202.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999998632 22334467789999999999999999999988543 36
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
.++||||+. ++|..++.. ...++++.++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 599988864 235899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ..+
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~--------------- 215 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS--------------- 215 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHH---------------
Confidence 332211 234568899999999876 57889999999999999999999999654311 000
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
....+......+ ...+..+..+.++|.+||..+|++|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 216 ---------LCKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------HHhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001111100000 111256778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=319.75 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=202.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC----------------cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG----------------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg----------------~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv 85 (558)
..+|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 358999999999999999999876644 458999987432 224567788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008644 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK 153 (558)
++++++... ...++|||++. ++|.+++.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999988543 46899999997 58999987765 68999999999999999999999999999999
Q ss_pred CCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh--CCCCC
Q 008644 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLF 231 (558)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF 231 (558)
|+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764332211 11233456778999999876 578999999999999999998 67888
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
...+....+..+.... . ...........+.++.++.+||.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFF--------------------R---DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcc--------------------c---cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 7655433332222110 0 0001111112345678999999999999999999999996
Q ss_pred c
Q 008644 312 A 312 (558)
Q Consensus 312 ~ 312 (558)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=315.22 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=201.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC-----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|++.+.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+|+.+.|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 368999999999999999999887544 889999986432 234456788999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~l 165 (558)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 46899999997 6999998653 236788999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (558)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.....+.+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765332211 11133456788999999866 568899999999999999998 999998766544332221
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .......+..+.+||.+||..||++|||+.++++
T Consensus 236 ---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 1112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=320.15 Aligned_cols=252 Identities=26% Similarity=0.451 Sum_probs=201.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCC-----cEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 68999999999999999999876543 789999987432 234456788999999999 799999999988443
Q ss_pred CCCccEEEEEecCc-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe
Q 008644 97 REFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~----------------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl 159 (558)
..+|+||||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 89 ---~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 ---GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 36899999997 699999864 2358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh
Q 008644 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVH 238 (558)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~ 238 (558)
+.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999998654322111 1122334567999999876 578899999999999999997 999998766544
Q ss_pred HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 239 ~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
....+.. ... .......+..+.+|+.+||..||++|||+.|+|++
T Consensus 243 ~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKE---------------------------GYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3322211 000 01223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.31 Aligned_cols=251 Identities=21% Similarity=0.355 Sum_probs=200.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC-----CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+|++.+.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 4588899999999999999987543 5789999987432 2234466889999999999999999999985443
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
.+++++||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 82 ---~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 ---PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 5899999998 5888888532 2478889999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998765322211 11233456788999999865 568899999999999999998 8889987665444
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
++.+.. .... ....+++..+.+|+.+||+.||.+||+++++++
T Consensus 236 ~~~i~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRN---------------------------RQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333322 1111 112457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=313.08 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=198.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||.|.+.. +..+|||.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 3579999999999999999997654 4569999886422 2245688999999999999999999988443 35
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999997 58999987643 6899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 2111 112335677999999976 578899999999999999998 99999766644333322210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.... .....+..+.+|+.+||..||.+|||+.+++.+
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 112347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=319.90 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=204.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+.|++.+.||+|+||.||+|.+..++..||||.+..... ......+.+|+.++..+. |+||+++++.+... .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~ 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----S 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----C
Confidence 4679999999999999999999999999999999874322 233456777888776665 99999999998543 3
Q ss_pred cEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+++.|..++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 6999999999888887766 4579999999999999999999997 5999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCCCCHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~lg~p~~~~i 255 (558)
.... ....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+.
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------- 232 (296)
T cd06618 168 SKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL----------- 232 (296)
T ss_pred CCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh-----------
Confidence 2211 2345788899999986521 34788999999999999999999999653221 1111110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
... .... .....++..+.+||.+||..||.+||++++++.||||....
T Consensus 233 ------------~~~--~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 233 ------------QEE--PPSL---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ------------cCC--CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 000 0001 11124678899999999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=355.64 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=201.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|++..+|+.||||++..... ......++.+|+.+++.++||||+++++++... ..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 589999999999999999999999999999999975332 233456789999999999999999999988443 46
Q ss_pred EEEEEecCc-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEee
Q 008644 102 IYVVFELME-SDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-----------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
.|+||||++ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5898888641 2355677889999999999999999999999999999999999999999
Q ss_pred cccceeccCCCCC---------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008644 170 FGLARVAFNDTPT---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (558)
Q Consensus 170 FGla~~~~~~~~~---------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (558)
||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999865211100 001123579999999999877 67899999999999999999999999764
Q ss_pred ChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 235 ~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
+....... ..+. .+... ..+..+++.+.+++.+||+.||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~-------------------------~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVIL-------------------------SPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhcc-------------------------Chhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221100 0000 00000 1124678889999999999999999887666543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=313.56 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=202.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc---CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
||.+.+.||+|+||.||++.+..++..+++|.++... ........+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 6999999999999999999999888878777765322 1223445677899999999999999999987543 3
Q ss_pred cEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 101 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..++|+||+. ++|..++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 488877753 456999999999999999999999999999999999999975 5699999999977
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCD---LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCcc---cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 543322 1234568889999999865 5678899999999999999999999976554332222110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
. ........++..+.+||.+||..||++||+++++++||||
T Consensus 220 -----------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 -----------------G---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------C---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 0111223567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=311.84 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=200.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----Cc
Confidence 468999999999999999999876 45789999987422 2346688999999999999999999987432 36
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 59999997653 689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+.....
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--------- 222 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21110 112234568999999876 578899999999999999998 9999987765554443322111
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.......+..+.+++.+||..||++||+++++++
T Consensus 223 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ---------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112344778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.89 Aligned_cols=270 Identities=23% Similarity=0.395 Sum_probs=201.3
Q ss_pred CCcEEEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--
Confidence 4589999999999999999987 4568899999998642 3344567889999999999999999999875432
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 -RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred -CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 236899999997 6999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...............++..|+|||.+.+ ..++.++|||||||++|||++|..++...... .. ...+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~~- 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQGQ- 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhcccccccc-
Confidence 5432221111112234456999999876 57889999999999999999998776433211 11 1111100000
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.........+...... .....++..+.+||.+||..||++|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 -----MIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -----cchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000111111111111 123567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=311.29 Aligned_cols=242 Identities=24% Similarity=0.410 Sum_probs=197.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+|++.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+|++++++++.... ..+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----Cce
Confidence 5799999999999999999965 4888999988632 33457889999999999999999999764322 368
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|.+++..+. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999998 59999997654 3889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+.
T Consensus 156 ~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------------- 213 (256)
T cd05082 156 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------------- 213 (256)
T ss_pred C------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------------
Confidence 2 22334567999999876 578899999999999999997 999997655433222111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+... ....+.+++.+.+||.+||..||++|||+.++++
T Consensus 214 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 214 -------------KGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------cCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 1123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.59 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=202.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..++..||||++... .........+.+|+.+|+.++|+||+++++.+... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 4689999999999999999999999999999988642 22334456788999999999999999999988543 36
Q ss_pred EEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 8999999984 89888763 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... .+
T Consensus 157 ~~~~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~------------- 216 (267)
T cd08229 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL------------- 216 (267)
T ss_pred ccCCcc---cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HH-------------
Confidence 433221 234578899999999876 5788899999999999999999999975442110 00
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
...+..... ........++.+.+||.+||..||++|||++++++
T Consensus 217 ----------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 ----------CKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------hhhhhcCCC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 001100000 01112346788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.66 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=199.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++++.||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+|+.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 467999999999999999999864 56789999987422 234578899999999999999999987632 25
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 899999997 6999988763 3689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----------- 219 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-----------
Confidence 22111 122345678999999876 578899999999999999999 99999877654433332211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+..+.+||.+||..||++|||++++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 220 ----------------YRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.71 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=201.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+.... .......+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---- 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC----
Confidence 3569999999999999999999887765 59999986432 334567789999999999999999999988433
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+++||||++ ++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 78 -RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred -CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 36899999998 4898888764 46899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccc--cCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~--gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
.............. .+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 43222111111111 2457999999876 678999999999999999886 99999776644333322111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
...+ ....++..+.+|+.+||..||.+||++++++.
T Consensus 228 --------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 --------------------YRLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 12456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=316.61 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=198.9
Q ss_pred CcE-EEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY-~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 456 999999999999998764 34578899999986432 223456788999999999999999999987442
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
....+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2246899999998 5898888764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh-hCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL-LGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~-lg~p~~~~i 255 (558)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+... .+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~--- 230 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV--- 230 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch---
Confidence 433221111122345667999999876 57889999999999999999999998643311 1111100 000000
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .....+...... .....++..+.+|+.+||..||++|||++++++
T Consensus 231 -----~---~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 -----V---RLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----h---hhhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000001111111 123456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.02 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=203.3
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~ 109 (558)
||.|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++|+||+++++.+.. ...+|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 699999999999999999999999987432 223355678899999999999999999988743 34799999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccc
Q 008644 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (558)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (558)
. ++|.+++.....+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998887899999999999999999999999999999999999999999999999999987544321 1244
Q ss_pred cccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHh
Q 008644 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (558)
Q Consensus 189 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~ 268 (558)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999876 4678899999999999999999999976654222221110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCccc
Q 008644 269 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYF 316 (558)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta---~elL~hp~f 316 (558)
... ......+..+.+||++||..||++|||+ +++++||||
T Consensus 208 -----~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 -----DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 001 1122347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.60 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=207.7
Q ss_pred cccCCC-CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 17 TEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 17 ~~~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.+|++. +...+.+.||+|+||+||+|++- ..||||+++....+....+.|.+|+.+|++-+|.||+=+.|++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 445553 56788999999999999999653 46999999877777778899999999999999999999999886554
Q ss_pred cCCCccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
+.||+.+|+| +|+.++.-. ..|.....+.|++||++|+.|||.++|||||||..|||+.++++|||+||||+
T Consensus 462 ------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 ------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 5899999997 888888653 36999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
.+...- ..........|...|||||++.. ...+|++.+|||||||++|||++|..||...+ .+|+-.+. |.
T Consensus 536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIifmV---Gr--- 607 (678)
T KOG0193|consen 536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQIIFMV---GR--- 607 (678)
T ss_pred eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheEEEe---cc---
Confidence 874322 11112234467788999999853 22579999999999999999999999998443 33321111 10
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
............+++.++++|+..||.+++++||.+.+||.
T Consensus 608 -------------------G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 608 -------------------GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------------cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00111222334566779999999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.43 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=198.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+|+.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 36899999999999999999987655 469999876321 234568899999999999999999987632 24
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 59999997643 488999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05069 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER------------ 218 (260)
T ss_pred Ccccc--cCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 22111 122346678999999876 578899999999999999999 8999987665443332221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+||.+||..||++||+++++++
T Consensus 219 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 ---------------GYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1011 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=333.19 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=198.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC-----CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~ 95 (558)
.++|+++++||+|+||.||+|.+... +..||||++... ........+.+|+.+|+.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 46899999999999999999987433 357999998643 22344567899999999996 99999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (558)
..+|||||||. |+|.+++..+
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 36999999998 6898887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 008644 121 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (558)
Q Consensus 121 ------------------------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NIL 158 (558)
..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23778889999999999999999999999999999999
Q ss_pred eCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChh
Q 008644 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (558)
Q Consensus 159 l~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~ 237 (558)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999865332211 11123456788999999876 578999999999999999997 99999765332
Q ss_pred hHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 238 ~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+... +...... .....++..+.+||.+||..||++|||+.++.+
T Consensus 347 ~~~~~~--------------------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK--------------------------IKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH--------------------------HhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 211110 0011011 112456788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.08 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=199.6
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC---
Confidence 46999999999999999999754 34567999987632 223446688999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
...++||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 36899999997 69999987542 388999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCcee-ecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999764332211 11234567788999999876 578899999999999999998 9999976654433
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
++.+.. ... .......+..+.+||.+||..||++|||+.++++
T Consensus 235 ~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CCC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 322211 100 1112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=340.32 Aligned_cols=243 Identities=30% Similarity=0.483 Sum_probs=201.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL-LRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~-l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
...|++...||.|+|++|..+.+..++..+++|+|.+. .....+|+.++.. -+||||+++++++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 56788899999999999999999999999999999754 2223457766544 4799999999998 4556
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe-CCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl-~~~~~lKL~DFGla~~~~~ 178 (558)
++|+|||++.| .|.+.+.....+. ..+..|++||+.|+.|||+.||+||||||+|||+ +..+.++|||||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999985 6777777765555 7888999999999999999999999999999999 6889999999999986544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. +.+-+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... ++ |...++.
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e-i~~~i~~--------- 528 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE-IHTRIQM--------- 528 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH-HHHhhcC---------
Confidence 3 234577899999999986 78999999999999999999999999755433 11 1111111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.+++ ..+|..|++||+.||++||.+|+++.+++.||||
T Consensus 529 -----------------~~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 -----------------PKFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------------Cccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111 5689999999999999999999999999999999
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.81 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=199.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+... ........+.+|+.+++.+ +|+||+++++.+..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3689999999999999999998643 2357999998743 2234456788999999999 79999999998844
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
. ..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 96 ~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 3 36899999998 59999997642 47889999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (558)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998764322111 01112234568999999876 578899999999999999998 889997765
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..+....+.. ... ......++..+.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4332222111 111 11224567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.14 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=197.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.+|++++.||+|+||+||+|.+..++. .+++|.+... ........+..|+.+++.+.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 578999999999999999999887776 4777776532 122334567888999999999999999998732
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...++++||+. |+|.+++... +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 24788999997 6999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+..
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDKK-YFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCcc-cccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 432211 12234457778999999876 578999999999999999998 9999987654332222111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ....++..+.+++.+||..||.+|||+.|+++
T Consensus 227 -----------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11111 11234677899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.92 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=198.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC--------------CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT--------------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t--------------g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
++|++.+.||+|+||.||+|++..+ ...||+|++.... .......+.+|+++|+.++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5899999999999999999987543 2359999987432 233456788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 008644 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 155 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~ 155 (558)
+.+... ...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 998543 36899999998 58998886432 3688899999999999999999999999999999
Q ss_pred cEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCC
Q 008644 156 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPG 233 (558)
Q Consensus 156 NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~~ 233 (558)
|||++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322211 11122345678999999876 578999999999999999988 6678876
Q ss_pred CChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 234 ~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+....+..+... +..... ..+....+..++.+.+||.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEF--------------------FRNQGR---QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHh--------------------hhhccc---cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6544433322211 111000 0011123456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.83 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=194.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhH---------HHHHHHHHHHHHhcCCCCccccc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSD---------ATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~---------~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
.+++|++.++||+|+||.||+|.+..+ +..+|+|+.......... ......++..++.+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 357999999999999999999998877 667777764321111000 01122344456677899999999
Q ss_pred eeecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
+....... .....+++++++..++.+.+......++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 87643321 11245788898887888777766567899999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 169 DFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999998653221110 11123579999999999877 678999999999999999999999998764322111111
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ..++..+.... ...+..++.+.++++.||..+|++||+++++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 11122221111 123456788999999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.36 Aligned_cols=237 Identities=28% Similarity=0.419 Sum_probs=197.1
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
-++.||.|+.|.||+|+ -.++.||||+++.. -..+|+-|++|+|+||+.+.++|.... .+||||
T Consensus 128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeee--ccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEee
Confidence 36889999999999995 45789999998631 124788899999999999999996544 589999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|||. |-|..+++....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++..... .+
T Consensus 192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST--- 267 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST--- 267 (904)
T ss_pred eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hh---
Confidence 9998 899999999999999999999999999999999999999999999999999999999999998765433 21
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
.-.++||..|||||++.. ...+.++|||||||+|||||||..||.+-+.... | +|.-+.
T Consensus 268 kMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I---wGVGsN------------- 326 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I---WGVGSN------------- 326 (904)
T ss_pred hhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchhee---E---EeccCC-------------
Confidence 145799999999999987 7899999999999999999999999975432211 1 111100
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
+ ... .....++..++=||+.||.-.|..||++.+||.|-
T Consensus 327 ---s--L~L-----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 327 ---S--LHL-----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ---c--ccc-----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 0 001 12245677899999999999999999999999985
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.15 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=205.7
Q ss_pred cEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (558)
.|++.+.||+|+||.||++.+. .+++.||||.+.+.. ........+.+|+.+|..+ .||||+.+++.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4899999999999999999864 467899999986421 1223446688999999999 599999999987433
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. ++|.+.+..+..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++..
T Consensus 78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 78 --TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred --CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 36899999998 599999988778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
...... ......|+..|+|||.+.+.....+.++|+|||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 433211 1123568899999999866322367899999999999999999999964432211111110
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCcc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLA 320 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt---a~elL~hp~f~~~~ 320 (558)
.... .. ......+++.+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 223 --------~~~~---~~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 223 --------RILK---SK-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --------HHHc---cC-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0000 00 1112346788999999999999999998 57789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.47 Aligned_cols=243 Identities=26% Similarity=0.439 Sum_probs=199.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++.+.||.|+||.||+|.+. |+.||+|++..... ...++.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CC
Confidence 467999999999999999999764 88999999975322 467789999999999999999999998543 36
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|+||||+. ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999998 59999998765 699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12334567999999876 578889999999999999997 9999976654332221110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .......++.+.+||.+||..+|++|||+.++++
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 0112356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.43 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=197.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +|+||+++++.+....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 36899999999999999999984 3567899999986432 223456788999999999 6899999999875432
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCC-----------------------------------------------------
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (558)
..+++|||||+ |+|.+++....
T Consensus 85 ----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 85 ----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 36899999998 59998886531
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccccc
Q 008644 122 --------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187 (558)
Q Consensus 122 --------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (558)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 3677888999999999999999999999999999999999999999999999764322111 1112
Q ss_pred ccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHH
Q 008644 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 266 (558)
Q Consensus 188 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~ 266 (558)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+...
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2345677999999876 578999999999999999997 99999765432211110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 267 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
+...... ......++.+.+++.+||+.||++|||+.++++|
T Consensus 295 ---~~~~~~~---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 ---LKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---HhccCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000000 0112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.40 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=200.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..+|.+.+.||+|+||.||+|... .++..+|+|.+... .......+.+|+++|+.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-- 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--
Confidence 457899999999999999999643 35678999988643 334556789999999999999999999988543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~---------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
...|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 35899999998 59999987642 488999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322211 11123345678999999876 578999999999999999998 9999976654443
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+..+.. .... .....+++.+.+||.+||+.||.+||+++++++
T Consensus 234 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 322211 0000 112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=322.16 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=222.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-ccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (558)
...|.++.+||+|+||.|.+|..+.|.+.||||++++ ......+.+..+.|-++|.... -|.+++++..|.+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---- 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---- 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence 3568899999999999999999999999999999974 3444566777788999998774 678889988886554
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+. |||...|+.-+++.|..+.+++.+|+-||-|||++|||+||||.+|||++.+|.+||+|||+++....
T Consensus 424 -RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 424 -RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred -heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 5999999998 59999999999999999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
+.. ...++|||+.|+|||++.= .+|+.++|.||+||+|||||.|++||.|.+..+.+..|++..
T Consensus 503 ~~~---TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------- 566 (683)
T KOG0696|consen 503 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------- 566 (683)
T ss_pred CCc---ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence 322 2367899999999999864 799999999999999999999999999999988888776521
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
......+|.+++++.+.+|.+.|.+|.. -.+|-.||||+.+.
T Consensus 567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred --------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 1123467899999999999999999964 46788999998753
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.31 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=201.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-------CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
..+|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 468999999999999999999753 234579999886432 234456789999999999 79999999998844
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
. ..+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 3 46899999998 5999998763 247788899999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (558)
||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999865332211 11123345678999999876 578999999999999999998 789998766
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..+....+.. ... ......++..+.+||.+||..+|.+|||+.|+|+.
T Consensus 245 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5443332211 000 01124567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=313.59 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=195.3
Q ss_pred EEEeEeeccCceEEEEEEEC----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 26 KIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57899999999999999877 4567899999964 23444578899999999999999999999999733 24
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+++|+|||. |+|.+++... ..+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6999999987 6799999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ...........|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+.+..+.+
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~------------ 220 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ------------ 220 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT------------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc------------
Confidence 2211 11233456778999999876 468899999999999999999 7799987765443333321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....++..+.+||.+||..||++|||+.++++
T Consensus 221 ---------------~~~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 221 ---------------GQRL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------TEET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------cccc---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 112356888999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.03 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=192.2
Q ss_pred EeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 30 VIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|+.++|+||+++++++.. ...++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 3899999999999765 445679999886432 23345678899999999999999999998732 25899999
Q ss_pred cCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccc
Q 008644 108 LME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (558)
Q Consensus 108 ~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (558)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....+......
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 997 589998875 446999999999999999999999999999999999999999999999999999754333221111
Q ss_pred ccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHH
Q 008644 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (558)
Q Consensus 186 ~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~ 264 (558)
.....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 122233568999999875 578899999999999999996 9999987654433222211
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ...+..++++.+||.+||..||++||++.++++
T Consensus 214 --------~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 --------GKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 122456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.39 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=200.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +|+||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 35899999999999999999975 3356689999887432 234456788999999999 799999999988543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 35899999998 69999987643 389999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~------- 257 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI------- 257 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH-------
Confidence 9765332211 11123346778999999876 578899999999999999998 999997665432221111
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .... .......++.+.+||.+||..||++|||+.|+++
T Consensus 258 ----------------~---~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 ----------------K---EGYR---MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------------H---cCCc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0000 0112345789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.61 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=197.9
Q ss_pred eEeeccCceEEEEEEECC-CCc--EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~-tg~--~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+.||+|++|.||+|.+.. .+. .||||.+...... .....+.+|+.+|+.++|+||+++++.+.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999998865 333 6999998754333 556788999999999999999999998854 368999
Q ss_pred EecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 106 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+||+. ++|.+.+..+. .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 69999998764 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456788999999876 578899999999999999998 99999776655443332210
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .......+..+.+|+.+||..+|++|||+.++++
T Consensus 217 -----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 -----------GER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------CCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000 0111345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.62 Aligned_cols=270 Identities=24% Similarity=0.375 Sum_probs=203.1
Q ss_pred CcEEEEeEeeccCceEEEEEEE----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 4579999999999999999973 5678899999986432 2344567899999999999999999999885431
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 246899999997 59999987653 5899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..............++..|+|||.+.+ ..++.++|||||||++|+|++++.|+.... ....+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhccccccccc-
Confidence 433221112234556778999999876 578899999999999999999886653221 111112221111100
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
....+..+..... ......++..+.+||.+||+.||++|||+++++++
T Consensus 232 ------~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 ------VTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ------HHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0011111111111 11234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.14 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=198.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~ 94 (558)
.+|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 589999999999999999997642 34579999887432 234456788999999999 699999999988543
Q ss_pred CcCCCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008644 95 SRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NI 157 (558)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 91 -----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 36899999998 6999999753 2488899999999999999999999999999999999
Q ss_pred EeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008644 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (558)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997653221111 0112234467999999876 578899999999999999999 8899987665
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
...+..+.. ... ......++..+.+||.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 443332211 100 1122456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=365.40 Aligned_cols=263 Identities=29% Similarity=0.399 Sum_probs=216.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.-|+.-...||.|.||.||.|.+..||+..|+|.|.-.....+....+.+|+++|..|+|||+|+++++=+... .
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence 44677788999999999999999999999999998743333455567889999999999999999999876543 4
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.||.||||+ |+|.+++...+-.+|-..+.+..|++.||.|||+.|||||||||.|||++.+|.+|++|||.|....+..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 899999998 6899998887778888899999999999999999999999999999999999999999999998876554
Q ss_pred CC-cccccccccCccccCcccccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 181 PT-AIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 181 ~~-~~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.+ .......+||+.|||||++.+.. .+..-+.|||||||++.||+||+.||...+..-++ |-++
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V------------ 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV------------ 1454 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH------------
Confidence 22 22346789999999999997643 34556899999999999999999999765543332 2211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.+..++.+ ...++++.+|||.+||.-||++|.++.|||+|-|-+.
T Consensus 1455 ----------~~gh~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 ----------AAGHKPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ----------hccCCCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 11222222 2347899999999999999999999999999998764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.23 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=201.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++|+||+++++++....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG-- 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 5789999999999999999999876 3678999988632 33455677889999999999999999999875432
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~--------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
...+++++|+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 82 --~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 --EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred --CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 35789999997 6999988653 358999999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~l 247 (558)
|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+.......+..
T Consensus 160 d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 234 (280)
T cd05043 160 DNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-- 234 (280)
T ss_pred CCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc--
Confidence 999997653322110 0122345677999999876 578899999999999999998 9999977654332221111
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 -------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 -------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1011 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.40 Aligned_cols=258 Identities=22% Similarity=0.388 Sum_probs=225.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+..+++..||-|+||.|=++.-......+|+|++++. ..+......+..|-+||..++.|.||++|..| .+.++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 4678889999999999999876666667999999753 34556677899999999999999999999988 66678
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+||+||-|- |+|+..++.++.|++..+++++..+++|+.|||++|||+|||||+|+|++.+|-+||.|||+|+....+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999985 7999999999999999999999999999999999999999999999999999999999999999887665
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.+ .++|||+.|.|||++.. ...+.++|.||||+++||||+|.+||.+.+....++.|.+.+..
T Consensus 575 KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------- 637 (732)
T KOG0614|consen 575 KT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------- 637 (732)
T ss_pred ce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence 43 67899999999999987 68899999999999999999999999999998888888753210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
-.....++..+.+||+++...+|.+|.. +.+|-.|-||.++.
T Consensus 638 ------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 638 ------------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ------------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 0112356778999999999999999975 99999999999764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.43 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=196.6
Q ss_pred cEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+|+.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD---- 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC----
Confidence 48899999999999999998754 23568888876432 234456788999999999999999999987433
Q ss_pred CccEEEEEecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK 153 (558)
...|+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+|||||
T Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 76 -GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred -CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 35899999998 6898887642 247889999999999999999999999999999
Q ss_pred CCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCC
Q 008644 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (558)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~ 232 (558)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 01122345678999998876 578899999999999999998 999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+.......+.+.. .... .....++..+.+||.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKT---------------------------GYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhC---------------------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7664433222111 0000 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.13 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=200.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
++|.+.+.||+|+||.||+|.+... ...|+||.+.... .......+.+|+.+|+.+.|+||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 4699999999999999999987654 4568999886432 23455678999999999999999999998743
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 24689999998 69999998754 58999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ..+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----------- 223 (270)
T cd05056 159 DESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN----------- 223 (270)
T ss_pred cccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Confidence 33211 1122334567999999866 578899999999999999986 9999987765443332211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ...+.++..+.+||.+||..+|.+|||+.+++.
T Consensus 224 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 ----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.89 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=199.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC-------CcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t-------g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~ 94 (558)
.+|++++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.+ +|+||+++++.+...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 4799999999999999999986432 236899987643 2234556789999999999 799999999988543
Q ss_pred CcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008644 95 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NI 157 (558)
..+|+|+||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 36899999997 59999987532 377888999999999999999999999999999999
Q ss_pred EeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008644 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (558)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999997654322111 1122334567999999876 678899999999999999998 8899987765
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
......+.. ... .......+..+.+||.+||+.+|.+|||+.|+|.+
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444332221 000 01123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=305.18 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=198.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+|+.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence 568999999999999999999754 4567999987632 2345678899999999999999999998744 35
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.|++|||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 899999997 5999999763 3578899999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......++..|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------ 218 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC------------
Confidence 2211 1122345677999999876 578899999999999999998 9999987665443332211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .......+..+.+++.+||+.||++||++.++++
T Consensus 219 ---------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ---------------GYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------------CCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 1122456788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=308.50 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=201.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
...+|++.+.||+|+||.||+|.++.+|. .||+|.+.... .......+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 34689999999999999999999877665 58999876432 23455678899999999999999999998864
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
...++||||+. ++|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 35899999997 6999998774 469999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
........ .......++..|+|||.+.. ..++.++|+|||||++|||++ |+.||.+....+....+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------- 226 (279)
T cd05057 158 LLDVDEKE-YHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-------- 226 (279)
T ss_pred cccCcccc-eecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC--------
Confidence 65432211 11111223567999998865 578899999999999999998 9999987654332222211
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+++.+||..||.+|||+.++++
T Consensus 227 -------------------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 -------------------GERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 112345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=303.61 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=198.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+++|+.+.||||+++++.+... ..
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----Cc
Confidence 457999999999999999999875 46789999886422 2235678899999999999999999987443 36
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+. ++|.+++... +.++++.++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5898888764 46899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.+
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 2111 112234568999999876 578899999999999999998 9999977664433322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..... .....+..+.+|+.+||..||++|||+.+++++
T Consensus 217 --------------~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00000 012346889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.41 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=201.2
Q ss_pred EEEEeEeeccCceEEEEEEECCCC----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+++.+.||.|+||.||+|.+..++ ..||+|++.... .......+..|+.+|+.+.|+||+++++.+... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 357889999999999999998876 899999986432 222567888999999999999999999988554 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..|++||++. ++|.+++..... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 6999999997 599999976554 9999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+..
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 4321111 12236788999999865 678899999999999999998 8899977554433332211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+++.+||..||++|||+.++++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ----------------GYRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1111 112346889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.01 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=190.8
Q ss_pred eEeeccCceEEEEEEECCCCc--EEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~--~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+.||+|+||.||+|.+..++. .+++|.+... ........+.+|+.++..+ +||||+++++++... ..+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 468999999999999988876 4688887632 2234456788999999999 799999999988543 358999
Q ss_pred EecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 106 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
|||+. ++|.+++..+. .++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99997 69999987543 47899999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~l 247 (558)
|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 9999863221111 112234567999999876 578899999999999999997 999997765433222211
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ......+..+.+|+.+||..||.+|||+.+++.
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 11000 112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=338.47 Aligned_cols=279 Identities=20% Similarity=0.272 Sum_probs=186.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCC----CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~t----g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..++|++.+.||+|+||.||+|.+..+ +..||||++.... .......| .++...+.++..+...+.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 356899999999999999999999998 9999999986321 11111111 1222233344444333322211
Q ss_pred -CCCccEEEEEecCc-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008644 97 -REFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (558)
Q Consensus 97 -~~~~~~~lV~E~~~-g~L~~~i~~~~~--------------------l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP 154 (558)
.....+++|+||++ ++|.+++..... ..+..++.++.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 34457999999998 589888865421 12345778999999999999999999999999
Q ss_pred CcEEeCC-CCcEEEeecccceeccCCCCCcccccccccCccccCcccccccc--------------------CCCCCcch
Q 008644 155 KNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (558)
Q Consensus 155 ~NILl~~-~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~--------------------~~y~~~~D 213 (558)
+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57999999999975432221 1224578999999999653211 12345679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCC---CCCCCCCHHHH
Q 008644 214 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS---QKFPNANPLAL 290 (558)
Q Consensus 214 IWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~ 290 (558)
|||||||||||+++..+ ..+...++..+....+..... +... +......... ..+......+.
T Consensus 362 VwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVA-WRKL-----------VEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHH-HHHh-----------hccccchhhhhhhhhccccchHHH
Confidence 99999999999986654 344444444444433332111 1110 0000000000 11122244577
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 291 ~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
+||.+||++||++|||+.++|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987544
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=312.07 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=197.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECC----------------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~----------------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~ 86 (558)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 3457999998643 22344567889999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008644 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (558)
Q Consensus 87 l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP 154 (558)
+++.+... ...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 99988543 35899999997 59999987642 367788999999999999999999999999999
Q ss_pred CcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh--CCCCCC
Q 008644 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFP 232 (558)
Q Consensus 155 ~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~ 232 (558)
+|||++.++.++|+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997643322111 1122345678999998765 578999999999999999998 678887
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+....+.... .++....... .......+++.+.+||.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTG--------------------EFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHH--------------------HHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 655433222111 1111110000 11122446788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=310.45 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=198.8
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
++|++++.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+.||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 57999999999999999999875 367899999986432 223456688999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP 154 (558)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++|++||||||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 35899999998 59999987431 377888999999999999999999999999999
Q ss_pred CcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 008644 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233 (558)
Q Consensus 155 ~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~ 233 (558)
+|||++.++.++|+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred hheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999987643322111 0122334667999999876 578999999999999999997 8889876
Q ss_pred CChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 234 ~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+..+....+.. ... .......+..+.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRD---------------------------GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 654433222211 111 0112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=304.32 Aligned_cols=240 Identities=26% Similarity=0.456 Sum_probs=195.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+|+.++||||+++++.+... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 579999999999999999984 57889999998642 2345788999999999999999999987432 36
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997654 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999999876 578899999999999999997 9999987664433222211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+++.+.+||.+||..+|++||++++++.
T Consensus 213 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1001 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=307.73 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=199.6
Q ss_pred EEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC-Cc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~-~~ 100 (558)
|++.++||+|+||.||+|.+. .++..||||.+............+.+|+.+|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 36789999999765555556677899999999999999999999886543221 22
Q ss_pred cEEEEEecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..+++++|+. ++|..++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578899997 6888776432 14789999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+......... ......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8653322111 1122345678999999876 568889999999999999999 8899977654433222211
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ....+..+..+.+|+.+||..+|++|||+.+++.
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 231 --------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0111356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=303.03 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=194.3
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~ 108 (558)
+.||.|+||.||+|.+.. ++.|++|++...... .....+.+|+++++.+.|+||+++++.+... ...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence 469999999999999888 999999998753332 3556789999999999999999999988543 368999999
Q ss_pred Cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 109 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 5899988663 468999999999999999999999999999999999999999999999999997653222110 00
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------------------- 210 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------------------- 210 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc--------------------
Confidence 11233567999999876 578899999999999999999 8899977654332222211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ......+..+.+||.+||..+|++|||+.|+|+
T Consensus 211 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 -------GYRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.69 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=193.3
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~ 108 (558)
++||+|+||.||+|.+. ++..+|+|.+..... ......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 47999999999999854 688999999875432 23345688999999999999999999988543 368999999
Q ss_pred Cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccc
Q 008644 109 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (558)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (558)
+. ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 97 5899888754 458999999999999999999999999999999999999999999999999997543322111 0
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 12234567999999876 568889999999999999998 9999987654332221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......++..+.+|+.+||..||++||++.++++
T Consensus 210 -------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 -------GYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000 1123456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.07 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=199.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
++|++++.||+|+||.||+|+.+. ..+.|++|.+... ........+.+|+.+|+.++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC---
Confidence 579999999999999999998754 3467999987642 2222456788999999999999999999987433
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEE
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~---------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL 167 (558)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 36899999998 69999998765 6899999999999999999999999999999999999999999999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~ 246 (558)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432221 12234456778999999876 567889999999999999998 788996654332222111
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ...+ .....++..+.++|.+||..||.+|||+.|++.+
T Consensus 233 -------------------------~~-~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 -------------------------AG-KLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------cC-CcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0011 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.23 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=199.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4678999999999999999999988776 46888876422 223344688999999999999999999988543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..++++||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 3578999998 68999987754 589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---------- 225 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------
Confidence 5432211 11223446778999999876 678899999999999999997 899997655332221111
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..... ...+..+..+.++|.+||..||++||++.++++
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 226 -----------------KGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01111 112345778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.13 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=189.7
Q ss_pred eEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++.... ...|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998653 3457999988532 23345677889999999999999999999775432 257899
Q ss_pred EecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCc
Q 008644 106 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (558)
Q Consensus 106 ~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~ 183 (558)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999998764 346788889999999999999999999999999999999999999999999997543221100
Q ss_pred -ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 184 -~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 01123345678999999876 578899999999999999999 467776655333221111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
....... ....++.+.+|+.+||..||++||++.+++.
T Consensus 217 ----------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 217 ----------QGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ----------cCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0111111 1234678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.15 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=188.0
Q ss_pred eEeeccCceEEEEEEECC--CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++.+... ...|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence 358999999999996432 4557888877532 2233445688999999999999999999988543 3589999
Q ss_pred ecCc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 107 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 59999987643 24678889999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccccccCccccCccccccc-----cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
... ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-------- 225 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------
Confidence 110 01223456779999987431 1356789999999999999999 78899766544333222111
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ....+.......++..+.+++..|+ .||++|||++++++
T Consensus 226 ---------------~--~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 ---------------Q--DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------------c--CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 0111112223457788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.69 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=199.0
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~ 96 (558)
++|.+.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+|..+. ||||+++++.+...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 57889999999999999999853 456789999997532 2234457889999999997 99999999998553
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC------------------------------------------------------
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (558)
..+|+|||||. |+|.+++..++
T Consensus 114 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 114 ---GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ---CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 36899999998 69999886532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008644 122 --------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (558)
Q Consensus 122 --------------------------------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NI 157 (558)
.+++..+..|+.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256777889999999999999999999999999999
Q ss_pred EeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008644 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (558)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999864322211 11123457788999999976 578899999999999999998 8899976543
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+.+..... .... ......++..+.+||.+||..||.+||++.+|+..
T Consensus 348 ~~~~~~~~~--------------------------~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK--------------------------RGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332211110 0000 01224568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=303.37 Aligned_cols=228 Identities=25% Similarity=0.363 Sum_probs=185.4
Q ss_pred cCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCc-cc
Q 008644 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SD 112 (558)
Q Consensus 34 G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~ 112 (558)
|.+|.||+|+++.+++.||+|.+.... ...+|...+....||||+++++.+... ...|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence 899999999999999999999986421 223455555566799999999988543 46899999998 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccC
Q 008644 113 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192 (558)
Q Consensus 113 L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT 192 (558)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 234567
Q ss_pred ccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhcc
Q 008644 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 272 (558)
Q Consensus 193 ~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~ 272 (558)
..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 57889999999999999999999887432110 0 00
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccc
Q 008644 273 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYF 316 (558)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-----~elL~hp~f 316 (558)
.... ...+.+++.+.+||.+||+.||++|+|+ +++++||||
T Consensus 192 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0000 1123568889999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=327.18 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=211.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+-|..++.||-|+||.|++++...|...||+|.+.+. ......+..+..|-.||.....+=||+|+..|.+. ..
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----Cc
Confidence 4588899999999999999999999999999998742 22345567788999999999999999999998554 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC-
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND- 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~- 179 (558)
+|+||+|+. ||+..++.+-+-|.|+.+++++.+|.+|+++.|..|+|||||||+|||||.+|.+||+||||++.....
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 599999999999999999999999999999999999999999999999999999999999999643110
Q ss_pred --------C-CCc-----------------------------ccccccccCccccCccccccccCCCCCcchhhhHHHHH
Q 008644 180 --------T-PTA-----------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (558)
Q Consensus 180 --------~-~~~-----------------------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il 221 (558)
. ... +.-...+||+.|+|||+|.. ..|+..+|.||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 0 000 00124689999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 008644 222 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301 (558)
Q Consensus 222 ~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP 301 (558)
|||+.|++||-.....+...+|..+ +.++ -+ ..-.++++++.+||.++.. ++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw-----------------~~~l-------~~---~~~~~ls~e~~~li~kLc~-sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW-----------------RNFL-------HI---PYQGNLSKEALDLIQKLCC-SA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh-----------------hhcc-------cc---ccccccCHHHHHHHHHHhc-Ch
Confidence 9999999999766543322222110 0000 00 1124679999999998765 67
Q ss_pred CCCC---CHHHHhcCccccCcc
Q 008644 302 KDRP---TAEEALADPYFKGLA 320 (558)
Q Consensus 302 ~~Rp---ta~elL~hp~f~~~~ 320 (558)
+.|. .++|+..||||+++.
T Consensus 914 d~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhhhhcCccccccc
Confidence 7885 478899999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.77 Aligned_cols=264 Identities=23% Similarity=0.425 Sum_probs=218.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (558)
-.+.|+|.++||.|.||.||++.++++|...|+|+..... .....+..|.++|+.+. |||++.++++|.-......
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3568999999999999999999999999999999986432 33456788999998885 9999999999987665666
Q ss_pred ccEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 100 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|||||||+ |+.-++++. ..++.|+.+.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 78999999998 577777765 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
..... ...+.+||+.|||||++... ...|+..+|+||||++..||.-|.+|+-+..... .+..+...|+
T Consensus 174 dsT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNPP-- 245 (953)
T KOG0587|consen 174 DSTVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNPP-- 245 (953)
T ss_pred ecccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCCC--
Confidence 44332 34678999999999998542 2357788999999999999999999996544322 2222222222
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+-...+..++..+.+||..||.+|-++||+..++|.|||++.
T Consensus 246 -----------------------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 -----------------------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------------------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 222234567889999999999999999999999999999983
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.08 Aligned_cols=238 Identities=20% Similarity=0.294 Sum_probs=184.1
Q ss_pred eEeeccCceEEEEEEECC------------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 29 EVIGKGSYGVVCSAYDTR------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~------------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
+.||+|+||.||+|.... ....|++|.+... .......+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 468999999999997432 2346888887642 2234456888999999999999999999885443
Q ss_pred CCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc-------EEE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 167 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~-------lKL 167 (558)
..++||||++ +.|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. +|+
T Consensus 78 ----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ----ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ----CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 5799999998 477777765 356999999999999999999999999999999999999987664 899
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~~~~i~~~ 246 (558)
+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+....+...
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----- 220 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----- 220 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----
Confidence 999998654221 234678889999988632 56888999999999999998 5888887654322111
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
+... . .......+..+.+||.+||+.||.+||++.+||++
T Consensus 221 -------------------~~~~----~----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 221 -------------------FYEG----Q----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------------HHhc----C----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0000 0 00112235678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=306.31 Aligned_cols=238 Identities=18% Similarity=0.281 Sum_probs=186.3
Q ss_pred eEeeccCceEEEEEEECCCCc-------EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 29 EVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~-------~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.||+|+||.||+|.+...+. .|++|.+... .......+.+|+.+|+.+.||||+++++.+... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 469999999999998866554 4888887532 223456788999999999999999999998643 35
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc--------EEEeecc
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 171 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~--------lKL~DFG 171 (558)
.++||||+. |+|.+++..++ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 58999987754 5899999999999999999999999999999999999987764 6999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~i~~~lg~p 250 (558)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++|. .||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 88654221 235688899999998652 35788999999999999999995 666544332211110
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 000 1112345779999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=301.75 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=187.9
Q ss_pred eEeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence 36899999999999754 4567899999864332 23445788999999999999999999988443 3589999
Q ss_pred ecCc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 107 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
||+. ++|.+++.... ..++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 69999986532 35677888999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCcccccccc-----CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~-----~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
.. .......++..|+|||++.+.. ..++.++|||||||++|+|++ |+.||......+.......
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 YY-VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred ee-ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 11 1112345778899999985421 135789999999999999996 9999976554332211100
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ....+........++.+.+||++|+ .||++|||++|++.
T Consensus 225 --------------~~--~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------EQ--QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------cc--cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 0011111112245778999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.19 Aligned_cols=263 Identities=23% Similarity=0.399 Sum_probs=209.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL-~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..+-+..||.|+||+|++-.|+.+|+..|||.|..... ..+..+++.|+... +.-.+||||+++++.+.. ++.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----Gdc 138 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDC 138 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Cce
Confidence 34446789999999999999999999999999975433 45677888888876 445699999999998654 379
Q ss_pred EEEEecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 103 YVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~-----~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
||.||+|+-+|..+.+ ....++|+.+-.|....+.||.||.. .+||||||||+|||++..|.+||||||.+-..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9999999976655443 34579999999999999999999985 58999999999999999999999999998655
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh-CCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-GTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l-g~p~~~~i 255 (558)
.+... -+.-.|-+.|||||.+......|+.++|+||||++|||+.||+.|+.+-+. .++.+..+. |.|+.
T Consensus 219 v~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~--- 289 (361)
T KOG1006|consen 219 VDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPI--- 289 (361)
T ss_pred HHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCe---
Confidence 43322 244578899999999976556799999999999999999999999976553 333333221 22211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
..+...--+.+..++++|.-||.+|-.+||...+++.+||++....
T Consensus 290 --------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 290 --------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred --------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 1111122346888999999999999999999999999999987653
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.69 Aligned_cols=270 Identities=26% Similarity=0.424 Sum_probs=202.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
...|++.+.||+|+||.||+|... .++..||||.+...... .....+.+|+.+|+.++|+||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-- 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-- 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence 357889999999999999999854 35889999998754332 34677899999999999999999999874422
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 -GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred -CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 346899999997 59999997754 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~- 230 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQM- 230 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccc-
Confidence 6432221111122345567999999876 578889999999999999999999886532211 11111100000
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .......+......+ ....++..+.+|+.+||..||.+|||+.|+++
T Consensus 231 ---~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 231 ---I---VTRLLELLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---c---HHHHHHHHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 001111111111111 12345688999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=300.42 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=199.1
Q ss_pred cEEEEeEeeccCceEEEEEEECC-CCcEEEEEEeCCcc--------CChhHHHHHHHHHHHHHh-cCCCCccccceeecC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHILLP 93 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~--------~~~~~~~~i~~Ei~iL~~-l~HpnIv~l~~i~~~ 93 (558)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999988 78899999885321 122344567789998864 799999999998854
Q ss_pred CCcCCCccEEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEE
Q 008644 94 PSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKI 167 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL 167 (558)
. ...|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .||+|+||+|.|||++.++.+||
T Consensus 81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 N-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred C-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 3 469999999984 78777643 3469999999999999999999996 78999999999999999999999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
+|||++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999998654332 2245678999999999976 568899999999999999999999997665443322221100
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..+ ......++.+.+||.+||+.||++||++.|+.++
T Consensus 230 -------------------------~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 -------------------------YEP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CCc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 000 0112457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=298.47 Aligned_cols=236 Identities=18% Similarity=0.277 Sum_probs=186.8
Q ss_pred eEeeccCceEEEEEEECCCC----------cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 29 EVIGKGSYGVVCSAYDTRTG----------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg----------~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+|+.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 125778899999999999999999998854
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-------cEEEee
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 169 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-------~lKL~D 169 (558)
...++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 24699999998 58999988765 799999999999999999999999999999999999999887 799999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg 248 (558)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----- 219 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----- 219 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-----
Confidence 9999765331 2345677899999987632368899999999999999999 57778655422111110
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .....+ ......+.+||.+||..||.+|||+.++++
T Consensus 220 -------------------~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 -------------------Q---DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------h---cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000000 111267899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.78 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=192.4
Q ss_pred eEeeccCceEEEEEEECCCC------cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 29 EVIGKGSYGVVCSAYDTRTG------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg------~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.||+|+||.||+|.++... ..+|||.+.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36899999999999876544 689999886432 123456788999999999999999999988543 358
Q ss_pred EEEEecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-----cEEEee
Q 008644 103 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 169 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-----~lKL~D 169 (558)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 5999988642 3478899999999999999999999999999999999999887 899999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg 248 (558)
||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997543322111 1122345678999999876 578999999999999999998 9999987664433222210
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......++..+.+||.+||..+|.+||+++++++
T Consensus 229 ------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 1122456788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.10 Aligned_cols=237 Identities=20% Similarity=0.261 Sum_probs=183.7
Q ss_pred EeeccCceEEEEEEECC------------------------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc
Q 008644 30 VIGKGSYGVVCSAYDTR------------------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~------------------------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv 85 (558)
.||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997432 2246889888632 223445688899999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC
Q 008644 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~ 163 (558)
++++++.... ..|+||||++ ++|..++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999985543 5899999998 578888765 45789999999999999999999999999999999999997654
Q ss_pred -------cEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH-hCCCCCCCCC
Q 008644 164 -------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKN 235 (558)
Q Consensus 164 -------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl-tG~~pF~~~~ 235 (558)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|+.||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643221 223577889999988653 56889999999999999985 6999997654
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
....... +.. ... .....++.+.+||.+||+.||++|||+.++|++
T Consensus 227 ~~~~~~~------------------------~~~---~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERF------------------------YEK---KHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHH------------------------HHh---ccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3221110 110 000 112235679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.80 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=186.3
Q ss_pred EeeccCceEEEEEEECCC--CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 30 VIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~t--g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
.||+|+||.||++..... ...+++|.+... ........+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 599999999999975432 345667766532 2233456789999999999999999999988543 36899999
Q ss_pred cCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 108 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 108 ~~~-g~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
|+. ++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 998 5999998764 24677788999999999999999999999999999999999999999999998643221110
Q ss_pred cccccccccCccccCccccccc-----cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
......+++..|+|||++... ...++.++|||||||++|||++ |..||...+..+.+..+..-
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---------- 224 (268)
T cd05086 156 -ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD---------- 224 (268)
T ss_pred -hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh----------
Confidence 111345688899999997531 1245778999999999999997 56788766654433332110
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .............++.+.+||..|| .||++||+++++++
T Consensus 225 -------------~--~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 225 -------------Q--QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------c--ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 0000111122346788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.88 Aligned_cols=269 Identities=26% Similarity=0.428 Sum_probs=213.2
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC-----ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-----IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~-----~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
-..+||-++.+||+|+|+.||+|.|....+.||||+-.. ........+...||..|-+.|.||.||++++.|...
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 346799999999999999999999999999999997431 111223345678999999999999999999998544
Q ss_pred CcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEeCC---CCcEEEe
Q 008644 95 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANA---DCKLKIC 168 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~--gIiHrDIKP~NILl~~---~~~lKL~ 168 (558)
+ ..+|-|+|||+| ||.-+++.+.-+++.+++.|+.||+.||.||... -|||-||||.|||+.. -|.+||+
T Consensus 540 t----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 T----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred c----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 3 368999999997 8999999998999999999999999999999976 4999999999999854 4789999
Q ss_pred ecccceeccCCCCCc----ccccccccCccccCcccccc--ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 169 DFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
||||+++...+.... ...+...||.||++||.+.- .-.+.+.++||||+|||||.++.|+.||..+.....+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--
Confidence 999999876554432 22345789999999997632 1245788999999999999999999999654332211
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
+.. ..+.+...+.|. .-|-+++++.+||++||+.--++|....++..||||.
T Consensus 694 Lqe----------------------NTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 694 LQE----------------------NTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred Hhh----------------------hchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 110 011111111222 2256899999999999999999999999999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.45 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=194.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|.-..+||+|+||.||+|.-... ..||||++....... ...|.+|+.+|..++|||+|+|+|+|..... .
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~ 146 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H 146 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence 35667778999999999999976544 899999887533221 4459999999999999999999999965431 5
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~g---IiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+||+|||. |+|.+.+.... .++|.....|+.++++||+|||... |+|||||++|||+|++...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999998 79999997755 7999999999999999999999864 99999999999999999999999999965
Q ss_pred ccCCCCCccccccc-ccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHHHHHHHhhCCCC
Q 008644 176 AFNDTPTAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---HQLDIMTDLLGTPS 251 (558)
Q Consensus 176 ~~~~~~~~~~~~~~-~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---~~~~~i~~~lg~p~ 251 (558)
.... . ...... .||..|+|||.+.. ...+.++|||||||+|.||++|+.+....... .........+
T Consensus 227 ~~~~-~--~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~---- 297 (361)
T KOG1187|consen 227 GPEG-D--TSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL---- 297 (361)
T ss_pred CCcc-c--cceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH----
Confidence 4331 1 111222 79999999999865 57889999999999999999999888654311 1111111110
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
........+.. .... ..++ ..-..+..+..+|++.+|.+||+..|++.
T Consensus 298 -------~~~~~~eiiD~----~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 298 -------EEGKLREIVDP----RLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -------HCcchhheeCC----CccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 01011111110 0000 1111 11223677889999999999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=326.99 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=206.5
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
+..++.+.||+|+||+||+|.-. .....||||.+++.. .......|.||+.+|..|+|||||+|+|+|...
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--- 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREG--- 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence 45677899999999999999753 234579999998542 333567899999999999999999999999543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------~----l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
+-+|||||||. |||+++++.+. . ++..+...|+.||+.|+.||-++.+|||||-..|+||+++
T Consensus 562 --~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 --DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred --CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 46999999998 89999997532 2 7889999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~ 241 (558)
..|||+||||++...+.+.-... ....-...||+||-+.- .+|+.++||||+||+|||+++ |+.||.|.+..+-++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred eEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 99999999999876554432211 12233457999998865 689999999999999999998 889999988877766
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.|.. .. .-....+++.++.+|+..||+.+|++||++.||-
T Consensus 717 ~i~~---------------------------g~---lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRA---------------------------GQ---LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHc---------------------------CC---cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 6543 11 1234467899999999999999999999999983
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.10 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=202.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCc---E-EEEEEeCC-ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGE---K-VAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~---~-vAiK~i~~-~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+-.+.+.||+|+||.||+|.-+..+. . ||+|..+. ..........+++|.++++.++|||||+++|+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 44566999999999999998765432 3 89998874 2345566788999999999999999999999986543
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
-+|||||+|. |+|.+++++++. ++..+...++++.++||+|||+++++||||-..|+|++.++.+||+||||++..
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 5999999998 599999999874 999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..-.... ........|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+....|...
T Consensus 313 ~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--------- 378 (474)
T KOG0194|consen 313 SQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--------- 378 (474)
T ss_pred cceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---------
Confidence 3111100 01124467999999987 589999999999999999999 88999998876554444210
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
..+.+. ....+..+..++.+|+..||++|||+.++.+
T Consensus 379 -----------------~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 -----------------GYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------CccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111111 1245677888999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=329.87 Aligned_cols=251 Identities=23% Similarity=0.416 Sum_probs=204.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCC-----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg-----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..-++.+.||+|+||.||.|.-.... ..||||.+.+. .+......|++|..+|+.+.|||||+++++++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-- 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-- 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence 46788999999999999999755432 34999998754 34567788999999999999999999999998743
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
..+|++|||+ |||..+|+.. ..++......|+.||++|+.||+++++|||||...|+|++....+||+|
T Consensus 769 ---~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 ---PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred ---CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 5899999998 6999999876 2489999999999999999999999999999999999999999999999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg 248 (558)
||+|+.......-... ....-...|||||.+.. ..++.++|||||||+|||+++ |..||++.+..+.+.-..+
T Consensus 846 FGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~--- 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE--- 919 (1025)
T ss_pred cchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---
Confidence 9999954333221110 11122346999999987 689999999999999999999 7899998887655432221
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.-+ -...+.++..+.+||..||+.+|++||++..|++
T Consensus 920 --------------------ggR-------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 --------------------GGR-------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------CCc-------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 110 1123567788899999999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.35 Aligned_cols=265 Identities=23% Similarity=0.421 Sum_probs=212.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.|.++++||+|+|.+|.+++++.|.+.||+|++++. +....+..-+..|..+..+. +||.+|.++.+|.+.+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes----- 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES----- 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-----
Confidence 5799999999999999999999999999999999864 34455666678888888766 5999999999997766
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+++|.||+. |+|.-.++....+++++++++...|+.||.|||+.|||.||||.+|+|++..|.+||+|+|.++.....
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 4999999998 599888888889999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
....+++|||+.|.|||++.+ ..|+.++|.|+|||+++||+.|+.||.- .|.-.++
T Consensus 405 ---gd~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~d------ 460 (593)
T KOG0695|consen 405 ---GDTTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNPD------ 460 (593)
T ss_pred ---CcccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCcc------
Confidence 223477999999999999998 7899999999999999999999999951 1100000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP------TAEEALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp------ta~elL~hp~f~~~~ 320 (558)
...++|+-.+...+.+.. ...++-.+..+++..|.+||.+|. .+.++-.|+||+.+.
T Consensus 461 -~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 461 -MNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred -cchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 000112111111111111 123456678899999999999995 478999999998653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.83 Aligned_cols=208 Identities=32% Similarity=0.493 Sum_probs=176.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-~~~ 98 (558)
|.+.-+...+.||+|+||.||+++++.||+.||||.++... .....++.-+|+++|++|+|+|||+++++=-+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 55667888999999999999999999999999999998543 4467788889999999999999999988753222 111
Q ss_pred CccEEEEEecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC--CCCc--EEEeec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK--LKICDF 170 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~--~~~~--lKL~DF 170 (558)
...-.+|||||. |+|..++..- ..|++.+...++..+..||.|||.+||+||||||.||++- .+|+ .||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 235689999998 6999999753 3699999999999999999999999999999999999864 3343 799999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 233 (558)
|.|+....+. .+.+.+||+.|.+||++.. ...|+..+|.|||||++|+++||..||.-
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9998765544 4588999999999999973 25788899999999999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=278.10 Aligned_cols=242 Identities=39% Similarity=0.658 Sum_probs=197.9
Q ss_pred CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCcc-cH
Q 008644 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113 (558)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L 113 (558)
+||.||+|.+..+|+.+++|++....... ....+.+|+..++.++|+||+++++.+... ...++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-KRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 58999999999999999999987432221 167889999999999999999999988554 368999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCc
Q 008644 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193 (558)
Q Consensus 114 ~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~ 193 (558)
..++.....+++..++.++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999998765432 124456888
Q ss_pred cccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhcc
Q 008644 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 272 (558)
Q Consensus 194 ~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~ 272 (558)
.|++||.+.+ ..++.++||||||+++++|++|..||........ ++.+.
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------------------------- 200 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------------------- 200 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------------------------
Confidence 9999999875 5778899999999999999999999976322221 11111
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 273 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
............++..+.+++.+||..||++||++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 201 KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00111111112267889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.36 Aligned_cols=287 Identities=29% Similarity=0.439 Sum_probs=213.4
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~ 95 (558)
++.+.|.++++||.|.|++||++.+.. .++.||+|.|... +...++.+|+++|..+. +.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 356789999999999999999999888 7899999998743 45677999999998885 89999999988
Q ss_pred cCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccc
Q 008644 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla 173 (558)
+......+|+||++. +..+++.. ++...++.+++.++.||.++|.+|||||||||+|+|.+.. ++-.|+|||||
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 444579999999996 45555433 6788999999999999999999999999999999999864 77899999999
Q ss_pred eeccC--------------CCC---------------------------CcccccccccCccccCccccccccCCCCCcc
Q 008644 174 RVAFN--------------DTP---------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAI 212 (558)
Q Consensus 174 ~~~~~--------------~~~---------------------------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~ 212 (558)
..... ..+ .....-...||++|+|||++..+ ...++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcc
Confidence 72100 000 00011246799999999999875 6778999
Q ss_pred hhhhHHHHHHHHHhCCCCC-CCCChhhHHHHHHHhhCCCCHHHHHHhhh-------------HHHHHHH-----hhhccC
Q 008644 213 DIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSPEAIARVRN-------------EKARRYL-----SSMRKK 273 (558)
Q Consensus 213 DIWSlG~il~eLltG~~pF-~~~~~~~~~~~i~~~lg~p~~~~i~~~~~-------------~~~~~~~-----~~~~~~ 273 (558)
||||.|||+..+++++.|| ...++.+.+..|..++|.-.......... .+...-+ ..+.+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999886 45566667777776666332211111000 0111111 111111
Q ss_pred CC-CCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 274 KP-IPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 274 ~~-~~~~~~~-~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. ......+ ...+..+.||+.+||..||.+|+||+++|.||||...
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 11 0111222 2335689999999999999999999999999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.86 Aligned_cols=276 Identities=18% Similarity=0.259 Sum_probs=187.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC----------------CCCcEEEEEEeCCccCCh------------hHHHHHHHHH
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT----------------RTGEKVAIKKINDIFEHV------------SDATRILREI 73 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~----------------~tg~~vAiK~i~~~~~~~------------~~~~~i~~Ei 73 (558)
.+.|++.++||+|+||+||+|.+. ..++.||||++....... ........|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 345689999986321110 0112234577
Q ss_pred HHHHhcCCCCc-----cccceeecCCCc---CCCccEEEEEecCc-ccHHHHHHhC------------------------
Q 008644 74 KLLRLLRHPDI-----VEIKHILLPPSR---REFKDIYVVFELME-SDLHQVIKAN------------------------ 120 (558)
Q Consensus 74 ~iL~~l~HpnI-----v~l~~i~~~~~~---~~~~~~~lV~E~~~-g~L~~~i~~~------------------------ 120 (558)
.++..++|.++ +.+++.|..... ......|+|+||++ ++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 556666543211 12346899999998 5888877532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccc
Q 008644 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200 (558)
Q Consensus 121 ~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~ 200 (558)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPEE 381 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChhh
Confidence 124567889999999999999999999999999999999999999999999997543322111 112345789999998
Q ss_pred cccccC------------------CCC--CcchhhhHHHHHHHHHhCCC-CCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 201 CGSFFS------------------KYT--PAIDIWSIGCIFAELLTGKP-LFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 201 l~~~~~------------------~y~--~~~DIWSlG~il~eLltG~~-pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
+..... .|+ .+.||||+|||+|+|++|.. ||.+....... .. ...
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~-----------~~~ 447 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LR-----------QYD 447 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hh-----------hcc
Confidence 753110 122 24799999999999999985 77543211110 00 000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCcccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP---KDRPTAEEALADPYFK 317 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP---~~Rpta~elL~hp~f~ 317 (558)
+ ....+... ......++ .+...++.+.|||.+||..+| .+|+|++|+|+||||.
T Consensus 448 ~--~~~~~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 448 N--DLNRWRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred c--hHHHHHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0 00001111 11122222 356778999999999999876 6899999999999996
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.90 Aligned_cols=247 Identities=31% Similarity=0.466 Sum_probs=191.4
Q ss_pred EeEeeccCceE-EEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKGSYGV-VCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G~~G~-Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
.+++|.|+.|+ ||+| .-.|+.||||.+-. .....+.||+.+|+.- .|||||++++.= .+...+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRG--VYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEE--eeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 46889999986 6899 45688999998753 3455678999999988 599999987754 334579999
Q ss_pred EecCcccHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---C--CcEEEeecccceec
Q 008644 106 FELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---D--CKLKICDFGLARVA 176 (558)
Q Consensus 106 ~E~~~g~L~~~i~~~~-~---l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~--~~lKL~DFGla~~~ 176 (558)
.|+|..+|.+++...+ . ......+.++.|++.||++||+.+|+||||||+||||.. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998841 1 111456789999999999999999999999999999976 3 46899999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..+...-.......||-.|+|||++.+ ..-+.++|||||||++|..++| ..||...- ..+.+.+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~~NIl~~---------- 728 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQANILTG---------- 728 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-HhhhhhhcC----------
Confidence 666554444567889999999999987 4556799999999999999997 79995432 222221111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
... ....-+....+|.|||.+||.+||..||+|.++|.||+|=.
T Consensus 729 -----------------~~~--L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 729 -----------------NYT--LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -----------------ccc--eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 000 11111222228999999999999999999999999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=289.14 Aligned_cols=246 Identities=22% Similarity=0.429 Sum_probs=207.7
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
...+...||-|-||.||.|+.++-.-.||||.++ .+......|+.|..+|+.++|||+|+|+++|.... -+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY 339 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY 339 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence 4566789999999999999999999999999987 34567889999999999999999999999996543 589
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
||+|||. |+|.++++..+ .++.-.+.+++.||..|+.||..+++|||||-..|+|+.++..|||+||||++....++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999998 89999998765 37788889999999999999999999999999999999999999999999999987776
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.+.. ...--..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||+|-+....+.++.+-+.
T Consensus 420 YTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR----------- 484 (1157)
T KOG4278|consen 420 YTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR----------- 484 (1157)
T ss_pred eecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc-----------
Confidence 5431 11222356999998854 678899999999999999998 7799999887665554443111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
- ....++++....|+..||+++|.+||++.|+-
T Consensus 485 ------------M-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 ------------M-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ------------c-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 0 12257889999999999999999999999983
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=301.86 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=206.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC-Cc--EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT-GE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t-g~--~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+.++.|+||+|+||+|++|..+.. |+ .||||++....... ....|++|+.+|.+|+|+|+++||++.++.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q----- 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ----- 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc-----
Confidence 4567789999999999999977653 33 69999997544432 667899999999999999999999999764
Q ss_pred ccEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 100 KDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
-+.||||++. |+|++.+.+ ...|-....+.|+.||+.||.||.++++|||||-..|||+-....||||||||.+..
T Consensus 184 -p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 3689999998 799999987 345888999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..+.....+....-....|+|||.|.- ..++.++|+|++||++|||++ |..||.|.+....+++|.+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 654432222222334457999999976 689999999999999999999 67999999887766655321
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. -...+.++.++.+++++||..+|.+|||+..|.+.
T Consensus 332 ----------------er-----LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ----------------ER-----LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----------------cc-----CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 00 11225678889999999999999999999988543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.71 Aligned_cols=246 Identities=26% Similarity=0.457 Sum_probs=197.3
Q ss_pred EEEeEeeccCceEEEEEEECC--CC--cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 26 KIEEVIGKGSYGVVCSAYDTR--TG--EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~--tg--~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++.+.||.|-||.||.|.-.. .| -.||||..+... +..+.+.|+.|..+|+.+.||||++++|++... -
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 445789999999999996432 23 358888876433 335578899999999999999999999999654 3
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|||||++. |.|..+++.+. .++......+++||+.||.|||+.+++||||-..|||+.....|||+||||+|....+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 799999998 89999999875 5899999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
..-.. +...-..-|||||-+.- ..++.++|||.|||++||++. |..||.|-...+-+-.|
T Consensus 545 ~yYka--S~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------------- 605 (974)
T KOG4257|consen 545 AYYKA--SRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------------- 605 (974)
T ss_pred chhhc--cccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe---------------
Confidence 43211 11122346999998854 678999999999999999876 88999875543322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+... ....++++|.+-.|+.+||+.||.+||++.+|.+
T Consensus 606 ------------EnGeR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 606 ------------ENGER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ------------cCCCC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 11111 2345789999999999999999999999988753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=305.12 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=215.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..+..+|.++||.|.||.||+|+.+..|+ .||||.++. -...+....|+.|..||=++.||||++|.++..-.
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--- 702 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--- 702 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC---
Confidence 45667899999999999999999887764 699999974 33446667899999999999999999999987332
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+-+.||+|||+ |.|..+++.++ .|+..++.-+++-|+.|++||-++|.|||||-..|||+|.+-.+||+||||+|+
T Consensus 703 --~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 703 --KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred --ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 35899999998 89999998864 699999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccc--CccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 176 AFNDTPTAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
..++.+.. .++.-| ...|.|||.+.- .+++.++||||+|++|||.+. |..||-..+..+-++.|.+-++-|++
T Consensus 781 ledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 781 LEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred cccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence 76655332 122222 256999999865 689999999999999999876 88999988888888888776555543
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+++..+-.|+..||++|-..||++.+|++
T Consensus 857 ------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 ------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 578889999999999999999999999886
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.56 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=203.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++..+++.||+|-||.|.+|.- ..+.+||+|+++.. .+......|.+||++|.+|+||||++++++|+... -+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 5778999999999999999963 33689999999742 23334577999999999999999999999997654 58
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
++|+|||+ |||.+++.++. .+.......|+.||+.||+||.+.+++||||.+.|+|++.++++||+|||.+|-...+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999998 89999999874 3345566679999999999999999999999999999999999999999999976655
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..-.. -...+-...|||+|.+.- .+++.++|+|+||+++||+++ ...||.........+....++..+....
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence 43221 123455678999998755 589999999999999999765 6688876665555444444333332211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.....+-++..+..||.+||..|-++||+++++.
T Consensus 765 --------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 765 --------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred --------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 1112245677889999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=257.21 Aligned_cols=211 Identities=26% Similarity=0.464 Sum_probs=172.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~-~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
...-++.||+|+||+|-+.+|..+|...|+|.+..... .+...+.++|+.+.. ...+|.+|.+++.+... .++
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdv 120 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDV 120 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccE
Confidence 34456789999999999999999999999999975443 456677889999874 45699999999987443 479
Q ss_pred EEEEecCcccHHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 103 YVVFELMESDLHQ----VIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 103 ~lV~E~~~g~L~~----~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
|+.||.|..+|.. +++.++.++|..+-+|+..++.||.|||++ .|+|||+||+|||||.+|++|+||||.+-...
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999999987754 445677899999999999999999999976 89999999999999999999999999997765
Q ss_pred CCCCCcccccccccCccccCccccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMT 244 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~-~~~~~~~~~i~ 244 (558)
+.... +-..|--.|||||.+... ...|+.++||||||+.+.||.+++.||+. .+...|+..+.
T Consensus 201 dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 201 DSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 44332 223566789999987432 23699999999999999999999999974 34445554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.31 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=216.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+-.++|+++.++|.|+||.||+|+|+.+++..|+|+++.. -..+..-+..|+-+++..+||||+.+++.++...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~d---- 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD---- 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhc----
Confidence 5567899999999999999999999999999999999742 3345667888999999999999999999986544
Q ss_pred ccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|++||||+| +|.+.....+.+++.++.+.++..+++|+|||+.|-+|||||-.|||+++.|.+||.|||.+.....
T Consensus 86 -klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 -KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred -CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 58999999994 7888777788999999999999999999999999999999999999999999999999998865543
Q ss_pred CCCCcccccccccCccccCccccc-cccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~-~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....+++||++|||||+.. +....|...+|||++|+...|+-.-++|.........+..+.+..-.|
T Consensus 165 ti---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp------- 234 (829)
T KOG0576|consen 165 TI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP------- 234 (829)
T ss_pred hh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-------
Confidence 32 2346789999999999852 222579999999999999999988887765444444444443322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
... ..-..+++.+-+|++.+|.++|++|||++.+|.|||...
T Consensus 235 ------------------p~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 235 ------------------PTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------------Ccc-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111 122356788999999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=319.66 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=185.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|...++||+|+||.||+|.+..+|..||||++..... ....|+.+|+.++||||+++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 346667899999999999999999999999999864321 113468899999999999999999544 358
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH---s~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
|+|||||+ |+|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||+++.++..+++ ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999985 3899999999999999999999 6799999999999999999888776 665543221
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~lg~p~~~~i~~ 257 (558)
. ....+|..|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+..+....-.
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 897 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-------- 897 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC--------
Confidence 1 23468899999999876 67999999999999999999999999532211 011111100000
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
......++..... ............+.+|+.+||+.||++|||+.|+++.
T Consensus 898 --~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 898 --DCHLDMWIDPSIR----GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --ccchhheeCcccc----CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000000 0000001112357789999999999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=286.10 Aligned_cols=198 Identities=25% Similarity=0.432 Sum_probs=174.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc--C----ChhHHHHHHHHHHHHHhcC---CCCccccceeecC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--E----HVSDATRILREIKLLRLLR---HPDIVEIKHILLP 93 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~----~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~ 93 (558)
..|..++.+|.|+||.|++|+++.+...|+||.|.+.. . .......+-.||.||..|+ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-- 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-- 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence 45999999999999999999999999999999987421 1 1123344678999999997 99999999999
Q ss_pred CCcCCCccEEEEEecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 94 PSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
++..++||+||.-+ | ||+++|....+++|.+++.|++||+.|+++||+.||+|||||-+|+.++.+|.+||+|||
T Consensus 639 ---Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 ---EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ---ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 55568999999887 5 999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFP 232 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~ 232 (558)
.|....++. +..++||..|.|||+++| .+| +..-|||+||++||.++....||.
T Consensus 716 saa~~ksgp-----fd~f~gtv~~aapevl~g--~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP-----FDVFVGTVDYAAPEVLGG--EKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC-----cceeeeeccccchhhhCC--CccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765543 356899999999999998 444 567899999999999999988885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.25 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=198.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHH--hcCCCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR--LLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~--~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.-.++.++||+|.||.||+| +-+++.||||++.. .+.+.+.+|-+|.+ .++|+||+++++.=...+. ...
T Consensus 210 ~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehh--hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-ccc
Confidence 45678899999999999999 55679999999864 56677888888876 4579999999876433332 245
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEeCCCCcEEEeec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~---------gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.++||++|.+ |+|.++++.+ .+++....+++..+++||+|||+- .|+|||||.+||||..|++.-|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 7999999998 8999999887 699999999999999999999964 5999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCC-----CcchhhhHHHHHHHHHhCCCCCC-CCChhhHHHHHH
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAELLTGKPLFP-GKNVVHQLDIMT 244 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~-----~~~DIWSlG~il~eLltG~~pF~-~~~~~~~~~~i~ 244 (558)
|||.....+.+.... -..+||..|||||+|.+- .... .++||||+|.+|+||++.-..+. +.-..-++-.-.
T Consensus 361 GLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999988765554433 337999999999999763 2222 25899999999999999765443 332222322223
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEA 310 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~mL~~dP~~Rpta~el 310 (558)
++...|+-+.... ++..-+.++ .+...|. ..-..+.+.|+.||+.|++.|.|+.=+
T Consensus 439 evG~hPt~e~mq~--------~VV~kK~RP--~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQE--------LVVRKKQRP--KIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHH--------HHHhhccCC--CChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 3444665544322 121111111 1111121 223458899999999999999997654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=264.48 Aligned_cols=273 Identities=24% Similarity=0.351 Sum_probs=199.0
Q ss_pred CCCCcccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHH--hcCCCCccc
Q 008644 9 SSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR--LLRHPDIVE 86 (558)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~--~l~HpnIv~ 86 (558)
+..+.+++-+=-++.+..+++.||+|.||.||+| +..|+.||||++.. .+.....||.+|.+ .|+|+||+.
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeec--cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhh
Confidence 4456667777778899999999999999999999 67799999999863 34556677777765 569999999
Q ss_pred cceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcE
Q 008644 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNI 157 (558)
Q Consensus 87 l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIiHrDIKP~NI 157 (558)
++..=.... ....++|||++|-+ |+|++++.. ..++.+.+..+++.++.||++||.. .|.|||||..||
T Consensus 270 FIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 270 FIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 887543222 33457999999998 899999988 4799999999999999999999954 499999999999
Q ss_pred EeCCCCcEEEeecccceeccCCC-CCcccccccccCccccCccccccccCC--C--CCcchhhhHHHHHHHHHhC-----
Q 008644 158 LANADCKLKICDFGLARVAFNDT-PTAIFWTDYVATRWYRAPELCGSFFSK--Y--TPAIDIWSIGCIFAELLTG----- 227 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~--y--~~~~DIWSlG~il~eLltG----- 227 (558)
|+.+++..-|+|+|||....++. .........+||-.|||||+|...-.. + -..+||||||.+++|++..
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 99999999999999998765553 233445678999999999998652110 1 1258999999999998862
Q ss_pred -----CCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCC--HHHHHHHHHhcccC
Q 008644 228 -----KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN--PLALRLLERMLAFE 300 (558)
Q Consensus 228 -----~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~mL~~d 300 (558)
++||.+--.. .|+-+...++- -++.++... ...|...+ ..+..|++.||..|
T Consensus 428 i~eey~~Pyyd~Vp~-----------DPs~eeMrkVV------Cv~~~RP~i----pnrW~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPS-----------DPSFEEMRKVV------CVQKLRPNI----PNRWKSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred EehhhcCCcccCCCC-----------CCCHHHHhcce------eecccCCCC----CcccccCHHHHHHHHHHHHhhcCC
Confidence 3566432211 11111111000 001111111 11122211 23567899999999
Q ss_pred CCCCCCHHHHh
Q 008644 301 PKDRPTAEEAL 311 (558)
Q Consensus 301 P~~Rpta~elL 311 (558)
|.-|.||--+-
T Consensus 487 p~aRltALriK 497 (513)
T KOG2052|consen 487 PAARLTALRIK 497 (513)
T ss_pred chhhhHHHHHH
Confidence 99999987663
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=285.34 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=196.3
Q ss_pred EEEeEeeccCceEEEEEEEC----C---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008644 26 KIEEVIGKGSYGVVCSAYDT----R---TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~----~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (558)
++.+.||+|+||.|++|.-. . ....||||.++..... .+...+..|+++|+.+ +|+||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 67779999999999998632 1 1457999998865444 6778899999999988 59999999999965
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
...+++|+||+. |+|..+++.+. .++......+.+||+.|++||++.+++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 346999999998 89999998765 388999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCccccccccc--CccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC-h
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN-V 236 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~-~ 236 (558)
.+..+||+|||+|+.......-.. ....+ ...|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986543332111 11122 234999999987 689999999999999999999 779998733 2
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+.++ ++.. ... -.....+++++-++++.||..+|++||++.++..
T Consensus 529 ~~l~~------------------------~l~~---G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLE------------------------FLKE---GNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHH------------------------HHhc---CCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 22221 1111 111 1122456889999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=237.51 Aligned_cols=212 Identities=38% Similarity=0.646 Sum_probs=181.5
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCc
Q 008644 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110 (558)
Q Consensus 31 IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~ 110 (558)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++.+... ...++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987432211 356789999999999999999999988554 36899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeecccceeccCCCCCccccc
Q 008644 111 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWT 187 (558)
Q Consensus 111 -g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (558)
++|.+++... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999998876 46899999999999999999999999999999999999999 89999999999986543321 123
Q ss_pred ccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHH
Q 008644 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (558)
Q Consensus 188 ~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~ 267 (558)
...+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 45678889999998762 2678899999999999999
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
..+.+++.+||..||++||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1256799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=238.22 Aligned_cols=200 Identities=38% Similarity=0.670 Sum_probs=172.8
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999999999999998753222 2567888999999999999999999987543 36899
Q ss_pred EEecCcc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 105 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
++|++.+ +|.+++..... +++..++.++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876544311
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~ 233 (558)
......++..|++||.+.+ ...++.++|+|||||++++|++|+.||.+
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234568889999999832 26778899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=298.50 Aligned_cols=208 Identities=16% Similarity=0.181 Sum_probs=148.3
Q ss_pred hcCC-CCccccceeecCCCc--CCCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008644 78 LLRH-PDIVEIKHILLPPSR--REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (558)
Q Consensus 78 ~l~H-pnIv~l~~i~~~~~~--~~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK 153 (558)
.++| +||..+++.|..... .....++++||+++++|.+++... ..+++.+++.|++||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777776622211 122357889999999999999763 459999999999999999999999999999999
Q ss_pred CCcEEeCCC-------------------CcEEEeecccceeccCCC-------------CCcccccccccCccccCcccc
Q 008644 154 PKNILANAD-------------------CKLKICDFGLARVAFNDT-------------PTAIFWTDYVATRWYRAPELC 201 (558)
Q Consensus 154 P~NILl~~~-------------------~~lKL~DFGla~~~~~~~-------------~~~~~~~~~~gT~~Y~APE~l 201 (558)
|+||||+.. +.+||+|||+++...... +........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999653 455666666665321100 000011225789999999998
Q ss_pred ccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCC
Q 008644 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 281 (558)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (558)
.+ ..|+.++|||||||+||||++|.+||..... .+..+... . .+ ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-----------------------~---~~----~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-----------------------V---LP----PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-----------------------h---cC----hh
Confidence 77 6789999999999999999999888753211 11111000 0 00 00
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 282 ~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+....+.+.+++.+||..||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123557789999999999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=248.17 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=197.6
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~ 97 (558)
....+.|.|.+.||+|.||.+.+|.|+.+...+++|.+.+.. .....+.+|...--.| .|.||+.-+++.+...
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-- 94 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-- 94 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcC--
Confidence 344677999999999999999999999999999999998643 3456788888876555 4899999888765433
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC--CCcEEEeecccce
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLAR 174 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~--~~~lKL~DFGla~ 174 (558)
+.+.+++||++ |||..-+..+ .+.|...+.++.|++.||.|||+.+|+|||||.+||||-. ..++||||||+.+
T Consensus 95 --d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 --DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred --ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 36778999999 8999988775 4889999999999999999999999999999999999854 3579999999987
Q ss_pred eccCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
....... ..--+..|.+||++... .-...+.+|||.||+|+|.+|||++||......+
T Consensus 172 k~g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d------------- 232 (378)
T KOG1345|consen 172 KVGTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD------------- 232 (378)
T ss_pred ccCceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------------
Confidence 6432221 11234568999987432 1235678999999999999999999996322111
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFK 317 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R---pta~elL~hp~f~ 317 (558)
....+++.-..++.+ .....|.-.++.+.++.++-|..++++| -++..-...-|..
T Consensus 233 ---------~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 233 ---------KPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ---------chHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 111222222222222 4556677889999999999999999999 4444444444443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=269.32 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=198.3
Q ss_pred EEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+-.++||+|+||+||+|...-.|+ +||||++.. +...+....+++|+-+|..|.|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 3445899999999999998765565 578887753 344556678999999999999999999999997653
Q ss_pred cEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+-||++||. |.|.++++.+ +.+-.+....|.+||++||.|||..+++||||-..|||+..-..+||.|||+|+....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 678999998 7999999875 4689999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
+...- .....-..+-|||=|.+.. ..|+.++||||+||++||+|| |..|+.+....+.-+.+.+
T Consensus 851 d~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------------ 915 (1177)
T KOG1025|consen 851 DEKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------------ 915 (1177)
T ss_pred ccccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc------------
Confidence 43221 1111122345788887765 689999999999999999998 8899988765443222211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... -...|.++-++--++-+||-.|++.||+++++.+
T Consensus 916 ---------------geR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 ---------------GER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------------ccc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 111 1234677888999999999999999999999754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=276.12 Aligned_cols=269 Identities=28% Similarity=0.359 Sum_probs=205.6
Q ss_pred CcE-EEEeEeeccCceEEEEEEECCCCcEEEEEEeCC----ccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND----IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~----~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..| ....++|.|++|.|+.+......+.++.|.+.. ..........+..|+.+-..|+|+|++....++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-- 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-- 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--
Confidence 334 446788999999999998888778788776541 1111122223667888888999999988777764432
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
.++-+||||.+||+.++...+.++...+..++.||+.||+|||+.||.|||||++|++++.+|.+||+|||.+.+..
T Consensus 395 ---~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 395 ---GILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred ---cchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 34445999999999999998899999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC-cccccccccCccccCccccccccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCChhhHHH-HHHHhhCCCCHHH
Q 008644 178 NDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEA 254 (558)
Q Consensus 178 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~~~~~~~-~i~~~lg~p~~~~ 254 (558)
..... .......+|+..|+|||++.+ ..|++ ..||||.|+++..|.+|+.||.-....++.. .+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 43332 234467899999999999987 67877 5799999999999999999997544322210 000
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
..............+..++...+.+|.+||++||.+|+|+++|++.+||+.+..
T Consensus 540 -------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 -------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000011111222333455677899999999999999999999999999997654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=222.42 Aligned_cols=165 Identities=22% Similarity=0.272 Sum_probs=127.4
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccccccc
Q 008644 111 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (558)
Q Consensus 111 g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (558)
|+|.+++..+ ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6889999874 45999999999999999999999998 999999999999999 9999865332 12
Q ss_pred ccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHHHhhhHHHHHHHh
Q 008644 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLS 268 (558)
Q Consensus 190 ~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~ 268 (558)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68999999999977 678999999999999999999999997654322 1111111
Q ss_pred hhccCCCCCCCCCCCCCCH--HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 269 SMRKKKPIPFSQKFPNANP--LALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
.+....+.. ......++. .+.+||.+||..||.+|||+.|+++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111000000 000111222 589999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-25 Score=219.92 Aligned_cols=265 Identities=34% Similarity=0.524 Sum_probs=204.7
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChh-HHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCccE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~-~~~~i~~Ei~iL~~l~Hp-nIv~l~~i~~~~~~~~~~~~ 102 (558)
|.+.+.||.|+||.||.+.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+.+.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 889999999999999999887 8899999976544433 567899999999999988 7999999983332 38
Q ss_pred EEEEecCcc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccceecc
Q 008644 103 YVVFELMES-DLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~~~~ 177 (558)
+++++++.+ ++.+++.... .+++.....++.|++.++.|+|+.|++||||||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999985 7887777664 799999999999999999999999999999999999999998 79999999998554
Q ss_pred CCCCCc---ccccccccCccccCcccccccc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---hhHHHHHHHhhCCC
Q 008644 178 NDTPTA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTP 250 (558)
Q Consensus 178 ~~~~~~---~~~~~~~gT~~Y~APE~l~~~~-~~y~~~~DIWSlG~il~eLltG~~pF~~~~~---~~~~~~i~~~lg~p 250 (558)
...... ......+||.+|+|||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 333221 1346789999999999987621 3677899999999999999999999877663 22222222211111
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1223578999999999999999999999988666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=230.24 Aligned_cols=180 Identities=21% Similarity=0.229 Sum_probs=134.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECC-CCcEEEEEEeCCccC---ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~---~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..++|.+.+.||+|+||+||+|+++. ++..||||++..... .......+.+|+.+|+.++|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 45689999999999999999999886 678889998753211 223456689999999999999998533221
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDI-KP~NILl~~~~~lKL~DFGla~ 174 (558)
...|+|||||+| +|. .+... . ...++.|++.||.|||+.||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 247999999986 665 22211 1 1468899999999999999999999 9999999999999999999998
Q ss_pred eccCCCCCcc-----cccccccCccccCccccccccCC----CCCcchhh
Q 008644 175 VAFNDTPTAI-----FWTDYVATRWYRAPELCGSFFSK----YTPAIDIW 215 (558)
Q Consensus 175 ~~~~~~~~~~-----~~~~~~gT~~Y~APE~l~~~~~~----y~~~~DIW 215 (558)
.......... ..+..++++.|+|||.+...... .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7643321111 12456788899999987542222 23345666
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=222.50 Aligned_cols=253 Identities=18% Similarity=0.307 Sum_probs=197.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC-----CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..|+++..++-+|.||.||.|+.... .+.|.+|.++.. ...-....++.|-.+|..+.|||+..+.++....
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-- 359 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-- 359 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec--
Confidence 35788889999999999999976543 234666666532 2334566788999999999999999999998643
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~--------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL 167 (558)
...-++++.+++ |+|..++... +.++..+...++.||..|+.|||+.||||.||-..|.+|++.-++||
T Consensus 360 --~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 360 --YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred --cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 235688889998 8999998721 23777888899999999999999999999999999999999999999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~ 246 (558)
+|=.|+|..+..+.....-. .-....||+||.+.. ..|+.++|+|||||+||||+| |+.|+..-+..+...
T Consensus 438 tDsaLSRDLFP~DYhcLGDn-EnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~----- 509 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDN-ENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH----- 509 (563)
T ss_pred ccchhccccCcccccccCCC-CCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-----
Confidence 99999998877665432211 123356999999987 689999999999999999998 888986655544322
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
|++.-.+ . ...-+++.++..++.-||+.+|++||+++|+..
T Consensus 510 -------------------ylkdGyR-l-----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 510 -------------------YLKDGYR-L-----AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -------------------HHhccce-e-----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2221111 0 112367889999999999999999999999853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=218.69 Aligned_cols=255 Identities=20% Similarity=0.226 Sum_probs=188.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCC-cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC----CCccccceeecCCCcCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRH----PDIVEIKHILLPPSRRE 98 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H----pnIv~l~~i~~~~~~~~ 98 (558)
+|++.+.||+|+||.||.|.+..++ ..+|+|........ .. ..+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-KP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-CC-ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988875 67888876542221 11 167789999988873 57777777663 12
Q ss_pred CccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-----CcEEEeecc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 171 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-----~~lKL~DFG 171 (558)
...-||||++++.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 2367999999999999988654 479999999999999999999999999999999999999865 469999999
Q ss_pred cce--eccCCCC-----CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 172 LAR--VAFNDTP-----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 172 la~--~~~~~~~-----~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
+++ ....... .......+.||..|+++....+ ...+.+.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3221111 1011134669999999999887 678899999999999999999999997655432222221
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .... .. ......+..+..+...+-..+...+|....+..
T Consensus 251 ~~~--------------------~~~~----~~--~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDP--------------------RKLL----TD--RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHh--------------------hhhc----cc--cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 100 0000 00 012223455666666666688888888877754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=199.03 Aligned_cols=241 Identities=21% Similarity=0.310 Sum_probs=186.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (558)
++-.|+|.++||.|+||+.+.|.+.-+++.||||.-... +++..+..|.+..+.|. .++|...+.+- .+.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 456799999999999999999999999999999975432 55677888999888885 67777665533 334
Q ss_pred ccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-----CcEEEeecccc
Q 008644 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFGLA 173 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-----~~lKL~DFGla 173 (558)
.+-.||+|+++.+|.+++.-.+ +|+...+..++.|++.-++|+|++.+|.|||||+|+||..- ..+.|+|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 4667999999988888887655 59999999999999999999999999999999999999764 35899999999
Q ss_pred eeccCCCC-Cc---ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hhhHHHHHHHh
Q 008644 174 RVAFNDTP-TA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---VVHQLDIMTDL 246 (558)
Q Consensus 174 ~~~~~~~~-~~---~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~---~~~~~~~i~~~ 246 (558)
+.+..-.. .. .......||-.||+-....| ...+...|+-|||-+|..+|-|..||.|.. ..+.+++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 87643211 11 12345679999999888777 577889999999999999999999998754 34445555444
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhcc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRK 272 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~ 272 (558)
-..-+.+.+..--.++...|+.-.+.
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 44444444444444555566655443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=193.90 Aligned_cols=211 Identities=26% Similarity=0.345 Sum_probs=167.1
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSR 96 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H-pnIv~l~~i~~~~~~ 96 (558)
++-++.+|++++.||.|+||.+|+|....+|+.||||.-.... ....+..|.++.+.|++ ..|..+.....
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~---- 81 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGT---- 81 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcc----
Confidence 4567889999999999999999999999999999999765322 23457789999999985 45555555442
Q ss_pred CCCccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEeeccc
Q 008644 97 REFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 172 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~DFGl 172 (558)
+..+-.+||++++.+|.+++.- +..++...+.-++-|++.-++|+|..+++||||||+|+|..-+ .++.|+||||
T Consensus 82 -e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 -EKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred -ccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 2235689999999888887764 3469999999999999999999999999999999999997532 4699999999
Q ss_pred ceeccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH
Q 008644 173 ARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239 (558)
Q Consensus 173 a~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~ 239 (558)
|+......... ..-....||..|.+-....+ ...+...|+-|+|.+|..+.-|..||.|-.....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 98754322111 11245679999998877665 4567789999999999999999999998654433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=232.06 Aligned_cols=232 Identities=27% Similarity=0.403 Sum_probs=176.0
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.....+.|..++.|..|+||-||+++|+.+..++|+ +|++. .-+ |+ ||..+.+
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-------~li------lR-----nilt~a~-------- 130 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-------NLI------LR-----NILTFAG-------- 130 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhh-ccccc-------chh------hh-----ccccccC--------
Confidence 345567899999999999999999999999999999 55421 111 11 1222211
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..++| ||-...++..+.++.+. +.|++|||+.||+|||+||+|+||+.-|.+|++|||+.+...
T Consensus 131 ---npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 131 ---NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 11233 56566666666665444 788999999999999999999999999999999999997643
Q ss_pred CCCCCc------------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 008644 178 NDTPTA------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (558)
Q Consensus 178 ~~~~~~------------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~ 245 (558)
...... ..-...|||+.|+|||++.. ..|+..+|.|++|+|+||.+-|..||.|....+.+...+.
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 221111 11234699999999999876 7899999999999999999999999999887776654432
Q ss_pred hhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccCcccC
Q 008644 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGLAKV 322 (558)
Q Consensus 246 ~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R---pta~elL~hp~f~~~~~~ 322 (558)
- .+.|.+.-...++++.+||.++|+.+|..| ..+-++.+|+||+.+...
T Consensus 273 d----------------------------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 273 D----------------------------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred h----------------------------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1 122344455678999999999999999999 467888899999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=230.38 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=197.7
Q ss_pred EeeccCceEEEEEEE---CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEE
Q 008644 30 VIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d---~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~lV 105 (558)
++|.|+||.|++++. ...|..+|+|+.++.........+...|-.++..++ ||.+++++..+.+.+ .+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence 479999999988753 345778999998765443334445667888998887 999999999986554 68999
Q ss_pred EecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcc
Q 008644 106 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (558)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~ 184 (558)
+++..| +|...+.....+++...+.+...++-|++++|+.+|+|||+|++||+++.+|.+++.|||+.+..-...
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999999988889999999999999999999999999999999999999999999999999998654332
Q ss_pred cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHH
Q 008644 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264 (558)
Q Consensus 185 ~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~ 264 (558)
..|||..|||||++.+ ...++|.||+|+++++|++|..||.+ +....|.+.-
T Consensus 152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------- 203 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------- 203 (612)
T ss_pred ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence 2289999999999863 67899999999999999999999976 3333332210
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcccC
Q 008644 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLAKV 322 (558)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~~~ 322 (558)
.......+..+.+++..|+..+|..|.- +.|+++|++|+.+...
T Consensus 204 --------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 --------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred --------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 0112345778999999999999999964 6899999999976543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=203.43 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=155.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCC----------CCccccceeec
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRH----------PDIVEIKHILL 92 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~H----------pnIv~l~~i~~ 92 (558)
.+...+.||.|+++.||.+.|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5677899999999999999999999999999975322 223355666666655544332 12222233222
Q ss_pred CCCc-------C--CC---ccEEEEEecCcccHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008644 93 PPSR-------R--EF---KDIYVVFELMESDLHQVIKA---NDD----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (558)
Q Consensus 93 ~~~~-------~--~~---~~~~lV~E~~~g~L~~~i~~---~~~----l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK 153 (558)
.... . .. ...+++|+-+.+||.+++.. ... +.......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0 00 13477888888898887653 222 2233345566999999999999999999999
Q ss_pred CCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccc------cCCCCCcchhhhHHHHHHHHHhC
Q 008644 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTG 227 (558)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG 227 (558)
|+|+|++.+|.++|+||+......... .....+..|.+||+.... ...++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999886543211 113455779999976431 13578899999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 008644 228 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304 (558)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R 304 (558)
..||........ ....|..+. +++..+++||..||+.||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999975542210 000345555 788999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=232.77 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=184.3
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.|...+.||++.|=+|++|.|.+ ..|+||++-+.. ..-....+.++|++ ...++|||.+.+..+.. ..+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHH
Confidence 78999999999999999996543 349999985432 22233344456666 67779999999877653 3346
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec--cCC
Q 008644 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA--FND 179 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~--~~~ 179 (558)
.|||-+|...+|++.+..+.-+..-+.+.|+.||+.||.-||..||+|||||.+||||+.=+.+.|+||..-+.. ..+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 799999999999999999988999999999999999999999999999999999999999999999999765432 233
Q ss_pred CCCc--ccccccccCccccCccccccc---------cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 008644 180 TPTA--IFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 180 ~~~~--~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~l 247 (558)
.+.+ .++.+...-.+|.|||.+... ....+++.||||+||+++||++ |++||.- .|+-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc--
Confidence 3322 122233333579999976431 0125678999999999999998 7899942 11111100
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
| ........++.+. +...++||..|++.||++|.+|++.|+.
T Consensus 250 ~----------~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 G----------NADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred c----------CccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0011112222221 3358899999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=216.72 Aligned_cols=308 Identities=22% Similarity=0.258 Sum_probs=219.1
Q ss_pred HHhcCCCCccccceeecCCCcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCC
Q 008644 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 152 (558)
Q Consensus 76 L~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gI-iHrDI 152 (558)
|+.+.|.|+.+++++++.. ..+++|.+||. |+|.+.+.. .-.++.-....++++|+.||.|||+.-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999766 46899999998 799999987 3468888999999999999999999877 99999
Q ss_pred CCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCcccccccc--CC---CCCcchhhhHHHHHHHHHhC
Q 008644 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--SK---YTPAIDIWSIGCIFAELLTG 227 (558)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~--~~---y~~~~DIWSlG~il~eLltG 227 (558)
+..|.+++.++.+||.|||+.......... .......-...|.|||++.+.. .. .+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999998776431110 1112223445699999987621 11 46679999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 008644 228 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307 (558)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta 307 (558)
+.||........-..+.. .+.........|.-.......+.+..++++||..+|..||++
T Consensus 155 ~~~~~~~~~~~~~~eii~--------------------~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIIL--------------------RVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHH--------------------HHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 999976432221111111 011101111111111112455679999999999999999999
Q ss_pred HHHhcCccccCcccCCCCC-C-CCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhHHhhhcCCCCCCCCCCchhHHH
Q 008644 308 EEALADPYFKGLAKVEREP-S-AQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHF 385 (558)
Q Consensus 308 ~elL~hp~f~~~~~~~~~~-~-~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~~~~~~~~~~~~p~~~~~~ 385 (558)
+++-.. +....... . ...++.+....+.+....|+..++.+.+.. .+..+.+.+.+-|+|..|+
T Consensus 215 ~~i~~~-----~~~~~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~-------~e~~k~d~LL~~mLP~~VA-- 280 (484)
T KOG1023|consen 215 EQIRSK-----LLTINKGGSSKGNLMDSLFRMLESYADNLEKLVDERTAELE-------EEKKKTDTLLGQMLPKSVA-- 280 (484)
T ss_pred HHHHhh-----hhhhcccccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHH-------HHHHHHHHHHHHhcCHHHh--
Confidence 998431 11111111 0 122333444556666666665555544443 3344566777889999998
Q ss_pred HHHHHHHHhhhCCCCCCCCCCCCCCCCCCcccccCCCCCCCccccc
Q 008644 386 KKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVT 431 (558)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (558)
+.++.|..|.|+....+.+..+.+++++++..+++|..
T Consensus 281 --------~~lk~G~~v~pe~~~~vti~fsDiv~fT~l~~~~~P~~ 318 (484)
T KOG1023|consen 281 --------ESLKLGKTVDPESFDSVTIYFSDIVGFTVLSSNSTPIQ 318 (484)
T ss_pred --------hHhhcCCcCCccccCceeeeeHHHHHHHHHHhcCCCce
Confidence 89999999999999999999999999999888877764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=192.81 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=109.3
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhH------------------------HHHHHHHHHHHHhcCCCC
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD------------------------ATRILREIKLLRLLRHPD 83 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~------------------------~~~i~~Ei~iL~~l~Hpn 83 (558)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999987 8999999999643211111 122345999999998887
Q ss_pred ccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEeCC
Q 008644 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 161 (558)
Q Consensus 84 Iv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~gIiHrDIKP~NILl~~ 161 (558)
+.....+.. ...+|||||++| ++...+...+.+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744332221 123899999996 5555544556799999999999999999999 799999999999999998
Q ss_pred CCcEEEeecccceec
Q 008644 162 DCKLKICDFGLARVA 176 (558)
Q Consensus 162 ~~~lKL~DFGla~~~ 176 (558)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=194.81 Aligned_cols=176 Identities=13% Similarity=0.127 Sum_probs=132.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-hHHHH------HHHHHHHHHhcCCCCccccceeecCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATR------ILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-~~~~~------i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
.++|+++++||.|+||.||++.+ ++..+|||.+....... ....+ +.+|+..+.++.|++|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999644 47789999997443322 22223 57899999999999999998886543
Q ss_pred CcCC---CccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 95 SRRE---FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 95 ~~~~---~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.... ....+|||||++| +|.++. .+++ ..+.+|+.+|..||+.||+||||+|+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2211 2358999999997 787763 2333 2466999999999999999999999999999988 999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 225 (558)
|..+........ + .+... ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~-----d----------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-----D----------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-----H----------HHHHH--hHhcccccccceeEeehHHH
Confidence 988654221110 0 02222 35667899999999988664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=184.95 Aligned_cols=142 Identities=23% Similarity=0.198 Sum_probs=112.0
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChh------------------------HHHHHHHHHHHHHhcCCC
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------------------DATRILREIKLLRLLRHP 82 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~------------------------~~~~i~~Ei~iL~~l~Hp 82 (558)
+.+.||+|++|.||+|.+. +|+.||||+++....... ....+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999874321100 012345899999999999
Q ss_pred CccccceeecCCCcCCCccEEEEEecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeC
Q 008644 83 DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (558)
Q Consensus 83 nIv~l~~i~~~~~~~~~~~~~lV~E~~~g~-L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~ 160 (558)
++.....+... ..||||||++|. +.........++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 88554443321 238999999973 44333344578899999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecccceecc
Q 008644 161 ADCKLKICDFGLARVAF 177 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~ 177 (558)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=196.41 Aligned_cols=200 Identities=24% Similarity=0.332 Sum_probs=145.0
Q ss_pred CCCCccccceeecCCC----------------------cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHH
Q 008644 80 RHPDIVEIKHILLPPS----------------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR 137 (558)
Q Consensus 80 ~HpnIv~l~~i~~~~~----------------------~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~ 137 (558)
+|||||++...|.+.- ..+...+|+||..+..+|++++-.+ ..+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence 5999999988875321 1234579999999999999999876 4677788889999999
Q ss_pred HHHHHHhCCceecCCCCCcEEeCC--CC--cEEEeecccceeccCCCCCccc---ccccccCccccCccccccccC---C
Q 008644 138 GLKYIHTANVFHRDLKPKNILANA--DC--KLKICDFGLARVAFNDTPTAIF---WTDYVATRWYRAPELCGSFFS---K 207 (558)
Q Consensus 138 aL~yLHs~gIiHrDIKP~NILl~~--~~--~lKL~DFGla~~~~~~~~~~~~---~~~~~gT~~Y~APE~l~~~~~---~ 207 (558)
|+.|||..||.|||+|.+|||+.- |+ .+.|+|||++-...+..-.-.+ .-+.-|.-.-||||+....-. .
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 999999999999999999999753 32 4899999988654332111111 123446778899998643111 1
Q ss_pred C-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCC
Q 008644 208 Y-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286 (558)
Q Consensus 208 y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (558)
. -.++|.|+.|.+.||++....||.+...... +.+.| +...+......++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------~~r~Y-------qe~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------DTRTY-------QESQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee----------------------chhhh-------hhhhCCCCcccCC
Confidence 1 1378999999999999999999976432110 00111 1112233445778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 008644 287 PLALRLLERMLAFEPKDRPTAEE 309 (558)
Q Consensus 287 ~~~~~Li~~mL~~dP~~Rpta~e 309 (558)
+.+++|+..+|+.||++|+++.=
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccH
Confidence 99999999999999999998543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=178.26 Aligned_cols=189 Identities=16% Similarity=0.041 Sum_probs=137.0
Q ss_pred EEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC--hhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008644 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--VSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+...|++|+||+|+.+.. .+.+++.+.+...... ......+.+|+++|++|. |++|..+++.. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 4578899999999998843 7888888877643221 112235789999999996 47788887742 46
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDI-KP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|++|||+.| +|.+.+.. . ...++.|++.+|.+||+.||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999987 56543321 1 1357889999999999999999999 7999999999999999999998543322
Q ss_pred CC----c--------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008644 181 PT----A--------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (558)
Q Consensus 181 ~~----~--------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (558)
.. . .++ ...++.|++|+...-....--.+.+.++.|+.+|.++|+..++-+.
T Consensus 147 ~~~r~L~~rDl~~llk~~--~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHK--RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHH--HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 011 1256778888854322112225678889999999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=205.35 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=153.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~~~~~~ 98 (558)
+..|.|.+.||+|+||.||.|.+.. |+.||||+=+- .....+.--.+++.+|+ -+.|+.+...++..+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P-----~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--- 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKP-----PNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN--- 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecC-----CCceeeeehHHHHHhhchhhhcchHHHHHHHccCC---
Confidence 5689999999999999999999887 99999997542 22222333344445554 234555555444333
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-------CcEEEeec
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------CKLKICDF 170 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-------~~lKL~DF 170 (558)
.-+||+||.+ |+|.+++..++.+++..+.+|++|+|+.|+.||..+|||+||||+|+||... --++|+||
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred --cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 3689999998 8999999988899999999999999999999999999999999999998542 34999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (558)
|.+-...- -+....+...++|-.+-.+|...| ..|+..+|.|.|+-+++.||.|+
T Consensus 846 G~siDm~l-fp~~~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKL-FPDGTKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeE-cCCCcEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 98864321 112234567788999999999988 78999999999999999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=174.72 Aligned_cols=136 Identities=20% Similarity=0.244 Sum_probs=106.9
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-----CCCCccccceeecCCCcCCCccE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-----RHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-----~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+|+.+ .||||+++++++.+.. ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 47899999999995 7777776 69988642 123456789999999999 5799999999986542 12343
Q ss_pred E-EEEecCc---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEeCCC----CcEEEeecccc
Q 008644 103 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANAD----CKLKICDFGLA 173 (558)
Q Consensus 103 ~-lV~E~~~---g~L~~~i~~~~~l~e~~~~~i~~QIl~aL-~yLHs~gIiHrDIKP~NILl~~~----~~lKL~DFGla 173 (558)
+ +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 57666 36688888888 99999999999999999999743 47999995543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=177.55 Aligned_cols=148 Identities=19% Similarity=0.146 Sum_probs=114.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEE-ECCCCcEEEEEEeCCccCCh--------------------h--HHHHHHHHHHHH
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAY-DTRTGEKVAIKKINDIFEHV--------------------S--DATRILREIKLL 76 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~-d~~tg~~vAiK~i~~~~~~~--------------------~--~~~~i~~Ei~iL 76 (558)
..+.-|++.+.||+|+||.||+|. +..+|..||||++....... . ....+.+|+.+|
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 345568999999999999999999 77899999999986421100 0 112356899999
Q ss_pred HhcCCCCccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCC
Q 008644 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKP 154 (558)
Q Consensus 77 ~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g-IiHrDIKP 154 (558)
..+.+. ++.+..++.. ...|+||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||
T Consensus 105 ~~L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 105 QRLYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 999763 3333333311 124899999997 55555444556777778899999999999999999 99999999
Q ss_pred CcEEeCCCCcEEEeeccccee
Q 008644 155 KNILANADCKLKICDFGLARV 175 (558)
Q Consensus 155 ~NILl~~~~~lKL~DFGla~~ 175 (558)
+||+++ ++.++|+|||++..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=192.12 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=165.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccce-------eec
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH-------ILL 92 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~-------i~~ 92 (558)
..+.+.+.++.+++|.+....-... .+.+.-|..+ ..+........+++-.+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 3445555566666665544322222 1222222211 111123344556666666555544333333 111
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
........++||.|++|. .+|.++|..+. ..+...+..++.|+..|++| +|.+|+|+||.||+...++.+||+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111112236899999998 69999997543 36778899999999999999 999999999999999999999999
Q ss_pred ecccceeccCCC---CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHHHHHH
Q 008644 169 DFGLARVAFNDT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 169 DFGla~~~~~~~---~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~ 244 (558)
|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+||+||+.- .-.| +.+.
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~--- 467 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQFSTQF------ERIA--- 467 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHHhccHH------HHHH---
Confidence 999998765443 12234577899999999999988 6899999999999999999971 1111 1111
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.+..++... ++..+-.-.|...+|+.+||...|.+||++.+.--|.|.
T Consensus 468 ---------------------t~~d~r~g~---ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 ---------------------TLTDIRDGI---IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---------------------hhhhhhcCC---CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111121111 111111123556789999999999999987776666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-20 Score=204.45 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=207.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~ 99 (558)
...|.+.+.||+|+|+.|-++... .+...+|.|.+...........++..|..+-+.+. |.|++.+++....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~----- 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP----- 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence 457889999999999999888664 34556788877654444455566777888888887 99999998877444
Q ss_pred ccEEEEEecCc-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEeCCCC-cEEEeecccce
Q 008644 100 KDIYVVFELME-SDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLAR 174 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i-~~~~-~l~e~~~~~i~~QIl~aL~yLH-s~gIiHrDIKP~NILl~~~~-~lKL~DFGla~ 174 (558)
...++++++.. ++++.-+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 35889999977 4888888 5554 6888899999999999999999 99999999999999999999 99999999999
Q ss_pred eccCCCCCccccccccc-CccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-T~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
....-..........+| ++.|+|||.+.+. ....+..|+||+|+++..+++|..||......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 87652333334566788 9999999998763 2446789999999999999999999864432210
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.|...+... ...-...|...+..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 239 -----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 -----------RYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111111111 11123446677889999999999999999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-19 Score=170.31 Aligned_cols=242 Identities=17% Similarity=0.250 Sum_probs=183.6
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
...++-+|...-.|..|+| +..|..+++|+++...-+....+.|..|.-.|+.+.||||+.+++.|-.+. ++.
T Consensus 191 ~lnl~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccc--cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----Cce
Confidence 3455667888999999999 567888999988754444455567888999999999999999999996654 689
Q ss_pred EEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEe--ecccceec
Q 008644 104 VVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKIC--DFGLARVA 176 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~--DFGla~~~ 176 (558)
++..||. |+|..++..... ++..++.+++.+|++|+.|||+.. |.---|....++|+++.+.+|. |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999 799999976543 677889999999999999999985 3334588889999998776553 3222211
Q ss_pred cCCCCCcccccccccCccccCccccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
. ....-.+.|++||.+...... .-.++|+|||+++++||.|...||..-+..+.-.+|
T Consensus 343 --e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------ 401 (448)
T KOG0195|consen 343 --E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------ 401 (448)
T ss_pred --c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------------
Confidence 1 223456789999998652111 224789999999999999999999877655432222
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.++.++. ...|++++.+..|+.-|+..||.+||.++.++
T Consensus 402 ----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 ----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 2233332 23478899999999999999999999988764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=164.20 Aligned_cols=136 Identities=22% Similarity=0.280 Sum_probs=109.9
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC-h-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-V-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~-~-----~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++.||+|++|.||+|.+ .|..+++|+....... . ....++.+|+.++..+.|++|.....++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999976 7788999986532211 1 1224578899999999999987766665432 25
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.++||||++| +|.+++.... . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7899999986 8888886543 2 7888999999999999999999999999999999 78999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=159.56 Aligned_cols=137 Identities=23% Similarity=0.189 Sum_probs=105.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh--------------------hHHHHHHHHHHHHHhcCCCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--------------------SDATRILREIKLLRLLRHPD 83 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~--------------------~~~~~i~~Ei~iL~~l~Hpn 83 (558)
.|.+.+.||.|+||.||++.+. +|+.||||++....... .......+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 79999999875321000 01123578999999998875
Q ss_pred c--cccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 84 I--VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 84 I--v~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
+ ...++. ...++||||++| +|..... ......++.+|+.++.++|+.||+||||||.||+++
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 222221 235899999996 6654432 134677899999999999999999999999999999
Q ss_pred CCCcEEEeecccceec
Q 008644 161 ADCKLKICDFGLARVA 176 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (558)
+++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=158.07 Aligned_cols=131 Identities=28% Similarity=0.390 Sum_probs=102.5
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeCCc-cCCh-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~-----~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.||+|+||.||+|. .+|..+++|..... .... ....++.+|+.+++.++|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 46789999986422 1111 1235678999999999988765444433322 2468
Q ss_pred EEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+||||++| +|.+++..... .++.|++.+|.+||+.||+|||++|.||+++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887654321 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=175.20 Aligned_cols=138 Identities=22% Similarity=0.309 Sum_probs=107.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeC-CccC-----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFE-----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~-~~~~-----~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..|...+.||+|+||+||++... +..+++|+.. +... ......++.+|+.+|+.++|++++.....+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34566789999999999999654 4445555432 2111 112345688999999999999988766555432
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
...++||||++| +|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 246899999985 8888775 356789999999999999999999999999999 678999999999976
Q ss_pred c
Q 008644 176 A 176 (558)
Q Consensus 176 ~ 176 (558)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=151.50 Aligned_cols=136 Identities=25% Similarity=0.261 Sum_probs=96.1
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHH----------------------HHHHHHHHHhcCCCC--
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR----------------------ILREIKLLRLLRHPD-- 83 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~----------------------i~~Ei~iL~~l~Hpn-- 83 (558)
.+.||+|+||.||+|.+. +|..||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999887 8999999998642221111111 135666666654433
Q ss_pred ccccceeecCCCcCCCccEEEEEecCcc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeC
Q 008644 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (558)
Q Consensus 84 Iv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~-~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~ 160 (558)
+.+.+.. ...++||||+++ .+. ..+.... .. ..++.++.+++.++.++|+ .||+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 2222221 135899999997 221 1111111 11 6788999999999999999 9999999999999999
Q ss_pred CCCcEEEeecccceec
Q 008644 161 ADCKLKICDFGLARVA 176 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (558)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.4e-17 Score=171.54 Aligned_cols=256 Identities=25% Similarity=0.253 Sum_probs=200.0
Q ss_pred cEEEEeEeec--cCceEEEEEEE--CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 008644 24 RYKIEEVIGK--GSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 24 rY~i~~~IG~--G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~ 98 (558)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..+.......+-.+|+...+.+. |+|.++.+..+ ++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 6677888999 99999999988 889999999986555554445555567887777775 99999877766 44
Q ss_pred CccEEEEEecCcccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEeCCC-CcEEEeeccc
Q 008644 99 FKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 172 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~-l~e~~~~~i~~QIl~----aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGl 172 (558)
.+..|+-+|+|+.+|..+...... +++..++..+.+... ||.++|+.+|+|-|+||.||++..+ +..+++|||+
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 457999999999999888877555 899999999999999 9999999999999999999999999 8899999999
Q ss_pred ceeccCCCCCcccc--cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ChhhHHHHHHHhhC
Q 008644 173 ARVAFNDTPTAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLG 248 (558)
Q Consensus 173 a~~~~~~~~~~~~~--~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~--~~~~~~~~i~~~lg 248 (558)
........-...+. ....|..-|++||++.+ .++.+.||+++|.++.+..+|..++... +.+.+++.+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---- 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---- 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----
Confidence 98765444222111 12246678999999986 5788999999999999999998776544 3333322111
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+ ..+.....+..+...+..|++.||..|++++.+++|+++...
T Consensus 343 ---------------------------i-p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ---------------------------I-PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ---------------------------C-chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0 011222345556669999999999999999999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.3e-15 Score=147.65 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=102.9
Q ss_pred eEee-ccCceEEEEEEECCCCcEEEEEEeCCc------cC-----ChhHHHHHHHHHHHHHhcCCCCc--cccceeecCC
Q 008644 29 EVIG-KGSYGVVCSAYDTRTGEKVAIKKINDI------FE-----HVSDATRILREIKLLRLLRHPDI--VEIKHILLPP 94 (558)
Q Consensus 29 ~~IG-~G~~G~Vy~a~d~~tg~~vAiK~i~~~------~~-----~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~~~ 94 (558)
..|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|+|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 788888888855 3788999987521 11 11234568899999999998885 4555543222
Q ss_pred CcCCCccEEEEEecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 95 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~g--~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
.. .....++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 11 11123599999985 78888755 3566543 57899999999999999999999999999999999999998
Q ss_pred cee
Q 008644 173 ARV 175 (558)
Q Consensus 173 a~~ 175 (558)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=130.88 Aligned_cols=131 Identities=23% Similarity=0.209 Sum_probs=105.8
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCccEEE
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H--pnIv~l~~i~~~~~~~~~~~~~l 104 (558)
+++.||.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++.+++..+... ...|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence 46789999999999998644 7899998864322 4568899999999986 4777777765322 46899
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~---gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+|||+.+ .+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||+++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 33332 5566777899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-15 Score=167.39 Aligned_cols=265 Identities=23% Similarity=0.256 Sum_probs=200.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+.+.+.+-+-+|+++.++.+.-..+|...++|.....- ....+.+.+..+-+++-..++|.++.....+. ...
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CCC
Confidence 345778889999999999999877788777777654221 11223455556666666666777776544422 223
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..+||++|.. ++|...+.+.+..+++-++.++..+..++.|||+..+.|+|++|.|+|+..++..++.|||+.....-.
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 5899999997 599999988888999999999999999999999999999999999999999999999999844321100
Q ss_pred --------CCC------------------c--ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 008644 180 --------TPT------------------A--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (558)
Q Consensus 180 --------~~~------------------~--~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF 231 (558)
... . ..-...+||+.|.+||.+.+ .....++|.|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 000 0 01124578999999999988 57788999999999999999999999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE--- 308 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~--- 308 (558)
........++. +. ....+|.......++.+.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~n---------------------------i~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFEN---------------------------IL-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhc---------------------------cc-cCCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 76654433322 22 123445556667789999999999999999999877
Q ss_pred HHhcCccccCccc
Q 008644 309 EALADPYFKGLAK 321 (558)
Q Consensus 309 elL~hp~f~~~~~ 321 (558)
+.-.|+||+....
T Consensus 1088 e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVDW 1100 (1205)
T ss_pred ccccCCccCCCCc
Confidence 8889999997643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-12 Score=142.19 Aligned_cols=185 Identities=23% Similarity=0.338 Sum_probs=137.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
-|.+ +..+-++.+.+-.|..+.++.+|.|.+.+.... .....+.+-++-|+.|+||||+++++.+. ..+.+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~y 85 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLY 85 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceE
Confidence 3555 555555555433566688899999998875322 34556778899999999999999999874 334799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
||+|-+. -|..+++. +....+...++||+.||.||| ..+++|++|.-+-|+++..|..||++|.++.........
T Consensus 86 lvTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 86 LVTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred EEeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 9999876 34445544 237788889999999999997 778999999999999999999999999988654322211
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG 227 (558)
. ....---.|..|+.+.. -+...|.|-|||+++|++.|
T Consensus 162 ~---~~~~~~~s~~~P~~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 A---KSLYLIESFDDPEEIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c---ccchhhhcccChhhcCc----cccchhhhhHHHHHHHHhCc
Confidence 0 11122224667776643 12568999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.3e-15 Score=145.33 Aligned_cols=247 Identities=20% Similarity=0.229 Sum_probs=162.0
Q ss_pred EEEEEEECCCCcEEEEEEeCCc-cCChhH-HHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCc-ccHH
Q 008644 38 VVCSAYDTRTGEKVAIKKINDI-FEHVSD-ATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLH 114 (558)
Q Consensus 38 ~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~-~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~ 114 (558)
.||++.|...|..|+.-.+... .++... ......-..-|-++-|.|||+++.+|.+...++...+.++.|||+ |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 3566777777777766554310 011111 111111223345567999999999997766666677899999998 7888
Q ss_pred HHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeecccceec--cCCCCCcccc
Q 008644 115 QVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVA--FNDTPTAIFW 186 (558)
Q Consensus 115 ~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFGla~~~--~~~~~~~~~~ 186 (558)
+++++. ..+.....++|+.||+.||.|||+.. |+|+++..+.|++..+|-+|++----.... .+.... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-AEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH-hhh
Confidence 888652 35888999999999999999999985 999999999999999999988642221111 000000 001
Q ss_pred cccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHH
Q 008644 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265 (558)
Q Consensus 187 ~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~ 265 (558)
.-..+-+.|.|||.=.. ...+.++|||++|.+..+|..|..- -.+.+...--..|...
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~------------------- 298 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV------------------- 298 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-------------------
Confidence 12335678899986433 4556789999999999999887732 2222221111111110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
+ +.--...-+++|.+||+-.|..||++.++|.||.+-.++.
T Consensus 299 -i--------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 299 -I--------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred -e--------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 0 0001223456899999999999999999999998765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-12 Score=124.10 Aligned_cols=139 Identities=22% Similarity=0.266 Sum_probs=99.3
Q ss_pred EeEeeccCceEEEEEEECC------CCcEEEEEEeCC---ccCC-----------------hhHHHHH----HHHHHHHH
Q 008644 28 EEVIGKGSYGVVCSAYDTR------TGEKVAIKKIND---IFEH-----------------VSDATRI----LREIKLLR 77 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~------tg~~vAiK~i~~---~~~~-----------------~~~~~~i----~~Ei~iL~ 77 (558)
...||.|--+.||.|.... .+..+|||+.+. .+.+ ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997653 357999998741 1111 1112223 38999999
Q ss_pred hcCCC--CccccceeecCCCcCCCccEEEEEecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCC
Q 008644 78 LLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 153 (558)
Q Consensus 78 ~l~Hp--nIv~l~~i~~~~~~~~~~~~~lV~E~~~g~-L~~~i~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~gIiHrDIK 153 (558)
++..- ++..++++. .-+|||||++++ +..-..+...++++.+..++.|++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 88643 444444431 348999999863 322222233466677788899999999999 89999999999
Q ss_pred CCcEEeCCCCcEEEeecccceec
Q 008644 154 PKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~ 176 (558)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 568999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.4e-13 Score=144.05 Aligned_cols=140 Identities=21% Similarity=0.320 Sum_probs=93.5
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC---------------------------h-----hHHHHHHHH
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---------------------------V-----SDATRILRE 72 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~---------------------------~-----~~~~~i~~E 72 (558)
|+. +.||+|++|.||+|+.+.+|+.||||+++..... . .....+.+|
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 454 6899999999999999888999999998632100 0 111223444
Q ss_pred HHHHHhc------C----CCCccccceeecCCCcCCCccEEEEEecCcc-cHHHH--HHhCC----CCCHHHHHHHHHHH
Q 008644 73 IKLLRLL------R----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQL 135 (558)
Q Consensus 73 i~iL~~l------~----HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~--i~~~~----~l~e~~~~~i~~QI 135 (558)
+.+++.. + +.+.+.+-.++..- ....+||||||.| .+.++ +...+ .+.+..+..++.|+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 4444333 2 23333333333211 1245799999997 66553 33333 25555666666666
Q ss_pred HHHHHHHHhCCceecCCCCCcEEeCCCC----cEEEeecccceec
Q 008644 136 LRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVA 176 (558)
Q Consensus 136 l~aL~yLHs~gIiHrDIKP~NILl~~~~----~lKL~DFGla~~~ 176 (558)
+ ..|++|+|++|.||+++.++ +++++|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5 48999999999999999988 9999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=140.37 Aligned_cols=249 Identities=21% Similarity=0.204 Sum_probs=177.6
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+|..+..||.|.|+.|+.+.-. .++..|++|.+.+......+...-+.|+-+...+ .|.+++.++..|.. ..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~r 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----LR 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----cc
Confidence 46788999999999999987644 6888999998876554444444456777777666 58999988887743 34
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccceeccC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~~~~~ 178 (558)
..|+-.|||++ ++...+.....+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||++....-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 67899999974 444444434458899999999999999999999999999999999999886 7789999999863111
Q ss_pred CCCCcccccccccCcccc-CccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~-APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
. ......+-++. ..|++... ..+..+.|++|||.-+.+.++|...-...+....
T Consensus 420 ~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~------------------ 474 (524)
T KOG0601|consen 420 S------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT------------------ 474 (524)
T ss_pred e------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee------------------
Confidence 0 11122333344 24544332 5677899999999999999998854332221110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
++.. .....+.....+..+.+.|+..|+..|+.+.++..|.=|.
T Consensus 475 ------------i~~~----~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 ------------IRSG----DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------------eecc----cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 0011233346678899999999999999999998776554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.5e-12 Score=134.99 Aligned_cols=140 Identities=22% Similarity=0.278 Sum_probs=92.0
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChh--H------------------------------HH------HHH
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS--D------------------------------AT------RIL 70 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~--~------------------------------~~------~i~ 70 (558)
+.||.|++|.||+|+.+ +|+.||||+.+......- + .. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999864 799999999753110000 0 00 133
Q ss_pred HHHHHHHhc----CCCCccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 008644 71 REIKLLRLL----RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 143 (558)
Q Consensus 71 ~Ei~iL~~l----~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~-aL~yLH 143 (558)
+|...+..+ +|.+-+.+-.++..-+ ..-+|||||++| +|.++.... ..++ ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 444444444 2333333333442211 235899999986 666655432 1222 2345555555 478899
Q ss_pred hCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 144 s~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..|++|+|++|.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.2e-12 Score=118.48 Aligned_cols=126 Identities=20% Similarity=0.162 Sum_probs=92.3
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccc-cceeecCCCcCCCccEEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE-IKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~-l~~i~~~~~~~~~~~~~lV~ 106 (558)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+|+.+.+.+++. ++... .. .-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~-----~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PE-----TGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CC-----CCeEEE
Confidence 467899999999999754 78999998753211 1234578999999887655543 33322 11 247999
Q ss_pred ecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEeCCCCcEEEeecccce
Q 008644 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gI-----iHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
|+++| ++... . .....++.+++.+|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 0 1123457899999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-10 Score=118.40 Aligned_cols=215 Identities=17% Similarity=0.207 Sum_probs=156.0
Q ss_pred CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCcc--c
Q 008644 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--D 112 (558)
Q Consensus 35 ~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g--~ 112 (558)
.-.+.|++....+|..|++|.++.. .. ........-++.++++.|+|||.+.++|.+..+ ....+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~-r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGD-RD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccc-cc-cCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence 3456799999999999999999421 10 111123345788999999999999999986553 33478999999984 7
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 113 LHQVIKA---------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 113 L~~~i~~---------------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
|.++.-. +...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776532 2347889999999999999999999999999999999999999999999888776654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCC-CCCChhh-HHHHHHHhhCCCCHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVH-QLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~-~~~~i~~~lg~p~~~~i 255 (558)
.+.. |.+.+ -.+-|.=.||.+++.|.||..-- ....... .++.|
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 4320 12222 24679999999999999996321 1111111 01111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+.++.+++++|.-+...++.+ -++++++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1345677888888888888776 778888764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-10 Score=104.49 Aligned_cols=130 Identities=22% Similarity=0.353 Sum_probs=92.9
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEE-eCCccCChh-----HHHHHHHHHHHHHhcCCCCcc--ccceeecCCCcCCCc
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKK-INDIFEHVS-----DATRILREIKLLRLLRHPDIV--EIKHILLPPSRREFK 100 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~-i~~~~~~~~-----~~~~i~~Ei~iL~~l~HpnIv--~l~~i~~~~~~~~~~ 100 (558)
..|++|+-+.++.+.. -|..+++|. +.+...++. ...+..+|..+|..++--.|. .++++. +.
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~----- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PD----- 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CC-----
Confidence 4578999999998833 455677775 333333322 234567899999888644433 333332 22
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.-.|+|||++| .|.+++... .-.++..+-.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 35799999998 556577655 245677777788889999999999999999998765 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=101.79 Aligned_cols=143 Identities=22% Similarity=0.284 Sum_probs=104.9
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEe-CCccC-----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFE-----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i-~~~~~-----~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+..|-+|+-+.|+++ ...|+..+||.= .+... ..-...+..+|+++|.++.--.|.--.-++.+..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 6788999999999999 567889888862 22222 2223466789999998886444433322332222
Q ss_pred cEEEEEecCcc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEeecccc
Q 008644 101 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 173 (558)
Q Consensus 101 ~~~lV~E~~~g--~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~DFGla 173 (558)
.-.|+|||++| ++.+++.... ....+....++.+|-+.+.-||.++|+|+||..+||++..++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 24789999998 8888887632 2334444789999999999999999999999999999987653 589999998
Q ss_pred eec
Q 008644 174 RVA 176 (558)
Q Consensus 174 ~~~ 176 (558)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=105.94 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=100.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.|+.|..+.||++.... |+.+++|+....... .....+.+|+.+++.+++.+ +.+++....... .....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 678999999999997643 689999987542211 13456789999999997643 455555442211 123468999
Q ss_pred ecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 008644 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 144 (558)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs----------------------------------------- 144 (558)
|+++| ++...+.. ..++++....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99997 44443321 346777777777777777777773
Q ss_pred ---------------CCceecCCCCCcEEeCC--CCcEEEeeccccee
Q 008644 145 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 175 (558)
Q Consensus 145 ---------------~gIiHrDIKP~NILl~~--~~~lKL~DFGla~~ 175 (558)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-10 Score=127.32 Aligned_cols=155 Identities=23% Similarity=0.336 Sum_probs=112.8
Q ss_pred HHHHHHHHH-hCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC-Cccccc-----ccccCccccCccccccccCC
Q 008644 135 LLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-TAIFWT-----DYVATRWYRAPELCGSFFSK 207 (558)
Q Consensus 135 Il~aL~yLH-s~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~-~~~~~~-----~~~gT~~Y~APE~l~~~~~~ 207 (558)
+..||.|+| +.++||++|.|++|.+++++.+||+.|+++........ ....++ -..-...|.|||++.+ ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--cc
Confidence 338999999 56999999999999999999999999999865433211 000011 1234567999999987 57
Q ss_pred CCCcchhhhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCC
Q 008644 208 YTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286 (558)
Q Consensus 208 y~~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (558)
.++++|+|||||.+|.+. .|+..|.+.+.......-...+ .......-.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------------------------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------------------------NAGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------------------------ccccccccccCc
Confidence 789999999999999998 6777776554322111100000 000111125778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 287 ~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+++++=|.++|..|+..||++.+++..|||.+
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 99999999999999999999999999999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.1e-09 Score=105.10 Aligned_cols=136 Identities=15% Similarity=0.113 Sum_probs=93.8
Q ss_pred eEEEEEEECCCCcEEEEEEeCCccCCh---------hHHHHHHHHHHHHHhcCCCCcccc--ceeecCCCcCCCccEEEE
Q 008644 37 GVVCSAYDTRTGEKVAIKKINDIFEHV---------SDATRILREIKLLRLLRHPDIVEI--KHILLPPSRREFKDIYVV 105 (558)
Q Consensus 37 G~Vy~a~d~~tg~~vAiK~i~~~~~~~---------~~~~~i~~Ei~iL~~l~HpnIv~l--~~i~~~~~~~~~~~~~lV 105 (558)
..|..+ ...|+.|.||......... .-...+.+|...+..|..-+|... ..+...........-++|
T Consensus 36 rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 345555 3467789999764211000 011147789999988865454433 222211111112357899
Q ss_pred EecCcc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-------CCcEEEeecccce
Q 008644 106 FELMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLAR 174 (558)
Q Consensus 106 ~E~~~g--~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-------~~~lKL~DFGla~ 174 (558)
||++++ +|.+++.. ....+......++.+|+..+.-||.+||+|+|+++.|||++. +..+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999996 68888764 335667788899999999999999999999999999999975 4679999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1e-08 Score=99.66 Aligned_cols=130 Identities=23% Similarity=0.312 Sum_probs=94.1
Q ss_pred CCCcEEEEEEeCCc-----cCChhHHHHHHHHHHHHHhcCCCCccc--cceeecCCCcCCCccEEEEEecCcc--cHHHH
Q 008644 46 RTGEKVAIKKINDI-----FEHVSDATRILREIKLLRLLRHPDIVE--IKHILLPPSRREFKDIYVVFELMES--DLHQV 116 (558)
Q Consensus 46 ~tg~~vAiK~i~~~-----~~~~~~~~~i~~Ei~iL~~l~HpnIv~--l~~i~~~~~~~~~~~~~lV~E~~~g--~L~~~ 116 (558)
..++.+-+|..... ........+..+|...+..|..-.|.. .+.+..... ......++|+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHH
Confidence 34566666653221 111134456888999988886544433 233222211 112356899999986 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecccceec
Q 008644 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVA 176 (558)
Q Consensus 117 i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFGla~~~ 176 (558)
+.....++......++.++...+.-||.+||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 88755577888899999999999999999999999999999999987 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.3e-09 Score=99.34 Aligned_cols=127 Identities=28% Similarity=0.312 Sum_probs=81.3
Q ss_pred EEEEEEECCCCcEEEEEEeCCc----------------cC------Chh--HHHHHHHHHHHHHhcCCCC--ccccceee
Q 008644 38 VVCSAYDTRTGEKVAIKKINDI----------------FE------HVS--DATRILREIKLLRLLRHPD--IVEIKHIL 91 (558)
Q Consensus 38 ~Vy~a~d~~tg~~vAiK~i~~~----------------~~------~~~--~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~ 91 (558)
.||.|.. ..|..+|||+.... +. ... ......+|.+.|..+..-+ +.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 45779999986310 00 011 1234678999999998654 44444432
Q ss_pred cCCCcCCCccEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 92 LPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~y-LHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 2379999999 6322223322 12245567788888886555 589999999999999999987 99999
Q ss_pred ecccceec
Q 008644 169 DFGLARVA 176 (558)
Q Consensus 169 DFGla~~~ 176 (558)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.1e-08 Score=99.42 Aligned_cols=262 Identities=17% Similarity=0.165 Sum_probs=162.1
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCC---CcCCCc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP---SRREFK 100 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~---~~~~~~ 100 (558)
....+.||+|+-+.+|..-. -+ ..+.|+.+..-. ..... -+..|... .||.+-. .-+|... ..+...
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Ppp--a~~aq---k~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPP--AAQAQ---KVAELAATPDAPLLNY-RVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecch--hh-chhheeecCCCc--hHHHH---HHHHhccCCCCcchhh-hhcccHHHhhCCCccc
Confidence 44567899999999987621 12 235566654211 11111 12223322 3554322 1112111 112233
Q ss_pred cEEEEEecCcc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 101 DIYVVFELMES--DLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 101 ~~~lV~E~~~g--~L~~~i~~------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
-+.+.|..+.| .++.++.. -....++.+.+..+.|+.|...||..|-+-+|+.++|+|+.+++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47888888875 45555532 22478899999999999999999999999999999999999999999998554
Q ss_pred ceeccCCCCCcccccccccCccccCccccc-ccc--CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhC
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~~~--~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~lg 248 (558)
-.+..++. .+.--+|...|.+||+-. +.+ ..-+...|.|.||+++++||.| +.||.|-.... --+
T Consensus 164 fqi~~ng~----~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap 232 (637)
T COG4248 164 FQINANGT----LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAP 232 (637)
T ss_pred eeeccCCc----eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCC
Confidence 43332222 234468999999999743 111 2345678999999999999997 89998743110 001
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccC--CCCCCCHHH
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE--PKDRPTAEE 309 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~d--P~~Rpta~e 309 (558)
.|....|....-..+.+ .-+..++.+.+.-|.-+++.+..|..+|+... +.-|||++-
T Consensus 233 ~p~E~~Ia~g~f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 233 NPLETDIAHGRFAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred Ccchhhhhcceeeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 12221232222221111 12233444445556677899999999999753 568999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.1e-08 Score=96.35 Aligned_cols=137 Identities=25% Similarity=0.243 Sum_probs=98.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeC-------Ccc-----------CCh--hHHHHHHHHHHHHHhcCCC-
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-------DIF-----------EHV--SDATRILREIKLLRLLRHP- 82 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~-------~~~-----------~~~--~~~~~i~~Ei~iL~~l~Hp- 82 (558)
-+.+...||-|--|.||.|.+. .|.++|||.=+ +.. ... -......+|..+|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3567789999999999999876 78999999632 100 000 1123367899999988754
Q ss_pred -CccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 83 -DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 83 -nIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
.+.+.++. +.-.+|||+++| .|... +++.+....++..|++-+.-+-..||+|+|+++-|||++
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence 44443332 245899999998 33322 123455566677777777777799999999999999999
Q ss_pred CCCcEEEeeccccee
Q 008644 161 ADCKLKICDFGLARV 175 (558)
Q Consensus 161 ~~~~lKL~DFGla~~ 175 (558)
++|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=90.61 Aligned_cols=142 Identities=17% Similarity=0.196 Sum_probs=102.4
Q ss_pred eccCceEEEEEEECCCCcEEEEEEeCC-c---cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCccEEEEE
Q 008644 32 GKGSYGVVCSAYDTRTGEKVAIKKIND-I---FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKDIYVVF 106 (558)
Q Consensus 32 G~G~~G~Vy~a~d~~tg~~vAiK~i~~-~---~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~~~~lV~ 106 (558)
|+|+-+.|+... ..|..+-+|.-.+ . ...+.....+.+|+..|+.|..-+|.-..-++..... ...-.-+||+
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 568888898874 3455788997642 1 1113345678999999999975444322222221111 1123468999
Q ss_pred ecCcc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc--EEEeeccccee
Q 008644 107 ELMES--DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (558)
Q Consensus 107 E~~~g--~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~--lKL~DFGla~~ 175 (558)
|-+++ +|.+++... .+.+......++.++..+|.-||..|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98884 899888653 34678888899999999999999999999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.1e-07 Score=87.00 Aligned_cols=143 Identities=19% Similarity=0.247 Sum_probs=91.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhH-HHH------HHHHHHHHHhcCCCCccccceeecC-
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHILLP- 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~-~~~------i~~Ei~iL~~l~HpnIv~l~~i~~~- 93 (558)
...|++++++-......|.+. ...|+.+++|........... ... ..+++..+..++...+..+.+.++-
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 568999999988887777766 567899999987642211111 111 2344444444443333333222211
Q ss_pred --CCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 94 --PSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 94 --~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
....-....+|||||++| .|.+... +++ .+...|..++.-||+.|++|+|..|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 111112345689999998 5544321 333 2445677889999999999999999999998655 999999
Q ss_pred cccee
Q 008644 171 GLARV 175 (558)
Q Consensus 171 Gla~~ 175 (558)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.3e-06 Score=82.13 Aligned_cols=143 Identities=22% Similarity=0.176 Sum_probs=93.7
Q ss_pred CCcEEEEe---EeeccCceEEEEEEECCCCcEEEEEEeCCccC--------------------ChhHH--HHHHHHHHHH
Q 008644 22 GSRYKIEE---VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--------------------HVSDA--TRILREIKLL 76 (558)
Q Consensus 22 ~~rY~i~~---~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--------------------~~~~~--~~i~~Ei~iL 76 (558)
.++..|.+ .|+.|--+.||+|.. ..+..+|+|++..... +.... .-..+|..-|
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL 122 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNL 122 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHH
Confidence 34444444 555677778999863 5688999999852110 10111 1134677777
Q ss_pred HhcCC--CCccccceeecCCCcCCCccEEEEEecCcccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecC
Q 008644 77 RLLRH--PDIVEIKHILLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRD 151 (558)
Q Consensus 77 ~~l~H--pnIv~l~~i~~~~~~~~~~~~~lV~E~~~g~L--~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrD 151 (558)
+++.. -.+.+-+.+. .-.||||+++.+. .-.++ .-.+..+.+..+..++++.+.-|-. +|++|+|
T Consensus 123 ~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgD 192 (268)
T COG1718 123 KRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGD 192 (268)
T ss_pred HHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCccccc
Confidence 77643 2333333332 3479999998531 01111 1124444788888999999998876 9999999
Q ss_pred CCCCcEEeCCCCcEEEeecccceec
Q 008644 152 LKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 152 IKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
|+.-|||+. ++.+.|+|||.|...
T Consensus 193 LSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 193 LSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred chhhheEEE-CCeEEEEECcccccc
Confidence 999999999 889999999988654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.7e-06 Score=79.98 Aligned_cols=139 Identities=21% Similarity=0.221 Sum_probs=79.9
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~~~~~~~~~~~~lV 105 (558)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.|....+ ..++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997655 59999987532 356678899999998864433 3444422111 122347999
Q ss_pred EecCcc-cHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 008644 106 FELMES-DLHQ----------------VIK---AN----DDLTPEH------YQFF---------------LYQLLR-GL 139 (558)
Q Consensus 106 ~E~~~g-~L~~----------------~i~---~~----~~l~e~~------~~~i---------------~~QIl~-aL 139 (558)
|++++| .+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999986 4444 111 11 0111000 0000 111222 23
Q ss_pred HHHH-------hCCceecCCCCCcEEeC-CCCcEEEeecccce
Q 008644 140 KYIH-------TANVFHRDLKPKNILAN-ADCKLKICDFGLAR 174 (558)
Q Consensus 140 ~yLH-------s~gIiHrDIKP~NILl~-~~~~lKL~DFGla~ 174 (558)
..++ ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 23589999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3e-06 Score=97.57 Aligned_cols=207 Identities=18% Similarity=0.219 Sum_probs=141.3
Q ss_pred HHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 008644 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145 (558)
Q Consensus 67 ~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~ 145 (558)
.....|+..+..++|+|++.++.+-+..-... -.+.+..++|.+ ++...+..-+.++.+..+.+..++++||.|+|+.
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34456777788999999999888765432211 123345577775 8888888888999999999999999999999999
Q ss_pred CceecCCCCC---cEEeCCCCcEEEe--ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHH
Q 008644 146 NVFHRDLKPK---NILANADCKLKIC--DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (558)
Q Consensus 146 gIiHrDIKP~---NILl~~~~~lKL~--DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~i 220 (558)
...|.-|.-+ +-..+..+.+.++ ||+.......... ......+..+.++|.+...........|+|++|..
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 7666655554 4445556666666 8887655432221 12234455677888876522222334699999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCH-HHHHHHHHhccc
Q 008644 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAF 299 (558)
Q Consensus 221 l~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~Li~~mL~~ 299 (558)
+..+..|..+-..... +.. ..+..+. ...+++.+|+.-
T Consensus 382 ~~~~~~~~~i~~~~~~------~~~-----------------------------------~l~~~~~~~~~d~~~~~~~~ 420 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------PVS-----------------------------------LLDVLSTSELLDALPKCLDE 420 (1351)
T ss_pred HhhhhhcCcccccccc------hhh-----------------------------------hhccccchhhhhhhhhhcch
Confidence 9999888754211100 000 0011111 567889999999
Q ss_pred CCCCCCCHHHHhcCccccCc
Q 008644 300 EPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 300 dP~~Rpta~elL~hp~f~~~ 319 (558)
|+++|+++.++|.|+|.+--
T Consensus 421 ~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 421 DSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhccchhhhhhchhcccc
Confidence 99999999999999998753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=79.53 Aligned_cols=132 Identities=18% Similarity=0.178 Sum_probs=78.2
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~~~~~~~~~~~~lV~ 106 (558)
..||.|..+.||+. .|..+++|..... .....+.+|.++|+.+..-.+ .+.+++... ....++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeee
Confidence 57899999999984 3567888887532 234457899999998864433 444444422 22467899
Q ss_pred ecCccc--HHHHH---------------------HhC--CCCCHHH-HHHHHHH----------HHH-HHHHHH----hC
Q 008644 107 ELMESD--LHQVI---------------------KAN--DDLTPEH-YQFFLYQ----------LLR-GLKYIH----TA 145 (558)
Q Consensus 107 E~~~g~--L~~~i---------------------~~~--~~l~e~~-~~~i~~Q----------Il~-aL~yLH----s~ 145 (558)
|+++|. +...+ ..- ....... ...+..+ +.. ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 000 0111111 0111100 111 112222 12
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 468999999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.3e-07 Score=97.80 Aligned_cols=243 Identities=16% Similarity=0.130 Sum_probs=160.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn-Iv~l~~i~~~~~~~~~~~~ 102 (558)
.|....-.++|+++++++.+...+...+ .+++... ..+.-++++|.+++||| .+..++ +.+...+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCccccc
Confidence 3444555789999999999887776655 6666421 33445889999999999 443333 33445578
Q ss_pred EEEEecCccc--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELMESD--LHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~g~--L~~~i~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+++++++++. ....+. +.-.+.+-+...+.+.-+++|+++|+.-=+|+| ||+..+ +..|+.||+........
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999853 211111 111244445556777778899999998778998 776554 67999999988765443
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC-HHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS-PEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~-~~~i~~~ 258 (558)
. ......+|+.++|||+... ..+....|.|++|+--.+|.-|-+|-... .... -..|... ...
T Consensus 385 ~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~----~~~g~~p~s~~---- 448 (829)
T KOG0576|consen 385 M----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVL----PMIGNGPNSPM---- 448 (829)
T ss_pred c----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCC--cccc----CCCCCCCCccc----
Confidence 3 2356789999999999877 57888999999998777777777664320 0000 0000000 000
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+. ....+...+. .++...|+..-|..|++..+++-|.+|++-
T Consensus 449 -----------L~--~~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 449 -----------LT--DKSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred -----------cc--hhhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00 0011111111 247778999999999999999999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=75.32 Aligned_cols=130 Identities=20% Similarity=0.263 Sum_probs=92.9
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~l 104 (558)
-++.+.|++|.+|.||++. ..|..+|+|+=.. .+....+..|.++|..++-.++..=.-.+ . ..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y-g-------~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY-G-------EDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe-c-------hhhh
Confidence 4567889999999999994 5677999997542 24556788999999999877665433322 1 2356
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEeCCCCcEEEeeccccee
Q 008644 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK-P~NILl~~~~~lKL~DFGla~~ 175 (558)
.|||+.| .|..+-... + +.-+..++++.--|-..||-|+.|. |..++|..++++.|+||..|++
T Consensus 90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6999998 666554321 2 2334566777666888999999997 5545555555999999998874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.4e-05 Score=87.47 Aligned_cols=149 Identities=22% Similarity=0.312 Sum_probs=90.2
Q ss_pred cccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc----------------------cCC------hh
Q 008644 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI----------------------FEH------VS 64 (558)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~----------------------~~~------~~ 64 (558)
.+.|++|+. +.|+.++-|.||.|.-+ +|+.||||+.+-- ... ..
T Consensus 122 ee~F~eF~~-------~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~ 193 (517)
T COG0661 122 EELFSEFEP-------EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE 193 (517)
T ss_pred HHHHHHcCC-------CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence 445667665 67999999999999865 4999999987411 000 00
Q ss_pred ----HHHH------HHHHHHHHHhcC----CCCccccceeecCCCcCCCccEEEEEecCcc-cHHHH--HHhCCCCCHHH
Q 008644 65 ----DATR------ILREIKLLRLLR----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLTPEH 127 (558)
Q Consensus 65 ----~~~~------i~~Ei~iL~~l~----HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~--i~~~~~l~e~~ 127 (558)
-.+. +.+|...+..++ +..-+.+-.+|..-+ ..-.|+|||++| .+.+. ++. ..++...
T Consensus 194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ 268 (517)
T COG0661 194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKE 268 (517)
T ss_pred HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHH
Confidence 0011 234444444332 222233333442211 235899999998 45444 444 3355333
Q ss_pred HHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 128 ~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+...+.++. +..+=..|++|.|..|.||+++.+|++.+.|||+....
T Consensus 269 ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 269 LAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 332222221 12233389999999999999999999999999988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=9.8e-05 Score=70.97 Aligned_cols=133 Identities=26% Similarity=0.306 Sum_probs=91.4
Q ss_pred CCcEEEEeEeeccCc-eEEEEEEECCCCcEEEEEEeCC-----------ccCC-h-------hHHHHHHHHHHHHHhc--
Q 008644 22 GSRYKIEEVIGKGSY-GVVCSAYDTRTGEKVAIKKIND-----------IFEH-V-------SDATRILREIKLLRLL-- 79 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~-----------~~~~-~-------~~~~~i~~Ei~iL~~l-- 79 (558)
+..++.++.||.|.- |.||++ ...|..||||.+.. .+.. . .....|..|.+..-+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv--~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKV--EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEE--EECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 389999999999999 999999 45788999999421 0000 0 1223466777765555
Q ss_pred -CCCCc--cccceeecCCC-------------cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 008644 80 -RHPDI--VEIKHILLPPS-------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143 (558)
Q Consensus 80 -~HpnI--v~l~~i~~~~~-------------~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH 143 (558)
.+.++ |++++.+.-.. ........||.||+...- .++. .-+.+|++-|..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHH
Confidence 45666 88888764321 011123467888776432 1222 23567888899999
Q ss_pred hCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 144 TANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 144 s~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 4589999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=72.09 Aligned_cols=71 Identities=14% Similarity=0.087 Sum_probs=45.1
Q ss_pred eEeeccCc-eEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEE
Q 008644 29 EVIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 29 ~~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
+.|..|.+ ..||++.. .+..++||...... ...+.+|+.+|+.+. +--+.+++...... ..-++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEE
Confidence 34555666 68898853 34688888765321 345678999998885 32233445444221 2468999
Q ss_pred ecCcc
Q 008644 107 ELMES 111 (558)
Q Consensus 107 E~~~g 111 (558)
++++|
T Consensus 72 e~i~G 76 (244)
T cd05150 72 SAVPG 76 (244)
T ss_pred EeeCC
Confidence 99987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=83.93 Aligned_cols=146 Identities=16% Similarity=0.284 Sum_probs=88.6
Q ss_pred EEeEeeccCceEEEEEEECCCC--cEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCcc
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTG--EKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKD 101 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg--~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnI--v~l~~i~~~~~~~~~~~ 101 (558)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.|. |.++ .+++..+.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3677899999999998655432 478888764321 1123456889999999996 6665 5555554332 12235
Q ss_pred EEEEEecCcccH-H--------------------HHHH---hCC----C---------CCHHHHHHHHHH----------
Q 008644 102 IYVVFELMESDL-H--------------------QVIK---AND----D---------LTPEHYQFFLYQ---------- 134 (558)
Q Consensus 102 ~~lV~E~~~g~L-~--------------------~~i~---~~~----~---------l~e~~~~~i~~Q---------- 134 (558)
.|+|||+++|.. . +.+. .-. . +-...+..|..+
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998742 1 0111 100 0 111233332222
Q ss_pred -----HHHHHHHHHh-----------CCceecCCCCCcEEeCCC-Cc-EEEeeccccee
Q 008644 135 -----LLRGLKYIHT-----------ANVFHRDLKPKNILANAD-CK-LKICDFGLARV 175 (558)
Q Consensus 135 -----Il~aL~yLHs-----------~gIiHrDIKP~NILl~~~-~~-lKL~DFGla~~ 175 (558)
+...+.+|.. ..++|+|+++.|||++.+ +. .-|.||+++..
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233556632 249999999999999853 33 57999999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=72.07 Aligned_cols=30 Identities=33% Similarity=0.482 Sum_probs=25.5
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+++|+|+.+.|||++.+...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876656799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00071 Score=65.27 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=89.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCcc--------------CChhHHHHHHHHHHHHHhcC------CCCccccc
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 88 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--------------~~~~~~~~i~~Ei~iL~~l~------HpnIv~l~ 88 (558)
..||+|+.-.||.- . ......||++.... ..........+|+.....+. +..|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999888854 3 34556888876432 11123566778888877776 77888999
Q ss_pred eeecCCCcCCCccEEEEEecCc---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC
Q 008644 89 HILLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~---g----~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~ 161 (558)
|...+. ....+|+|.+. | +|.+++... .+++ .+. ..|-+-.+||-..+|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 987443 35788998864 3 688888554 4666 333 33444567889999999999999999865
Q ss_pred CC----cEEEee
Q 008644 162 DC----KLKICD 169 (558)
Q Consensus 162 ~~----~lKL~D 169 (558)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 578888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00032 Score=75.21 Aligned_cols=176 Identities=26% Similarity=0.359 Sum_probs=118.6
Q ss_pred HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008644 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144 (558)
Q Consensus 65 ~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs 144 (558)
....++-...+|+.+.|+|...++++.-... ....+|+|+++.+|.+..+.+. +-.... + .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~-------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESL-------L-------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhh-------c-------c
Confidence 3456777789999999999999888664322 2388999999999999987764 211111 1 2
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHH
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eL 224 (558)
+|+.|- || ++++| -++ +. | |- ...+++||||+|.|+.++
T Consensus 86 ~~~~~~-----~~-------~~~td-~~~-------------t~------~--~~-------~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLHL-----NI-------IYITD-HFL-------------TK------Y--PS-------PIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccccee-----hh-------hhccc-ccc-------------cc------C--CC-------CCCcchhhhhHHHHHHHH
Confidence 222222 22 23333 110 00 0 11 122599999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 008644 225 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 304 (558)
Q Consensus 225 ltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R 304 (558)
..|...|......+++..|.++...+....+-..-. ..+ -.++....+++.+|+-..|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~----------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQ----------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHH----------------HhhhHhHHHHhccCCccccccc
Confidence 999999998888888888887765554332221111 000 1245667889999999999999
Q ss_pred CCHHHHhcCccccCc
Q 008644 305 PTAEEALADPYFKGL 319 (558)
Q Consensus 305 pta~elL~hp~f~~~ 319 (558)
|...++..++-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00021 Score=68.37 Aligned_cols=98 Identities=22% Similarity=0.202 Sum_probs=77.7
Q ss_pred HHHHHHHHhcCC-CCccccceeecCCCcCCCccEEEEEecCc-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008644 70 LREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT 144 (558)
Q Consensus 70 ~~Ei~iL~~l~H-pnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~---i~~~~~l~e~~~~~i~~QIl~aL~yLHs 144 (558)
..|.-+|+.+++ +++.+++|.| +-++|.||.+ +.+... +..-...++.....|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999986 6899999998 3467888888 444321 1111236799999999999999999987
Q ss_pred ---CCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 145 ---ANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 145 ---~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+.-.|++++|+-+++++++|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35788999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00075 Score=74.01 Aligned_cols=140 Identities=25% Similarity=0.302 Sum_probs=84.7
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-----------------------------hHHHHH------HHHH
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----------------------------SDATRI------LREI 73 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----------------------------~~~~~i------~~Ei 73 (558)
+.||.-+.|.|++|+.+. |+.||||+-+...... .-...+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998766 9999999854211110 001112 2333
Q ss_pred HHHH----hcCCCCc---cccceeecCCCcCCCccEEEEEecCcc----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 008644 74 KLLR----LLRHPDI---VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142 (558)
Q Consensus 74 ~iL~----~l~HpnI---v~l~~i~~~~~~~~~~~~~lV~E~~~g----~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yL 142 (558)
+... .++|-+. |.+-.++..-+ ..-.|+||||+| || +.|.+++ ++...+..-+.+... .-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~~l~~~~~--~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILNKLVEAYL--EQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHHHHHHHHH--HHH
Confidence 3222 2234441 22333332221 246899999997 45 5555553 555543332222222 223
Q ss_pred HhCCceecCCCCCcEEeCC----CCcEEEeecccceecc
Q 008644 143 HTANVFHRDLKPKNILANA----DCKLKICDFGLARVAF 177 (558)
Q Consensus 143 Hs~gIiHrDIKP~NILl~~----~~~lKL~DFGla~~~~ 177 (558)
=..|++|+|=.|.||+++. ++.+.+-|||+.....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3568999999999999994 6789999999987643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=4.8e-05 Score=89.68 Aligned_cols=154 Identities=18% Similarity=0.122 Sum_probs=114.4
Q ss_pred HHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh
Q 008644 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHT 144 (558)
Q Consensus 70 ~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----~l~e~~~~~i~~QIl~aL~yLHs 144 (558)
..|...++...|+++.....-..+. +....|.+++|+. |+++..|.++- .+.+.-+.....+.+.+..-+|+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 3455556667899987665544332 2345789999998 69999887642 34444454444554777888775
Q ss_pred C-C----ceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHH
Q 008644 145 A-N----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (558)
Q Consensus 145 ~-g----IiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~ 219 (558)
. + .+|++||+-|.+|..+..+|++++|+.+.... ...+....++++.|+++++... -.++.++|+|..||
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHH
Confidence 4 2 58999999999999999999999999984322 2234456778889999998766 57778899999999
Q ss_pred HHHHHHhCCCCC
Q 008644 220 IFAELLTGKPLF 231 (558)
Q Consensus 220 il~eLltG~~pF 231 (558)
-+|++..|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999999988777
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00071 Score=69.74 Aligned_cols=153 Identities=16% Similarity=0.128 Sum_probs=87.1
Q ss_pred cccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC--ccccceeec
Q 008644 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILL 92 (558)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~~ 92 (558)
++..|+++ ...-++.|+.|....+|++.. ++..+++|+.... .....+..|+.+++.|.... +.+++...-
T Consensus 15 ~l~~y~~~-~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 15 FLDGYDLG-ELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHhcCCC-CceeccccCCccccceEEEEe--CCCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 45566663 455577888888889998853 3446888976531 12345667888888885433 233322110
Q ss_pred CC-CcCCCccEEEEEecCccc-H-----H------HHH---H-hCCCCCH-------HHHH----------------HHH
Q 008644 93 PP-SRREFKDIYVVFELMESD-L-----H------QVI---K-ANDDLTP-------EHYQ----------------FFL 132 (558)
Q Consensus 93 ~~-~~~~~~~~~lV~E~~~g~-L-----~------~~i---~-~~~~l~e-------~~~~----------------~i~ 132 (558)
.. .....+..++++++++|. + . ..+ . ....++. ...+ ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 00 001124578999998761 1 1 011 0 0011100 0000 001
Q ss_pred HHHHHHHHHHHh-------CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 133 YQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 133 ~QIl~aL~yLHs-------~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+..+++++.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123334555542 589999999999999998877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0016 Score=64.15 Aligned_cols=72 Identities=10% Similarity=0.171 Sum_probs=44.7
Q ss_pred EeEeeccCceEEEEEEECC-CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVV 105 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~~~~~~~~~lV 105 (558)
++.|..|-...+|++.... .++.|++|+.... . .......+|+.+++.+...+++ +++..+ . -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~--~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-------~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK--T-ELIIDRERELRIHKLLSKHGLAPKLYATF--Q-------NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC--c-cceecHHHHHHHHHHHHhCCCCCeEEEEe--C-------CcEE
Confidence 4667888899999985433 3578999976531 1 1112234799999988654443 333221 1 1379
Q ss_pred EecCcc
Q 008644 106 FELMES 111 (558)
Q Consensus 106 ~E~~~g 111 (558)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0014 Score=67.69 Aligned_cols=151 Identities=17% Similarity=0.146 Sum_probs=79.7
Q ss_pred cccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
+...|+.+ .-.-++.|+.|....+|.+.. ++..+++|++.. .....+..|+.+++.|...++. +-.++...
T Consensus 15 ~l~~y~~~-~~~~~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~-----~~~~~l~~~~~~l~~L~~~glp-vP~~i~~~ 85 (319)
T PRK05231 15 FLAPYDLG-ELLSLKGIAEGIENSNFFLTT--TQGEYVLTLFER-----LTAEDLPFFLGLMQHLAARGVP-VPAPVARR 85 (319)
T ss_pred HHHhcCCc-hhhccchhccccccceEEEEe--CCCcEEEEEecc-----CChHHhHHHHHHHHHHHHCCCC-CCcceeCC
Confidence 34456664 333346677888889998853 334789998751 1234455567777776433321 11111111
Q ss_pred Cc----CCCccEEEEEecCccc-H--------H---HHHH----hCCCC--------C--H-HH-HH-----------HH
Q 008644 95 SR----REFKDIYVVFELMESD-L--------H---QVIK----ANDDL--------T--P-EH-YQ-----------FF 131 (558)
Q Consensus 95 ~~----~~~~~~~lV~E~~~g~-L--------~---~~i~----~~~~l--------~--e-~~-~~-----------~i 131 (558)
+. ...+..++++++++|. + . +.+. ....+ . . .. .. ..
T Consensus 86 ~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (319)
T PRK05231 86 DGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAAL 165 (319)
T ss_pred CCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHH
Confidence 10 1123478999998863 1 1 1110 00011 0 0 00 00 11
Q ss_pred HHHHH-HHHHHHH-------hCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 132 LYQLL-RGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 132 ~~QIl-~aL~yLH-------s~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
+.+.+ ..+..+. ..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 166 l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 166 LEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11111 1122222 2389999999999999976656899999764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0011 Score=67.71 Aligned_cols=151 Identities=17% Similarity=0.075 Sum_probs=85.4
Q ss_pred ccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC--ccccceeecC
Q 008644 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLP 93 (558)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~~~ 93 (558)
+..|+.++ ..-++.|..|....+|++.. .+..+++|+... .....+..|+.+++.|.+-+ +.+++...-.
T Consensus 8 l~~y~~~~-~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g 79 (296)
T cd05153 8 LADYDLGE-LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDG 79 (296)
T ss_pred HHHcCCCc-hhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCC
Confidence 34566533 23356788888889998843 445799998753 23455778899888886433 3333221100
Q ss_pred CC-cCCCccEEEEEecCcc-cH--------HHHHH-------hCCCC----------CH--HHHH--------HHHHHHH
Q 008644 94 PS-RREFKDIYVVFELMES-DL--------HQVIK-------ANDDL----------TP--EHYQ--------FFLYQLL 136 (558)
Q Consensus 94 ~~-~~~~~~~~lV~E~~~g-~L--------~~~i~-------~~~~l----------~e--~~~~--------~i~~QIl 136 (558)
.. ....+..++|+++++| .+ ..+.+ ....+ .+ .... .....+.
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 00 0112356899999986 21 01100 00000 00 0000 0111123
Q ss_pred HHHHHHHh-------CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 137 RGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 137 ~aL~yLHs-------~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 34444443 479999999999999998778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0045 Score=66.04 Aligned_cols=77 Identities=21% Similarity=0.185 Sum_probs=51.6
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCc----cC-ChhHHHHHHHHHHHHHhcC-C--CCccccceeecCCCcCCC
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI----FE-HVSDATRILREIKLLRLLR-H--PDIVEIKHILLPPSRREF 99 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~----~~-~~~~~~~i~~Ei~iL~~l~-H--pnIv~l~~i~~~~~~~~~ 99 (558)
.+.||.|.+..||++.+...++.|+||.-... .. ......+...|...|+.+. + ..+.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~----- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E----- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-----
Confidence 46789999999999988654468999985311 01 1234567788999998764 2 3345555432 1
Q ss_pred ccEEEEEecCcc
Q 008644 100 KDIYVVFELMES 111 (558)
Q Consensus 100 ~~~~lV~E~~~g 111 (558)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 236899999874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0012 Score=66.11 Aligned_cols=131 Identities=15% Similarity=0.229 Sum_probs=74.0
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEEec
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVFEL 108 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~~~~~~~~~lV~E~ 108 (558)
.+..|-.+.+|+.. .++..+++|......... .....+|..+|+.+..-.++ +++... . -++|+|+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEe
Confidence 35568888999885 567789998754321110 01246799999988654443 222221 1 2689999
Q ss_pred Ccc-cHH--------------HHHHh---C----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCce
Q 008644 109 MES-DLH--------------QVIKA---N----DDLTP-EHYQFFLYQL---------LRGLKYIHT--------ANVF 148 (558)
Q Consensus 109 ~~g-~L~--------------~~i~~---~----~~l~e-~~~~~i~~QI---------l~aL~yLHs--------~gIi 148 (558)
++| .+. +.+.+ . ..++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 986 221 11111 0 01121 1222222222 111222221 2489
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccce
Q 008644 149 HRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 149 HrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
|+|+.|.||+++.++ +.|+||+.|.
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccC
Confidence 999999999999877 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0022 Score=66.47 Aligned_cols=141 Identities=24% Similarity=0.297 Sum_probs=96.4
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc---cC-------------------ChhHHHH--HHHHHHHHHhcC
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI---FE-------------------HVSDATR--ILREIKLLRLLR 80 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~---~~-------------------~~~~~~~--i~~Ei~iL~~l~ 80 (558)
-+|...|..|--+.||.|. ...|..+|||+++.. |. ++...-+ ...|++-|.+|.
T Consensus 146 ~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 4566778899999999986 456888999987421 11 1111112 346777787776
Q ss_pred CCCccccceeecCCCcCCCccEEEEEecCcccHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEE
Q 008644 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNIL 158 (558)
Q Consensus 81 HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g~L~~~-i~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~gIiHrDIKP~NIL 158 (558)
.-.|.-..-+.+ +.-.|||++++++=+-. ..+.-.++...+..+-.|++.-+.-| |.+++||.||.--|+|
T Consensus 225 ~aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 225 NAGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred hcCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 555443333332 23479999998532221 12233578888888888888888877 5789999999999999
Q ss_pred eCCCCcEEEeecccce
Q 008644 159 ANADCKLKICDFGLAR 174 (558)
Q Consensus 159 l~~~~~lKL~DFGla~ 174 (558)
+. +|.+.|+|-+.+.
T Consensus 298 yh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSV 312 (520)
T ss_pred EE-CCEEEEEEccccc
Confidence 86 5689999998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0074 Score=62.06 Aligned_cols=80 Identities=13% Similarity=0.130 Sum_probs=53.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCC---CccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP---DIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hp---nIv~l~~i~~~~~~~~~~ 100 (558)
.-.-.+.||.|..+.||...+ .+..+++|..+. ......+.+|...|+.|... .+.++++++.... ..+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCC
Confidence 344567899999999999843 233577777432 11235788999999988642 4566666553321 123
Q ss_pred cEEEEEecCcc
Q 008644 101 DIYVVFELMES 111 (558)
Q Consensus 101 ~~~lV~E~~~g 111 (558)
.-++|||+++|
T Consensus 87 ~~~LVmE~i~G 97 (297)
T PRK10593 87 PDVLLLERLRG 97 (297)
T ss_pred CeEEEEeccCC
Confidence 47999999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0035 Score=64.26 Aligned_cols=72 Identities=17% Similarity=0.137 Sum_probs=43.8
Q ss_pred EeEeeccCceEEEEEEECC------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCc
Q 008644 28 EEVIGKGSYGVVCSAYDTR------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFK 100 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~~~~~~ 100 (558)
++.|..|-...||++.... +++.+++|+..... .......+|+.+++.+....+. +++..+ . .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~----- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIF-P-N----- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEe-C-C-----
Confidence 4556668888899886433 26789999865321 1223456788888888644433 333333 1 1
Q ss_pred cEEEEEecCcc
Q 008644 101 DIYVVFELMES 111 (558)
Q Consensus 101 ~~~lV~E~~~g 111 (558)
.+|+++++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 247777765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0096 Score=61.52 Aligned_cols=146 Identities=18% Similarity=0.187 Sum_probs=84.2
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCcc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKD 101 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~~~~~~~~~~ 101 (558)
.-.+++.+..|....+|...+. ++++++. ...............+|+.+|+.+.--.+ ...++++.... ...
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~ 99 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGT 99 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCC
Confidence 3455666655655566766544 8889988 33222333456667788888887753222 22333332222 346
Q ss_pred EEEEEecCcc-cHH----------HHHH--------h-------C-------CCCCHHHHHHHHHHH-------------
Q 008644 102 IYVVFELMES-DLH----------QVIK--------A-------N-------DDLTPEHYQFFLYQL------------- 135 (558)
Q Consensus 102 ~~lV~E~~~g-~L~----------~~i~--------~-------~-------~~l~e~~~~~i~~QI------------- 135 (558)
.|.||++++| .+. +++. . . +.+...++..+..+.
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 7999999987 211 1111 0 0 001111222222222
Q ss_pred -HHHHHHHHhC--------CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 136 -LRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 136 -l~aL~yLHs~--------gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..-..+|+.+ .++|+|+.+.||+++..+.+=|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1223444432 389999999999999999999999999865
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00083 Score=68.49 Aligned_cols=137 Identities=19% Similarity=0.236 Sum_probs=92.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeC-------Ccc-----------CChhHHH--HHHHHHHHHHhcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-------DIF-----------EHVSDAT--RILREIKLLRLLRH 81 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~-------~~~-----------~~~~~~~--~i~~Ei~iL~~l~H 81 (558)
+.-|.+.++||-|--+-||.+-+. .|+..++|.=. ... ....... ...+|...|+.|..
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred chhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 345778899999999999999754 57888888521 000 0011111 24578888887753
Q ss_pred CC--ccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 008644 82 PD--IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (558)
Q Consensus 82 pn--Iv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NIL 158 (558)
.. +.+.++ ...-++|||++.| .|.++-.-. .+..+...+..-+.-|...|+||+|..-=||+
T Consensus 170 ~gfpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 170 RGFPVPKPID---------HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred cCCCCCCccc---------ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 22 222222 2246899999987 555543221 12344556666677889999999999999999
Q ss_pred eCCCCcEEEeecccce
Q 008644 159 ANADCKLKICDFGLAR 174 (558)
Q Consensus 159 l~~~~~lKL~DFGla~ 174 (558)
+.+++.++++||-...
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999997654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.014 Score=60.21 Aligned_cols=29 Identities=17% Similarity=0.139 Sum_probs=27.1
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
+++|+|+.+.|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0076 Score=61.29 Aligned_cols=30 Identities=33% Similarity=0.570 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEeCCCCc-EEEeeccccee
Q 008644 146 NVFHRDLKPKNILANADCK-LKICDFGLARV 175 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~-lKL~DFGla~~ 175 (558)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.021 Score=58.51 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.3
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.044 Score=57.56 Aligned_cols=82 Identities=18% Similarity=0.183 Sum_probs=52.5
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeC---Cc--cCChhHHHHHHHHHHHHHhcC--CCCcc-ccceeecCCCcCCCcc
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN---DI--FEHVSDATRILREIKLLRLLR--HPDIV-EIKHILLPPSRREFKD 101 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~---~~--~~~~~~~~~i~~Ei~iL~~l~--HpnIv-~l~~i~~~~~~~~~~~ 101 (558)
.||-|.-..||++.+...++.|+||.-. +. ....-...+...|...|+... .|..+ +++. | ++ ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~-----e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DT-----EM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-cc-----cc
Confidence 4799999999999976444689999743 11 123456677778999987764 34433 3333 2 11 23
Q ss_pred EEEEEecCcc--cHHHHHH
Q 008644 102 IYVVFELMES--DLHQVIK 118 (558)
Q Consensus 102 ~~lV~E~~~g--~L~~~i~ 118 (558)
..+|||+++. .|...+.
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 5689999863 4545443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.036 Score=58.88 Aligned_cols=91 Identities=21% Similarity=0.245 Sum_probs=58.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeC---Cc-cCChhHHHHHHHHHHHHHhcC--CCCccc-cceeec
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DI-FEHVSDATRILREIKLLRLLR--HPDIVE-IKHILL 92 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~---~~-~~~~~~~~~i~~Ei~iL~~l~--HpnIv~-l~~i~~ 92 (558)
...+.+. .+.||-|.-.-||++.+...++.|+||.-. +. ....-...+...|...|+.+. .|..|+ ++. +
T Consensus 27 ~~~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~- 103 (409)
T PRK12396 27 EHAKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F- 103 (409)
T ss_pred CCcccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-
Confidence 3444455 677899999999999885446789999742 11 123456778888999998764 454443 333 2
Q ss_pred CCCcCCCccEEEEEecCcc--cHHHHHH
Q 008644 93 PPSRREFKDIYVVFELMES--DLHQVIK 118 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~g--~L~~~i~ 118 (558)
++ ....+|||+++. .|...+.
T Consensus 104 D~-----e~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 104 DS-----VMNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred Cc-----HHhhHHHHhCcccHHHHHHHH
Confidence 11 235788988863 4555443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.065 Score=56.27 Aligned_cols=141 Identities=13% Similarity=0.131 Sum_probs=78.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECC----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~ 95 (558)
..+...+. .|..|-...+|++.... +++.|++|+..... ..... -.+|..+++.+..-++. ++++.+. .
T Consensus 35 ~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~ 108 (344)
T PLN02236 35 DDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--N 108 (344)
T ss_pred CcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEEC--C
Confidence 34455555 45448888999985322 34789999875421 11112 25688998888654443 3444431 1
Q ss_pred cCCCccEEEEEecCcc-cHH-----------HH---HH---hCC----C-C-CHHHHHHHHHHHH---------------
Q 008644 96 RREFKDIYVVFELMES-DLH-----------QV---IK---AND----D-L-TPEHYQFFLYQLL--------------- 136 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~-----------~~---i~---~~~----~-l-~e~~~~~i~~QIl--------------- 136 (558)
..|.+|+++ .|. .+ +. ... . . -.+.+..++.++.
T Consensus 109 -------g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~ 181 (344)
T PLN02236 109 -------GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDS 181 (344)
T ss_pred -------ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHH
Confidence 146777764 221 11 11 000 0 1 1233333332221
Q ss_pred --HHHHHH----H----hCCceecCCCCCcEEeCC-CCcEEEeecccce
Q 008644 137 --RGLKYI----H----TANVFHRDLKPKNILANA-DCKLKICDFGLAR 174 (558)
Q Consensus 137 --~aL~yL----H----s~gIiHrDIKP~NILl~~-~~~lKL~DFGla~ 174 (558)
..+..| . ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 182 l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 182 LEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111112 1 225899999999999986 4689999998774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.11 Score=55.58 Aligned_cols=76 Identities=16% Similarity=0.123 Sum_probs=49.6
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc--C---ChhHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--E---HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~---~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~~~~~~ 98 (558)
..+.||-|....||++.+. +..++||.-.... . ......+...|+..|+.+. -..+.+++.+...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-----
Confidence 4678899999999999763 4579999754111 1 1124556667788887664 1355566665421
Q ss_pred CccEEEEEecCcc
Q 008644 99 FKDIYVVFELMES 111 (558)
Q Consensus 99 ~~~~~lV~E~~~g 111 (558)
.-+++||++++
T Consensus 109 --~~vlvME~L~~ 119 (418)
T PLN02756 109 --MALIGMRYLEP 119 (418)
T ss_pred --CCEEEEeecCC
Confidence 35788999975
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.1 Score=54.45 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=24.6
Q ss_pred ceecCCCCCcEEeCC-CCcEEEeecccce
Q 008644 147 VFHRDLKPKNILANA-DCKLKICDFGLAR 174 (558)
Q Consensus 147 IiHrDIKP~NILl~~-~~~lKL~DFGla~ 174 (558)
++|.|+.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 699999999999975 5789999999763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.15 Score=49.86 Aligned_cols=101 Identities=18% Similarity=0.207 Sum_probs=64.7
Q ss_pred cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCcc--cHHHHHHhCCCCCHH
Q 008644 49 EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPE 126 (558)
Q Consensus 49 ~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g--~L~~~i~~~~~l~e~ 126 (558)
....+|++....-. -...-+..+.+++.++. .|+++.. ++.-.+.+++|.|-. .+.
T Consensus 86 G~L~lKKi~slp~~-~~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------ 143 (308)
T PF07387_consen 86 GPLFLKKIRSLPCC-INDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------ 143 (308)
T ss_pred chhhhhhccCCCcc-cchhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch------------
Confidence 45567776532111 12234567788887654 4555542 122357899999863 111
Q ss_pred HHHHHHHHHHHHHHHHHh--CCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 127 HYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 127 ~~~~i~~QIl~aL~yLHs--~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..++..=+.+|.-.|+ .+.+|+|-.|+||+.++.|-+||.|-+.-
T Consensus 144 --~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 144 --SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1122222566788894 36899999999999999999999998743
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.1 Score=54.42 Aligned_cols=75 Identities=21% Similarity=0.324 Sum_probs=57.7
Q ss_pred CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+..+.|++|++-++.|.-.- .-..+++..|+.+.+..++-+..+ ..-|||+.-.||||+ +|.|-|+||-++|.
T Consensus 296 de~~y~yl~~kdhgt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CCceEEEEEEecCCceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 344578999998887654221 234667777888888777666644 679999999999999 99999999999985
Q ss_pred c
Q 008644 176 A 176 (558)
Q Consensus 176 ~ 176 (558)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 4
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.8 Score=47.64 Aligned_cols=28 Identities=36% Similarity=0.387 Sum_probs=23.5
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999663
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.34 Score=51.64 Aligned_cols=28 Identities=32% Similarity=0.309 Sum_probs=23.3
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
...+|.|+-+.|||.++ +.++++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 35799999999999765 45999999866
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.67 Score=55.72 Aligned_cols=31 Identities=42% Similarity=0.574 Sum_probs=26.4
Q ss_pred CCceecCCCCCcEEeCCCC--cEE-Eeeccccee
Q 008644 145 ANVFHRDLKPKNILANADC--KLK-ICDFGLARV 175 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~--~lK-L~DFGla~~ 175 (558)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.59 Score=47.81 Aligned_cols=75 Identities=16% Similarity=0.184 Sum_probs=43.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC--CC-CccccceeecCCCcCCCc
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HP-DIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~--Hp-nIv~l~~i~~~~~~~~~~ 100 (558)
..+-.+.|+-|....+|... .+++.+.||+-.. .....+..|..-|+.|. .+ .+.+.+.+....+
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~----- 85 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD----- 85 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----
Confidence 34556788989999999985 7788999998652 23345677888888884 22 2445555442221
Q ss_pred cEEEEEecCc
Q 008644 101 DIYVVFELME 110 (558)
Q Consensus 101 ~~~lV~E~~~ 110 (558)
.-|+|||+++
T Consensus 86 ~~fLlle~l~ 95 (288)
T PF03881_consen 86 DAFLLLEFLE 95 (288)
T ss_dssp CCEEEEE---
T ss_pred CceEEEEeec
Confidence 3489999987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.57 E-value=0.9 Score=49.42 Aligned_cols=27 Identities=33% Similarity=0.701 Sum_probs=23.1
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
.++|.|+.+.|||.+.++ ++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccc
Confidence 479999999999987554 999999866
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.24 E-value=0.15 Score=52.41 Aligned_cols=135 Identities=21% Similarity=0.288 Sum_probs=88.6
Q ss_pred EEeEeeccCceEEEEEEE-------C---CCCcEEEEEEeCC---cc-------------C------ChhHHHHHH--HH
Q 008644 27 IEEVIGKGSYGVVCSAYD-------T---RTGEKVAIKKIND---IF-------------E------HVSDATRIL--RE 72 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d-------~---~tg~~vAiK~i~~---~~-------------~------~~~~~~~i~--~E 72 (558)
|..+|..|.-++|+-|+- . ..-..+|||+++. .| . +....-++. +|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 446788899999988742 1 1234688987741 11 1 112222233 44
Q ss_pred HHHHHhcC-----CCCccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhC
Q 008644 73 IKLLRLLR-----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTA 145 (558)
Q Consensus 73 i~iL~~l~-----HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~ 145 (558)
+.-|.+++ +|.+|.+.. -.|||.+++. .+..=-.++-.|+.++.+..-.|++.++.-| |..
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec 403 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC 403 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence 44454443 566666543 3589999874 2221112233588889999999999998887 678
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
-++|-||.--|||...+ ++.++|...+.
T Consensus 404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 404 LLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred heeecchhhhhheecCC-ceEEEechhcc
Confidence 89999999999999876 89999987653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.35 E-value=0.18 Score=52.24 Aligned_cols=75 Identities=25% Similarity=0.301 Sum_probs=45.7
Q ss_pred EEEEEecCccc-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCCCCcEEeCCCC---------
Q 008644 102 IYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH----TANVFHRDLKPKNILANADC--------- 163 (558)
Q Consensus 102 ~~lV~E~~~g~-----L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH----s~gIiHrDIKP~NILl~~~~--------- 163 (558)
-.+|+.+..++ +....+.+-..-.+-+++++.||+.-.--+- -.+.+|-||||+||||-+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 35788876542 2222211111234567888888876432232 34689999999999975432
Q ss_pred ---------cEEEeecccceec
Q 008644 164 ---------KLKICDFGLARVA 176 (558)
Q Consensus 164 ---------~lKL~DFGla~~~ 176 (558)
..+|.||.++++.
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 2577788887664
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.62 E-value=0.37 Score=48.82 Aligned_cols=45 Identities=29% Similarity=0.366 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHHHhC--CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 131 FLYQLLRGLKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 131 i~~QIl~aL~yLHs~--gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+..+-.++.-+|.. -++|+|+.|.|+|.++.+.++|+||.-|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 444444455555544 479999999999999999999999987743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 558 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-86 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-86 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-81 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-81 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-81 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-81 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-81 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-81 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-81 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-81 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-81 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-81 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-81 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-81 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-80 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-80 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-80 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-79 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-79 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-79 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-79 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-79 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-79 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-78 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-78 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-77 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-75 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-74 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-74 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-74 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-73 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-73 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-73 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-73 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-73 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-72 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-72 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-72 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-71 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-70 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-70 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-65 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-65 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-65 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-62 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-62 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-58 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-57 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-56 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-56 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-56 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-56 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-56 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-56 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-56 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-55 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-55 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-55 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-55 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-55 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-55 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-54 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-54 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-54 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-54 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-54 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-54 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-54 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-53 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-53 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-49 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-49 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-47 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-47 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-47 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-41 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-40 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-40 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-40 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-40 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-40 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-40 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-40 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-40 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-40 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-40 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-40 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-40 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-40 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-40 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-40 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-40 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-40 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-40 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-40 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-40 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-40 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-40 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-40 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-40 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-40 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-40 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-40 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-40 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-40 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-40 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-40 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-40 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-39 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-39 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-39 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-37 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-37 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-37 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-37 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-37 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-37 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-36 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-36 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-36 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-36 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-36 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-36 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-36 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-36 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-34 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-34 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-34 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-34 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-34 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-34 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-34 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-31 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-31 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-31 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-28 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-24 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-23 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-22 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-22 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-22 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-22 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-21 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-21 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-21 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-19 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-19 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-19 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-07 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 584 bits (1508), Expect = 0.0
Identities = 145/351 (41%), Positives = 217/351 (61%), Gaps = 13/351 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
Y S ++++ ++G+G+YGVVCSA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDY 189
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AEL +P+FPG++ HQL ++ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPEA-IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
P + + + + +AR Y+ S+ P + FP NP + LL+RML F+P R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEF--ERRRITKEDVRELIYREIL 357
EAL PY + EP +P+ FEF + +T +D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 584 bits (1508), Expect = 0.0
Identities = 164/361 (45%), Positives = 229/361 (63%), Gaps = 5/361 (1%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ + G RY IG+G+YG+VCSAYD +VAIKKI+ FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FE 64
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
H + R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ +LG+PS E + + N KAR YL S+ K +P+++ FPNA+ AL LL++ML F P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
R E+ALA PY + EP A+ +F+ E + KE ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 Q 362
Sbjct: 361 G 361
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 586 bits (1512), Expect = 0.0
Identities = 142/426 (33%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQPDQRKKSSADVDFFTEYGE---GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M S + +F Y I+ +IG+GSYG V AYD T + VAIKK+N
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI 117
+FE + D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
K LT EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 NDTPTAI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
++ T I T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAELLTG-----------KPLFPG-----------------KNVVHQLDIMTDLLGTP 250
CIFAELL PLFPG K+ QL+I+ +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ + + + + +Y+ +KPI QK+P+ + + LLE ML F P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEG 370
L PY K + K + E + + F+ + +++ +R + +E+ +HP+++ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 SEPTGF 376
F
Sbjct: 419 IHENNF 424
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 560 bits (1446), Expect = 0.0
Identities = 125/368 (33%), Positives = 185/368 (50%), Gaps = 21/368 (5%)
Query: 5 QRKKSSADVDFF-TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND----- 58
Q K +A D + S Y ++ I GSYG VC+ D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLH 114
I R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRL 292
+QL+ + +++GTP E + + AR YL +S+ ++ P A+P+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELI 352
+ +ML F P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 558 bits (1441), Expect = 0.0
Identities = 142/372 (38%), Positives = 217/372 (58%), Gaps = 13/372 (3%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + +V T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+
Sbjct: 6 PARSGFYRQEV-TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS 64
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAND 121
A R RE++LL+ +RH +++ + + P + +F D Y+V M +DL +++K
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++
Sbjct: 125 -LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T YV TRWYRAPE+ ++ +YT +DIWS+GCI AE++TGK LF G + + QL
Sbjct: 182 ----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ + GTP E + R+++++A+ Y+ + + + F+ NA+PLA+ LLE+ML +
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
+ R TA EALA PYF+ L E EP Q + F+ T ++ + + Y+E+L + P
Sbjct: 297 EQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDSFDDVDRTLDEWKRVTYKEVLSFKP 353
Query: 362 QMLKEFLEGSEP 373
E
Sbjct: 354 PRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 557 bits (1437), Expect = 0.0
Identities = 139/346 (40%), Positives = 205/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + Y +G G+YG VCSA D R+GEKVAIKK++ F+ A R RE+ LL
Sbjct: 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 77 RLLRHPDIVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQM 135
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GLKYIH+A V HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWY
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ S+ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P E +
Sbjct: 190 RAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ ++ A+ Y+ S+ + F+Q FP A+P A LLE+ML + R TA +AL P+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F+ E E AQ + E ++T ++ ++ IY+EI+ + P
Sbjct: 309 FEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 557 bits (1438), Expect = 0.0
Identities = 138/387 (35%), Positives = 216/387 (55%), Gaps = 43/387 (11%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
+Y++ + +GKG+YG+V + D RTGE VA+KKI D F++ +DA R REI +L L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +IV + ++L + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +K
Sbjct: 68 HENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIK 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------AFNDTPT 182
Y+H+ + HRD+KP NIL NA+C +K+ DFGL+R N
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 183 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 184 QPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF----------------PNA 285
+ ++ PS E + +++ A+ + S+++K I S K +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITK 345
N AL LL+++L F P R +A +AL P+ EP+ + + + + +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSI 360
Query: 346 EDVRELIYREILEYHPQMLKEFLEGSE 372
+D R L+Y EI +++ + +
Sbjct: 361 DDYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 554 bits (1430), Expect = 0.0
Identities = 148/373 (39%), Positives = 221/373 (59%), Gaps = 18/373 (4%)
Query: 1 MQPDQRKKSSADVDFF------TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
M S F+ T + RY+ +G G+YG VC+A+DT+TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDL 113
K++ F+ + A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ ++K LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R + T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
+ + QL ++ L+GTP E + ++ +E AR Y+ S+ + + F+ F ANPLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIY 353
E+ML + R TA +ALA YF + EP A P + E R + ++ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQMLKE 366
E++ + P L +
Sbjct: 350 DEVISFVPPPLDQ 362
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 556 bits (1434), Expect = 0.0
Identities = 149/417 (35%), Positives = 213/417 (51%), Gaps = 57/417 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
Q K +++ +++ RY+I +IG GSYG VC AYD VAIKKI +FE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
+ D RILREI +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA----- 176
LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAELLT-----------GKPLFPGKNVV--------------------HQLDIMTDL 246
GCIFAELL PLFPG + QL+++ ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
LGTPS E I + E A+RY+ K++ +++FP ++ A+ LL+RML F P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363
E LA P+FK + E E +A ++ F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 535 bits (1380), Expect = 0.0
Identities = 128/378 (33%), Positives = 204/378 (53%), Gaps = 27/378 (7%)
Query: 1 MQPDQRKKS---SADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M ++ + S ++ + + RY+ + IG G+ G+VC+AYD VAIKK++
Sbjct: 1 MGSRSKRDNNFYSVEI-GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS 59
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQV 116
F++ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QV
Sbjct: 60 RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176
I+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 120 IQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG +
Sbjct: 178 ----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA----------- 285
+ Q + + + LGTP PE + ++ R Y+ + K F + FP+
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 286 -NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRIT 344
A LL +ML + R + +EAL PY + P + + + R T
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP-KIPDKQLDEREHT 349
Query: 345 KEDVRELIYREILEYHPQ 362
E+ +ELIY+E+++
Sbjct: 350 IEEWKELIYKEVMDLEHH 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 133/400 (33%), Positives = 214/400 (53%), Gaps = 29/400 (7%)
Query: 1 MQPDQRKKSSADVDFFT-EYGE-----GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
+ KS D F++ E G+ RY+ + IG G+ G+VC+AYD VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDL 113
K++ F++ + A R RE+ L++ + H +I+ + ++ P + EF+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-------- 285
++ + Q + + + LGTP PE + ++ R Y+ + K + F + FP++
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 341
A LL +ML +P R + ++AL PY A P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSA 381
T E+ +ELIY+E++ + ++G ++
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS 423
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 523 bits (1350), Expect = 0.0
Identities = 125/315 (39%), Positives = 175/315 (55%), Gaps = 15/315 (4%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRY + +G G G+V SA D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
+IV++ IL P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ ++ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
E + + Y+ + + P +Q P + A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKVEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-168
Identities = 115/351 (32%), Positives = 176/351 (50%), Gaps = 27/351 (7%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E R+++E + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 81 HPDIVEIKHILLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 134
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 135 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKF----PNANPLALRLLERMLAFEPKDRPTA 307
E + ++ L K IP+S F A LL +L + P++R
Sbjct: 253 REVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 308 EEALADPYFKGLAKVERE-PSAQPVTKMEFEFERR--RITKEDVRELIYRE 355
EAL PYF L + P+ + + + F F + E + + R+
Sbjct: 310 YEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-153
Identities = 119/399 (29%), Positives = 195/399 (48%), Gaps = 33/399 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
+ + D T Y +VIG GS+GVV A + E VAIKK+
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV---- 72
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFKDIYVVFELMESDLHQVI-- 117
+ D RE++++R+++HP++V++K +++ + +V E + +++
Sbjct: 73 --LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH 130
Query: 118 --KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 174
K + + ++YQLLR L YIH+ + HRD+KP+N+L + LK+ DFG A+
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ P Y+ +R+YRAPEL G+ + YT IDIWS GC+ AEL+ G+PLFPG
Sbjct: 191 ILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRL 292
++ + QL + +LGTPS E I + + +P PFS+ F P P A+ L
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP---QIRPHPFSKVFRPRTPPDAIDL 301
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVE-REPSAQPVTKM-EFEFERRRITKEDVRE 350
+ R+L + P R TA EAL P+F L E R P+ + + + + E + + +
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISR 361
Query: 351 LIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQF 389
L+ H + + G + F P ++ K
Sbjct: 362 LVP-----QHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 441 bits (1135), Expect = e-152
Identities = 104/382 (27%), Positives = 178/382 (46%), Gaps = 67/382 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y + + +G GS+G+VC +D +G++ A+KK+ D RE+ ++++L H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHV 60
Query: 83 DIVEIKHIL---------------------------------LPPSRREFKDIYVVFELM 109
+I+++ + + + K + V+ E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 110 ESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCK 164
LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAE 223
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F E
Sbjct: 181 LKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFGE 234
Query: 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 283
L+ GKPLF G+ + QL + ++GTP+ E + R+ K + + P
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKILP 291
Query: 284 NANP-LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME------- 335
P LA+ LLE++L +EP R EA+A P+F L
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 336 --FEF---ERRRITKEDVRELI 352
F F E I + ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 429 bits (1104), Expect = e-147
Identities = 110/339 (32%), Positives = 170/339 (50%), Gaps = 25/339 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKHILLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRG 138
IV +++ +++ + +V + + +++V + A L + + ++YQL R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PEL G+ + YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + K P+++ F P P A+ L R+L + P R T EA A +
Sbjct: 283 EMNPNYTEFKFP---QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERR--RITKEDVRELI 352
F L + T F F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-137
Identities = 87/318 (27%), Positives = 153/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK 74
E+G Y++ +G+G Y V A + EKV +K + + +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PEA-IARVRNEKARRYLSSMRKKKPIPFSQKFPNAN-----PLALRLLERMLAFEPKDRP 305
I + E R+ + + + + + N P AL L+++L ++ + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKVE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-124
Identities = 104/309 (33%), Positives = 162/309 (52%), Gaps = 12/309 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H N HRD+KP+NIL +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G ++Y P +D+W+IGC+FAELL+G PL+PGK+ V QL ++ LG P
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ + + P KFPN + AL LL+ L +P +R T E+ L PYF+ + +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 322 VEREPSAQP 330
+E
Sbjct: 294 IEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-116
Identities = 96/296 (32%), Positives = 158/296 (53%), Gaps = 12/296 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
G KY A+D+W+IGC+ E+ G+PLFPG + + QL + LG P
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ K+ P +++P + + + L ++ L +P RP E L +F+
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-105
Identities = 99/309 (32%), Positives = 140/309 (45%), Gaps = 30/309 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-----LREIKLLR 77
SRY+ IG G+YG V A D +G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 78 LLR---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 132
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 252 PE---AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
+ + + + P P P +LL ML F P R +A
Sbjct: 240 EDDWPRDVSLPR-------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 309 EALADPYFK 317
AL Y
Sbjct: 293 RALQHSYLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-104
Identities = 123/325 (37%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
S+ + G +Y+ E +G+G+YGVV A D G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIR--LDAE 58
Query: 64 SDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-N 120
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
L + +LGTP+P + + K R + + + P+S P + LL M
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 LAFEPKDRPTAEEALADPYFKGLAK 321
L F+P R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-104
Identities = 112/328 (34%), Positives = 168/328 (51%), Gaps = 24/328 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARV 258
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E I
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K Y K + P + LL ++L FE ++R +AE+A+ P+F
Sbjct: 232 EEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
Query: 319 L----AKVEREPSAQPVTKMEFEFERRR 342
L K+ S + +++ + E
Sbjct: 288 LGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-104
Identities = 114/298 (38%), Positives = 166/298 (55%), Gaps = 19/298 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H V HRDLKP+N+L N + +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ + V
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ +Y + +P+P+ + + LL +ML +P R TA++AL YFK
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 110/303 (36%), Positives = 157/303 (51%), Gaps = 24/303 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRI--LREIKLLRLL 79
RY+ + +G+G + V A D T + VAIKKI D LREIKLL+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+G
Sbjct: 70 SHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H + HRDLKP N+L + + LK+ DFGLA+ +F P + T V TRWYRAP
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA--- 254
E L G+ Y +D+W++GCI AELL P PG + + QL + + LGTP+ E
Sbjct: 182 ELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+ + + + + IP F A L L++ + F P R TA +AL
Sbjct: 240 MCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 315 YFK 317
YF
Sbjct: 294 YFS 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 116/301 (38%), Positives = 163/301 (54%), Gaps = 19/301 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV + +L + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K Y P N LL+ +L P R +AEEAL PYF
Sbjct: 231 T--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 319 L 319
Sbjct: 289 F 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 105/326 (32%), Positives = 161/326 (49%), Gaps = 23/326 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
R + K P + + + L LL + L F P R +A AL+
Sbjct: 242 DWPRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 314 PYFKGLAK-VEREPSAQPVTKMEFEF 338
PYF+ L + E S P ++ E
Sbjct: 298 PYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-102
Identities = 111/306 (36%), Positives = 161/306 (52%), Gaps = 23/306 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
RY+ +G+G+YG V A DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ H+ HRDLKP+N+L + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALAD 313
V + S K + + + L LL ML +P R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-101
Identities = 108/309 (34%), Positives = 168/309 (54%), Gaps = 25/309 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S++K E +G G+Y V + TG VA+K++ E + +T I REI L++ L+H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELKHE 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLL 136
+IV + ++ ++ + +VFE M++DL + + + L ++F +QLL
Sbjct: 64 NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+GL + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLWYR 175
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
AP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL ++ D++GTP+
Sbjct: 176 APDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNA-----NPLALRLLERMLAFEPKDRPTAEEA 310
V K +Y +++++ P Q + + L +L P R +A++A
Sbjct: 234 PSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 311 LADPYFKGL 319
L P+F
Sbjct: 292 LHHPWFAEY 300
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 108/338 (31%), Positives = 163/338 (48%), Gaps = 28/338 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
S+Y+ IG+G++G V A +TG+KVA+KK+ + E+ + I LREIK+L+LL+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLK 74
Query: 81 HPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLL 136
H ++V EI P R IY+VF+ E DL ++ T + + LL
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---VATR 193
GL YIH + HRD+K N+L D LK+ DFGLAR AF+ Y V T
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVVTL 192
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +P
Sbjct: 193 WYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 253 EA---IARVRNEKARRYLSSMRKKKPIPFSQKFPN--ANPLALRLLERMLAFEPKDRPTA 307
E + + K + + +P AL L++++L +P R +
Sbjct: 251 EVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKVEREPSAQPVTKMEFEFERRR 342
++AL +F + ++ S + E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 5e-88
Identities = 109/366 (29%), Positives = 173/366 (47%), Gaps = 56/366 (15%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ E +G+G+YG V A D + + A+K+I +S + REI LLR L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLREL 75
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQF 130
+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 76 KHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIF- 185
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPLA 190
Query: 186 -WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAELLT +P+F +
Sbjct: 191 DLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 236 -VVHQLDIMTDLLGTPS----------PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 284
QLD + +++G P+ PE +++ + Y + K +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK---YMEKHKVK 305
Query: 285 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRIT 344
+ A LL+++L +P R T+E+A+ DPYF P++ + + +R
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL----PTSDVFAGCQIPYPKREFL 361
Query: 345 KEDVRE 350
E+ +
Sbjct: 362 TEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 2e-75
Identities = 88/399 (22%), Positives = 155/399 (38%), Gaps = 65/399 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHP 82
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE L T +DI+S GC+F +++ GK++ Q +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL------------ 241
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + + +A L+E+M+A +P+ RP+A+ L P+
Sbjct: 242 ---------------LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE------ 358
F L K +E+E P+ K + E R + K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHY 396
Y +++ L Y ++ L + +
Sbjct: 346 TYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-69
Identities = 96/331 (29%), Positives = 157/331 (47%), Gaps = 46/331 (13%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
RY++ +VIGKGS+G V AYD + + VA+K + + + EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 139 LKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L +H + H DLKP+NIL +K+ DFG + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT------YIQSRFYR 266
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE + G+ +Y ID+WS+GCI AELLTG PL PG++ QL M +LLG PS + +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 256 ARVRN-------------------EKARRYLSSMRKK----KPIPFSQKFPNANPLALR- 291
+ L+ R + + P S+++ NA
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 292 ----LLERMLAFEPKDRPTAEEALADPYFKG 318
L++ L ++P R T +AL P+ +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-68
Identities = 80/343 (23%), Positives = 122/343 (35%), Gaps = 51/343 (14%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ F + +G Y I + IG G V + + AIK +N
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 65
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 T-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F +Q+ + AI + I F
Sbjct: 239 FQQII--NQISKL---------HAI--------------IDPNHEIEFP---DIPEKDLQ 270
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 333
+L+ L +PK R + E LA PY +++ P Q
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKG 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 5e-66
Identities = 54/350 (15%), Positives = 98/350 (28%), Gaps = 61/350 (17%)
Query: 9 SSADVDFFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDA 66
+A+ + +G R K+ E + G VV D E A+K S+
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 67 TRILREIKLLRLLRHPDIVEIK---HILLPP------------------SRREFKDIYVV 105
R+ L E + +LLP + ++
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 106 FELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158
DL + D + QL+R + + + H P N+
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
D +L + D P Y E + + +T A++ W +G
Sbjct: 227 IMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 219 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 278
+ F + L P +++ + P+P
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL-------------AFGSCTPLP- 326
Query: 279 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 328
L+ R L F+ + R EA+ P F +++ E S+
Sbjct: 327 --------DFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEISS 365
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 78/332 (23%), Positives = 118/332 (35%), Gaps = 47/332 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G Y I + IG G V + + AIK +N EI L L+
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 82 P--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 67 HSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
IH + H DLKP N L D LK+ DFG+A DT T++ V T Y PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPE 179
Query: 200 L---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
G SK +P D+WS+GCI + GK F +Q+ +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKL------- 230
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
AI + I F +L+ L +PK R + E
Sbjct: 231 --HAI--------------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
LA PY + + + +M++ +
Sbjct: 272 LAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-65
Identities = 94/354 (26%), Positives = 159/354 (44%), Gaps = 57/354 (16%)
Query: 11 ADVDFFTEYGE--GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDA 66
+ D+ + GE RY+I+ +IGKGS+G V AYD E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--L 123
E++LL L+ D +I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TPEHYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFND 179
+ + F Q+ L ++ T ++ H DLKP+NIL +KI DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q
Sbjct: 215 IYQ------YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDIMTDLLGTPSPEAIARVRNEK-----------ARRYLSSMRKKKPIPFSQKFPNANPL 288
++ + ++LG P + + + + +++ P ++K N +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 289 ALR----------------------LLERMLAFEPKDRPTAEEALADPYFKGLA 320
L+ RML ++PK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-64
Identities = 70/344 (20%), Positives = 135/344 (39%), Gaps = 65/344 (18%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + + +G G++G V + A+K + +I + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 139 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 173
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 174 RVAFNDTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
A F +D + TR YRAPE + + + D+WS GC+ AEL TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-------------SSMRKKKP 275
LF + L +M ++ + +Y+ SS+ K
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 276 IPFSQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + L L +L +P RP+ E L + +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 81/352 (23%), Positives = 127/352 (36%), Gaps = 49/352 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
D K SS+ + + +G Y I + IG G V + + AIK +N
Sbjct: 37 TDDDDKASSSANECISV--KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 93
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 148
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V Y PE G SK +P D+WS+GCI + GK
Sbjct: 208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F ++ ++ L AI + I F
Sbjct: 267 FQ-----QIINQISKL------HAI--------------IDPNHEIEFP---DIPEKDLQ 298
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
+L+ L +PK R + E LA PY + + + +M++ +
Sbjct: 299 DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-63
Identities = 88/345 (25%), Positives = 144/345 (41%), Gaps = 65/345 (18%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+RY+I + +G+G++G V D + G VA+K + ++ + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFS 279
+ L +M +LG I + R K A RY + P
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY----VSRACKPLK 292
Query: 280 QKFPNANP---LALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ + + L+++ML ++P R T EAL P+F L K
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-63
Identities = 92/352 (26%), Positives = 142/352 (40%), Gaps = 59/352 (16%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
RY+I +G+G++G V D R +VA+K I ++ +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEK------ARRYLSSMRKKKPIPFSQKFPNA-- 285
L +M +LG I R R +K +S + + +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 286 -----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER--EPSAQP 330
+ L+ RML F+P R T EAL P+F GL ER S P
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 9e-62
Identities = 80/339 (23%), Positives = 129/339 (38%), Gaps = 49/339 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVNDA 75
Query: 83 DIVEIKHILLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQF 130
D + + + K VFE++ +L +IK + + + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 131 FLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--- 192
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------ 236
T+ + TR YR+PE L G+ + DIWS C+ EL+TG LF
Sbjct: 193 ---TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 237 VHQLDIMTDLLGTPSPEAIARVR------NEKARRYLSSMRKKKP----IPFSQKFPNAN 286
+ + +LLG + + N + S K P + KF
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 287 PLALR-LLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324
+ L ML +P+ R A + P+ K +E
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 345
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-60
Identities = 79/358 (22%), Positives = 137/358 (38%), Gaps = 52/358 (14%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI 59
M S D+ Y + +Y + IG+GS+G T G + IK+IN
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-- 58
Query: 60 FEHVSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
+S R RE+ +L ++HP+IV+ + S E +Y+V + E DL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKR 113
Query: 117 IK-ANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
I L E + Q+ LK++H + HRD+K +NI D +++ DFG+AR
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
V + A + T +Y +PE+C + Y DIW++GC+ EL T K F
Sbjct: 174 VLNSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRL 292
++ + ++ + P+ +S + L
Sbjct: 229 SM---------------KNLVLKIISGSF----------PPVSLHYSYDLRS-------L 256
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
+ ++ P+DRP+ L + + P F + +
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-60
Identities = 74/323 (22%), Positives = 120/323 (37%), Gaps = 56/323 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQ 62
Query: 83 DIVEIKH--------ILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFFL 132
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW------ 186
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 187 -----TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN--- 236
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFE 300
I+ L + I F F N + +++ ++ +
Sbjct: 237 ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKVE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-59
Identities = 63/314 (20%), Positives = 119/314 (37%), Gaps = 26/314 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
AI+ V+ + S S L +L +L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKV 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 7e-59
Identities = 75/321 (23%), Positives = 117/321 (36%), Gaps = 67/321 (20%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G +K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVEIKH-----------ILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 128
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 129 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246
T Y +PE S Y +D++++G I AELL F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDR 304
+ I F +K LL+++L+ +P+DR
Sbjct: 232 -------------------------RDGIISDIFDKKEKT-------LLQKLLSKKPEDR 259
Query: 305 PTAEEALADPYFKGLAKVERE 325
P E L + + E
Sbjct: 260 PNTSEILRTLTVWKKSPEKNE 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 85/313 (27%), Positives = 137/313 (43%), Gaps = 49/313 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK----------- 354
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ I F + + + AL L++++L +PK R T EEAL
Sbjct: 355 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 312 ADPYFKGLAKVER 324
P+ + +
Sbjct: 399 RHPWLQDEDMKRK 411
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 72/327 (22%), Positives = 119/327 (36%), Gaps = 55/327 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIVEIKH-------ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 131
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------- 183
Q+ ++++H+ + HRDLKP NI D +K+ DFGL D
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T V T+ Y +PE + Y+ +DI+S+G I ELL P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 302
+ VRN K F F P +++ ML+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQ 329
+RP A + + F+ L + Q
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-58
Identities = 83/308 (26%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLYQLL 136
P+IV ++ R +Y+V E E DL VI E + + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 137 RGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
LK H + V HRDLKP N+ + +K+ DFGLAR+ +DT A +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTFVG 178
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ EL P F +
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------------- 221
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
E ++R K + IP +S + ++ RML + RP+ EE
Sbjct: 222 KELAGKIREGKF----------RRIPYRYSDELNE-------IITRMLNLKDYHRPSVEE 264
Query: 310 ALADPYFK 317
L +P
Sbjct: 265 ILENPLIL 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-58
Identities = 73/361 (20%), Positives = 140/361 (38%), Gaps = 29/361 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 308
AI+ V+ + S S L +L +L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE--ILEYHPQMLKE 366
+ A+ V S Q +T + T EL+Y++ I+ + +++ E
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQELIYE 357
Query: 367 F 367
Sbjct: 358 G 358
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-58
Identities = 70/297 (23%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
++ +G GSYG V G A+K+ F D R L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
P V ++ + E +Y+ EL L Q +A PE +L L L
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
Y A D++S+G E+ L G QL
Sbjct: 228 LQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P F+ + +L ML +PK R TAE LA P +
Sbjct: 265 ---------RQGYLPPEFTAGLSSE---LRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-57
Identities = 86/316 (27%), Positives = 139/316 (43%), Gaps = 49/316 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE L + Y A+D WS+G I L+G P F Q+ +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLK--------- 229
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ I F + + + AL L++++L +PK R T EEAL
Sbjct: 230 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 312 ADPYFKGLAKVEREPS 327
P+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-56
Identities = 77/338 (22%), Positives = 131/338 (38%), Gaps = 51/338 (15%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + + + Y + ++IE+ IG+G + V A G VA+KK+ IF+
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDL 70
Query: 63 VSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
+ R ++EI LL+ L HP++++ S E ++ +V EL ++ DL ++IK
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKH 125
Query: 120 ---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
L PE + QL L+++H+ V HRD+KP N+ A +K+ D GL R
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ T A V T +Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 186 FSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240
Query: 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP---FSQKFPNANPLALRL 292
++ P+P +S++ L
Sbjct: 241 -------------MNLYSLCKKIEQCDY----------PPLPSDHYSEELRQ-------L 270
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
+ + +P+ RP
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 97/336 (28%), Positives = 144/336 (42%), Gaps = 53/336 (15%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKAN 120
D + ILRE++LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAF 177
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ F
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-F 174
Query: 178 NDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
D + T +Y APE L G Y D+WS G I LL+G P F GKN
Sbjct: 175 QQNTK---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN- 226
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLER 295
+ DI+ + + + F ++ + A L+ +
Sbjct: 227 --EYDIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 296 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPV 331
ML F P R TA + L P+ + + S P
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPS 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-54
Identities = 75/361 (20%), Positives = 130/361 (36%), Gaps = 74/361 (20%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLR 80
+ E+++G GS G V + G VA+K++ + L EIKLL
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDD 67
Query: 81 HPDIVEIKHILLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF------- 130
HP+++ +Y+ EL +L ++++ +
Sbjct: 68 HPNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VA 176
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 177 FNDTPTAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F K + + + A
Sbjct: 240 FGDKY-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEAT 273
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
L+ +M+ +P RPTA + L P F +K + V+ E E R + +
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMK 330
Query: 351 L 351
Sbjct: 331 F 331
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-54
Identities = 86/316 (27%), Positives = 142/316 (44%), Gaps = 52/316 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
RYK + V+GKGS+G V D TG++ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ F + D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASKK---MKDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y D+WS G I LL+G P F G N + DI+ +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDIL---------KK 238
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ +K F ++ + A L+ +ML + P R +A +AL
Sbjct: 239 V----------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282
Query: 314 PYFKGLAKVEREPSAQ 329
+ + K +
Sbjct: 283 EWIQTYTKEQISVDVP 298
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 87/316 (27%), Positives = 140/316 (44%), Gaps = 51/316 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+ + +G G+YG V D T + AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V F + + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK---MKERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ KY D+WSIG I LL G P F G+ +I+ +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEIL---------RKV 249
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+K F S ++ N + A L+++ML F+ + R +A++AL P
Sbjct: 250 ----------------EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 315 YFKGLAKVEREPSAQP 330
+ K + + P
Sbjct: 294 WIKEMCSKKESGIELP 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 75/324 (23%), Positives = 132/324 (40%), Gaps = 45/324 (13%)
Query: 2 QPDQRKKSSADVDFFTEYGEGS---RY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
Q ++ ++ + T+ S R+ K + IG+GS+ V DT T +VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
D S+ R E ++L+ L+HP+IV + + K I +V ELM S L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTY 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLA 173
+K + + + + Q+L+GL+++HT + HRDLK NI +KI D GLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ A+ T + APE+ KY ++D+++ G E+ T + +
Sbjct: 180 TLKRASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSE 231
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
Q+ Y KP F + A P ++
Sbjct: 232 CQNAAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEII 263
Query: 294 ERMLAFEPKDRPTAEEALADPYFK 317
E + +R + ++ L +F+
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 79/347 (22%), Positives = 126/347 (36%), Gaps = 81/347 (23%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+Y ++ IG+GSYGVV A + +T AIK +N + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQLLRGLKYIHTANVFHRDLKPKNIL 158
+ Q+ L Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275
S G + LL G FPG N D + + K
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---DADTI---------SQV----------------LNKK 292
Query: 276 IPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+ F + + +PLA LL +L +R A AL P+ +
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-53
Identities = 89/361 (24%), Positives = 134/361 (37%), Gaps = 61/361 (16%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIF 60
P + + + RY +GKG + D T E A K + +
Sbjct: 20 APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL 79
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
++ EI + R L H +V ++VV EL L ++ K
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKR 134
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
LT +++L Q++ G +Y+H V HRDLK N+ N D ++KI DFGLA D
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 180 ---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
TP +Y+ APE+ ++ +D+WSIGCI LL GKP
Sbjct: 195 GERKKVLCGTP------NYI------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 290
F + E R++ Y IP + NP+A
Sbjct: 241 FETSCL---------------KETYLRIKK---NEY--------SIP-----KHINPVAA 269
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 350
L+++ML +P RPT E L D +F R P F + + +
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKP 329
Query: 351 L 351
L
Sbjct: 330 L 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 84/307 (27%), Positives = 123/307 (40%), Gaps = 61/307 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY +GKG + D T E A K + + ++ EI + R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H +V ++VV EL L ++ K LT +++L Q++ G
Sbjct: 74 HQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYV 190
+Y+H V HRDLK N+ N D ++KI DFGLA D TP +Y+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI 182
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
APE+ ++ +D+WSIGCI LL GKP F +
Sbjct: 183 ------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------------- 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
E R++ Y IP + NP+A L+++ML +P RPT E
Sbjct: 221 -KETYLRIKK---NEY--------SIP-----KHINPVAASLIQKMLQTDPTARPTINEL 263
Query: 311 LADPYFK 317
L D +F
Sbjct: 264 LNDEFFT 270
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 43/305 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
Y + +G+G + V G A+K+I D RE + RL H
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNH 85
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLL 136
P+I+ + L + + +++ + L I+ + LT + + L +
Sbjct: 86 PNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------IFWTDYV 190
RGL+ IH HRDLKP NIL + + + D G A + W
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 191 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV--------------- 249
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+K +++ + IP S + +A +LL M+ +P RP
Sbjct: 250 ----------FQKGDSVALAVQNQLSIPQSPRHSSA---LWQLLNSMMTVDPHQRPHIPL 296
Query: 310 ALADP 314
L+
Sbjct: 297 LLSQL 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 89/327 (27%), Positives = 131/327 (40%), Gaps = 64/327 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-----------DIFEHVSDATRILR 71
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 127
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAI 184
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ F+
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYK-- 204
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
D + T +Y APE L KY D+WS G I LL G P F G+N DI+
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDII 256
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPK 302
+ + +K F + N + A L++ ML ++
Sbjct: 257 ---------KKV----------------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQ 329
R TAEEAL + K A + +
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-52
Identities = 78/350 (22%), Positives = 132/350 (37%), Gaps = 36/350 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++++E +G G +G V TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 138
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK------------ 235
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL-------ALRLLERMLAFEPKDRPTAE 308
VR + + + FS P N L R L+ ML + + R T
Sbjct: 236 --VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 309 EALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 358
+ F+ L + + + +T+ + + + + +
Sbjct: 294 QNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-52
Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y +E IG+GS+G V A T + A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H NV HRDLKP+N L + D LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
+ L G Y P D WS G + LL G P F ++M I
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM---------LKI-- 219
Query: 258 VRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
++ F + + N +P A L+ R+L PK R T+ +AL +F
Sbjct: 220 --------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 317 KG 318
+
Sbjct: 266 EK 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-52
Identities = 96/325 (29%), Positives = 144/325 (44%), Gaps = 47/325 (14%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL 123
D + ILRE++LL+ L HP+I+++ IL + Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDT 180
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ +T
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
D + T +Y APE L G Y D+WS G I LL+G P F GKN +
Sbjct: 179 ----KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---E 227
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLA 298
DI+ + + + F ++ + A L+ +ML
Sbjct: 228 YDIL---------KRV----------------ETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 299 FEPKDRPTAEEALADPYFKGLAKVE 323
F P R TA + L P+ + + E
Sbjct: 263 FHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 85/313 (27%), Positives = 135/313 (43%), Gaps = 46/313 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L Y+ +DIW+ G I LL G P F ++ Q + I
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQI-- 219
Query: 258 VRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + S ++ P A L++ ML PK R TA++AL P+
Sbjct: 220 --------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 317 KGLAKVEREPSAQ 329
+V Q
Sbjct: 266 CNRERVASAIHRQ 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 79/323 (24%), Positives = 135/323 (41%), Gaps = 53/323 (16%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + + + +G G++G V + +G + IK IN
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQV 62
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL 123
+I EI++L+ L HP+I++I + ++ ++Y+V E E +L + I +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA- 116
Query: 124 TPEHY-----QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV 175
+ + Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA +
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 176 AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+D T+ T Y APE T DIWS G + LLTG F G
Sbjct: 177 FKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 235 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 294
+ ++ + K ++ + P A+ LL+
Sbjct: 229 S---LEEVQ---------QKA----------------TYKEPNYAVECRPLTPQAVDLLK 260
Query: 295 RMLAFEPKDRPTAEEALADPYFK 317
+ML +P+ RP+A + L +FK
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFK 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-50
Identities = 79/318 (24%), Positives = 131/318 (41%), Gaps = 51/318 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-------DIFEHVSDATRILREIKL 75
Y+ +E++G+G VV T ++ A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y APE + S Y +D+WS G I LL G P F + Q+ ++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML------ 238
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAE 308
I F S ++ + + L+ R L +P+ R TAE
Sbjct: 239 ---RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 309 EALADPYFKGLAKVEREP 326
EALA P+F+ E
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-49
Identities = 87/329 (26%), Positives = 138/329 (41%), Gaps = 52/329 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + ++ Y+VF+L+ +L + I A + + + Q+L
Sbjct: 89 NIVRLHDS--------IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGY 196
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+PE L Y+ +DIW+ G I LL G P F ++ Q +
Sbjct: 197 LSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY---------AQ 241
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I K + S ++ P A L++ ML PK R TA++AL
Sbjct: 242 I----------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRR 342
P+ +V Q +F RR
Sbjct: 286 PWICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-49
Identities = 70/320 (21%), Positives = 132/320 (41%), Gaps = 62/320 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------------------------DI 59
+Y +++ IGKGSYGVV AY+ A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK 118
+ ++ +EI +L+ L HP++V++ +L P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 119 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NEF 187
Query: 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVV 237
A+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
++++++ P P+ L+ RML
Sbjct: 246 --------------MCLHSKIKSQALE-----------FP---DQPDIAEDLKDLITRML 277
Query: 298 AFEPKDRPTAEEALADPYFK 317
P+ R E P+
Sbjct: 278 DKNPESRIVVPEIKLHPWVT 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 75/318 (23%), Positives = 132/318 (41%), Gaps = 55/318 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+RHP+I+ + I F++ + ++ EL+ +L + + LT + FL Q
Sbjct: 65 IRHPNIITLHDI--------FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIF 172
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G+ + + +
Sbjct: 173 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL------- 220
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I+ V F + F N + LA + R+L +PK R T +
Sbjct: 221 --TNISAVN----------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 310 ALADPYFKGLAKVEREPS 327
+L + K + +
Sbjct: 263 SLEHSWIKAIRRRNVRGE 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 83/329 (25%), Positives = 132/329 (40%), Gaps = 51/329 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ E +GKG++ VV G++ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + + Y++F+L+ +L + I A + + + Q+L
Sbjct: 71 NIVRLHDS--------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + H V HR+LKP+N+L +K+ DFGLA + W + T Y
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGY 179
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+PE L Y +D+W+ G I LL G P F ++ Q + +
Sbjct: 180 LSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---------QQ 224
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I K F S ++ P A L+ +ML P R TA EAL
Sbjct: 225 I----------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268
Query: 314 PYFKGLAKVEREPSAQPVTKMEFEFERRR 342
P+ + V Q +F RR
Sbjct: 269 PWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
++ V F + F N + LA + R+L +PK R T ++
Sbjct: 227 --ANVSAVN----------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
+L P+ K + ME
Sbjct: 269 SLQHPWIKPKDTQQALSRKASAVNME 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 62/306 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K+ ++GKGS+ V A TG +VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYVA 191
Y+H+ + HRDL N+L + +KI DFGLA TP +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI- 179
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+PE+ S + D+WS+GC+F LL G+P F V
Sbjct: 180 -----SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--------------- 217
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ +V +P + A L+ ++L P DR + L
Sbjct: 218 KNTLNKVVLADYE-----------MP-----SFLSIEAKDLIHQLLRRNPADRLSLSSVL 261
Query: 312 ADPYFK 317
P+
Sbjct: 262 DHPFMS 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 59/324 (18%), Positives = 101/324 (31%), Gaps = 71/324 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRH 81
+ + E IG G +G V G AIK+ D LRE+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQLL 136
+V + E + + E L I N + E + L Q+
Sbjct: 71 SHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 137 RGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAF 177
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-I 184
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 185 SSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
H++ R+ + Q LL+ M+
Sbjct: 238 HEI------------------------------RQGRLPRIPQVLS---QEFTELLKVMI 264
Query: 298 AFEPKDRPTAEEALADPYFKGLAK 321
+P+ RP+A + ++
Sbjct: 265 HPDPERRPSAMALVKHSVLLSASR 288
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 73/326 (22%), Positives = 130/326 (39%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ H +++ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHHNVITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 227
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I V F + F + + LA + ++L E + R T +E
Sbjct: 228 --ANITSVS----------------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
AL P+ + + + V +E
Sbjct: 270 ALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 55/326 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHPNIITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL------- 227
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
I V F + F + LA + ++L E + R T +E
Sbjct: 228 --ANITAVS----------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 310 ALADPYFKGLAKVEREPSAQPVTKME 335
AL P+ + + + V +E
Sbjct: 270 ALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 84/341 (24%), Positives = 149/341 (43%), Gaps = 58/341 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y++ + IGKG++ V A TG +VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +AD +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
F KY P +D+WS+G I L++G F G+N+ E RV
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---------------KELRERVL 227
Query: 260 NEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
K R Y+S LL+R L P R T E+ + D +
Sbjct: 228 RGKYRIPFYMS------------------TDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
Query: 318 -GLAKVEREPSAQPVTKMEFEF-----ERRRITKEDVRELI 352
G + E +P +P + + ++E+++E +
Sbjct: 270 AGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 40/306 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
++ +D+WS G + +L G+ + ++
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQP-------------------------SD 213
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF-KGLA 320
+ Y KK + +K L LL ++L P R T + D ++ K L
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKID---SAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KVEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 73/311 (23%), Positives = 129/311 (41%), Gaps = 56/311 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLL 76
+Y ++VIG+G VV TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFF 131
R + HP I+ + ++ +++VF+LM +L + L+ + +
Sbjct: 154 RQVAGHPHIITLIDS--------YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ LL + ++H N+ HRDLKP+NIL + + ++++ DFG + +
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELCG 261
Query: 192 TRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
T Y APE L S Y +D+W+ G I LL G P F + Q+ ++
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML---- 314
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
I + F S ++ + + L+ R+L +P+ R T
Sbjct: 315 -----RMI----------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
Query: 307 AEEALADPYFK 317
AE+AL P+F+
Sbjct: 354 AEQALQHPFFE 364
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 79/336 (23%), Positives = 130/336 (38%), Gaps = 59/336 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
Y++ EVIGKG + VV + TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 RHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVI----KANDDLTPEHYQFF 131
+HP IVE+ + +Y+VFE M+ +DL I A + +
Sbjct: 84 KHPHIVELLET--------YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L L+Y H N+ HRD+KP +L +K+ FG+A
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---AGG 192
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V T + APE + Y +D+W G I LL+G F G +
Sbjct: 193 RVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---- 241
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
E I + + +++ + + A L+ RML +P +R T
Sbjct: 242 -----EGIIKGK----------------YKMNPRQWSHISESAKDLVRRMLMLDPAERIT 280
Query: 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
EAL P+ K + + + +F RR
Sbjct: 281 VYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 65/320 (20%), Positives = 119/320 (37%), Gaps = 56/320 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
+Y + +++G+GSYG V D+ T + A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
+++++ +L + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRW 194
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ + ++ +DIWS G + TG F G N+ +
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---------------YK 220
Query: 254 AIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+ P LL+ ML +EP R + +
Sbjct: 221 LFENIGKGSYAIPGDCG------------------PPLSDLLKGMLEYEPAKRFSIRQIR 262
Query: 312 ADPYF-KGLAKVEREPSAQP 330
+F K E P
Sbjct: 263 QHSWFRKKHPPAEAPVPIPP 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 69/317 (21%), Positives = 122/317 (38%), Gaps = 55/317 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+ I +GKG +G V A + + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRWY 195
Y H V HRD+KP+N+L +LKI DFG + P+ T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PE+ + +D+W G + E L G P F + E
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---------------TETH 221
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+ N + P P + + L+ ++L + P R + + P+
Sbjct: 222 RRIVNVDLK-----------FP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
Query: 316 FKGLAKVEREPSAQPVT 332
K ++ P Q
Sbjct: 266 VKANSRRVLPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 61/305 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDYVATR 193
Y H+ V HRD+KP+N+L + +LKI DFG + A + T DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL------DYL--- 174
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
PE+ + +D+WS+G + E L GKP F +
Sbjct: 175 ---PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------------K 217
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALA 312
I+RV FP+ A L+ R+L P RP E L
Sbjct: 218 RISRVE--------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 313 DPYFK 317
P+
Sbjct: 258 HPWIT 262
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 76/331 (22%), Positives = 126/331 (38%), Gaps = 52/331 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 137
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GLK++H ++ H D+KP+NI+ +KI DFGLA D AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEF 216
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ D+W+IG + LL+G F G++ L+ + + +
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETL---------QNV 262
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
R F F + +P A ++ +L EP+ R T +AL P
Sbjct: 263 KRCD----------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRRITK 345
+ KG + + +
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-46
Identities = 73/354 (20%), Positives = 136/354 (38%), Gaps = 52/354 (14%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + +Y ++V+G G G V + RTG+K A+K + D
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLS-----KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-- 64
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ + +E+ + P IV I + + + + ++ E ME +L I
Sbjct: 65 -----SPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQ 118
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++++H+ N+ HRD+KP+N+L D LK+ DFG A
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + T +Y APE+ G KY + D+WS+G I LL G P F
Sbjct: 179 KETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYS 231
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRL 292
I + R+R + F + ++ + A +L
Sbjct: 232 NT---GQAISPGMK--------RRIRLGQ-------------YGFPNPEWSEVSEDAKQL 267
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
+ +L +P +R T + + P+ V + P E + + +E
Sbjct: 268 IRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEE 321
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-46
Identities = 74/306 (24%), Positives = 118/306 (38%), Gaps = 49/306 (16%)
Query: 18 EYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
EY E + +G+GS+G V D +TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV--AFNDTPTAIFWTDYVA 191
L GL+Y+HT + H D+K N+L ++D + +CDFG A + +
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T + APE+ +DIWS C+ +L G + + + + P
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPP 273
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
P + IP P+ PL + ++ L EP R +A E
Sbjct: 274 P--------------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELR 308
Query: 312 ADPYFK 317
Sbjct: 309 RKVGKA 314
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 90/361 (24%), Positives = 146/361 (40%), Gaps = 64/361 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G+GS+G V A +T +KVA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YRA 197
H + HRDLKP+N+L + + +KI DFGL+ I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------NIMTDGNFLKTSCGSPNYAA 175
Query: 198 PELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE+ Y P +D+WS G + +L G+ F + + P
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI---------------PNLFK 218
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+V + +P +P A L+ RM+ +P R T +E DP+F
Sbjct: 219 KVNSCVYV-----------MP-----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGF 376
V +P+ E + V +L E + + + E L E
Sbjct: 263 ----NVNLPDYLRPME----EVQGSYADSRIVSKLG--EAMGFSEDYIVEALRSDENNEV 312
Query: 377 M 377
Sbjct: 313 K 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 73/345 (21%), Positives = 135/345 (39%), Gaps = 53/345 (15%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D F+ Y ++ +G+GS+ + ++ + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 72 EIKLLRLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 126
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTA 183
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEP 301
+++ + I KK F + + N + A L++ +L +P
Sbjct: 221 AVEIM-----KKI----------------KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
R + + + +++ P P K
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 54/340 (15%), Positives = 114/340 (33%), Gaps = 58/340 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---------------DIFEHVSDATR 68
Y+I + +G + + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 69 ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 127
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 128 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 179 DTPTAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+++ PE + S +DIWS+G + F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293
K + +L I E + + + + L
Sbjct: 255 KISLVEL-----------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 333
+ L P +R T+E+AL + + ++ + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 76/317 (23%), Positives = 128/317 (40%), Gaps = 44/317 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
++ +D+WS G + +L G+ +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP------------------------- 211
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF-KG 318
++ + Y KK + +K L LL ++L P R T + D ++ K
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKID---SAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 319 LAKVEREPSAQPVTKME 335
L K + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 70/314 (22%), Positives = 126/314 (40%), Gaps = 40/314 (12%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
Y++ E+V+G+G++ V + + T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----AFNDTPTAIFWTDYV 190
L ++H + HRDLKP+NIL N +KICDF L +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+ Y APE+ S Y D+WS+G I LL+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 306
++ K F + + + + A L+ ++L + K R +
Sbjct: 243 PACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
Query: 307 AEEALADPYFKGLA 320
A + L P+ +G A
Sbjct: 290 AAQVLQHPWVQGCA 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 79/307 (25%), Positives = 123/307 (40%), Gaps = 65/307 (21%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND--------TPTAIFWTDYVATR 193
H V HRDLKP+N+L +A KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
Y APE+ Y P +DIWS G I LL G F ++V P
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------------P 217
Query: 253 EAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
++R YL+ LL ML +P R T ++
Sbjct: 218 TLFKKIRGGVFYIPEYLN------------------RSVATLLMHMLQVDPLKRATIKDI 259
Query: 311 LADPYFK 317
+FK
Sbjct: 260 REHEWFK 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 52/345 (15%), Positives = 98/345 (28%), Gaps = 82/345 (23%)
Query: 15 FFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK------------------- 54
+E GE R V+G+ A D TGE +
Sbjct: 64 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123
Query: 55 ----KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110
++ ++ A LR I L++ P ++ + L + ++ M+
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 111 SDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163
S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDI 214
+ + F + +R + PEL + T + D
Sbjct: 244 GVFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKK 274
W++G + + + R K
Sbjct: 297 WALGLVIYWIWCADLPITKDAALG--------------------------GSEWIFRSCK 330
Query: 275 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
IP LLE L + +DR +A+ P ++ L
Sbjct: 331 NIP---------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 55/307 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++E +G+G+ +V T + A+K + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++K I F+ I +V EL+ +L I + + Q+L
Sbjct: 109 NIIKLKEI--------FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H + HRDLKP+N+L D LKI DFGL+++ + T Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGY 216
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE L G Y P +D+WS+G I LL G F + +
Sbjct: 217 CAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-----------RR 262
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I F S + + A L+ +++ +PK R T +AL
Sbjct: 263 I----------------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 314 PYFKGLA 320
P+ G A
Sbjct: 307 PWVTGKA 313
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-45
Identities = 64/333 (19%), Positives = 116/333 (34%), Gaps = 58/333 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
R ++ V+ +G + V A D +G + A+K++ I++E+ ++ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSG 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQ 134
HP+IV+ L E L + + ++ L+ + YQ
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 135 LLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA- 191
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 192 --------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T YR PE+ +S DIW++GCI L + F +
Sbjct: 205 EEEITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
I +Y IP L+ ML P
Sbjct: 260 ------------RIVNG------KY--------SIPPHDTQYTV---FHSLIRAMLQVNP 290
Query: 302 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 334
++R + E + + +A P+T++
Sbjct: 291 EERLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-44
Identities = 69/328 (21%), Positives = 123/328 (37%), Gaps = 52/328 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ D+WS+G + LL+G F G+N + + +
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETL---------RNV 368
Query: 256 ARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
F + + ++L +P R T +AL P
Sbjct: 369 KSCD----------------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412
Query: 315 YFKGLAKVEREPSAQPVTKMEFEFERRR 342
+ R+ + +
Sbjct: 413 WLTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 67/308 (21%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE + A D+WS+G + LL+G F + I+ E
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---NQQII---------EN 214
Query: 255 IARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
I F + F + A+ ++R+L E K R TA EAL
Sbjct: 215 IMNAE----------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 314 PYFKGLAK 321
P+ K +
Sbjct: 259 PWLKQKIE 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 85/342 (24%), Positives = 129/342 (37%), Gaps = 58/342 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYRAP 198
H+ + HRDLK +N L + +LKICDFG ++ + + + V T Y AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 186
Query: 199 ELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
E+ +Y D+WS G +L G F + I
Sbjct: 187 EV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-----------KTI 231
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+ + K IP + P L+ R+ +P R + E +
Sbjct: 232 QRILSVKYS-----------IPDDIRIS---PECCHLISRIFVADPATRISIPEIKTHSW 277
Query: 316 F-KGLAKVEREPSAQPVTKMEFEF------ERRRITKEDVRE 350
F K L S E E +I E
Sbjct: 278 FLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 82/363 (22%), Positives = 139/363 (38%), Gaps = 57/363 (15%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+Y +V+G G G V ++ RT EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREV 105
Query: 74 KLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY--- 128
+L R + P IV I + K + +V E ++ +L I+ D + +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD---QAFTER 161
Query: 129 --QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTA 183
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ +
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-- 219
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
T T +Y APE+ G KY + D+WS+G I LL G P F +
Sbjct: 220 --LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH-------- 267
Query: 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPK 302
SP R+R + F + ++ + L+ +L EP
Sbjct: 268 ---GLAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 303 DRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
R T E + P+ KV + P E + + +E L + +
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK 371
Query: 363 MLK 365
+ K
Sbjct: 372 IKK 374
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-44
Identities = 84/311 (27%), Positives = 125/311 (40%), Gaps = 47/311 (15%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRW 194
GLKY+H + HRD+K N+L N LKI DFG + R+A + T F T
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF----TGTLQ 188
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM----------- 235
Query: 255 IARVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ M K P IP + + A + + +P R A + L D
Sbjct: 236 -----------FKVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279
Query: 314 PYFKGLAKVER 324
+ K +K ++
Sbjct: 280 EFLKVSSKKKK 290
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 56/321 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHP 82
Y+++E IG GSY V T + A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
+ APE L Y A DIWS+G + +LTG F +I+
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---------A 233
Query: 254 AIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
I + + + A L+ +ML +P R TA L
Sbjct: 234 RI----------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
Query: 313 DPYFKGLAKVEREPSAQPVTK 333
P+ ++ + +
Sbjct: 278 HPWIVHWDQLPQYQLNRQDAP 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 49/344 (14%), Positives = 87/344 (25%), Gaps = 70/344 (20%)
Query: 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------------------ 61
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 62 -----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 117 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLT 226
F A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
+ E I R K IP
Sbjct: 313 ADLPNTDDAALG------------GSEWI--------------FRSCKNIP--------- 337
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 330
LLE L + +DR +A+ P ++ L
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 59/305 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L +++ H V HRD+K +NIL + + +LK+ DFG + DT +TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTV----YTDFDGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +I+ +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--- 263
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ +S L+ LA P DRPT EE
Sbjct: 264 -----------QRVS------------------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 69/310 (22%), Positives = 125/310 (40%), Gaps = 60/310 (19%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ Y + + +G+G + VV TG++ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 131
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R + +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LRE 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248
+ T Y APE+ + T A D+W+IG I LLT F G++ +
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY----- 242
Query: 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 307
I++V + + + F + + LA ++ +L P+ RPTA
Sbjct: 243 ----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 308 EEALADPYFK 317
E L+ + +
Sbjct: 283 EICLSHSWLQ 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 74/328 (22%), Positives = 126/328 (38%), Gaps = 62/328 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
+ Y++ ++GKG +G V + + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 79 LR----HPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 132
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVA 191
Q++ +++ H+ V HRD+K +NIL + K+ DFG + +D P +TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEP----YTDFDG 200
Query: 192 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
TR Y PE +Y +WS+G + +++ G F +I+ L P
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEAELHFP 253
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
++S P L+ R LA +P RP+ EE
Sbjct: 254 --------------AHVS------------------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 311 LADPYFK-GLAKVEREPSAQPVTKMEFE 337
L DP+ + V PS + +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-42
Identities = 68/335 (20%), Positives = 116/335 (34%), Gaps = 45/335 (13%)
Query: 23 SRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
Y++ VIGKG V A TGE V +++IN T + E+ + +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKA--NDDLTPEHYQFFLYQLL 136
HP+IV + + + +++VV M S +I D + + L +L
Sbjct: 85 HPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQGVL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVAT 192
+ L YIH HR +K +IL + D K+ + + F V
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----------LF----------P 232
+ +PE+ Y DI+S+G EL G L
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANPLAL 290
+ + ++ + + ++ R + P FS F +
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH------ 312
Query: 291 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325
+E+ L P RP+A L +FK + + E
Sbjct: 313 -FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 72/363 (19%), Positives = 129/363 (35%), Gaps = 72/363 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
+Y +G G++G V +A D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
+ H +I+++ I +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + Y+ ++ HRD+K +NI+ D +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
APE+ Y P +++WS+G L+ + F
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------------------- 232
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ P S + L+ +L P+ R T E+ +
Sbjct: 233 -----LEETVEAAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 313 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 372
DP+ QPV ++ +E + ++ LE + L + + E
Sbjct: 275 DPWVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
Query: 373 PTG 375
G
Sbjct: 324 LCG 326
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 77/354 (21%), Positives = 131/354 (37%), Gaps = 75/354 (21%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + K +A +D + +V+G G G V ++ RT EK A+K + D
Sbjct: 4 VKSGLQIKKNAIIDDY--------KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC- 54
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ RE++L R + P IV I + K + +V E ++ +L I
Sbjct: 55 ------PKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQ 107
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF- 166
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
A E G KY + D+WS+G I LL G P F
Sbjct: 167 -----------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRL 292
+ SP R+R + F + ++ + L
Sbjct: 201 NHG-----------LAISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKML 236
Query: 293 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 346
+ +L EP R T E + P+ KV + P E + + +E
Sbjct: 237 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 106/488 (21%), Positives = 172/488 (35%), Gaps = 83/488 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YR 196
H V HRDLKP+N+L +A KI DFGL+ + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---------NMMSDGEFLRTSCGSPNYA 182
Query: 197 APELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ Y P +DIWS G I LL G F +V P
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------------PTLF 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ + P NP + LL+ ML +P R T ++ +
Sbjct: 226 KKICDGIFY-----------TP-----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTG 375
FK P + + I E ++E+ E E + + L
Sbjct: 270 FKQDLPKYLFPE-------DPSYSSTMIDDEALKEVC--EKFECSEEEVLSCLYNRNHQ- 319
Query: 376 FMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLS 435
D + +L + A S P + T + V ++
Sbjct: 320 -------DPLAVAY-HLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVA 371
Query: 436 KCSIKEVEKPPMDRT--SGIPMARLPIQVPQAGAARPGKVVSSVLRYNNCGAAAAAEALD 493
+ ++ + + + +RP +++ V R A + LD
Sbjct: 372 ETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCR--------AIKQLD 423
Query: 494 QRRVVRNP 501
V NP
Sbjct: 424 YEWKVVNP 431
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 76/316 (24%), Positives = 123/316 (38%), Gaps = 56/316 (17%)
Query: 23 SRYKIE--EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKHILLPPSRREF---KDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQL 135
H +++++ F DI +V E ++ +L I E F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
G++++H + H DLKP+NIL ++KI DFGLAR T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKVNFGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
+ APE + F + D+WS+G I LL+G F G N + +
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETL--------- 297
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
I R ++F + + A + ++L E R +A EAL
Sbjct: 298 NNILACR----------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 312 ADPYFKGLAKVEREPS 327
P+ R +
Sbjct: 342 KHPWLSDHKLHSRLSA 357
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 57/306 (18%), Positives = 101/306 (33%), Gaps = 52/306 (16%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
I + + + + S +I+ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKYI 142
+Y+ +L +L + L + Q+ ++++
Sbjct: 126 QLQ-----PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYVATR 193
H+ + HRDLKP NI D +K+ DFGL D P T V T+
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y +PE + Y+ +DI+S+G I ELL
Sbjct: 241 LYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQ-------------------- 276
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
E+ R K P+ F+QK+P + +++ ML+ P +RP A + + +
Sbjct: 277 ------MERVRIITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTERPEATDIIEN 326
Query: 314 PYFKGL 319
F+ L
Sbjct: 327 AIFENL 332
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 43/307 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G G+ G V +TG +A+K++ + + RIL ++ +L+ P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
IV+ + + D+++ ELM + ++ K PE +++ L Y+
Sbjct: 86 IVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 143 HTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
V HRD+KP NIL + ++K+CDFG++ + Y APE
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYMAPERI 196
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
Y D+WS+G EL TG+ + +++T +L P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEPP------ 248
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
+ FS F + ++ L + + RP + L + K
Sbjct: 249 ------------LLPGHMGFSGDFQS-------FVKDCLTKDHRKRPKYNKLLEHSFIKR 289
Query: 319 LAKVERE 325
+E +
Sbjct: 290 YETLEVD 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 83/373 (22%), Positives = 137/373 (36%), Gaps = 91/373 (24%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY + +G G + V ++D + + VA+K + EH ++ EI+LL+ +R+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRNS 93
Query: 83 DIVEIKHILLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFLY 133
D + ++ +FK I +VFE++ L + I ++ L + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 134 QLLRGLKYIHT-ANVFHRDLKPKNILANAD------------------------------ 162
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 163 -------------------CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
K+KI D G A +T+ + TR YR+ E+
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL-- 265
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI------MTDLLGTPSPEAIAR 257
S Y DIWS C+ EL TG LF + + +LLG + I
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV- 324
Query: 258 VRNEKARRY------LSSMRKKKPIPFSQKFPNANPL-------ALRLLERMLAFEPKDR 304
+ ++ + L + K KP + L ML P+ R
Sbjct: 325 -AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 305 PTAEEALADPYFK 317
TA E L P+
Sbjct: 384 ATAAECLRHPWLN 396
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-40
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 54/298 (18%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-----NDIFEHVSDATRILREIKLLRLLR 80
+ E+ IGKG +G+V + VAIK + E + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 138
HP+IV++ ++ P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
++Y+ N + HRDL+ NI NA K+ DFGL++ + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F +
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ I +R E R IP + P ++E + +PK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-40
Identities = 67/333 (20%), Positives = 122/333 (36%), Gaps = 53/333 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ + ++ K + + E ++ L +IK+ D F + G+ Y+H
Sbjct: 71 K----FIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-----------PTAIFWTDYVAT 192
+ N+ HRDL N L + + + DFGLAR+ ++ P V
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
++ APE+ Y +D++S G + E++ P P
Sbjct: 186 PYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRT 229
Query: 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ P PN P + R +P+ RP+ +
Sbjct: 230 MDFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 313 --DPYFKGLAK-VEREPSAQPVTKMEFEFERRR 342
+ LA + P + + + +E RR
Sbjct: 276 WLETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 66/315 (20%), Positives = 119/315 (37%), Gaps = 55/315 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 142
+ + PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + + K+ I DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
++ D++++G I+ EL + F + E
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----------------AE 249
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERMLAFEPKDRPTAEEALA 312
AI + + + +L AFE ++RPT + +
Sbjct: 250 AIIWQMGTGMKP---------NLS-----QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 313 DPYFKGLAKVEREPS 327
+ L K R S
Sbjct: 296 --MLEKLPKRNRRLS 308
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ V HRD+K NIL D +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
Y P +DIWS+G I A E++ G+P P N + L + + +P
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEP--PYLN-ENPLRALYLIATNGTP-------- 234
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P S F + L R L + + R +A+E L + K
Sbjct: 235 ----------ELQNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 89/380 (23%), Positives = 146/380 (38%), Gaps = 80/380 (21%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG---SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M R S D D + + + IG GS+G V A D R E VAIKK++
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 -DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ I++E++ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDL 143
Query: 117 IKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-- 173
++ + E + L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-ELLTGK 228
+F TP +W APE+ +Y +D+WS+G I EL K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP------FSQKF 282
P P N A L + + + P +S+ F
Sbjct: 251 P----------------------PLF-----NMNAMSALYHIAQNES-PALQSGHWSEYF 282
Query: 283 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
N ++ L P+DRPT+E L + +P T + +R +
Sbjct: 283 RN-------FVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTK 326
Query: 343 ITKEDVRELIYREILEYHPQ 362
++ L YR++ + Q
Sbjct: 327 DAVRELDNLQYRKMKKILFQ 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 83/374 (22%), Positives = 150/374 (40%), Gaps = 70/374 (18%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M D +S ++D +++ E++G G+YG V +TG+ AIK ++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 61 EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLH 114
+ + I +EI +L+ H +I + + D +++V E +DL
Sbjct: 62 DEEEE---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 115 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA- 173
+ K N L E + ++LRGL ++H V HRD+K +N+L + ++K+ DFG++
Sbjct: 119 KNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 174 --------RVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA 222
R F TP +W APE C + Y D+WS+G I A
Sbjct: 178 QLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-ITA 224
Query: 223 -ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 281
E+ G P P + +H + + + P+P + K +S+K
Sbjct: 225 IEMAEGAP--PLCD-MHPMRALFLIPRNPAP-------------------RLKSKKWSKK 262
Query: 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 341
F + +E L RP E+ + P+ + Q +++ +R
Sbjct: 263 FQS-------FIESCLVKNHSQRPATEQLMKHPFIRDQPN-----ERQVRIQLKDHIDRT 310
Query: 342 RITKEDVRELIYRE 355
+ + + E Y
Sbjct: 311 KKKRGEKDETEYEY 324
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 44/302 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
K IG+G+YG V +G+ +A+K+I + ++L ++ ++R P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
IV+ L D ++ ELM + V DD+ PE ++
Sbjct: 83 IVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 139 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L ++ + HRD+KP NIL + +K+CDFG++ + +I T R Y A
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMA 193
Query: 198 PE--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PE + Y D+WS+G EL TG+ +P N V D +T ++ P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGDPP--- 248
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ + FS F N + L + RP +E L P+
Sbjct: 249 -------------QLSNSEEREFSPSFIN-------FVNLCLTKDESKRPKYKELLKHPF 288
Query: 316 FK 317
Sbjct: 289 IL 290
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + IG GS+G V + VA+K +N E+ +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
P + +V + E S L+ + A++ + Q RG+ Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + D +KI DFGLA + + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y+ D+++ G + EL+TG+ + N + + I +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---------------NRDQIIEMVGRG 241
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRPTAEE 309
+ P K + P + RL+ L + +RP+
Sbjct: 242 SLS-----------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G+G+YGVV +G+ +A+K+I + + R+L ++ +R + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
V L D+++ ELM + QVI + + +++ L
Sbjct: 68 TVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 140 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + + Y AP
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAP 178
Query: 199 E--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E Y+ DIWS+G EL + FP + + ++ PSP+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQL-- 234
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
FS +F + + L K+RPT E + P+F
Sbjct: 235 -----------------PADKFSAEFVD-------FTSQCLKKNSKERPTYPELMQHPFF 270
Query: 317 K 317
Sbjct: 271 T 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 76/292 (26%), Positives = 120/292 (41%), Gaps = 57/292 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++EEV+G+G++GVVC A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 141
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 142 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ S Y+ D++S G I E++T + F I
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIG--------------GPAFRIMW 215
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ R P+ N L+ R + +P RP+ EE
Sbjct: 216 AVHNGTRP---------PLI-----KNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 78/337 (23%), Positives = 131/337 (38%), Gaps = 32/337 (9%)
Query: 5 QRKKSSADVDFFTEYGEGSR--YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
QRK+ A + + GE ++ +G G+ GVV +G +A K I +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIK 71
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND 121
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAG 126
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+ + +++GL Y+ + HRD+KP NIL N+ ++K+CDFG++ D+
Sbjct: 127 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS 185
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
F V TR Y +PE L G + Y+ DIWS+G E+ G+ P +
Sbjct: 186 MANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP---IPFSQKFPNANPLALR----- 291
+ + + E R R M + P N P L
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
Query: 292 -----LLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323
+ + L P +R ++ + + K E
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 51/289 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
I+E IG GS+G V A + G VA+K + + H LRE+ +++ LRHP+I
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 85 VE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
V + + PP ++ +V E + L++++ + L Y + +G+
Sbjct: 97 VLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 140 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
Y+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + A
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMA 207
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ D++S G I EL T + + N + +A
Sbjct: 208 PEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAA 250
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
V + R IP N NP ++E EP RP+
Sbjct: 251 VGFKCKR---------LEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V HRD+K +IL D ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
S Y +DIWS+G I E++ G+P P + + M L +P P
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEP--PYFS-DSPVQAMKRLRDSPPP-------- 259
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320
+ K S + LERML +P++R TA+E L P+
Sbjct: 260 ----------KLKNSHKVSPVLRD-------FLERMLVRDPQERATAQELLDHPFLLQTG 302
Query: 321 KVE 323
E
Sbjct: 303 LPE 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 39/312 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+++EVIG G+ VV +AY EKVAIK+I ++ + + +L+EI+ + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFLY 133
+IV + ++++V +L+ D+ + I A + L
Sbjct: 74 NIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVA 191
++L GL+Y+H HRD+K NIL D ++I DFG++ D +V
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T + APE+ Y DIWS G EL TG + H+ M L+ T
Sbjct: 189 TPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTL- 240
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
+N+ K+ + + F ++ L +P+ RPTA E L
Sbjct: 241 -------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAELL 286
Query: 312 ADPYFKGLAKVE 323
+F+ E
Sbjct: 287 RHKFFQKAKNKE 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+EE+IG G +G V A G++VA+K + T + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ ++ + L + +V E L++V+ + P+ + Q+ RG+ Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
H + HRDLK NIL ++ LKI DFGLAR T +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
W APE+ + S ++ D+WS G + ELLTG+ F G +
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID---------------G 219
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
V K PIP +L+E +P RP+
Sbjct: 220 LAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 45/348 (12%), Positives = 96/348 (27%), Gaps = 74/348 (21%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
+ ++G+G++ V A D + +K +K + + + ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERL 121
Query: 77 RLLRHPDIVEIKHILLPPSRREFKD-IYVVFELME-SDLHQVIK-----ANDDLTPEHYQ 129
+ ++ F++ +V EL L I +
Sbjct: 122 KPSMQHMFMKFYSAH------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNIL-----------ANADCKLKICDFGLARVAFN 178
F ++L ++ +H + H D+KP N + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
IF T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMK------ 285
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 297
V+NE + ++ P + ML
Sbjct: 286 --------------------VKNEGGECKPEGLFRRLPHL---------DMWNEFFHVML 316
Query: 298 AFEPKDRPTAEEALA---DPYFKGLAKVEREPSAQPVTKMEFEFERRR 342
+ + L F+ + + + E +R R
Sbjct: 317 NIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 88/340 (25%), Positives = 127/340 (37%), Gaps = 80/340 (23%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M + + E + E IGKGS+G V D RT + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPE-ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLE 58
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQV 116
E + I +EI +L P + + L + ++++ E + DL +
Sbjct: 59 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE- 112
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--- 173
L L ++L+GL Y+H+ HRD+K N+L + ++K+ DFG+A
Sbjct: 113 ---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
Query: 174 ------RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLT 226
R F TP FW APE+ S Y DIWS+G I A EL
Sbjct: 170 TDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELAR 214
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-----FSQK 281
G+P +L M L P K P +S+
Sbjct: 215 GEPPH------SELHPMKVLFLIP----------------------KNNPPTLEGNYSKP 246
Query: 282 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
+E L EP RPTA+E L + AK
Sbjct: 247 LKE-------FVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 87/327 (26%), Positives = 142/327 (43%), Gaps = 51/327 (15%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
P +R+ D D T+ E + + E +G+GSYG V A TG+ VAIK++ +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPE-EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVES 66
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVI 117
+ + I++EI +++ P +V+ + D+++V E SD+ ++
Sbjct: 67 DLQE---IIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR 118
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
N LT + L L+GL+Y+H HRD+K NIL N + K+ DFG VA
Sbjct: 119 --NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAG 173
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNV 236
T T + T ++ APE+ Y DIWS+G I A E+ GKP P +
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKP--PYAD- 227
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+H + + + P P +KP +S F + +++
Sbjct: 228 IHPMRAIFMIPTNPPP------------------TFRKPELWSDNFTD-------FVKQC 262
Query: 297 LAFEPKDRPTAEEALADPYFKGLAKVE 323
L P+ R TA + L P+ + V
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 67/317 (21%), Positives = 124/317 (39%), Gaps = 67/317 (21%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + TG A K I + + + EI++L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPY 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
IV++ ++++ E + +++ + LT Q Q+L L
Sbjct: 78 IVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEAL 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
++H+ + HRDLK N+L + +++ DFG++ R +F TP +W
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM--- 184
Query: 191 ATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDL 246
APE+ K Y DIWS+G I E+ +P P ++ + ++ +
Sbjct: 185 ------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHE-LNPMRVLLKI 234
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
+ P P +S +F + L+ L P+ RP+
Sbjct: 235 AKSDPP------------------TLLTPSKWSVEFRD-------FLKIALDKNPETRPS 269
Query: 307 AEEALADPYFKGLAKVE 323
A + L P+ + +
Sbjct: 270 AAQLLEHPFVSSITSNK 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 79 LRHPDIVEIKHILLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 130
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + T T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ---TNHV 172
Query: 191 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
T Y +PE DI+SIG + E+L G+P F G
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG---------------- 214
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAE 308
+ +IA + ++ P + + ++ R + +R T +
Sbjct: 215 ETAVSIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 309 EALADPYFKGLAKVEREPSA 328
E D L+ V E A
Sbjct: 265 EMKDD-----LSSVLHENRA 279
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 46/289 (15%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ + G + + G + +K + + E LR+ HP++
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 85 VEIK-HILLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+ + PP+ ++ M L+ V+ N + F + RG+
Sbjct: 70 LPVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 141 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++HT + L ++++ + D +I + + + W AP
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM---YA----PAWV-AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L + D+WS + EL+T + F + + E +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
V E R IP P +P +L++ + +P RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 75/303 (24%), Positives = 115/303 (37%), Gaps = 40/303 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E IGKG +G V GE+VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYV 190
++H V HRDLK KNIL + I D GLA + T T I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G + +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
PS E + +V E+ R IP + A + +++ R T
Sbjct: 272 PSDPSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 307 AEE 309
A
Sbjct: 324 ALR 326
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 76/300 (25%), Positives = 111/300 (37%), Gaps = 34/300 (11%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + IGKG YG V + GEKVA+K E S EI L+RH +I
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENI 93
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ I + +Y++ + E+ L+ +K+ L + Y + GL ++
Sbjct: 94 LGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150
Query: 143 HTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
HT HRDLK KNIL + I D GLA +DT I V T+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 194 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y PE L S + + D++S G I E+ G +QL +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSD 269
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
PS E + + K R P +L+ A P R TA
Sbjct: 270 PSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 59/308 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RY++ E++G G V A D R VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 79 LRHPDIVEI--------KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 129
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 190 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248
V T Y +PE D++S+GC+ E+LTG+P F G
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD-------------- 222
Query: 249 TPSPEAIA--RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP- 305
SP ++A VR + PIP S + + ++ + LA P++R
Sbjct: 223 --SPVSVAYQHVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267
Query: 306 TAEEALAD 313
TA E AD
Sbjct: 268 TAAEMRAD 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 75/318 (23%), Positives = 115/318 (36%), Gaps = 53/318 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLR 80
Y++ ++G+G G V A DT VA+K +++ SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 81 HPDIVEIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P +V I H E YV L+ DL +++ L P + Q+
Sbjct: 93 EPHVVPI-H-----DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRA 197
L H A HRD+KP+NIL +AD + DFG+A ++ T T +Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ---LGNTVGTLYYMA 203
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE S T DI+++ C+ E LTG P + G + A
Sbjct: 204 PERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS---------------VMGAH 246
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-PTAEEALADPYF 316
+ S P ++ R +A P+DR T + A
Sbjct: 247 INQA-------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA--- 290
Query: 317 KGLAKVEREPSAQPVTKM 334
T +
Sbjct: 291 --AHAALATADQDRATDI 306
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 63/305 (20%), Positives = 107/305 (35%), Gaps = 40/305 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYV 190
++H + HRDLK KNIL + + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
T+ Y APE L + +DIW+ G + E+ G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306
PS E + +V +R IP +L++ P R T
Sbjct: 238 PNDPSFEDMRKVVCVDQQR--------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 307 AEEAL 311
A
Sbjct: 290 ALRIK 294
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 70/313 (22%), Positives = 114/313 (36%), Gaps = 61/313 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+Y+++ I G G + A D G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP IV+I + + R Y+V E + L + L +L ++L L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ + +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + T A DI+++G A L P G+ V P + + +
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDDPVLKT- 293
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRP-TAEEALADPYFK 317
+ RLL R + +P+ R TAEE A
Sbjct: 294 ---------------------------YDSYGRLLRRAIDPDPRQRFTTAEEMSAQ---- 322
Query: 318 GLAKVEREPSAQP 330
L V RE AQ
Sbjct: 323 -LTGVLREVVAQD 334
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 42/304 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 86 -----EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
E + D++++ E L +KAN ++ + RGL
Sbjct: 82 QFIGAEKR------GTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGL 134
Query: 140 KYIHTA----------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
Y+H + HRD+K KN+L + I DFGLA F +A
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQ 193
Query: 190 VATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
V TR Y APE+ +F ID++++G + EL + G + L ++
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
Query: 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDRP 305
PS E + V K +R P+ +A L +E + + R
Sbjct: 254 GQHPSLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 306 TAEE 309
+A
Sbjct: 305 SAGC 308
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 29/240 (12%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
P Q +K + DF K +++G+GS+ V A + T + AIK + I
Sbjct: 20 PPPQPRKKRPE-DF----------KFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQ 115
+ + + RE ++ L HP V++ F+D +Y ++ +L +
Sbjct: 69 IKE-NKVPYVTRERDVMSRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLK 119
Query: 116 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
I+ +F+ +++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
++ A + +V T Y +PEL + D+W++GCI +L+ G P F N
Sbjct: 180 LSPESKQARANS-FVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 71 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D +
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEPGESPI 181
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WY APE SK++ A D+WS G + EL T + K+ + M +
Sbjct: 182 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG 234
Query: 253 EAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + L + R +P P + ++ M RP+
Sbjct: 235 Q----MIVFHLIELLKNNGRLPRP-------DGC-PDEIYMI--MTECWNNNVNQRPS 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 49/298 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 101
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 102 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D Y
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEPGESPI 212
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WY APE SK++ A D+WS G + EL T + K+ + M +
Sbjct: 213 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG 265
Query: 253 EAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + L + R +P P + ++ M RP+
Sbjct: 266 Q----MIVFHLIELLKNNGRLPRP-------DGC-PDEIYMI--MTECWNNNVNQRPS 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 57/302 (18%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
K +G+G +G V TGE+VA+K + + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNL 80
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
H +IV+ K I + I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
WY APE SK+ A D+WS G ELLT + + + ++G
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
Query: 251 SPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDR 304
+ + + L + P P + L M F+P +R
Sbjct: 244 HGQ----MTVTRLVNTLKEGKRLPC----------PPNCPDEVYQL--MRKCWEFQPSNR 287
Query: 305 PT 306
+
Sbjct: 288 TS 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 83 DIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLY 133
++V+ LL PP Y++ E M +L ++ + +++ +
Sbjct: 70 NLVQ----LLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 186
Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ DT TA I W
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
T APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 179 T---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 52/299 (17%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +GKG++G V TG VA+K++ REI++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHS 83
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
IV+ + + P R + + +V E + S L ++ + L + Q+ +G+
Sbjct: 84 DFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + HRDL +NIL ++ +KI DFGLA++ D YV
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREPGQSPI 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTP 250
WY APE + ++ D+WS G + EL T K P + + D
Sbjct: 195 FWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VPA 249
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRPT 306
+ + E+ +R + P A P + L M A P+DRP+
Sbjct: 250 LSRLLELL--EEGQR----LPA----------PPACPAEVHEL--MKLCWAPSPQDRPS 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRW 194
++Y+ N HRDL +N+L + D K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 49/312 (15%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+ E+IG+G YG V D VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKGSLD---ERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNI 69
Query: 85 V-----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + + +V E + L + + + + + RG
Sbjct: 70 ARFIVGDER-----VTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRG 123
Query: 139 LKYIHTANVF---------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
L Y+HT HRDL +N+L D I DFGL+ + D
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 190 -----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVV- 237
V T Y APE L G+ +D++++G I+ E+ LFPG++V
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-QKFPNANPLALRLLERM 296
+Q+ T++ P+ E + + + + +R P + ++ A +E
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQR--------PKFPEAWKENSLAVRSLKETIEDC 295
Query: 297 LAFEPKDRPTAE 308
+ + R TA+
Sbjct: 296 WDQDAEARLTAQ 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 34/234 (14%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGE--KVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
++ E +G GS+GVV +D +G+ VA+K + D+ +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/301 (22%), Positives = 106/301 (35%), Gaps = 57/301 (18%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
H I++ K + +V E + L + + + F Q+ G
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+H + HRDL +N+L + D +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
WY APE K+ A D+WS G ELLT + +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERML---AFEPKDRP 305
+ + + L + + P+ P + L M E RP
Sbjct: 253 GQ----MTVLRLTELLERGERLPR----------PDKCPAEVYHL--MKNCWETEASFRP 296
Query: 306 T 306
T
Sbjct: 297 T 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + +G G +GVV + VA+K I E +E + + L HP +V
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 86 EIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLR 137
+ P IY+V E + + L ++++ L P Y +
Sbjct: 67 K----FYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ ++ + HRDL +N L + D +K+ DFG+ R +D YV++
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKF 167
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 168 PVKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 49/298 (16%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G VC T + A+K +N E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +++V +L+ DL ++ N E + F+ +L+ L Y+
Sbjct: 81 WY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL + + I DF +A + +T T+ Y APE
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSS 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y+ A+D WS+G ELL G+ + +R+
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPY-------------------------HIRSST 223
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-PTAEEALADPYFKGL 319
+ + + + + + + + LL+++L P R + PY +
Sbjct: 224 SSKEIVHTFETTVVTYPSAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 53/233 (22%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 139
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
+Y+ N HR+L +N L + +K+ DFGL+R+ DT TA I WT
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 386
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ IG G +G+V Y +KVAIK I E + E +++ L HP +V
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ L + I +V E ME L ++ E + G+ Y+
Sbjct: 67 Q----LYGVCLEQ-APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKWA- 172
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 173 SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPD 83
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQL 135
IV L+ P IY+V EL++ D ++ L + +
Sbjct: 174 IVR----LIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
G++Y+ + HRDL +N L LKI DFG++R + A V +W
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + + +Y+ D+WS G + E + G +P + ++
Sbjct: 283 -APE---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 75/343 (21%), Positives = 123/343 (35%), Gaps = 63/343 (18%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y + D +S+GC+ +LL G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYF 316
K + + M + F P LLE +L + R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 317 KGL--AKVER---EPSAQPVTKM---EFEFERRRITKEDVREL 351
+ L V P P F+ +ED + +
Sbjct: 454 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI 496
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 28 EEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYRA 197
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE++IG G G VC G+ VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
++Y+ HRDL +N+L +++ K+ DFGL+RV +D A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 81 HPDIVEIKHILL-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 47/299 (15%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 89 HILLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 265
+YT + D W++GC+ E++ G+ F + + + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------------- 399
Query: 266 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
+ K+ P +S++F A L ++L +P +R +A E P FK L
Sbjct: 400 ----LVKEVPEEYSERFSPQ---ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 34/236 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G +G V GE V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E F KYT D+WS G EL+T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
+ ++G+G +G V Y GEK VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 193 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/338 (19%), Positives = 130/338 (38%), Gaps = 59/338 (17%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEE-------VIGKGSYGVVCSAYDTRTGEKVAIK 54
P Q S F ++ + E V+G+G +G V + TG+ A K
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 55 KIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES- 111
K+N + + + E K+L + IV + + + + +V +M
Sbjct: 217 KLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGG 270
Query: 112 DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
D+ + V + N F+ Q++ GL+++H N+ +RDLKP+N+L + D ++I
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRI 330
Query: 168 CDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
D GLA + T T + T + APEL +Y ++D +++G E++
Sbjct: 331 SDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIA 384
Query: 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 286
+ F + + + + ++ + + KF
Sbjct: 385 ARGPFRARGEKVENKELKQRV------------------------LEQAVTYPDKFS--- 417
Query: 287 PLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 319
P + E +L +P+ R + + P F+ +
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 33/236 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLR 77
+ I++V+G G +G VCS +K VAIK + ++ R L E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMG 101
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQL 135
HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L +
Sbjct: 102 QFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT--- 192
G+KY+ HRDL +NIL N++ K+ DFGL RV +D A Y
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGK 211
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW +PE + K+T A D+WS G + E+++ G+ + + V+ +D
Sbjct: 212 IPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 348
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 349 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ +G G +GVV R VAIK I E + E K++ L H +V
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
++ + + + I+++ E M + L ++ + + ++Y+
Sbjct: 83 QLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
+ HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRWS- 188
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 189 PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 34/237 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLL 76
S ++VIG G +G V + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-- 192
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
++Y+ N HRDL +N+L + D K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 431
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 432 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQ 134
+V L P IY++ E ME+ L +K LT Q
Sbjct: 69 RLVR----LYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWT 187
+ G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 178 ---------APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 72
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 64/306 (20%), Positives = 116/306 (37%), Gaps = 55/306 (17%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++ V +TG+ A+K +N D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
F+D +Y+V E DL + K + + E +F+L +++ + +
Sbjct: 127 HF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEIL 235
Query: 201 ----CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
G Y P D W++G E+ G+ F +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------------------- 276
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALAD 313
Y + K+ + A ++R+L P+ R A +
Sbjct: 277 -------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
Query: 314 PYFKGL 319
P+F GL
Sbjct: 329 PFFFGL 334
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 86
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 87 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNKTGAKL 194
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 195 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 33/241 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
+ + +++G+G +G V + KVA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 132
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVA 191
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 192 T-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQL 240
+W A E YT D+W+ G E+ T G +PG + L
Sbjct: 206 GRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 241 D 241
Sbjct: 263 L 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E+ +G G +G V A + KVA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 39/291 (13%), Positives = 68/291 (23%), Gaps = 65/291 (22%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY++ G A DT +VA+ ++ L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
P + + ++ + VV E + L +V + +P + L
Sbjct: 90 KPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H A V P + + D + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
P DI IG LL + P V L A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTA 219
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ PI + + + R + + R +
Sbjct: 220 GQ-------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V + A+K +N ++ + ++ E +L I +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTL 139
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ F+D +Y+V + DL + K D L E +F+L +++ + +
Sbjct: 140 HY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H + HRD+KP NIL + + +++ DFG ++ + T + V T Y +PE+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SV-AVGTPDYISPEIL 248
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+Y P D WS+G E+L G+ F +++V
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------------------- 287
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALA 312
Y M K+ F + + + A L+ R++ R E+
Sbjct: 288 -----ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI----CSREHRLGQNGIEDFKK 338
Query: 313 DPYFKGL 319
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ VIGKG +GVV + + AIK ++ I E LRE L+R L HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHP 82
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ L+ +V+ M DL Q I++ + T + F Q+ RG++
Sbjct: 83 NVLA----LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHARL 190
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E ++T D+WS G + ELLT G P + + + H L
Sbjct: 191 PVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 150
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 151 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNKTGAKL 258
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 259 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V T + A+K ++ ++ + SD+ E ++ P +V++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQL 134
Query: 88 KHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +Y+V E M DL ++ N D+ + +F+ +++ L IH
Sbjct: 135 FY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIH 185
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LC 201
+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPEVLKS 243
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y D WS+G E+L G F ++V
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-25
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 48/239 (20%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 81 HPDIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLY 133
HP IV+ L+ P ++++ EL +L ++ L + Y
Sbjct: 450 HPHIVK----LIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
QL L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKAS 550
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 551 KGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ + ++GKG +G V A + KVA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 80 RHPDIVEIKHI-LLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 131
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQ 239
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 240 LD 241
L
Sbjct: 252 LI 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 32/243 (13%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K + I + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPE 253
E L S + A+D WS+G + ++LTG P F G+N +D I+ L P + E
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247
Query: 254 AIA 256
A
Sbjct: 248 ARD 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKLLRL 78
E +G+G++ + G+ +V +K ++ H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVAFNDTPTAIFWTD 188
+ ++ + H ++ KNIL + K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/245 (23%), Positives = 106/245 (43%), Gaps = 38/245 (15%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
K+ D E + ++++ +G GS+G V +G A+K +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 60 F-----EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELME- 110
EH + RIL+ + P +V+++ FKD +Y+V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAG 125
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
++ ++ + H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G A+ T WT T APE+ S Y A+D W++G + E+ G P
Sbjct: 186 GFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 231 FPGKN 235
F
Sbjct: 238 FFADQ 242
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 61/238 (25%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K + I + + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R + V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 147 VFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
V +RD+K +N++ + D +KI DFGL + ++ T F T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTF----CGTPEYLAPEVLED- 179
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIA 256
+ Y A+D W +G + E++ G+ F ++ +L I+ + + P SPEA +
Sbjct: 180 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKS 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHP 82
++I +G GS+G V G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
I+ + F+D I+++ + +E +L +++ + +F+ ++
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATR 193
L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + T +T DY+
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI--- 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
APE+ + Y +ID WS G + E+L G F N
Sbjct: 171 ---APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 42/269 (15%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI----- 56
+P + K + DF + +++GKGS+G V A +T + AIK +
Sbjct: 7 RPSLQIKLKIE-DF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 57 --NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113
+D E T + + + L HP + + ++ V E + DL
Sbjct: 56 LMDDDVEC----TMVEKRV-LSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDL 105
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
I++ F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG+
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
Query: 174 R--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + + T F T Y APE+ KY ++D WS G + E+L G+ F
Sbjct: 166 KENMLGDAK-TNTF----CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 232 PGKNVVHQLD-IMTDLLGTP---SPEAIA 256
G++ I D P EA
Sbjct: 219 HGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 48/273 (17%)
Query: 9 SSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKI------- 56
++ V F G R K+ + V+GKGS+G V + T E A+K +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 57 NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE------LME 110
+D E T + + + L + P + ++ R +Y V E LM
Sbjct: 61 DDDVEC----TMVEKRV-LALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLM- 109
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
H I+ H F+ ++ GL ++ + + +RDLK N++ +++ +KI DF
Sbjct: 110 --YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165
Query: 171 GLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 227
G+ + + T T F T Y APE + Y ++D W+ G + E+L G
Sbjct: 166 GMCKENIWDGVT-TKTF----CGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAG 217
Query: 228 KPLFPGKNVVHQLD-IMTDLLGTP---SPEAIA 256
+ F G++ IM + P S EA+A
Sbjct: 218 QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 56/255 (21%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V Y+ + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAEL 70
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L L+H IV+ + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVK----FYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 121 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 179 DTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 230 LFPGKN---VVHQLD 241
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 17/234 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 146
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIA 256
Y A+D W +G + E++ G+ F ++ + I+ + + P PEA +
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 378
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 7e-22
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 33/242 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 402
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ R +Y V E + DL I+ H F+ ++ GL +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE 199
+ + + +RDLK N++ +++ +KI DFG+ + + T T F T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTF----CGTPDYIAPE 512
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
+ Y ++D W+ G + E+L G+ F G++ IM + P S EA
Sbjct: 513 IIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 255 IA 256
+A
Sbjct: 570 VA 571
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 55/254 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V ++ + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 122
L +L+H IV + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVR----FFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 123 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 180 TPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 231 FPGKN---VVHQLD 241
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 63/242 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
S + E +G+ +G V + GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+HP++V LL P + ++F DLH+ +
Sbjct: 66 RARLQHPNVVC----LLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 173 ARVAFNDTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R ++ DY RW APE + K++ DIWS G + E+
Sbjct: 175 FRE--------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEV 223
Query: 225 LT 226
+
Sbjct: 224 FS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 66/247 (26%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRL 78
+ +G+GS+G+V A E +VAIK +N E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 79 LRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----------D 121
+V LL P V+ ELM DL +++
Sbjct: 85 FNCHHVVR----LLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------ 187
Query: 182 TAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ TDY YR +PE +T D+WS G + E+ T +
Sbjct: 188 --IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 229 PLFPGKN 235
+ G +
Sbjct: 239 QPYQGLS 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 65/244 (26%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ +L + T E +F+L +L
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALA 138
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H+ + +RDLKP+NIL + + +K+ DFGL++ + + A + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SP 252
E + +T + D WS G + E+LTG F GK+ + I+ LG P SP
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFLSP 251
Query: 253 EAIA 256
EA +
Sbjct: 252 EAQS 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + +RDLK N+L + + K+ DFG+ + T TA F T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATF----CGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
L Y PA+D W++G + E+L G F +N + I+ D + P +A
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA 251
Query: 255 IA 256
Sbjct: 252 TG 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 70/318 (22%), Positives = 125/318 (39%), Gaps = 54/318 (16%)
Query: 20 GEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILRE 72
G +++ VIG+GSY V +T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 73 IK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF 130
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTD 188
+ ++ L Y+H + +RDLK N+L +++ +K+ D+G+ + + DT T+ F
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF--- 170
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 171 -CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------ 220
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR--- 304
+ YL + +K I + A +L+ L +PK+R
Sbjct: 221 -------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 264
Query: 305 ---PTAEEALADPYFKGL 319
+ P+F+ +
Sbjct: 265 HPQTGFADIQGHPFFRNV 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 48/281 (17%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKK 55
M + + K + VIGKGS+G V A A+K
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 56 I-------NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF-- 106
+ +H R + LL+ ++HP +V + + +Y V
Sbjct: 71 LQKKAILKKKEEKH----IMSERNV-LLKNVKHPFLVGLHFSFQTADK-----LYFVLDY 120
Query: 107 ----ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162
EL H ++ +F+ ++ L Y+H+ N+ +RDLKP+NIL ++
Sbjct: 121 INGGELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 163 CKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
+ + DFGL + + N T T+ F T Y APE+ Y +D W +G +
Sbjct: 176 GHIVLTDFGLCKENIEHNST-TSTF----CGTPEYLAPEVLHK--QPYDRTVDWWCLGAV 228
Query: 221 FAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIA 256
E+L G P F +N ++ +I+ L + A
Sbjct: 229 LYEMLYGLPPFYSRN-TAEMYDNILNKPLQLKPNITNSARH 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (229), Expect = 1e-20
Identities = 51/349 (14%), Positives = 87/349 (24%), Gaps = 75/349 (21%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI------NDIFEHVSDATRI 69
F+ + + E IG+G +G V T VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 70 LREIKLLRLL---------RHPDIVEIKHILL-------------------------PPS 95
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 154
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK-------ARRYL 267
+F ++ + LF G +Q DI L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFDI-YRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
K + ML F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
VIG+GSY V +T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ +RDLK N+L +++ +K+ D+G+ + + DT T+ F T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF----CGTPNYIAPEILRG 227
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD----------IMTDLLGTP-- 250
Y ++D W++G + E++ G+ F D I+ + P
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 251 -SPEAIA 256
S +A +
Sbjct: 285 LSVKAAS 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 86
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 87 ISKFNHQNIVR----CIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 193
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 194 YRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 251 NQEVLEFVT 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
R K+ + +G+G++G V A+ VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V LL + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 178 NDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 229 PLFPGKNVVHQL 240
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 70/336 (20%), Positives = 135/336 (40%), Gaps = 57/336 (16%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYG---VVCSAYDTRTGEKVAIKK 55
+Q ++ G + IE V+G G+YG +V TG+ A+K
Sbjct: 30 EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 56 IN--DIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELMES- 111
+ I + E ++L +R P +V + + ++ ++++ + +
Sbjct: 90 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK-----LHLILDYINGG 144
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171
+L + + T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 172 LAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
L++ VA F T Y AP++ S + A+D WS+G + ELLTG
Sbjct: 205 LSKEFVADETERAYDF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPL 288
F + ++ +S K P+ Q+ A L
Sbjct: 261 PFTVDG------------------------EKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 289 ALRLLERMLAFEPKDR----PT-AEEALADPYFKGL 319
RLL + +PK R P A+E +F+ +
Sbjct: 297 IQRLLMK----DPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 127
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 128 ISKFNHQNIVR----CIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 234
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 235 YRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 292 NQEVLEFVT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/247 (22%), Positives = 91/247 (36%), Gaps = 81/247 (32%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKANDD------ 122
+ +P+IV+ LL P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVK----LLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 123 ------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
L+ Q+ G+ Y+ HRDL +N L +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYR------------APELCGS-FFSKYTPA 211
+KI DFGL+R I+ DY Y+ PE S F+++YT
Sbjct: 213 VKIADFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTE 256
Query: 212 IDIWSIG 218
D+W+ G
Sbjct: 257 SDVWAYG 263
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 62/231 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLL-R 77
+ K ++VIG+G++G V A + G + AIK++ E+ S E+++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81
Query: 78 LLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN---------- 120
L HP+I+ LL +Y+ E +L ++ +
Sbjct: 82 LGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 121 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 175 VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIG 218
+ YV RW A E +S YT D+WS G
Sbjct: 191 --GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYG 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 61/255 (23%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + + +G G++G V +A+ + KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME---------------SDL 113
+ L +H +IV LL P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
AN + F Q+ +G+ ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 227 -GKPLFPGKNVVHQL 240
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 73/243 (30%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + +G+G +G V +A+ + VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+ + HP +++ L P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 121 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 165 LKICDFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 215
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 216 SIG 218
S G
Sbjct: 237 SFG 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 68/260 (26%), Positives = 96/260 (36%), Gaps = 67/260 (25%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+R + +G G++G V +AY + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 120
L L H +IV LL P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 222 AELLT-GKPLFPGKNVVHQL 240
EL + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G +++ + IG G++G + + T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
+ + + +G+G++G V A + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I D Y T +W APE F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLM 249
Query: 222 AELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 72/261 (27%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREIKLL 76
+ + +G+G +G V A + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 77 -RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
+ +H +I+ LL P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 173 ARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 223
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 224 LLT-GKPLFPG---KNVVHQL 240
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 63/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
R + + +G+G++G V A + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 220
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 221 FAELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+RY++ IG GS+G + D GE+VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 74/266 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +V+G G++G V +AY +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME------------------ 110
+ +L H +IV LL P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 111 ------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
+ + + LT E F YQ+ +G++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 165 LKICDFGLAR-VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 215
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 216 SIGCIFAELLT-GKPLFPGKNVVHQL 240
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 35/170 (20%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+++ + + IG G +G++ A+ T EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVE-------IKHILLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
D ++ + ++ +P + ++V E + DL ++ N
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 81.4 bits (200), Expect = 3e-16
Identities = 94/519 (18%), Positives = 165/519 (31%), Gaps = 153/519 (29%)
Query: 44 DTRTGE-KVAIKKINDIFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHIL 91
D TGE + K I +FE V D + IL + EI HI+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHII 55
Query: 92 LPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLKY 141
+ +F + S ++++ + L Y+F + + + Y
Sbjct: 56 MSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRMY 112
Query: 142 IHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVAFN 178
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 179 DT------PTAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWS-----IGC 219
IFW + + +PE L +T D S I
Sbjct: 173 SYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 220 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA------RV----RNEKARRYLSS 269
I AEL + L K + L ++ ++ + +A ++ R ++ +LS+
Sbjct: 230 IQAEL---RRLLKSKPYENCLLVLLNVQ---NAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 270 MRKKKP--IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA-DPYFKGL-AKVERE 325
S LL + L P+D P E L +P + A+ R+
Sbjct: 284 ATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRD 339
Query: 326 PSAQPVTKMEFEFER-RRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDH 384
A ++ + + + + +I + L EP
Sbjct: 340 GLAT--------WDNWKHVNCDKLTTII------------ESSLNVLEP---------AE 370
Query: 385 FKKQFAYLEEHYGKGTTVAPPERQHASLPRP--CVLYSDKTVQNSAAVTDDLSKCSIKEV 442
++K F L +V PP A +P +++ D + V + L K S+ V
Sbjct: 371 YRKMFDRL--------SVFPP---SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--V 417
Query: 443 EKPPMDRTSGIPMARLPIQVPQAGAARPGKVVSSVLRYN 481
EK P + T IP L ++V + + V YN
Sbjct: 418 EKQPKESTISIPSIYLELKVKLENEYALHRSI--VDHYN 454
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+++++ IG GS+G + + +T E+VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 76/235 (32%)
Query: 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLR 80
+IG G +G V Y R G KVA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKV---YKGVLRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 81 HPDIV-------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 128
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 129 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 182 TAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGKP 229
T +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 65/230 (28%)
Query: 30 VIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSD--ATRILREIKLLRLLRHPDIV- 85
+G+G +GVV Y VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVV---YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL--- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 137 ---------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
G+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 182 TAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
T + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 TVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 36/176 (20%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ +K+ IG+G +G + A D + E V + SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVE-------IKHILLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
P+ ++ +K++ +P + +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 YQFFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 174
+F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 26/176 (14%), Positives = 63/176 (35%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG--------EKVAIKKINDIFEHVSDATRILREI 73
G ++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQ 93
Query: 74 KLL-RLLRHPDIVEIKHILLPPS----------RREFKDIYVVFELMESDLHQVIKANDD 122
R + + + K + P + K ++V + L + +
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK 153
Query: 123 LT-PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 174
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AELLT-GKPLFPGKNVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 30 VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIV- 85
++G+G +G V Y G VA+K++ + E E++++ + H +++
Sbjct: 37 ILGRGGFGKV---YKGRLADGTLVAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 86 ------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLY 133
LL V+ M S L + ++ L P+ + L
Sbjct: 92 LRGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL- 138
Query: 134 QLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
RGL Y+H + HRD+K NIL + + + + DFGLA++ + T + T
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVR 196
Query: 191 ATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
T + APE G K + D++ G + EL+TG+
Sbjct: 197 GTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.03 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-68 Score=565.70 Aligned_cols=344 Identities=50% Similarity=0.886 Sum_probs=300.8
Q ss_pred cccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
+-..|.++++|++++.||+|+||+||+|+++.+|+.||||+|++.........++.+|+.+|+.|+|||||++++++...
T Consensus 46 ~~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 46 FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp --CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 33446788999999999999999999999999999999999987766667778899999999999999999999998654
Q ss_pred C-cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 95 S-RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 95 ~-~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
. +.+...+|||||||+|+|.+++..++.+++..++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 2 345578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCC-CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDT-PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+...... .......+.+||++|||||++.+. ..|+.++||||+|||+|||++|++||.+.+..+++..|....|+|+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8654322 122234678999999999998763 46799999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVT 332 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~ 332 (558)
..+..+.......++..+....+.++...+++++++++|||.+||.+||.+|||++|+|+||||+....+..++...+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~-- 362 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP-- 362 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--
Confidence 988888777888888888888888888889999999999999999999999999999999999999888777776554
Q ss_pred cchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 333 KMEFEFERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 333 ~~~~~~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
.+++.++...++.+++++.+++||.++|.
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 34566788889999999999999998876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-60 Score=509.61 Aligned_cols=347 Identities=42% Similarity=0.756 Sum_probs=290.3
Q ss_pred ccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
...+.+.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 46 HSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CSSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 34577889999999999999999999999999999999999877777777889999999999999999999999998776
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
......+|+||||++++|.+++.....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 66677899999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC------------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-----
Q 008644 176 AFNDTPT------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT----- 226 (558)
Q Consensus 176 ~~~~~~~------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt----- 226 (558)
....... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 5422111 1134667899999999986432 579999999999999999999
Q ss_pred ------CCCCCCCCC--------------------hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCC
Q 008644 227 ------GKPLFPGKN--------------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 280 (558)
Q Consensus 227 ------G~~pF~~~~--------------------~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (558)
|+++|+|.+ ..+++..|.+++|+|..+.+..+.......++..+.......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 888998865 368899999999999999999999999999999998888888899
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 008644 281 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (558)
Q Consensus 281 ~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (558)
.++.+++.+++||.+||.+||.+|||++|+|+||||+++.....++.......+.+. +...++.+++++.+++||..||
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~ 443 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYH 443 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999999999999877666554433333332 3357889999999999999999
Q ss_pred hhhH
Q 008644 361 PQML 364 (558)
Q Consensus 361 p~~~ 364 (558)
|++.
T Consensus 444 ~~~~ 447 (458)
T 3rp9_A 444 PEIQ 447 (458)
T ss_dssp TTCC
T ss_pred cccc
Confidence 8643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=503.47 Aligned_cols=351 Identities=39% Similarity=0.698 Sum_probs=302.6
Q ss_pred CCcccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcccccee
Q 008644 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (558)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i 90 (558)
.....+..+.+.++|++++.||+|+||.||+|+++.+|+.||||++...+.......++.+|+.+|+.++||||++++++
T Consensus 14 ~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 14 LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 34456788899999999999999999999999999999999999998777777788899999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
+..........+|+|||||+++|.+++.....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence 98766556678999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCC-------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-----
Q 008644 171 GLARVAFNDTPT-------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT----- 226 (558)
Q Consensus 171 Gla~~~~~~~~~-------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt----- 226 (558)
|+++........ ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccc
Confidence 999876433211 0134678999999999986432 579999999999999999998
Q ss_pred ------CCCCCCCCC-----------------hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCC
Q 008644 227 ------GKPLFPGKN-----------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 283 (558)
Q Consensus 227 ------G~~pF~~~~-----------------~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (558)
|.++|++.+ ..+++..|.+++|+|+.+.+..+.......++..+....+.++...++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 667777765 478999999999999999999999999999999998888888888889
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 008644 284 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 363 (558)
Q Consensus 284 ~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~ 363 (558)
.+++.+.+||.+||++||.+|||++|+|+||||+++.....++.........++ +...++.+++++.+++|+..++|++
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 999999999999999999999999999999999999887776644332222332 2357899999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=480.69 Aligned_cols=254 Identities=32% Similarity=0.549 Sum_probs=206.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .......++.+|+.+|+.++|||||++++++.+. ..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 47999999999999999999999999999999997533 2334456799999999999999999999999544 46
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+|||||||+|+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
...+.+||+.|||||++.+ ..| +.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-------------- 227 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-------------- 227 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence 2356799999999999987 454 67999999999999999999999988766554444321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. . .....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 228 -------------~-~---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -------------V-Y---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------C-C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------C-C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 0 112457899999999999999999999999999999973
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=489.31 Aligned_cols=260 Identities=26% Similarity=0.457 Sum_probs=225.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||+++++|.+. .
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 357999999999999999999999999999999997422 2234457799999999999999999999999543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------- 249 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------- 249 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 123467899999999999987 68999999999999999999999999998877666555431
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~e------lL~hp~f~~~~ 320 (558)
. .. ....+++++++||.+||+.||++|||++| +++||||+++.
T Consensus 250 --------------~-~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 250 --------------E-YD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp --------------C-CC---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------C-CC---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 0 11 12467899999999999999999999987 68999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-61 Score=497.38 Aligned_cols=271 Identities=26% Similarity=0.442 Sum_probs=221.7
Q ss_pred cCCCCcccccc---cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc
Q 008644 8 KSSADVDFFTE---YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84 (558)
Q Consensus 8 ~~~~~~~~~~~---~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI 84 (558)
-.|.++|+=++ |..-++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.|+||||
T Consensus 6 ~~ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI 85 (350)
T 4b9d_A 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85 (350)
T ss_dssp CC-------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC
Confidence 34556666444 233579999999999999999999999999999999998665566677889999999999999999
Q ss_pred cccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC
Q 008644 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (558)
Q Consensus 85 v~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~ 161 (558)
|++++++... ..+|||||||+ |+|.++|...+ .+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 86 V~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 160 (350)
T 4b9d_A 86 VQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160 (350)
T ss_dssp CCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT
T ss_pred CcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 9999999543 46999999998 59999997643 5799999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 008644 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241 (558)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~ 241 (558)
+|.+||+|||+|+...... ...+..+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.
T Consensus 161 ~g~vKl~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 235 (350)
T 4b9d_A 161 DGTVQLGDFGIARVLNSTV---ELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235 (350)
T ss_dssp TCCEEECSTTEESCCCHHH---HHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCEEEcccccceeecCCc---ccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 9999999999998653221 12356789999999999987 689999999999999999999999999988776665
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.|... . +......+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 236 ~i~~~---------------------------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 236 KIISG---------------------------S---FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHT---------------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHcC---------------------------C---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 55431 0 11223567999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=492.94 Aligned_cols=257 Identities=28% Similarity=0.511 Sum_probs=222.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
..|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+.+|+.++|||||+++++|... ..+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 569999999999999999999999999999999974322 2345688999999999999999999999654 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999998 599998876 4699999999999999999999999999999999999999999999999999987644322
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
..++.+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2366899999999999987 689999999999999999999999999988777665554311
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.+....+..+++++++||.+||+.||++|||++|+|+||||+...
T Consensus 287 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 011223456899999999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=474.02 Aligned_cols=260 Identities=27% Similarity=0.377 Sum_probs=218.0
Q ss_pred CCcE-EEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..|| ++.+.||+|+||+||+|+++.++..||||++...........++.+|+.+|+.|+|||||+++++|.... ....
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCc
Confidence 3455 8889999999999999999999999999999865556666788999999999999999999999985422 2234
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCC-CCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~-~~~lKL~DFGla~~~ 176 (558)
.+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. ++.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 6899999998 599999999889999999999999999999999999 999999999999985 799999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+....+...... +
T Consensus 183 ~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~-------- 245 (290)
T 3fpq_A 183 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-------- 245 (290)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T--------
T ss_pred CCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C--------
Confidence 322 2356799999999999865 6999999999999999999999999876654433222110 0
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.. .......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 246 ----------------~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 ----------------VK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------CC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00 01122456889999999999999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=482.76 Aligned_cols=335 Identities=42% Similarity=0.777 Sum_probs=287.5
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~- 95 (558)
+.+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 3467889999999999999999999999999999999999876666667788999999999999999999999997653
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
......+|+|||||+++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 234457899999998899999987 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.... .+..++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|+|+.+.+
T Consensus 178 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5432 2557899999999998653 56899999999999999999999999999999999999999999999999
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcch
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 335 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~ 335 (558)
..+.......++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+...+.++... .+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~ 327 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 327 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCC
Confidence 99999999999999988888888888999999999999999999999999999999999999998877776655 345
Q ss_pred hhHhhhcCCHHHHHHHHHHHHHhhChh
Q 008644 336 FEFERRRITKEDVRELIYREILEYHPQ 362 (558)
Q Consensus 336 ~~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (558)
+.++....+.+++++.+|++++.++|+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 328 DSFDDVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred CChhhhcCCHHHHHHHHHHHHHHhccc
Confidence 667777889999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=494.67 Aligned_cols=256 Identities=28% Similarity=0.508 Sum_probs=222.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||+++++|... ..+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ 223 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DEL 223 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEE
Confidence 57999999999999999999999999999999997432 23345688999999999999999999999654 369
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|||||||+ |+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999998 599998875 4699999999999999999999999999999999999999999999999999987644322
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 303 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 363 (423)
T 4fie_A 303 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 363 (423)
T ss_dssp ---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2367899999999999987 689999999999999999999999999988776665554311
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+....+..+++++++||.+||+.||++|||++|||+||||+..
T Consensus 364 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp --------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11123346789999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=481.16 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=215.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.++|||||++++++.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---- 98 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE---- 98 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----
Confidence 478999999999999999999984 4788999999975433333445688999999999999999999999544
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 99 -~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 99 -GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp -TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 46999999998 5999999998899999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+.
T Consensus 178 ~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------- 241 (304)
T 3ubd_A 178 DHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------- 241 (304)
T ss_dssp ---C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------
Confidence 3222 2356799999999999987 68999999999999999999999999998877666555431
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. . .....+++++.+||.+||+.||++||| ++|+|+||||+++
T Consensus 242 ---------------~--~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 ---------------K--L---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ---------------C--C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------C--C---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 0 0 112467999999999999999999998 5899999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-58 Score=482.83 Aligned_cols=340 Identities=39% Similarity=0.725 Sum_probs=275.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CC
Confidence 46899999999999999999999999999999999877777778888999999999997 999999999986532 34
Q ss_pred cEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.+|+|||||+++|..++..+ .+++..++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 79999999999999999874 79999999999999999999999999999999999999999999999999998653211
Q ss_pred ------------------CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 181 ------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 181 ------------------~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567999999999998652 5789999999999999999999999999999999999
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCC---CCCCCCCCC-------------CCCHHHHHHHHHhcccCCCCCCC
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKK---PIPFSQKFP-------------NANPLALRLLERMLAFEPKDRPT 306 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-------------~~s~~~~~Li~~mL~~dP~~Rpt 306 (558)
|...++.|..+.+..+.......++..+.... ...+...++ .+++.+.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999998887777777766655433 222333332 77999999999999999999999
Q ss_pred HHHHhcCccccCcccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhHHhh
Q 008644 307 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEF 367 (558)
Q Consensus 307 a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~ 367 (558)
++|+|+||||+.+.....++.+.......+. +....+.+++++.+|++|.++++++..+.
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 382 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISNK 382 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC-
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhhc
Confidence 9999999999999888887766554333332 23567899999999999999999876553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-58 Score=481.65 Aligned_cols=336 Identities=43% Similarity=0.822 Sum_probs=283.6
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~- 95 (558)
+.|.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 3467789999999999999999999999999999999999876666667788999999999999999999999987542
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
......+|+|+|+++++|.+++.. +.+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 103 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp GGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred cccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 234467899999999999998876 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.... .+..+||++|+|||++.+. ..|+.++|||||||++|+|++|+.||.+.+..+++..|.+.+|+|..+.+
T Consensus 182 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322 2557899999999998652 56899999999999999999999999999999999999999999999999
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcch
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 335 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~ 335 (558)
..+.....+.++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+.....++...+ +.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~ 331 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YD 331 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CC
Confidence 999999999999988887777888888999999999999999999999999999999999999888777765553 45
Q ss_pred hhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 008644 336 FEFERRRITKEDVRELIYREILEYHPQM 363 (558)
Q Consensus 336 ~~~e~~~~~~e~~~e~i~~ei~~~~p~~ 363 (558)
+.++......+++++++|+|+..++|+.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 332 QSLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred cchhhccCCHHHHHHHHHHHHHHhccCc
Confidence 6667778899999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=473.96 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=216.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++... ..
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~-----~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG-----PW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET-----TE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 3579999999999999999999999999999999974211 24799999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~~~~~~ 179 (558)
+|||||||+ |+|.++++..+.+++..++.|+.||+.||.|||++||+||||||+||||+.+| .+||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 59999999988999999999999999999999999999999999999999987 6999999999876443
Q ss_pred CCCc--ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~~--~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999987 6899999999999999999999999988776554444432
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCccccCccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA-------------LADPYFKGLAK 321 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el-------------L~hp~f~~~~~ 321 (558)
.+.++....+.+++.+.+||.+||+.||.+|||+.|+ |+|||+.....
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1112234457889999999999999999999999997 57999987643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=475.29 Aligned_cols=286 Identities=27% Similarity=0.437 Sum_probs=224.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
+.++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ .||||++++++|...
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 4578999999999999999999875 46789999998642 3456788999999988 599999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccce
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~ 174 (558)
.++|||||||+ ++|.+++. .+++..++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 93 ---~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 ---DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp ---TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred ---CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 47999999998 59999883 59999999999999999999999999999999999999887 799999999998
Q ss_pred eccCCCCC-------------------------cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 008644 175 VAFNDTPT-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229 (558)
Q Consensus 175 ~~~~~~~~-------------------------~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~ 229 (558)
........ ....++.+||++|+|||++.+. ..|+.++||||+|||+|||++|+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCC
Confidence 65322110 1123457899999999998762 468999999999999999999998
Q ss_pred CC-CCCChhhHHHHHHHhhCCCCHHHHHHhhh-----------HHHHHHHhhhccC------------CCCCCCCCCCCC
Q 008644 230 LF-PGKNVVHQLDIMTDLLGTPSPEAIARVRN-----------EKARRYLSSMRKK------------KPIPFSQKFPNA 285 (558)
Q Consensus 230 pF-~~~~~~~~~~~i~~~lg~p~~~~i~~~~~-----------~~~~~~~~~~~~~------------~~~~~~~~~~~~ 285 (558)
|| .+.+..+++..|..++|++.......... ...+.....+... ........+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 87 67788899999999999765443322110 0011111111110 001122346788
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 286 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 286 s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+++++|||++||++||++|+|++|+|+||||+++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-57 Score=487.28 Aligned_cols=333 Identities=37% Similarity=0.696 Sum_probs=267.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~ 98 (558)
.+.++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .+
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 44689999999999999999999999999999999998766677778889999999999999999999999976542 45
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
...+|+|||||+++|.+.+.. .+++..++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 567999999999999988854 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ..+..+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|+|.++.+..+
T Consensus 217 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred Cc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 22 2356899999999999987 68999999999999999999999999999999999999999999999988776
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCC------------CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 326 (558)
. ...+.++..........+...++.. ++.+++||.+||++||++|||++|+|+||||+.+.......
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 4455666655444444443333332 57899999999999999999999999999999876544332
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChh
Q 008644 327 SAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362 (558)
Q Consensus 327 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (558)
. .+.....+.++....+.+++++.+++++..++..
T Consensus 370 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 404 (464)
T 3ttj_A 370 A-PPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEK 404 (464)
T ss_dssp C-CC-----------CCCHHHHHHHHHHHHHC----
T ss_pred C-CCCccCCcchhhccCCHHHHHHHHHHHHHHhhhc
Confidence 2 1222345566777889999999999999876553
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=458.75 Aligned_cols=340 Identities=48% Similarity=0.864 Sum_probs=293.5
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+.++++|++++.||+|+||.||+|++..++..||||++.. .........+.+|+.+|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 46788999999999999999999999999999999999974 23445567889999999999999999999999776655
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+||||++++|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 66789999999999999999764 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..|...++.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 443333334567899999999987542 4589999999999999999999999999999999999999999999999998
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
..+.....+...+......++...++.+++.+.+||.+||+.||.+|||++|+|+||||+.......++.... .+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 8888888888888877777778888899999999999999999999999999999999998866555544332 23344
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhChh
Q 008644 338 FERRRITKEDVRELIYREILEYHPQ 362 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (558)
.+...+.++++++++++|+..++|.
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC-
T ss_pred cccccCCHHHHHHHHHHHHHHhhhh
Confidence 5666788999999999999988885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=450.24 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=201.0
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-------
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------- 96 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~------- 96 (558)
.|++++.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+.+|+.|+|||||+++++|.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999999643 233455779999999999999999999999865432
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~---l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
....++|||||||. |+|.+++..... .++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12345899999998 599999987664 45567899999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCc---------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 008644 173 ARVAFNDTPTA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (558)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i 243 (558)
|+......... ...+..+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+. .+....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 98764332211 12345789999999999987 689999999999999999996 77542 2233333
Q ss_pred HHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+..... ...++..++.+.+||++||+.||++|||+.|+|+||||+++.
T Consensus 238 ~~~~~~~~---------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKF---------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCC---------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCC---------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22211111 111223467788999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=446.19 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=283.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+...++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 556789999999999999999999999999999999998766666667889999999999999999999999976542 2
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 233469999999999988874 359999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+..
T Consensus 196 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 32 2456899999999998652 5789999999999999999999999999999999999999999999999888
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+.......++..+.......+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+.....+..... .+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~~ 346 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDS 346 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCcc
Confidence 8777777888877776666667777889999999999999999999999999999999998866554433221 12223
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
.+....+.+++++.+++++.+|+|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 347 LEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred hhhcccchHHHHHHHHHHHHhccc
Confidence 455678899999999999999887
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=476.74 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=226.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
-++|++++.||+|+||+||+|+++.+|+.||||++... ...+...+.+|+.+|+.|+|||||+++++|... ..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CE
Confidence 36899999999999999999999999999999999642 345567789999999999999999999999543 47
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC--CcEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~--~~lKL~DFGla~~~~ 177 (558)
+|||||||. |+|.++|.. .+.+++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599999864 4579999999999999999999999999999999999999864 899999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .....+||++|||||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|......
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-------- 374 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-------- 374 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--------
Confidence 332 2356799999999999987 68999999999999999999999999999887776665432111
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
.....++.+++.+++||.+||+.||.+|||++|+|+||||+.....
T Consensus 375 -------------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 375 -------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred -------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 1123456789999999999999999999999999999999875543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=438.93 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=283.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
+...++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 345689999999999999999999999999999999998665555667788999999999999999999999876432 2
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+||||+.++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 2345799999999998887743 59999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....++|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|..+.+..
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2456899999999998652 5688999999999999999999999999999999999999999999999888
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
+.......++..+.......+...++.+++.+.+||.+||..||.+|||++|+|+||||+.+...+.+..... .+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~ 328 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDS 328 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccc
Confidence 8877777888877776666777788899999999999999999999999999999999998776554433322 23344
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 338 FERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
.+...++.+++++.|++++.++.|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 329 LEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred hhhccCCHHHHHHHHHHHHHhhcc
Confidence 556788999999999999998775
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=434.61 Aligned_cols=337 Identities=42% Similarity=0.808 Sum_probs=277.8
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+.+.++|++.+.||+|+||.||+|.+..+|+.||||++.. .........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 45788999999999999999999999999999999999963 23445566788999999999999999999998766555
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+|+||||+.++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999877 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCc-------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 178 NDTPTA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 178 ~~~~~~-------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346899999999987542 568899999999999999999999999999999999999999887
Q ss_pred CHH-HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCC
Q 008644 251 SPE-AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 329 (558)
Q Consensus 251 ~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~ 329 (558)
... ............++..+.......+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.......++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 632 2233333444556665555444455556678999999999999999999999999999999999987776665555
Q ss_pred CCCc--chhhHhhhcCCHHHHHHHHHHHHH
Q 008644 330 PVTK--MEFEFERRRITKEDVRELIYREIL 357 (558)
Q Consensus 330 ~~~~--~~~~~e~~~~~~e~~~e~i~~ei~ 357 (558)
++.. +++......++.+++++++++||.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 5443 344555678899999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=472.87 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=213.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHH---HHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~---~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+. +++.+++.++|||||+++++|.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---- 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC----
Confidence 679999999999999999999999999999999964211 111222333 446677788999999999999554
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|||||||. |+|..+|...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 265 -~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred -CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 46999999998 5999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ..+.|||+.|||||++.+. ..|+.++||||||||||||++|++||.+.+..+....+...
T Consensus 344 ~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----------- 406 (689)
T 3v5w_A 344 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------- 406 (689)
T ss_dssp SCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH-----------
T ss_pred CCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-----------
Confidence 332 2457999999999998531 57999999999999999999999999875433322211110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
... . ...+..+++++++||.+||+.||.+|++ ++||++||||+++.
T Consensus 407 -------------~~~-~---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 407 -------------LTM-A---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------HHC-C---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------cCC-C---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 000 1 1123568999999999999999999998 89999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=433.80 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=207.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+++++.+.||+|+||+||+|+.. ..||||+++...........+.+|+.+|+.++|||||++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 368999999999999999999753 369999997655566677889999999999999999999998743 24
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|||||||+ |+|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 799999998 6999999764 57999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 186 ~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~------------ 252 (307)
T 3omv_A 186 SGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR------------ 252 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT------------
T ss_pred Ccc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 123557899999999998642 246899999999999999999999999887655444333211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...........+++++.+.+||.+||+.||++|||+.|++++
T Consensus 253 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 -------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112334556789999999999999999999999988653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=440.78 Aligned_cols=330 Identities=38% Similarity=0.694 Sum_probs=256.9
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-~~~~ 99 (558)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457999999999999999999999999999999999865556666778999999999999999999999987543 2344
Q ss_pred ccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred cceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 57999999999999999863 5999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|.++.+..+.
T Consensus 181 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345789999999999987 679999999999999999999999999999999999999999999988776653
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS 327 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~ 327 (558)
. ....++..........+...++. .++.+++||.+||+.||.+|||++|+|+||||+.+........
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 255 P-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp H-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred h-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 3 22333333222211111111111 1567999999999999999999999999999987654322111
Q ss_pred CCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 008644 328 AQPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (558)
Q Consensus 328 ~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (558)
. +........+....+.+++++++|.++..+.
T Consensus 334 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 334 P-PPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp C-CCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred C-CCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 1 1111223445567789999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=432.00 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=213.9
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
.+.-..++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|+.|+|||||++++++
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 33344578999999999999999999875 46889999999753 344567799999999999999999999999
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~-------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NI 157 (558)
... ..+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||
T Consensus 85 ~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI 159 (299)
T 4asz_A 85 VEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 159 (299)
T ss_dssp CSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence 654 36999999998 6999999764 2599999999999999999999999999999999999
Q ss_pred EeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008644 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (558)
|++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+.
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999865433221 11234579999999999987 689999999999999999998 8999998876
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.+.+..+... .. ......+++.+.+||.+||+.||++|||++|+ |+|+
T Consensus 237 ~~~~~~i~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L 284 (299)
T 4asz_A 237 NEVIECITQG---------------------------RV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLL 284 (299)
T ss_dssp HHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHH
T ss_pred HHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHH
Confidence 6554444321 11 11224678999999999999999999999999 4577
Q ss_pred cCcc
Q 008644 317 KGLA 320 (558)
Q Consensus 317 ~~~~ 320 (558)
+.+.
T Consensus 285 ~~~~ 288 (299)
T 4asz_A 285 QNLA 288 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=425.58 Aligned_cols=292 Identities=40% Similarity=0.680 Sum_probs=239.6
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
+.-+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 91 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-- 91 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--
Confidence 45588899999999999999999999985 589999999975544444567788999999999999999999998543
Q ss_pred CCCccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 92 ---RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp ---SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ---CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 4699999999999999988754 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.+..+
T Consensus 169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred cCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 543222 22456899999999998652 46899999999999999999999999999999999999999999887665
Q ss_pred HHhhhHHHHHHHh-hhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLS-SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
........ +.. ........++....+.+++++.+||.+||++||++|||++|+|+||||+++.
T Consensus 245 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPL--WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHH--HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccch--hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 54432211 111 0111112233344567899999999999999999999999999999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=431.66 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=203.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|+.|+|||||++++++...
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG-- 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 357999999999999999999865 46889999999742 345567899999999999999999999999543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~---------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
..+|||||||+ |+|.+++... +.+++..+..|+.||+.||.|||+.+|+||||||+|||++
T Consensus 116 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 36999999998 6999999753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12245689999999999987 689999999999999999999 8999998876655
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+..|... ... .....+++.+.+||.+||+.||++|||+.|+++
T Consensus 270 ~~~i~~g---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 270 IDCITQG---------------------------REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHHcC---------------------------CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 5444321 011 122467899999999999999999999999976
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=428.01 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=208.6
Q ss_pred CcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
+.+++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|+.|+|||||++++++...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 5789999999999999999985 3467899999997532 234457799999999999999999999999554
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
..+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||+.+|+||||||+||||+
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 35899999998 6999999653 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
+++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999875433221 12345689999999999977 689999999999999999998 8999998886655
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
+..|.. .... ...+++++.+.+||.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~---------------------------~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRN---------------------------RQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHT---------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHc---------------------------CCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444322 1111 1235678999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=414.09 Aligned_cols=287 Identities=38% Similarity=0.616 Sum_probs=236.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 589999999999999999999999999999999976555555667889999999999999999999998543 469
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+|||||+++|.+.+.. ++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887776 56799999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+...++.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22556899999999998762 3489999999999999999987755 788888899999999999888765543321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
... +...-............+.+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 100 0000000011223344567899999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=422.88 Aligned_cols=332 Identities=36% Similarity=0.670 Sum_probs=265.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---------ChhHHHHHHHHHHHHHhcCCCCcccccee
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---------HVSDATRILREIKLLRLLRHPDIVEIKHI 90 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---------~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i 90 (558)
...++|++++.||+|+||.||+|.+.. |..||||++..... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 356899999999999999999999865 99999999864222 22234778999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEee
Q 008644 91 LLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
+..........+|+||||++++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8765544556799999999999999988654 699999999999999999999999999999999999999999999999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
||+++....... ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975433222 2456899999999998653 46899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKK-KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 328 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~ 328 (558)
|..+.+..........++...... ....+....+..++.+.+||.+||+.||.+|||++|+|+||||+.+.........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 998887776666666665443322 2233444567789999999999999999999999999999999987644332211
Q ss_pred CCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 008644 329 QPVTKMEFEFERRRITKEDVRELIYREILEYH 360 (558)
Q Consensus 329 ~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~ 360 (558)
. ...+.+++...+.+++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1123445567788999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=417.90 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=224.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..-++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE----- 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence 345689999999999999999999999999999999987666667778899999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 46999999997 59999999888999999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 167 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 229 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----------- 229 (328)
T ss_dssp SC----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 32 2356789999999999976 455 47899999999999999999999988866554444321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
... ....+++.+.+||++||..||.+|||++|+|+||||+....
T Consensus 230 ---------------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 ---------------KYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---------------CCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---------------CCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 111 11346899999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=413.34 Aligned_cols=284 Identities=38% Similarity=0.657 Sum_probs=232.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5799999999999999999998 6799999999975433333446788999999999999999999998543 369
Q ss_pred EEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999874 5799999999999999999999999999999999999999999999999999976532211
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12456789999999998652 45899999999999999999999999999999999999988888766544332110
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+...+....+.++......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0111112223334455566788999999999999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=427.51 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=209.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCC-----CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H-pnIv~l~~i~~~~~~ 96 (558)
++|++++.||+|+||+||+|.+..+ ++.||||++... ........+.+|+.+|.+++| ||||+++++|....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~- 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence 6899999999999999999987654 468999999743 233456779999999999975 89999999986432
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl 159 (558)
..+|||||||+ |+|.++|+.. ..+++..+..|+.||+.||.|||+++||||||||+|||+
T Consensus 142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 35899999998 6999999753 248999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhh
Q 008644 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVH 238 (558)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~ 238 (558)
++++.+||+|||+|+....+.. .......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+...
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987644332 122355789999999999987 689999999999999999998 999998876443
Q ss_pred HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 239 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 239 ~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+..+.. ..... .....+++++.+||.+||+.||++|||+.||++|
T Consensus 296 ~~~~~i~--------------------------~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 296 EFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH--------------------------cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 3322211 01111 1224578999999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=416.68 Aligned_cols=288 Identities=34% Similarity=0.570 Sum_probs=233.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---ChhHHHHHHHHHHHHHhcC---CCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~~~ 95 (558)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5799999999999999999999999999999999863221 1122345667888777665 999999999987654
Q ss_pred cCCCccEEEEEecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
......+++||||++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 444446899999999999999988654 999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76533222 256789999999999976 678999999999999999999999999999999999999998888765
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+........ ..+....+.+.....+.+++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 4322111000 0111122233334456889999999999999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=421.57 Aligned_cols=269 Identities=28% Similarity=0.455 Sum_probs=229.1
Q ss_pred cccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh----hHHHHHHHHHHHHHhcCCCCccccc
Q 008644 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
|+.|..-.+.++|++++.||+|+||+||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp --CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 455666778889999999999999999999999999999999997533221 2356789999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC----
Q 008644 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---- 163 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---- 163 (558)
+++... ..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 82 ~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 82 DVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 998543 46999999996 69999998888899999999999999999999999999999999999998877
Q ss_pred cEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 008644 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (558)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i 243 (558)
.+||+|||+++....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|
T Consensus 157 ~vkl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CEEECCCSSCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CEEEEecCCceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 799999999987644322 255789999999999976 67999999999999999999999999998877666655
Q ss_pred HHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......... ..++.+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 231 ~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 231 TAVSYDFDE---------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HTTCCCCCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HhcCCCCCc---------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 543222211 1235678999999999999999999999999999999854
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=407.84 Aligned_cols=290 Identities=37% Similarity=0.673 Sum_probs=231.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
-++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----Ce
Confidence 3689999999999999999999999999999999976555555567788999999999999999999998543 46
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||++ +|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999996 677777777789999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++...+........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456899999999998652 5689999999999999999999999999999999999999888877654432221
Q ss_pred HHHHHHHhhhccCCC---CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 261 EKARRYLSSMRKKKP---IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
.. ++.......+ .+....++++++.+.+||.+||+.||.+|||++|+|+||||+++...+
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQ---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CG---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cc---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 11 1111111111 111223467899999999999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=424.66 Aligned_cols=289 Identities=36% Similarity=0.646 Sum_probs=235.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~ 100 (558)
..+|++++.||+|+||+||+|.+..++. ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999988776 88888753211 12379999999999999999999865432 3344
Q ss_pred cEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC-CCCcEEEeeccccee
Q 008644 101 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~-~~~~lKL~DFGla~~ 175 (558)
.+|+|||||++++...+. ....+++..++.|++||+.||.|||+.||+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 588999999987766654 356799999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
....... ..++||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|+|..+.+
T Consensus 192 ~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEPN----VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCCC----CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCCC----cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6443322 457899999999998652 46899999999999999999999999999999999999999999999877
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQK-FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 325 (558)
......... ..+....+.++... .+.+++++.+||.+||++||.+|||+.|+|+||||+.+......
T Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 267 KTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred HhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 654322110 01111122222222 23589999999999999999999999999999999988765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=416.66 Aligned_cols=288 Identities=35% Similarity=0.626 Sum_probs=231.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEE
Confidence 579999999999999999999999999999999864221 11122355799999999999999999998543 469
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999976432221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.|..+.+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22456789999999998652 46899999999999999999999999999999999999999999988776554433
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
...... ..............+.+++.+.+||.+||+.||.+|||++|+|+||||..+..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 221111 11111122223345678999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=415.43 Aligned_cols=289 Identities=33% Similarity=0.607 Sum_probs=220.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----Ce
Confidence 468999999999999999999999999999999986432 223346788999999999999999999998543 46
Q ss_pred EEEEEecCcccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 102 IYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+|+|||||+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999998753 3599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..|.+.+|.|....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543221 12456899999999998652 46899999999999999999999999999999999999999998876554
Q ss_pred HHhhhHHHHHHHhhhccCCCCCC-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPF-----SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
..+.... .+...+....+..+ ......+++.+.+||.+||+.||.+|||++|+|+||||+.+...
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 4322100 00000000000000 01123578999999999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=428.04 Aligned_cols=288 Identities=35% Similarity=0.624 Sum_probs=233.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (558)
.+|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++||||+++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999986321 123479999999999999999998865322 23345
Q ss_pred EEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecccceec
Q 008644 102 IYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFGla~~~ 176 (558)
+++||||++++|.+.+. ....+++..++.|++||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877665 35679999999999999999999999999999999999999965 67899999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 44332 2457899999999998652 468999999999999999999999999999999999999999999988775
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 324 (558)
........ + .+......++.. ..+.+++.+.+||.+||++||.+|||+.|+|+||||+.+.....
T Consensus 283 ~~~~~~~~-~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNYTE-F--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCCCC-C--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhhhh-h--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 43211000 0 000001111111 22467899999999999999999999999999999998765543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=414.63 Aligned_cols=291 Identities=35% Similarity=0.561 Sum_probs=224.0
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.-...++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--- 105 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET---
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC---
Confidence 33445799999999999999999999999999999999975544444456778999999999999999999998543
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC-----CCCcEEEeeccc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGL 172 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~-----~~~~lKL~DFGl 172 (558)
..+|+||||++++|.+++..++.+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 106 --~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 --HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp --TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred --CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 4699999999999999999998999999999999999999999999999999999999994 455699999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..
T Consensus 184 a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 986532221 22456789999999998762 45899999999999999999999999999999999999998888876
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..+....... .+...........+.. ....+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 260 TTWPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTSTTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 5443221100 0000000000000000 001267899999999999999999999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=419.47 Aligned_cols=286 Identities=34% Similarity=0.683 Sum_probs=231.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-----
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR----- 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~----- 96 (558)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 568999999999999999999999999999999986321 122379999999999999999999865432
Q ss_pred ----------------------------CCCccEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008644 97 ----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT 144 (558)
Q Consensus 97 ----------------------------~~~~~~~lV~E~~~g~L~~~i~----~~~~l~e~~~~~i~~QIl~aL~yLHs 144 (558)
....++++|||||+++|.+.+. .+..+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2334689999999998777765 35679999999999999999999999
Q ss_pred CCceecCCCCCcEEeC-CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHH
Q 008644 145 ANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~-~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~e 223 (558)
.||+||||||+|||++ .++.+||+|||+++....... ....++|+.|+|||++.+. ..|+.++|||||||++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999998 689999999999987543332 2456899999999998662 458999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhcccCCC
Q 008644 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPK 302 (558)
Q Consensus 224 LltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~mL~~dP~ 302 (558)
|++|++||.+.+..+++..|...+|+|..+.+.......... .+.......+.. ....+++.+.+||.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999988776543211000 000001111111 2245789999999999999999
Q ss_pred CCCCHHHHhcCccccCccc
Q 008644 303 DRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 303 ~Rpta~elL~hp~f~~~~~ 321 (558)
+|||+.|+|+||||+.+..
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=408.07 Aligned_cols=256 Identities=24% Similarity=0.446 Sum_probs=219.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CE
Confidence 58999999999999999999999999999999996421 1223456788999999999999999999998554 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......|..
T Consensus 160 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------- 219 (337)
T 1o6l_A 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred C---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2356789999999999977 6789999999999999999999999988776554443321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. . .....+++.+.+||.+||+.||.+|| +++|+++||||+++
T Consensus 220 -----------~~--~---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 220 -----------EE--I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -----------CC--C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------CC--C---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 00 0 11245789999999999999999999 99999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=424.78 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=223.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++... .
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----G 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----S
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----C
Confidence 34689999999999999999999999999999999976544455667789999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC---CCCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~---~~~~lKL~DFGla~~~ 176 (558)
.+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+++..
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 7999999998 59999999998999999999999999999999999999999999999998 4678999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+...
T Consensus 164 ~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 228 (444)
T 3soa_A 164 EGEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG---------- 228 (444)
T ss_dssp CTTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred cCCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------
Confidence 43322 2356789999999999977 67999999999999999999999999888766555444321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
........++.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 229 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 229 -----------------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 1112233456789999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=414.22 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=216.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----- 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Confidence 368999999999999999999999999999999997421 2233456788999999988 699999999998544
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 36999999998 59999999888999999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 239 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------ 239 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---ccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 22 12356789999999999977 57899999999999999999999999998877665555431
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta------~elL~hp~f~~~ 319 (558)
.. .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 240 --------------~~-----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 --------------EV-----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp --------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred --------------CC-----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 00 1123478999999999999999999998 999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=406.57 Aligned_cols=299 Identities=34% Similarity=0.552 Sum_probs=237.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~--- 96 (558)
+..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 55689999999999999999999999999999999987554444445678899999999999999999999865431
Q ss_pred CCCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.....+|+|||||+++|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 113468999999999999888764 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....+.+.++.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 542221 12233567899999999998652 4689999999999999999999999999999999999999999887766
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
+...........+...... .......+ ...++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 5444322111000000000 00000000 01267899999999999999999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=402.90 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=222.7
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC----hhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.+.++|++.+.||+|+||.||+|.++.+|..||||++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK- 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 4567899999999999999999999999999999999753222 12457789999999999999999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC----cEEEeec
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 170 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~----~lKL~DF 170 (558)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 87 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 87 ----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 46999999997 59999998888899999999999999999999999999999999999999887 7999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
|+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 163 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 163 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp TTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 99987643322 245689999999999976 678999999999999999999999999887766655544322111
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. ...++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 237 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 237 E---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp C---------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred C---------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 1 1123467889999999999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=400.95 Aligned_cols=301 Identities=41% Similarity=0.644 Sum_probs=236.1
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC--
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-- 95 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-- 95 (558)
.+..+++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 45678999999999999999999999999999999999863 24456678899999999999999999999885432
Q ss_pred -------cCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC-CCCcEEE
Q 008644 96 -------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKI 167 (558)
Q Consensus 96 -------~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~-~~~~lKL 167 (558)
......+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 133457999999999999999864 5799999999999999999999999999999999999997 5679999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
+|||+++................+|.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754322222223456789999999988542 468899999999999999999999999999988888888887
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
+.+..+........ ...++.........++....+.+++.+.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 77766654443221 1112222222223334445577899999999999999999999999999999999765443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=411.03 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=222.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.++.+|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 4689999999999999999999999999999999976555556677899999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFGla~~~~ 177 (558)
+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 899999998 59999998888899999999999999999999999999999999999998654 59999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 246 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---------- 246 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----------
Confidence 322 2345789999999999977 679999999999999999999999998877655544443211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.......+..+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 247 -----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 247 -----------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 111122345678999999999999999999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=417.68 Aligned_cols=281 Identities=32% Similarity=0.562 Sum_probs=232.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc------CCCCccccceeecCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL------RHPDIVEIKHILLPP 94 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l------~HpnIv~l~~i~~~~ 94 (558)
+..+|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+ .|+||+.+++.+...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45789999999999999999999999999999999974 234456677899988877 467999999988543
Q ss_pred CcCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc--EEEeec
Q 008644 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDF 170 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~--lKL~DF 170 (558)
..+|+||||++++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+||
T Consensus 172 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 -----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp -----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred -----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 4699999999999999998764 4999999999999999999999999999999999999999987 999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
|+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999764332 245689999999999987 579999999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCC-----------------------------CCCCC-CCCCCCHHHHHHHHHhcccC
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKP-----------------------------IPFSQ-KFPNANPLALRLLERMLAFE 300 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~-~~~~~s~~~~~Li~~mL~~d 300 (558)
..+.+...... ..++........ ..+.. .....++.+.+||.+||++|
T Consensus 319 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 99887654322 222221110000 00000 11234788999999999999
Q ss_pred CCCCCCHHHHhcCccccCc
Q 008644 301 PKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 301 P~~Rpta~elL~hp~f~~~ 319 (558)
|++|||++|+|+||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=409.05 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=215.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 589999999999999999999999999999999864221 112235788999999999999999999998554 36
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
+|+||||++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.+.....
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------------- 217 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------------- 217 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------------
T ss_pred ---ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------------
Confidence 2355789999999999976 344 68999999999999999999999765432211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.............+++.+.+||++||+.||.+|||++|+++||||+..
T Consensus 218 -----------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 -----------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 111111112234578999999999999999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=409.61 Aligned_cols=276 Identities=23% Similarity=0.234 Sum_probs=195.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
++.+|.+.+.||+|+||+||+|.+ +|+.||||+++.. ........+|+..+..++|||||++++++.... ....
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~ 74 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT 74 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCce
Confidence 457899999999999999999976 6899999998642 122223345666677899999999999986532 1223
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEeCCCCcEEEeecc
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
.+|||||||+ |+|.+++... .++++.+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 6899999998 6999999765 699999999999999999999987 99999999999999999999999999
Q ss_pred cceeccCCCCC-cccccccccCccccCcccccccc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 008644 172 LARVAFNDTPT-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 172 la~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~----~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (558)
+|+........ .......+||++|||||++.+.. ..|+.++|||||||+||||+||.+||.......... ....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~ 232 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLV 232 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTS
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcc
Confidence 99876543322 11224568999999999986521 136778999999999999999998875433211000 0000
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
...+..+.+ ...+..-.....++.......+...+.+||.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~--------~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 233 PSDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHH--------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHH--------HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 001111111 0111000001111111111223456889999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=411.77 Aligned_cols=298 Identities=23% Similarity=0.321 Sum_probs=222.2
Q ss_pred cCCCCcEEEEeEeecc--CceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 19 YGEGSRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G--~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.+.+++|++++.||+| +||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 3668899999999999 999999999999999999999986555556667888999999999999999999998644
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..+|+|||||. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 ---NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp ---TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred ---CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 36999999998 6999999875 67999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCC----CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh--
Q 008644 174 RVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-- 247 (558)
Q Consensus 174 ~~~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l-- 247 (558)
........ ........+||+.|+|||++.+....|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 75432211 111123358999999999987633468999999999999999999999999877665544332110
Q ss_pred ------CCCCHHHHHHhh----hHHHHHHHhh---hccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 248 ------GTPSPEAIARVR----NEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 248 ------g~p~~~~i~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
..+..+...... .......+.. .......+.......+++.+.+||.+||+.||.+|||++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000000000 0000000000 000011112234456789999999999999999999999999999
Q ss_pred cccCccc
Q 008644 315 YFKGLAK 321 (558)
Q Consensus 315 ~f~~~~~ 321 (558)
||+.+..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=406.12 Aligned_cols=283 Identities=23% Similarity=0.399 Sum_probs=231.7
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-----CCCccccceeecC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----HPDIVEIKHILLP 93 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-----HpnIv~l~~i~~~ 93 (558)
.-..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 4456899999999999999999999999999999999863 2345566788999999997 9999999999855
Q ss_pred CCcCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC----------
Q 008644 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 161 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---------- 161 (558)
. ..+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 108 ~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 Y-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp T-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred C-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 4 3699999999889999998765 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh
Q 008644 162 ---------------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226 (558)
Q Consensus 162 ---------------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt 226 (558)
++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHH
Confidence 7889999999998643322 45689999999999987 679999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCC---------------CCCCCCCCHHHHH
Q 008644 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF---------------SQKFPNANPLALR 291 (558)
Q Consensus 227 G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~s~~~~~ 291 (558)
|+.||.+.+..+.+..+....+.++...+..........++.........+. .......++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999999999999999999998888776654433221111111000000000 0000122477889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 292 LLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 292 Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
||.+||+.||.+|||++|+|+||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=401.20 Aligned_cols=253 Identities=24% Similarity=0.446 Sum_probs=219.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CE
Confidence 679999999999999999999999999999999964211 123456788999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999998 599999999889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 160 -----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------- 218 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 218 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 145689999999999977 67899999999999999999999999988766555444321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. . ...+.+++.+.+||.+||..||.+|| +++++++||||+++
T Consensus 219 ------------~--~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 219 ------------E--L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp ------------C--C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------C--C---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 0 0 11245789999999999999999999 99999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=403.00 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=221.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+.+|+.+|+.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESM-----E 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----T
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----C
Confidence 56789999999999999999999999999999999863 234556788999999999999999999998543 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC--CCcEEEeecccceec
Q 008644 101 DIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~--~~~lKL~DFGla~~~ 176 (558)
.+|+|||||+| +|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 69999999984 9999997754 6999999999999999999999999999999999999997 789999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......+..
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 224 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---- 224 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh----
Confidence 4332 2355689999999999977 56789999999999999999999999988877666655543222211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 225 -----------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 -----------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1235678999999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=405.88 Aligned_cols=288 Identities=33% Similarity=0.615 Sum_probs=231.5
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
|..-++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 96 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK---- 96 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC----
Confidence 3556799999999999999999999999999999999876555555566788999999999999999999998543
Q ss_pred CccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+++ .|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 97 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 97 -KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp -TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred -CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 469999999996 555666666789999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++...+.....
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 22456799999999998762 4688999999999999999999999999999999999988888877654432
Q ss_pred hhhHHHHHHHhhhcc---CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
...... +..... ....+....++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPV---FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGG---GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccc---cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 211110 000000 0111222334678999999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=396.49 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=218.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++... .
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----D 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----C
Confidence 45689999999999999999999999999999999864322 3356788999999999999999999998654 3
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 6899999996 6999998775 6999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------ 232 (297)
T 3fxz_A 170 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------ 232 (297)
T ss_dssp TC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC------------
T ss_pred cc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 22 2345689999999999977 678999999999999999999999998877665544332210
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. +.......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 233 -------------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 233 -------------T---PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------S---CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------C---CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0 0111224578899999999999999999999999999999854
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=407.78 Aligned_cols=289 Identities=37% Similarity=0.606 Sum_probs=229.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh---hHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~---~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--- 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC---
Confidence 4578999999999999999999999999999999987422111 1124678999999999999999999998543
Q ss_pred CCccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||++++|..++..+. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 85 --~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 85 --SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp --TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred --CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 4689999999999999987654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..+.+.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 33221 23456899999999998652 458899999999999999999999999999999999999988888765443
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
...... .++ ........++...+..+++.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 239 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 239 DMCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 321100 000 00111112223344678899999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=397.11 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=225.3
Q ss_pred ccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh----hHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
+..-.+.++|++.+.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 344456778999999999999999999999999999999997432221 2356789999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC----cEE
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLK 166 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~----~lK 166 (558)
... ..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 85 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 ENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp ECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred ecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence 543 46999999997 59999999888899999999999999999999999999999999999999988 799
Q ss_pred EeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 008644 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (558)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 160 l~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp ECCCTTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EccCccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999999987644322 245679999999999976 67899999999999999999999999988876665555432
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
...... ..+..+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 234 ~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 234 SYDFDE---------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCCCCH---------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccccCh---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 221111 1124678899999999999999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=423.20 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=217.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence 489999999999999999999999999999999976544444567789999999999999999999998543 469
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEeecccceeccC
Q 008644 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFN 178 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~DFGla~~~~~ 178 (558)
|+|||||. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888889999999999999999999999999999999999999764 4599999999987643
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 253 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK----------- 253 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 32 2355789999999999864 68999999999999999999999999888766555543321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.......+..+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 254 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 254 ----------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ----------------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ----------------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 1112233567899999999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=385.22 Aligned_cols=265 Identities=29% Similarity=0.479 Sum_probs=225.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----C
Confidence 46789999999999999999999999999999999976555556677899999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~DFGla~~~ 176 (558)
..|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 6899999998 499999988888999999999999999999999999999999999999987655 999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------- 222 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc----------
Confidence 4322 2245689999999999977 67899999999999999999999999887765544433321
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
........+..+++.+.+||.+||+.||++|||++|+|+||||+......
T Consensus 223 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 223 -----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred -----------------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 11111233457789999999999999999999999999999998765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=406.38 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=219.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
..++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|..+|+.+ +||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~---- 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK---- 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC----
Confidence 3468999999999999999999999999999999997421 1123456678899999876 899999999998543
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 91 -ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 46999999997 5999999988889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------ 232 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------ 232 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------------
Confidence 2221 2356789999999999987 6789999999999999999999999998876655544432
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~-elL~hp~f~~~~ 320 (558)
..+ .....+++.+.+||.+||..||.+||++. ++++||||+++.
T Consensus 233 ---------------~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 233 ---------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ---------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---------------CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 000 11235789999999999999999999998 999999999763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=401.00 Aligned_cols=267 Identities=22% Similarity=0.400 Sum_probs=215.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----
Confidence 357999999999999999999999999999999997543 3444567788999999887 899999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||. ++|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 46999999997 59999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+........ ..
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~----- 222 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QN----- 222 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------cc-----
Confidence 221 2356789999999999987 678999999999999999999999996532111000 00
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta------~elL~hp~f~~~~ 320 (558)
.. ......+.... .. ....+++.+.+||.+||+.||.+||++ +|+++||||+++.
T Consensus 223 ~~---~~~~~~i~~~~-~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 223 TE---DYLFQVILEKQ-IR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CH---HHHHHHHHHCC-CC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred cH---HHHHHHHHcCC-CC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 00 00001111111 11 224678999999999999999999995 8999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=403.54 Aligned_cols=255 Identities=21% Similarity=0.384 Sum_probs=220.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----- 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----
Confidence 3478999999999999999999999999999999986421 1223456788999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 46999999997 69999999888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 194 ~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 253 (350)
T 1rdq_E 194 RT------WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------ 253 (350)
T ss_dssp CB------CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred Cc------ccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence 21 45689999999999987 67899999999999999999999999988766555444321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
. . .....+++.+.+||.+||+.||.+||+ ++|+++||||+++
T Consensus 254 --------------~--~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 --------------K--V---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C--C---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C--C---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 0 0 112457899999999999999999998 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=409.54 Aligned_cols=266 Identities=21% Similarity=0.403 Sum_probs=213.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|+++++||+|+||+||+|+++.+++.||||++++... .......+.+|..+|+.+ +||||+++++++...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----- 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----
Confidence 4689999999999999999999999999999999975432 233445688999999877 899999999998554
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||. |+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 36999999998 59999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+......... ..
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~------- 266 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 266 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CC-------
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hh-------
Confidence 221 2356789999999999987 6899999999999999999999999975432111000 00
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta------~elL~hp~f~~~ 319 (558)
.. .....+.... . .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 267 -~~---~~~~~i~~~~-~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 267 -ED---YLFQVILEKQ-I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp -HH---HHHHHHHHCC-C---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred -HH---HHHHHHhccc-c---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 00 0001111111 1 1224678999999999999999999985 899999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=396.29 Aligned_cols=292 Identities=34% Similarity=0.593 Sum_probs=236.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC-CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~-~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~ 96 (558)
..++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999874333322333566788777766 89999999999864332
Q ss_pred CCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3445799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.|..+.
T Consensus 169 ~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 643221 2345679999999999977 5789999999999999999999999999999999999998888877654
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
+........ ..+......+.....+.+++.+.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 432110000 0111122233445567889999999999999999999999999999999977543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=417.87 Aligned_cols=292 Identities=33% Similarity=0.585 Sum_probs=215.7
Q ss_pred CCCcEEE-EeEeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKI-EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i-~~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
+.+.|++ .++||+|+||+||+|+++ .+++.||||++... .....+.+|+.+|+.++||||+++++++....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 91 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHA-- 91 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT--
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC--
Confidence 3456887 458999999999999966 57899999999743 22346789999999999999999999986432
Q ss_pred CCccEEEEEecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----CCCCc
Q 008644 98 EFKDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCK 164 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl----~~~~~ 164 (558)
...+|+||||++++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.
T Consensus 92 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 -DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred -CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 2479999999999999888632 249999999999999999999999999999999999999 67789
Q ss_pred EEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--------
Q 008644 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-------- 236 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-------- 236 (558)
+||+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999998764432222234567899999999998762 3589999999999999999999999987654
Q ss_pred -hhHHHHHHHhhCCCCHHHHHHhhhHH-HHHHHhhhccCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 008644 237 -VHQLDIMTDLLGTPSPEAIARVRNEK-ARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAE 308 (558)
Q Consensus 237 -~~~~~~i~~~lg~p~~~~i~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~ 308 (558)
.+++..|...+|.|....+..+.... .......+....... ........++.+.+||.+||++||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 47889999999999877665443211 111111111110000 0011223467899999999999999999999
Q ss_pred HHhcCccccCcc
Q 008644 309 EALADPYFKGLA 320 (558)
Q Consensus 309 elL~hp~f~~~~ 320 (558)
|+|+||||+...
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=395.60 Aligned_cols=258 Identities=27% Similarity=0.471 Sum_probs=209.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
..++|++++.||+|+||.||+|++. .+|+.||||+++... ........+.+|+.+|+.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG- 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-
Confidence 3578999999999999999999985 689999999997532 2233456678999999999999999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 94 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 ----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp ----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred ----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 46999999998 5999999988889999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------- 236 (327)
T 3a62_A 170 ESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------- 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--------
T ss_pred ccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--------
Confidence 5432221 2245689999999999977 67899999999999999999999999988766555444321
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. ....+.+++.+.+||.+||..||.+|| +++|+|+||||+++
T Consensus 237 ------------------~-----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 ------------------K-----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------------------C-----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------------------C-----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0 012245789999999999999999999 89999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=403.31 Aligned_cols=257 Identities=21% Similarity=0.376 Sum_probs=219.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|..+|..+ +||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----- 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----- 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----
Confidence 468999999999999999999999999999999997421 1223456788999999887 799999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 46999999997 59999999888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 236 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 236 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 221 2356789999999999977 67899999999999999999999999988766555444321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. .....+++.+.+||.+||..||.+|| +++++++||||+++
T Consensus 237 --------------~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 237 --------------NV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp --------------CC-----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred --------------CC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 00 11246789999999999999999999 47999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=402.28 Aligned_cols=291 Identities=35% Similarity=0.616 Sum_probs=225.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc--CCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--REFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~--~~~~ 100 (558)
++|++.+.||+|+||.||+|.+..+|..||||++.... .......+|+..|+.++||||+++++++..... ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 58999999999999999999999999999999985422 223356678888999999999999999865332 2233
Q ss_pred cEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEeCC-CCcEEEeecccc
Q 008644 101 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGLA 173 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~----~~~~l~e~~~~~i~~QIl~aL~yLH--s~gIiHrDIKP~NILl~~-~~~lKL~DFGla 173 (558)
.+|+||||++++|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 588999999998776654 4557999999999999999999999 999999999999999997 899999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...++.|..+
T Consensus 180 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 86543322 2456799999999998652 458999999999999999999999999999999999999999999988
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCC
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQ----KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 324 (558)
.+..+....... ........++.. .....++.+.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 255 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 255 VLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 776553321110 001111122222 22336789999999999999999999999999999998866544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=406.39 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=218.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 368999999999999999999999999999999986421 2223456788999999999999999999998544 3
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. |+|..++..++.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6999999997 599999999889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------- 231 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------- 231 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------
Confidence 2 23567899999999998642 14588999999999999999999999986543322111111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-a~elL~hp~f~~~~ 320 (558)
+... .......+++.+.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 232 -----------~~~~----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 232 -----------FETT----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -----------HHHC----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -----------Hhhc----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 0000 01122467899999999999999999998 99999999999763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=406.59 Aligned_cols=262 Identities=28% Similarity=0.418 Sum_probs=214.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc---CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.+.++|++.+.||+|+||+||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-- 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 34578999999999999999999999999999999986321 1112456789999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEe
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKIC 168 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~ 168 (558)
..+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 99 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 ---GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp ---TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred ---CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 46999999998 5998877542 35899999999999999999999999999999999999987654 9999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
|||+++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+. ..+..+....
T Consensus 176 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~- 248 (351)
T 3c0i_A 176 GFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGK- 248 (351)
T ss_dssp CCTTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTC-
T ss_pred cCcceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCC-
Confidence 9999987643321 2245689999999999977 5789999999999999999999999987532 2222222111
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.......++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 249 --------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 249 --------------------------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp --------------------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred --------------------------CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 011112235678999999999999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=422.70 Aligned_cols=271 Identities=33% Similarity=0.518 Sum_probs=224.2
Q ss_pred CCcccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcccccee
Q 008644 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (558)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i 90 (558)
.......+-.+.++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.+|+.++||||++++++
T Consensus 10 ~~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp ----CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 33334344345689999999999999999999999999999999997543333456788999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC---CCCcEE
Q 008644 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLK 166 (558)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~---~~~~lK 166 (558)
+... ..+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 90 ~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 90 LEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEcC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 8543 46999999998 59999998888899999999999999999999999999999999999995 456799
Q ss_pred EeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 008644 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (558)
|+|||+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+...
T Consensus 165 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp ECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EEECCcCeECCCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999997654332 2355689999999999876 5899999999999999999999999998876665555431
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. ......+..+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 238 ~~---------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 238 KY---------------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CC---------------------------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CC---------------------------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 11 111123456789999999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=417.82 Aligned_cols=266 Identities=22% Similarity=0.395 Sum_probs=221.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|+++++||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..++||||+++++++... .
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----N 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----S
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----C
Confidence 4689999999999999999999999999999999864211 111223478899999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+|||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6999999996 699999987 56899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
... ......+||++|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 297 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 297 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence 322 122456899999999998621 1468999999999999999999999999988777666654310
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~~~ 320 (558)
....+......+++.+++||++||..+|++ |++++|+++||||+++.
T Consensus 298 ------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 298 ------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 011223344678999999999999998888 99999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=393.36 Aligned_cols=288 Identities=30% Similarity=0.579 Sum_probs=225.6
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~ 95 (558)
.+++..++|++++.||+|+||.||+|++..+++.||||++.. .....+.+|+.+|+.++ ||||+++++++....
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 345678899999999999999999999999999999999863 33567889999999997 999999999986532
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla 173 (558)
....++||||+. ++|.+++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 105 ---~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 ---SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp ---TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 346899999998 58888774 389999999999999999999999999999999999999777 8999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCC-CCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+..
T Consensus 179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 179 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 87543332 2456899999999998652 56899999999999999999999888 456667777777777664332
Q ss_pred HHH-HHhhhHHHHHHHhhhccCCCCCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 253 EAI-ARVRNEKARRYLSSMRKKKPIPFSQ-----KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 253 ~~i-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
... ..........+...+.......+.. ....+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111 1100000001111111111111111 1223789999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=418.71 Aligned_cols=262 Identities=31% Similarity=0.490 Sum_probs=223.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
+.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK----- 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 3468999999999999999999999999999999986432 2234567899999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeeccccee
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 47999999997 5999999998899999999999999999999999999999999999999 5678999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------- 244 (484)
T 3nyv_A 179 FEASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY------- 244 (484)
T ss_dssp BCCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred ccccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 54332 2355689999999999875 589999999999999999999999999887666555543111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
......+..+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 245 --------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 245 --------------------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------------------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------------------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 1111234567899999999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=401.37 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=204.3
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
....++|++++.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 88 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTP---- 88 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC----
Confidence 456789999999999999999999999999999999996432 2235678999999999999999999999654
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc--EEEeeccccee
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~--lKL~DFGla~~ 175 (558)
..+|+|||||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 89 -THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred -CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 36999999997 599999988888999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCc-chhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~-~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...... ....+||++|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+....+..+...
T Consensus 168 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-------- 233 (361)
T 3uc3_A 168 SVLHSQ----PKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-------- 233 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH--------
T ss_pred ccccCC----CCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH--------
Confidence 322221 245689999999999876 455544 89999999999999999999876543322221110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+ ...... .....+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 234 -----------~~---~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 234 -----------IL---SVKYSI---PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -----------HH---TTCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -----------Hh---cCCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00 000011 1123578999999999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=389.60 Aligned_cols=260 Identities=26% Similarity=0.467 Sum_probs=207.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC------------------------hhHHHHHHHHHHHHH
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------------------------VSDATRILREIKLLR 77 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~------------------------~~~~~~i~~Ei~iL~ 77 (558)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999999999999999998643211 112356889999999
Q ss_pred hcCCCCccccceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 78 ~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
.++||||+++++++.... ...+|+||||++ ++|.+++ ....+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986532 347999999998 4776654 34579999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~-y~~~~DIWSlG~il~eLltG~~pF~~~~ 235 (558)
||++.++.+||+|||+++....... .....+||+.|+|||++.+.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999987543321 23456899999999998762111 3678999999999999999999998776
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
.......+.. ... . ....+.+++.+.+||.+||+.||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~~--------------------------~~~--~-~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKS--------------------------QAL--E-FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHH--------------------------CCC--C-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhc--------------------------ccC--C-CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 5433322211 000 0 1123568899999999999999999999999999999
Q ss_pred cc
Q 008644 316 FK 317 (558)
Q Consensus 316 f~ 317 (558)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 96
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=402.97 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=219.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CE
Confidence 46899999999999999999999999999999998643 234456788999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC--CCcEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~--~~~lKL~DFGla~~~~ 177 (558)
+|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999997 59999987654 6999999999999999999999999999999999999974 4779999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------- 265 (387)
T 1kob_A 203 PDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------- 265 (387)
T ss_dssp TTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCc----ceeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 332 1244689999999999977 67899999999999999999999999988766555444321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
........+..+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 266 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 ----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1111223456789999999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=403.17 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=211.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~i-L~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
..++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~---- 111 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---- 111 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC----
Confidence 34689999999999999999999999999999999975322 23345567778877 5778999999999998554
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 112 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 112 -DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 46999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..|...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Confidence 2221 2256789999999999987 67999999999999999999999999988766655544320
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta----~elL~hp~f~~~~ 320 (558)
+. ...+.+++.+.+||++||+.||.+||++ +++++||||+++.
T Consensus 255 -----------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 -----------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp -----------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred -----------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 01 1225678999999999999999999986 7999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=413.68 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=210.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 468999999999999999999999999999999997432 2334456778999999999999999999998544 3
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+|||||+ ++|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 6999999998 5999999888889999999999999999999998 9999999999999999999999999999975332
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 12356789999999999977 68999999999999999999999999888766555444320
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. .....+++.+.+||.+||+.||.+|| |++|+|+||||+++
T Consensus 365 --------------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 --------------EI-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --------------CC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CC-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 00 11245789999999999999999999 99999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=410.87 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=218.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|+++++||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD----- 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----
Confidence 3578999999999999999999999999999999986421 1112233478999999999999999999999543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||||. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 46999999996 5999988764 699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~--~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. .......+||+.|+|||++.+... .|+.++|||||||++|||++|++||.+.+....+..|.....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 22 112346789999999999875211 178899999999999999999999999887776665543100
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~--Rpta~elL~hp~f~~~ 319 (558)
. .. ......+++.+++||.+||..+|.+ |++++||++||||+++
T Consensus 291 ------------~----~~---~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 ------------S----LT---FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ------------H----CC---CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ------------c----cc---CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0 00 1122468999999999999999988 9999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=401.41 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=212.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+|+.+|..+ +||||+++++++... .
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDG-----K 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECS-----S
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcC-----C
Confidence 4679999999999999999999999999999999975322 234688888877 799999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC----CcEEEeeccccee
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~----~~lKL~DFGla~~ 175 (558)
.+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 7999999997 5999999998899999999999999999999999999999999999998543 3599999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+........
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------------- 230 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-------------- 230 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH--------------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH--------------
Confidence 543322 2245689999999999976 468899999999999999999999997643211111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
.+..+...........++.+++.+.+||++||..||.+|||+.++|+||||..+...
T Consensus 231 ----------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 231 ----------ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp ----------HHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred ----------HHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 111111111222233456789999999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=391.18 Aligned_cols=252 Identities=26% Similarity=0.304 Sum_probs=207.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|++..+|+.||||++..............+|+..+..+ +||||+++++++.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 689999999999999999999999999999999876555555666666777766555 89999999999854 346
Q ss_pred EEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||+++|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 99999999999999887644 69999999999999999999999999999999999999999999999999997754332
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..+|.+...... +.. +...
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~--------- 270 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLP--------- 270 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCC---------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCC---------
Confidence 2 244579999999999875 689999999999999999999877754332111 110 0000
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 271 ------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1112457899999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=394.78 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=213.9
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++... .
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----N 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----C
Confidence 45689999999999999999999999999999999863221 22345688999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
..|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 6899999997 499999988878999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------- 222 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 222 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--------------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------------
Confidence 21 1123457899999999998762 2346789999999999999999999987654322111100
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
. . ......+..+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 223 --------~---~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 --------E---K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp --------T---T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------c---c---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 0 0 011122356789999999999999999999999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=389.35 Aligned_cols=283 Identities=31% Similarity=0.525 Sum_probs=230.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEE-CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLP 93 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d-~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn------Iv~l~~i~~~ 93 (558)
+.++|++++.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.+|+.++|++ |+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 467999999999999999999999 568899999998642 344567889999999887654 8899998844
Q ss_pred CCcCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC----------
Q 008644 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 161 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---------- 161 (558)
. ..+|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 H-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp T-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred C-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 3 4799999999989999998876 6899999999999999999999999999999999999988
Q ss_pred ---------CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 008644 162 ---------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (558)
Q Consensus 162 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (558)
++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999998643322 44689999999999987 678999999999999999999999999
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHH--------------HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 298 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~ 298 (558)
+.+..+.+..+...++.++...+....... ...++..... ....+.......++.+.+||.+||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhC
Confidence 999999999999999988877665443211 0111111110 0011111223345779999999999
Q ss_pred cCCCCCCCHHHHhcCccccCcc
Q 008644 299 FEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 299 ~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.||.+|||++|+|+||||+.+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=397.93 Aligned_cols=264 Identities=24% Similarity=0.452 Sum_probs=194.9
Q ss_pred CcEEEE---eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 008644 23 SRYKIE---EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~---~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~ 98 (558)
++|++. +.||+|+||.||+|.++.+|+.||||++.. .....+.+|+.+|+.+. ||||+++++++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~---- 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ---- 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC----
Confidence 357775 789999999999999999999999999864 34566789999999997 99999999998543
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecccce
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLAR 174 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFGla~ 174 (558)
..+|+|||||+ ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 79 -LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred -CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 46999999998 49999999988999999999999999999999999999999999999998765 89999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..... ..
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------~~---- 220 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------TS---- 220 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------CC----
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------cc----
Confidence 6543322 2355678999999999977 67899999999999999999999999875432110 00
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
....+..+...........+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 221 --------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 221 --------AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp --------HHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred --------HHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 00111122222111122223467899999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=409.78 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=218.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|++++.||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++...
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~----- 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE----- 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----
Confidence 3578999999999999999999999999999999996421 1112334578999999999999999999998544
Q ss_pred ccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 46999999996 6999999875 479999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
.... ......+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+..+.+..|....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 3322 112346899999999998621 1468899999999999999999999999988776665554310
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccCccc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGLAK 321 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~R---pta~elL~hp~f~~~~~ 321 (558)
. ...+......+++.+++||++||. ||.+| ++++|+++||||+++..
T Consensus 287 ---------------~------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 287 ---------------E------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp ---------------H------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred ---------------c------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0 001111234689999999999999 99998 59999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=402.49 Aligned_cols=283 Identities=28% Similarity=0.424 Sum_probs=226.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC--------CCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--------HPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~--------HpnIv~l~~i~~~ 93 (558)
.++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4799999999999999999999999999999999963 2345577889999999986 7889999998853
Q ss_pred CCcCCCccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCC-------
Q 008644 94 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 163 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~------- 163 (558)
.. .....+|+||||++++|.+.+... +.+++..++.|+.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 133479999999999988888765 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEeecccceeccCCCCCcccccccccCccccCcccc
Q 008644 164 ------------------------------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201 (558)
Q Consensus 164 ------------------------------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l 201 (558)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999875432 2456899999999999
Q ss_pred ccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC------hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCC
Q 008644 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275 (558)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~------~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (558)
.+ ..|+.++|||||||++|+|++|+.||.+.+ ...++..+...+|.++...+....... .++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCcccccc
Confidence 87 579999999999999999999999998765 567788888999988877654332110 01100000000
Q ss_pred CCC-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 276 IPF-------------SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 276 ~~~-------------~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
... .......++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0011223467899999999999999999999999999973
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=413.77 Aligned_cols=262 Identities=31% Similarity=0.446 Sum_probs=220.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-----------hHHHHHHHHHHHHHhcCCCCccccc
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----------SDATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-----------~~~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
.+.++|++++.||+|+||+||+|.++.++..||||++....... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35689999999999999999999999999999999997532211 3356788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---c
Q 008644 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---K 164 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~ 164 (558)
+++... ..+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 113 ~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 998543 47999999997 59999998888899999999999999999999999999999999999999876 6
Q ss_pred EEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
+||+|||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998764332 2355789999999999875 58999999999999999999999999988776666554
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
....... ...+..+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 261 ~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 261 KGKYYFD---------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HCCCCCC---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cCCCCCC---------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 4211111 112356789999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.17 Aligned_cols=258 Identities=31% Similarity=0.472 Sum_probs=220.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++... .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----T 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----C
Confidence 45689999999999999999999999999999999975332 3456788999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFGla~~~ 176 (558)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 6999999997 5999999888889999999999999999999999999999999999999 78899999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.........
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 228 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE---- 228 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH----
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence 4332 2245679999999999875 4889999999999999999999999988776655555432222211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 -----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 -----------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -----------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -----------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1123568899999999999999999999999999999854
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=381.93 Aligned_cols=258 Identities=30% Similarity=0.459 Sum_probs=210.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+.++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY----- 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----
Confidence 45679999999999999999999999999999999987543 223467789999999999999999999998543
Q ss_pred ccEEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeecc
Q 008644 100 KDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFG 171 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFG 171 (558)
..+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 469999999984 99888854 3679999999999999999999999999999999999999 456889999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
+++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~----- 240 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK----- 240 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-----
Confidence 9976543321 245679999999999864 6889999999999999999999999887754433222110
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
...+......+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 241 -----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 -----------------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 01112223447899999999999999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.94 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=219.1
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
...+..|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CC
Confidence 34567899999999999999999999999999999999865556667788999999999999999999999875432 23
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeC-CCCcEEEeecccce
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLAR 174 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~-~~~~lKL~DFGla~ 174 (558)
...+|+||||++ ++|.+++...+.+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 457899999997 599999998888999999999999999999999999 99999999999998 78999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+......
T Consensus 181 ~~~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------- 244 (290)
T 1t4h_A 181 LKRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------- 244 (290)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------
T ss_pred ccccc-----ccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--------
Confidence 54322 1245679999999998865 5899999999999999999999999875544332211110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. ..........++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 245 ------------------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 ------------------G--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------T--CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------c--CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0 0011122345788999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=396.37 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=202.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----Ce
Confidence 46799999999999999999999999999999998743 2345678999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCcEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~lKL~DFGla~~~~ 177 (558)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999997 599999988888999999999999999999999999999999999999976 8899999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~lg~p~~~~i~ 256 (558)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... .+..+.
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------------ 264 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------------ 264 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------------
Confidence 322 2245689999999999987 578999999999999999999999997665433 222111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..........++.++..+.+||.+||+.||++|||+.|+|+||||.+..
T Consensus 265 ---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 265 ---------------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1111122334567899999999999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=411.16 Aligned_cols=256 Identities=32% Similarity=0.533 Sum_probs=218.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 368999999999999999999999999999999996421 1123356789999999999999999999998554 3
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 6999999996 699999988888999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred c----cccccCCCcCeEChhhccC--CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 2 2356789999999999976 344 679999999999999999999999877655544443210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 233 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01123578999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=391.41 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=207.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc------
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------ 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~------ 96 (558)
++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999996432 33456789999999999999999999998854321
Q ss_pred ----------------------------------------------CCCccEEEEEecCcc-cHHHHHHhCCC---CCHH
Q 008644 97 ----------------------------------------------REFKDIYVVFELMES-DLHQVIKANDD---LTPE 126 (558)
Q Consensus 97 ----------------------------------------------~~~~~~~lV~E~~~g-~L~~~i~~~~~---l~e~ 126 (558)
.....+|+|||||++ +|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 112348999999985 99999987653 5667
Q ss_pred HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC---------cccccccccCccccC
Q 008644 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---------AIFWTDYVATRWYRA 197 (558)
Q Consensus 127 ~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~---------~~~~~~~~gT~~Y~A 197 (558)
.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 79999999999999999999999999999999999999999999999876543211 012245689999999
Q ss_pred ccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCC
Q 008644 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 277 (558)
Q Consensus 198 PE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (558)
||++.+ ..++.++|||||||++|+|++|..|+. .....+.......
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~--------------------------- 290 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLK--------------------------- 290 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTC---------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccC---------------------------
Confidence 999977 678999999999999999999876652 1111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 278 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 278 ~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+...+...++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 111122346778999999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=396.82 Aligned_cols=280 Identities=32% Similarity=0.546 Sum_probs=228.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCC-----ccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD-----IVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-Hpn-----Iv~l~~i~~~~~ 95 (558)
.++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |++ |+.+++.+...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 4789999999999999999999999999999999974 2334566788999998885 554 88888887543
Q ss_pred cCCCccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEeC--CCCcEEEee
Q 008644 96 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 169 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLH--s~gIiHrDIKP~NILl~--~~~~lKL~D 169 (558)
..+|+||||++++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 129 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 ----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 469999999999999999876 35999999999999999999999 57999999999999995 478899999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999876332 245689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCC---------CCCC-CCC------------------C-------CCCHHHHHHHH
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKP---------IPFS-QKF------------------P-------NANPLALRLLE 294 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~---------~~~~-~~~------------------~-------~~s~~~~~Li~ 294 (558)
|+...+... ...+.++..+..... ..+. ... . ..++.+.+||.
T Consensus 277 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 988766532 233444443321100 0000 000 0 00147899999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCc
Q 008644 295 RMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 295 ~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+||++||++|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=390.92 Aligned_cols=274 Identities=24% Similarity=0.403 Sum_probs=226.1
Q ss_pred CCCCcccccccCCCCcEEEE-eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccc
Q 008644 9 SSADVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVE 86 (558)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~ 86 (558)
+++.+.|...-.+.++|.+. +.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++ ||||++
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 44556665555667899998 8999999999999999999999999999865555555678999999999995 699999
Q ss_pred cceeecCCCcCCCccEEEEEecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC--
Q 008644 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-- 161 (558)
Q Consensus 87 l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-- 161 (558)
+++++... ..+|+|||||.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 94 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 94 LHEVYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 99998543 469999999985 898888553 57999999999999999999999999999999999999998
Q ss_pred -CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHH
Q 008644 162 -DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (558)
Q Consensus 162 -~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (558)
++.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp TBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCcEEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 78999999999987643322 245689999999999976 67899999999999999999999999988776655
Q ss_pred HHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 241 ~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+..... ......+..+++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 243 ~~i~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 243 LNISQVNV---------------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHTCC---------------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHhccc---------------------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 44433211 112234467889999999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=391.15 Aligned_cols=271 Identities=25% Similarity=0.361 Sum_probs=216.7
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 45679999999999999999999999999999999997533 23345567899999999999999999999885432 12
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 234699999997 5999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 235 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED---------- 235 (311)
T ss_dssp --------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------
T ss_pred ccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----------
Confidence 43322222345679999999999977 678999999999999999999999999887655443332211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+.......+++.+.+||.+||+.||.+||++.++|.|+|++...
T Consensus 236 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 -----------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----------------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----------------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1111122356789999999999999999999999999999998543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=379.40 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=214.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++... ..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----CE
Confidence 68999999999999999999999999999999986321 1122345688999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||++ ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999986543222
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 223 (279)
T 3fdn_A 164 -----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 223 (279)
T ss_dssp ---------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred -----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence 245679999999999977 678899999999999999999999999877655544433210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
......+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 224 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 011234688999999999999999999999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.24 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=218.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST----- 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----
Confidence 34578999999999999999999999999999999997422 22345688999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeeccccee
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFGla~~ 175 (558)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 46999999997 5999999888889999999999999999999999999999999999999 7889999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------- 222 (304)
T 2jam_A 159 EQNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG--------- 222 (304)
T ss_dssp CCCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC---------
T ss_pred cCCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC---------
Confidence 4322 1244679999999999977 57899999999999999999999999887765544443321
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 223 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 223 ------------------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ------------------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ------------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 11111233467889999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=391.77 Aligned_cols=269 Identities=28% Similarity=0.434 Sum_probs=215.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc---CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++++.||+|+||+||+|.+..++..||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 100 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--- 100 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC---
Confidence 3578999999999999999999999999999999986421 1334567899999999999999999999998543
Q ss_pred CCccEEEEEecCc-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHH
Q 008644 98 EFKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLL 136 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~----------------------------------------~~~l~e~~~~~i~~QIl 136 (558)
..+|+|||||+ ++|.+++.. ...+++..++.++.||+
T Consensus 101 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 101 --QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp --SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred --CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 46999999997 699998842 11246788999999999
Q ss_pred HHHHHHHhCCceecCCCCCcEEeCCCC--cEEEeecccceeccCCCC-CcccccccccCccccCccccccccCCCCCcch
Q 008644 137 RGLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (558)
Q Consensus 137 ~aL~yLHs~gIiHrDIKP~NILl~~~~--~lKL~DFGla~~~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~D 213 (558)
.||.|||+.||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999998776 899999999986543221 11123456899999999998654357899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHH
Q 008644 214 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 293 (558)
Q Consensus 214 IWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li 293 (558)
||||||++|+|++|+.||.+.+..+.+..+.... .......+..+++.+.+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK---------------------------LCFENPNYNVLSPLARDLL 311 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------CCTTSGGGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc---------------------------cccCCcccccCCHHHHHHH
Confidence 9999999999999999999888766554443211 1111122345789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 294 ERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 294 ~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.+||+.||.+|||+.++|+||||+.+..
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999999997653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.60 Aligned_cols=262 Identities=28% Similarity=0.484 Sum_probs=218.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC----hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--- 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC---
Confidence 35799999999999999999999999999999998643221 12467789999999999999999999998543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC----cEEEeeccc
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGL 172 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~----~lKL~DFGl 172 (558)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 81 --TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 46999999997 69999998888899999999999999999999999999999999999999887 899999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 159 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 231 (283)
T 3bhy_A 159 AHKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD- 231 (283)
T ss_dssp CEECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-
T ss_pred ceeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-
Confidence 987543321 245679999999999976 6789999999999999999999999998876655544433211111
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
...++.+++.+.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 232 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 --------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1122467889999999999999999999999999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=386.98 Aligned_cols=283 Identities=31% Similarity=0.510 Sum_probs=228.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCC-cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLP 93 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg-~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn------Iv~l~~i~~~ 93 (558)
+.++|++++.||+|+||.||+|.+..++ ..||||++.. .......+.+|+.+|+.++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3579999999999999999999998887 6899999864 2344567889999999998766 7787777743
Q ss_pred CCcCCCccEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe------------
Q 008644 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------ 159 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl------------ 159 (558)
. ..+|+||||++++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 94 ~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 H-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp T-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred C-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 3 4799999999999998887754 69999999999999999999999999999999999999
Q ss_pred -------CCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 008644 160 -------NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (558)
Q Consensus 160 -------~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~ 232 (558)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999998643322 44689999999999977 678999999999999999999999999
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHHH--------------HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKA--------------RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 298 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~ 298 (558)
+.+..+.+..+...++.++...+........ ..++....... ..........++.+.+||.+||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhc
Confidence 9999999999999999888776654432110 11111110000 00011112235678999999999
Q ss_pred cCCCCCCCHHHHhcCccccCcc
Q 008644 299 FEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 299 ~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.||.+|||+.|+|+||||+++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=399.08 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=205.4
Q ss_pred CCCCcEEEE-eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCcC
Q 008644 20 GEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 20 ~~~~rY~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL-~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+.++|.+. ++||+|+||+||+|+++.+|+.||||++.. ...+.+|+.++ +.++||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 344678887 799999999999999999999999999853 23567899887 5568999999999874311 2
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCcEEEeecc
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 171 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~lKL~DFG 171 (558)
+...+|||||||. |+|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 2347899999998 59999998754 5999999999999999999999999999999999999998 7889999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh----HHHHHHHhh
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLL 247 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~----~~~~i~~~l 247 (558)
+++...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+... ....+.
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--- 280 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--- 280 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---
Confidence 998654322 2356789999999999976 689999999999999999999999998765322 111110
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..........+..+++.+.+||++||..||.+|||++|+|+||||....
T Consensus 281 ------------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 281 ------------------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ------------------------HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ------------------------cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0111111233567899999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=389.39 Aligned_cols=263 Identities=27% Similarity=0.362 Sum_probs=208.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H--pnIv~l~~i~~~~~~~~ 98 (558)
.+++|++++.||+|+||.||+|.+ .++..||||++............+.+|+.+|+.++| +||+++++++...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~---- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC----
Confidence 467899999999999999999987 468999999997655555666789999999999987 9999999998543
Q ss_pred CccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+|||+++++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 82 -~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 -QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 3699999988889999999998999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCCcccccccccCccccCccccccc---------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
.... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ...+...
T Consensus 160 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~--- 233 (343)
T 3dbq_A 160 DTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI--- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH---
T ss_pred cccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH---
Confidence 3221 122456899999999998531 146788999999999999999999999764321 1111111
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+..... .......+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 234 --------------------~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 --------------------IDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp --------------------HCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --------------------hcCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 001111 11223456789999999999999999999999999999853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=383.03 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=214.6
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.|+..+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++... ..+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 4899999999999999999999999999999986432 23456788999999999999999999998554 3699
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999997 588887754 47999999999999999999999999999999999999999999999999999875443222
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------- 256 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------------- 256 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Confidence 245689999999999977 67899999999999999999999999887765544333221
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. +.......+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 257 -----------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 257 -----------PP-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -----------SC-CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -----------CC-CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00 0111223568899999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=395.90 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=212.3
Q ss_pred CcEEE--EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 23 SRYKI--EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i--~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.|.+ .+.||+|+||.||+|.+..+|..||+|++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----N 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----C
Confidence 45555 67899999999999999999999999998742 234567789999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe--CCCCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl--~~~~~lKL~DFGla~~~ 176 (558)
.+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 6999999997 5898888664 469999999999999999999999999999999999999 56789999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43322 244679999999999976 57889999999999999999999999998877666555432111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.....++.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1123346789999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=390.75 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=216.4
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 126 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE---- 126 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----
Confidence 344679999999999999999999999999999999974322 233446789999999999999999999998654
Q ss_pred CccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|||||.|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 127 -~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred -CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 36999999999999888864 5679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.. ...+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------- 268 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 268 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------
Confidence 21 346799999999998421 256889999999999999999999999887765544333210
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+ ......+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 269 ----------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 ----------------ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------------CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 111 1112457889999999999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=383.02 Aligned_cols=281 Identities=25% Similarity=0.389 Sum_probs=209.1
Q ss_pred CCCcEEEE-eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
..++|++. +.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~---- 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE---- 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC----
Confidence 45789996 7899999999999999999999999999653 223456789999999885 799999999998543
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEeecccce
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 174 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~DFGla~ 174 (558)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+++
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 84 -DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred -CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 46999999998 699999998888999999999999999999999999999999999999998776 9999999997
Q ss_pred eccCCCC----CcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 175 VAFNDTP----TAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 6432211 11112346799999999998631 024788999999999999999999999876532100000
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..... ......+..+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 239 ~~~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 239 GEACP--------ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp --CCH--------HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccch--------hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 00000 000011111111111111122346789999999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.32 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence 4689999999999999999999999999999999975433333334455566668889999999999998643 36
Q ss_pred EEEEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999988777653 56799999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCcccccc--ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhhCCCCHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~-~~~~~~i~~~lg~p~~~ 253 (558)
...... ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+... ...+..+..
T Consensus 161 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVAK----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred cccccc----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 433221 33579999999999631 115688899999999999999999999976432 222211111
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
...+ ......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0111 11124578999999999999999999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=374.82 Aligned_cols=263 Identities=30% Similarity=0.440 Sum_probs=222.9
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.-...++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 87 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 87 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--
Confidence 3456789999999999999999999999999999999986432 3344567788999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 88 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 ---DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ---SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ---CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 46999999998 59999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------- 229 (294)
T 2rku_A 165 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------- 229 (294)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----------
T ss_pred cccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----------
Confidence 5432221 244679999999999977 5788999999999999999999999988775443332211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.. ......+++.+.+||.+||+.||++|||++|+|+||||.....
T Consensus 230 ----------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 ----------------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp ----------------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ----------------cc-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 0122457889999999999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=405.55 Aligned_cols=255 Identities=16% Similarity=0.193 Sum_probs=202.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHH---HHhcCCCCccccc-------ee
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKL---LRLLRHPDIVEIK-------HI 90 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~i---L~~l~HpnIv~l~-------~i 90 (558)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999999999999999743 2334566788999954 5555799999998 44
Q ss_pred ecCCCc-------CCC-----ccEEEEEecCcccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCceecC
Q 008644 91 LLPPSR-------REF-----KDIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRD 151 (558)
Q Consensus 91 ~~~~~~-------~~~-----~~~~lV~E~~~g~L~~~i~~~~~l~e-------~~~~~i~~QIl~aL~yLHs~gIiHrD 151 (558)
+..... .+. ...||||||++|+|.+++...+.+++ ..++.|+.||+.||.|||+.||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 000 13899999999999999987655655 88888999999999999999999999
Q ss_pred CCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccC-----------CCCCcchhhhHHHH
Q 008644 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (558)
Q Consensus 152 IKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~-----------~y~~~~DIWSlG~i 220 (558)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985322 2245678 99999999876 4 68999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 008644 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 300 (558)
Q Consensus 221 l~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~d 300 (558)
+|+|++|+.||.+.+....+. .+ ....+.+++.+.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~---------------------------~~--------~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE---------------------------WI--------FRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSG---------------------------GG--------GSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchh---------------------------hh--------hhhccCCCHHHHHHHHHHcCCC
Confidence 999999999997654322110 00 1123577899999999999999
Q ss_pred CCCCCCHHHHhcCccccCcc
Q 008644 301 PKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 301 P~~Rpta~elL~hp~f~~~~ 320 (558)
|.+|||+.|+|+||||+.+.
T Consensus 348 p~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHHH
T ss_pred chhCCCHHHHhhChHHHHHH
Confidence 99999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=383.63 Aligned_cols=263 Identities=30% Similarity=0.435 Sum_probs=223.4
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 113 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 113 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 3456789999999999999999999999999999999987432 3445567789999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 114 ---~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 ---DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp ---SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ---CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 46999999998 59999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 191 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 191 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred cccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 5433221 245679999999999977 57889999999999999999999999887755443332210
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
. ......+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 257 -----------------~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 -----------------E-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------C-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 0 0112457889999999999999999999999999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=375.21 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=218.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR----- 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----
Confidence 3468999999999999999999999999999999986321 1122346788999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 46999999997 59999999888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 227 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred cc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------
Confidence 21 234679999999999987 57899999999999999999999999887755443333210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
. ....+.++..+.+||.+||..||.+|||++++|+||||+....
T Consensus 228 --------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 --------------D-----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp --------------C-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred --------------c-----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0 0122457899999999999999999999999999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=390.94 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=211.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh------hHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~------~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.++|++++.||+|+||.||+|+++.+++.||||++....... .....+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~- 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ- 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-
Confidence 468999999999999999999999999999999997532211 1334577899999999999999999998543
Q ss_pred cCCCccEEEEEecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..+|+||||+. | +|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 102 ----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 ----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 46999999986 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+....
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 87644322 245689999999999876 444 78899999999999999999999642210
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.... ......+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 237 -----------------~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -----------------VEAA-----IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------------TTTC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------------Hhhc-----cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0000 01123478999999999999999999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=421.73 Aligned_cols=258 Identities=21% Similarity=0.381 Sum_probs=221.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|+++++||+|+||.||+|.++.+++.||||++.+.. ........+.+|..+|..+ +||+|+.+++++...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~----- 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----- 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----
Confidence 468999999999999999999999999999999997421 1223456788999999887 699999999988543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+||||||+. |+|..++...+.+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 46999999998 59999999888999999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 495 ~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------------ 557 (674)
T 3pfq_A 495 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 557 (674)
T ss_dssp TTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS------------
T ss_pred CCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC------------
Confidence 222 2356789999999999977 68999999999999999999999999998876665555321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta-----~elL~hp~f~~~~ 320 (558)
. . .....+++++.+||++||+.||.+|+++ +||++||||+++.
T Consensus 558 --------------~--~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 558 --------------N--V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp --------------C--C---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred --------------C--C---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 0 0 1124678999999999999999999997 9999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=386.32 Aligned_cols=259 Identities=27% Similarity=0.484 Sum_probs=216.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC------hhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------VSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~------~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.+ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 5799999999999999999999999999999998643211 11245678999999999 799999999988543
Q ss_pred cCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
...|+||||++| +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 173 ----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 ----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 469999999985 999999888889999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccc----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
....... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 7543322 2457899999999998532 1357889999999999999999999998877655554443321111
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
. ...+...++.+.+||.+||+.||++|||++|+|+||||+
T Consensus 325 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 S---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp C---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred C---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 1 112246688999999999999999999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.82 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=219.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC---C----hhHHHHHHHHHHHHHhcC-CCCccccceee
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---H----VSDATRILREIKLLRLLR-HPDIVEIKHIL 91 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~---~----~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~ 91 (558)
+..++|++.+.||+|+||.||+|.++.+|+.||||++..... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 446789999999999999999999999999999999864321 1 123456789999999996 99999999998
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
... ..+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 94 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred ccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 543 46999999998 599999998888999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccc----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~ 246 (558)
|++........ .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99987543322 2456799999999998521 246788999999999999999999999887765544433321
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
. .......++.++..+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 245 ~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 N---------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp C---------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred C---------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1 1111122346789999999999999999999999999999998653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=393.54 Aligned_cols=261 Identities=28% Similarity=0.369 Sum_probs=208.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC--CCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~--HpnIv~l~~i~~~~~~~~~ 99 (558)
+.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.++ ||||+++++++....
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~---- 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---- 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC----
Confidence 4569999999999999999999865 899999999755445566778999999999997 599999999886543
Q ss_pred ccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|||||+++++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 130 -~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 -YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp -EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred -EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 599999977789999999988999999999999999999999999999999999999995 589999999999865432
Q ss_pred CCCcccccccccCccccCccccccc---------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCC
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGT 249 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~lg~ 249 (558)
... ......+||+.|+|||++.+. ...|+.++||||||||+|+|++|+.||.+.... ..+..+..
T Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Ccc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 211 123456899999999998641 135888999999999999999999999764321 11111110
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
...... .....+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 283 ----------------------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ----------------------PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------ccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 011111 123347889999999999999999999999999999853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=387.23 Aligned_cols=288 Identities=25% Similarity=0.372 Sum_probs=226.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-----------CCCccccce
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKH 89 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-----------HpnIv~l~~ 89 (558)
..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ |+||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999863 2344567889999999886 899999999
Q ss_pred eecCCCcCCCccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeC------
Q 008644 90 ILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------ 160 (558)
Q Consensus 90 i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~------ 160 (558)
++.... .+...+++|||+++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 223468999999988999999874 4599999999999999999999998 999999999999994
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN----- 235 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 235 (558)
..+.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999875432 244579999999999987 578999999999999999999999998764
Q ss_pred -hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCC-------------CCCCCCCHHHHHHHHHhcccCC
Q 008644 236 -VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-------------QKFPNANPLALRLLERMLAFEP 301 (558)
Q Consensus 236 -~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~s~~~~~Li~~mL~~dP 301 (558)
....+..+.+.+|.++...+...... ..++............ ......++.+.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 56677888888998887765543221 1111111100000000 1112345788999999999999
Q ss_pred CCCCCHHHHhcCccccCcccC
Q 008644 302 KDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 302 ~~Rpta~elL~hp~f~~~~~~ 322 (558)
.+|||++|+|+||||++....
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTTC
T ss_pred cccCCHHHHhhChhhhcccCc
Confidence 999999999999999976443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=376.39 Aligned_cols=267 Identities=23% Similarity=0.402 Sum_probs=217.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++++.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+|+.++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence 468999999999999999999999999999999997421 11234577899999999999999999999985432 2
Q ss_pred ccEEEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 46899999999888888876 3469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------------ 227 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------------ 227 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------------
Confidence 32221 12345679999999999876322346789999999999999999999988775544333321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
.. ......+++.+.+||.+||+.||.+|||++|+|+||||+......
T Consensus 228 ---------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 228 ---------------GS----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------CC----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------CC----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 00 012246789999999999999999999999999999998765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=378.29 Aligned_cols=267 Identities=28% Similarity=0.340 Sum_probs=214.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
-+.++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 83 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED---- 83 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS----
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC----
Confidence 34679999999999999999999999999999999986432 3344567889999999999999999999998443
Q ss_pred CccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||++| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 84 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 84 -DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred -CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 469999999985 999999988889999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------ 226 (294)
T 4eqm_A 163 ETSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------ 226 (294)
T ss_dssp --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------
T ss_pred ccccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Confidence 32211 1244679999999999977 6789999999999999999999999998775543322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
...+.......+.+++.+.+||.+||+.||.+||+..+.+.+.|..-+..
T Consensus 227 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 227 --------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp --------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred --------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11111112234567899999999999999999996666666777655443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=401.30 Aligned_cols=260 Identities=32% Similarity=0.548 Sum_probs=204.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC------ChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4689999999999999999999999999999999864321 11122347899999999999999999998732
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cEEEeecc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~lKL~DFG 171 (558)
..+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 24799999997 59999998888999999999999999999999999999999999999997644 59999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHhhCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGT 249 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~-~~i~~~lg~ 249 (558)
+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+......+ ..+..
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---- 359 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---- 359 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----
Confidence 998654322 23457899999999998531 246788999999999999999999999875433222 22211
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.........+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 360 -----------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 360 -----------------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -----------------------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 1111112233567899999999999999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=371.12 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=208.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----D 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----T
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----C
Confidence 3689999999999999999999999999999999986555556677889999999999 899999999998543 3
Q ss_pred cEEEEEecCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-------------
Q 008644 101 DIYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------------- 162 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~------------- 162 (558)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 69999999975 999999764 679999999999999999999999999999999999999844
Q ss_pred ------CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q 008644 163 ------CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (558)
Q Consensus 163 ------~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~ 236 (558)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.+++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47999999999875432 234699999999998762 3566799999999999999999987754332
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. .+. ... .......+++.+.+||.+||+.||.+|||+.|+|+||||
T Consensus 237 ~~---~~~---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 237 WH---EIR---------------------------QGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HH---HHH---------------------------TTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HH---HHH---------------------------cCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 11 111 000 112234678999999999999999999999999999999
Q ss_pred cCc
Q 008644 317 KGL 319 (558)
Q Consensus 317 ~~~ 319 (558)
+..
T Consensus 284 ~~~ 286 (289)
T 1x8b_A 284 LSA 286 (289)
T ss_dssp ---
T ss_pred hhh
Confidence 853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=375.23 Aligned_cols=260 Identities=34% Similarity=0.551 Sum_probs=219.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----Ce
Confidence 5689999999999999999999999999999999976544455677899999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~DFGla~~~~ 177 (558)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999997 5999999887889999999999999999999999999999999999999764 469999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 237 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG----------- 237 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3321 244578999999999875 4889999999999999999999999987765544433221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
........+..+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 238 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 ----------------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ----------------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00011122356789999999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=413.94 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=216.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|+++++||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~----- 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK----- 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----
Confidence 4578999999999999999999999999999999996421 1223446688999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 100 KDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+|||||. |+|.+++...+. +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 46999999997 699999987553 999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 43321 245689999999999977 5789999999999999999999999987653211111111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.+... +. .....+++.+.+||.+||+.||.+|| +++|+++||||+++
T Consensus 400 ---------~i~~~----~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 400 ---------LVKEV----PE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHHC----CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------Hhhcc----cc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 11111 11 12256789999999999999999999 89999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=372.02 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=192.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
-++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----N 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----S
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----C
Confidence 367999999999999999999999999999999986321 1112346788999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 6999999997 5999999875 5699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 224 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence 2211 234679999999999976 57889999999999999999999999876543322111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
... .......++..+.+||.+||+.||.+|||++++|+||||....
T Consensus 225 ------------~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 225 ------------VLA----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------CSS----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------hhc----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 000 0112245789999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=395.99 Aligned_cols=276 Identities=17% Similarity=0.146 Sum_probs=199.1
Q ss_pred ccccCCCC-cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhc--CCCCccccc---
Q 008644 16 FTEYGEGS-RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL--RHPDIVEIK--- 88 (558)
Q Consensus 16 ~~~~~~~~-rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l--~HpnIv~l~--- 88 (558)
-++++... .|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++
T Consensus 54 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~ 133 (371)
T 3q60_A 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133 (371)
T ss_dssp EETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CB
T ss_pred EecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence 34445443 49999999999999999999999999999999976433 334456677885555444 699988755
Q ss_pred ----eeecCCCcC------------CCccEEEEEecCcccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhC
Q 008644 89 ----HILLPPSRR------------EFKDIYVVFELMESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHTA 145 (558)
Q Consensus 89 ----~i~~~~~~~------------~~~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~------~~i~~QIl~aL~yLHs~ 145 (558)
+++...... ....+|+|||||+++|.+++...+ .+++... ..++.||+.||.|||++
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 333222110 014589999999999999998743 3455555 67779999999999999
Q ss_pred CceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHH
Q 008644 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (558)
Q Consensus 146 gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLl 225 (558)
||+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999999865321 1245677999999999652246899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 008644 226 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305 (558)
Q Consensus 226 tG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp 305 (558)
+|+.||.+......- ..... ...............+.+++.+.+||.+||+.||++||
T Consensus 288 tg~~Pf~~~~~~~~~-----~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 288 CLFLPFGLVTPGIKG-----SWKRP-----------------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp HSSCSTTBCCTTCTT-----CCCBC-----------------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred hCCCCCCCcCccccc-----chhhh-----------------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC
Confidence 999999876422100 00000 00000011111122357899999999999999999999
Q ss_pred CHHHHhcCccccCc
Q 008644 306 TAEEALADPYFKGL 319 (558)
Q Consensus 306 ta~elL~hp~f~~~ 319 (558)
|+.++|+||||+.+
T Consensus 346 t~~e~l~hp~f~~~ 359 (371)
T 3q60_A 346 LPLEAMETPEFLQL 359 (371)
T ss_dssp CHHHHTTSHHHHHH
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=388.64 Aligned_cols=285 Identities=22% Similarity=0.342 Sum_probs=219.7
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||.||+|.+..++..||+|++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----T
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----C
Confidence 357899999999999999999999999999999998753 2345567789999999999999999999998543 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+|||||++ +|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 69999999975 9999999888899999999999999999999996 999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh-CCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-GTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l-g~p~~~~i~~ 257 (558)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... +.+.......
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234689999999999987 678999999999999999999999998877554332221111 1110000000
Q ss_pred --------------hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 258 --------------VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 258 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.........+..+....... .....++..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00000111122222221111 11235688999999999999999999999999999998644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=405.18 Aligned_cols=262 Identities=22% Similarity=0.347 Sum_probs=215.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|+++++||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----T 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----C
Confidence 478999999999999999999999999999999996422 1123346788999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 101 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+|+|||||. |+|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 6999999998 5999998764 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---------- 403 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------- 403 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----------
Confidence 5433221 245689999999999987 6899999999999999999999999987642111111110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (558)
.+... . ......+++.+.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 404 -------------~i~~~-~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 404 -------------RVLEQ-A---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp -------------HHHHC-C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred -------------HHhhc-c---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 00000 0 1122567899999999999999999996 58999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=369.09 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=214.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence 57999999999999999999999999999999986432 224557789999999999999999999988543 468
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|+||||+++ +|.+++..+..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999988777899999999999999999999999999999999999999999999999999986533221
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~lg~p~~~~i~~~~~ 260 (558)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.... +..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1123456799999999998762 2246789999999999999999999987654321 111110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. .....+..+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 224 -----------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 224 -----------KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------cc---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 00 0112234678999999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=369.43 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=207.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... .
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 468999999999999999999999999999999986421 1123346788999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 6999999997 599999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 225 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------- 225 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred c----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-------------
Confidence 2 1245679999999999876 333 5789999999999999999999987765444333221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. ......++..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 226 --------------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 --------------GV----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------Cc----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00 01123568899999999999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=375.49 Aligned_cols=274 Identities=22% Similarity=0.408 Sum_probs=213.2
Q ss_pred CCcccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccce
Q 008644 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKH 89 (558)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~ 89 (558)
...++-..-...++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+|+.+ +||||+++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence 34444444566789999999999999999999999999999999986422 2346788999999998 7999999999
Q ss_pred eecCCCcC-CCccEEEEEecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcE
Q 008644 90 ILLPPSRR-EFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (558)
Q Consensus 90 i~~~~~~~-~~~~~~lV~E~~~g-~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~l 165 (558)
++...... ....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence 98654311 13578999999985 999999874 469999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
||+|||++........ .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 169 kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 9999999976533221 12446799999999998621 14688999999999999999999999987765544332
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+.. ...+ ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 246 ~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 246 IPR--------------------------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHH--------------------------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred hhc--------------------------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 211 0000 11234678999999999999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=381.06 Aligned_cols=260 Identities=32% Similarity=0.525 Sum_probs=208.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC------ChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4689999999999999999999999999999999864321 112234578999999999999999999988432
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEeecc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~DFG 171 (558)
.+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 3899999997 599999988888999999999999999999999999999999999999987664 9999999
Q ss_pred cceeccCCCCCcccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhhCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGT 249 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~-~~~i~~~lg~ 249 (558)
+++...... .....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+...... ...+....
T Consensus 163 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 236 (322)
T 2ycf_A 163 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 236 (322)
T ss_dssp TCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--
T ss_pred cceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--
Confidence 998753221 2245679999999999742 115688999999999999999999999976543322 12221110
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.......+..+++.+.+||.+||..||.+|||++++|+||||+.
T Consensus 237 -------------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 -------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -------------------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 00111223467899999999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=371.97 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=213.2
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.....++|++++.||+|+||.||+|.+..++..||+|++... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--- 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC---
Confidence 356678999999999999999999999999999999998643 234467788999999999999999999998654
Q ss_pred CCccEEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~g-~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 89 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 89 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred --CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 369999999984 88888865 45799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCcccccccccCccccCcccccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
...... ......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 237 (302)
T 2j7t_A 167 NLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------ 237 (302)
T ss_dssp HHHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred cccccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc------
Confidence 321110 1134579999999999831 1156889999999999999999999999887755443332211
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. +.......++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 238 --------------------~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 --------------------DP--PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp --------------------CC--CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred --------------------CC--cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 01112245688999999999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=369.91 Aligned_cols=260 Identities=30% Similarity=0.465 Sum_probs=215.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4689999999999999999999999999999999976544556677899999999999999999999987532 2246
Q ss_pred EEEEEecCcc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEeCCCCcEEEeecc
Q 008644 102 IYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~----~~l~e~~~~~i~~QIl~aL~yLHs~g-----IiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 8999999984 999998753 34999999999999999999999999 9999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------ 230 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 230 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh------
Confidence 997653321 11234679999999999977 5788999999999999999999999988765443333321
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. .......+++.+.+||.+||+.||.+|||++|+|+|+|+.+-
T Consensus 231 ---------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 231 ---------------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------cc---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 00 011224678999999999999999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=376.51 Aligned_cols=278 Identities=22% Similarity=0.375 Sum_probs=212.2
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---C
Confidence 456899999999999999999999999999999999974322 234567789999999999999999999886433 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----CCCCcEEEeecc
Q 008644 100 KDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 171 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~---l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl----~~~~~lKL~DFG 171 (558)
..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 46899999997 699999986543 9999999999999999999999999999999999999 788889999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHH
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMT 244 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~ 244 (558)
+++....... ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||...... .....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9987644332 2456799999999987521 157889999999999999999999999754322 1222222
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~ 315 (558)
.++...+...+..+... ...+..+. .....++..+.+||.+||+.||++|||++|+|+||=
T Consensus 238 ~~~~~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcc----------cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22211111100000000 00011111 112234567899999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=388.14 Aligned_cols=263 Identities=23% Similarity=0.390 Sum_probs=211.9
Q ss_pred CcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++++.||+|+||.||+|++. .+|+.||||+++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 68999999999999999999984 589999999987422 1222345567899999999 699999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 132 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ---ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 36999999998 59999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+..
T Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 532221 12245689999999999875334578999999999999999999999976543222111111
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
..+. .. ......+++.+.+||.+||..||.+|| |++|+|+||||+.+
T Consensus 277 ---------~~~~----~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 277 ---------RILK----SE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---------HHHH----CC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------HHhc----cC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0000 00 112356789999999999999999999 99999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=370.88 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=210.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++... .
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----T 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----C
Confidence 467899999999999999999999999999999998642 2346688999999999999999999998543 3
Q ss_pred cEEEEEecCcc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999985 9999987 456799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 239 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------- 239 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------
Confidence 321 1245679999999999977 5789999999999999999999999987665443322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
... +.......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 240 --------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 240 --------------NPP-PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------SCC-CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------CCC-cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 000 1111223468899999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.94 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=204.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Cc
Confidence 46899999999999999999976 688999999986555556667899999999999999999999998543 35
Q ss_pred EEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 102 IYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~---l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+|+||||+. ++|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987654 999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--------- 254 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--------- 254 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS---------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 433221 1245689999999999987 67899999999999999999999999887755443322110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFK 317 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~--hp~f~ 317 (558)
.. .......+++.+.+||.+||+.||.+|||++++++ +++++
T Consensus 255 -----------------~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 -----------------CK---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -----------------CC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -----------------CC---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 11223567899999999999999999999999987 34443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=372.46 Aligned_cols=272 Identities=28% Similarity=0.424 Sum_probs=194.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----- 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-----
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----
Confidence 3578999999999999999999999999999999986422 1234567889999999999999999999986543
Q ss_pred cEEEEEecCc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 101 DIYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~--------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
.+|+||||+. ++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 5899999997 599998874 4569999999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCC--CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 172 LARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~- 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP- 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC-
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC-
Confidence 9976533211 11122446799999999998642 3588999999999999999999999988765544332221100
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
+.. ............+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 245 ~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSL--------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCT--------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred Ccc--------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 000 000111233467789999999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.69 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=208.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcE---EEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~---vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++.+.||+|+||.||+|.+..++.. ||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR---- 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 457899999999999999999999876654 9999997432 34456778999999999999999999999843
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
...+|+||||++ ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 -GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp -GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred -CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 346899999997 5999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------
Confidence 6544333223344567888999999976 578899999999999999999 999998877655444333211
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 272 --------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 --------------------R---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------C---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1122467899999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=365.18 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=217.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD----- 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 45678999999999999999999999999999999986432 224567889999999999999999999998543
Q ss_pred ccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 369999999985 89888864 5799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 321 1245679999999999977 5788999999999999999999999987665433322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
..+ ......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 234 --------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 234 --------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 111 12234678999999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=372.90 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=196.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
-..++|++++.||+|+||.||+|.+..++. .||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445789999999999999999999887775 89999997654455667889999999999999999999999866442
Q ss_pred C-CCccEEEEEecCcc-cHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 97 R-EFKDIYVVFELMES-DLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 97 ~-~~~~~~lV~E~~~g-~L~~~i~~~~------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
. .....|+||||+.+ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 11235999999985 9999986532 59999999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhh
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~l 247 (558)
|||+++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 180 Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~- 255 (323)
T 3qup_A 180 DFGLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG- 255 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred ecccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-
Confidence 999998654332211 1234457788999999977 678999999999999999999 99999887766554433221
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCccccCc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-------AEEALADPYFKGL 319 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-------a~elL~hp~f~~~ 319 (558)
. .....+.+++.+.+||.+||+.||.+||| +++++.|||+...
T Consensus 256 --------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 --------------------------N---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp --------------------------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred --------------------------C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 11223567899999999999999999999 7888999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=373.57 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=192.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~-iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++... .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 478999999999999999999999999999999997532 2234455666666 77888999999999998654 3
Q ss_pred cEEEEEecCcccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 101 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 101 ~~~lV~E~~~g~L~~~i~~-----~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+|+||||++++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 6899999999998888764 56799999999999999999999999 99999999999999999999999999997
Q ss_pred eccCCCCCcccccccccCccccCccccccc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
....... .....||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+... ..
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---------- 238 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQ---------- 238 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HH----------
Confidence 6543321 2345799999999998321 1468899999999999999999999997644211 00
Q ss_pred HHHHHhhhHHHHHHHhhhccCCC-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+..+....+ .........+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 239 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 239 --------------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 111111111 11122335689999999999999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=366.53 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=195.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
-++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 4689999999999999999999999999999999975433333334445555678889999999999998654 36
Q ss_pred EEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~-gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||+++.+..+... .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999997777666654 56799999999999999999999995 9999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCcccccc---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhhCCCCHHHH
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~---~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~~~~i~~~lg~p~~~~i 255 (558)
.. .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.. ....+..+..
T Consensus 179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 244 (318)
T 2dyl_A 179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---------- 244 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH----------
T ss_pred cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc----------
Confidence 21 234579999999999852 11468899999999999999999999997643 2222222211
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..+ +.......+++.+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 245 -----------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 -----------------EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -----------------SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 111 11122346789999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=373.05 Aligned_cols=269 Identities=25% Similarity=0.382 Sum_probs=189.8
Q ss_pred ccccCCCCcEEEEe-EeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 16 FTEYGEGSRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 16 ~~~~~~~~rY~i~~-~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
...+.+.++|++++ +||+|+||.||+|+++.+|+.||||++... .....+....++.++||||+++++++...
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 45577889999965 699999999999999999999999998631 11122233446778999999999988542
Q ss_pred CcCCCccEEEEEecCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---CcEEEe
Q 008644 95 SRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKIC 168 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~g-~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~---~~lKL~ 168 (558)
. .....+|+|||||++ +|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+
T Consensus 95 ~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 95 H-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp E-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred c-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 1 223468999999985 9999998764 69999999999999999999999999999999999999864 559999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
|||+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 174 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---- 242 (336)
T 3fhr_A 174 DFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---- 242 (336)
T ss_dssp CCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred ccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----
Confidence 999998654322 244678999999999866 578889999999999999999999997655332111100
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
..+...........+..+++.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 243 -------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 243 -------------------RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ---------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred -------------------HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 001111111122334678999999999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=375.20 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=208.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-------CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999875 35567999999753 2334567899999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
. ..+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 3 36899999998 59999998753 48999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (558)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865433221 11234567889999999977 679999999999999999999 999998877
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
....+..+.. ... ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHT---------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5554433321 110 11234678899999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=360.05 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=202.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC------
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS------ 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~------ 95 (558)
.++|++++.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999863 2345577899999999999999999999886432
Q ss_pred --cCCCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 96 --RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 96 --~~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
......+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 123457899999997 59999998654 58899999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCC-----------CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hhhH
Q 008644 172 LARVAFNDTP-----------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQ 239 (558)
Q Consensus 172 la~~~~~~~~-----------~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-~~~~ 239 (558)
+++....... ........+||+.|+|||++.+. ..++.++|||||||++|+|++ ||.... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976532210 01123456799999999998752 468899999999999999998 453211 1111
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
+. .+...............++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 238 ~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LK---------------------------KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HH---------------------------HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HH---------------------------hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11 11111111112233466788999999999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=364.32 Aligned_cols=265 Identities=27% Similarity=0.349 Sum_probs=208.0
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC--CCCccccceeecCCCc
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSR 96 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~--HpnIv~l~~i~~~~~~ 96 (558)
--.+++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ |+||+++++++...
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 100 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 100 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--
Confidence 345678999999999999999999885 5899999999755455566778999999999997 59999999988554
Q ss_pred CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+|||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++..
T Consensus 101 ---~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 ---QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp ---SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred ---CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 3699999987889999999988999999999999999999999999999999999999996 489999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccc---------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHh
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDL 246 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~ 246 (558)
...... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 177 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-- 253 (313)
T 3cek_A 177 QPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-- 253 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH--
T ss_pred cCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH--
Confidence 433221 122346799999999998641 135788999999999999999999999764321 1111110
Q ss_pred hCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 247 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 247 lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
..... .......+..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 254 ------------------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 254 ------------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ------------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ------------------------hcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 01111 112234578899999999999999999999999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=378.35 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=209.6
Q ss_pred CCcEEEEeEeeccCceEEEEEE-----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|++++.||+|+||+||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4689999999999999999999 5567889999999643 3345566788999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC---cE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~---~l 165 (558)
...|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 35799999997 59999998643 489999999999999999999999999999999999999555 59
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (558)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754322111 11234578999999999976 679999999999999999998 999999887665544433
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
... . ......+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 301 ~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------C---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211 0 111246788999999999999999999999999988764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=373.22 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=209.1
Q ss_pred CCcEEEEeEeeccCceEEEEEE-----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4799999999999999999998 5667899999999743 2334557789999999999 7899999999986533
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCCC----------------------------------------------------
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 122 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~~---------------------------------------------------- 122 (558)
..+|+|||||. |+|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 35899999998 599999987543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccc
Q 008644 123 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (558)
Q Consensus 123 --------------l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (558)
+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986543322 122345
Q ss_pred cccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHH
Q 008644 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 267 (558)
Q Consensus 189 ~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~ 267 (558)
..||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 311 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------- 311 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------------
Confidence 678999999999976 678999999999999999998 99999887644333222110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 268 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ......+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 312 -----~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 -----GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 001 11224578999999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.81 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=210.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh----hHHHHHHHHHHHHHhcC--CCCccccceeecC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLR--HPDIVEIKHILLP 93 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~~Ei~iL~~l~--HpnIv~l~~i~~~ 93 (558)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45779999999999999999999999999999999986432211 12245678999999996 5999999999854
Q ss_pred CCcCCCccEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC-CCCcEEEeec
Q 008644 94 PSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~-~~~~lKL~DF 170 (558)
. ..+++|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 120 ~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 P-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp S-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 3 46999999997 69999999888899999999999999999999999999999999999999 7899999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +.
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~------ 256 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II------ 256 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh------
Confidence 9998764322 2456799999999998652 2346789999999999999999999964321 00
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. .. ......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 257 -----------------~---~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 -----------------R---GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -----------------H---CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------------c---cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0 00 01224678999999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=373.14 Aligned_cols=273 Identities=19% Similarity=0.301 Sum_probs=211.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh---------------hHHHHHHHHHHHHHhcCCCCccc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---------------SDATRILREIKLLRLLRHPDIVE 86 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~---------------~~~~~i~~Ei~iL~~l~HpnIv~ 86 (558)
.++|++++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999998 89999999986422111 11277899999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCcc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCc
Q 008644 87 IKHILLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 156 (558)
Q Consensus 87 l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~------i~~--~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~N 156 (558)
+++++... ..+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998553 469999999985 99888 655 5679999999999999999999999 999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~-~~DIWSlG~il~eLltG~~pF~~~~ 235 (558)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|+.||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875433 22456899999999999762 25555 8999999999999999999998876
Q ss_pred h-hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 236 V-VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 236 ~-~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
. ...+..+.......+.. . ..+. ..............+++.+.+||.+||+.||.+|||++|+|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~-~--------~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLD-R--------NHFL---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCS-S--------SSST---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccc-h--------hhhh---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 33333332110000000 0 0000 00000001112257889999999999999999999999999999
Q ss_pred cccCc
Q 008644 315 YFKGL 319 (558)
Q Consensus 315 ~f~~~ 319 (558)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.57 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=209.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++.+.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----K 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----C
Confidence 45789999999999999999999999999999999854 3445667899999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 6999999998 599999987 45799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-----------ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 179 DTPTA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 179 ~~~~~-----------~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------ 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------ 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------
Confidence 32211 11125689999999999987 688999999999999999999999987543211000
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. ......+.. ...+.+++.+.+||.+||+.||++|||+.++++ |++.+
T Consensus 233 ~------------~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 233 G------------LNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp S------------BCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred h------------hhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 0 000011111 112456788999999999999999999999986 55443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=369.41 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=205.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
-++++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---- 77 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG---- 77 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecC----
Confidence 45689999999999999999999999999999999986432 223578899999999 899999999988543
Q ss_pred CccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc-----EEEeeccc
Q 008644 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGL 172 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~-----lKL~DFGl 172 (558)
...|+||||++++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 78 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 78 -KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred -CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 468999999988999999874 67999999999999999999999999999999999999999887 99999999
Q ss_pred ceeccCCCCCcc----cccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 173 ARVAFNDTPTAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 173 a~~~~~~~~~~~----~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
++.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 987543322110 1245789999999999987 6789999999999999999999999988554333222221100
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... +.+.......+ +.+.+||.+||+.||.+||+++++++
T Consensus 235 ------------~~~-----------~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 ------------TKR-----------ATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------HHH-----------HSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------hhc-----------cCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000 00000011222 38999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=358.51 Aligned_cols=258 Identities=18% Similarity=0.245 Sum_probs=208.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.+ +|+|++.+++++.. .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----G 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----T
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----C
Confidence 467899999999999999999999999999999998643 2234577899999999 79999999998743 3
Q ss_pred ccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc-----EEEeecccc
Q 008644 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLA 173 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~-----lKL~DFGla 173 (558)
...|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 4689999999889999998754 5999999999999999999999999999999999999987776 999999999
Q ss_pred eeccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 174 RVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-- 234 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 234 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH--
Confidence 8765432211 11245689999999999977 678999999999999999999999998854332222211110
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ...+.....+.+++.+.+||.+||+.||.+|||++++++
T Consensus 235 ----------~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 235 ----------EKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------HHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------hhc-----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 000 000111223467899999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.70 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=202.9
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
..+||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++... ..+|+|||
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 99 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFME 99 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEEE
Confidence 34899999999999999999999999998643 234456788999999999999999999998543 36899999
Q ss_pred cCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-CCcEEEeecccceeccCCCCC
Q 008644 108 LME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 108 ~~~-g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-~~~lKL~DFGla~~~~~~~~~ 182 (558)
|+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 997 69999998752 4679999999999999999999999999999999999988 89999999999987543221
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+..........
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------------- 237 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK------------------- 237 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-------------------
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-------------------
Confidence 12456799999999998653234788999999999999999999999654322111000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
...... .......+++.+.+||.+||+.||++|||++++|+||||+...
T Consensus 238 -----~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 238 -----VGMFKV----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -----HHHHCC----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -----hccccc----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 1122356789999999999999999999999999999998543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.74 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=206.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----Cc
Confidence 478999999999999999999987 57789999997532 2345688999999999999999999998543 36
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999997 5899999764 45999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~----------- 224 (269)
T 4hcu_A 160 QY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 224 (269)
T ss_dssp HH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred cc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----------
Confidence 11 11234567788999999976 578999999999999999999 999998877655444332210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. .......++.+.+||.+||+.||.+|||+.++++|
T Consensus 225 ----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ----------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------c---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 11123468899999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=362.76 Aligned_cols=271 Identities=22% Similarity=0.362 Sum_probs=206.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..++|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 46799999999999999999998 677899999999874 23455677899999999999999999999985422
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp --HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred --CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 235899999997 59999998765 49999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... .....++......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 76443322222344567888999999977 5789999999999999999999999864321 1111122111110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ........+...... .....+++.+.+||.+||+.||++|||+.|+++
T Consensus 236 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 001111222222211 223567899999999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.89 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=206.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+|+.++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----Y 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 3468999999999999999999776 56789999997432 2345688999999999999999999998433 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 6999999997 58999998754 599999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 221 (268)
T 3sxs_A 157 DQYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----------- 221 (268)
T ss_dssp TCEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----------
T ss_pred hhhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----------
Confidence 3221 1234556778999999976 578899999999999999999 99999877765444333211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 222 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 ----------------HR---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123457899999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.88 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=210.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-- 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence 579999999999999999999983 45689999998743 2345567889999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~------------------------l~e~~~~~i~~QIl~aL~yLHs~gIiHrD 151 (558)
..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 36899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 008644 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (558)
Q Consensus 152 IKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 230 (558)
|||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865433221 11234567889999999976 578899999999999999999 9999
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008644 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (558)
Q Consensus 231 F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el 310 (558)
|.+.+.......+.. .. .......+++.+.+||.+||+.||.+|||+.++
T Consensus 253 ~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 253 YPGIPPERLFNLLKT---------------------------GH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp STTCCGGGHHHHHHT---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHhhc---------------------------CC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 988776544333321 00 112235678999999999999999999999999
Q ss_pred hcC
Q 008644 311 LAD 313 (558)
Q Consensus 311 L~h 313 (558)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.46 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=197.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 46999999999999999999998754 457999998643 234456778999999999999999999998732
Q ss_pred CccEEEEEecCcc-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 257999999984 9999998754 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~---------- 232 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------- 232 (281)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----------
T ss_pred Cccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc----------
Confidence 432211 1233457789999999976 578999999999999999997 9999988776554443322
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ....+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 233 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 233 -----------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1123567899999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=356.18 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=204.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||+||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----R 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----C
Confidence 3579999999999999999999876 67789999997432 2345688999999999999999999998443 4
Q ss_pred cEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 6999999997 699999987 45799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+.....
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 239 (283)
T 3gen_A 173 DEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------- 239 (283)
T ss_dssp HHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence 211 11233457788999999976 578999999999999999998 9999988776554443332110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.......++.+.+||.+||+.||.+|||++++|+|
T Consensus 240 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ---------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123457899999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=384.53 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=195.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+|++.++||+|+||+||. ....+|+.||||++.... ...+.+|+.+|+.+ +||||+++++++... ..
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDR-----QF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEET-----TE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CE
Confidence 5799999999999999763 446789999999986422 12356899999999 799999999988443 46
Q ss_pred EEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-----CCcEEEeeccccee
Q 008644 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARV 175 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-----~~~lKL~DFGla~~ 175 (558)
+|+|||||+++|.+++.... .+.+..++.++.||+.||.|||+.||+||||||+|||++. ...+||+|||+++.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999998764 4666677899999999999999999999999999999953 33588999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
..............+||++|+|||++.+. ...++.++|||||||++|+|++ |..||...... +...+. +
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~~---~----- 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILL---G----- 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHHT---T-----
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHHh---c-----
Confidence 65433222233567899999999998631 2467789999999999999999 89999654322 111111 1
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.............+..+.+||.+||+.||.+|||++|+|+||||..+.
T Consensus 244 -------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 244 -------------------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp -------------------CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred -------------------cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 001111111123356689999999999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=351.96 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=204.4
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHH-----HHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-----TRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~-----~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
-..++|++.+.||+|+||.||+|.+..+++.||||++.......... ..+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34579999999999999999999999999999999986433222211 6788999999999999999999998443
Q ss_pred CcCCCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCc-----E
Q 008644 95 SRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----L 165 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~-----l 165 (558)
. ++||||+. ++|.+.+.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +
T Consensus 96 ~-------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T-------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C-------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 2 69999998 69988887654 6999999999999999999999999 999999999999988776 9
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhH--HHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ--LDIM 243 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~--~~~i 243 (558)
||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999753321 245689999999999854335678899999999999999999999986653322 1111
Q ss_pred HHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ... .......+++.+.+||.+||+.||.+|||++|+++
T Consensus 243 ~~--------------------------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE--------------------------EGL---RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH--------------------------SCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--------------------------cCC---CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 10 000 11223567899999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=368.25 Aligned_cols=276 Identities=23% Similarity=0.243 Sum_probs=209.8
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
+-..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 456689999999999999999999775 789999998642 234455667999999999999999999986533 12
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEeCCCCcEEE
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKI 167 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~----------gIiHrDIKP~NILl~~~~~lKL 167 (558)
...+|+|||||. ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 346899999997 5999999775 599999999999999999999999 9999999999999999999999
Q ss_pred eecccceeccCCCCCcccccccccCccccCcccccccc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
+|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+...........
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999876443322 1224468999999999986521 134567899999999999999999998765443333333
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.....|....+... +.. ......+...+ ...++.+.+||.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEV--------VVH--KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHH--------HTT--SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhh--------hhc--ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33344443332211 111 11111111111 122456999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.84 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=201.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++.+.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35799999999999999999998765 566899999976555556667899999999999999999999999765543
Q ss_pred CCccEEEEEecCc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~------~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999998 599999853 346999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 265 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC---
Confidence 999765432211 11234567889999999977 678999999999999999999 89999887765544333211
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 266 ------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 ------------------------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 11224678999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.34 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=207.2
Q ss_pred CCCcEEEEe-EeeccCceEEEEEE--ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEE-VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~-~IG~G~~G~Vy~a~--d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++.+ .||+|+||.||+|. +..+++.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 457999999 99999999999995 46678999999998654444556789999999999999999999998822
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 35899999998 699999999888999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------- 235 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------- 235 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------
Confidence 443322222233456788999999976 568889999999999999999 9999988775443332221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 -----------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 -----------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1123567899999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=363.77 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=201.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh----hHHHHHHHHHHHHHhc----CCCCccccceeec
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLL----RHPDIVEIKHILL 92 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----~~~~~i~~Ei~iL~~l----~HpnIv~l~~i~~ 92 (558)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999999999999999999996432211 2233466899999998 8999999999885
Q ss_pred CCCcCCCccEEEEEec-Cc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC-CCCcEEEee
Q 008644 93 PPSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICD 169 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~-~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~-~~~~lKL~D 169 (558)
.. ..+++|||+ +. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 109 ~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 TQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred cC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 43 368999998 55 69999999888899999999999999999999999999999999999999 889999999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
||+++...... .....||..|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+... +.
T Consensus 184 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~---- 246 (312)
T 2iwi_A 184 FGSGALLHDEP-----YTDFDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERDQE------IL---- 246 (312)
T ss_dssp CSSCEECCSSC-----BCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH----
T ss_pred cchhhhcccCc-----ccccCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh----
Confidence 99998764332 245679999999999865 344 4589999999999999999999964321 00
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. . ......+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 247 -------------------~~---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 -------------------EA---E-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -------------------HT---C-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -------------------hh---c-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00 0 012246789999999999999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=358.44 Aligned_cols=254 Identities=28% Similarity=0.379 Sum_probs=200.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
-++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++... .
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----G 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----C
Confidence 4689999999999999999999999999999999975332 333457789999999999999999999998543 4
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 69999999985 99999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 188 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------------- 248 (309)
T 2h34_A 188 KLT--QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN--------------- 248 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---------------
T ss_pred ccc--cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---------------
Confidence 211 2245679999999999977 678899999999999999999999998765432111111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALA 312 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-ta~elL~ 312 (558)
..........+.+++.+.+||.+||+.||++|| |++++++
T Consensus 249 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 -------------QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112234467889999999999999999999 7888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=368.35 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=209.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC-------CcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t-------g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47999999999999999999997543 357999999753 3445567899999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
. ..+|+||||+. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 3 35899999997 59999998754 49999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (558)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 12244567889999999977 678999999999999999999 999998877
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.......+.. ... ......+++.+.+||.+||+.||++|||+.|++++
T Consensus 299 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHT---------------------------TCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5544333321 111 11224678999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.25 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=201.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEE----EEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~v----AiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
-..++|++++.||+|+||.||+|++..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 45678999999999999999999998888765 77776532 2234456789999999999999999999998643
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..++|++++. |+|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 3788999987 6999999874 56999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------ 235 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ 235 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC------
Confidence 876433221 12234567889999999977 678999999999999999999 99999887655443332211
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ....+.++..+.+||.+||+.||.+|||+.+++++
T Consensus 236 ---------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 ---------------------ER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------CC---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 11234578899999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=354.16 Aligned_cols=274 Identities=24% Similarity=0.378 Sum_probs=212.3
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~ 93 (558)
..-...+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 33456789999999999999999998 67799999999997432 23345778999999999999999999999865
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
.. ...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 95 ~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DG---GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp ------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CC---CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 42 246899999997 499999954 4579999999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
++.................||..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~ 244 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTH 244 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCC
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcc
Confidence 99876544332223345678899999999876 57888999999999999999999886422 222222333222
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .......+...... ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 245 GQMT-------VTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGGH-------HHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cccC-------HHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2111 11222222222222 233577899999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.52 Aligned_cols=250 Identities=21% Similarity=0.425 Sum_probs=211.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++.+.||+|+||.||+|.+..++..||+|++.. .......+.+|+.+|+.++||||+++++++... .
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----P 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 46789999999999999999999999999999999874 334567789999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 6999999998 69999998743 49999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---------- 228 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---------- 228 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----------
Confidence 3322 12344567889999999976 578999999999999999999 99999887755443333211
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 229 -----------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 -----------------YR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 1123567899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.36 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=202.7
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecC----CC
Confidence 56789999999999999999999999999999999875422 22347789999999999998887776643 22
Q ss_pred ccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeeccccee
Q 008644 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFGla~~ 175 (558)
...|+||||++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 46899999998899999985 4579999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh---HHHHHHHhhC
Q 008644 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---QLDIMTDLLG 248 (558)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~---~~~~i~~~lg 248 (558)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 233 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 233 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc--
Confidence 65433211 11245689999999999987 578999999999999999999999998754322 22111110
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ..+.......+++.+.+||.+||+.||++|||++++++
T Consensus 234 -------------~~-----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 -------------KM-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------HH-----------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------cc-----------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 00111122456889999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=363.04 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=208.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
..++|++++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG- 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence 3578999999999999999999987 456899999997432 334567789999999999999999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHr 150 (558)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||
T Consensus 123 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 123 ----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 46899999998 5999999874 469999999999999999999999999999
Q ss_pred CCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCC
Q 008644 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229 (558)
Q Consensus 151 DIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~ 229 (558)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999765322211 11234568899999999876 578999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 008644 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309 (558)
Q Consensus 230 pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~e 309 (558)
||.+.+..+....+.. ... ......+++.+.+||.+||+.||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9988765544333221 111 1123467899999999999999999999999
Q ss_pred Hhc
Q 008644 310 ALA 312 (558)
Q Consensus 310 lL~ 312 (558)
+++
T Consensus 326 ~~~ 328 (343)
T 1luf_A 326 IHR 328 (343)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=353.69 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=199.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||+.++++... .
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence 3568999999999999999999754 359999998665666677889999999999999999999996522 2
Q ss_pred cEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
.+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 5799999998 5999998654 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 173 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 240 (289)
T 3og7_A 173 WSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----------- 240 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH-----------
T ss_pred ccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc-----------
Confidence 221 1123456799999999998521 146788999999999999999999999876655443322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
......+......+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 --------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122233445678899999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=352.07 Aligned_cols=257 Identities=20% Similarity=0.244 Sum_probs=206.6
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..+++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 457899999999999999999999999999999999864322 2357899999999999998877766633 22
Q ss_pred ccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC---CCCcEEEeeccccee
Q 008644 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~---~~~~lKL~DFGla~~ 175 (558)
...|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 46899999998899999984 45799999999999999999999999999999999999994 788999999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh---hHHHHHHHhhC
Q 008644 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---HQLDIMTDLLG 248 (558)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~---~~~~~i~~~lg 248 (558)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 65433211 11245689999999999987 57899999999999999999999999874422 22222221000
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. .+.....+.+++.+.+||.+||+.||.+|||++++++
T Consensus 236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred C--------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 0001112457899999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.70 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=201.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCC----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
-..++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 45689999999999999999999887654 359999997432 33455678999999999999999999999844
Q ss_pred cCCCccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
...+|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 118 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 ---YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ---CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 3469999999985 999999875 57999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------ 266 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------ 266 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC------
Confidence 875443222222233456789999999976 578999999999999999999 99999877654443333211
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus 267 ---------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 ---------------------FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 1124678899999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=364.17 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=205.2
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcE----EEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~----vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~ 92 (558)
...-..++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3445678999999999999999999999988876 6777765322 1223345678999999999999999999873
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
. ..+++||||+. ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 86 ~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 86 G------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp B------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred C------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence 2 35899999998 6999999875 47999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
|+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 160 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 233 (325)
T 3kex_A 160 GVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--- 233 (325)
T ss_dssp SGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---
T ss_pred CcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---
Confidence 999876433222 12345678889999999976 578999999999999999999 99999887654443333211
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 234 ------------------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 ------------------------ER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------------CB---CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------------CC---CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01122356678899999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=361.20 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=190.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc---C
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR---R 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~---~ 97 (558)
..+|++.+.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+|+.+. ||||+++++++..... .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4589999999999999999999999999999999853 23455677899999999996 9999999999853221 3
Q ss_pred CCccEEEEEecCcccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 98 EFKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~---~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
....+|+||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999999998865 557999999999999999999999999 99999999999999999999999999
Q ss_pred ceeccCCCCCc---------ccccccccCccccCcccccc-ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 008644 173 ARVAFNDTPTA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (558)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gT~~Y~APE~l~~-~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~ 242 (558)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~- 263 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN- 263 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc-
Confidence 98754322110 01124569999999999831 11567889999999999999999999997544321110
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
..... ......++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 264 -----------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 264 -----------------------------GKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -------------------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -----------------------------CcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00000 11234566789999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=362.07 Aligned_cols=276 Identities=22% Similarity=0.343 Sum_probs=215.3
Q ss_pred ccccCCCCcEEEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
..++-..++|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4455667899999999999999999998 5778999999999742 345566789999999999999999999988
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEee
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
... +...+|+||||++ ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 94 ~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 94 YGP---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp ECS---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ecC---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 643 2346899999996 699999987 44699999999999999999999999999999999999999999999999
Q ss_pred cccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
||+++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~ 243 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGC 243 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC-
T ss_pred cccceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccc
Confidence 9999876544332223345678899999999876 5688999999999999999999999965432111 00000
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ...........+...... ...+.+++.+.+||.+||+.||.+|||+.|++++
T Consensus 244 ~~-------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 244 ER-------DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ----------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-------ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 000011112222222211 2245788999999999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=361.24 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 47899999999999999999997 3466789999997432 223456789999999999 899999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~-----------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrD 151 (558)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+|||
T Consensus 122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 36899999997 59999998753 279999999999999999999999999999
Q ss_pred CCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 008644 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (558)
Q Consensus 152 IKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 230 (558)
|||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999876443321 12344667889999999876 578999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008644 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (558)
Q Consensus 231 F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el 310 (558)
|.+......+..+.. .... ......+++.+.+||.+||..||.+|||+.++
T Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp STTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 987764433322211 1101 11224568999999999999999999999999
Q ss_pred hcCc
Q 008644 311 LADP 314 (558)
Q Consensus 311 L~hp 314 (558)
++|.
T Consensus 326 ~~~l 329 (344)
T 1rjb_A 326 TSFL 329 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.16 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=206.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+..++..||||+++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 46899999999999999999999999999999998743 2334445688999999999999999999998543 35
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999997 69999998754 5999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 267 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 330 (377)
T 3cbl_A 267 VYAA-SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------- 330 (377)
T ss_dssp EEEC-CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-------------
T ss_pred ceee-cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence 1110 0112235678999999976 578899999999999999998 9999988765443332221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+++.+.+||.+||+.||++|||++++++
T Consensus 331 --------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 --------------GGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111 112456889999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=354.97 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=212.6
Q ss_pred ccccccCC-CCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccc
Q 008644 14 DFFTEYGE-GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVE 86 (558)
Q Consensus 14 ~~~~~~~~-~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~ 86 (558)
.+...|.+ .++|++.+.||+|+||.||+|.+ ..++..||||++... ........+.+|+.+|+.+ +||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeee
Confidence 34444444 47999999999999999999985 467889999999743 2334567889999999999 8999999
Q ss_pred cceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 008644 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANV 147 (558)
Q Consensus 87 l~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~------------------~l~e~~~~~i~~QIl~aL~yLHs~gI 147 (558)
+++++... ..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||
T Consensus 92 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 92 LLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp EEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 99998543 35899999997 49999998754 38999999999999999999999999
Q ss_pred eecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-
Q 008644 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 226 (558)
Q Consensus 148 iHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt- 226 (558)
+||||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876443321 12244567889999999876 678999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 008644 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 306 (558)
Q Consensus 227 G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt 306 (558)
|+.||.+......+..+.. .. .. ......+++.+.+||.+||+.||.+|||
T Consensus 244 g~~p~~~~~~~~~~~~~~~-----------------------~~---~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps 294 (313)
T 1t46_A 244 GSSPYPGMPVDSKFYKMIK-----------------------EG---FR---MLSPEHAPAEMYDIMKTCWDADPLKRPT 294 (313)
T ss_dssp TCCSSTTCCSSHHHHHHHH-----------------------HT---CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCcccchhHHHHHhc-----------------------cC---CC---CCCcccCCHHHHHHHHHHcCCCchhCcC
Confidence 9999987765433322211 00 00 1112457899999999999999999999
Q ss_pred HHHHhcC
Q 008644 307 AEEALAD 313 (558)
Q Consensus 307 a~elL~h 313 (558)
+.|++++
T Consensus 295 ~~ell~~ 301 (313)
T 1t46_A 295 FKQIVQL 301 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.71 Aligned_cols=248 Identities=15% Similarity=0.202 Sum_probs=205.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||.||+|.+. +..||||++............+.+|+.+|+.++||||+++++++.... ...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APHP 84 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSSC
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCCe
Confidence 68999999999999999999874 889999999865555566778999999999999999999999986542 2468
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999998 59999998765 4899999999999999999999999 9999999999999999999999999875422
Q ss_pred CCCCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
. ....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 165 ~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 226 (271)
T 3kmu_A 165 S--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE---------- 226 (271)
T ss_dssp C--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS----------
T ss_pred c--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc----------
Confidence 1 335789999999998652 122334799999999999999999999887755443322210
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||+.||++|||++++++
T Consensus 227 ----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 ----------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1223567899999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=357.96 Aligned_cols=253 Identities=21% Similarity=0.371 Sum_probs=208.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 468999999999999999999876 46789999998743 2334556788999999999999999999998543
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcE
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~l 165 (558)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 101 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 36899999998 5999998752 357999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 008644 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~ 244 (558)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999765332211 11234567889999999976 578999999999999999999 899998876554433322
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. .. .......+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 255 ~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 E---------------------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp T---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 00 112235678999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=357.38 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=198.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHh--cCCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~--l~HpnIv~l~~i~~~~~~~~ 98 (558)
..++|++++.||+|+||.||+|.+ +|+.||||++.. .....+.+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 567999999999999999999977 689999999864 344556677777776 78999999999875432 23
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEeCCCCcEEEee
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH--------s~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
...+|+||||++ ++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 356899999998 599999954 47999999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCCc-ccccccccCccccCccccccccC----CCCCcchhhhHHHHHHHHHhC----------CCCCCCC
Q 008644 170 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KPLFPGK 234 (558)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG----------~~pF~~~ 234 (558)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| +.||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998754433221 11234589999999999876211 344689999999999999999 8888653
Q ss_pred Chhh-HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 235 NVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 235 ~~~~-~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ....+.. .+.........+........++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRK--------------------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHH--------------------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhH--------------------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2111 0111110 00000111111111111234577999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=369.73 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=196.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--- 118 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--- 118 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC---
Confidence 3568999999999999999999877 467789999987432 344567799999999999999999999998543
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||+ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 119 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 119 --KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp --SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 46899999997 69999998754 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...............+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+....+..+....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------- 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------- 267 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-------
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 6433222111223345778999999976 678999999999999999998 999998777554433332110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. . .....++..+.+||.+||+.||.+|||+.++++
T Consensus 268 ----------------~--~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 ----------------R--L-----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------E--C-----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------C--C-----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0 112356889999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.63 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=208.8
Q ss_pred CCCcEEEEe-EeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEE-VIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~-~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|.+.+ .||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC----
Confidence 356788887 9999999999999864 46788999999753 334566789999999999999999999999832
Q ss_pred CCccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 248999999985 999998654 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--------- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred eccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---------
Confidence 6433322222234457899999999976 578899999999999999998 9999987765444332221
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
... ....+.+++.+.+||.+||+.||.+|||+.++++|.
T Consensus 229 ------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 229 ------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ------------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 122357789999999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.83 Aligned_cols=248 Identities=28% Similarity=0.457 Sum_probs=193.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC--hhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~--~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++.+.||+|+||.||+|.+. |..||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 468999999999999999999874 889999998643221 23346788999999999999999999998543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEeCC--------CCcEEE
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 167 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g---IiHrDIKP~NILl~~--------~~~lKL 167 (558)
..+|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 35899999997 58888774 457999999999999999999999999 899999999999986 778999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-- 228 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--
Confidence 99999976533221 34579999999999976 5789999999999999999999999988765443322211
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.... ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0111 11234678999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.19 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=201.3
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEE----EEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~v----AiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
-..++|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 44678999999999999999999999888865 66666432 2334567889999999999999999999998643
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..++|++++. ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 3788999987 6999999874 56999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~------ 235 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ 235 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------
Confidence 875432221 12234567889999999977 678999999999999999999 99999887765543333221
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ....+.+++.+.+||.+||..||.+|||+.|+++
T Consensus 236 ---------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 ---------------------ER---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------------CC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 1123457889999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=363.22 Aligned_cols=267 Identities=16% Similarity=0.158 Sum_probs=201.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChh---------HHHHHHHHHHHHHhcCCCCccccc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVS---------DATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~---------~~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
.+++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 46799999999999999999999987 889999999864321100 112366888999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC--cEE
Q 008644 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLK 166 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~--~lK 166 (558)
+++.... .+...+|+|||||+++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986522 2345799999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred EeecccceeccCCCC----CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--hhhHH
Q 008644 167 ICDFGLARVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQL 240 (558)
Q Consensus 167 L~DFGla~~~~~~~~----~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~--~~~~~ 240 (558)
|+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999987533211 1112245689999999999987 578999999999999999999999996532 22111
Q ss_pred HHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 241 ~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
............ .+... .....+++.+.+||.+||..||++|||++++++
T Consensus 272 ~~~~~~~~~~~~-------------~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQ-------------SVLKW---------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTH-------------HHHHH---------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccH-------------HHHhh---------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111110 00000 001267889999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=355.69 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=209.2
Q ss_pred CCCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~ 94 (558)
..++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357999999999999999999985 457789999999753 2334556789999999999 699999999998543
Q ss_pred CcCCCccEEEEEecCc-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 008644 95 SRREFKDIYVVFELME-SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~~~~----------------l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NI 157 (558)
. ..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 104 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp T----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred C----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2 35899999998 599999987654 89999999999999999999999999999999999
Q ss_pred EeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008644 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (558)
Q Consensus 158 Ll~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~ 236 (558)
|++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 122345678899999999976 678999999999999999998 9999987664
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
...+..... .... ......+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 257 ~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK--------------------------EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH--------------------------HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc--------------------------cCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332221111 0011 11224578999999999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=359.30 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=206.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEE-----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~-----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 45799999999999999999998 6678899999999643 2345566789999999999999999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCK 164 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~~-------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~ 164 (558)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. +..
T Consensus 106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 35799999996 69999998753 4899999999999999999999999999999999999994 446
Q ss_pred EEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 008644 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i 243 (558)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999999764332211 11234568899999999876 578999999999999999998 99999887755443333
Q ss_pred HHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 244 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 244 ~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
... .. ......+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 259 ~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSG---------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC---------------------------CC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 211 00 112346788999999999999999999999999998864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=375.21 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=194.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~ 98 (558)
...+.|.+.+.||+|+||+||.+ ...+|+.||||++.. .....+.+|+.+|+.+ +||||+++++++...
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~---- 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETTD---- 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS----
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecC----
Confidence 45678999999999999999875 456899999999864 2345678999999876 899999999988543
Q ss_pred CccEEEEEecCcccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC---------
Q 008644 99 FKDIYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--------- 162 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~~~~l-------~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~--------- 162 (558)
..+|+|||||+|+|.+++...... ++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 82 -~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 -RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp -SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred -CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 469999999999999999876533 233457899999999999999999999999999999754
Q ss_pred ----CcEEEeecccceeccCCCCC-cccccccccCccccCccccccc-----cCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 008644 163 ----CKLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (558)
Q Consensus 163 ----~~lKL~DFGla~~~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~-----~~~y~~~~DIWSlG~il~eLlt-G~~pF 231 (558)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876443221 1112456899999999998641 1468899999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.+..... .. +.. ........ .......+++.+.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~-~~-i~~-----------------------~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE-SN-IIR-----------------------GIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH-HH-HHH-----------------------TCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH-HH-Hhc-----------------------CCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 11 111 00000000 0001123457899999999999999999999999
Q ss_pred cCccccC
Q 008644 312 ADPYFKG 318 (558)
Q Consensus 312 ~hp~f~~ 318 (558)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.65 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=207.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEEC-------CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~-------~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~ 93 (558)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 479999999999999999999986 46778999999743 2345567789999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~N 156 (558)
. ..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 3 36899999998 59999998654 38999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008644 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (558)
Q Consensus 157 ILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~ 235 (558)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999875432211 11234567889999999876 568899999999999999999 999998877
Q ss_pred hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 236 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 236 ~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.......+... .. ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 265 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------CC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55443333211 00 11234678999999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.95 Aligned_cols=268 Identities=16% Similarity=0.148 Sum_probs=202.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC-----CcEEEEEEeCCccCChhH---------HHHHHHHHHHHHhcCCCCcccc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSD---------ATRILREIKLLRLLRHPDIVEI 87 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t-----g~~vAiK~i~~~~~~~~~---------~~~i~~Ei~iL~~l~HpnIv~l 87 (558)
.++|++++.||+|+||.||+|.+..+ ++.||||++......... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45999999999999999999998775 588999998642110000 0123455666777889999999
Q ss_pred ceeecCCCcCCCccEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC--CCCc
Q 008644 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK 164 (558)
Q Consensus 88 ~~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~--~~~~ 164 (558)
++++.... .....+|||||||+++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99986532 223468999999988999999876 5799999999999999999999999999999999999999 8899
Q ss_pred EEEeecccceeccCCCCC----cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHH
Q 008644 165 LKICDFGLARVAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~ 240 (558)
+||+|||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 999999999875432211 111244569999999999987 57899999999999999999999999864332222
Q ss_pred HHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 241 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 241 ~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
....... ........+.... ...++++.+.+||.+||..||.+||++.++++
T Consensus 271 ~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIR-----------YRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHH-----------HHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHH-----------hhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111100 0000111111110 01467889999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.04 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=203.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC---CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~---tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 4689999999999999999998654 3446999998753 2345567899999999999999999999987432
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4689999998 59999997654 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--------- 230 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------- 230 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---------
Confidence 432211 1234567889999999976 578999999999999999998 99999876655444333221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 231 ------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 ------------------DR---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00 11124568899999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.27 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=205.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CC
Confidence 478999999999999999999986 678899999975322 346788999999999999999999998543 35
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999997 5999999875 46999999999999999999999999999999999999999999999999999764321
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.. .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 158 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~------------ 221 (267)
T 3t9t_A 158 QY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------ 221 (267)
T ss_dssp HH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------
T ss_pred cc--cccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC------------
Confidence 11 11133567889999999976 578899999999999999999 89999887755444333211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 222 ---------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 ---------------FR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------Cc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=353.18 Aligned_cols=246 Identities=17% Similarity=0.280 Sum_probs=200.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCC-------cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg-------~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~ 93 (558)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998887 47999998643 23455778999999999999999999999865
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc-------
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK------- 164 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~------- 164 (558)
. ...|+||||+. ++|.+++...+. +++..++.++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 84 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 G-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp T-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 3 35799999998 699999988664 999999999999999999999999999999999999998887
Q ss_pred -EEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHHHH
Q 008644 165 -LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDI 242 (558)
Q Consensus 165 -lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~ 242 (558)
+||+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|. +||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP-------KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccC-------ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999999864321 1335689999999998652 46889999999999999999955 55555443322211
Q ss_pred HHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 243 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 243 i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
+.. .. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~---------------------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YED---------------------------RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHT---------------------------TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhc---------------------------cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 110 00 1112345678999999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=360.40 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=206.1
Q ss_pred CCcccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEE--EEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCcccc
Q 008644 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87 (558)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~v--AiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l 87 (558)
.....|..... ++|++.+.||+|+||.||+|++..+|..+ |+|.+... ........+.+|+.+|+.+ +||||+++
T Consensus 14 ~~~~~~p~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 14 PDPTIYPVLDW-NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp --CCCSSBCCG-GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCCcccccccH-HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhh
Confidence 33344444333 68999999999999999999999998865 99988642 2234456788999999999 89999999
Q ss_pred ceeecCCCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008644 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHR 150 (558)
Q Consensus 88 ~~i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHr 150 (558)
++++... ..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||
T Consensus 92 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 166 (327)
T 1fvr_A 92 LGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 166 (327)
T ss_dssp EEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 9998543 46999999997 59999998754 69999999999999999999999999999
Q ss_pred CCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCC
Q 008644 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229 (558)
Q Consensus 151 DIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~ 229 (558)
||||+|||++.++.+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.
T Consensus 167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 167 DLAARNILVGENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCccceEEEcCCCeEEEcccCcCcccccccc----ccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCC
Confidence 9999999999999999999999974322111 133467889999999976 568899999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 008644 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309 (558)
Q Consensus 230 pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~e 309 (558)
||.+.+.......+.. ... ......+++.+.+||.+||..||.+|||+++
T Consensus 241 pf~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 241 PYCGMTCAELYEKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp TTTTCCHHHHHHHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCcHHHHHHHhhc---------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9988775443322211 111 1122467899999999999999999999999
Q ss_pred HhcC
Q 008644 310 ALAD 313 (558)
Q Consensus 310 lL~h 313 (558)
++++
T Consensus 291 ll~~ 294 (327)
T 1fvr_A 291 ILVS 294 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=348.40 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=203.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC---cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.. .........+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--- 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC---
Confidence 457999999999999999999876443 3689999875 234456678899999999999999999999875432
Q ss_pred CccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|+||||+++ +|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 100 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 -GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred -CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 368999999985 999999864 45899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC-CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 177 FNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 177 ~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
..... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------
Confidence 33221 1112244668889999999977 678999999999999999999 66788776655443333211
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 249 -------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 -------------------RR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 1112456889999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.24 Aligned_cols=249 Identities=28% Similarity=0.392 Sum_probs=205.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-----
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR----- 96 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~----- 96 (558)
+.+|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467999999999999999999999999999999986421 346789999999999999999998743111
Q ss_pred ------CCCccEEEEEecCcc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEE
Q 008644 97 ------REFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (558)
Q Consensus 97 ------~~~~~~~lV~E~~~g-~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL 167 (558)
.....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 123468999999985 999999764 57999999999999999999999999999999999999999999999
Q ss_pred eecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhh
Q 008644 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~l 247 (558)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------ 225 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS------------ 225 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH------------
Confidence 99999987644322 244679999999999977 678999999999999999999998873210
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
.....+... .....+++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 226 -----------------~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 226 -----------------KFFTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -----------------HHHHHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------HHHHHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111 01235688999999999999999999999999988754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=348.60 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=195.9
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 104 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED---- 104 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence 4557899999999999999999999999999999999742 23445667789999999999999999999998643
Q ss_pred CccEEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccc
Q 008644 99 FKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (558)
Q Consensus 99 ~~~~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla 173 (558)
..+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 105 -NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp -TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred -CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 369999999985 99988864 456999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh--hHHHHHHHhhCCCC
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMTDLLGTPS 251 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~--~~~~~i~~~lg~p~ 251 (558)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .....+
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 250 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-------- 250 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH--------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh--------
Confidence 76543221 1234579999999999877 57889999999999999999999999764321 111111
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ..... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 251 ----------------~---~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 251 ----------------E---QCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ----------------H---TTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------h---cccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 10000 0112467899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=362.80 Aligned_cols=261 Identities=13% Similarity=0.176 Sum_probs=201.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC--------CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT--------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t--------g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~ 93 (558)
+++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999884 889999998642 357899999999999999985432211
Q ss_pred CC-----------cCCCccEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 94 PS-----------RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 94 ~~-----------~~~~~~~~lV~E~~~g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
.. ......+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0123578999999988999999986 6799999999999999999999999999999999999999
Q ss_pred CCC--cEEEeecccceeccCCCCC----cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008644 161 ADC--KLKICDFGLARVAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (558)
Q Consensus 161 ~~~--~lKL~DFGla~~~~~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~ 234 (558)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999765432211 112244589999999999987 57899999999999999999999999865
Q ss_pred C-hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 235 N-VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 235 ~-~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
. ....+..... .+.... .........+..+++.+.+||.+||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQ-------------------KFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHH-------------------HHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHH-------------------hccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 2222111110 000000 0000111123467899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.12 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=204.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 35799999999999999999999999999999999853 34456678899999999999999999999986321 2234
Q ss_pred cEEEEEecCcc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 101 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 68999999985 99998876 45799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCc------ccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 176 AFNDTPTA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 176 ~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 43211110 012345679999999998652 1236889999999999999999999994311000
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
......+. ..... ...+.+++.+.+||.+||+.||.+|||+++++++
T Consensus 254 ------------~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 ------------DSVALAVQ---NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------SCHHHHHH---CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhhHHhh---ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000011 11111 1235678999999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=345.64 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=203.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-+|++.+.||+|+||.||+|.+..++. .||+|++.. .........+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 368888999999999999999765554 799999874 234456678899999999999999999999986543
Q ss_pred ccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23589999996 699999987 4469999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 178 NDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 178 ~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+.+.......+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---------
Confidence 2211 1112244678899999999977 6789999999999999999995 5666655544433332221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 245 ------------------RR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 1122456889999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=354.07 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=207.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCc-----EEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~-----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~ 95 (558)
.++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTHG- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-
Confidence 4789999999999999999999987765 7999998743 2334567789999999999 899999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~~--------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 123 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 ----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 36899999998 4999998752 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~ 239 (558)
.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999865443221 12234567889999999876 578999999999999999998 9999987664433
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+..+.. . ... .......++.+.+||.+||+.||.+|||+.|+++
T Consensus 276 ~~~~~~-----------------------~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVK-----------------------D---GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHH-----------------------H---TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHh-----------------------c---CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 322211 0 000 0112346889999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=369.51 Aligned_cols=243 Identities=23% Similarity=0.402 Sum_probs=202.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||.||+|.+. |+.||||+++.. .....+.+|+.+|+.++||||+++++++.... ..
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cc
Confidence 478999999999999999999774 789999999743 24567899999999999999999999986432 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+|||||. |+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 899999998 599999987653 79999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+..
T Consensus 342 ~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------------ 401 (450)
T 1k9a_A 342 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 401 (450)
T ss_dssp -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT------------
T ss_pred cc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 21 22367889999999976 679999999999999999998 9999987765444333221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 402 ---------------~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 ---------------GYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 123467899999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=377.40 Aligned_cols=249 Identities=21% Similarity=0.418 Sum_probs=208.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 468999999999999999999999999999999997432 3456789999999999999999999998543 36
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 6999999874 3599999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 371 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 434 (495)
T 1opk_A 371 DTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 434 (495)
T ss_dssp CCEE--CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT------------
T ss_pred Ccee--ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 3211 1233456788999999976 578999999999999999999 9999988775544333221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 435 ---------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ---------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 101 1123467899999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.23 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=201.0
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECC-CCc--EEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~-tg~--~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~ 92 (558)
+..-..++|++++.||+|+||.||+|.+.. ++. .||||+++... ........+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 344567899999999999999999998643 333 68999986432 23355678899999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.. ..++||||+. ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 92 ~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 92 TP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp SS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred cC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence 43 3789999998 6999998764 56999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
|+++................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--- 240 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--- 240 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc---
Confidence 999876443332222334567889999999976 568889999999999999999 99999887765444333210
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 -----------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----------------------GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 1123467899999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=344.76 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=205.5
Q ss_pred cCC-CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 19 YGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~-~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
|.+ .++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---- 79 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC----
Confidence 444 479999999999999999999875 56789999987432 235678899999999999999999998742
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 80 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 80 --EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp --SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred --CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 24799999997 69999987543 69999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 158 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------- 226 (279)
T 1qpc_A 158 LIEDNEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------- 226 (279)
T ss_dssp ECSSSCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------
T ss_pred cccCcccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-------
Confidence 76433211 1234557889999999976 568899999999999999999 99999887755443333211
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 227 --------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 --------------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 1112467899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=346.24 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=196.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+ +|+.||||++... .....+.+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----Cc
Confidence 47999999999999999999976 4889999998642 35567899999999999999999999875432 36
Q ss_pred EEEEEecCcc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+||||+++ +|.+++...+. +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 99999987543 89999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------------ 229 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 229 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 23467889999999976 678999999999999999998 9999987665443322211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ---------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ---------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 111 1223567899999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=349.21 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=192.4
Q ss_pred cCCCCcEEEE-eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHH-HhcCCCCccccceeecCCCc
Q 008644 19 YGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 19 ~~~~~rY~i~-~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL-~~l~HpnIv~l~~i~~~~~~ 96 (558)
..+.++|.++ +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~- 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY- 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-
Confidence 3455678888 889999999999999999999999999853 23567899988 6679999999999885311
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCcEEEeec
Q 008644 97 REFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDF 170 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~lKL~DF 170 (558)
.....+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 223578999999985 9999998764 6999999999999999999999999999999999999998 788999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p 250 (558)
|++.... + ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 165 g~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~------ 211 (299)
T 3m2w_A 165 GFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------ 211 (299)
T ss_dssp TTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC------
T ss_pred ccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH------
Confidence 9986431 1 346789999999999999999999997655322110000
Q ss_pred CHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
..+...........+..+++.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 212 -----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 212 -----------------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -----------------CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -----------------HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 000000000011112467899999999999999999999999999999987554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=373.54 Aligned_cols=262 Identities=18% Similarity=0.192 Sum_probs=199.5
Q ss_pred ccccCCCC-cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCc-cCChhHHHHHHHHHHHHHhcCC-CCcccc-----
Q 008644 16 FTEYGEGS-RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH-PDIVEI----- 87 (558)
Q Consensus 16 ~~~~~~~~-rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~-~~~~~~~~~i~~Ei~iL~~l~H-pnIv~l----- 87 (558)
.++.+... .|++.++||+|+||+||+|.+..+|+.||||++... .........+.+|+.+++.++| .|+..+
T Consensus 70 ~s~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 70 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EESSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eccCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 33444444 489999999999999999999999999999998732 2222335678899999999987 322111
Q ss_pred ----ceeecC------------CCcCCCccEEEEEecCcccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 008644 88 ----KHILLP------------PSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHT 144 (558)
Q Consensus 88 ----~~i~~~------------~~~~~~~~~~lV~E~~~g~L~~~i~~-------~~~l~e~~~~~i~~QIl~aL~yLHs 144 (558)
.++... ........++++|+++.++|.+++.. ...+++..+..++.||+.||.|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 111111 00011235789999999999988852 2347888999999999999999999
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCcccccc--------ccCCCCCcchhhh
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~~y~~~~DIWS 216 (558)
.||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999999998764332 245678 99999999831 1145788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHh
Q 008644 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296 (558)
Q Consensus 217 lG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~m 296 (558)
|||++|+|++|+.||.+.+....... + ......+++.+.+||.+|
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~---------------------------~--------~~~~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEW---------------------------I--------FRSCKNIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGG---------------------------G--------GSSCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHH---------------------------H--------HhhcccCCHHHHHHHHHH
Confidence 99999999999999977653221100 0 112246789999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCc
Q 008644 297 LAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 297 L~~dP~~Rpta~elL~hp~f~~~ 319 (558)
|+.||++|||+.++|+||||+.+
T Consensus 348 l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp TCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=363.15 Aligned_cols=269 Identities=23% Similarity=0.315 Sum_probs=206.6
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
...++|++.+.||+|+||.||+|.+ .+|..||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER----- 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----
Confidence 4568999999999999999999986 46899999998643 334567789999999999999999999988443
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 100 KDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~----~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 46899999998 59998886543 58999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~------- 257 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV------- 257 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-------
Confidence 64332211 12244579999999999876 578999999999999999999999997654322111110000
Q ss_pred HHHhhhHHHHHHHhhhccC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 008644 255 IARVRNEKARRYLSSMRKK-KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp 314 (558)
.... ...+... .+.......+..+..+.+||.+||+.||++|||+.|++++.
T Consensus 258 -~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 -ESHN-------NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp -HHHT-------TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -hccc-------cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000 0000000 00001112234456789999999999999999999999753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.98 Aligned_cols=282 Identities=21% Similarity=0.343 Sum_probs=207.1
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..+++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---C
Confidence 356799999999999999999999999999999999974322 234567789999999999999999999986432 2
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----CCCCcEEEeecc
Q 008644 100 KDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 171 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl----~~~~~lKL~DFG 171 (558)
..+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999997 59999997643 39999999999999999999999999999999999999 778889999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHH
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMT 244 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~ 244 (558)
+++...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 998754322 22456799999999997531 024677999999999999999999999753321 1122222
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+++..+...+..+...... .+. .....+ ........+++.+.+||.+||+.||++|||++|+++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~-~~~-~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENG-PID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTC-CEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHhcCCCcccchhheeccCC-Ccc-cCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22221111111000000000 000 000000 001112234567899999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.15 Aligned_cols=269 Identities=25% Similarity=0.346 Sum_probs=206.2
Q ss_pred CCcE-EEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 22 GSRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 22 ~~rY-~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
.++| ++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|+.++||||+++++++....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG- 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC-
Confidence 3455 999999999999998774 4568899999999753 33455677899999999999999999999986532
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 107 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 --AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp --TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred --CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 246899999998 5999998765 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQMT 256 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccchh
Confidence 6544322222345678889999999976 57888999999999999999999999643211 1111121111110
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.......+..... ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 257 -------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 -------VLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------HHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------HHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0111111112211 1223567899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.58 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=204.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999885 46789999997432 346778999999999999999999998842 25
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 899999997 69999997543 689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......+|..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 337 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 402 (454)
T 1qcf_A 337 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 402 (454)
T ss_dssp HHHH--TTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred Ccee--ccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2110 1123456788999999976 578999999999999999999 999999877655444332211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. .....+++.+.+||.+||+.||++|||++++++
T Consensus 403 -----------------~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 -----------------RM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 00 112467899999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=383.38 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=203.8
Q ss_pred cEEEE-eEeeccCceEEEEEEE--CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 24 RYKIE-EVIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 24 rY~i~-~~IG~G~~G~Vy~a~d--~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.++||||+++++++.. .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------E 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 34443 4899999999999954 5677899999998655555667889999999999999999999998842 2
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||. ++|.+++..+..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 4899999998 599999999888999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
...........+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.......+...
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~------------ 588 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------ 588 (635)
T ss_dssp ------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred ccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 322222244567889999999976 679999999999999999998 99999988765544433221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. ......+++.+.+||.+||+.||++|||++++++
T Consensus 589 ---------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 ---------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11 1122467899999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.62 Aligned_cols=272 Identities=20% Similarity=0.306 Sum_probs=204.9
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
....++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS----
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC----
Confidence 34568999999999999999999974 46899999998743221 1223588999999999999999999998544
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEeCCCCcEEEeec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~----~l~e~~~~~i~~QIl~aL~yLHs~---gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
...|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 100 -TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred -CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 35799999998 49999998653 399999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----hhhHHHHHHH
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-----VVHQLDIMTD 245 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~-----~~~~~~~i~~ 245 (558)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+.+..
T Consensus 179 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 179 GLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp SSCEECCSSSSC--EECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccccccCccccc--ccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999875433221 2345679999999999976 568899999999999999999999995211 1111111111
Q ss_pred hhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 246 ~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.+..... ..+. ............+..+.+||.+||+.||.+|||+.|+|+|-+-..
T Consensus 255 ~~~~~~~---------------~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKL---------------EALV--DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCS---------------TTSS--CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred Hhhchhh---------------hhhc--ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 0000000 0000 000000111223467999999999999999999999999866443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.63 Aligned_cols=242 Identities=31% Similarity=0.464 Sum_probs=193.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+. ++.||||++.. ......+.+|+.+|+.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 468999999999999999999764 78999999863 2456778999999999999999999998742 3
Q ss_pred EEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEeCCCCc-EEEeecccc
Q 008644 102 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGLA 173 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs---~gIiHrDIKP~NILl~~~~~-lKL~DFGla 173 (558)
.|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 689999997 59999998765 37899999999999999999999 89999999999999998886 799999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..+
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~---------- 214 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIM---------- 214 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHH----------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHH----------
Confidence 754322 134579999999999977 6789999999999999999999999975432211 000
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
....... .......+++.+.+||.+||+.||.+|||++++++
T Consensus 215 --------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 215 --------------WAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --------------HHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------HHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000111 11223567899999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=359.66 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=196.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCC---cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+|+.++||||+++++++....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---- 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---- 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----
Confidence 46899999999999999999875433 46899998743 34456778999999999999999999999875432
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 100 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 35799999998 59999998754 58999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC-cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 178 NDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 178 ~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------
Confidence 32211 111234567889999999976 678999999999999999999 7788987665443332221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus 312 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 -----------------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01124578899999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.80 Aligned_cols=269 Identities=23% Similarity=0.335 Sum_probs=206.8
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~ 95 (558)
.|.....|...+.||+|+||.||+|.+ ++..||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 26 ~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 102 (307)
T 2nru_A 26 NFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG- 102 (307)
T ss_dssp TTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-
Confidence 355566677779999999999999975 68899999987432 2334567789999999999999999999998543
Q ss_pred cCCCccEEEEEecCc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecc
Q 008644 96 RREFKDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~-g~L~~~i~~---~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 103 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 178 (307)
T 2nru_A 103 ----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178 (307)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ----CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 36899999997 699999874 3469999999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
+++........ .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+...+....
T Consensus 179 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (307)
T 2nru_A 179 LARASEKFAQT-VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254 (307)
T ss_dssp TCEECCSCSSC-EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS
T ss_pred ccccccccccc-ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh
Confidence 99875432221 12244679999999999875 478999999999999999999999987654333222222111000
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
. ....++. . .........+..+.+||.+||..||.+|||+.+++++
T Consensus 255 ~---------~~~~~~~----~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 255 K---------TIEDYID----K---KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp C---------CHHHHSC----S---SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred h---------hhhhhcc----c---cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0001110 0 0111122345678999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=368.71 Aligned_cols=260 Identities=19% Similarity=0.254 Sum_probs=205.0
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-++++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+|+.|+|++++..+..+.. ..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGV----EG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eC
Confidence 356899999999999999999999999999999998764322 2347789999999998665555554432 23
Q ss_pred ccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---CCCCcEEEeeccccee
Q 008644 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl---~~~~~lKL~DFGla~~ 175 (558)
...||||||++++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||| +.++.+||+|||+++.
T Consensus 76 ~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 46899999998899999986 4579999999999999999999999999999999999999 5889999999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
........ ......+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----- 228 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-----
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-----
Confidence 65433211 11235789999999999987 67899999999999999999999999876543332222211
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
........+. .....+++++.+||.+||..||++||++++|++
T Consensus 229 -------~~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 -------SEKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------HHHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------hhccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011000011 111356889999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=347.40 Aligned_cols=271 Identities=22% Similarity=0.364 Sum_probs=209.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEE----ECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~----d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
..++|++++.||+|+||.||+|. +..+|+.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45689999999999999999998 567899999999975 23455678999999999999999999999886532
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 236899999997 59999998764 59999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 76443322112234567888999999876 568899999999999999999999885321 11112222221110
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.. .......+...... .....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 267 ~~------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 MI------VFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH------HHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh------HHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 01111112111111 123567899999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=352.91 Aligned_cols=273 Identities=22% Similarity=0.274 Sum_probs=195.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHH--HHhcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL--LRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~i--L~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.++|++++.||+|+||.||+|.+ +++.||||++.. .....+..|..+ +..++||||+++++.+........
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeec-----cchhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 47899999999999999999965 689999999863 223334444444 456899999999986644333444
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEeCCCCcEEEee
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~---------gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
..+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 57899999997 5999999775 468999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCC-----CcccccccccCccccCcccccccc-----CCCCCcchhhhHHHHHHHHHhCCCCC-CCCChhh
Q 008644 170 FGLARVAFNDTP-----TAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVH 238 (558)
Q Consensus 170 FGla~~~~~~~~-----~~~~~~~~~gT~~Y~APE~l~~~~-----~~y~~~~DIWSlG~il~eLltG~~pF-~~~~~~~ 238 (558)
||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..|| .+.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987543221 111224567999999999986521 23556899999999999999996554 4433222
Q ss_pred HHHHHH-HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 239 QLDIMT-DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP---NANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 239 ~~~~i~-~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
....+. .....|..+.+.. .+.. ......+...++ .+++.+.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQV--------LVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHH--------HHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHh--------hhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111 1122232222111 1111 111112222222 24567999999999999999999999954
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.74 Aligned_cols=270 Identities=25% Similarity=0.331 Sum_probs=196.5
Q ss_pred ccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc--CCCCccccceee
Q 008644 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL--RHPDIVEIKHIL 91 (558)
Q Consensus 14 ~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l--~HpnIv~l~~i~ 91 (558)
.....-.+.++|++++.||+|+||.||+|.+. |+.||||++.. .......+|..++..+ +||||+++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 33334445679999999999999999999875 89999999853 2334455666666554 899999999998
Q ss_pred cCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEeCCC
Q 008644 92 LPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANAD 162 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIiHrDIKP~NILl~~~ 162 (558)
.... .....+|+|||||.+ +|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 101 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 101 IKGT-GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EESC-GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred ccCC-CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 6542 122479999999984 999999765 699999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceeccCCCCCc-ccccccccCccccCccccccccCCCCCc------chhhhHHHHHHHHHhC--------
Q 008644 163 CKLKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAELLTG-------- 227 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~y~~~------~DIWSlG~il~eLltG-------- 227 (558)
+.+||+|||+++......... ......+||+.|+|||++.+ ..++.. +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999997654332211 11235689999999999876 344444 8999999999999999
Q ss_pred --CCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 008644 228 --KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305 (558)
Q Consensus 228 --~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp 305 (558)
..||....... +....+ ...+.........+.......+++.+.+||.+||+.||.+||
T Consensus 257 ~~~~p~~~~~~~~-----------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 257 EYQLPYHDLVPSD-----------PSYEDM--------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp CCCCTTTTTSCSS-----------CCHHHH--------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred cccccHhhhcCCC-----------Cchhhh--------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 66665432110 000000 000100000111111111124567799999999999999999
Q ss_pred CHHHHhcC
Q 008644 306 TAEEALAD 313 (558)
Q Consensus 306 ta~elL~h 313 (558)
|+.++++|
T Consensus 318 s~~ell~~ 325 (337)
T 3mdy_A 318 TALRVKKT 325 (337)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.16 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=199.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4689999999999999999999875 4679999987432 234678999999999999999999998843 35
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|+|||||. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999997 5999999643 4699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 397 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 397 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2211 1133457788999999876 578999999999999999999 99999887765544333211
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ...+.+++.+.+||.+||+.||++|||++++++
T Consensus 398 ----------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 398 ----------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ----------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 122467889999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.27 Aligned_cols=244 Identities=15% Similarity=0.186 Sum_probs=194.7
Q ss_pred CCcEEEEeEeeccCceEEEEE-----EECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC---CCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a-----~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~---HpnIv~l~~i~~~ 93 (558)
.++|++.+.||+|+||+||+| .+..+++.||||++.. .....+.+|+.+++.++ |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 578999999999999999999 4788999999999864 23456778888888887 9999999999865
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC------
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------ 161 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~-----~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~------ 161 (558)
.. ..|+|||||+ |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 139 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 QN-----GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp SS-----CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred CC-----CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 43 6899999998 699999974 456999999999999999999999999999999999999998
Q ss_pred -----CCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q 008644 162 -----DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (558)
Q Consensus 162 -----~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~ 236 (558)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976532222 223456789999999999987 5799999999999999999999999954321
Q ss_pred hhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 237 ~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... .+ . ..+.. ...++.+.+|+.+||..+|.+|++..+.|.+
T Consensus 291 ~~~-----------------------------~~--~--~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 291 GEC-----------------------------KP--E--GLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TEE-----------------------------EE--C--SCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred Cce-----------------------------ee--c--hhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 100 00 0 00000 1235678999999999999999665554443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=374.26 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCCcEEEEe-EeeccCceEEEEEEECC--CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEE-VIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~-~IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..+.|.+.+ .||+|+||.||+|.++. ++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 345666666 89999999999998763 56679999997542 33456789999999999999999999999853
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 24899999998 5999998754 4599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+..
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~--------- 554 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 554 (613)
T ss_dssp CC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---------
Confidence 5433221111123345688999999976 679999999999999999998 9999988776554433322
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ...+.+++.+.+||.+||..||++|||+.++++
T Consensus 555 ------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 ------------------GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ------------------TCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 123467899999999999999999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=383.28 Aligned_cols=281 Identities=25% Similarity=0.340 Sum_probs=212.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~-~~~~~~ 101 (558)
++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999999999999998753 24455677899999999999999999999875422 223457
Q ss_pred EEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc---EEEeecccce
Q 008644 102 IYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 174 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~---lKL~DFGla~ 174 (558)
.|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999996 59999998754 5999999999999999999999999999999999999997765 9999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+. ..+......
T Consensus 173 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~---~~i~~~~~~- 242 (676)
T 3qa8_A 173 ELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH---GKVREKSNE- 242 (676)
T ss_dssp BTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS---TTCC------
T ss_pred ccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh---hhhhcccch-
Confidence 7543322 245689999999999976 689999999999999999999999997754332110 000000000
Q ss_pred HHHhhhHHHHHHHhhhccC-----CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 255 IARVRNEKARRYLSSMRKK-----KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
.. .....+... .........+.+++.+.+||.+||.+||.+|||+.|+|+||||+.+...
T Consensus 243 --~~------~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 243 --HI------VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp ---C------CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred --hh------hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 00 000000000 0001112334467889999999999999999999999999999976543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=370.17 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=203.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4689999999999999999999875 4679999997432 234678999999999999999999998843 35
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
+|||||||. ++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 899999998 5999999643 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... .......++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+.+..+...
T Consensus 416 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 480 (535)
T 2h8h_A 416 NEY--TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 480 (535)
T ss_dssp HHH--HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred Cce--ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 110 01123456788999999876 578999999999999999999 99999887765544333221
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... .....+++.+.+||.+||+.||++|||+++|++
T Consensus 481 ----------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 481 ----------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 122467889999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=344.93 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=203.5
Q ss_pred ccccccCC-CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008644 14 DFFTEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (558)
Q Consensus 14 ~~~~~~~~-~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~ 92 (558)
.+..++.+ .++|++.+.||+|+||.||+|.+.. .||+|++............+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 34455555 4899999999999999999998754 4999998754444444556788999999999999999999986
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.. ..+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus 100 ~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 100 SP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred cC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeec
Confidence 54 35999999997 59999998755 699999999999999999999999999999999999998 689999999
Q ss_pred ccceeccCCC--CCcccccccccCccccCccccccc-------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 008644 171 GLARVAFNDT--PTAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241 (558)
Q Consensus 171 Gla~~~~~~~--~~~~~~~~~~gT~~Y~APE~l~~~-------~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~ 241 (558)
|+++...... ..........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987642211 111122445699999999998642 1357889999999999999999999998776544433
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.+.. ... .......++..+.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~---------------------------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 254 QMGT---------------------------GMK--PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHT---------------------------TCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred Hhcc---------------------------CCC--CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2221 000 01112356778999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.35 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=201.3
Q ss_pred ccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHh--cCCCCccccceeecC
Q 008644 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILLP 93 (558)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~--l~HpnIv~l~~i~~~ 93 (558)
...-.+.++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+.+++. ++||||+++++++..
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33334467999999999999999999987 589999999863 345667889999987 789999999999865
Q ss_pred CCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEeCCCCc
Q 008644 94 PSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCK 164 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH--------s~gIiHrDIKP~NILl~~~~~ 164 (558)
.. .....+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.
T Consensus 108 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 108 DN-GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CC-SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred cC-CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 43 222379999999985 999999764 6999999999999999999999 899999999999999999999
Q ss_pred EEEeecccceeccCCCCCc-ccccccccCccccCccccccccC----CCCCcchhhhHHHHHHHHHhC----------CC
Q 008644 165 LKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KP 229 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG----------~~ 229 (558)
+||+|||++.......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998764433211 11245679999999999876211 123689999999999999999 67
Q ss_pred CCCCCChhh-HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCC
Q 008644 230 LFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK--FPNANPLALRLLERMLAFEPKDRPT 306 (558)
Q Consensus 230 pF~~~~~~~-~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Li~~mL~~dP~~Rpt 306 (558)
||....... ....+.. .+. .......+... ...++..+.+||.+||+.||.+|||
T Consensus 266 p~~~~~~~~~~~~~~~~--------------------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRK--------------------VVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp TTTTTSCSSCCHHHHHH--------------------HHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred CccccCcCcccHHHHHH--------------------HHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 886543110 0000100 000 00000111111 1233467899999999999999999
Q ss_pred HHHHhcC
Q 008644 307 AEEALAD 313 (558)
Q Consensus 307 a~elL~h 313 (558)
++++++|
T Consensus 324 ~~~i~~~ 330 (342)
T 1b6c_B 324 ALRIKKT 330 (342)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=356.49 Aligned_cols=255 Identities=20% Similarity=0.168 Sum_probs=191.8
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC------ChhHHHHHHHHHHHHHhcC---------CCCc
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLR---------HPDI 84 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~------~~~~~~~i~~Ei~iL~~l~---------HpnI 84 (558)
-..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999988 789999999974321 2234477889999998886 6676
Q ss_pred cccceeecCCC-------------------------cCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 008644 85 VEIKHILLPPS-------------------------RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138 (558)
Q Consensus 85 v~l~~i~~~~~-------------------------~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~a 138 (558)
+++.+++.... ..+...+|||||||. |++.+.+.. +.+++..++.|+.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 66666543110 112457999999997 455555543 568999999999999999
Q ss_pred HHHHH-hCCceecCCCCCcEEeCCCC--------------------cEEEeecccceeccCCCCCcccccccccCccccC
Q 008644 139 LKYIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197 (558)
Q Consensus 139 L~yLH-s~gIiHrDIKP~NILl~~~~--------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~A 197 (558)
|.||| +.||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccC
Confidence 99999 99999999999999999887 899999999987643 23589999999
Q ss_pred ccccccccCCCCCcchhhhHHHH-HHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCC
Q 008644 198 PELCGSFFSKYTPAIDIWSIGCI-FAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 275 (558)
Q Consensus 198 PE~l~~~~~~y~~~~DIWSlG~i-l~eLltG~~pF~~~~~~~-~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (558)
||++.+ .. +.++||||||++ .++++.|..||.+..... ..+.+ +... ....
T Consensus 246 PE~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~-----------------------~~~~-~~~~ 298 (336)
T 2vuw_A 246 EDLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-----------------------LKQM-TFKT 298 (336)
T ss_dssp SGGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH-----------------------HHTC-CCSS
T ss_pred hhhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh-----------------------hhhh-ccCc
Confidence 999987 23 789999998777 788899999984321101 11111 1111 0111
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh-cCcccc
Q 008644 276 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL-ADPYFK 317 (558)
Q Consensus 276 ~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL-~hp~f~ 317 (558)
......++.+++++.+||++||++| |++|+| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111223356788999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=369.05 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=204.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC---CcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t---g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998654 457999998643 233455778999999999999999999998832
Q ss_pred CccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+|+||||+. |+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 24799999998 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332211 1234567789999999976 578999999999999999997 99999887765544433221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 123567899999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=373.28 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=199.7
Q ss_pred CCcEEEEeEeeccCceEEEEEEECC-CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~-tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999999999999986 7899999998642 3334556788999999999999999999998654432223
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|||||||+| +|.+++.. .+++..++.|+.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 37999999984 88877654 69999999999999999999999999999999999999985 8999999999875332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+..
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~------- 287 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED------- 287 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT-------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc-------
Confidence 34579999999999875 3588999999999999999999998653211 00000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
......++.+.+||.+||+.||.+||+..++|.|+|+..+
T Consensus 288 --------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 --------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0001124678999999999999999999999999988643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=324.30 Aligned_cols=229 Identities=17% Similarity=0.103 Sum_probs=185.4
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
-++++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---- 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC----
Confidence 345799999999999999999999999999999999975433 244557889999999999999999999998543
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+||||++ ++|.+++..+ .....+..|+.||+.||.|||+.||+||||||+|||++.++.+||+++|.
T Consensus 104 -~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 104 -AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp -TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred -CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 46999999998 5999998543 46667889999999999999999999999999999999999999985542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
++ .++.++|||||||++|+|++|+.||.+.+....+......
T Consensus 176 ------------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~----------- 217 (286)
T 3uqc_A 176 ------------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD----------- 217 (286)
T ss_dssp ------------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-----------
T ss_pred ------------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-----------
Confidence 22 3678999999999999999999999886643211000000
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
............+++++.+.+||.+||+.||.+| |+.|+++
T Consensus 218 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 218 -------------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -------------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -------------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0011111122346788999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-33 Score=306.43 Aligned_cols=187 Identities=18% Similarity=0.112 Sum_probs=133.7
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEeCCccC--------ChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 008644 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--------HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 30 ~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--------~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++.|+.|.+..++....|+.||+|++.+... .....+.+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 35678888888888888999999999864211 123345689999999999 699999999988 4445
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|||||||+| +|.++|...+.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 79999999996 999999999889875 47899999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p 230 (558)
.. ...+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 22 2356799999999999976 467789999999999988776533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-27 Score=260.45 Aligned_cols=191 Identities=21% Similarity=0.260 Sum_probs=142.4
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-Ch-----hHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~-----~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+...+.||+|+||.||+| ...+..+++|++..... .. ....++.+|+.+|+.++||||+.+..++...
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--- 411 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--- 411 (540)
T ss_dssp -----------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---
T ss_pred cCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---
Confidence 3345679999999999999 56788999998653211 11 1235589999999999999999554444322
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
...|||||||+ ++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++..
T Consensus 412 --~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 412 --DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp --TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred --CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 24599999997 699999875 5689999999999999999999999999999998 9999999999876
Q ss_pred cCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 008644 177 FNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (558)
Q Consensus 177 ~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF 231 (558)
....... ......+||+.|+|||++.+....|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 4321110 012467899999999999764456888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=216.27 Aligned_cols=147 Identities=18% Similarity=0.203 Sum_probs=116.9
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh----------------hHHHHHHHHHHHHHhcCCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----------------SDATRILREIKLLRLLRHPDIV 85 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~----------------~~~~~i~~Ei~iL~~l~HpnIv 85 (558)
+..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 45566779999999999999999 889999999986321110 13456889999999999 5 6
Q ss_pred ccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCc
Q 008644 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (558)
Q Consensus 86 ~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~ 164 (558)
.+.+++.. ...|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 66665522 246999999985 8887 32 123557999999999999999999999999999999 999
Q ss_pred EEEeecccceeccCCCCCcccccccccCccccCccccc
Q 008644 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202 (558)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~ 202 (558)
+||+|||+|+. +..|.|||++.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999863 33578999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.3e-21 Score=190.05 Aligned_cols=144 Identities=17% Similarity=0.158 Sum_probs=111.0
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcE--EEEEEeCCccCCh----------------------hHHHHHHHHHHHH
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHV----------------------SDATRILREIKLL 76 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~----------------------~~~~~i~~Ei~iL 76 (558)
.+.-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 345689999999999999999998788999 9999875321110 1123678999999
Q ss_pred HhcCCCCccccceeecCCCcCCCccEEEEEecCcc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcee
Q 008644 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES------DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFH 149 (558)
Q Consensus 77 ~~l~HpnIv~l~~i~~~~~~~~~~~~~lV~E~~~g------~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIiH 149 (558)
+.+.|+++.-..-+.. ...+|||||+++ .|.++... .++..+..++.||+.||.||| +.||+|
T Consensus 125 ~~l~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHHHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHHHhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9998886522211111 245899999953 67766432 345578899999999999999 999999
Q ss_pred cCCCCCcEEeCCCCcEEEeecccceec
Q 008644 150 RDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 150 rDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=171.80 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=98.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc---CC---------hhHHHH--------HHHHHHHHHhcCC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EH---------VSDATR--------ILREIKLLRLLRH 81 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~---~~---------~~~~~~--------i~~Ei~iL~~l~H 81 (558)
+.-|+|.+.||.|++|.||+|.+. +|+.||||+++... .. ...... ..+|...|..+.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 345999999999999999999875 69999999875210 00 000111 2356666666644
Q ss_pred CCccccceeecCCCcCCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 82 pnIv~l~~i~~~~~~~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
.++....-+.. ...+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||++
T Consensus 173 ~gv~vp~p~~~-------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 173 EGFPVPEPIAQ-------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp TTCSCCCEEEE-------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred cCCCCCeeeec-------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 44321111110 123799999986 554432 2234567889999999999999999999999999999
Q ss_pred CCC----------cEEEeeccccee
Q 008644 161 ADC----------KLKICDFGLARV 175 (558)
Q Consensus 161 ~~~----------~lKL~DFGla~~ 175 (558)
.++ .+.|+||+.+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 877 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.5e-11 Score=119.98 Aligned_cols=137 Identities=12% Similarity=0.108 Sum_probs=104.6
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.+. +..+.++++.... ....
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 488999999999999999964 378999999864221 12235889999999885 5667777776633 2468
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------- 144 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------- 144 (558)
|+|||+++| +|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 6766521 222345788999999999998
Q ss_pred ----------------------CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 145 ----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 145 ----------------------~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=118.21 Aligned_cols=184 Identities=17% Similarity=0.254 Sum_probs=119.7
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCccEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnI--v~l~~i~~~~~~~~~~~~~l 104 (558)
++.++.|....||++ +..+++|+... ......+.+|..+|+.+. +..+ ..++... ........-|+
T Consensus 25 i~~~~~G~~n~v~~v-----~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI-----NRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEES-----TTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEE-----CCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 456899999999987 25799998653 234567889999999884 3333 2222221 11111223588
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 008644 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 144 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs--------------------------------------- 144 (558)
||++++| .|..... ..++.+....++.|+...|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247788888888999998888886
Q ss_pred -------------------CCceecCCCCCcEEeCC--CCcEEEeecccceeccCCCCCcccccccccCccc---cCccc
Q 008644 145 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY---RAPEL 200 (558)
Q Consensus 145 -------------------~gIiHrDIKP~NILl~~--~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y---~APE~ 200 (558)
..++|+|++|.||+++. .+.+.|+||+.+...... .+......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-------NDFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-------HHHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-------HHHHHHHhhccccCHHH
Confidence 13699999999999998 456889999998763211 011111111 23332
Q ss_pred cccccCCCC------------CcchhhhHHHHHHHHHhCCCCC
Q 008644 201 CGSFFSKYT------------PAIDIWSIGCIFAELLTGKPLF 231 (558)
Q Consensus 201 l~~~~~~y~------------~~~DIWSlG~il~eLltG~~pF 231 (558)
.......|. .-.+.|++|.+++.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111001111 1258999999999999998766
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.2e-10 Score=112.10 Aligned_cols=133 Identities=14% Similarity=0.085 Sum_probs=94.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~~~~~~~~~ 100 (558)
..|.+..+.+.|..+.||++. ..+|..+++|..... ....+.+|+.+|+.+.+.++ .+++...... +
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----G 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----S
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----C
Confidence 346665555567779999995 456788999987542 22456789999998865454 4466655322 3
Q ss_pred cEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 008644 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--------------------------------- 146 (558)
Q Consensus 101 ~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--------------------------------- 146 (558)
..|+|||+++| +| . . ...+ ...++.++..+|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 1 1122 2356777888888888754
Q ss_pred -------------------------ceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 147 -------------------------VFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 147 -------------------------IiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.2e-09 Score=113.17 Aligned_cols=143 Identities=15% Similarity=0.214 Sum_probs=102.7
Q ss_pred EEEeEeeccCceEEEEEEECCCCcEEEEEEeC--CccCChhHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCcc
Q 008644 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~--~~~~~~~~~~~i~~Ei~iL~~l~H--pnIv~l~~i~~~~~~~~~~~ 101 (558)
.-++.|+.|.++.||++.. .+..+++|+.. ... .......+.+|+.+|+.|.. ..+.+++..+...+ ..+.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~ 115 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGR 115 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSS
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCC
Confidence 3467899999999999864 35689998765 211 11223567899999999974 44667777664331 2245
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------ 144 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------ 144 (558)
.|+|||+++| .+.+. .-..+++.....++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 7899999997 33221 12247888889999999999999997
Q ss_pred ----------------------CCceecCCCCCcEEeCCCCc--EEEeeccccee
Q 008644 145 ----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (558)
Q Consensus 145 ----------------------~gIiHrDIKP~NILl~~~~~--lKL~DFGla~~ 175 (558)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 69999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.1e-06 Score=88.86 Aligned_cols=133 Identities=21% Similarity=0.186 Sum_probs=90.0
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCCCccEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRREFKDIYV 104 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn---Iv~l~~i~~~~~~~~~~~~~l 104 (558)
++.++.|....||++ |..+++|+-. .......+.+|..+|+.|.+.. +.+.+..... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456788999999988 6789999853 2234567889999999997532 2333333321 1235689
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 008644 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-------------------------------------- 145 (558)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~-------------------------------------- 145 (558)
||++++| .|..... ..++......+..++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1245555555555555555555542
Q ss_pred ----------------------CceecCCCCCcEEeCC---CCc-EEEeeccccee
Q 008644 146 ----------------------NVFHRDLKPKNILANA---DCK-LKICDFGLARV 175 (558)
Q Consensus 146 ----------------------gIiHrDIKP~NILl~~---~~~-lKL~DFGla~~ 175 (558)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999997 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=4.3e-06 Score=82.32 Aligned_cols=132 Identities=20% Similarity=0.271 Sum_probs=90.5
Q ss_pred EeeccCce-EEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCCccEEEEEe
Q 008644 30 VIGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFE 107 (558)
Q Consensus 30 ~IG~G~~G-~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H-pnIv~l~~i~~~~~~~~~~~~~lV~E 107 (558)
.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|.. --+.+++..+... ..-|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEE
Confidence 34556555 689988777788899997642 345678899999998852 2244555554322 35799999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008644 108 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------------- 145 (558)
Q Consensus 108 ~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~----------------------------------------- 145 (558)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 565554332 122334555666666666642
Q ss_pred -----------------CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 146 -----------------NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 146 -----------------gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 179999999999999877778999997743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=9.9e-06 Score=84.75 Aligned_cols=77 Identities=19% Similarity=0.151 Sum_probs=47.9
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccC--C---hhHHHHHHHHHHHHHhcCC--CCcc-ccceeecCCCcCCC
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--H---VSDATRILREIKLLRLLRH--PDIV-EIKHILLPPSRREF 99 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~--~---~~~~~~i~~Ei~iL~~l~H--pnIv-~l~~i~~~~~~~~~ 99 (558)
.+.||.|..+.||++.+..++..++||....... . .....++.+|..+|+.+.. +.++ +++... .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence 5689999999999997666778999998652111 0 1123456789999988743 3333 343321 1
Q ss_pred ccEEEEEecCcc
Q 008644 100 KDIYVVFELMES 111 (558)
Q Consensus 100 ~~~~lV~E~~~g 111 (558)
...++|||++++
T Consensus 108 ~~~~lvmE~l~g 119 (397)
T 2olc_A 108 EMAVTVMEDLSH 119 (397)
T ss_dssp TTTEEEECCCTT
T ss_pred CccEEEEEeCCC
Confidence 124799999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=7.9e-06 Score=82.94 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.1
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=1.7e-05 Score=81.53 Aligned_cols=85 Identities=11% Similarity=0.150 Sum_probs=51.9
Q ss_pred EEEEeEe-eccCceEEEEEEECC------CCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCC---CCccccceeecC
Q 008644 25 YKIEEVI-GKGSYGVVCSAYDTR------TGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRH---PDIVEIKHILLP 93 (558)
Q Consensus 25 Y~i~~~I-G~G~~G~Vy~a~d~~------tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~H---pnIv~l~~i~~~ 93 (558)
...++.| +.|..+.+|++.... ++..+++|....... .......+.+|+.+|+.|.. -.+.+++.....
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4556788 889999999885431 266899997643210 00012346788888888753 235556655432
Q ss_pred CCcCCCccEEEEEecCcc
Q 008644 94 PSRREFKDIYVVFELMES 111 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g 111 (558)
.+ ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 11346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00087 Score=70.55 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.2
Q ss_pred HhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 143 HTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 143 Hs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999998865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0015 Score=62.37 Aligned_cols=98 Identities=18% Similarity=0.103 Sum_probs=65.5
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCCccccccc
Q 008644 112 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (558)
Q Consensus 112 ~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLH-s~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (558)
+|.+++.. +.+++|+++|.+++|.+.+|+-+- .+.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999886 458999999999999999988872 22212333457899999999987764 2110
Q ss_pred ccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC
Q 008644 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (558)
Q Consensus 190 ~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~ 228 (558)
.....+.+||... ...+.+.-|||||+++|.-+--.
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456888763 24456788999999999988644
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00043 Score=69.71 Aligned_cols=152 Identities=15% Similarity=0.148 Sum_probs=81.6
Q ss_pred cccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc--cccceeec
Q 008644 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILL 92 (558)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI--v~l~~i~~ 92 (558)
+...||.+ ...-++.|+.|....+|++... +..+++|..... .....+..|+.+++.|...++ .+++...
T Consensus 15 ~l~~~~~~-~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~- 86 (322)
T 2ppq_A 15 FLTQYDVG-SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK- 86 (322)
T ss_dssp HHTTBCCC-CEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-
T ss_pred HHHhCCCC-cceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-
Confidence 34456763 4445677888998999998643 337899988642 122345678888887753222 2222110
Q ss_pred CCC-c-CCCccEEEEEecCccc-H-----H----------HHHHhCCCC--------CHHHHHHH---------------
Q 008644 93 PPS-R-REFKDIYVVFELMESD-L-----H----------QVIKANDDL--------TPEHYQFF--------------- 131 (558)
Q Consensus 93 ~~~-~-~~~~~~~lV~E~~~g~-L-----~----------~~i~~~~~l--------~e~~~~~i--------------- 131 (558)
... . ...+..++++++++|. + . .+......+ ........
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 000 0 0113468999999862 1 0 011111111 11100000
Q ss_pred HHHHHHHHHHHHh-------CCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 132 LYQLLRGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 132 ~~QIl~aL~yLHs-------~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
-..+...+..+.. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113344555542 368999999999999987666899999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0021 Score=64.17 Aligned_cols=68 Identities=15% Similarity=0.063 Sum_probs=42.0
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++. +++... .. .-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-----~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PA-----TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT-----TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CC-----CCEEEE
Confidence 688999999999999 56899987532111 11124688888777533333 344332 11 136899
Q ss_pred ecC-cc
Q 008644 107 ELM-ES 111 (558)
Q Consensus 107 E~~-~g 111 (558)
|++ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0062 Score=60.31 Aligned_cols=76 Identities=12% Similarity=-0.011 Sum_probs=51.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn---Iv~l~~i~~~~~~~~~ 99 (558)
.+..-++.+|.|..+.||++.. .+|+.|++|+-... .......+.+|...|+.|.... +.+++...
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 4567788999999999999964 56889999986532 1122334678999999885322 22333321
Q ss_pred ccEEEEEecCc
Q 008644 100 KDIYVVFELME 110 (558)
Q Consensus 100 ~~~~lV~E~~~ 110 (558)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 2378999986
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0027 Score=64.30 Aligned_cols=74 Identities=18% Similarity=0.130 Sum_probs=53.1
Q ss_pred EEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCccE
Q 008644 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H---pnIv~l~~i~~~~~~~~~~~~ 102 (558)
.-.+.|+.|....+|++.. .+..+++|.... .....+.+|...|+.|.. ..+.+++..... ....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCce
Confidence 3467789999999999863 577899998653 235668889999988852 345555555422 2368
Q ss_pred EEEEecCcc
Q 008644 103 YVVFELMES 111 (558)
Q Consensus 103 ~lV~E~~~g 111 (558)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=67.11 Aligned_cols=72 Identities=14% Similarity=0.109 Sum_probs=47.9
Q ss_pred EEeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCC
Q 008644 27 IEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRRE 98 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI-v~l~~i~~~~~~~~ 98 (558)
-++.|+.|....||++.... .+..+++|+.... . ....+.+|+.+|+.|...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C
Confidence 35678889999999997643 3578999987431 1 12445589999988864444 45555441 1
Q ss_pred CccEEEEEecCcc
Q 008644 99 FKDIYVVFELMES 111 (558)
Q Consensus 99 ~~~~~lV~E~~~g 111 (558)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 288999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0049 Score=62.01 Aligned_cols=76 Identities=13% Similarity=0.067 Sum_probs=46.0
Q ss_pred eEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCc--CCCccEEE
Q 008644 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSR--REFKDIYV 104 (558)
Q Consensus 29 ~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~~~~~~--~~~~~~~l 104 (558)
+.|+ |....||++.. .+|+.+++|...... .....+..|+.+++.|.... +.+++.. .... ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998743 346689999985211 13456777999888875322 3333332 1100 11235688
Q ss_pred EEecCcc
Q 008644 105 VFELMES 111 (558)
Q Consensus 105 V~E~~~g 111 (558)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0036 Score=63.37 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=27.0
Q ss_pred CCceecCCCCCcEEeCCC----CcEEEeeccccee
Q 008644 145 ANVFHRDLKPKNILANAD----CKLKICDFGLARV 175 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~----~~lKL~DFGla~~ 175 (558)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0026 Score=65.48 Aligned_cols=72 Identities=8% Similarity=0.031 Sum_probs=41.7
Q ss_pred EeEeeccCceEEEEEEECC--------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCC
Q 008644 28 EEVIGKGSYGVVCSAYDTR--------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRRE 98 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~--------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI-v~l~~i~~~~~~~~ 98 (558)
++.|+.|....+|++.... .+..+++|+..... .......+|..+|+.|...++ .++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C----
Confidence 5667888889999997543 13688998765311 111123578888888854343 3455433 1
Q ss_pred CccEEEEEecCcc
Q 008644 99 FKDIYVVFELMES 111 (558)
Q Consensus 99 ~~~~~lV~E~~~g 111 (558)
-++||++++|
T Consensus 109 ---~~~v~e~i~G 118 (369)
T 3c5i_A 109 ---GGRIEEWLYG 118 (369)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CcEEEEEecC
Confidence 1689999886
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.006 Score=63.43 Aligned_cols=139 Identities=13% Similarity=0.191 Sum_probs=80.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc-cccceeecCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPP 94 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI-v~l~~i~~~~ 94 (558)
+..+ ++.|..|-...+|++.... .+..+++|+.... ......+.+|..+|+.|..-++ .++++.+.
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-- 124 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP-- 124 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--
Confidence 3444 3567778888999987532 3578999986321 1234456689999988863333 34554441
Q ss_pred CcCCCccEEEEEecCcc-cH-----------HHH---HH---hC----C-CC--CHHHHHHHHHHHHH------------
Q 008644 95 SRREFKDIYVVFELMES-DL-----------HQV---IK---AN----D-DL--TPEHYQFFLYQLLR------------ 137 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~g-~L-----------~~~---i~---~~----~-~l--~e~~~~~i~~QIl~------------ 137 (558)
+ .+||||++| .| ..+ +. .. + .. -...+..|+.++-.
T Consensus 125 ---~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 125 ---E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp ---T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred ---C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 1 289999986 21 111 11 11 1 11 13566666655432
Q ss_pred -------HHHHHH----h----CCceecCCCCCcEEeCCC----CcEEEeecccce
Q 008644 138 -------GLKYIH----T----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 174 (558)
Q Consensus 138 -------aL~yLH----s----~gIiHrDIKP~NILl~~~----~~lKL~DFGla~ 174 (558)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 248999999999999876 789999999774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0093 Score=60.81 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.6
Q ss_pred CCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 145 ANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 145 ~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.065 Score=57.01 Aligned_cols=72 Identities=18% Similarity=0.202 Sum_probs=45.7
Q ss_pred EeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCccEEEEE
Q 008644 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI-v~l~~i~~~~~~~~~~~~~lV~ 106 (558)
++.|+.|-...+|++.....+..+++|+........-+ ..+|+.+|+.|...++ .++++.+ .. .+|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~--~~-------G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF--TN-------GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE--TT-------EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe--CC-------eEEE
Confidence 46788899999999976554578999987432111111 1579999999975555 3555554 11 2599
Q ss_pred ecCcc
Q 008644 107 ELMES 111 (558)
Q Consensus 107 E~~~g 111 (558)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.14 E-value=0.44 Score=49.47 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.8
Q ss_pred ceecCCCCCcEEe------CCCCcEEEeeccccee
Q 008644 147 VFHRDLKPKNILA------NADCKLKICDFGLARV 175 (558)
Q Consensus 147 IiHrDIKP~NILl------~~~~~lKL~DFGla~~ 175 (558)
++|+|+.+.|||+ +.+..+.|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.55 E-value=1.5 Score=45.92 Aligned_cols=72 Identities=13% Similarity=0.079 Sum_probs=44.4
Q ss_pred EeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCC
Q 008644 28 EEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRREF 99 (558)
Q Consensus 28 ~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnI-v~l~~i~~~~~~~~~ 99 (558)
++.|..|-...+|++.... .+..+++++....... .-...+|..+++.|..-++ .++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~----- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--P----- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--T-----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--C-----
Confidence 4556678888999997652 1678999986432111 1123578888888753333 3444433 1
Q ss_pred ccEEEEEecCcc
Q 008644 100 KDIYVVFELMES 111 (558)
Q Consensus 100 ~~~~lV~E~~~g 111 (558)
-++|++|++|
T Consensus 145 --~~~I~efI~G 154 (424)
T 3mes_A 145 --EGRIEEFIDG 154 (424)
T ss_dssp --TEEEEECCCS
T ss_pred --CCEEEEEeCC
Confidence 1688999986
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.03 E-value=0.12 Score=55.02 Aligned_cols=63 Identities=16% Similarity=0.095 Sum_probs=17.1
Q ss_pred EEEeEeeccCceEEEEEEECCCCcEEEE------EEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAI------KKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 26 ~i~~~IG~G~~G~Vy~a~d~~tg~~vAi------K~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
.+.+.|| ||.||++....+...||+ |..............+.+|..+++.++|||+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 3445565 999999977665568888 66553222333445678899999999999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 558 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-101 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-92 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-91 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-81 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-80 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-77 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-74 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-74 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-72 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-71 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-68 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-68 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-65 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 308 bits (789), Expect = e-101
Identities = 163/341 (47%), Positives = 223/341 (65%), Gaps = 5/341 (1%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY IG+G+YG+VCSAYD +VAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N C LKICDFGLARVA D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
KAR YL S+ K +P+++ FPNA+ AL LL++ML F P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 362
EP A+ +F+ E + KE ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 285 bits (729), Expect = 2e-92
Identities = 147/346 (42%), Positives = 217/346 (62%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
++ +E AR Y+ S+ + + F+ F ANPLA+ LLE+ML + R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F + EP A P + FE R + ++ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADP---YDQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 282 bits (721), Expect = 2e-91
Identities = 140/346 (40%), Positives = 214/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
R+++++A+ Y+ + + + F+ NA+PLA+ LLE+ML + + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 361
F+ L E EP Q K + F+ T ++ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 1e-81
Identities = 126/347 (36%), Positives = 195/347 (56%), Gaps = 23/347 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE + ++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPT 248
Query: 263 ARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEA 310
R Y+ + K + F + FP++ A LL +ML +P R + ++A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 357
L PY E A P + + + R T E+ +ELIY+E++
Sbjct: 309 LQHPYINVWYD-PAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (643), Expect = 4e-80
Identities = 101/301 (33%), Positives = 154/301 (51%), Gaps = 7/301 (2%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S+Y+ IG+G++G V A +TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRG 138
++V + I + + IY+VF+ E DL + T + + LL G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
L YIH + HRD+K N+L D LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARRYLSSMR-KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
V N + L ++ +K+ + K +P AL L++++L +P R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 4e-77
Identities = 106/331 (32%), Positives = 167/331 (50%), Gaps = 21/331 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 138
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
+ + K P+++ F P P A+ L R+L + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQI---KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 317 KGLAKVEREPSAQPVTKMEFEFERRRITKED 347
L + T F F + ++
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-74
Identities = 100/306 (32%), Positives = 154/306 (50%), Gaps = 16/306 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL--- 79
+Y+ IG+G+YG V A D + G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ + K P + + + L LL + L F P R +A AL+ PYF+
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 318 GLAKVE 323
L + +
Sbjct: 298 DLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 5e-74
Identities = 101/310 (32%), Positives = 149/310 (48%), Gaps = 22/310 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLRHPDIV 85
+ +G+G + V A D T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 EIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRDLKP N+L + + LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 264
Y +D+W++GCI AELL P PG + + QL + + LGTP+ E + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 265 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 324
+ IP F A L L++ + F P R TA +AL YF
Sbjct: 235 VT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN------ 285
Query: 325 EPSAQPVTKM 334
P P ++
Sbjct: 286 RPGPTPGCQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 6e-74
Identities = 64/310 (20%), Positives = 120/310 (38%), Gaps = 28/310 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ Y+ DIWS+G E+ G+ P + + + + E R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 262 KARRYLSSMRKKKPIPFSQKFPNA-------------NPLALRLLERMLAFEPKDRPTAE 308
M + P+ + + + + L P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 309 EALADPYFKG 318
+ + + K
Sbjct: 294 QLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-73
Identities = 110/300 (36%), Positives = 162/300 (54%), Gaps = 13/300 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 141
IV++ + +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDV-----IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321
Y S K FS+ P + LL +ML ++P R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 230 bits (586), Expect = 4e-72
Identities = 106/295 (35%), Positives = 157/295 (53%), Gaps = 13/295 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K + +VFE + + + L + FL QLL G+ Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ + V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+Y + +P+P+ + + LL +ML +P R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-71
Identities = 107/297 (36%), Positives = 149/297 (50%), Gaps = 11/297 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV + +L + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
Y+ +ID+WS GCIFAEL PLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
Y P N LL+ +L P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 225 bits (575), Expect = 8e-70
Identities = 92/328 (28%), Positives = 163/328 (49%), Gaps = 27/328 (8%)
Query: 5 QRKKSSADVDFFT-EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
R + D + E+G Y++ +G+G Y V A + EKV +K + + +
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK- 74
Query: 64 SDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND 121
+I REIK+L LR P+I+ + I+ P R +VFE + +D Q+ +
Sbjct: 75 ----KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT-- 125
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 180
LT +F++Y++L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQ 239
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + Q
Sbjct: 185 E----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 240 LDIMTDLLGTPSP-EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN-----PLALRLL 293
L + +LGT + I + E R+ + + + + + N P AL L
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
Query: 294 ERMLAFEPKDRPTAEEALADPYFKGLAK 321
+++L ++ + R TA EA+ PYF + K
Sbjct: 300 DKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 1e-69
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 43/327 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +V+G G++ V A D RT + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 143 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ Y+ A+D WSIG I LL G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
+ K + S + + + A + ++ +P+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 320 AKVEREPSAQPVTKMEFEFERRRITKE 346
+++ +++ F + + +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-69
Identities = 69/294 (23%), Positives = 122/294 (41%), Gaps = 40/294 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------------- 226
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
+ P Q + + L R L + + R +A+E L + K
Sbjct: 227 ------LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-69
Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 37/295 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317
K+ + + + L LL ++L P R T + D ++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 2e-68
Identities = 76/345 (22%), Positives = 131/345 (37%), Gaps = 45/345 (13%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILRE 72
+ F + + IG GS+G V A D R E VAIKK++ + I++E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFF 131
++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVG 173
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T ++ APE + +Y +D+WS+G EL KP N + L +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ + P S + ++ L P+DRPT+E
Sbjct: 227 -------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVL 264
Query: 311 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 355
L + TK E + +++++++E
Sbjct: 265 LKHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKILFQE 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 4e-68
Identities = 84/359 (23%), Positives = 146/359 (40%), Gaps = 46/359 (12%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
YK+ +V+G G G V ++ RT EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE+ G KY + D+WS+G I LL G P F + + M
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 315
+ +R + + ++ + L+ +L EP R T E + P+
Sbjct: 226 -----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 316 FKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPT 374
KV + P ++ + ER KE++ + ++Y +K+ + S P
Sbjct: 275 IMQSTKVPQTPL-HTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 218 bits (557), Expect = 8e-68
Identities = 75/307 (24%), Positives = 127/307 (41%), Gaps = 49/307 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-------TRILREIKLL 76
Y+ +E++G+G VV T ++ A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
Y APE+ Y +D+WS G I LL G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 251 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310
+ S ++ + + L+ R L +P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-67
Identities = 70/327 (21%), Positives = 137/327 (41%), Gaps = 47/327 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 141
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + A D+WS+G + LL+G F + ++
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------------ 213
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
++ + + F + A+ ++R+L E K R TA EAL P+ K
Sbjct: 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ- 263
Query: 320 AKVEREPSAQPVTKMEFEFERRRITKE 346
K+ER + T + I K+
Sbjct: 264 -KIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-67
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 45/298 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LKI DFG + A + T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
+ +D+WS+G + E L GKP F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
R + P A L+ R+L P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 218 bits (555), Expect = 1e-66
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 44/299 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 141
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ D+W+IG + LL+G F G++ + L
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------------------ 238
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
++++ F + +P A ++ +L EP+ R T +AL P+ KG
Sbjct: 239 ---------NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 217 bits (554), Expect = 2e-66
Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 44/311 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ D+WS+G + LL+G F G+N L + A
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----- 248
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
F + + ++L +P R T +AL P+
Sbjct: 249 ----------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
Query: 320 AKVEREPSAQP 330
R+
Sbjct: 287 NAPGRDSQIPS 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-66
Identities = 62/300 (20%), Positives = 105/300 (35%), Gaps = 43/300 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 141
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLK NIL D +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
SK Y D+WS+G E+ +P N + L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----------------- 225
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
K P + + L++ L R T + L P+
Sbjct: 226 -----------KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 5e-66
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+G K + IG+GS+ V DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP+IV + + K I +V ELM S L +K + + + + Q+L+GL
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYIHTAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+++HT + HRDLK NI +KI D GLA + A+ + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
Y KP F + P ++E + +R + ++ L +F
Sbjct: 222 ---------YRRVTSGVKPASFDKVAI---PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-65
Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 48/301 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+HP+I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLLRGL 139
V ++ + +Y+V E E DL VI L E + QL L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 140 KYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
K H V HRDLKP N+ + +K+ DFGLAR+ +DT A +V T +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVGTPY 179
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
Y +PE Y DIWS+GC+ EL P F +
Sbjct: 180 YMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------- 224
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
+R+ K ++ ++ RML + RP+ EE L +P
Sbjct: 225 --------------KIREGKFRRIPYRYS---DELNEIITRMLNLKDYHRPSVEEILENP 267
Query: 315 Y 315
Sbjct: 268 L 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 5e-63
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+ D+W++GCI +L+ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA------LADPY 315
K F +KF P A L+E++L + R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-61
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 138
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 139 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+ APE+ D+WSIG I LL+G F G L ++ + E
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE- 238
Query: 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 314
F N + LA + R+L +PK R T +++L P
Sbjct: 239 --------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 315 YFKG 318
+ K
Sbjct: 273 WIKP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 64/293 (21%), Positives = 108/293 (36%), Gaps = 38/293 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ + + IG GS+G V + VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y+H ++ HRDLK NI + D +KI DFGLA V + + F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
+ + Y+ D+++ G + EL+TG+ + N Q+ M
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------------- 222
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
R S+ N RL+ L + +RP + LA
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 2e-59
Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 33/293 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
RY++ E++G G V A D R VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------------------- 224
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALAD 313
++ PIP S + + ++ + LA P++R TA E AD
Sbjct: 225 -------QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-59
Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 57/306 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
S+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79 LR--HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
+ ++ + P ++ E E DL I L E + F +Q
Sbjct: 64 VSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ TR
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTR 173
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y PE + + + +WS+G + +++ G F +
Sbjct: 174 VYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 216
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
+ + F Q+ L+ LA P DRPT EE
Sbjct: 217 ------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 314 PYFKGL 319
P+ + +
Sbjct: 256 PWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-58
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 45/300 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRH 81
+ + +++GKGS+G V A +T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P + + ++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + +RDLK NIL + D +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260
KY ++D WS G + E+L G+ F G++ +
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------- 215
Query: 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGL 319
+ + + A LL ++ EP+ R + P F+ +
Sbjct: 216 -----------RMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 65/302 (21%), Positives = 126/302 (41%), Gaps = 48/302 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
+ +++GKG++G V + TG A+K + ++ + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ +V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y A+D W +G + E++ G+ F ++ +++
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFK 317
+ I F + P A LL +L +PK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 318 GL 319
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 189 bits (480), Expect = 2e-55
Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 49/306 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ Y + D +S+GC+ +LL G F + +I
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALAD 313
M + F P LLE +L + R A+E
Sbjct: 219 ----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 314 PYFKGL 319
P+F+ L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (463), Expect = 1e-53
Identities = 63/302 (20%), Positives = 117/302 (38%), Gaps = 51/302 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
++I +G GS+G V G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
+ Y +ID WS G + E+L G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFK 317
+ + P P N LL R++ + R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 2e-52
Identities = 55/307 (17%), Positives = 99/307 (32%), Gaps = 44/307 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ E +V EL+ S + + + Q++ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTAIFW----TDYVATR 193
YIH+ N HRD+KP N L + I DFGLA+ + + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----------- 224
Query: 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE---EA 310
Y KK P L + D+P +
Sbjct: 225 ------------YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 7e-52
Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 52/293 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ + IGKG +G V G KVA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHS 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+ N HRDL +N+L + D K+ DFGL + A + T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
K++ D+WS G + E+ + G+ +P + + + RV
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPRV 213
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
K P P +++ + RP+ +
Sbjct: 214 EKGY----------KMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 9e-52
Identities = 58/299 (19%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 28 EEVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + + VA+K + + + +L E +++ L +P IV
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 72 RMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+N HRDL +N+L KI DFGL++ D T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184
Query: 205 FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 263
K++ D+WS G + E + G+ + G +
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------------------- 222
Query: 264 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPYFKGL 319
+ K + + P L+ ++ ++RP L + Y+ +
Sbjct: 223 ------LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (448), Expect = 1e-51
Identities = 49/298 (16%), Positives = 98/298 (32%), Gaps = 43/298 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVAFNDTPTAIFW----TDYVA 191
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------- 222
Query: 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
+ R+ KK+ P + + + P +
Sbjct: 223 -QKYERI-----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 59/307 (19%), Positives = 124/307 (40%), Gaps = 44/307 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKIN--DIFEHVSDATRILREIKLLRL 78
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+++H + +RD+K +NIL +++ + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
+ G S + A+D WS+G + ELLTG F + ++ + P
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----- 253
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALA 312
P P + LA L++R+L +PK R A+E
Sbjct: 254 -----------------PYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 313 DPYFKGL 319
+F+ +
Sbjct: 292 HLFFQKI 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-51
Identities = 69/302 (22%), Positives = 113/302 (37%), Gaps = 30/302 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++E IGKG +G V GE+VA+K + + EI +LRH +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 58
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + + +++V + E L + +T E GL ++
Sbjct: 59 ILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 143 HTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
H + HRDLK KNIL + I D GLA + T T I V T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 194 WYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSD 235
Query: 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 309
PS E + +V E+ R IP + A + +++ R TA
Sbjct: 236 PSVEEMRKVVCEQKLR--------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 310 AL 311
Sbjct: 288 IK 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-51
Identities = 74/314 (23%), Positives = 116/314 (36%), Gaps = 55/314 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V +VAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
++T D+WS G + EL T G+ +PG LD + P P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP------ 236
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYF 316
P L+ + EP++RPT E A + YF
Sbjct: 237 ------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 317 KGLAKVEREPSAQP 330
EP QP
Sbjct: 273 TST-----EPQYQP 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (446), Expect = 1e-50
Identities = 70/340 (20%), Positives = 116/340 (34%), Gaps = 47/340 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 83 DIVE------------IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 130
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------CKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------V 237
+T+ + TR YR+PE+ + + DIWS C+ EL+TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 238 HQLDIMTDLLGTPSPEAIARVRNEK----ARRYLSSMRKKKPIPFSQKF-------PNAN 286
+ + +LLG + + + +R L ++ K K P +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 287 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 326
L ML +P+ R A + P+ K +E
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 2e-50
Identities = 53/301 (17%), Positives = 110/301 (36%), Gaps = 49/301 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVK----LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +++ DFG A+ T T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP------EALAPEIIL 211
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262
S Y A+D W++G + E+ G P F + + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------- 250
Query: 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFK 317
+ K P + + LL +L + R + +F
Sbjct: 251 -------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 318 G 318
Sbjct: 299 T 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-50
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 48/309 (15%)
Query: 24 RYKIEEV-IGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
I ++ +G G++G V + VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 138
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E K++ D+WS G E L+ G+ + PE +A
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------------GPEVMAF 224
Query: 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADP 314
+ K+ P P P L+ ++ +DRP +
Sbjct: 225 IEQ----------GKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 315 YFKGLAKVE 323
Y+ +KVE
Sbjct: 270 YYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-49
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 46/304 (15%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILRE 72
F + + S KIE+VIG G +G VCS + G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT--PTAIFWTD 188
L + G+KY+ N HRDL +NIL N++ K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ AP + K+T A D+WS G + E+++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA 307
P P + +L+ + RP
Sbjct: 251 RLPPPM------------------------------DCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEAL 311
+ +
Sbjct: 281 GQIV 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-49
Identities = 59/295 (20%), Positives = 107/295 (36%), Gaps = 44/295 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL 79
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE + ++ A D W G E+ T G+ + G N + +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH 225
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
++ E R P P + ++ + A +P+DRPT
Sbjct: 226 KIDKEGERL---------PRP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 7e-49
Identities = 55/292 (18%), Positives = 104/292 (35%), Gaps = 46/292 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G +GVV R VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N L N +K+ DFGL+R +D T+ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
SK++ DIW+ G + E+ + GK + + + L P
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH-------- 224
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313
A+ ++ + +RPT + L++
Sbjct: 225 ----------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-49
Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 50/300 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 139
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+I N HRDL+ NIL + KI DFGLAR+ ++ TA + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTAPE 180
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +T D+WS G + E++T G+ +PG +
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---------------- 222
Query: 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYF 316
+ + + P +L+ P+DRPT + + + +F
Sbjct: 223 -----------LERGYRMVRPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 64/321 (19%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLL- 76
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDS-NYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
PG V + ++ +
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQPFYAT---EEIYI 298
Query: 292 LLERMLAFEPKDRPTAEEALA 312
+++ AF+ + RP+ +
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 3e-48
Identities = 54/290 (18%), Positives = 111/290 (38%), Gaps = 40/290 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++V++ + ++ + + L + +++ + Q+ ++Y+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL 131
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL +N L + +K+ DFGL+R+ DT TA + APE
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLA 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261
+K++ D+W+ G + E+ T G +PG ++ +++
Sbjct: 190 Y--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------------ 229
Query: 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
K + + P L+ + P DRP+ E
Sbjct: 230 ---------EKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-48
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 46/292 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + IG G +G+V Y +KVAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ A V HRDL +N L + +K+ DFG+ R +D T T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEV 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
FS+Y+ D+WS G + E+ + GK + ++ ++ ++ P
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------ 225
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311
A+ +++ P+DRP L
Sbjct: 226 ------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 61/319 (19%), Positives = 112/319 (35%), Gaps = 48/319 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+K +V+G G++G V GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+P + + I L + + + L V + D++ ++ + Q+ +G+
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +KI DFGLA++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259
YT D+WS G EL+T G + G I+ P P
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP------- 235
Query: 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319
P ++ + + RP E + +
Sbjct: 236 -----------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKVEREPSAQPVTKMEFEF 338
+K+ R+P V + +
Sbjct: 268 SKMARDPQRYLVIQGDERM 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-46
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 43/296 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
S ++VIG G +G V + K VAIK + + L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +I+ ++ + ++K + ++ E ME + + + + + + L +
Sbjct: 66 FSHHNIIRLEGV-----ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE K+T A D+WS G + E++T + H++
Sbjct: 181 APEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------- 222
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ ++ +P P +L+ + E RP + ++
Sbjct: 223 ----------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 58/296 (19%), Positives = 111/296 (37%), Gaps = 44/296 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
EVIG+G +G V A+K +N I + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 138
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E + K+T D+WS G + EL+T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--------------- 245
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312
+ + + + + P+ ++ + + + RP+ E ++
Sbjct: 246 ------------YLLQGRRLLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 52/313 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
R ++ IG+G +G V VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + T + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE ++T A D+W G E+L G F G + + I
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------------NNDVIG 220
Query: 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316
R+ N ++ P+P PN P L+ + A++P RP E A
Sbjct: 221 RIEN----------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--- 262
Query: 317 KGLAKVEREPSAQ 329
L+ + E AQ
Sbjct: 263 --LSTILEEEKAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 66/315 (20%), Positives = 113/315 (35%), Gaps = 64/315 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLL- 76
+R + +G G++G V A VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 123 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
ND+ + + +W + YT D+WS G EL + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+ M +++ + + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 297 LAFEPKDRPTAEEAL 311
+P RPT ++ +
Sbjct: 285 WDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 61/311 (19%), Positives = 109/311 (35%), Gaps = 63/311 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLL-RLL 79
+ K ++VIG+G++G V A + G + AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 122
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 123 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 301
+ P N + L+ + +P
Sbjct: 238 KLPQGYRLEKPL------------------------------NCDDEVYDLMRQCWREKP 267
Query: 302 KDRPTAEEALA 312
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-44
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 70/320 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + IG+G++G V A VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + K + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGV-----CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
+R ++ D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 291
G + +R + + P
Sbjct: 244 YGMAHEEVIY---------------------------YVRDGNILACPENCP---LELYN 273
Query: 292 LLERMLAFEPKDRPTAEEAL 311
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-43
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 65/317 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKL 75
R + + +G+G++G V A + KVA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 118
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGA-----CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 119 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 237 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 296
+ +++ + N ++
Sbjct: 244 EELFKL---------------------------LKEGHRMDKPSNCTNE---LYMMMRDC 273
Query: 297 LAFEPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 65/312 (20%), Positives = 116/312 (37%), Gaps = 59/312 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
R K+ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 120
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQ 239
P + D + APE YT D+WS G + E+ + +PG + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 299
+++ + P + +
Sbjct: 246 F--------------------------CRRLKEGTRMRAPDYTT---PEMYQTMLDCWHG 276
Query: 300 EPKDRPTAEEAL 311
EP RPT E +
Sbjct: 277 EPSQRPTFSELV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-41
Identities = 54/318 (16%), Positives = 107/318 (33%), Gaps = 62/318 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + +G+GS+G+V +VAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 126
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
++ G+ Y++ HRDL +N + D +KI DFG+ R +T
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTD 245
+ + +PE +T D+WS G + E+ T + + G + L
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--- 247
Query: 246 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 305
+ + + P + L+ + PK RP
Sbjct: 248 ------------------------VMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRP 280
Query: 306 TAEEALA------DPYFK 317
+ E ++ +P F+
Sbjct: 281 SFLEIISSIKEEMEPGFR 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (252), Expect = 2e-25
Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 27/203 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--------NDIFEHVSDATRILREIKLL 76
I +++G+G V + Y + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVATRWY 195
+ + + H DL N+L ++ + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 558 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.41 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-61 Score=500.59 Aligned_cols=334 Identities=42% Similarity=0.782 Sum_probs=283.1
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
+.|.+.++|++++.||+|+||+||+|+++.+|+.||||+++....+......+.+|+.+|+.++|||||+++++|.....
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34678899999999999999999999999999999999998766666677889999999999999999999999976542
Q ss_pred -CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 -~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
....++|+|||||+.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 33456899999998888887765 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.... .+..+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++.+.+
T Consensus 171 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5432 2557899999999998653 46789999999999999999999999999999999999999999999999
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcch
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 335 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~ 335 (558)
..........+...+.......+...++++++.+++||.+||..||.+|||++|||+||||+.+...+.++..+ ++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~ 320 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYD 320 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCC
Confidence 98888888888888887777888888899999999999999999999999999999999999988777666544 344
Q ss_pred hhHhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 336 FEFERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 336 ~~~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
..++....+.+++++++++|+++++|
T Consensus 321 ~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 321 DSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp CC-----CCHHHHHHHHHHHHHTCCC
T ss_pred CchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 55666678899999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=487.67 Aligned_cols=340 Identities=48% Similarity=0.849 Sum_probs=287.9
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.|.+++||++++.||+|+||+||+|+++.+|+.||||++... ........+.+|+.+|+.|+||||+++++++...+..
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 378899999999999999999999999999999999999743 3445567889999999999999999999999877665
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
....+||++++++++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 66678999988889999999765 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
............+||+.|+|||++... ..|+.++||||+||++|+|++|+.||.+.+..++...+...++.+..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333344667899999999998553 5688999999999999999999999999999999999999999999888777
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcchhh
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 337 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (558)
........+...+......++...++++++.+++||.+||+.||.+|||++|+|+||||+.......++..... ..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 76667777777777777777778889999999999999999999999999999999999987766555544332 3345
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhChh
Q 008644 338 FERRRITKEDVRELIYREILEYHPQ 362 (558)
Q Consensus 338 ~e~~~~~~e~~~e~i~~ei~~~~p~ 362 (558)
.+......+++++++++|...++|+
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence 5667889999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=485.48 Aligned_cols=334 Identities=43% Similarity=0.827 Sum_probs=288.4
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~ 96 (558)
|.|++++||++++.||+|+||+||+|+++.+|+.||||++.....+.....++.+|+.+|+.++||||+++++++.....
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 34677899999999999999999999999999999999998766666777889999999999999999999999876543
Q ss_pred -CCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 -~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
++...+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 33445677777667899998854 4799999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+..
T Consensus 171 ~~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 432 22557899999999987662 45788999999999999999999999999999999999999999999888
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCCCCCCCCCcch
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 335 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~ 335 (558)
..........+...+.......+...+.++++.+++||.+||+.||.+|||++|||+||||+++.....++...+. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~ 320 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---D 320 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---C
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---C
Confidence 8777777777777777766677777788999999999999999999999999999999999998877777765543 4
Q ss_pred hhHhhhcCCHHHHHHHHHHHHHhhCh
Q 008644 336 FEFERRRITKEDVRELIYREILEYHP 361 (558)
Q Consensus 336 ~~~e~~~~~~e~~~e~i~~ei~~~~p 361 (558)
..++....+.+++++++++|++++.|
T Consensus 321 ~~~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 321 QSFESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp CGGGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred CcccchhcCHHHHHHHHHHHhhccCC
Confidence 56778899999999999999999887
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=458.01 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=219.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence 57999999999999999999999999999999986422 2223456788999999999999999999999544 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------- 219 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 219 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 245689999999999987 67999999999999999999999999988866655444321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. . .....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 220 -------------~-~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------E-F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------C-C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------C-C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1 0 112457899999999999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=473.87 Aligned_cols=330 Identities=37% Similarity=0.692 Sum_probs=258.1
Q ss_pred cCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 008644 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (558)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~ 97 (558)
|.+-++|+++++||+|+||+||+|+|+.+|+.||||++.....+.....++.+|+.+|+.++||||++++++|..... +
T Consensus 13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 344579999999999999999999999999999999998766666777889999999999999999999999976543 3
Q ss_pred CCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...++|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred cCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 557899999999998888774 469999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ..+..++|+.|+|||++.+ ..+++++||||+||++|+|++|++||.+.+...++..+...++.+.++.+..
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 171 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp --------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 332 2356789999999999987 6899999999999999999999999999999999999999999999988766
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCCCC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKF------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 325 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 325 (558)
... ....+...........+...+ ...++.+++||++||.+||++||||+|||+||||+.....+..
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~ 323 (355)
T d2b1pa1 245 LQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 323 (355)
T ss_dssp SCH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH
T ss_pred hhh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc
Confidence 543 233333333222211111111 1236789999999999999999999999999999976543333
Q ss_pred CCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHh
Q 008644 326 PSAQPVTKMEFEFERRRITKEDVRELIYREILE 358 (558)
Q Consensus 326 ~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~ 358 (558)
....+ ...+.+.+++..+.++++++|++|+++
T Consensus 324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 324 EAPPP-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp TCCCC--------CCCCCCHHHHHHHHHHHHHC
T ss_pred cCCCC-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 32222 333456677889999999999999873
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=462.28 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=215.1
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
-++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ce
Confidence 357999999999999999999999999999999996432 122345688999999999999999999999554 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||||+ |+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCccccCccccccccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y-~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ...+..+||+.|+|||++.+ ..+ +.++|||||||++|||++|++||.+.+..........
T Consensus 158 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 RE-RLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp EE-CCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred cc-ccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 21 22356789999999999976 444 6789999999999999999999987654332221111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. .......++.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 221 ------------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 ------------E--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------T--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------c--CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 01112234567899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=459.94 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=219.4
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CE
Confidence 4589999999999999999999999999999999874322 3456789999999999999999999999554 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||||+ |+|.+++..+ .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998 5999887664 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------- 232 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 2 2356789999999999987 689999999999999999999999999888766554443210
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
. +.....+.+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 233 ------------~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 233 ------------T---PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------S---CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------C---CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 011223567899999999999999999999999999999973
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-57 Score=451.17 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=216.1
Q ss_pred CcE-EEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY-~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.|| ++.+.||+|+||+||+|+++.++..||+|++............+.+|+++|+.++|||||++++++.... .....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCE
Confidence 345 8888999999999999999999999999999865555666778999999999999999999999985432 23357
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEeC-CCCcEEEeecccceecc
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAF 177 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IiHrDIKP~NILl~-~~~~lKL~DFGla~~~~ 177 (558)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 899999998 599999999889999999999999999999999999 99999999999997 47899999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
.. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+...... +
T Consensus 167 ~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~--------- 228 (270)
T d1t4ha_ 167 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G--------- 228 (270)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T---------
T ss_pred CC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C---------
Confidence 22 2246789999999999865 6999999999999999999999999876544432211110 0
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 317 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~ 317 (558)
.. ........++++.+||.+||+.||++|||++|+|+||||+
T Consensus 229 ---------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 ---------------VK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------CC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00 1112245688999999999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-58 Score=464.60 Aligned_cols=283 Identities=36% Similarity=0.579 Sum_probs=228.9
Q ss_pred EEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh---hHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 008644 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (558)
Q Consensus 27 i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~---~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~~ 103 (558)
.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++... .++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 5789999999999999999999999999997432221 1234688999999999999999999999554 3699
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCCC
Q 008644 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (558)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~~ 182 (558)
||||||.+++...+.. +..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9999999755555544 56799999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhHH
Q 008644 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 262 (558)
Q Consensus 183 ~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~ 262 (558)
.....+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 22457899999999998652 568999999999999999999999999999999999999999999876543322111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 263 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
.. .........++...++.+++++++||.+||+.||++|||++|+|+||||+....
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 00 011112223334456778999999999999999999999999999999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-57 Score=462.31 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=207.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+.++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++... .
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----G 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 456799999999999999999999999999999999753322 2345678999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC---CCCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~---~~~~lKL~DFGla~~~ 176 (558)
.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 6999999998 69999999988999999999999999999999999999999999999995 5789999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|..
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----------- 223 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------- 223 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT-----------
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------
Confidence 4332 2245789999999999987 6899999999999999999999999998876655544432
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.........++++++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 224 ----------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 ----------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ----------------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11112223456789999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=454.60 Aligned_cols=264 Identities=28% Similarity=0.451 Sum_probs=225.8
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC----ChhHHHHHHHHHHHHHhcCCCCccccceeecC
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~----~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~ 93 (558)
.-++.++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++|||||+++++|..
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 33567899999999999999999999999999999999964322 22245778999999999999999999999954
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC----cEEEe
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKIC 168 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~----~lKL~ 168 (558)
. ..+|||||||+ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+
T Consensus 85 ~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 K-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp S-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred C-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEec
Confidence 4 47999999998 59999999888999999999999999999999999999999999999999876 49999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...-.
T Consensus 160 DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 160 DFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp CCTTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred chhhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 999998764332 2255789999999999987 6799999999999999999999999999887776665544322
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.+. ...++++++.+++||++||+.||.+|||++|+|+||||+..
T Consensus 234 ~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 234 EFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCC---------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCC---------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 211 11235678999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=452.80 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=209.3
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++++.||+|+||+||+|+++.+|+.||||++.....+......+.+|+++|+.++||||+++++++.... ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 35799999999999999999999999999999999866556666778999999999999999999999986532 246
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEeCCCCcEEEeecc
Q 008644 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 171 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~----~~~l~e~~~~~i~~QIl~aL~yLHs~g-----IiHrDIKP~NILl~~~~~lKL~DFG 171 (558)
+|||||||+ |+|.+++.. ++.+++..++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 599998864 457999999999999999999999876 9999999999999999999999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|..
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~------ 228 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc------
Confidence 9987643322 2356789999999999977 6799999999999999999999999998876554444322
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 316 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f 316 (558)
.. +......+++++.+||.+||+.||.+|||++|+|+|||+
T Consensus 229 ---------------------~~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 ---------------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------CC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11 112234678999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=468.45 Aligned_cols=283 Identities=22% Similarity=0.361 Sum_probs=218.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|... ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 468999999999999999999999999999999997543 334567889999999999999999999999654 36
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+|||||. |+|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999998 5999999988899999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~-~~~~i~~~lg~p~~~~i~~~ 258 (558)
. .++.+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+... +...+....+.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999987 689999999999999999999999998766433 22223333332221110000
Q ss_pred h--------------hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 259 R--------------NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 259 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
. .......+..+....+... ....+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 0001111122222211111 112468999999999999999999999999999999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=457.33 Aligned_cols=260 Identities=26% Similarity=0.464 Sum_probs=219.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----S
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----C
Confidence 357999999999999999999999999999999996422 2223456789999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 6999999998 599999999889999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 162 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------- 225 (288)
T d1uu3a_ 162 SKQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------------
T ss_pred Ccc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------------
Confidence 221 22356789999999999987 68999999999999999999999999988866655544321
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCccccCcc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 320 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~e------lL~hp~f~~~~ 320 (558)
. . .....+++.+++||++||+.||.+|||++| +++||||+++.
T Consensus 226 --------------~-~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 226 --------------E-Y---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp --------------C-C---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------C-C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 1 1 112467899999999999999999999988 58899998763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=457.06 Aligned_cols=290 Identities=34% Similarity=0.605 Sum_probs=237.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCC-CcEEEEEEeCCccCChhHHHHHHHHHHHHHhc---CCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~t-g~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l---~HpnIv~l~~i~~~~~~~ 97 (558)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999776 56799999975443333344566788887766 799999999998755444
Q ss_pred CCccEEEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
....+|++||+|++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5568999999999866555443 34699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...++.|....+
T Consensus 166 ~~~~~----~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hcccc----cCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 43322 3356789999999999977 68999999999999999999999999999999999999999999877654
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCccc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 321 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 321 (558)
........ .........+.......+++.+.+||.+||++||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 32211100 111223334445566788999999999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=460.66 Aligned_cols=256 Identities=24% Similarity=0.446 Sum_probs=222.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----cc
Confidence 57999999999999999999999999999999997432 1223467789999999999999999999999544 47
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|..++...+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999998 5999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..+..
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--------------- 219 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---------------
Confidence 2 2356899999999999987 6899999999999999999999999999887655544432
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
.. . .....+++++++||++||++||.+|+ +++|+++||||+++
T Consensus 220 ------------~~-~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 220 ------------EE-I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------CC-C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------CC-C---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 01 1 12346799999999999999999999 49999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=456.38 Aligned_cols=289 Identities=38% Similarity=0.640 Sum_probs=235.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+++|++++||||+++++++... ..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 579999999999999999999999999999999975433334457789999999999999999999999554 469
Q ss_pred EEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|+|||||++++..++.. ...+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777654 3469999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23567899999999987652 4468899999999999999999999999999999999999888887655443221
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
. ..+...........+...++.+++.+.+||.+||..||++|||++|+|+||||+.+.++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 11111111222222333456789999999999999999999999999999999977543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-56 Score=463.92 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=224.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+-++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+.+|+.|+|||||++++++... .
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----N 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----T
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 346899999999999999999999999999999999743 335567789999999999999999999998543 4
Q ss_pred cEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC--CCcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~--~~~lKL~DFGla~~~ 176 (558)
.+|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 7999999998 599999854 457999999999999999999999999999999999999964 688999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|......+
T Consensus 177 ~~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 244 (350)
T d1koaa2 177 DPKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------ 244 (350)
T ss_dssp CTTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred cccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 4332 2356789999999999987 678999999999999999999999999988777666654422111
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 322 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 322 (558)
....++.+++.+++||.+||..||++|||++|+|+||||+.....
T Consensus 245 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 245 ---------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ---------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ---------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 122345678999999999999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=454.71 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=217.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+.|++++.||+|+||+||+|+++.+|..||||++... .....+.+.+|+++|+.++|||||++++++... ..+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeE
Confidence 4699999999999999999999999999999999743 334556788999999999999999999999654 369
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 103 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 599998765 4569999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccCccccCccccccc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~---~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
......+||+.|+|||++... ...|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 122457899999999998431 246899999999999999999999999988876665544321
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
.+ +.....+.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 231 ----------------~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ----------------EP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----------------CC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----------------CC-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 111223567899999999999999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-56 Score=462.04 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=224.5
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
.+-++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||+++++|...
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----- 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK----- 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 3446799999999999999999999999999999998753 234556788999999999999999999999543
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC--CCCcEEEeeccccee
Q 008644 100 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~--~~~~lKL~DFGla~~ 175 (558)
..+|||||||+ |+|.+.+...+ .+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 47999999998 59998877654 699999999999999999999999999999999999998 578999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...+. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|....
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------- 244 (352)
T d1koba_ 179 LNPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------- 244 (352)
T ss_dssp CCTTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--------
T ss_pred cCCCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 65432 2355789999999999987 689999999999999999999999999988777666554321
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.......++.+++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 245 -------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 245 -------------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -------------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 112234457889999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=451.56 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=216.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||++++++... ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 479999999999999999999999999999999975433 334456789999999999999999999998654 36
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|||||||.+ +|..++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999985 66666677788999999999999999999999999999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
...+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------- 229 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 229 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------------
Confidence 346899999999998642 246899999999999999999999999888766555443321
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+. .....+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 230 -------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 -------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1111 112457899999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-55 Score=450.77 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=221.1
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ce
Confidence 46999999999999999999999999999999997422 2234467789999999999999999999999554 47
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+|||||. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999998 5899999999999999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 159 ------~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 159 ------YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp ------CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 45789999999999987 67999999999999999999999999998876655544321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. ....+.+++++.+||.+||..||.+|+ |++++|+||||+++
T Consensus 217 ------------~-----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 ------------E-----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------C-----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------C-----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 0 012256789999999999999999996 99999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-55 Score=445.71 Aligned_cols=284 Identities=38% Similarity=0.657 Sum_probs=235.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++.+.... .+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 58999999999999999999986 7899999999764444444678999999999999999999999996543 69
Q ss_pred EEEEecCcccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g~L~~~i~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
|++||++.+++...+. ..+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999976655554 466799999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhhH
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 261 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~ 261 (558)
.....++++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+++..+...++.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22456799999999998763 56799999999999999999999999999999999999999999877665433211
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 262 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..+........+.++...++.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1112222334445556677889999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-55 Score=456.98 Aligned_cols=253 Identities=21% Similarity=0.386 Sum_probs=220.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence 68999999999999999999999999999999986421 2234456789999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
+|+||||+. |+|...+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 196 ------~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 253 (350)
T d1rdqe_ 196 ------WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------- 253 (350)
T ss_dssp ------CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--------------
Confidence 45689999999999987 67999999999999999999999999988876665554321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 319 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~ 319 (558)
. ......+++++.+||++||+.||.+|+ |+++||+||||++.
T Consensus 254 -------------~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 -------------K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -------------C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -------------C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 1 012246789999999999999999995 99999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-55 Score=438.98 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=222.2
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCCh-------hHHHHHHHHHHHHHhcC-CCCccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~-------~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~ 93 (558)
.++|++++.||+|+||+||+|+++.+|+.||||++....... .....+.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999999999999999996432211 12346889999999997 9999999999954
Q ss_pred CCcCCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 94 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
. ..+|||||||+ |+|.+++..++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp S-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred C-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 3 47999999998 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccc----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhC
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg 248 (558)
++....... .+..+||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+....+..|...
T Consensus 157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 987644322 2567899999999998531 235788999999999999999999999998876665554431
Q ss_pred CCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 249 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 249 ~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
........++++|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 231 -------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 -------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111223345789999999999999999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=453.23 Aligned_cols=287 Identities=36% Similarity=0.611 Sum_probs=234.8
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~-~~~~~ 101 (558)
-+|+.+++||+|+||+||+|+++.+|+.||||++..... .+.+|+.+|+.++||||++++++|..... .+..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 379999999999999999999999999999999964321 23479999999999999999999865432 34457
Q ss_pred EEEEEecCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccceec
Q 008644 102 IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVA 176 (558)
Q Consensus 102 ~~lV~E~~~g~L~~~i----~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~~~ 176 (558)
+|||||||++++...+ .....+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999998665544 3456799999999999999999999999999999999999999875 8999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
..... ....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 174 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 44332 2557899999999987652 578999999999999999999999999999999999999999999988876
Q ss_pred HhhhHHHHHHHhhhccCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcccCC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 323 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~ 323 (558)
.......... +......++ ....+..++++.+||.+||.+||++|||+.|+|+||||+.+....
T Consensus 249 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 249 EMNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HHCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 5543221111 011111111 123457899999999999999999999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=446.59 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=221.1
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
+-++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++||||++++++|... .
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----E 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----T
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----C
Confidence 346799999999999999999999999999999999742 23455688999999999999999999999543 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC--CcEEEeecccceec
Q 008644 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVA 176 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~--~~lKL~DFGla~~~ 176 (558)
.+|||||||+ |+|.+++...+ .+++..++.|+.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 6999999998 59999998765 69999999999999999999999999999999999999854 58999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...-..+.
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 223 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----- 223 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence 4332 2345689999999999977 5789999999999999999999999999887776666654222221
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
...++.+++++++||.+||+.||++|||++|+|+||||++
T Consensus 224 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 224 ----------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1233567899999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-54 Score=450.44 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=213.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC----ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~----~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .........+|+.+|+.++|||||++++++...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---- 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence 579999999999999999999999999999999863211 111122233457777888899999999998554
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
..+|+|||||. |+|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 80 -~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred -CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 46999999998 6999999998899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHH
Q 008644 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 178 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ....+||+.|+|||++.+. ..|+.++|||||||+||||++|+.||.+.+..+....+....
T Consensus 159 ~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---------- 222 (364)
T d1omwa3 159 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 222 (364)
T ss_dssp SSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS----------
T ss_pred CCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Confidence 332 2456899999999998642 568999999999999999999999998766443322211110
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccCc
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 319 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpt-----a~elL~hp~f~~~ 319 (558)
.. .......+++.+.+||.+||+.||.+||| ++|+|+||||+++
T Consensus 223 ---------------~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 223 ---------------TM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ---------------SC---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ---------------cC---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 11 11223468999999999999999999999 8999999999976
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=443.30 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=218.5
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCcc-CChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFK 100 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~-~~~~~~~~i~~Ei~iL~-~l~HpnIv~l~~i~~~~~~~~~~ 100 (558)
++|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|..++. .++||||+++++++... .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 46999999999999999999999999999999996421 12234456677777764 78999999999999554 4
Q ss_pred cEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 101 ~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
.+|||||||+ |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 599999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2356789999999999987 6899999999999999999999999999887665554432
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCccccCc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGL 319 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~-elL~hp~f~~~ 319 (558)
..+ .....+++.+.+||++||+.||.+|||+. ++++||||+++
T Consensus 218 -------------~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 -------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 111 11246799999999999999999999995 89999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=443.74 Aligned_cols=295 Identities=34% Similarity=0.563 Sum_probs=230.0
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCc---CC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---RE 98 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~---~~ 98 (558)
-++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 489999999999999999999999999999999987554444556778899999999999999999999865432 22
Q ss_pred CccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceecc
Q 008644 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (558)
Q Consensus 99 ~~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~ 177 (558)
...+|+|||||.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 346999999999766665544 4579999999999999999999999999999999999999999999999999997653
Q ss_pred CCCC-CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHH
Q 008644 178 NDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (558)
Q Consensus 178 ~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~ 256 (558)
.... ........+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+....+..+...++.+..+...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 2221 11223456899999999998653 468999999999999999999999999999999999999999988876655
Q ss_pred HhhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 008644 257 RVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318 (558)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 318 (558)
..........+....... ......+ ...++.++|||.+||++||++|||++|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 443332222221111100 0000000 123678999999999999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=429.92 Aligned_cols=287 Identities=37% Similarity=0.586 Sum_probs=236.9
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
+||++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++||||+++++++.... .+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 5899999999999999999999999999999999765555567788999999999999999999999995543 68
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCCC
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~~ 181 (558)
++|++++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999986 6777777788899999999999999999999999999999999999999999999999999987643332
Q ss_pred CcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhhCCCCHHHHHHhhh
Q 008644 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRN 260 (558)
Q Consensus 182 ~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~ 260 (558)
......+++.|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445788999999998762 4578999999999999999999976 677888888999998888887654432211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 261 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.. .+...-............+.+++.+.+||.+||+.||.+||||+|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 00 00000001112234445678899999999999999999999999999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-53 Score=437.31 Aligned_cols=287 Identities=29% Similarity=0.552 Sum_probs=227.1
Q ss_pred ccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 008644 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (558)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~ 96 (558)
+|+..++|++++.||+|+||+||+|+++.+|+.||||+++. ....++.+|+.+|+.++ ||||++++++|...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 46788999999999999999999999999999999999874 23567889999999996 99999999998643
Q ss_pred CCCccEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCC-cEEEeecccce
Q 008644 97 REFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 174 (558)
Q Consensus 97 ~~~~~~~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~-~lKL~DFGla~ 174 (558)
....+|+|||||.+ +|... .+.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 23479999999995 77654 34699999999999999999999999999999999999998655 69999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~-~~~~~~~~~i~~~lg~p~~~ 253 (558)
....... ....++|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.. .+..++...+...+|.|...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7644332 2567899999999998763 4689999999999999999999999865 45667777888888866544
Q ss_pred HHHHhhhHHHHHHHhhhc-cCCCC-----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCcc
Q 008644 254 AIARVRNEKARRYLSSMR-KKKPI-----PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 320 (558)
.+...........+.... ..... ........+++++.|||++||.+||.+|||++|||+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 332221111111111111 11111 11122345789999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=432.08 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=209.4
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC----hhHHHHHHHHHHHHHhcC--CCCccccceeecCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLR--HPDIVEIKHILLPP 94 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----~~~~~~i~~Ei~iL~~l~--HpnIv~l~~i~~~~ 94 (558)
..++|++.+.||+|+||+||+|+++.+|+.||||++...... .....++.+|+.+|+.++ ||||+++++++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467999999999999999999999999999999998643211 112234678999999997 89999999998544
Q ss_pred CcCCCccEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC-CcEEEeecc
Q 008644 95 SRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~--g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~-~~lKL~DFG 171 (558)
..+|+||||+. +++.+++..+..++++.++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 82 -----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 82 -----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp -----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred -----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 46999999997 4888999888899999999999999999999999999999999999999854 799999999
Q ss_pred cceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh------
Confidence 99865332 23567899999999998762 2346779999999999999999999975321 110
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
.. ....+.+++++.+||++||+.||++|||++|+|+||||+++
T Consensus 219 --------------------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 --------------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --------------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --------------------cc-----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 01224678999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-53 Score=428.16 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=214.5
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
..++|++.+.||+|+||+||+|+++.+|+.||||+++.... +.....++.+|+.+|+.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 46789999999999999999999999999999999975433 4455677999999999999999999999986543 223
Q ss_pred ccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccC
Q 008644 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~ 178 (558)
..+|||||||+ ++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 45899999998 59999999988999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 179 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
...........+||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+..+.+..+..
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~------------- 228 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------- 228 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------------
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh-------------
Confidence 4433334466789999999999977 6799999999999999999999999998876655443332
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhcCcccc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALADPYFK 317 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-ta~elL~hp~f~ 317 (558)
..+.+.....+++++.+.+||.+||+.||.+|| |++++ .|+|++
T Consensus 229 --------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp --------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred --------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 222333445578899999999999999999999 55554 566654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=443.75 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=209.7
Q ss_pred CCcEEEEe-EeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCC
Q 008644 22 GSRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 22 ~~rY~i~~-~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~-~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-++|+|++ +||+|+||+||+|+++.+|+.||||++++ ...+.+|+.++. .++|||||+++++|.+.. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 45799875 69999999999999999999999999863 245778999865 558999999999885321 223
Q ss_pred ccEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCcEEEeecccc
Q 008644 100 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 173 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~lKL~DFGla 173 (558)
..+|||||||+ |+|.+++...+ .+++.+++.|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 57999999998 59999998753 6999999999999999999999999999999999999986 467999999999
Q ss_pred eeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
+....... ....+||+.|+|||++.+ ..|+.++||||||||+|+|+||++||.+.+.......+...
T Consensus 162 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~------- 228 (335)
T d2ozaa1 162 KETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------- 228 (335)
T ss_dssp EECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-------
T ss_pred eeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-------
Confidence 87644332 255789999999999987 67999999999999999999999999887654443332211
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 319 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 319 (558)
+...........++.+++++.+||.+||+.||++|||++|+|+||||...
T Consensus 229 ----------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 229 ----------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------------CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------------HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 11111111111234578999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=417.16 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=207.6
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++.+.||+|+||+||+|.. +..||||+++...........+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 46899999999999999999964 3469999997655556677889999999999999999999998643 24
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999998 6999999764 56999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......+||+.|+|||++.+. ...|+.++|||||||++|||+||+.||.+.+...++..+...
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------------ 224 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------------
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 223557899999999998642 135889999999999999999999999887765544333221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
............++++.+.+||.+||+.||.+|||++|++++
T Consensus 225 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 -------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233456788999999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=416.89 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=206.4
Q ss_pred EEEE-eEeeccCceEEEEEEEC--CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 25 YKIE-EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 25 Y~i~-~~IG~G~~G~Vy~a~d~--~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.+. +.||+|+||+||+|.+. .+++.||||+++....+......+.+|+.+|++++|||||++++++... .
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------S 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------S
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------C
Confidence 4444 46999999999999764 4567899999976555555667899999999999999999999988432 4
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCCC
Q 008644 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~~ 180 (558)
.|||||||+ |+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999998 5999999998899999999999999999999999999999999999999999999999999998765443
Q ss_pred CCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHhh
Q 008644 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 259 (558)
Q Consensus 181 ~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~~ 259 (558)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33223345679999999999976 578999999999999999998 8999998776544333321
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccc
Q 008644 260 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA---LADPYFK 317 (558)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el---L~hp~f~ 317 (558)
.... .....+++.+.+||.+||+.||++|||++++ |+|+|++
T Consensus 226 -------------~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 -------------GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111 1224678999999999999999999999998 4666654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=417.37 Aligned_cols=258 Identities=20% Similarity=0.397 Sum_probs=211.7
Q ss_pred cccccccCCC-CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 13 VDFFTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 13 ~~~~~~~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
-+.|.+|.+. ++|++.+.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 3455666654 6999999999999999999999999999999998743 23456789999999999999999999999
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
... ..+|+|||||+ |+|..++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 83 ~~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 83 TRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp CSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred eeC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 544 36899999998 6999998764 468999999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhh
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLL 247 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~p-F~~~~~~~~~~~i~~~l 247 (558)
|||+|+....+... ......||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.....+.+..
T Consensus 158 DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-- 231 (287)
T d1opja_ 158 DFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-- 231 (287)
T ss_dssp CCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--
T ss_pred cccceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc--
Confidence 99999875433221 2244568899999999977 6899999999999999999997655 444443332222211
Q ss_pred CCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 248 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 248 g~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 232 -------------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 -------------------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111 1123467899999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-51 Score=413.70 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=198.6
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCc---EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~---~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
..++|++.++||+|+||+||+|+++.+++ .||||++... ......+.+.+|+.+|+.++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--- 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence 35789999999999999999999987765 5888888643 2334567799999999999999999999998544
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||+ |+|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 --~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 --TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp --SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 36899999998 5899988774 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCc--ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 008644 176 AFNDTPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (558)
Q Consensus 176 ~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~ 252 (558)
........ .......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+..+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~------ 249 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD------ 249 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 64332221 11223568999999999976 689999999999999999998 89999988766554443321
Q ss_pred HHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 253 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ....++++.+.+||.+||+.||++|||+.|++++
T Consensus 250 ---------------------~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 ---------------------YRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 1224678999999999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=413.16 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=213.4
Q ss_pred CCcEEEEeE-eeccCceEEEEEEECC--CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 22 GSRYKIEEV-IGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 22 ~~rY~i~~~-IG~G~~G~Vy~a~d~~--tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ........+.+|+++|+.++|||||++++++...
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---- 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC----
Confidence 467999985 9999999999998764 4457999999743 3445667899999999999999999999988432
Q ss_pred CccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
.+|||||||+ |+|.+++.. ++.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 --~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 --ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp --SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred --eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 4899999998 599998765 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
.............+||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+..|.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~---------- 227 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 227 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred cccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------
Confidence 544333333345678999999999976 578999999999999999998 8999988776554443322
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCccccC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA---LADPYFKG 318 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el---L~hp~f~~ 318 (558)
.... ...+.+++++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 228 -----------------~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 -----------------GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -----------------TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------------CCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111 1235688999999999999999999999888 67888753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=406.43 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=197.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.++|++++.||+|+||+||+|++. ++..||||+++... .....+.+|+.+|+.++||||+++++++.... .
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----P 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----c
Confidence 578999999999999999999976 56789999997532 33467899999999999999999999996543 5
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+|||||. |+|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 899999998 6999988765 46899999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+....
T Consensus 155 ~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------- 219 (263)
T d1sm2a_ 155 QYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 219 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----------
T ss_pred Ccee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 2221 234679999999999987 689999999999999999999 567777766555444433210
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .....+++.+.+||.+||+.||++|||++|+|+|
T Consensus 220 ----------------~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 ----------------RL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 1123568899999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=411.52 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=208.3
Q ss_pred cCCC-CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 19 YGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 19 ~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
|.+. ++|++++.||+|+||.||+|+++ ++..||||+++... .....+.+|+.+|++++|||||++++++...
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--- 80 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE--- 80 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC---
Confidence 4443 69999999999999999999975 57889999997432 3346789999999999999999999987432
Q ss_pred CCccEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccce
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~ 174 (558)
.+|+|||||+ |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 ---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 ---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp ---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceE
Confidence 4799999998 6898876543 359999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhhCCCCHH
Q 008644 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPE 253 (558)
Q Consensus 175 ~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~~~~~~~~~~~i~~~lg~p~~~ 253 (558)
....... .......||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+..
T Consensus 158 ~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-------- 225 (272)
T d1qpca_ 158 LIEDNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------- 225 (272)
T ss_dssp ECSSSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------
T ss_pred EccCCcc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------
Confidence 7643321 12245679999999999976 5789999999999999999995 566666655444333321
Q ss_pred HHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccccc
Q 008644 254 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFK 317 (558)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~--hp~f~ 317 (558)
.... .....+++.+.+||.+||+.||++|||++|+++ |+||.
T Consensus 226 -------------------~~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 -------------------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------cCCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111 112467899999999999999999999999998 78875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=417.96 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=207.2
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCc-----EEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~-----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~ 96 (558)
++|++.++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 689999999999999999999876554 69999986432 233456788999999988 899999999999544
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008644 97 REFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~-----------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDI 152 (558)
..+|+|||||+ |+|.+++.... .+++..++.|+.||+.||+|||++||+||||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 36899999998 69999997642 4899999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 008644 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (558)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF 231 (558)
||+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++ |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999876443322 22345678999999999976 689999999999999999997 89999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.+.+....+..+... .... .....+++.+.+||.+||+.||++|||++||+
T Consensus 268 ~~~~~~~~~~~~~~~--------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN--------------------------GFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHHT--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHhc--------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887655444333221 1111 12346789999999999999999999999999
Q ss_pred cC
Q 008644 312 AD 313 (558)
Q Consensus 312 ~h 313 (558)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=419.55 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=216.2
Q ss_pred CcEEEEeEeeccCceEEEEEEEC---CCCcEEEEEEeCCcc--CChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSR 96 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~---~tg~~vAiK~i~~~~--~~~~~~~~i~~Ei~iL~~l~H-pnIv~l~~i~~~~~~ 96 (558)
++|++++.||+|+||+||+|++. .+|+.||||++++.. .+......+.+|+.+|++++| |||+++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 67999999999999999999984 478999999997432 223345668899999999976 8999999998544
Q ss_pred CCCccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 97 ~~~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ---CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 36999999998 59999999988999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .......||+.|+|||.+.+....++.++|||||||+||+|++|+.||.+.+.......+...
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------- 247 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 247 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---------
Confidence 533222 123557899999999998764346788999999999999999999999887655444333221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCcc
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 320 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (558)
.. ... ......+++++.+||.+||+.||.+|| |++|+|+||||+++.
T Consensus 248 ----------~~---~~~-----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 248 ----------IL---KSE-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ----------HH---HCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------cc---cCC-----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 00 011 112346899999999999999999999 599999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=400.83 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=209.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
.+.|++++.||+|+||+||+|+++ ++..||||+++... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Confidence 467899999999999999999984 78899999997532 2345789999999999999999999998543 46
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+|+||||++ |+|.+++.. ...+++..+++|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999997 688888765 456999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......||..|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.+..
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 218 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 222 2245679999999999987 689999999999999999998 899999888665544443211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.. .....+++.+.+||.+||+.||++|||++++|+|
T Consensus 219 ----------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 ----------------RL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 11 1123567899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=402.66 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=200.2
Q ss_pred cCCC-CcEEEEeEeeccCceEEEEEEECCCC---cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 008644 19 YGEG-SRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (558)
Q Consensus 19 ~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~ 94 (558)
|.+. ++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4555 69999999999999999999987654 46899988643 334456779999999999999999999998842
Q ss_pred CcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccc
Q 008644 95 SRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (558)
Q Consensus 95 ~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGl 172 (558)
..+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 -----~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -----SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred -----CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 25899999998 588887765 44699999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
|+........ ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 155 a~~~~~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~------ 224 (273)
T d1mp8a_ 155 SRYMEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------ 224 (273)
T ss_dssp ------------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------
T ss_pred heeccCCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc------
Confidence 9875432221 2245678999999999976 689999999999999999998 8999998877665544432
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ....+++++.+.+||.+||+.||++|||++|+++|
T Consensus 225 ---------------------~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 225 ---------------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 12346789999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=398.75 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=195.8
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCC----cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg----~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
.+.|++.++||+|+||.||+|.++.++ ..||||+++.. ........+.+|+.+|+.++|||||++++++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence 467999999999999999999887655 46999999643 2334556789999999999999999999999544
Q ss_pred CCccEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 98 ~~~~~~lV~E~~~g-~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
..+++|||||.+ ++.+.+... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 --~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred --CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 368999999984 777777654 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCCCHHH
Q 008644 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEA 254 (558)
Q Consensus 176 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~i~~~lg~p~~~~ 254 (558)
...............||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND--------- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc---------
Confidence 6544332222344678999999999977 68999999999999999999965 55555444333332221
Q ss_pred HHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 255 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.... ....+++..+.+||.+||+.||++|||+.|+++
T Consensus 229 ------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 ------------------GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------cCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1111 122457889999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=398.48 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=202.7
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++.+.||+|+||+||+|+++.+ ..||||+++... .....+.+|+.+|++++|||||++++++.. ..+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCe
Confidence 6899999999999999999998765 579999997432 234678999999999999999999998843 247
Q ss_pred EEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+|||||. |+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999998 578877754 346999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|. ++|.+.+..+.+..+...
T Consensus 167 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~------------ 230 (285)
T d1fmka3 167 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------ 230 (285)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred Cce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------
Confidence 221 2244679999999999977 68999999999999999999965 556666554444433221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CccccCc
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKGL 319 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~ 319 (558)
... ...+.+++.+.+||.+||+.||++|||++++++ ++||...
T Consensus 231 ---------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ---------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111 123567899999999999999999999999988 8888754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=404.40 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=201.3
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCc----EEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~----~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
++|+++++||+|+||+||+|.+..+|+ +||+|+++.. ......+.+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 569999999999999999999988876 5888888643 2334567799999999999999999999998653
Q ss_pred CccEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceec
Q 008644 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~ 176 (558)
..+++++++. ++|.+.+... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3677778776 6888877764 57999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 008644 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (558)
Q Consensus 177 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i 255 (558)
...... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 443322 12244578999999999977 689999999999999999998 78999887765544333221
Q ss_pred HHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 256 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
... ...+.+++.+.+||.+||..||.+|||+.|+++|
T Consensus 230 ------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ------------------ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 000 1225678999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=394.49 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=202.1
Q ss_pred cccCCCCcEEEEeEeeccCceEEEEEEEC-CCC--cEEEEEEeCCccC-ChhHHHHHHHHHHHHHhcCCCCccccceeec
Q 008644 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDT-RTG--EKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (558)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~-~tg--~~vAiK~i~~~~~-~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~ 92 (558)
|++-..++|++++.||+|+||.||+|+.. .++ ..||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44455678999999999999999999764 333 3689999875332 3345578999999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeec
Q 008644 93 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (558)
Q Consensus 93 ~~~~~~~~~~~lV~E~~~-g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DF 170 (558)
.+ .+++|||||+ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 TP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp SS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred ec------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 42 4689999998 688877665 456999999999999999999999999999999999999999999999999
Q ss_pred ccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCC
Q 008644 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
|+++................|+..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..|...
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--- 230 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--- 230 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---
Confidence 999986554443333455678889999999987 678999999999999999998 89999988876655544321
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
... ....+.+++.+.+||.+||..||++|||++|+++
T Consensus 231 -----------------------~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 -----------------------GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1223567899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=396.41 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=200.0
Q ss_pred ccCCC-CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCcccccee
Q 008644 18 EYGEG-SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHI 90 (558)
Q Consensus 18 ~~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i 90 (558)
.|.+. ++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+.+|..++.++ +|+||+.++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34443 689999999999999999999754 4568999998743 2334556678888888766 68999999998
Q ss_pred ecCCCcCCCccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 008644 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (558)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIK 153 (558)
+.... ..+|+|||||+ |+|.+++... ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 86 ~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 86 CTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp ECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 85443 36899999998 6999999753 248999999999999999999999999999999
Q ss_pred CCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhC-CCCCC
Q 008644 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFP 232 (558)
Q Consensus 154 P~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG-~~pF~ 232 (558)
|+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999875433222 22355789999999999977 6899999999999999999986 57888
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 233 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 233 ~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+.+....+..+.. .... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 239 GVKIDEEFCRRLK--------------------------EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp TCCCSHHHHHHHH--------------------------HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHh--------------------------cCCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7665443322211 0111 1123467899999999999999999999999998
Q ss_pred C
Q 008644 313 D 313 (558)
Q Consensus 313 h 313 (558)
|
T Consensus 290 ~ 290 (299)
T d1ywna1 290 H 290 (299)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=388.51 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=197.0
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
++|++++.||+|+||.||+|.+ +|..||||++++. ...+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcE
Confidence 5699999999999999999987 4789999999642 34567899999999999999999999986432 357
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 103 ~lV~E~~~-g~L~~~i~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
|+||||++ |+|.+++...+ .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999998 69999986643 4899999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhhCCCCHHHHHHh
Q 008644 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (558)
Q Consensus 180 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~~~~i~~~lg~p~~~~i~~~ 258 (558)
. ....+|..|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+..|..
T Consensus 157 ~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------- 215 (262)
T d1byga_ 157 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 215 (262)
T ss_dssp -----------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------------
T ss_pred C------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 2 34568899999999976 689999999999999999998 7899987765554433321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 259 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.... ...+.+++.+.+||++||+.||.+|||+.+++++
T Consensus 216 --------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 --------------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111 2234678999999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-48 Score=391.22 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=206.9
Q ss_pred CcEEEEeEeeccCceEEEEEEEC-----CCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~-----~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~ 97 (558)
++|++++.||+|+||+||+|+++ .++..||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 57999999999999999999875 35678999998743 2334567799999999999999999999999554
Q ss_pred CCccEEEEEecCc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008644 98 EFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (558)
Q Consensus 98 ~~~~~~lV~E~~~-g~L~~~i~~~~------------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDI 152 (558)
..+++|||||. |+|.+++.... .+++..+..|+.||+.||+|||+.||+||||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 36899999998 69999986532 3889999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCC
Q 008644 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLF 231 (558)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF 231 (558)
||+|||++.++.+||+|||+|+........ ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999865433221 12345678999999999987 68999999999999999999985 788
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.+.+..+.+..+.+ ... ......+++++.+||.+||+.||++|||+.|++
T Consensus 244 ~~~~~~e~~~~v~~---------------------------~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHc---------------------------CCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88776655444322 111 112346789999999999999999999999996
Q ss_pred c
Q 008644 312 A 312 (558)
Q Consensus 312 ~ 312 (558)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=393.96 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=202.6
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcE--EEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~--vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i~~~~~~~~~ 99 (558)
++|++.++||+|+||+||+|+++.+|.. ||||+++... .....+.+.+|+++|+.+ +|||||++++++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 6899999999999999999999888874 6778775332 223456789999999998 799999999999654
Q ss_pred ccEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCC
Q 008644 100 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (558)
Q Consensus 100 ~~~~lV~E~~~-g~L~~~i~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~ 162 (558)
..+|+|||||+ |+|.+++..+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 36999999998 6999998754 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhHHH
Q 008644 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLD 241 (558)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~~~ 241 (558)
+.+||+|||+++........ ....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999765332221 34568999999999976 67999999999999999999975 6788777555433
Q ss_pred HHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 242 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 242 ~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
.+.+ ... ......+++.+.+||.+||+.||++|||++|+|+|
T Consensus 238 ~i~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh---------------------------cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3221 111 11234678999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=386.67 Aligned_cols=255 Identities=24% Similarity=0.419 Sum_probs=204.9
Q ss_pred cCC-CCcEEEEeEeeccCceEEEEEEECCCC-------cEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCccccce
Q 008644 19 YGE-GSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKH 89 (558)
Q Consensus 19 ~~~-~~rY~i~~~IG~G~~G~Vy~a~d~~tg-------~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~ 89 (558)
|.+ .++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|..++.++ +|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 444 479999999999999999999876654 479999997533 334556788899999888 7999999999
Q ss_pred eecCCCcCCCccEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 008644 90 ILLPPSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (558)
Q Consensus 90 i~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDI 152 (558)
++... ..+|+|||||+ |+|.++|.... .+++..+..|+.||+.||+|||+.||+||||
T Consensus 87 ~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 87 ACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp EECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 99543 46999999998 69999997542 4899999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 008644 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (558)
Q Consensus 153 KP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~pF 231 (558)
||+|||++.++.+||+|||+++......... .....+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccceeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 9999999999999999999998765543322 2355679999999999977 689999999999999999998 78999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 008644 232 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 311 (558)
Q Consensus 232 ~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL 311 (558)
.+.+....+..+.. .... .....+++.+.+||.+||+.||.+|||+.|+|
T Consensus 239 ~~~~~~~~~~~i~~---------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil 288 (299)
T d1fgka_ 239 PGVPVEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288 (299)
T ss_dssp TTCCHHHHHHHHHT---------------------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHc---------------------------CCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 87775543332221 1111 12246789999999999999999999999998
Q ss_pred c
Q 008644 312 A 312 (558)
Q Consensus 312 ~ 312 (558)
+
T Consensus 289 ~ 289 (299)
T d1fgka_ 289 E 289 (299)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=388.90 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=205.6
Q ss_pred CCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 008644 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (558)
Q Consensus 20 ~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~ 99 (558)
-++++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+|++..+..+.. +.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~ 75 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 75 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ET
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe----cC
Confidence 467899999999999999999999999999999998864322 2347789999999998887766655532 22
Q ss_pred ccEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC---CCcEEEeeccccee
Q 008644 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARV 175 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~---~~~lKL~DFGla~~ 175 (558)
...++|||||+++|...+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 46899999999988877765 457999999999999999999999999999999999999764 45799999999997
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCCCC
Q 008644 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (558)
Q Consensus 176 ~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~p~ 251 (558)
........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--- 230 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---
Confidence 65432211 12245689999999999987 6799999999999999999999999987665443332221100
Q ss_pred HHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCcccc
Q 008644 252 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPYFK 317 (558)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~e---lL~hp~f~ 317 (558)
. ....+.....+++++++.+||.+||..||++||++++ +|+|+|.+
T Consensus 231 ---------~-----------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 ---------K-----------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---------H-----------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------c-----------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 0001111223567899999999999999999999875 56777754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=386.87 Aligned_cols=256 Identities=21% Similarity=0.355 Sum_probs=210.5
Q ss_pred ccCCC-CcEEEEeEeeccCceEEEEEEECC-----CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceee
Q 008644 18 EYGEG-SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (558)
Q Consensus 18 ~~~~~-~rY~i~~~IG~G~~G~Vy~a~d~~-----tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~ 91 (558)
+|.+. ++|++.+.||+|+||+||+|.+.. ++..||||+++.. ........+.+|+.+|++++||||+++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34343 899999999999999999998753 4578999999743 3445556789999999999999999999999
Q ss_pred cCCCcCCCccEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeC
Q 008644 92 LPPSRREFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~ 160 (558)
... ..+++|||||. |+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 93 ~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 93 SQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp CSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred ecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence 543 36899999998 6999888642 2478999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChhhH
Q 008644 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQ 239 (558)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~-~pF~~~~~~~~ 239 (558)
.++.+||+|||+|+........ ......+||+.|+|||.+.+ ..++.++|||||||++|||+||. +||.+.+..+.
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred CCceEEEeecccceeccCCcce-eeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999865433221 22344578999999999987 67899999999999999999984 88888776655
Q ss_pred HHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 240 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 240 ~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
+..+.+. .. ....+.+++.+.+||.+||+.||++|||++++++
T Consensus 245 ~~~i~~~---------------------------~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 245 LRFVMEG---------------------------GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhC---------------------------CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5444321 11 1122467899999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=382.78 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=211.3
Q ss_pred ccCC-CCcEEEEeEeeccCceEEEEEEE-----CCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhc-CCCCcccccee
Q 008644 18 EYGE-GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHI 90 (558)
Q Consensus 18 ~~~~-~~rY~i~~~IG~G~~G~Vy~a~d-----~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l-~HpnIv~l~~i 90 (558)
.|.+ .++|++.++||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4544 37999999999999999999986 356779999999743 3445666789999999999 69999999999
Q ss_pred ecCCCcCCCccEEEEEecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 008644 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (558)
Q Consensus 91 ~~~~~~~~~~~~~lV~E~~~-g~L~~~i~~~~------------------~l~e~~~~~i~~QIl~aL~yLHs~gIiHrD 151 (558)
+... ..+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+|||
T Consensus 96 ~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 96 CTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp ECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9544 35899999998 69999987543 589999999999999999999999999999
Q ss_pred CCCCcEEeCCCCcEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 008644 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (558)
Q Consensus 152 IKP~NILl~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLlt-G~~p 230 (558)
|||+|||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+|
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999999987654332 223355789999999999976 678999999999999999998 6777
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 008644 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 310 (558)
Q Consensus 231 F~~~~~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~el 310 (558)
|.+.+....+..+.+. ..+ . .....+++.+.+||.+||+.||++|||++||
T Consensus 248 ~~~~~~~~~~~~~i~~----------------------~~~----~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKE----------------------GFR----M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp STTCCSSHHHHHHHHH----------------------TCC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhc----------------------CCC----C---CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 8777665554433321 000 0 1124568999999999999999999999999
Q ss_pred hc
Q 008644 311 LA 312 (558)
Q Consensus 311 L~ 312 (558)
|+
T Consensus 299 l~ 300 (311)
T d1t46a_ 299 VQ 300 (311)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-46 Score=385.34 Aligned_cols=282 Identities=25% Similarity=0.354 Sum_probs=212.4
Q ss_pred CcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-----------CCCccccceee
Q 008644 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHIL 91 (558)
Q Consensus 23 ~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-----------HpnIv~l~~i~ 91 (558)
.||+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999742 234466788999998875 47788888887
Q ss_pred cCCCcCCCccEEEEEecCc--ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEeCCCC---
Q 008644 92 LPPSRREFKDIYVVFELME--SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC--- 163 (558)
Q Consensus 92 ~~~~~~~~~~~~lV~E~~~--g~L~~~i~--~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIiHrDIKP~NILl~~~~--- 163 (558)
.... ....+++++++. ++...... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 4322 234556666554 34433333 34579999999999999999999998 8999999999999998765
Q ss_pred ---cEEEeecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----
Q 008644 164 ---KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN----- 235 (558)
Q Consensus 164 ---~lKL~DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~----- 235 (558)
.++|+|||.+....... ...+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 49999999997653322 45689999999999876 689999999999999999999999997543
Q ss_pred -hhhHHHHHHHhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCC-------------CCCCCCCCCHHHHHHHHHhcccCC
Q 008644 236 -VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-------------FSQKFPNANPLALRLLERMLAFEP 301 (558)
Q Consensus 236 -~~~~~~~i~~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~s~~~~~Li~~mL~~dP 301 (558)
..+.+..+...+|+++.+.+...... ..++.......... ........++.+.|||.+||++||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34566777888898887766443221 11111110000000 001123446789999999999999
Q ss_pred CCCCCHHHHhcCccccCcc
Q 008644 302 KDRPTAEEALADPYFKGLA 320 (558)
Q Consensus 302 ~~Rpta~elL~hp~f~~~~ 320 (558)
.+|||++|||+||||+...
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999999654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-46 Score=378.04 Aligned_cols=258 Identities=18% Similarity=0.242 Sum_probs=205.8
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREF 99 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H-pnIv~l~~i~~~~~~~~~ 99 (558)
++++|+|++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.|+| +|++.+++++.. .
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----G 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----T
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----C
Confidence 3679999999999999999999999999999999886432 22346789999999975 899999888743 3
Q ss_pred ccEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCC-----CCcEEEeecccc
Q 008644 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLA 173 (558)
Q Consensus 100 ~~~~lV~E~~~g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~-----~~~lKL~DFGla 173 (558)
...|+|||||+++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 4689999999999999997754 6999999999999999999999999999999999999975 578999999999
Q ss_pred eeccCCCCCc----ccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhhCC
Q 008644 174 RVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (558)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~~~lg~ 249 (558)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i--- 228 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH---
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH---
Confidence 8764332211 12345789999999999987 67999999999999999999999999876544332222111
Q ss_pred CCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 250 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 250 p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
...+ ...+.....+++++++.+|+..|+..+|++||+.+.+.+
T Consensus 229 ---------~~~~-----------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 229 ---------GEKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ---------HHHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------Hhcc-----------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0000 000111223567889999999999999999999877653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=378.34 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=200.0
Q ss_pred EEEEeEeeccCceEEEEEEECCCC---cEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg---~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~~~~~~~~~ 101 (558)
+.+.++||+|+||+||+|++..++ ..||||++++ ..+.....++.+|+++|++++||||+++++++.... ..
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cc
Confidence 345789999999999999987653 3699999974 235566788999999999999999999999885432 36
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEeecccceeccCC
Q 008644 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (558)
Q Consensus 102 ~~lV~E~~~-g~L~~~i~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~DFGla~~~~~~ 179 (558)
+++|||||+ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999998 58888887544 5788899999999999999999999999999999999999999999999999875433
Q ss_pred CCC-cccccccccCccccCccccccccCCCCCcchhhhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhhCCCCHHHHHH
Q 008644 180 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIAR 257 (558)
Q Consensus 180 ~~~-~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~il~eLltG~~pF~~~~~~-~~~~~i~~~lg~p~~~~i~~ 257 (558)
... ........||..|+|||++.+ ..++.++|||||||++|||++|..||...... +....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 222 222345679999999999876 67999999999999999999988777543321 1111111
Q ss_pred hhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 008644 258 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 313 (558)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~h 313 (558)
..... ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 249 --------------~g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 --------------QGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11111 1224678899999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=378.91 Aligned_cols=274 Identities=23% Similarity=0.255 Sum_probs=195.3
Q ss_pred CCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHH--HHHHHHHhcCCCCccccceeecCCCcCC
Q 008644 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL--REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (558)
Q Consensus 21 ~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~--~Ei~iL~~l~HpnIv~l~~i~~~~~~~~ 98 (558)
++.+|.+.+.||+|+||.||+|++ +|+.||||+++.. ...... +|+..+..++||||+++++++.... ..
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~ 72 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 72 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Cc
Confidence 357899999999999999999975 6899999998642 233334 4555556789999999999987543 23
Q ss_pred CccEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEeCCCCcEEEee
Q 008644 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICD 169 (558)
Q Consensus 99 ~~~~~lV~E~~~-g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs--------~gIiHrDIKP~NILl~~~~~lKL~D 169 (558)
...+|+|||||. |+|..++++. .++++.+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 346899999998 6999999875 69999999999999999999996 5999999999999999999999999
Q ss_pred cccceeccCCCCCc-ccccccccCccccCccccccccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 008644 170 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (558)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~----~y~~~~DIWSlG~il~eLltG~~pF~~~~~~~~~~~i~ 244 (558)
||+++......... ......+||+.|+|||++.+... .++.++|||||||+||||+||..||......... ...
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYD 230 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhh
Confidence 99998765433221 12345789999999999865311 2567899999999999999999887543211100 000
Q ss_pred HhhCCCCHHHHHHhhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 008644 245 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 312 (558)
Q Consensus 245 ~~lg~p~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~mL~~dP~~Rpta~elL~ 312 (558)
.....+..+.+. ..+..-......+...........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~--------~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 231 LVPSDPSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSCSSCCHHHHH--------HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHH--------HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 001111111111 111100001111111111122345889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=4.2e-25 Score=207.99 Aligned_cols=171 Identities=17% Similarity=0.125 Sum_probs=120.9
Q ss_pred EEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCC----------------hhHHHHHHHHHHHHHhcCCCCccccc
Q 008644 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 88 (558)
Q Consensus 25 Y~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~----------------~~~~~~i~~Ei~iL~~l~HpnIv~l~ 88 (558)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ......+.+|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 6899999987521100 01123456789999999999998877
Q ss_pred eeecCCCcCCCccEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEeCCCCcEEEe
Q 008644 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (558)
Q Consensus 89 ~i~~~~~~~~~~~~~lV~E~~~g~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIiHrDIKP~NILl~~~~~lKL~ 168 (558)
+.. ..+++|||+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++++ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 653 13799999997322 125666778899999999999999999999999999999965 58999
Q ss_pred ecccceeccCCCCCcccccccccCccccCccccccccCCCCCcchhhhHHHH
Q 008644 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (558)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~y~~~~DIWSlG~i 220 (558)
|||+|.......... .+...+. .-.+.+. ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f~---r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYFS---RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHHH---HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHHc---CCCCCcccHHHHHHH
Confidence 999997643221100 0000000 0001111 367889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=1.8e-06 Score=82.29 Aligned_cols=138 Identities=12% Similarity=0.109 Sum_probs=86.1
Q ss_pred cEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~-HpnIv~l~~i~~~~~~~~~~~~ 102 (558)
.|++++..+-++.+.||++ ...+..++||+...... .....+.+|..+|+.|. +--+.+++.... ..+..
T Consensus 15 ~~~~~~~~~G~s~~~v~rv--~~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~~ 85 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKL--VGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS 85 (263)
T ss_dssp TSEEEECSCCCSSSEEEEE--ECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred ceEEEEcCCCCCCCcEEEE--EeCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCce
Confidence 5677776655666789988 35677888998763221 12335678999988775 322344444432 22467
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 008644 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA------------------------------------ 145 (558)
Q Consensus 103 ~lV~E~~~g-~L~~~i~~~~~l~e~~~~~i~~QIl~aL~yLHs~------------------------------------ 145 (558)
|+||++++| .+....... .....++.++...|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999987 554332111 11122333344444444421
Q ss_pred -----------------------CceecCCCCCcEEeCCCCcEEEeeccccee
Q 008644 146 -----------------------NVFHRDLKPKNILANADCKLKICDFGLARV 175 (558)
Q Consensus 146 -----------------------gIiHrDIKP~NILl~~~~~lKL~DFGla~~ 175 (558)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 279999999999999876677999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=6.6e-05 Score=76.15 Aligned_cols=82 Identities=20% Similarity=0.169 Sum_probs=47.5
Q ss_pred CCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCC---ccC--ChhHHHHHHHHHHHHHhcC-C-CC-ccccceeecC
Q 008644 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFE--HVSDATRILREIKLLRLLR-H-PD-IVEIKHILLP 93 (558)
Q Consensus 22 ~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~---~~~--~~~~~~~i~~Ei~iL~~l~-H-pn-Iv~l~~i~~~ 93 (558)
....+ .+.||.|....||++.+..+++.|+||.-.. ... ......+..+|...|+.+. + |. +.+++...
T Consensus 26 ~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-- 102 (392)
T d2pula1 26 KSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-- 102 (392)
T ss_dssp --CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--
T ss_pred CCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--
Confidence 33444 4568999999999998888888999997431 111 1123445677998888763 2 22 33343322
Q ss_pred CCcCCCccEEEEEecCcc
Q 008644 94 PSRREFKDIYVVFELMES 111 (558)
Q Consensus 94 ~~~~~~~~~~lV~E~~~g 111 (558)
. ...++|||++++
T Consensus 103 ~-----~~~~lvmE~L~~ 115 (392)
T d2pula1 103 T-----EMAVTVMEDLSH 115 (392)
T ss_dssp T-----TTTEEEECCCTT
T ss_pred C-----CCCEEEEeccCC
Confidence 1 134789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.56 E-value=9e-05 Score=69.63 Aligned_cols=71 Identities=8% Similarity=0.005 Sum_probs=44.9
Q ss_pred EeeccCc-eEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEEE
Q 008644 30 VIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVVF 106 (558)
Q Consensus 30 ~IG~G~~-G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~Hpn--Iv~l~~i~~~~~~~~~~~~~lV~ 106 (558)
.+..|.. +.||++.. ..+..+++|..... ....+.+|..+|+.|.... +.+++.+... .+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 4455554 57898853 45667888876432 2234677888888775433 3445554422 23579999
Q ss_pred ecCcc
Q 008644 107 ELMES 111 (558)
Q Consensus 107 E~~~g 111 (558)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0013 Score=64.40 Aligned_cols=74 Identities=14% Similarity=0.079 Sum_probs=44.1
Q ss_pred cCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCccccceeecC--CCcCCCccEEEEEecCcc
Q 008644 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP--PSRREFKDIYVVFELMES 111 (558)
Q Consensus 34 G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv~l~~i~~~--~~~~~~~~~~lV~E~~~g 111 (558)
+.--.||++.. .+|..|++|+.+. .......+..|+.+|..|...+|.-..-+... .........+.++++++|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp---~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRP---ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECT---TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCC---CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44568999954 5688899998752 22345668889999988864333211111111 111223457888998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.00097 Score=64.65 Aligned_cols=61 Identities=16% Similarity=0.179 Sum_probs=38.1
Q ss_pred ccccccCCCCcEEEEeEeeccCceEEEEEEECCCCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCC
Q 008644 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81 (558)
Q Consensus 14 ~~~~~~~~~~rY~i~~~IG~G~~G~Vy~a~d~~tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~H 81 (558)
.++..|+.+. ..-.+.|..|---+.|++... +..+++|++... .....+..|+.+|..|..
T Consensus 10 ~~l~~Y~lg~-~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~----~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 10 NFLTQYDVGS-LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp HHHTTBCCCC-EEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCC-ceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC----CCHHHHHHHHHHHHhhhh
Confidence 3567788864 555667888888889998643 346999987532 233455667888877753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.41 E-value=0.0045 Score=62.02 Aligned_cols=74 Identities=15% Similarity=0.160 Sum_probs=48.5
Q ss_pred cEEEEeEeeccCceEEEEEEECC-------CCcEEEEEEeCCccCChhHHHHHHHHHHHHHhcCCCCcc-ccceeecCCC
Q 008644 24 RYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPS 95 (558)
Q Consensus 24 rY~i~~~IG~G~~G~Vy~a~d~~-------tg~~vAiK~i~~~~~~~~~~~~i~~Ei~iL~~l~HpnIv-~l~~i~~~~~ 95 (558)
..+| +.|+-|-.-.+|++.... ..+.|++++.... .......+|..+++.+.--++. ++++++- .
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~ 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C
Confidence 4554 578878899999997653 3456788776421 2233456899999888644443 5666551 1
Q ss_pred cCCCccEEEEEecCcc
Q 008644 96 RREFKDIYVVFELMES 111 (558)
Q Consensus 96 ~~~~~~~~lV~E~~~g 111 (558)
.+|+||++|
T Consensus 117 -------g~I~efi~g 125 (395)
T d1nw1a_ 117 -------GRLEEYIPS 125 (395)
T ss_dssp -------EEEECCCCE
T ss_pred -------ceEEEEecc
Confidence 578899885
|